1 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00643 |
7.87724737558726e-05 |
|
2 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00644 |
7.87724737558726e-05 |
|
3 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRKCH |
0.000100490113655427 |
|
4 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HIF1A |
0.00010994888436 |
|
5 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNAPC1 |
0.000115756753601981 |
|
6 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SYT16 |
0.000115756753601981 |
|
7 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NOVA1 |
0.000496252774663031 |
|
8 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WDR89 |
0.000915559873100658 |
|
9 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U3|ENSG00000200693.1 |
0.000915559873100658 |
|
10 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SGPP1 |
0.000915559873100658 |
|
11 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPP2R5E |
0.000940045866814621 |
|
12 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL540P |
0.000940045866814621 |
|
13 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCARNA20|ENSG00000252800.1 |
0.000940045866814621 |
|
14 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCNH5 |
0.00097097056231632 |
|
15 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RHOJ |
0.00097097056231632 |
|
16 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SYNE2 |
0.00097652965301509 |
|
17 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPHB5 |
0.00100282460758572 |
|
18 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ESR2 |
0.00110933111410105 |
|
19 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR548H1 |
0.00119086164132676 |
|
20 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4307 |
0.00126227405187673 |
|
21 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NDRG2 |
0.00130283375409868 |
|
22 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
METTL17 |
0.00147681834362656 |
|
23 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC39A2 |
0.00147681834362656 |
|
24 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPTB |
0.00161511421674676 |
|
25 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00645 |
0.00162089012412858 |
|
26 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STXBP6 |
0.00166346516618576 |
|
27 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CHURC1 |
0.00180035242942311 |
|
28 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPX2 |
0.00181703462629457 |
|
29 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAB15 |
0.00181703462629457 |
|
30 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FNTB |
0.00190045655995785 |
|
31 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAX |
0.00190045655995785 |
|
32 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4706 |
0.00190045655995785 |
|
33 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U3|ENSG00000253014.1 |
0.00214266693414833 |
|
34 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BNIP3P1 |
0.00217692313462081 |
|
35 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COCH |
0.00250403223244211 |
|
36 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FUT8 |
0.00264528069017678 |
|
37 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR625 |
0.00264528069017678 |
|
38 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FOXG1 |
0.00265905765523544 |
|
39 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MTHFD1 |
0.00268225135416167 |
|
40 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZBTB25 |
0.00268225135416167 |
|
41 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AKAP5 |
0.00268225135416167 |
|
42 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZBTB1 |
0.00268225135416167 |
|
43 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HSPA2 |
0.00268225135416167 |
|
44 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPP1R36 |
0.00268225135416167 |
|
45 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLEKHG3 |
0.00268225135416167 |
|
46 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
G2E3 |
0.00271777381332039 |
|
47 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCFD1 |
0.00271777381332039 |
|
48 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STRN3 |
0.00271777381332039 |
|
49 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C14orf23 |
0.00274999329042636 |
|
50 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF491 |
0.00288151856568541 |
|
51 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF439 |
0.00288151856568541 |
|
52 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF440 |
0.00288151856568541 |
|
53 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP307 |
0.0029887239983154 |
|
54 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
APBB1IP |
0.00301526899785409 |
|
55 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LDLR |
0.00324586212595823 |
|
56 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPC24 |
0.00324586212595823 |
|
57 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KANK2 |
0.00324586212595823 |
|
58 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DOCK6 |
0.00324586212595823 |
|
59 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL298P |
0.00324586212595823 |
|
60 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C19orf80 |
0.00324586212595823 |
|
61 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DKFZP761J1410 |
0.00346592841294968 |
|
62 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EPOR |
0.00346592841294968 |
|
63 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SWSAP1 |
0.00346592841294968 |
|
64 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RGL3 |
0.00346592841294968 |
|
65 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR624 |
0.00393582022282546 |
|
66 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AP4S1 |
0.00393582022282546 |
|
67 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HECTD1 |
0.00393582022282546 |
|
68 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HEATR5A |
0.00393582022282546 |
|
69 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DTD2 |
0.00393582022282546 |
|
70 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPR33 |
0.00393582022282546 |
|
71 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NUBPL |
0.00393582022282546 |
|
72 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GAD2 |
0.00402120118786964 |
|
73 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SIX6 |
0.00402315816585197 |
|
74 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SIX1 |
0.00402315816585197 |
|
75 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC38A6 |
0.00405243408811418 |
|
76 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD112|ENSG00000252380.1 |
0.00405243408811418 |
|
77 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM30B |
0.00405243408811418 |
|
78 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPM1A |
0.00408776188220128 |
|
79 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SIX4 |
0.00408776188220128 |
|
80 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MNAT1 |
0.00408776188220128 |
|
81 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRMT5 |
0.00408776188220128 |
|
82 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP48 |
0.00412175641663937 |
|
83 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SYPL2 |
0.0041490825178524 |
|
84 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM71D |
0.00420522547284519 |
|
85 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ELAVL3 |
0.00476481083979963 |
|
86 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF653 |
0.00476481083979963 |
|
87 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ECSIT |
0.00476481083979963 |
|
88 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL833P |
0.00476481083979963 |
|
89 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC159 |
0.0047750411004176 |
|
90 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM205 |
0.0047750411004176 |
|
91 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PSRC1 |
0.00491898679026859 |
|
92 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MYBPHL |
0.00491898679026859 |
|
93 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SORT1 |
0.00491898679026859 |
|
94 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PSMA5 |
0.00491898679026859 |
|
95 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF844 |
0.00492560913223117 |
|
96 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00264 |
0.00498165711143683 |
|
97 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRRC9 |
0.00499621071250023 |
|
98 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00238 |
0.00503247718749422 |
|
99 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCNXL4 |
0.00505633255665139 |
|
100 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DHRS7 |
0.00505633255665139 |
|
101 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4708 |
0.0050681098841282 |
|
102 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CHRM3 |
0.00508850589454746 |
|
103 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TSPAN16 |
0.00513104088618177 |
|
104 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAB3D |
0.00513104088618177 |
|
105 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C14orf105 |
0.00534968497503252 |
|
106 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF69 |
0.00535397042018249 |
|
107 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF700 |
0.00535397042018249 |
|
108 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF763 |
0.00535397042018249 |
|
109 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP464 |
0.00535397042018249 |
|
110 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF433 |
0.00535397042018249 |
|
111 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP465 |
0.00535397042018249 |
|
112 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF878 |
0.00535397042018249 |
|
113 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP466 |
0.00535397042018249 |
|
114 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PARD3 |
0.00548299803446128 |
|
115 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAPK10 |
0.0056073744657904 |
|
116 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4452 |
0.0056073744657904 |
|
117 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PTPN13 |
0.0056073744657904 |
|
118 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GTF2I |
0.00593788571715903 |
|
119 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STAG3L2 |
0.00593788571715903 |
|
120 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GTF2IRD2 |
0.00593788571715903 |
|
121 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NCF1 |
0.00593788571715903 |
|
122 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GATSL1 |
0.00601992458184419 |
|
123 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WBSCR16 |
0.00601992458184419 |
|
124 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GTF2IRD2B |
0.00601992458184419 |
|
125 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GATSL2 |
0.00602162374369963 |
|
126 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STAG3L1 |
0.00602162374369963 |
|
127 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRIM73 |
0.00602162374369963 |
|
128 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NSUN5P1 |
0.00602162374369963 |
|
129 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BANK1 |
0.00605038470440389 |
|
130 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AGPAT9 |
0.00613090564434204 |
|
131 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR575 |
0.00630565981092768 |
|
132 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM150C |
0.00631152943197277 |
|
133 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00575 |
0.00631152943197277 |
|
134 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ALOX12B |
0.00631443859809233 |
|
135 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4314 |
0.00631443859809233 |
|
136 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ALOXE3 |
0.00631443859809233 |
|
137 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HES7 |
0.00631443859809233 |
|
138 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RFC2 |
0.00645945117855262 |
|
139 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CNN1 |
0.00651003419896323 |
|
140 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ELOF1 |
0.00651003419896323 |
|
141 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF627 |
0.00651003419896323 |
|
142 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACP5 |
0.00651003419896323 |
|
143 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF833P |
0.00651003419896323 |
|
144 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NID1 |
0.0066004422519651 |
|
145 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPR137B |
0.0066004422519651 |
|
146 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ERO1LB |
0.0066004422519651 |
|
147 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000252638.1 |
0.0066004422519651 |
|
148 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EDARADD |
0.0066004422519651 |
|
149 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LGALS8 |
0.0066004422519651 |
|
150 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HEATR1 |
0.0066004422519651 |
|
151 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLAC8 |
0.00663448689897594 |
|
152 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COQ2 |
0.00663448689897594 |
|
153 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HPSE |
0.00663448689897594 |
|
154 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP285 |
0.00670680465858153 |
|
155 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AMY1A |
0.00670680465858153 |
|
156 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AMY1B |
0.00670680465858153 |
|
157 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AMY1C |
0.00670680465858153 |
|
158 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AMY2A |
0.00670680465858153 |
|
159 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AMY2B |
0.00670680465858153 |
|
160 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNPC3 |
0.00670680465858153 |
|
161 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF563 |
0.00674010651630541 |
|
162 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LAT2 |
0.0067660202764821 |
|
163 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC151 |
0.00677826604238962 |
|
164 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRKCSH |
0.00677826604238962 |
|
165 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238349.1 |
0.00677826604238962 |
|
166 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL669P |
0.00677826604238962 |
|
167 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CEP128 |
0.00704215324028756 |
|
168 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GJD4 |
0.00704390942035427 |
|
169 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FZD8 |
0.00704390942035427 |
|
170 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4683 |
0.00704390942035427 |
|
171 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4428 |
0.0070762023885822 |
|
172 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA25|ENSG00000252290.1 |
0.0070762023885822 |
|
173 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MPP5 |
0.00712405835226804 |
|
174 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C14orf39 |
0.00730689955890174 |
|
175 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF442 |
0.0073201859648564 |
|
176 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF443 |
0.0073201859648564 |
|
177 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF799 |
0.0073201859648564 |
|
178 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF709 |
0.0073201859648564 |
|
179 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF564 |
0.0073201859648564 |
|
180 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PNMA2 |
0.00739841550980358 |
|
181 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DPYSL2 |
0.00739841550980358 |
|
182 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADRA1A |
0.00739841550980358 |
|
183 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARMC4P1 |
0.00743249987049699 |
|
184 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PTCHD3 |
0.00743249987049699 |
|
185 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAB18 |
0.00743249987049699 |
|
186 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MKX |
0.00743249987049699 |
|
187 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARMC4 |
0.00743249987049699 |
|
188 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP132 |
0.00743249987049699 |
|
189 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C17orf51 |
0.00746383581265753 |
|
190 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM27L |
0.00746383581265753 |
|
191 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MTND1P15 |
0.00746383581265753 |
|
192 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MTRNR2L1 |
0.00746383581265753 |
|
193 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UBBP4 |
0.00746383581265753 |
|
194 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TSHR |
0.0075612567979676 |
|
195 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OTX2 |
0.00758641641529989 |
|
196 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL461P |
0.00758641641529989 |
|
197 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EXOC5 |
0.00758641641529989 |
|
198 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AP5M1 |
0.00758641641529989 |
|
199 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NAA30 |
0.00758641641529989 |
|
200 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC35F4 |
0.00758641641529989 |
|
201 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP99 |
0.00758641641529989 |
|
202 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GNG4 |
0.00763030498968065 |
|
203 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAB8B |
0.00785446753143326 |
|
204 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
APH1B |
0.00785446753143326 |
|
205 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MTR |
0.00799567420198199 |
|
206 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MT1HL1 |
0.00799567420198199 |
|
207 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP195 |
0.00799567420198199 |
|
208 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00838 |
0.00834968106505607 |
|
209 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATXN7L2 |
0.00854991915954018 |
|
210 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CYB561D1 |
0.00854991915954018 |
|
211 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AMIGO1 |
0.00854991915954018 |
|
212 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZP4 |
0.00867129026373936 |
|
213 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MTRNR2L11 |
0.00867129026373936 |
|
214 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF625 |
0.00871275989914977 |
|
215 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM81A |
0.00901412877858021 |
|
216 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EPS15 |
0.00915406744738934 |
|
217 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANXA2 |
0.0093264535119586 |
|
218 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NARG2 |
0.0093264535119586 |
|
219 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FRG1B |
0.0093582247909294 |
|
220 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CTSG |
0.00936589520210496 |
|
221 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GZMH |
0.00936589520210496 |
|
222 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARHGAP12 |
0.00943855075551769 |
|
223 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA67|ENSG00000207027.1 |
0.00962918952969982 |
|
224 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DHTKD1 |
0.00975030222731066 |
|
225 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR548AK |
0.00975030222731066 |
|
226 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SEC61A2 |
0.00975030222731066 |
|
227 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U6|ENSG00000272507.1 |
0.00975030222731066 |
|
228 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRKD1 |
0.00976863560276187 |
|
229 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CUL2 |
0.00978718799028899 |
|
230 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3611 |
0.00978718799028899 |
|
231 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CREM |
0.00978718799028899 |
|
232 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCNY |
0.00978718799028899 |
|
233 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP28 |
0.00989755745486809 |
|
234 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FOXB1 |
0.00990132334382443 |
|
235 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DHRS7B |
0.0100828171652063 |
|
236 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM11 |
0.0100828171652063 |
|
237 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL426P |
0.0100828171652063 |
|
238 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C17orf103 |
0.0100828171652063 |
|
239 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAP2K3 |
0.0100828171652063 |
|
240 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCNJ12 |
0.0100828171652063 |
|
241 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF136 |
0.0101606941893773 |
|
242 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF44 |
0.0101606941893773 |
|
243 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACTN2 |
0.0106521513196717 |
|
244 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BAZ1B |
0.0107046425707047 |
|
245 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BCL7B |
0.0107046425707047 |
|
246 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TBL2 |
0.0107046425707047 |
|
247 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MLXIPL |
0.0107195487148882 |
|
248 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VPS37D |
0.0107195487148882 |
|
249 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PDSS1 |
0.010758892923788 |
|
250 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ABI1 |
0.010758892923788 |
|
251 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA57|ENSG00000223027.1 |
0.010758892923788 |
|
252 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238414.1 |
0.010758892923788 |
|
253 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00614 |
0.010758892923788 |
|
254 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANKRD26 |
0.010758892923788 |
|
255 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
YME1L1 |
0.010758892923788 |
|
256 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MASTL |
0.010758892923788 |
|
257 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACBD5 |
0.010758892923788 |
|
258 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRRC37A6P |
0.010758892923788 |
|
259 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP396 |
0.0108539416887322 |
|
260 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GCNT3 |
0.0108539416887322 |
|
261 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPTBN5 |
0.0108620898914983 |
|
262 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C1orf64 |
0.010908528257101 |
|
263 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HSPB7 |
0.010908528257101 |
|
264 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF788 |
0.0109312452197359 |
|
265 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF20 |
0.0109312452197359 |
|
266 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP467 |
0.0109312452197359 |
|
267 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VCAM1 |
0.0111007185963308 |
|
268 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VAV3 |
0.0112565349706532 |
|
269 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DIO2 |
0.0113357106521604 |
|
270 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SMOC1 |
0.0114988793640034 |
|
271 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238978.1 |
0.0116049694149859 |
|
272 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GTF2A2 |
0.0116657707975608 |
|
273 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BNIP2 |
0.0116657707975608 |
|
274 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SRSF5 |
0.0118620535776591 |
|
275 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC10A1 |
0.0118620535776591 |
|
276 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA11|ENSG00000221060.1 |
0.0118620535776591 |
|
277 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HELQ |
0.0119082395809867 |
|
278 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MRPS18C |
0.0119082395809867 |
|
279 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM175A |
0.0119082395809867 |
|
280 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF490 |
0.0119506474889599 |
|
281 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF791 |
0.0119506474889599 |
|
282 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL583P |
0.0119839383146985 |
|
283 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC25A24 |
0.0121186012224013 |
|
284 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NBPF4 |
0.0121186012224013 |
|
285 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC25A24P1 |
0.0121186012224013 |
|
286 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NBPF5P |
0.0121186012224013 |
|
287 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NBPF6 |
0.0121186012224013 |
|
288 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCNX |
0.0121442542709238 |
|
289 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACIN1 |
0.0121508573114582 |
|
290 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C14orf119 |
0.0121508573114582 |
|
291 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CEBPE |
0.0121508573114582 |
|
292 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC7A8 |
0.0121508573114582 |
|
293 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATP6V1D |
0.0122579745548064 |
|
294 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EIF2S1 |
0.0122579745548064 |
|
295 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLEK2 |
0.0122579745548064 |
|
296 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR5694 |
0.0122579745548064 |
|
297 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAB11FIP1 |
0.0124148109069793 |
|
298 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SIPA1L1 |
0.012427094158056 |
|
299 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL825P |
0.0124273170239197 |
|
300 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIF5B |
0.0124273170239197 |
|
301 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SELRC1 |
0.0126165195778141 |
|
302 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL62P |
0.0126165195778141 |
|
303 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZYG11B |
0.0126165195778141 |
|
304 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZYG11A |
0.0126165195778141 |
|
305 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ECHDC2 |
0.0126165195778141 |
|
306 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCP2 |
0.0126165195778141 |
|
307 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR1273F |
0.0126165195778141 |
|
308 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR5095 |
0.0126165195778141 |
|
309 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR1273G |
0.0126165195778141 |
|
310 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PODN |
0.0126165195778141 |
|
311 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADAM21P1 |
0.012665611358057 |
|
312 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COX16 |
0.012665611358057 |
|
313 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SYNJ2BP |
0.012665611358057 |
|
314 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADAM21 |
0.012665611358057 |
|
315 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADAM20P1 |
0.012665611358057 |
|
316 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADAM20 |
0.012665611358057 |
|
317 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MED6 |
0.012665611358057 |
|
318 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL77P |
0.012665611358057 |
|
319 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TTC9 |
0.012665611358057 |
|
320 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAP3K9 |
0.012665611358057 |
|
321 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARHGAP24 |
0.0126905557087024 |
|
322 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4451 |
0.0126905557087024 |
|
323 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP96 |
0.0126905557087024 |
|
324 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CPT2 |
0.0129319890319108 |
|
325 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C1orf123 |
0.0129319890319108 |
|
326 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAGOH |
0.0129319890319108 |
|
327 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRP8 |
0.0129319890319108 |
|
328 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZBTB17 |
0.0130978715498875 |
|
329 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AJUBA |
0.0132000476220174 |
|
330 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C14orf93 |
0.0132000476220174 |
|
331 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PSMB5 |
0.0132000476220174 |
|
332 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA73|ENSG00000252114.1 |
0.0132000476220174 |
|
333 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PSMB11 |
0.0132000476220174 |
|
334 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDH24 |
0.0132000476220174 |
|
335 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADM |
0.0134166970429715 |
|
336 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AMPD3 |
0.0134166970429715 |
|
337 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNU6ATAC33P |
0.0134166970429715 |
|
338 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MTRNR2L8 |
0.0134166970429715 |
|
339 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNF141 |
0.0134166970429715 |
|
340 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GZMB |
0.0134249161051734 |
|
341 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL706P |
0.0134763622280738 |
|
342 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL108P |
0.0134763622280738 |
|
343 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPHN |
0.0135130727538847 |
|
344 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAN2B1 |
0.0136056594489211 |
|
345 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WDR83OS |
0.0136056594489211 |
|
346 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WDR83 |
0.0136056594489211 |
|
347 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DHPS |
0.0136056594489211 |
|
348 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FBXW9 |
0.0136056594489211 |
|
349 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TNPO2 |
0.0136056594489211 |
|
350 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD41|ENSG00000209702.1 |
0.0136056594489211 |
|
351 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C19orf43 |
0.0136056594489211 |
|
352 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADAM5 |
0.0136188259114287 |
|
353 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADAM3A |
0.0136188259114287 |
|
354 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZFHX2 |
0.0137407481508182 |
|
355 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
THTPA |
0.0137407481508182 |
|
356 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AP1G2 |
0.0137407481508182 |
|
357 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
JPH4 |
0.0137407481508182 |
|
358 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DHRS2 |
0.0137407481508182 |
|
359 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4695 |
0.0140172692453002 |
|
360 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR1290 |
0.0140172692453002 |
|
361 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IFFO2 |
0.0140172692453002 |
|
362 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC39A9 |
0.0140799342080524 |
|
363 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLEKHD1 |
0.0140799342080524 |
|
364 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC177|ENSG00000255994.1 |
0.0140799342080524 |
|
365 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC177|ENSG00000267909.1 |
0.0140799342080524 |
|
366 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIAA0247 |
0.0140799342080524 |
|
367 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TNFRSF10C |
0.0141492656252686 |
|
368 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TNFRSF10D |
0.0141492656252686 |
|
369 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TNFRSF10A |
0.0141492656252686 |
|
370 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CHMP7 |
0.0141492656252686 |
|
371 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
R3HCC1 |
0.0141492656252686 |
|
372 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LOXL2 |
0.0141492656252686 |
|
373 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ENTPD4 |
0.0141492656252686 |
|
374 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC25A37 |
0.0141492656252686 |
|
375 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FP15737 |
0.0141492656252686 |
|
376 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF823 |
0.0142435148086305 |
|
377 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF441 |
0.0142435148086305 |
|
378 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C1orf185 |
0.0142756456586519 |
|
379 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238618.1 |
0.0142756456586519 |
|
380 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNF11 |
0.0142756456586519 |
|
381 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TTC39A |
0.0142756456586519 |
|
382 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
POM121C |
0.0143298818206216 |
|
383 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PMS2P3 |
0.0143298818206216 |
|
384 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HIP1 |
0.0143298818206216 |
|
385 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA79|ENSG00000221303.1 |
0.014402649387266 |
|
386 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CA12 |
0.0144604932516951 |
|
387 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WHSC1L1 |
0.0144835548481387 |
|
388 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LETM2 |
0.0144835548481387 |
|
389 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FGFR1 |
0.0144835548481387 |
|
390 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPS20P22 |
0.0144835548481387 |
|
391 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C8orf86 |
0.0144835548481387 |
|
392 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PER1 |
0.0145704186294794 |
|
393 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VAMP2 |
0.0145704186294794 |
|
394 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GALNT16 |
0.0148554234077646 |
|
395 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ERH |
0.0148554234077646 |
|
396 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAD51B |
0.0150111157885394 |
|
397 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EXTL2 |
0.0150756668320859 |
|
398 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC30A7 |
0.0150756668320859 |
|
399 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DPH5 |
0.0150756668320859 |
|
400 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCARNA16|ENSG00000252765.1 |
0.0150756668320859 |
|
401 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238296.1 |
0.0150756668320859 |
|
402 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
S1PR1 |
0.0150756668320859 |
|
403 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIAA1324 |
0.0152632618288714 |
|
404 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SARS |
0.0152632618288714 |
|
405 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CELSR2 |
0.0152632618288714 |
|
406 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD37|ENSG00000212270.1 |
0.0153091824890478 |
|
407 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZFP36L1 |
0.0154567384770038 |
|
408 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL224P |
0.0154567384770038 |
|
409 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACTN1 |
0.0154567384770038 |
|
410 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DCAF5 |
0.0154567384770038 |
|
411 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EXD2 |
0.0154567384770038 |
|
412 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SSBP3 |
0.0154670299941377 |
|
413 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C1orf191 |
0.0154670299941377 |
|
414 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD112|ENSG00000252646.1 |
0.0154670299941377 |
|
415 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACOT11 |
0.0154670299941377 |
|
416 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM151A |
0.0154670299941377 |
|
417 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ASNA1 |
0.015483552209797 |
|
418 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BEST2 |
0.015483552209797 |
|
419 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HOOK2 |
0.015483552209797 |
|
420 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR5684 |
0.015483552209797 |
|
421 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
JUNB |
0.015483552209797 |
|
422 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRDX2 |
0.015483552209797 |
|
423 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNASEH2A |
0.015483552209797 |
|
424 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RTBDN |
0.015483552209797 |
|
425 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAST1 |
0.015483552209797 |
|
426 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DNASE2 |
0.015483552209797 |
|
427 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RDH12 |
0.0156011276267307 |
|
428 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U3|ENSG00000252792.1 |
0.0156011276267307 |
|
429 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL213P |
0.0156011276267307 |
|
430 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OSBPL9 |
0.0156347833293538 |
|
431 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA26|ENSG00000212624.1 |
0.0156347833293538 |
|
432 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HTRA4 |
0.015727630796513 |
|
433 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TM2D2 |
0.015727630796513 |
|
434 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADAM9 |
0.015727630796513 |
|
435 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD38|ENSG00000207199.1 |
0.015727630796513 |
|
436 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GLIS1 |
0.0157491718238565 |
|
437 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NDC1 |
0.0157491718238565 |
|
438 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA58|ENSG00000201003.1 |
0.0157491718238565 |
|
439 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
YIPF1 |
0.0157491718238565 |
|
440 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DIO1 |
0.0157491718238565 |
|
441 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HSPB11 |
0.0157491718238565 |
|
442 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRRC42 |
0.0157491718238565 |
|
443 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LDLRAD1 |
0.0157491718238565 |
|
444 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM59 |
0.0157491718238565 |
|
445 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4781 |
0.0157491718238565 |
|
446 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TCEANC2 |
0.0157491718238565 |
|
447 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDCP2 |
0.0157491718238565 |
|
448 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CYB5RL |
0.0157491718238565 |
|
449 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MRPL37 |
0.0157491718238565 |
|
450 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SEMG2 |
0.0157551658829586 |
|
451 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLCNKA |
0.0157630437371417 |
|
452 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLCNKB |
0.0157630437371417 |
|
453 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM131C |
0.0157630437371417 |
|
454 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EPHA2 |
0.0157630437371417 |
|
455 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARHGEF19 |
0.0157630437371417 |
|
456 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANO7P1 |
0.0157630437371417 |
|
457 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C1orf134 |
0.0157630437371417 |
|
458 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RSG1 |
0.0157630437371417 |
|
459 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FBXO42 |
0.0157630437371417 |
|
460 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SZRD1 |
0.0157630437371417 |
|
461 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPATA21 |
0.0157630437371417 |
|
462 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NECAP2 |
0.0157630437371417 |
|
463 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CROCCP3 |
0.0157630437371417 |
|
464 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATP13A2 |
0.0157630437371417 |
|
465 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CROCCP2 |
0.0157630437371417 |
|
466 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CROCC |
0.0157630437371417 |
|
467 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ESPNP |
0.0157630437371417 |
|
468 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MFAP2 |
0.0157630437371417 |
|
469 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3675 |
0.0157630437371417 |
|
470 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MST1L |
0.0157630437371417 |
|
471 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NBPF1 |
0.0157630437371417 |
|
472 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U1|ENSG00000228549.2 |
0.0157630437371417 |
|
473 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U1|ENSG00000233421.3 |
0.0157630437371417 |
|
474 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RYR2 |
0.0158421475273514 |
|
475 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLIP2 |
0.0159667699952784 |
|
476 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STC1 |
0.0159723317035674 |
|
477 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FRRS1 |
0.015977087426619 |
|
478 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AGL |
0.015977087426619 |
|
479 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HIAT1 |
0.015977087426619 |
|
480 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SASS6 |
0.015977087426619 |
|
481 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRMT13 |
0.015977087426619 |
|
482 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRRC39 |
0.015977087426619 |
|
483 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDC14A |
0.015977087426619 |
|
484 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPR88 |
0.015977087426619 |
|
485 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARHGAP21 |
0.0159932242804522 |
|
486 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP305 |
0.0159932242804522 |
|
487 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C14orf164 |
0.016110194686909 |
|
488 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL847P |
0.0161326966167785 |
|
489 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ASAH1 |
0.0162531622406996 |
|
490 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNF111 |
0.0163710444883175 |
|
491 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCNB2 |
0.0163710444883175 |
|
492 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MYO1E |
0.0163710444883175 |
|
493 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C15ORF31 |
0.0163710444883175 |
|
494 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR2116 |
0.0163710444883175 |
|
495 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LDHAL6B |
0.0163710444883175 |
|
496 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238767.1 |
0.0163710444883175 |
|
497 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CYTIP |
0.0164076910107719 |
|
498 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC35A3 |
0.0164340629849229 |
|
499 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ELN |
0.0165319970479529 |
|
500 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LIMK1 |
0.0165319970479529 |
|
501 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EIF4H |
0.0165319970479529 |
|
502 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR590 |
0.0165319970479529 |
|
503 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM159A |
0.0165775194728235 |
|
504 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GTF2IRD1 |
0.0166115002149202 |
|
505 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLDN4 |
0.0166439447415986 |
|
506 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WBSCR27 |
0.0166439447415986 |
|
507 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WBSCR28 |
0.0166439447415986 |
|
508 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4421 |
0.0166879838836814 |
|
509 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NRP1 |
0.0167015680218746 |
|
510 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FZD9 |
0.0168368612006192 |
|
511 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNU6ATAC28P |
0.0168395702714849 |
|
512 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DNAJC30 |
0.016850209946095 |
|
513 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WBSCR22 |
0.016850209946095 |
|
514 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STX1A |
0.016850209946095 |
|
515 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4284 |
0.016850209946095 |
|
516 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ABHD11 |
0.016850209946095 |
|
517 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00035 |
0.016850209946095 |
|
518 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL265P |
0.016850209946095 |
|
519 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLDN3 |
0.016850209946095 |
|
520 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP205 |
0.0168841315165736 |
|
521 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00596 |
0.0168841315165736 |
|
522 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLCA4 |
0.0169443186667871 |
|
523 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLCA3P |
0.0169443186667871 |
|
524 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZBTB16 |
0.0169516497513043 |
|
525 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NNMT |
0.0169516497513043 |
|
526 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RORA |
0.0169813651831949 |
|
527 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP397 |
0.0169813651831949 |
|
528 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLA2G4B |
0.0170035163737916 |
|
529 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP393 |
0.0170035163737916 |
|
530 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238900.1 |
0.0171240104433892 |
|
531 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NUDT5 |
0.0171240104433892 |
|
532 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HOMEZ |
0.0175088496903438 |
|
533 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPP1R3E |
0.0175088496903438 |
|
534 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BCL2L2 |
0.0175088496903438 |
|
535 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PABPN1 |
0.0175088496903438 |
|
536 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC22A17 |
0.0175088496903438 |
|
537 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EFS |
0.0175088496903438 |
|
538 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IL25 |
0.0175088496903438 |
|
539 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CMTM5 |
0.0175088496903438 |
|
540 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MYH6 |
0.0175088496903438 |
|
541 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR208A |
0.0175088496903438 |
|
542 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MYH7 |
0.0175088496903438 |
|
543 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR208B |
0.0175088496903438 |
|
544 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NGDN |
0.0175088496903438 |
|
545 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RBM23 |
0.0176684276192532 |
|
546 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRMT5 |
0.0176684276192532 |
|
547 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HAUS4 |
0.0176684276192532 |
|
548 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4707 |
0.0176684276192532 |
|
549 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OTUD1 |
0.0177110234215594 |
|
550 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LACTB |
0.0177137341872405 |
|
551 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPS27L |
0.0177137341872405 |
|
552 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ITGB1 |
0.0177668229102053 |
|
553 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TAS1R2 |
0.0178565287160114 |
|
554 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ALDH4A1 |
0.0178565287160114 |
|
555 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STON2 |
0.0179155180742573 |
|
556 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ASH2L |
0.017939693208623 |
|
557 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STAR |
0.017939693208623 |
|
558 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LSM1 |
0.017939693208623 |
|
559 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BAG4 |
0.017939693208623 |
|
560 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPAPDC1B |
0.017939693208623 |
|
561 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZFYVE26 |
0.0180053014930313 |
|
562 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACVR1C |
0.0181145758619112 |
|
563 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BRF2 |
0.0181838600561 |
|
564 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WFDC10A |
0.0182681369438192 |
|
565 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COL24A1 |
0.0184524781913892 |
|
566 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NRD1 |
0.0186506219552961 |
|
567 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR761 |
0.0186506219552961 |
|
568 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAB3B |
0.0186506219552961 |
|
569 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP48 |
0.0186506219552961 |
|
570 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL290P |
0.0186506219552961 |
|
571 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TXNDC12 |
0.0186506219552961 |
|
572 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KTI12 |
0.0186506219552961 |
|
573 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BTF3L4 |
0.0186506219552961 |
|
574 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZFYVE9 |
0.0186506219552961 |
|
575 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL788P |
0.0186506219552961 |
|
576 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CC2D1B |
0.0186506219552961 |
|
577 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ORC1 |
0.0186506219552961 |
|
578 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRPF38A |
0.0186506219552961 |
|
579 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZCCHC11 |
0.0186506219552961 |
|
580 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000239063.1 |
0.0186506219552961 |
|
581 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPX7 |
0.0186506219552961 |
|
582 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIAA1217 |
0.018730343252178 |
|
583 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SEL1L |
0.0187943032799398 |
|
584 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRMT6 |
0.0187993168754733 |
|
585 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NTNG1 |
0.0187993168754733 |
|
586 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADAM18 |
0.0188948336865158 |
|
587 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD56B |
0.0189993031607266 |
|
588 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNU4ATAC6P |
0.0191224436314198 |
|
589 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BAMBI |
0.0191224436314198 |
|
590 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00837 |
0.0191224436314198 |
|
591 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C10orf126 |
0.0191224436314198 |
|
592 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP308 |
0.0191224436314198 |
|
593 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GTF2A1 |
0.0191238536659477 |
|
594 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL398P |
0.0193619308954165 |
|
595 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AKNAD1 |
0.0193996271913703 |
|
596 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPSM2 |
0.0193996271913703 |
|
597 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLCC1 |
0.0193996271913703 |
|
598 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MEA1 |
0.0194280650062546 |
|
599 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KLHDC3 |
0.0194280650062546 |
|
600 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPR124 |
0.0195551464902071 |
|
601 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DDHD2 |
0.0195865851712068 |
|
602 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DNTTIP1 |
0.019825226518393 |
|
603 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UBE2C |
0.019825226518393 |
|
604 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TNNC2 |
0.019825226518393 |
|
605 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNX21 |
0.019825226518393 |
|
606 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACOT8 |
0.019825226518393 |
|
607 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZSWIM3 |
0.019825226518393 |
|
608 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZSWIM1 |
0.019825226518393 |
|
609 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NEURL2 |
0.019825226518393 |
|
610 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPATA25 |
0.019825226518393 |
|
611 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CTSA |
0.019825226518393 |
|
612 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLTP |
0.019825226518393 |
|
613 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCIF1 |
0.019825226518393 |
|
614 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF335 |
0.019825226518393 |
|
615 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MMP9 |
0.019825226518393 |
|
616 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC12A5 |
0.019825226518393 |
|
617 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NCOA5 |
0.019825226518393 |
|
618 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CD40 |
0.019825226518393 |
|
619 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDH22 |
0.019825226518393 |
|
620 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC35C2 |
0.019825226518393 |
|
621 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ELMO2 |
0.019825226518393 |
|
622 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF334 |
0.019825226518393 |
|
623 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CSGALNACT1 |
0.0199255808817904 |
|
624 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC35F3 |
0.0199797992905576 |
|
625 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZBED5 |
0.0200888173797562 |
|
626 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL198P |
0.0201013884011215 |
|
627 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD45|ENSG00000252438.1 |
0.0201013884011215 |
|
628 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNU6ATAC39P |
0.0201013884011215 |
|
629 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ROR1 |
0.0203813331684956 |
|
630 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UBE2U |
0.0203813331684956 |
|
631 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CACHD1 |
0.0203813331684956 |
|
632 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4794 |
0.0203813331684956 |
|
633 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLPI |
0.0204220943836574 |
|
634 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MATN4 |
0.0204220943836574 |
|
635 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RBPJL |
0.0204220943836574 |
|
636 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SDC4 |
0.0204220943836574 |
|
637 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SYS1 |
0.0204220943836574 |
|
638 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TP53TG5 |
0.0204220943836574 |
|
639 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DBNDD2 |
0.0204220943836574 |
|
640 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PIGT |
0.0204220943836574 |
|
641 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WFDC2 |
0.0204220943836574 |
|
642 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPINT3 |
0.0204220943836574 |
|
643 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WFDC6 |
0.0204220943836574 |
|
644 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EPPIN |
0.0204220943836574 |
|
645 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WFDC8 |
0.0204220943836574 |
|
646 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP485 |
0.0204220943836574 |
|
647 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WFDC9 |
0.0204220943836574 |
|
648 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC7A7 |
0.0205738158736167 |
|
649 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MRPL52 |
0.0205738158736167 |
|
650 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MMP14 |
0.0205738158736167 |
|
651 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRP10 |
0.0205738158736167 |
|
652 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
REM2 |
0.0205738158736167 |
|
653 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OLFM3 |
0.0206948109777016 |
|
654 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR1538 |
0.0211034542429208 |
|
655 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NFAT5 |
0.0211034542429208 |
|
656 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NQO1 |
0.0211034542429208 |
|
657 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238683.1 |
0.0211034542429208 |
|
658 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NOB1 |
0.0211034542429208 |
|
659 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA62|ENSG00000252443.1 |
0.0211034542429208 |
|
660 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR140 |
0.0211034542429208 |
|
661 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ABHD4 |
0.0211069027754207 |
|
662 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DAD1 |
0.0211069027754207 |
|
663 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR4E2 |
0.0211069027754207 |
|
664 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR6J1 |
0.0211069027754207 |
|
665 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAC |
0.0211069027754207 |
|
666 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAJ10 |
0.0211069027754207 |
|
667 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAJ11 |
0.0211069027754207 |
|
668 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAJ12 |
0.0211069027754207 |
|
669 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAJ13 |
0.0211069027754207 |
|
670 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAJ14 |
0.0211069027754207 |
|
671 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAJ16 |
0.0211069027754207 |
|
672 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAJ17 |
0.0211069027754207 |
|
673 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAJ18 |
0.0211069027754207 |
|
674 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAJ19 |
0.0211069027754207 |
|
675 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAJ1 |
0.0211069027754207 |
|
676 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAJ20 |
0.0211069027754207 |
|
677 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAJ21 |
0.0211069027754207 |
|
678 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAJ22 |
0.0211069027754207 |
|
679 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAJ23 |
0.0211069027754207 |
|
680 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAJ24 |
0.0211069027754207 |
|
681 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAJ25 |
0.0211069027754207 |
|
682 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAJ26 |
0.0211069027754207 |
|
683 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAJ27 |
0.0211069027754207 |
|
684 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAJ28 |
0.0211069027754207 |
|
685 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAJ29 |
0.0211069027754207 |
|
686 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAJ2 |
0.0211069027754207 |
|
687 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAJ30 |
0.0211069027754207 |
|
688 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAJ31 |
0.0211069027754207 |
|
689 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAJ32 |
0.0211069027754207 |
|
690 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAJ33 |
0.0211069027754207 |
|
691 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAJ34 |
0.0211069027754207 |
|
692 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAJ35 |
0.0211069027754207 |
|
693 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAJ36 |
0.0211069027754207 |
|
694 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAJ37 |
0.0211069027754207 |
|
695 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAJ38 |
0.0211069027754207 |
|
696 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAJ39 |
0.0211069027754207 |
|
697 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAJ3 |
0.0211069027754207 |
|
698 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAJ40 |
0.0211069027754207 |
|
699 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAJ41 |
0.0211069027754207 |
|
700 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAJ42 |
0.0211069027754207 |
|
701 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAJ43 |
0.0211069027754207 |
|
702 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAJ44 |
0.0211069027754207 |
|
703 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAJ45 |
0.0211069027754207 |
|
704 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAJ46 |
0.0211069027754207 |
|
705 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAJ47 |
0.0211069027754207 |
|
706 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAJ48 |
0.0211069027754207 |
|
707 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAJ49 |
0.0211069027754207 |
|
708 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAJ4 |
0.0211069027754207 |
|
709 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAJ50 |
0.0211069027754207 |
|
710 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAJ52 |
0.0211069027754207 |
|
711 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAJ53 |
0.0211069027754207 |
|
712 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAJ54 |
0.0211069027754207 |
|
713 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAJ56 |
0.0211069027754207 |
|
714 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAJ57 |
0.0211069027754207 |
|
715 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAJ58 |
0.0211069027754207 |
|
716 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAJ59 |
0.0211069027754207 |
|
717 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAJ5 |
0.0211069027754207 |
|
718 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAJ61 |
0.0211069027754207 |
|
719 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAJ6 |
0.0211069027754207 |
|
720 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAJ7 |
0.0211069027754207 |
|
721 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAJ8 |
0.0211069027754207 |
|
722 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAJ9 |
0.0211069027754207 |
|
723 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAV10 |
0.0211069027754207 |
|
724 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAV14DV4 |
0.0211069027754207 |
|
725 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAV16 |
0.0211069027754207 |
|
726 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAV17 |
0.0211069027754207 |
|
727 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAV18 |
0.0211069027754207 |
|
728 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAV19 |
0.0211069027754207 |
|
729 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAV20 |
0.0211069027754207 |
|
730 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAV21 |
0.0211069027754207 |
|
731 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAV22 |
0.0211069027754207 |
|
732 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAV23DV6 |
0.0211069027754207 |
|
733 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAV24 |
0.0211069027754207 |
|
734 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAV25 |
0.0211069027754207 |
|
735 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAV27 |
0.0211069027754207 |
|
736 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAV29DV5 |
0.0211069027754207 |
|
737 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAV2 |
0.0211069027754207 |
|
738 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAV30 |
0.0211069027754207 |
|
739 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAV34 |
0.0211069027754207 |
|
740 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAV35 |
0.0211069027754207 |
|
741 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAV36DV7 |
0.0211069027754207 |
|
742 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAV39 |
0.0211069027754207 |
|
743 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAV3 |
0.0211069027754207 |
|
744 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAV40 |
0.0211069027754207 |
|
745 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAV41 |
0.0211069027754207 |
|
746 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAV4 |
0.0211069027754207 |
|
747 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAV5 |
0.0211069027754207 |
|
748 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAV6 |
0.0211069027754207 |
|
749 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAV7 |
0.0211069027754207 |
|
750 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRDC |
0.0211069027754207 |
|
751 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRDD1 |
0.0211069027754207 |
|
752 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRDD2 |
0.0211069027754207 |
|
753 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRDD3 |
0.0211069027754207 |
|
754 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRDJ1 |
0.0211069027754207 |
|
755 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRDJ2 |
0.0211069027754207 |
|
756 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRDJ3 |
0.0211069027754207 |
|
757 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRDJ4 |
0.0211069027754207 |
|
758 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRDV1 |
0.0211069027754207 |
|
759 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRDV2 |
0.0211069027754207 |
|
760 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRDV3 |
0.0211069027754207 |
|
761 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MROH7 |
0.0212123139835609 |
|
762 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TTC4 |
0.0212123139835609 |
|
763 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C1orf177 |
0.0212123139835609 |
|
764 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PARS2 |
0.0212123139835609 |
|
765 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TTC22 |
0.0212123139835609 |
|
766 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DHCR24 |
0.0212123139835609 |
|
767 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM61 |
0.0212123139835609 |
|
768 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BSND |
0.0212123139835609 |
|
769 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCSK9 |
0.0212123139835609 |
|
770 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PALMD |
0.0212756318484748 |
|
771 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACVR1 |
0.0213396982272099 |
|
772 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TOMM20 |
0.0213525244619091 |
|
773 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARID4B |
0.0213525244619091 |
|
774 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RBM34 |
0.0213525244619091 |
|
775 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA14B |
0.0213525244619091 |
|
776 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4753 |
0.0213525244619091 |
|
777 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GGPS1 |
0.0213525244619091 |
|
778 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TBCE |
0.0213525244619091 |
|
779 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
B3GALNT2 |
0.0213525244619091 |
|
780 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CAPZB |
0.0213594301966232 |
|
781 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DHRS1 |
0.0213744797770146 |
|
782 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NOP9 |
0.0213744797770146 |
|
783 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CIDEB |
0.0213744797770146 |
|
784 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LTB4R2 |
0.0213744797770146 |
|
785 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LTB4R |
0.0213744797770146 |
|
786 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADCY4 |
0.0213744797770146 |
|
787 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RIPK3 |
0.0213744797770146 |
|
788 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NFATC4 |
0.0213744797770146 |
|
789 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIAA0586 |
0.0213981720678582 |
|
790 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DACT1 |
0.0213981720678582 |
|
791 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DAAM1 |
0.0213981720678582 |
|
792 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDC5L |
0.0214419616656294 |
|
793 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4642 |
0.0214419616656294 |
|
794 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL709P |
0.0215653502574333 |
|
795 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADAM32 |
0.0218558868127904 |
|
796 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U3|ENSG00000251944.1 |
0.0219958174553572 |
|
797 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GFRA2 |
0.0219958174553572 |
|
798 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DOK2 |
0.0219958174553572 |
|
799 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
XPO7 |
0.0219958174553572 |
|
800 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NPM2 |
0.0219958174553572 |
|
801 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238466.1 |
0.0219958174553572 |
|
802 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FGF17 |
0.0219958174553572 |
|
803 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DMTN |
0.0219958174553572 |
|
804 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM160B2 |
0.0219958174553572 |
|
805 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NUDT18 |
0.0219958174553572 |
|
806 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HR |
0.0219958174553572 |
|
807 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
REEP4 |
0.0219958174553572 |
|
808 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LGI3 |
0.0219958174553572 |
|
809 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SFTPC |
0.0219958174553572 |
|
810 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BMP1 |
0.0219958174553572 |
|
811 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PHYHIP |
0.0219958174553572 |
|
812 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR320A |
0.0219958174553572 |
|
813 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
POLR3D |
0.0219958174553572 |
|
814 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EGR3 |
0.0219958174553572 |
|
815 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PEBP4 |
0.0219958174553572 |
|
816 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL303P |
0.0219958174553572 |
|
817 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RHOBTB2 |
0.0219958174553572 |
|
818 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TNFRSF10B |
0.0219958174553572 |
|
819 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM63B |
0.0220958961826925 |
|
820 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CAPN11 |
0.0220958961826925 |
|
821 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC29A1 |
0.0220958961826925 |
|
822 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HSP90AB1 |
0.0220958961826925 |
|
823 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4647 |
0.0220958961826925 |
|
824 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC35B2 |
0.0220958961826925 |
|
825 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NFKBIE |
0.0220958961826925 |
|
826 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TCTE1 |
0.0220958961826925 |
|
827 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM229B |
0.0221320058042123 |
|
828 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLEKHH1 |
0.0221320058042123 |
|
829 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PIGH |
0.0221320058042123 |
|
830 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARG2 |
0.0221320058042123 |
|
831 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VTI1B |
0.0221320058042123 |
|
832 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RDH11 |
0.0221320058042123 |
|
833 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL369P |
0.0221320058042123 |
|
834 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SMARCA4 |
0.0222639571376917 |
|
835 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMCO4 |
0.0223523319661052 |
|
836 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4671 |
0.022394536283342 |
|
837 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL192P |
0.0225295384471607 |
|
838 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C11orf71 |
0.0226073222538413 |
|
839 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RBM7 |
0.0226073222538413 |
|
840 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
REXO2 |
0.0226073222538413 |
|
841 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NXPE2 |
0.0226073222538413 |
|
842 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AARS2 |
0.0226539144930656 |
|
843 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPATS1 |
0.0226539144930656 |
|
844 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CUL7 |
0.0227030520573496 |
|
845 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MRPL2 |
0.0227030520573496 |
|
846 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TTC13 |
0.0227323608671384 |
|
847 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C1orf194 |
0.0227865103993931 |
|
848 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCARNA2 |
0.0227865103993931 |
|
849 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM167B |
0.0227865103993931 |
|
850 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C1orf131 |
0.0228353334429243 |
|
851 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RGS6 |
0.0229252332240352 |
|
852 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ERLIN2 |
0.0229263727953219 |
|
853 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PROSC |
0.0229263727953219 |
|
854 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL299P |
0.0230019677040526 |
|
855 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAP10 |
0.0230019677040526 |
|
856 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NTPCR |
0.0230019677040526 |
|
857 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCNXL2 |
0.0230019677040526 |
|
858 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MLK4 |
0.0230019677040526 |
|
859 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL683P |
0.0230043837029893 |
|
860 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TUB |
0.0231447324066563 |
|
861 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RIC3 |
0.0231447324066563 |
|
862 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LMO1 |
0.0231447324066563 |
|
863 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SH3GLB1 |
0.0231645156531844 |
|
864 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HS2ST1 |
0.0231645156531844 |
|
865 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP52 |
0.0231645156531844 |
|
866 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LMO4 |
0.0233425338837154 |
|
867 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARID4A |
0.0233649947180613 |
|
868 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TOMM20L |
0.0233649947180613 |
|
869 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TIMM9 |
0.0233649947180613 |
|
870 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RRP36 |
0.0234409050271527 |
|
871 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL403P |
0.0234409050271527 |
|
872 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNY4P16 |
0.0234421622469074 |
|
873 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL668P |
0.0234421622469074 |
|
874 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SIPA1L2 |
0.0234909818067245 |
|
875 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCNK1 |
0.0235937691560099 |
|
876 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4427 |
0.0235937691560099 |
|
877 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KLC4 |
0.023598012584323 |
|
878 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HP1BP3 |
0.0237421968652024 |
|
879 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TTC12 |
0.0237873483221649 |
|
880 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANKK1 |
0.0237873483221649 |
|
881 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DRD2 |
0.0237873483221649 |
|
882 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4301 |
0.0237873483221649 |
|
883 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMPRSS5 |
0.0237873483221649 |
|
884 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZW10 |
0.0237873483221649 |
|
885 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLDN25 |
0.0237873483221649 |
|
886 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATF4P4 |
0.0237873483221649 |
|
887 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
USP28 |
0.0237873483221649 |
|
888 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HTR3B |
0.0237873483221649 |
|
889 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HTR3A |
0.0237873483221649 |
|
890 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4310 |
0.0238186689199675 |
|
891 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DHRS4 |
0.0238345419442169 |
|
892 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DHRS4L2 |
0.0238345419442169 |
|
893 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARV1 |
0.0238796351950196 |
|
894 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM89A |
0.0238796351950196 |
|
895 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR1182 |
0.0238796351950196 |
|
896 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TPM1 |
0.0238882164832324 |
|
897 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM38A |
0.0239213932479205 |
|
898 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLEKHM2 |
0.0239376592471913 |
|
899 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FBLIM1 |
0.0239376592471913 |
|
900 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC25A34 |
0.0239376592471913 |
|
901 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM82 |
0.0239376592471913 |
|
902 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPEN |
0.0239376592471913 |
|
903 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238818.1 |
0.0239376592471913 |
|
904 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP256 |
0.0239865646886378 |
|
905 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FGL1 |
0.0239865646886378 |
|
906 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCM1 |
0.0239865646886378 |
|
907 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NAT1 |
0.0239865646886378 |
|
908 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NAT2 |
0.0239865646886378 |
|
909 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PSD3 |
0.0239865646886378 |
|
910 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA62|ENSG00000201157.1 |
0.0239865646886378 |
|
911 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SH2D4A |
0.0239865646886378 |
|
912 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCNS1 |
0.0239949907738901 |
|
913 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WFDC5 |
0.0239949907738901 |
|
914 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WFDC12 |
0.0239949907738901 |
|
915 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PI3 |
0.0239949907738901 |
|
916 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SEMG1 |
0.0239949907738901 |
|
917 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DDI2 |
0.0240060185011277 |
|
918 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SDHB |
0.0240853952491336 |
|
919 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PADI2 |
0.0240853952491336 |
|
920 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PADI1 |
0.0240853952491336 |
|
921 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PADI3 |
0.0240853952491336 |
|
922 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3972 |
0.0240853952491336 |
|
923 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PADI4 |
0.0240853952491336 |
|
924 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PADI6 |
0.0240853952491336 |
|
925 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RCC2 |
0.0240853952491336 |
|
926 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000239020.1 |
0.0240853952491336 |
|
927 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARHGEF10L |
0.0240853952491336 |
|
928 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KLF1 |
0.0243261511782693 |
|
929 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OXA1L |
0.0246772593683545 |
|
930 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD41|ENSG00000212302.1 |
0.0246772593683545 |
|
931 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UPP2 |
0.024701465597437 |
|
932 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SFMBT2 |
0.0248571494872191 |
|
933 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACTL8 |
0.0250499818487645 |
|
934 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PAX7 |
0.0250499818487645 |
|
935 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
YIPF2 |
0.0250921858105616 |
|
936 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C19orf52 |
0.0250921858105616 |
|
937 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SC5D |
0.0255925178886584 |
|
938 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ALG6 |
0.0256472832920889 |
|
939 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ITGB3BP |
0.0256472832920889 |
|
940 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EFCAB7 |
0.0256472832920889 |
|
941 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL488P |
0.0256472832920889 |
|
942 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DLEU2L |
0.0256472832920889 |
|
943 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PGM1 |
0.0256472832920889 |
|
944 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL130P |
0.0256472832920889 |
|
945 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR603 |
0.025818805795587 |
|
946 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HSD17B7P2 |
0.0259316519793392 |
|
947 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SEPT7P9 |
0.0259316519793392 |
|
948 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PTPN6 |
0.0260574197411642 |
|
949 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR141 |
0.0260574197411642 |
|
950 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR200C |
0.0260574197411642 |
|
951 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PHB2 |
0.0260574197411642 |
|
952 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCARNA12 |
0.0260574197411642 |
|
953 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EMG1 |
0.0260574197411642 |
|
954 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LPCAT3 |
0.0260574197411642 |
|
955 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C1S |
0.0260574197411642 |
|
956 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TPPP2 |
0.0261104190515969 |
|
957 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNASE13 |
0.0261104190515969 |
|
958 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNASE7 |
0.0261104190515969 |
|
959 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNASE8 |
0.0261104190515969 |
|
960 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARHGEF40 |
0.0261104190515969 |
|
961 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF219 |
0.0261104190515969 |
|
962 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM253 |
0.0261104190515969 |
|
963 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR5AU1 |
0.0261104190515969 |
|
964 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF248 |
0.026149742031282 |
|
965 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF25 |
0.026149742031282 |
|
966 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF33A |
0.026149742031282 |
|
967 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF37A |
0.026149742031282 |
|
968 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RSC1A1 |
0.0261566839251481 |
|
969 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SVIL |
0.0261810934247136 |
|
970 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD115|ENSG00000212411.1 |
0.0261810934247136 |
|
971 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR938 |
0.0261810934247136 |
|
972 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SERINC3 |
0.0262779408898152 |
|
973 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PKIG |
0.0262779408898152 |
|
974 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADA |
0.0262779408898152 |
|
975 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WISP2 |
0.0262779408898152 |
|
976 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCNK15 |
0.0262779408898152 |
|
977 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RIMS4 |
0.0262779408898152 |
|
978 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL31P |
0.0262779408898152 |
|
979 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
YWHAB |
0.0262779408898152 |
|
980 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PABPC1L |
0.0262779408898152 |
|
981 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TOMM34 |
0.0262779408898152 |
|
982 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STK4 |
0.0262779408898152 |
|
983 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLCA2 |
0.0263274795812878 |
|
984 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLCA1 |
0.0263274795812878 |
|
985 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GTF2IRD2P1 |
0.0263685346585126 |
|
986 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NCF1B |
0.0263685346585126 |
|
987 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NSUN5P2 |
0.0263685346585126 |
|
988 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NSUN5 |
0.0263685346585126 |
|
989 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STAG3L3 |
0.0263685346585126 |
|
990 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRIM50 |
0.0263685346585126 |
|
991 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRIM74 |
0.0263685346585126 |
|
992 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DAB1 |
0.0267165877402153 |
|
993 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DHRS4L1 |
0.0268730734024741 |
|
994 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRRC16B |
0.0268730734024741 |
|
995 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CPNE6 |
0.0268730734024741 |
|
996 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NRL |
0.0268730734024741 |
|
997 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCK2 |
0.0268730734024741 |
|
998 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DCAF11 |
0.0268730734024741 |
|
999 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FITM1 |
0.0268730734024741 |
|
1000 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EMC9 |
0.0268730734024741 |
|
1001 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PSME1 |
0.0268730734024741 |
|
1002 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PSME2 |
0.0268730734024741 |
|
1003 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNF31 |
0.0268730734024741 |
|
1004 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IRF9 |
0.0268730734024741 |
|
1005 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP383 |
0.0268730734024741 |
|
1006 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
REC8 |
0.0268730734024741 |
|
1007 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IPO4 |
0.0268730734024741 |
|
1008 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TM9SF1 |
0.0268730734024741 |
|
1009 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CHMP4A |
0.0268730734024741 |
|
1010 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TSSK4 |
0.0268730734024741 |
|
1011 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MDP1 |
0.0268730734024741 |
|
1012 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NEDD8 |
0.0268730734024741 |
|
1013 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GMPR2 |
0.0268730734024741 |
|
1014 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TINF2 |
0.0268730734024741 |
|
1015 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TGM1 |
0.0268730734024741 |
|
1016 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RABGGTA |
0.0268730734024741 |
|
1017 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP331 |
0.0268843950656826 |
|
1018 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM102B |
0.0269123940761007 |
|
1019 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HENMT1 |
0.0269123940761007 |
|
1020 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRPF38B |
0.0269123940761007 |
|
1021 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FNDC7 |
0.0269123940761007 |
|
1022 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STXBP3 |
0.0269123940761007 |
|
1023 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPATA42 |
0.0269123940761007 |
|
1024 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COA6 |
0.0270387834341335 |
|
1025 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WFDC11 |
0.0271927575352637 |
|
1026 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WFDC10B |
0.0271927575352637 |
|
1027 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WFDC13 |
0.0271927575352637 |
|
1028 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3617 |
0.0271927575352637 |
|
1029 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPINT4 |
0.0271927575352637 |
|
1030 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WFDC3 |
0.0271927575352637 |
|
1031 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNU6ATAC38P |
0.0271927575352637 |
|
1032 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BNIP3L |
0.0271942006078596 |
|
1033 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SDAD1P1 |
0.0271942006078596 |
|
1034 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPP3CC |
0.0272456015760968 |
|
1035 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SORBS3 |
0.0272456015760968 |
|
1036 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PDLIM2 |
0.0272456015760968 |
|
1037 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C8orf58 |
0.0272456015760968 |
|
1038 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIAA1967 |
0.0272456015760968 |
|
1039 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BIN3 |
0.0272456015760968 |
|
1040 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRIM67 |
0.0272469501443705 |
|
1041 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GNPAT |
0.0272469501443705 |
|
1042 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP80 |
0.0272469501443705 |
|
1043 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EXOC8 |
0.0272469501443705 |
|
1044 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPRTN |
0.0272469501443705 |
|
1045 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRTFDC1 |
0.0272528837686975 |
|
1046 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP241 |
0.0272528837686975 |
|
1047 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ENKUR |
0.0272528837686975 |
|
1048 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
THNSL1 |
0.0272528837686975 |
|
1049 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCARNA15|ENSG00000252193.1 |
0.0273035299447081 |
|
1050 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TUSC3 |
0.0274366857543659 |
|
1051 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FGF20 |
0.0274366857543659 |
|
1052 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MICU3 |
0.0274366857543659 |
|
1053 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZDHHC2 |
0.0274366857543659 |
|
1054 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CNOT7 |
0.0274366857543659 |
|
1055 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VPS37A |
0.0274366857543659 |
|
1056 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MTMR7 |
0.0274366857543659 |
|
1057 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL474P |
0.0274718368667964 |
|
1058 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NYNRIN |
0.0276006881153767 |
|
1059 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CBLN3 |
0.0276006881153767 |
|
1060 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KHNYN |
0.0276006881153767 |
|
1061 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SDR39U1 |
0.0276006881153767 |
|
1062 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CMA1 |
0.0276006881153767 |
|
1063 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HNF4A |
0.0276433280735877 |
|
1064 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C20orf62 |
0.0276433280735877 |
|
1065 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TTPAL |
0.0276433280735877 |
|
1066 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00582 |
0.0276804889531244 |
|
1067 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MFSD6L |
0.0277524608954112 |
|
1068 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PIK3R6 |
0.0277524608954112 |
|
1069 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GOT1L1 |
0.0278049643873827 |
|
1070 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLEKHA2 |
0.0278555967563056 |
|
1071 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DBT |
0.0279234049737087 |
|
1072 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RTCA |
0.0279234049737087 |
|
1073 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR553 |
0.0279234049737087 |
|
1074 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3671 |
0.0279333692352374 |
|
1075 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR1256 |
0.0279414096231859 |
|
1076 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FITM2 |
0.0279492195809242 |
|
1077 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
R3HDML |
0.0279492195809242 |
|
1078 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DENND5A |
0.0280547610383484 |
|
1079 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM41B |
0.0280547610383484 |
|
1080 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VPS13C |
0.0281166434832532 |
|
1081 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL613P |
0.0281166434832532 |
|
1082 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C2CD4A |
0.0281166434832532 |
|
1083 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C2CD4B |
0.0281166434832532 |
|
1084 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TLN2 |
0.0281166434832532 |
|
1085 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U8|ENSG00000212144.1 |
0.0281882265136842 |
|
1086 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IRF2BP2 |
0.0281882265136842 |
|
1087 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00184 |
0.0281882265136842 |
|
1088 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FKBP6 |
0.0283558998705493 |
|
1089 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LYVE1 |
0.0284593407899008 |
|
1090 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MRVI1 |
0.0284593407899008 |
|
1091 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CTR9 |
0.0284593407899008 |
|
1092 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EIF4G2 |
0.0284593407899008 |
|
1093 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD97 |
0.0284593407899008 |
|
1094 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR137HG |
0.0285361394186943 |
|
1095 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC25A3P1 |
0.02861142950857 |
|
1096 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DMRTB1 |
0.02861142950857 |
|
1097 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ODF2L |
0.0287278070012836 |
|
1098 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL713P |
0.0288852651626721 |
|
1099 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TACSTD2 |
0.0288852651626721 |
|
1100 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MYSM1 |
0.0288852651626721 |
|
1101 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
JUN |
0.0288852651626721 |
|
1102 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IGSF21 |
0.0289350403714718 |
|
1103 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KLHDC7A |
0.0289350403714718 |
|
1104 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP493 |
0.0291299885347335 |
|
1105 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDC123 |
0.0292325092850871 |
|
1106 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL232P |
0.0292325092850871 |
|
1107 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UBR4 |
0.0292597587899024 |
|
1108 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EMC1 |
0.0292597587899024 |
|
1109 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MRTO4 |
0.0292597587899024 |
|
1110 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AKR7A3 |
0.0292597587899024 |
|
1111 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AKR7L |
0.0292597587899024 |
|
1112 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AKR7A2 |
0.0292597587899024 |
|
1113 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PQLC2 |
0.0292597587899024 |
|
1114 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL85P |
0.0292597587899024 |
|
1115 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL277P |
0.0292597587899024 |
|
1116 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000239027.1 |
0.0292597587899024 |
|
1117 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MINOS1 |
0.0292597587899024 |
|
1118 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NBL1 |
0.0292597587899024 |
|
1119 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HTR6 |
0.0292597587899024 |
|
1120 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNF186 |
0.0292597587899024 |
|
1121 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OTUD3 |
0.0292597587899024 |
|
1122 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLA2G2E |
0.0292597587899024 |
|
1123 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLA2G2A |
0.0292597587899024 |
|
1124 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL304P |
0.0292597587899024 |
|
1125 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLA2G5 |
0.0292597587899024 |
|
1126 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLA2G2D |
0.0292597587899024 |
|
1127 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLA2G2F |
0.0292597587899024 |
|
1128 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLA2G2C |
0.0292597587899024 |
|
1129 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UBXN10 |
0.0292597587899024 |
|
1130 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VWA5B1 |
0.0292597587899024 |
|
1131 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CAMK2N1 |
0.0292597587899024 |
|
1132 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MUL1 |
0.0292597587899024 |
|
1133 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM43B |
0.0292597587899024 |
|
1134 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADRB3 |
0.0293269534529267 |
|
1135 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EPS15P1 |
0.0293765440026325 |
|
1136 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238931.1 |
0.0294046006275226 |
|
1137 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NTN1 |
0.0296293249366217 |
|
1138 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NR4A1 |
0.0296501542159576 |
|
1139 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LPPR4 |
0.0298551313718993 |
|
1140 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL598P |
0.0299204383827496 |
|
1141 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACTR10 |
0.0299204383827496 |
|
1142 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EIF4EBP1 |
0.0299849383273535 |
|
1143 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GRASP |
0.0301480029066135 |
|
1144 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C12orf44 |
0.0301480029066135 |
|
1145 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR7E47P |
0.0301480029066135 |
|
1146 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
INTS10 |
0.0304569638834051 |
|
1147 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LPL |
0.0304569638834051 |
|
1148 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC18A1 |
0.0304569638834051 |
|
1149 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATP6V1B2 |
0.0304569638834051 |
|
1150 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LZTS1 |
0.0304569638834051 |
|
1151 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR663A |
0.0307915130755942 |
|
1152 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TPM4 |
0.0308254676988119 |
|
1153 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CHERP |
0.0308254676988119 |
|
1154 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC35E1 |
0.0308254676988119 |
|
1155 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MED26 |
0.0308254676988119 |
|
1156 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SMIM7 |
0.0308254676988119 |
|
1157 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANO9 |
0.030861008561484 |
|
1158 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATHL1 |
0.030861008561484 |
|
1159 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
B4GALNT4 |
0.030861008561484 |
|
1160 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BET1L |
0.030861008561484 |
|
1161 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IFITM1 |
0.030861008561484 |
|
1162 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IFITM2 |
0.030861008561484 |
|
1163 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IFITM3 |
0.030861008561484 |
|
1164 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IFITM5 |
0.030861008561484 |
|
1165 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NLRP6 |
0.030861008561484 |
|
1166 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ODF3 |
0.030861008561484 |
|
1167 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PKP3 |
0.030861008561484 |
|
1168 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PSMD13 |
0.030861008561484 |
|
1169 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PTDSS2 |
0.030861008561484 |
|
1170 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RIC8A |
0.030861008561484 |
|
1171 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL838P |
0.030861008561484 |
|
1172 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCGB1C1 |
0.030861008561484 |
|
1173 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SIGIRR |
0.030861008561484 |
|
1174 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SIRT3 |
0.030861008561484 |
|
1175 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPR135 |
0.030889775517347 |
|
1176 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
L3HYPDH |
0.030889775517347 |
|
1177 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
JKAMP |
0.030889775517347 |
|
1178 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC175 |
0.030889775517347 |
|
1179 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RTN1 |
0.030889775517347 |
|
1180 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR5586 |
0.030889775517347 |
|
1181 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EHD4 |
0.0309088258858421 |
|
1182 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDA |
0.030914111393924 |
|
1183 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PINK1 |
0.030914111393924 |
|
1184 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DDOST |
0.030914111393924 |
|
1185 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIF17 |
0.030914111393924 |
|
1186 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SH2D5 |
0.030914111393924 |
|
1187 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KLHL8 |
0.0309738043567369 |
|
1188 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR5705 |
0.0309738043567369 |
|
1189 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HSD17B13 |
0.0309738043567369 |
|
1190 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HSD17B11 |
0.0309738043567369 |
|
1191 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL681P |
0.0309738043567369 |
|
1192 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NUDT9 |
0.0309738043567369 |
|
1193 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238652.1 |
0.0309738043567369 |
|
1194 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IBSP |
0.0309738043567369 |
|
1195 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MEPE |
0.0309738043567369 |
|
1196 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPP1 |
0.0309738043567369 |
|
1197 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PKD2 |
0.0309738043567369 |
|
1198 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ABCG2 |
0.0309738043567369 |
|
1199 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNU6ATAC31P |
0.0309738043567369 |
|
1200 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPM1K |
0.0309738043567369 |
|
1201 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HERC6 |
0.0309738043567369 |
|
1202 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HERC5 |
0.0309738043567369 |
|
1203 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HERC3 |
0.0309738043567369 |
|
1204 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PIGY |
0.0309738043567369 |
|
1205 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PYURF |
0.0309738043567369 |
|
1206 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP244 |
0.0309738043567369 |
|
1207 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NAP1L5 |
0.0309738043567369 |
|
1208 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM13A |
0.0309738043567369 |
|
1209 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TIGD2 |
0.0309738043567369 |
|
1210 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPRIN3 |
0.0309738043567369 |
|
1211 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL854P |
0.0311204750081595 |
|
1212 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDKN2C |
0.0311705982983621 |
|
1213 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C12orf80 |
0.0312133829469866 |
|
1214 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00592 |
0.0312133829469866 |
|
1215 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KRT7 |
0.0312133829469866 |
|
1216 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KRT121P |
0.0312133829469866 |
|
1217 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TNS3 |
0.0312489457468277 |
|
1218 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPTLC2 |
0.0314302503050991 |
|
1219 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EDDM3B |
0.0315113801781459 |
|
1220 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNASE6 |
0.0315113801781459 |
|
1221 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNASE1 |
0.0315113801781459 |
|
1222 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL189P |
0.0315113801781459 |
|
1223 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNASE2 |
0.0315113801781459 |
|
1224 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNASE3 |
0.0315113801781459 |
|
1225 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HNRNPC |
0.0318750715434951 |
|
1226 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP233 |
0.032180409866828 |
|
1227 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ENOPH1 |
0.0322918247605629 |
|
1228 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U3|ENSG00000222666.1 |
0.0323597829108103 |
|
1229 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP39 |
0.0323597829108103 |
|
1230 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF703 |
0.0324096925770566 |
|
1231 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C14orf37 |
0.0324165396878949 |
|
1232 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PSMA3 |
0.0324165396878949 |
|
1233 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IFT52 |
0.0324595835136782 |
|
1234 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MYBL2 |
0.0324595835136782 |
|
1235 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GTSF1L |
0.0324595835136782 |
|
1236 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TOX2 |
0.0324595835136782 |
|
1237 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL443P |
0.0324595835136782 |
|
1238 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
JPH2 |
0.0324595835136782 |
|
1239 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OSER1 |
0.0324595835136782 |
|
1240 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GDAP1L1 |
0.0324595835136782 |
|
1241 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PARVA |
0.0326762776198053 |
|
1242 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GCDH |
0.0327101105904198 |
|
1243 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SYCE2 |
0.0327101105904198 |
|
1244 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FARSA |
0.0327101105904198 |
|
1245 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR5695 |
0.0327101105904198 |
|
1246 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CALR |
0.0327101105904198 |
|
1247 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
USP3 |
0.0328899609153994 |
|
1248 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FBXL22 |
0.0328899609153994 |
|
1249 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HERC1 |
0.0328899609153994 |
|
1250 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TBCEL |
0.0329109933914919 |
|
1251 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ABCA13 |
0.0329547610700006 |
|
1252 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MPP7 |
0.0329790525805443 |
|
1253 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WDR47 |
0.0330963212140413 |
|
1254 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TAF13 |
0.0330963212140413 |
|
1255 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR5P2 |
0.033252904707031 |
|
1256 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR5P3 |
0.033252904707031 |
|
1257 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR10A6 |
0.033252904707031 |
|
1258 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR10A3 |
0.033252904707031 |
|
1259 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NLRP10 |
0.033252904707031 |
|
1260 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EIF3F |
0.033252904707031 |
|
1261 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AQP9 |
0.03352221191972 |
|
1262 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRIM29 |
0.0335309955397776 |
|
1263 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OAF |
0.0335309955397776 |
|
1264 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3117 |
0.0335374038651858 |
|
1265 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATG4D |
0.0335410611397131 |
|
1266 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR1238 |
0.0335410611397131 |
|
1267 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KRI1 |
0.0335410611397131 |
|
1268 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AP1M2 |
0.0335410611397131 |
|
1269 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDKN2D |
0.0335410611397131 |
|
1270 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MYO3A |
0.0337623878106188 |
|
1271 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KRT80 |
0.0338114426317109 |
|
1272 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PIWIL2 |
0.0339018241496063 |
|
1273 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TECTA |
0.0339053719172447 |
|
1274 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC10A6 |
0.0340503196016069 |
|
1275 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C4orf36 |
0.0340503196016069 |
|
1276 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AFF1 |
0.0340503196016069 |
|
1277 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PDHA2 |
0.0342960320995688 |
|
1278 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATP5L |
0.0344217262844091 |
|
1279 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAP1GDS1 |
0.0345699267201625 |
|
1280 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAB8A |
0.0347523685122848 |
|
1281 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HSH2D |
0.0347523685122848 |
|
1282 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00466 |
0.0349220127055256 |
|
1283 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP49 |
0.0349220127055256 |
|
1284 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL642P |
0.0349618501940738 |
|
1285 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCL24 |
0.0350243764481217 |
|
1286 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RHBDD2 |
0.0350527948090906 |
|
1287 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
POR |
0.0350527948090906 |
|
1288 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4651 |
0.0350777808704492 |
|
1289 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA14A |
0.0350777808704492 |
|
1290 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SRRM3 |
0.0350777808704492 |
|
1291 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL212P |
0.0350777808704492 |
|
1292 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HSPB1 |
0.0350777808704492 |
|
1293 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCL26 |
0.0350978317033532 |
|
1294 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM120A |
0.0351196801423383 |
|
1295 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STYXL1 |
0.0351196801423383 |
|
1296 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MDH2 |
0.0351196801423383 |
|
1297 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238935.1 |
0.0351196801423383 |
|
1298 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TSPAN5 |
0.0353805187743501 |
|
1299 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EIF4E |
0.0353805187743501 |
|
1300 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
METAP1 |
0.0353805187743501 |
|
1301 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3684 |
0.0353805187743501 |
|
1302 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADH5 |
0.0353805187743501 |
|
1303 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADH4 |
0.0353805187743501 |
|
1304 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCNAP1 |
0.0353805187743501 |
|
1305 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADH6 |
0.0353805187743501 |
|
1306 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADH1A |
0.0353805187743501 |
|
1307 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADH1B |
0.0353805187743501 |
|
1308 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADH1C |
0.0353805187743501 |
|
1309 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADH7 |
0.0353805187743501 |
|
1310 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C4orf17 |
0.0353805187743501 |
|
1311 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRMT10A |
0.0353805187743501 |
|
1312 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPP3CA |
0.0353805187743501 |
|
1313 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR1255A |
0.0353805187743501 |
|
1314 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC1A7 |
0.0357499142128379 |
|
1315 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MMRN1 |
0.0359169029736846 |
|
1316 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TSPAN4 |
0.0361352785010225 |
|
1317 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CHID1 |
0.0361352785010225 |
|
1318 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PKN2 |
0.0361527941458936 |
|
1319 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VPS4A |
0.0361708663184004 |
|
1320 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COG8 |
0.0361708663184004 |
|
1321 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PDF |
0.0361708663184004 |
|
1322 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NIP7 |
0.0361708663184004 |
|
1323 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMED6 |
0.0361708663184004 |
|
1324 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TERF2 |
0.0361708663184004 |
|
1325 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CYB5B |
0.0361708663184004 |
|
1326 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SRSF6 |
0.0362419027979795 |
|
1327 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
L3MBTL1 |
0.0362419027979795 |
|
1328 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PDE4B |
0.0365095934389005 |
|
1329 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OCSTAMP |
0.0365096087288069 |
|
1330 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC13A3 |
0.0365096087288069 |
|
1331 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AKAP8 |
0.0365755326608059 |
|
1332 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AKAP8L |
0.0365755326608059 |
|
1333 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CYP4F22 |
0.0365755326608059 |
|
1334 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CYP4F23P |
0.0365755326608059 |
|
1335 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IPO7 |
0.0366545694186096 |
|
1336 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA23 |
0.0366545694186096 |
|
1337 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF143 |
0.0366545694186096 |
|
1338 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL56P |
0.0366545694186096 |
|
1339 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WEE1 |
0.0366545694186096 |
|
1340 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238387.1 |
0.0366545694186096 |
|
1341 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SWAP70 |
0.0366545694186096 |
|
1342 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP50 |
0.0366545694186096 |
|
1343 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAVER2 |
0.0366953949494011 |
|
1344 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
JAK1 |
0.0366953949494011 |
|
1345 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL314P |
0.0366982191041235 |
|
1346 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MTRNR2L7 |
0.0366982191041235 |
|
1347 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM56 |
0.0367667575363804 |
|
1348 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RWDD3 |
0.0367667575363804 |
|
1349 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CALR3 |
0.0367862292530091 |
|
1350 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C19orf44 |
0.0367862292530091 |
|
1351 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARHGAP5 |
0.036825088565742 |
|
1352 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LIPC |
0.0369510068325106 |
|
1353 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADAM10 |
0.0369510068325106 |
|
1354 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000239100.1 |
0.0369510068325106 |
|
1355 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP95 |
0.0369510068325106 |
|
1356 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U3|ENSG00000200318.1 |
0.0369510068325106 |
|
1357 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM63B |
0.0369510068325106 |
|
1358 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLTM |
0.0369510068325106 |
|
1359 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MRPL14 |
0.0371888076444024 |
|
1360 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C6orf223 |
0.037191091126363 |
|
1361 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPDYE4 |
0.0373475458175172 |
|
1362 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANGEL1 |
0.0373973187663195 |
|
1363 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C14orf166B |
0.0373973187663195 |
|
1364 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PNPLA2 |
0.0374323800895134 |
|
1365 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CD151 |
0.0374323800895134 |
|
1366 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EFCAB4A |
0.0374323800895134 |
|
1367 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
POLR2L |
0.0374323800895134 |
|
1368 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EIF4G3 |
0.0376912130154085 |
|
1369 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SGK2 |
0.0377358133441491 |
|
1370 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ALDH3B1 |
0.0377423857949929 |
|
1371 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NDUFS8 |
0.0377423857949929 |
|
1372 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4691 |
0.0377423857949929 |
|
1373 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TCIRG1 |
0.0377423857949929 |
|
1374 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CHKA |
0.0377423857949929 |
|
1375 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SUV420H1 |
0.0377423857949929 |
|
1376 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C11orf24 |
0.0377423857949929 |
|
1377 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRP5 |
0.0377423857949929 |
|
1378 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPP6R3 |
0.0377423857949929 |
|
1379 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GAL |
0.0377423857949929 |
|
1380 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MTL5 |
0.0377423857949929 |
|
1381 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SVILP1 |
0.0378514639128315 |
|
1382 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ALPL |
0.0380482891025008 |
|
1383 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ECE1 |
0.0380936412058517 |
|
1384 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NBPF3 |
0.0380936412058517 |
|
1385 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STPG2 |
0.0381199624418554 |
|
1386 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TACC1 |
0.0381985300914519 |
|
1387 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GALNT5 |
0.0384823721481528 |
|
1388 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP281 |
0.0384823721481528 |
|
1389 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ERMN |
0.0384823721481528 |
|
1390 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00641 |
0.0385241247943063 |
|
1391 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HINFP |
0.0387654199249118 |
|
1392 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ABCG4 |
0.0387654199249118 |
|
1393 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NLRX1 |
0.0387654199249118 |
|
1394 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PDZD3 |
0.0387654199249118 |
|
1395 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC153 |
0.0387654199249118 |
|
1396 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CBL |
0.0387654199249118 |
|
1397 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MCAM |
0.0387654199249118 |
|
1398 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACA64|ENSG00000252119.1 |
0.0387654199249118 |
|
1399 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNF26 |
0.0387654199249118 |
|
1400 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C1QTNF5 |
0.0387654199249118 |
|
1401 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MFRP |
0.0387654199249118 |
|
1402 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
USP2 |
0.0387654199249118 |
|
1403 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
THY1 |
0.0387654199249118 |
|
1404 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PVRL1 |
0.0387654199249118 |
|
1405 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NXPE1 |
0.0388719238740757 |
|
1406 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238724.1 |
0.0388719238740757 |
|
1407 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NXPE4 |
0.0388719238740757 |
|
1408 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GALNT18 |
0.038968457384559 |
|
1409 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CSNK2A3 |
0.038968457384559 |
|
1410 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4299 |
0.038968457384559 |
|
1411 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TP53RK |
0.0390063617796343 |
|
1412 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC2A10 |
0.0390063617796343 |
|
1413 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP33 |
0.0390063617796343 |
|
1414 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VASH1 |
0.0390278718636252 |
|
1415 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CIRH1A |
0.0393325581349245 |
|
1416 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL180P |
0.0393801706851356 |
|
1417 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ALKBH1 |
0.0395643756432866 |
|
1418 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLIRP |
0.0395643756432866 |
|
1419 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNW1 |
0.0395643756432866 |
|
1420 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C14orf178 |
0.0395643756432866 |
|
1421 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADCK1 |
0.0395643756432866 |
|
1422 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPSB2 |
0.0397605061752196 |
|
1423 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRRC23 |
0.0397605061752196 |
|
1424 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPL13P5 |
0.0397605061752196 |
|
1425 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DSTNP2 |
0.0397605061752196 |
|
1426 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ENO2 |
0.0397605061752196 |
|
1427 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATN1 |
0.0397605061752196 |
|
1428 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C12orf57 |
0.0397605061752196 |
|
1429 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ST5 |
0.0397893483237057 |
|
1430 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP330 |
0.0397893483237057 |
|
1431 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AKIP1 |
0.0397893483237057 |
|
1432 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNH1 |
0.0398425642324011 |
|
1433 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3646 |
0.0400675395789433 |
|
1434 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ISM2 |
0.0404807273883041 |
|
1435 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL587P |
0.0404807273883041 |
|
1436 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNTB2 |
0.040606257401909 |
|
1437 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WIZ |
0.0406272836357413 |
|
1438 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR1470 |
0.0406272836357413 |
|
1439 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RASAL3 |
0.0406272836357413 |
|
1440 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PGLYRP2 |
0.0406272836357413 |
|
1441 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNCA |
0.0413222741445617 |
|
1442 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL666P |
0.0413650750262111 |
|
1443 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MGA |
0.0413974951402304 |
|
1444 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR626 |
0.0413974951402304 |
|
1445 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR190A |
0.0417361984413047 |
|
1446 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C11orf16 |
0.0418261021828993 |
|
1447 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ASCL3 |
0.0418261021828993 |
|
1448 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM9B |
0.0418261021828993 |
|
1449 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPTSSA |
0.0418517838375829 |
|
1450 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WAC |
0.0420790912449273 |
|
1451 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAX |
0.0421568637281228 |
|
1452 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TSNAX |
0.0421568637281228 |
|
1453 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
APOBEC1 |
0.0422282756477641 |
|
1454 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DPYD |
0.0424133407732501 |
|
1455 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NFIA |
0.0426851696064431 |
|
1456 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF438 |
0.0427573495897674 |
|
1457 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CEP164 |
0.0427664863733358 |
|
1458 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC42 |
0.0427962801235797 |
|
1459 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
METTL3 |
0.0429261320206745 |
|
1460 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SALL2 |
0.0429261320206745 |
|
1461 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR10G3 |
0.0429261320206745 |
|
1462 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR10G2 |
0.0429261320206745 |
|
1463 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VIPAS39 |
0.0429439278786972 |
|
1464 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AHSA1 |
0.0429439278786972 |
|
1465 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA46|ENSG00000212371.1 |
0.0429439278786972 |
|
1466 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP297 |
0.0429604363899547 |
|
1467 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP298 |
0.0429604363899547 |
|
1468 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TUBB8 |
0.0429604363899547 |
|
1469 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZMYND11 |
0.0429604363899547 |
|
1470 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC44A2 |
0.0430107278350637 |
|
1471 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ILF3 |
0.0430107278350637 |
|
1472 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
POU2F3 |
0.0431783553122177 |
|
1473 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM136 |
0.0431783553122177 |
|
1474 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARHGEF12 |
0.0431783553122177 |
|
1475 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FXYD6 |
0.0432812675302764 |
|
1476 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP388 |
0.0433320723265005 |
|
1477 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAR1 |
0.0435633292960934 |
|
1478 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TM2D1 |
0.0435788102797416 |
|
1479 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
INADL |
0.0435788102797416 |
|
1480 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
L1TD1 |
0.0435788102797416 |
|
1481 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KANK4 |
0.0435788102797416 |
|
1482 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RSL24D1 |
0.0436236289913164 |
|
1483 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238625.1 |
0.0436384362133377 |
|
1484 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BUD13 |
0.0436384362133377 |
|
1485 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF259 |
0.0436384362133377 |
|
1486 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
APOA5 |
0.0436384362133377 |
|
1487 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
APOA4 |
0.0436384362133377 |
|
1488 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
APOC3 |
0.0436384362133377 |
|
1489 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
APOA1 |
0.0436384362133377 |
|
1490 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SIK3 |
0.0436384362133377 |
|
1491 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNY4P6 |
0.0436384362133377 |
|
1492 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PAFAH1B2 |
0.0436384362133377 |
|
1493 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SIDT2 |
0.0436384362133377 |
|
1494 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TAGLN |
0.0436384362133377 |
|
1495 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCSK7 |
0.0436384362133377 |
|
1496 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNF214 |
0.0436457532314951 |
|
1497 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCARNA11|ENSG00000252992.1 |
0.0436457532314951 |
|
1498 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BACE1 |
0.0436457532314951 |
|
1499 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KMT2A |
0.0438420322041764 |
|
1500 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM25 |
0.0438420322041764 |
|
1501 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TTC36 |
0.0438420322041764 |
|
1502 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IFT46 |
0.0438420322041764 |
|
1503 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CD163 |
0.0442521023025451 |
|
1504 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GDF3 |
0.0442521023025451 |
|
1505 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DPPA3 |
0.0442521023025451 |
|
1506 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLEC4C |
0.0442521023025451 |
|
1507 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NANOGNB |
0.0442521023025451 |
|
1508 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NANOG |
0.0442521023025451 |
|
1509 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATG4C |
0.0443588729009243 |
|
1510 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP255 |
0.0444177677578288 |
|
1511 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C8orf48 |
0.0444177677578288 |
|
1512 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CYP4F8 |
0.0446089256956193 |
|
1513 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CYP4F3 |
0.0446089256956193 |
|
1514 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CYP4F12 |
0.0446089256956193 |
|
1515 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR10H2 |
0.0446089256956193 |
|
1516 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SRP54 |
0.0446189632145294 |
|
1517 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM177A1 |
0.0446189632145294 |
|
1518 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPP2R3C |
0.0446189632145294 |
|
1519 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AP2A2 |
0.0446276623027544 |
|
1520 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MUC6 |
0.0446276623027544 |
|
1521 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MUC2 |
0.0446276623027544 |
|
1522 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MRPL23 |
0.0446276623027544 |
|
1523 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
H19 |
0.0446276623027544 |
|
1524 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CFL2 |
0.0447425214536595 |
|
1525 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BAZ1A |
0.0447425214536595 |
|
1526 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRKAA2 |
0.0451306202695719 |
|
1527 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C1orf168 |
0.0451306202695719 |
|
1528 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C8A |
0.0451306202695719 |
|
1529 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C8B |
0.0451306202695719 |
|
1530 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP201 |
0.0454346519804613 |
|
1531 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HIGD1C |
0.0454903745260138 |
|
1532 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC11A2 |
0.0454903745260138 |
|
1533 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U6|ENSG00000272028.1 |
0.0454903745260138 |
|
1534 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LETMD1 |
0.0454903745260138 |
|
1535 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CSRNP2 |
0.0454903745260138 |
|
1536 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TFCP2 |
0.0454903745260138 |
|
1537 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
POU6F1 |
0.0454903745260138 |
|
1538 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DAZAP2 |
0.0454903745260138 |
|
1539 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SMAGP |
0.0454903745260138 |
|
1540 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CD3E |
0.0458967328001623 |
|
1541 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CD3D |
0.0458967328001623 |
|
1542 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CD3G |
0.0458967328001623 |
|
1543 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UBE4A |
0.0458967328001623 |
|
1544 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL831P |
0.045951193363253 |
|
1545 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP270 |
0.045951193363253 |
|
1546 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PTBP2 |
0.045951193363253 |
|
1547 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UNC5C |
0.0460963269293683 |
|
1548 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNX7 |
0.0461120290968809 |
|
1549 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OMA1 |
0.0461247869980311 |
|
1550 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPAP2B |
0.0462723255502351 |
|
1551 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HRAS |
0.0463378948746576 |
|
1552 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRRC56 |
0.0463378948746576 |
|
1553 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C11orf35 |
0.0463378948746576 |
|
1554 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RASSF7 |
0.0463378948746576 |
|
1555 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR210HG |
0.0463378948746576 |
|
1556 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR210 |
0.0463378948746576 |
|
1557 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PHRF1 |
0.0463378948746576 |
|
1558 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDHR5 |
0.0463378948746576 |
|
1559 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IRF7 |
0.0463378948746576 |
|
1560 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCT |
0.0463378948746576 |
|
1561 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DRD4 |
0.0463378948746576 |
|
1562 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DEAF1 |
0.0463378948746576 |
|
1563 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EPS8L2 |
0.0463378948746576 |
|
1564 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM80 |
0.0463378948746576 |
|
1565 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TALDO1 |
0.0463378948746576 |
|
1566 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PDDC1 |
0.0463378948746576 |
|
1567 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CEND1 |
0.0463378948746576 |
|
1568 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC25A22 |
0.0463378948746576 |
|
1569 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PIDD |
0.0463378948746576 |
|
1570 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPLP2 |
0.0463378948746576 |
|
1571 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA52 |
0.0463378948746576 |
|
1572 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR10H3 |
0.0463834696443699 |
|
1573 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CNN3 |
0.0464659276044515 |
|
1574 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ALG14 |
0.0464659276044515 |
|
1575 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PIK3R5 |
0.0464865453837539 |
|
1576 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NANOGP1 |
0.0465035935803331 |
|
1577 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC2A14 |
0.0465035935803331 |
|
1578 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC2A3 |
0.0465035935803331 |
|
1579 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FOXJ2 |
0.0465035935803331 |
|
1580 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C3AR1 |
0.0465035935803331 |
|
1581 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM66C |
0.0465035935803331 |
|
1582 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM86FP |
0.0465035935803331 |
|
1583 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM90A1 |
0.0465035935803331 |
|
1584 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00937 |
0.0465035935803331 |
|
1585 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLEC6A |
0.0465035935803331 |
|
1586 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLEC4D |
0.0465035935803331 |
|
1587 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLEC4E |
0.0465035935803331 |
|
1588 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCARNA11|ENSG00000252727.1 |
0.0465035935803331 |
|
1589 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AICDA |
0.0465035935803331 |
|
1590 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MFAP5 |
0.0465035935803331 |
|
1591 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP17 |
0.0465240189635934 |
|
1592 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SHFM1 |
0.0466929819919648 |
|
1593 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AES |
0.0467630517808778 |
|
1594 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADAM28 |
0.0467899461182238 |
|
1595 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADAMDEC1 |
0.0467899461182238 |
|
1596 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADAM7 |
0.0467899461182238 |
|
1597 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NEFM |
0.0467899461182238 |
|
1598 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NEFL |
0.0467899461182238 |
|
1599 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL651P |
0.0467899461182238 |
|
1600 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GNRH1 |
0.0467899461182238 |
|
1601 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCTD9 |
0.0467899461182238 |
|
1602 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDCA2 |
0.0467899461182238 |
|
1603 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARCN1 |
0.0470943102386197 |
|
1604 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PHLDB1 |
0.0470943102386197 |
|
1605 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TREH |
0.0470943102386197 |
|
1606 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DDX6 |
0.0470943102386197 |
|
1607 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CXCR5 |
0.0470943102386197 |
|
1608 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BCL9L |
0.0470943102386197 |
|
1609 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4492 |
0.0470943102386197 |
|
1610 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UPK2 |
0.0470943102386197 |
|
1611 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL688P |
0.0470943102386197 |
|
1612 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FOXR1 |
0.0470943102386197 |
|
1613 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL529P |
0.0470943102386197 |
|
1614 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC84 |
0.0470943102386197 |
|
1615 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPS25 |
0.0470943102386197 |
|
1616 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3656 |
0.0470943102386197 |
|
1617 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAPPC4 |
0.0470943102386197 |
|
1618 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC37A4 |
0.0470943102386197 |
|
1619 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HYOU1 |
0.0470943102386197 |
|
1620 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VPS11 |
0.0470943102386197 |
|
1621 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HMBS |
0.0470943102386197 |
|
1622 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DPAGT1 |
0.0470943102386197 |
|
1623 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
H2AFX |
0.0470943102386197 |
|
1624 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C2CD2L |
0.0470943102386197 |
|
1625 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CACNA1C |
0.0472558565643949 |
|
1626 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR4N5 |
0.0475412510025811 |
|
1627 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP381 |
0.0475412510025811 |
|
1628 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR11G2 |
0.0475412510025811 |
|
1629 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR11H6 |
0.0475412510025811 |
|
1630 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR11H7 |
0.0475412510025811 |
|
1631 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR11H4 |
0.0475412510025811 |
|
1632 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TTC5 |
0.0475412510025811 |
|
1633 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCNB1IP1 |
0.0475412510025811 |
|
1634 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA79|ENSG00000222489.1 |
0.0475412510025811 |
|
1635 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD126 |
0.0475412510025811 |
|
1636 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPPH1 |
0.0475412510025811 |
|
1637 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PARP2 |
0.0475412510025811 |
|
1638 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TEP1 |
0.0475412510025811 |
|
1639 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP382 |
0.0475412510025811 |
|
1640 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KLHL33 |
0.0475412510025811 |
|
1641 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OSGEP |
0.0475412510025811 |
|
1642 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
APEX1 |
0.0475412510025811 |
|
1643 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM55B |
0.0475412510025811 |
|
1644 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PNP |
0.0475412510025811 |
|
1645 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNASE10 |
0.0475412510025811 |
|
1646 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM65C |
0.0476047710837812 |
|
1647 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PARD6B |
0.0476047710837812 |
|
1648 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA31|ENSG00000253059.1 |
0.0476572540468967 |
|
1649 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238718.1 |
0.0476572540468967 |
|
1650 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BRMS1L |
0.0476572540468967 |
|
1651 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PTCSC3 |
0.0476572540468967 |
|
1652 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP21 |
0.0476572540468967 |
|
1653 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNRF1 |
0.0477097514841125 |
|
1654 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EFCAB4B |
0.0478224514741888 |
|
1655 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PARP11 |
0.0478224514741888 |
|
1656 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NECAP1 |
0.0478613423308303 |
|
1657 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLEC4A |
0.0478613423308303 |
|
1658 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF705A |
0.0478613423308303 |
|
1659 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DIRAS1 |
0.0479563037858334 |
|
1660 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC39A3 |
0.0479563037858334 |
|
1661 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SGTA |
0.0479563037858334 |
|
1662 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
THOP1 |
0.0479563037858334 |
|
1663 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF554 |
0.0479563037858334 |
|
1664 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF555 |
0.0479563037858334 |
|
1665 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF556 |
0.0479563037858334 |
|
1666 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF57 |
0.0479563037858334 |
|
1667 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF77 |
0.0479563037858334 |
|
1668 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TLE6 |
0.0479563037858334 |
|
1669 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TLE2 |
0.0479563037858334 |
|
1670 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NFATC2 |
0.0479605364426899 |
|
1671 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3194 |
0.0479605364426899 |
|
1672 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C1orf141 |
0.0479638157007104 |
|
1673 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FOXD3 |
0.0481194969859662 |
|
1674 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADNP |
0.0484119541544811 |
|
1675 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DPM1 |
0.0484119541544811 |
|
1676 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MOCS3 |
0.0484119541544811 |
|
1677 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCNG1 |
0.0484119541544811 |
|
1678 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRR7 |
0.0484223967849986 |
|
1679 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DBN1 |
0.0484223967849986 |
|
1680 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PDLIM7 |
0.0484223967849986 |
|
1681 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DOK3 |
0.0484223967849986 |
|
1682 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WDR63 |
0.048546900895017 |
|
1683 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MCOLN3 |
0.048546900895017 |
|
1684 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4423 |
0.048546900895017 |
|
1685 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SYDE2 |
0.048546900895017 |
|
1686 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C1orf52 |
0.048546900895017 |
|
1687 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BCL10 |
0.048546900895017 |
|
1688 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DDAH1 |
0.048546900895017 |
|
1689 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CYR61 |
0.048546900895017 |
|
1690 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD81|ENSG00000199934.1 |
0.048546900895017 |
|
1691 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNHIT6 |
0.048546900895017 |
|
1692 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP51 |
0.048546900895017 |
|
1693 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL621P |
0.0485608901009351 |
|
1694 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DUSP26 |
0.0485608901009351 |
|
1695 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLCO1B3 |
0.0486592134697899 |
|
1696 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LST3 |
0.0486592134697899 |
|
1697 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLCO1B7 |
0.0486592134697899 |
|
1698 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP380 |
0.0488051265939706 |
|
1699 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR4K17 |
0.0488051265939706 |
|
1700 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TACR3 |
0.0488153982496951 |
|
1701 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIER1 |
0.048834022509444 |
|
1702 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA31|ENSG00000252433.1 |
0.048834022509444 |
|
1703 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IL23R |
0.048834022509444 |
|
1704 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNU4ATAC4P |
0.048834022509444 |
|
1705 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IL12RB2 |
0.048834022509444 |
|
1706 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SERBP1 |
0.048834022509444 |
|
1707 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CYP4F24P |
0.0490607905415646 |
|
1708 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR10H5 |
0.0490607905415646 |
|
1709 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR10H1 |
0.0490607905415646 |
|
1710 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UCA1 |
0.0490607905415646 |
|
1711 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CYP4F2 |
0.0490607905415646 |
|
1712 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CYP4F11 |
0.0490607905415646 |
|
1713 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR10H4 |
0.0490607905415646 |
|
1714 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00661 |
0.0490607905415646 |
|
1715 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00905 |
0.0490607905415646 |
|
1716 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COPS7A |
0.0492976760682546 |
|
1717 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MLF2 |
0.0492976760682546 |
|
1718 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PTMS |
0.0492976760682546 |
|
1719 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LAG3 |
0.0492976760682546 |
|
1720 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL380P |
0.0492976760682546 |
|
1721 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CD4 |
0.0492976760682546 |
|
1722 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPR162 |
0.0492976760682546 |
|
1723 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LEPREL2 |
0.0492976760682546 |
|
1724 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GNB3 |
0.0492976760682546 |
|
1725 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDCA3 |
0.0492976760682546 |
|
1726 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
USP5 |
0.0492976760682546 |
|
1727 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TPI1 |
0.0492976760682546 |
|
1728 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3935 |
0.0493555066410124 |
|
1729 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AMFR |
0.0493555066410124 |
|
1730 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NUDT21 |
0.0493555066410124 |
|
1731 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OGFOD1 |
0.0493555066410124 |
|
1732 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BBS2 |
0.0493555066410124 |
|
1733 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CPT1A |
0.0493597253498774 |
|
1734 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MRPL21 |
0.0493597253498774 |
|
1735 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IGHMBP2 |
0.0493597253498774 |
|
1736 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MRGPRD |
0.0493597253498774 |
|
1737 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MRGPRF |
0.0493597253498774 |
|
1738 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TPCN2 |
0.0493597253498774 |
|
1739 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3164 |
0.0493597253498774 |
|
1740 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNRPB2 |
0.0493696281152881 |
|
1741 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OTOR |
0.0493696281152881 |
|
1742 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPP2R2A |
0.0494991268810232 |
|
1743 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAPKBP1 |
0.0498036704948236 |
|
1744 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
JMJD7 |
0.0498036704948236 |
|
1745 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLEC18B |
0.0499773114578672 |
|
1746 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NPIPB15 |
0.0499773114578672 |
|
1747 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PSMD7 |
0.0499773114578672 |
|
1748 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DSPP |
0.050067320392409 |
|
1749 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DMP1 |
0.050067320392409 |
|
1750 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COX4I2 |
0.0501791368546421 |
|
1751 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BCL2L1 |
0.0501791368546421 |
|
1752 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP100 |
0.050265917718477 |
|
1753 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL86P |
0.0503316878753245 |
|
1754 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NWD1 |
0.0504044428187953 |
|
1755 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SIN3B |
0.0504044428187953 |
|
1756 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
F2RL3 |
0.0504044428187953 |
|
1757 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL835P |
0.0504044428187953 |
|
1758 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL823P |
0.0504044428187953 |
|
1759 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACSM4 |
0.0505119953298917 |
|
1760 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CD163L1 |
0.0505119953298917 |
|
1761 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAB2B |
0.0506514294295238 |
|
1762 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TOX4 |
0.0506514294295238 |
|
1763 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCARA3 |
0.0506679606199177 |
|
1764 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EGLN1 |
0.0508773828718051 |
|
1765 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAP1GAP |
0.0509261636593629 |
|
1766 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
USP48 |
0.0509261636593629 |
|
1767 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LDLRAD2 |
0.0509261636593629 |
|
1768 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
POM121 |
0.0509409349668221 |
|
1769 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NTF3 |
0.0509953154770905 |
|
1770 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANKLE1 |
0.0510037751844676 |
|
1771 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ABHD8 |
0.0510037751844676 |
|
1772 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MRPL34 |
0.0510037751844676 |
|
1773 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DDA1 |
0.0510037751844676 |
|
1774 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANO8 |
0.0510037751844676 |
|
1775 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GTPBP3 |
0.0510037751844676 |
|
1776 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLVAP |
0.0510037751844676 |
|
1777 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BST2 |
0.0510037751844676 |
|
1778 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MVB12A |
0.0510037751844676 |
|
1779 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM221 |
0.0510037751844676 |
|
1780 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NXNL1 |
0.0510037751844676 |
|
1781 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC27A1 |
0.0510037751844676 |
|
1782 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PGLS |
0.0510037751844676 |
|
1783 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM129C |
0.0510037751844676 |
|
1784 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NUP93 |
0.0514143867834916 |
|
1785 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC12A3 |
0.0514143867834916 |
|
1786 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLIC4 |
0.0514383478932665 |
|
1787 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RUNX3 |
0.0514383478932665 |
|
1788 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00516 |
0.0515990149012923 |
|
1789 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MED15P1 |
0.0515990149012923 |
|
1790 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MED15P6 |
0.0515990149012923 |
|
1791 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR11H12 |
0.0515990149012923 |
|
1792 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR4K13 |
0.0515990149012923 |
|
1793 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR4K14 |
0.0515990149012923 |
|
1794 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR4K15 |
0.0515990149012923 |
|
1795 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR4K1 |
0.0515990149012923 |
|
1796 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR4K2 |
0.0515990149012923 |
|
1797 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR4K5 |
0.0515990149012923 |
|
1798 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR4M1 |
0.0515990149012923 |
|
1799 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR4N2 |
0.0515990149012923 |
|
1800 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR4Q2 |
0.0515990149012923 |
|
1801 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR4Q3 |
0.0515990149012923 |
|
1802 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
POTEG |
0.0515990149012923 |
|
1803 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
POTEM |
0.0515990149012923 |
|
1804 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238492.1 |
0.0515990149012923 |
|
1805 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR4L1 |
0.0515990149012923 |
|
1806 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SORL1 |
0.0516670944708623 |
|
1807 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NUSAP1 |
0.0517098433119414 |
|
1808 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NDUFAF1 |
0.0517098433119414 |
|
1809 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RTF1 |
0.0517098433119414 |
|
1810 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ITPKA |
0.0517098433119414 |
|
1811 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LTK |
0.0517098433119414 |
|
1812 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPAP1 |
0.0517098433119414 |
|
1813 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TYRO3 |
0.0517098433119414 |
|
1814 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNCB |
0.0517661684354005 |
|
1815 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EIF4E1B |
0.0517661684354005 |
|
1816 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4281 |
0.0517661684354005 |
|
1817 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TSPAN17 |
0.0517661684354005 |
|
1818 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UNC5A |
0.0517661684354005 |
|
1819 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIF16B |
0.0518036973547215 |
|
1820 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL356P |
0.0518089985832725 |
|
1821 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HSPG2 |
0.0518450040964534 |
|
1822 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDC42 |
0.0518450040964534 |
|
1823 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CELA3A |
0.0518450040964534 |
|
1824 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CELA3B |
0.0518450040964534 |
|
1825 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00339 |
0.0518450040964534 |
|
1826 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL186P |
0.0518450040964534 |
|
1827 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL386P |
0.0518450040964534 |
|
1828 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL421P |
0.0518450040964534 |
|
1829 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL768P |
0.0518450040964534 |
|
1830 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WNT4 |
0.0518450040964534 |
|
1831 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZBTB40 |
0.0518450040964534 |
|
1832 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EPHA8 |
0.0518450040964534 |
|
1833 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C1QA |
0.0518450040964534 |
|
1834 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C1QC |
0.0518450040964534 |
|
1835 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C1QB |
0.0518450040964534 |
|
1836 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACY3 |
0.0520356274713756 |
|
1837 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ALDH3B2 |
0.0520356274713756 |
|
1838 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C11orf72 |
0.0520356274713756 |
|
1839 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DOC2GP |
0.0520356274713756 |
|
1840 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM86C2P |
0.0520356274713756 |
|
1841 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GSTP1 |
0.0520356274713756 |
|
1842 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NDUFV1 |
0.0520356274713756 |
|
1843 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NUDT8 |
0.0520356274713756 |
|
1844 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL59P |
0.0520356274713756 |
|
1845 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TBX10 |
0.0520356274713756 |
|
1846 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UNC93B1 |
0.0520356274713756 |
|
1847 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TANGO6 |
0.0520364727881687 |
|
1848 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL63P |
0.0523916663751048 |
|
1849 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LYZL2 |
0.0523916663751048 |
|
1850 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CPAMD8 |
0.0525432520149759 |
|
1851 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HAUS8 |
0.0526727664790235 |
|
1852 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MYO9B |
0.0526727664790235 |
|
1853 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OCEL1 |
0.0526727664790235 |
|
1854 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
USE1 |
0.0526727664790235 |
|
1855 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NR2F6 |
0.0526727664790235 |
|
1856 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
USHBP1 |
0.0526727664790235 |
|
1857 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BABAM1 |
0.0526727664790235 |
|
1858 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLU |
0.0528446295937144 |
|
1859 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TCF12 |
0.052997996778505 |
|
1860 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TARBP1 |
0.0530205610860646 |
|
1861 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRBV30 |
0.0531764417709418 |
|
1862 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EPHB6 |
0.0531764417709418 |
|
1863 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRPV6 |
0.0531764417709418 |
|
1864 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRPV5 |
0.0531764417709418 |
|
1865 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C7orf34 |
0.0531764417709418 |
|
1866 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KEL |
0.0531764417709418 |
|
1867 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR9A2 |
0.0531764417709418 |
|
1868 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR6V1 |
0.0531764417709418 |
|
1869 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR6W1P |
0.0531764417709418 |
|
1870 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FOXM1 |
0.0531828740050984 |
|
1871 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RHNO1 |
0.0531828740050984 |
|
1872 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TULP3 |
0.0531828740050984 |
|
1873 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TEAD4 |
0.0531828740050984 |
|
1874 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TSPAN9 |
0.0531828740050984 |
|
1875 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRMT8 |
0.0531828740050984 |
|
1876 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
USP47 |
0.0532711943542615 |
|
1877 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DKK3 |
0.0532711943542615 |
|
1878 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COQ9 |
0.0534557184387032 |
|
1879 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
POLR2C |
0.0534557184387032 |
|
1880 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DOK4 |
0.0534557184387032 |
|
1881 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC102A |
0.0534557184387032 |
|
1882 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPR114 |
0.0534557184387032 |
|
1883 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCUBE2 |
0.0534940499375455 |
|
1884 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR5691 |
0.0534940499375455 |
|
1885 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARHGEF38 |
0.0536801615907659 |
|
1886 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TBCK |
0.0536801615907659 |
|
1887 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AIMP1 |
0.0536801615907659 |
|
1888 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GIMD1 |
0.0536801615907659 |
|
1889 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
INTS12 |
0.054113081235993 |
|
1890 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GSTCD |
0.054113081235993 |
|
1891 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NPNT |
0.054113081235993 |
|
1892 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GRIK4 |
0.0542889030809521 |
|
1893 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COLGALT1 |
0.0543740222689545 |
|
1894 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UNC13A |
0.0543740222689545 |
|
1895 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAP1S |
0.0543740222689545 |
|
1896 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FCHO1 |
0.0543740222689545 |
|
1897 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IGF2 |
0.0544272315350687 |
|
1898 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR483 |
0.0544272315350687 |
|
1899 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
INS |
0.0544272315350687 |
|
1900 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4686 |
0.0544272315350687 |
|
1901 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TH |
0.0544272315350687 |
|
1902 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DUT |
0.0546245778995171 |
|
1903 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FBN1 |
0.0546245778995171 |
|
1904 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CEP152 |
0.0546245778995171 |
|
1905 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SHC4 |
0.0546245778995171 |
|
1906 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EID1 |
0.0546245778995171 |
|
1907 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SECISBP2L |
0.0546245778995171 |
|
1908 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL577P |
0.0546245778995171 |
|
1909 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COPS2 |
0.0546245778995171 |
|
1910 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GALK2 |
0.0546245778995171 |
|
1911 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4716 |
0.0546245778995171 |
|
1912 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL307P |
0.0546245778995171 |
|
1913 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM227B |
0.0546245778995171 |
|
1914 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FGF7 |
0.0546245778995171 |
|
1915 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DTWD1 |
0.0546245778995171 |
|
1916 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MICALCL |
0.0547344456697634 |
|
1917 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ABCD3 |
0.0549595953752496 |
|
1918 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
F3 |
0.0549595953752496 |
|
1919 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC39A14 |
0.0549624024465489 |
|
1920 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MT1G |
0.0550311922063614 |
|
1921 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MT1H |
0.0550311922063614 |
|
1922 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MT1X |
0.0550311922063614 |
|
1923 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRIM66 |
0.0550377975022573 |
|
1924 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPL27A |
0.0550377975022573 |
|
1925 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA3|ENSG00000200983.1 |
0.0550377975022573 |
|
1926 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA45 |
0.0550377975022573 |
|
1927 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GTF2B |
0.0550865690339529 |
|
1928 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCBL2 |
0.0550865690339529 |
|
1929 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RBMXL1 |
0.0550865690339529 |
|
1930 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GBP3 |
0.0550865690339529 |
|
1931 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GBP1 |
0.0550865690339529 |
|
1932 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GBP2 |
0.0550865690339529 |
|
1933 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GBP7 |
0.0550865690339529 |
|
1934 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GBP4 |
0.0550865690339529 |
|
1935 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GBP5 |
0.0550865690339529 |
|
1936 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GBP6 |
0.0550865690339529 |
|
1937 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GBP1P1 |
0.0550865690339529 |
|
1938 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRRC8C |
0.0550865690339529 |
|
1939 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000239176.1 |
0.0550865690339529 |
|
1940 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRRC8D |
0.0550865690339529 |
|
1941 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP272 |
0.0550865690339529 |
|
1942 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF326 |
0.0550865690339529 |
|
1943 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U3|ENSG00000199666.1 |
0.0550865690339529 |
|
1944 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BARHL2 |
0.0550865690339529 |
|
1945 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF644 |
0.0550865690339529 |
|
1946 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD8 |
0.0551429828791692 |
|
1947 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL650P |
0.0551429828791692 |
|
1948 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZFHX3 |
0.0551463219378312 |
|
1949 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PIK3C2G |
0.0551930454215699 |
|
1950 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLCZ1 |
0.0551930454215699 |
|
1951 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CAPZA3 |
0.0551930454215699 |
|
1952 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RERGL |
0.0554803648989431 |
|
1953 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238676.1 |
0.0556545568243072 |
|
1954 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ALOX15B |
0.0556545568243072 |
|
1955 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR638 |
0.0557065194826485 |
|
1956 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BCAS4 |
0.0557355308285246 |
|
1957 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL459P |
0.0557367674143936 |
|
1958 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL67P |
0.0557367674143936 |
|
1959 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AEBP2 |
0.0557367674143936 |
|
1960 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EPHX3 |
0.0558248342811238 |
|
1961 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BRD4 |
0.0558248342811238 |
|
1962 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SGIP1 |
0.0560458849589329 |
|
1963 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FEM1A |
0.0561189540425471 |
|
1964 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TICAM1 |
0.0561189540425471 |
|
1965 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLIN3 |
0.0561189540425471 |
|
1966 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARRDC5 |
0.0561189540425471 |
|
1967 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NRIP3 |
0.0561751051491095 |
|
1968 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NRXN3 |
0.0565199970846242 |
|
1969 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL660P |
0.0565971751344959 |
|
1970 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAD23A |
0.0567561060062218 |
|
1971 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GADD45GIP1 |
0.0567561060062218 |
|
1972 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DNTTIP2 |
0.0568904042823203 |
|
1973 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GCLM |
0.0568904042823203 |
|
1974 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TTLL7 |
0.0569304010490749 |
|
1975 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRKACB |
0.0569304010490749 |
|
1976 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA2|ENSG00000199959.1 |
0.0569304010490749 |
|
1977 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SAMD13 |
0.0569304010490749 |
|
1978 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UOX |
0.0569304010490749 |
|
1979 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DNASE2B |
0.0569304010490749 |
|
1980 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPF1 |
0.0569465040888062 |
|
1981 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GNG5 |
0.0569465040888062 |
|
1982 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPATA1 |
0.0569465040888062 |
|
1983 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CTBS |
0.0569465040888062 |
|
1984 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C1orf180 |
0.0569465040888062 |
|
1985 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SSX2IP |
0.0569465040888062 |
|
1986 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LMO3 |
0.05717741730584 |
|
1987 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NPAS3 |
0.0572633004958953 |
|
1988 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GCOM1 |
0.0572764838779606 |
|
1989 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
POLR2M |
0.0572764838779606 |
|
1990 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C7orf65 |
0.0573799771360715 |
|
1991 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HUS1 |
0.0573799771360715 |
|
1992 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00525 |
0.0575167701262086 |
|
1993 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PKD1L1 |
0.0575167701262086 |
|
1994 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C7orf69 |
0.0575167701262086 |
|
1995 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SUN3 |
0.057518946173522 |
|
1996 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C7orf57 |
0.057518946173522 |
|
1997 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UPP1 |
0.057518946173522 |
|
1998 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HAS3 |
0.0575953357394524 |
|
1999 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CHTF8 |
0.0575953357394524 |
|
2000 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MUC5AC |
0.0577196219970382 |
|
2001 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MUC5B |
0.0577196219970382 |
|
2002 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TOLLIP |
0.0577196219970382 |
|
2003 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BRSK2 |
0.0577196219970382 |
|
2004 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MOB2 |
0.0577196219970382 |
|
2005 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DUSP8 |
0.0577196219970382 |
|
2006 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CTSD |
0.0577196219970382 |
|
2007 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM99A |
0.0577196219970382 |
|
2008 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM99B |
0.0577196219970382 |
|
2009 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IFITM10 |
0.0577196219970382 |
|
2010 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LSP1|ENSG00000130592.9 |
0.0577196219970382 |
|
2011 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4298 |
0.0577196219970382 |
|
2012 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SYT8 |
0.0577196219970382 |
|
2013 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TNNI2 |
0.0577196219970382 |
|
2014 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C11orf89 |
0.0577196219970382 |
|
2015 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TNNT3 |
0.0577196219970382 |
|
2016 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SBF2 |
0.0578375050330207 |
|
2017 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NFIX |
0.0581740705377726 |
|
2018 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LYL1 |
0.0581740705377726 |
|
2019 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRMT1 |
0.0581740705377726 |
|
2020 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NACC1 |
0.0581740705377726 |
|
2021 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STX10 |
0.0581740705377726 |
|
2022 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IER2 |
0.0581740705377726 |
|
2023 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TP53TG1 |
0.0583098063230575 |
|
2024 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CROT |
0.0583098063230575 |
|
2025 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ABCB4 |
0.0583098063230575 |
|
2026 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UPF2 |
0.058466538205148 |
|
2027 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PIH1 |
0.058527958591616 |
|
2028 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LPPR5 |
0.058681896927846 |
|
2029 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NCOA3 |
0.0587219299212883 |
|
2030 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SULF2 |
0.0587219299212883 |
|
2031 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP486 |
0.0587219299212883 |
|
2032 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD36|ENSG00000252227.1 |
0.0587219299212883 |
|
2033 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00494 |
0.0587219299212883 |
|
2034 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MTPAP |
0.0587268576492899 |
|
2035 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL241P |
0.0587268576492899 |
|
2036 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAP3K8 |
0.0587268576492899 |
|
2037 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF43 |
0.0588258516782104 |
|
2038 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMPRSS4 |
0.0588307634519797 |
|
2039 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCN4B |
0.0588307634519797 |
|
2040 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCN2B |
0.0588307634519797 |
|
2041 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AMICA1 |
0.0588307634519797 |
|
2042 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MPZL3 |
0.0588307634519797 |
|
2043 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MPZL2 |
0.0588307634519797 |
|
2044 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPS2P45 |
0.0588859417679358 |
|
2045 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000239035.1 |
0.0590362792977134 |
|
2046 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00926 |
0.0590362792977134 |
|
2047 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CGNL1 |
0.0590362792977134 |
|
2048 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MYZAP |
0.0590362792977134 |
|
2049 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GFI1 |
0.0592217935902983 |
|
2050 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPL5 |
0.0592217935902983 |
|
2051 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD21 |
0.0592217935902983 |
|
2052 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA66|ENSG00000251795.1 |
0.0592217935902983 |
|
2053 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA66|ENSG00000207523.1 |
0.0592217935902983 |
|
2054 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM69A |
0.0592217935902983 |
|
2055 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA51|ENSG00000207022.1 |
0.0592217935902983 |
|
2056 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL692P |
0.0592217935902983 |
|
2057 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP123 |
0.0592217935902983 |
|
2058 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MTF2 |
0.0592217935902983 |
|
2059 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FMN2 |
0.0592440396130142 |
|
2060 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GREM2 |
0.0592440396130142 |
|
2061 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
F5 |
0.0593487276963203 |
|
2062 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR760 |
0.0593888903202419 |
|
2063 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC25 |
0.0594409325620356 |
|
2064 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ESCO2 |
0.0594409325620356 |
|
2065 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PBK |
0.0594409325620356 |
|
2066 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCARA5 |
0.0594409325620356 |
|
2067 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4287 |
0.0594409325620356 |
|
2068 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NUGGC |
0.0594409325620356 |
|
2069 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ELP3 |
0.0594409325620356 |
|
2070 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C12orf5 |
0.0594690292150328 |
|
2071 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FGF23 |
0.0594690292150328 |
|
2072 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FGF6 |
0.0594690292150328 |
|
2073 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C12orf4 |
0.0594690292150328 |
|
2074 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAD51AP1 |
0.0594690292150328 |
|
2075 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DYRK4 |
0.0594690292150328 |
|
2076 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NDUFA9 |
0.0594690292150328 |
|
2077 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AKAP3 |
0.0594690292150328 |
|
2078 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WWP2 |
0.0594968843992325 |
|
2079 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LDHD |
0.0595972151152381 |
|
2080 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZFP1 |
0.0595972151152381 |
|
2081 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CTRB1 |
0.0595972151152381 |
|
2082 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CTRB2 |
0.0595972151152381 |
|
2083 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BCAR1 |
0.0595972151152381 |
|
2084 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CFDP1 |
0.0595972151152381 |
|
2085 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA76|ENSG00000252122.1 |
0.0595972151152381 |
|
2086 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM170A |
0.0595972151152381 |
|
2087 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CHST6 |
0.0595972151152381 |
|
2088 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACA59|ENSG00000252870.1 |
0.0597015560002871 |
|
2089 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CADM1 |
0.0597015560002871 |
|
2090 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000239153.1 |
0.0597015560002871 |
|
2091 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00900 |
0.0597015560002871 |
|
2092 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CELF5 |
0.0597913365303571 |
|
2093 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NFIC |
0.0597913365303571 |
|
2094 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C19orf77 |
0.0597913365303571 |
|
2095 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DOHH |
0.0597913365303571 |
|
2096 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL866P |
0.0597913365303571 |
|
2097 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FZR1 |
0.0597913365303571 |
|
2098 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD38|ENSG00000252408.1 |
0.0597913365303571 |
|
2099 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C19orf71 |
0.0597913365303571 |
|
2100 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MFSD12 |
0.0597913365303571 |
|
2101 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GIPC3 |
0.0597913365303571 |
|
2102 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HMG20B |
0.0597913365303571 |
|
2103 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AGK |
0.0598084643803517 |
|
2104 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIAA1147 |
0.0598084643803517 |
|
2105 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WEE2 |
0.0598084643803517 |
|
2106 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SSBP1 |
0.0598084643803517 |
|
2107 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TAS2R3 |
0.0598084643803517 |
|
2108 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TAS2R4 |
0.0598084643803517 |
|
2109 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TAS2R5 |
0.0598084643803517 |
|
2110 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRSS37 |
0.0598084643803517 |
|
2111 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR9A3P |
0.0598084643803517 |
|
2112 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR9A1P |
0.0598084643803517 |
|
2113 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR9A4 |
0.0598084643803517 |
|
2114 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLEC5A |
0.0598084643803517 |
|
2115 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TAS2R38 |
0.0598084643803517 |
|
2116 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL392P |
0.0598406612213656 |
|
2117 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GADD45A |
0.0598406612213656 |
|
2118 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GNG12 |
0.0598406612213656 |
|
2119 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DIRAS3 |
0.0598406612213656 |
|
2120 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR1262 |
0.0598406612213656 |
|
2121 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DSCAML1 |
0.0604984025204651 |
|
2122 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AKAP6 |
0.060525048622162 |
|
2123 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL754P |
0.0606869857877035 |
|
2124 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR5699 |
0.0606869857877035 |
|
2125 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRR26 |
0.0606869857877035 |
|
2126 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U3|ENSG00000212165.1 |
0.0609249077725745 |
|
2127 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HNRNPD |
0.0610410094845686 |
|
2128 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD42|ENSG00000202440.1 |
0.0610410094845686 |
|
2129 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HNRNPDL |
0.0610410094845686 |
|
2130 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLEKHA5 |
0.0610507513388298 |
|
2131 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TEX12 |
0.0611061756795084 |
|
2132 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STK33 |
0.0612242078170095 |
|
2133 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EPHX4 |
0.061302500216416 |
|
2134 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
USP1 |
0.0613609824818093 |
|
2135 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNASE9 |
0.0614209205506011 |
|
2136 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNASE11 |
0.0614209205506011 |
|
2137 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNASE12 |
0.0614209205506011 |
|
2138 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR6S1 |
0.0614209205506011 |
|
2139 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANG |
0.0614209205506011 |
|
2140 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNASE4 |
0.0614209205506011 |
|
2141 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RGS7 |
0.0614492308809151 |
|
2142 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FGGY |
0.0616064803353488 |
|
2143 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4711 |
0.0616064803353488 |
|
2144 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HCCAT5 |
0.0617105938559548 |
|
2145 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C16orf47 |
0.0617105938559548 |
|
2146 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRRC8B |
0.0617361694756497 |
|
2147 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EPHX2 |
0.0617441704495785 |
|
2148 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EGLN3 |
0.0618677310924148 |
|
2149 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAB27A |
0.0620606356059579 |
|
2150 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PIGB |
0.0620606356059579 |
|
2151 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCPG1 |
0.0620606356059579 |
|
2152 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR628 |
0.0620606356059579 |
|
2153 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C15orf65 |
0.0620606356059579 |
|
2154 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DYX1C1 |
0.0620606356059579 |
|
2155 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PYGO1 |
0.0620606356059579 |
|
2156 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRTG |
0.0620606356059579 |
|
2157 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NEDD4 |
0.0620606356059579 |
|
2158 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238513.1 |
0.0620606356059579 |
|
2159 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL568P |
0.0620606356059579 |
|
2160 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RFX7 |
0.0620606356059579 |
|
2161 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF280D |
0.0620606356059579 |
|
2162 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPGRIP1 |
0.0622241360810403 |
|
2163 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SUPT16H |
0.0622241360810403 |
|
2164 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CHD8 |
0.0622241360810403 |
|
2165 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD9 |
0.0622241360810403 |
|
2166 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4748 |
0.0624319363822793 |
|
2167 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DEFB118 |
0.0626401831777519 |
|
2168 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DEFB119 |
0.0626401831777519 |
|
2169 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA40|ENSG00000212134.1 |
0.0626401831777519 |
|
2170 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DEFB121 |
0.0626401831777519 |
|
2171 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DEFB122 |
0.0626401831777519 |
|
2172 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DEFB123 |
0.0626401831777519 |
|
2173 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DEFB124 |
0.0626401831777519 |
|
2174 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
REM1 |
0.0626401831777519 |
|
2175 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00028 |
0.0626401831777519 |
|
2176 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HM13 |
0.0626401831777519 |
|
2177 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EBF2 |
0.0626628144986817 |
|
2178 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP258 |
0.0626628144986817 |
|
2179 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCND2 |
0.0629787956331153 |
|
2180 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CELA1 |
0.0629891424075951 |
|
2181 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FXYD2 |
0.0631051838361807 |
|
2182 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMPRSS13 |
0.0631051838361807 |
|
2183 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IL10RA |
0.0631051838361807 |
|
2184 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CPLX2 |
0.0631897800432881 |
|
2185 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
THOC3 |
0.0631897800432881 |
|
2186 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SOX8 |
0.0633441309647147 |
|
2187 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00609 |
0.0633946997087009 |
|
2188 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UBE2I |
0.0634167444461119 |
|
2189 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BAIAP3 |
0.0634167444461119 |
|
2190 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GNPTG |
0.0634167444461119 |
|
2191 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TSR3 |
0.0634167444461119 |
|
2192 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UNKL |
0.0634167444461119 |
|
2193 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C16orf91 |
0.0634167444461119 |
|
2194 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC154 |
0.0634167444461119 |
|
2195 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLCN7 |
0.0634167444461119 |
|
2196 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PTX4 |
0.0634167444461119 |
|
2197 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TELO2 |
0.0634167444461119 |
|
2198 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IFT140 |
0.0634167444461119 |
|
2199 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM204 |
0.0634167444461119 |
|
2200 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM193B |
0.0638493733431561 |
|
2201 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM153B |
0.0643009085403021 |
|
2202 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SIMC1 |
0.0643009085403021 |
|
2203 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIAA1191 |
0.0643009085403021 |
|
2204 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARL10 |
0.0643009085403021 |
|
2205 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR1271 |
0.0643009085403021 |
|
2206 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NOP16 |
0.0643009085403021 |
|
2207 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HIGD2A |
0.0643009085403021 |
|
2208 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLTB |
0.0643009085403021 |
|
2209 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAF2 |
0.0643009085403021 |
|
2210 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNF44 |
0.0643009085403021 |
|
2211 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDHR2 |
0.0643009085403021 |
|
2212 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL684P |
0.0643009085403021 |
|
2213 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPRIN1 |
0.0643009085403021 |
|
2214 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP309 |
0.0645688284215278 |
|
2215 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4418 |
0.0646135202286584 |
|
2216 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BTBD11 |
0.0647180824786763 |
|
2217 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL747P |
0.0647782342410531 |
|
2218 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CIB3 |
0.0649365143701344 |
|
2219 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM32A |
0.0649365143701344 |
|
2220 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AP1M1 |
0.0649365143701344 |
|
2221 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KLF2 |
0.0649365143701344 |
|
2222 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAPK1 |
0.0652760328112313 |
|
2223 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA31|ENSG00000252762.1 |
0.0653506088609247 |
|
2224 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TGIF2 |
0.065424198193781 |
|
2225 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C20orf24 |
0.065424198193781 |
|
2226 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLA2 |
0.065424198193781 |
|
2227 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NDRG3 |
0.065424198193781 |
|
2228 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DSN1 |
0.065424198193781 |
|
2229 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SOGA1 |
0.065424198193781 |
|
2230 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL156P |
0.065424198193781 |
|
2231 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TLDC2 |
0.065424198193781 |
|
2232 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SAMHD1 |
0.065424198193781 |
|
2233 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RBL1 |
0.065424198193781 |
|
2234 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TLL1 |
0.0654760220030493 |
|
2235 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP170 |
0.0654760220030493 |
|
2236 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP171 |
0.0654760220030493 |
|
2237 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FKBP8 |
0.0656651253228464 |
|
2238 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COPE |
0.0656651253228464 |
|
2239 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRTM2 |
0.065742503986397 |
|
2240 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00940 |
0.065742503986397 |
|
2241 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DCP1B |
0.065742503986397 |
|
2242 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CST11 |
0.0658647998309503 |
|
2243 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CST13P |
0.0658647998309503 |
|
2244 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CST8 |
0.0658647998309503 |
|
2245 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CST9L |
0.0658647998309503 |
|
2246 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CSTL1 |
0.0658647998309503 |
|
2247 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
QTRT1 |
0.0658673927789158 |
|
2248 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CACNA1A |
0.0658805679136342 |
|
2249 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HPGDS |
0.0658925774553046 |
|
2250 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCLO |
0.0660124898608929 |
|
2251 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snosnR66 |
0.0660588877203516 |
|
2252 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NCAM1 |
0.0660588877203516 |
|
2253 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UBE3B |
0.0661446102687797 |
|
2254 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MMAB |
0.0661446102687797 |
|
2255 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FICD |
0.0662203439718148 |
|
2256 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MYL9 |
0.0663221918072995 |
|
2257 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
B3GNT3 |
0.0664137546605088 |
|
2258 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
INSL3 |
0.0664137546605088 |
|
2259 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
JAK3 |
0.0664137546605088 |
|
2260 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPL18A |
0.0664137546605088 |
|
2261 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA68|ENSG00000207166.1 |
0.0664137546605088 |
|
2262 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDH1 |
0.0664561300327859 |
|
2263 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP429 |
0.0664561300327859 |
|
2264 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC8A3 |
0.0666249278529144 |
|
2265 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C1R |
0.0669881151385773 |
|
2266 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C1RL |
0.0669881151385773 |
|
2267 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RBP5 |
0.0669881151385773 |
|
2268 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLSTN3 |
0.0669881151385773 |
|
2269 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PEX5 |
0.0669881151385773 |
|
2270 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GNAO1 |
0.066996981260054 |
|
2271 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MT3 |
0.066996981260054 |
|
2272 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MT2A |
0.066996981260054 |
|
2273 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MT1L |
0.066996981260054 |
|
2274 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MT1E |
0.066996981260054 |
|
2275 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MT1M |
0.066996981260054 |
|
2276 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MT1JP |
0.066996981260054 |
|
2277 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MT1A |
0.066996981260054 |
|
2278 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MT1DP |
0.066996981260054 |
|
2279 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MT1B |
0.066996981260054 |
|
2280 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MT1F |
0.066996981260054 |
|
2281 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HNRNPAB |
0.0671045720183596 |
|
2282 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PHYKPL |
0.0671045720183596 |
|
2283 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SRF |
0.0672268372218454 |
|
2284 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CUL9 |
0.0672268372218454 |
|
2285 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZGLP1 |
0.0672463663673999 |
|
2286 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FDX1L |
0.0672463663673999 |
|
2287 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAVER1 |
0.0672463663673999 |
|
2288 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ICAM3 |
0.0672463663673999 |
|
2289 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PDE3A |
0.0672479842846312 |
|
2290 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLCO1C1 |
0.0672479842846312 |
|
2291 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLCO1B1 |
0.0672479842846312 |
|
2292 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GCH1 |
0.0674283115430836 |
|
2293 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNU6ATAC9P |
0.0674283115430836 |
|
2294 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4308 |
0.0674283115430836 |
|
2295 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WSCD2 |
0.067453777955607 |
|
2296 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DNAH2 |
0.0676467417711117 |
|
2297 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KDM6B |
0.0676467417711117 |
|
2298 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CYB5D1 |
0.0676467417711117 |
|
2299 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LSMD1 |
0.0676467417711117 |
|
2300 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM88 |
0.0676467417711117 |
|
2301 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CHD3 |
0.0676467417711117 |
|
2302 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCARNA21|ENSG00000252835.1 |
0.0676467417711117 |
|
2303 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCNAB3 |
0.0676467417711117 |
|
2304 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CNTROB |
0.0676467417711117 |
|
2305 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAPPC1 |
0.0676467417711117 |
|
2306 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GALNT6 |
0.0676791893514535 |
|
2307 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC4A8 |
0.0676791893514535 |
|
2308 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCN8A |
0.0676791893514535 |
|
2309 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACVRL1 |
0.0676791893514535 |
|
2310 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANKRD33 |
0.0676791893514535 |
|
2311 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP480 |
0.0677357559265506 |
|
2312 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ID1 |
0.0677357559265506 |
|
2313 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3193 |
0.0677357559265506 |
|
2314 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HNRNPR |
0.0677588544079841 |
|
2315 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF436 |
0.0677588544079841 |
|
2316 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C1orf213 |
0.0677588544079841 |
|
2317 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HOOK1 |
0.0680924559351037 |
|
2318 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CYP2J2 |
0.0680924559351037 |
|
2319 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3616 |
0.0681290943662368 |
|
2320 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZMYND8 |
0.0681290943662368 |
|
2321 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL243P |
0.0681290943662368 |
|
2322 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DEFB115 |
0.0682968560500578 |
|
2323 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DEFB116 |
0.0682968560500578 |
|
2324 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TPX2 |
0.0682968560500578 |
|
2325 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PELI2 |
0.068518551128593 |
|
2326 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR378G |
0.0685917256220261 |
|
2327 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC44A3 |
0.0685917256220261 |
|
2328 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DNPH1 |
0.0687152741326628 |
|
2329 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TTBK1 |
0.0687152741326628 |
|
2330 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC22A7 |
0.0687152741326628 |
|
2331 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CRIP3 |
0.0687152741326628 |
|
2332 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HAUS2 |
0.0687321560459943 |
|
2333 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WDR59 |
0.0687968147833077 |
|
2334 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DOCK5 |
0.0688076797964515 |
|
2335 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DNM2 |
0.0688347730891696 |
|
2336 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR199A1 |
0.0688347730891696 |
|
2337 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C19orf38 |
0.0688347730891696 |
|
2338 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMED1 |
0.0688347730891696 |
|
2339 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CARM1 |
0.0688347730891696 |
|
2340 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EPS15L1 |
0.0689657621796372 |
|
2341 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL844P |
0.0689657621796372 |
|
2342 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DAND5 |
0.0689662106923288 |
|
2343 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CHST5 |
0.0689891277972651 |
|
2344 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM231 |
0.0689891277972651 |
|
2345 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GABARAPL2 |
0.0689891277972651 |
|
2346 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADAT1 |
0.0689891277972651 |
|
2347 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC6A2 |
0.0690057049791953 |
|
2348 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CES1P1 |
0.0690057049791953 |
|
2349 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CES1 |
0.0690057049791953 |
|
2350 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CES5A |
0.0690057049791953 |
|
2351 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF318 |
0.0690926814049646 |
|
2352 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PTPN1 |
0.0693107737659515 |
|
2353 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL672P |
0.0693107737659515 |
|
2354 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR645 |
0.0693107737659515 |
|
2355 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC35D1 |
0.0695493927576228 |
|
2356 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SOX5 |
0.0696341922030077 |
|
2357 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM63C |
0.0696659786626296 |
|
2358 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GNA11 |
0.0698054221713951 |
|
2359 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GNA15 |
0.0698054221713951 |
|
2360 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
S1PR4 |
0.0698054221713951 |
|
2361 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NCLN |
0.0698054221713951 |
|
2362 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZHX3 |
0.0700126772127719 |
|
2363 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL615P |
0.0700126772127719 |
|
2364 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LPIN3 |
0.0700126772127719 |
|
2365 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EMILIN3 |
0.0700126772127719 |
|
2366 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CHD6 |
0.0700126772127719 |
|
2367 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA26|ENSG00000212224.1 |
0.0700126772127719 |
|
2368 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACVR1B |
0.070022008780536 |
|
2369 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZFP90 |
0.0700864893625154 |
|
2370 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU109|ENSG00000252040.1 |
0.0700864893625154 |
|
2371 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU109|ENSG00000252640.1 |
0.0700864893625154 |
|
2372 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDH3 |
0.0700864893625154 |
|
2373 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CRNDE |
0.0700981852597529 |
|
2374 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IRX5 |
0.0700981852597529 |
|
2375 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL841P |
0.0700981852597529 |
|
2376 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IRX6 |
0.0700981852597529 |
|
2377 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MMP2 |
0.0700981852597529 |
|
2378 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LPCAT2 |
0.0700981852597529 |
|
2379 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CAPNS2 |
0.0700981852597529 |
|
2380 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR1260A |
0.070295318410582 |
|
2381 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NGB |
0.070295318410582 |
|
2382 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
POMT2 |
0.070295318410582 |
|
2383 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GUCY2D |
0.0703272101137421 |
|
2384 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SSTR4 |
0.0703974416115239 |
|
2385 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
THBD |
0.0703974416115239 |
|
2386 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TEAD1 |
0.0706661676794929 |
|
2387 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCARNA16|ENSG00000252329.1 |
0.0706661676794929 |
|
2388 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00958 |
0.0706661676794929 |
|
2389 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HTR1D |
0.070683368343652 |
|
2390 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PEX26 |
0.0709279746412786 |
|
2391 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TUBA8 |
0.0709279746412786 |
|
2392 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AIFM3 |
0.0709279746412786 |
|
2393 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARVCF |
0.0709279746412786 |
|
2394 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BCRP2 |
0.0709279746412786 |
|
2395 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C22orf29 |
0.0709279746412786 |
|
2396 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C22orf39 |
0.0709279746412786 |
|
2397 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC116 |
0.0709279746412786 |
|
2398 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDC45 |
0.0709279746412786 |
|
2399 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLDN5 |
0.0709279746412786 |
|
2400 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLTCL1 |
0.0709279746412786 |
|
2401 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COMT |
0.0709279746412786 |
|
2402 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CRKL |
0.0709279746412786 |
|
2403 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DGCR14 |
0.0709279746412786 |
|
2404 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DGCR2 |
0.0709279746412786 |
|
2405 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DGCR5 |
0.0709279746412786 |
|
2406 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DGCR6L |
0.0709279746412786 |
|
2407 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DGCR6 |
0.0709279746412786 |
|
2408 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DGCR8 |
0.0709279746412786 |
|
2409 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM230A |
0.0709279746412786 |
|
2410 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM230B |
0.0709279746412786 |
|
2411 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM230C |
0.0709279746412786 |
|
2412 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GGT2 |
0.0709279746412786 |
|
2413 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GGT3P |
0.0709279746412786 |
|
2414 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GGTLC3 |
0.0709279746412786 |
|
2415 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GNB1L |
0.0709279746412786 |
|
2416 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GP1BB |
0.0709279746412786 |
|
2417 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GSC2 |
0.0709279746412786 |
|
2418 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HIC2 |
0.0709279746412786 |
|
2419 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HIRA |
0.0709279746412786 |
|
2420 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KLHL22 |
0.0709279746412786 |
|
2421 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LZTR1 |
0.0709279746412786 |
|
2422 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MED15 |
0.0709279746412786 |
|
2423 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR1286 |
0.0709279746412786 |
|
2424 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR1306 |
0.0709279746412786 |
|
2425 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR130B |
0.0709279746412786 |
|
2426 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR185 |
0.0709279746412786 |
|
2427 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR301B |
0.0709279746412786 |
|
2428 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3618 |
0.0709279746412786 |
|
2429 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4761 |
0.0709279746412786 |
|
2430 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR649 |
0.0709279746412786 |
|
2431 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MRPL40 |
0.0709279746412786 |
|
2432 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
P2RX6P |
0.0709279746412786 |
|
2433 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
P2RX6 |
0.0709279746412786 |
|
2434 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PI4KAP1 |
0.0709279746412786 |
|
2435 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PI4KAP2 |
0.0709279746412786 |
|
2436 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PI4KA |
0.0709279746412786 |
|
2437 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
POM121L4P |
0.0709279746412786 |
|
2438 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
POM121L7 |
0.0709279746412786 |
|
2439 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPIL2 |
0.0709279746412786 |
|
2440 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRODH |
0.0709279746412786 |
|
2441 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RANBP1 |
0.0709279746412786 |
|
2442 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RIMBP3B |
0.0709279746412786 |
|
2443 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RIMBP3C |
0.0709279746412786 |
|
2444 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RIMBP3 |
0.0709279746412786 |
|
2445 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP131 |
0.0709279746412786 |
|
2446 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP221 |
0.0709279746412786 |
|
2447 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP63 |
0.0709279746412786 |
|
2448 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL168P |
0.0709279746412786 |
|
2449 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL280P |
0.0709279746412786 |
|
2450 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL389P |
0.0709279746412786 |
|
2451 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL812P |
0.0709279746412786 |
|
2452 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RTN4R |
0.0709279746412786 |
|
2453 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCARF2 |
0.0709279746412786 |
|
2454 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCARNA17|ENSG00000252020.1 |
0.0709279746412786 |
|
2455 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCARNA17|ENSG00000252143.1 |
0.0709279746412786 |
|
2456 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCARNA17|ENSG00000252571.1 |
0.0709279746412786 |
|
2457 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCARNA18|ENSG00000252024.1 |
0.0709279746412786 |
|
2458 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCARNA18|ENSG00000252314.1 |
0.0709279746412786 |
|
2459 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCARNA18|ENSG00000252605.1 |
0.0709279746412786 |
|
2460 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SDF2L1 |
0.0709279746412786 |
|
2461 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SEPT5 |
0.0709279746412786 |
|
2462 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SERPIND1 |
0.0709279746412786 |
|
2463 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC25A1 |
0.0709279746412786 |
|
2464 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC7A4 |
0.0709279746412786 |
|
2465 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SMPD4P1 |
0.0709279746412786 |
|
2466 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNAP29 |
0.0709279746412786 |
|
2467 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA15|ENSG00000251940.1 |
0.0709279746412786 |
|
2468 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA77|ENSG00000264346.1 |
0.0709279746412786 |
|
2469 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TANGO2 |
0.0709279746412786 |
|
2470 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TBX1 |
0.0709279746412786 |
|
2471 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
THAP7 |
0.0709279746412786 |
|
2472 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM191A |
0.0709279746412786 |
|
2473 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM191C |
0.0709279746412786 |
|
2474 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRMT2A |
0.0709279746412786 |
|
2475 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TSSK2 |
0.0709279746412786 |
|
2476 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TUBA3FP |
0.0709279746412786 |
|
2477 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TXNRD2 |
0.0709279746412786 |
|
2478 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UBE2L3 |
0.0709279746412786 |
|
2479 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UFD1L |
0.0709279746412786 |
|
2480 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
USP18 |
0.0709279746412786 |
|
2481 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
USP41 |
0.0709279746412786 |
|
2482 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
YDJC |
0.0709279746412786 |
|
2483 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
YPEL1 |
0.0709279746412786 |
|
2484 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZDHHC8 |
0.0709279746412786 |
|
2485 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF74 |
0.0709279746412786 |
|
2486 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000252402.1 |
0.0709279746412786 |
|
2487 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000252799.1 |
0.0709279746412786 |
|
2488 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000271796.1 |
0.0709279746412786 |
|
2489 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EYA2 |
0.0711851509567644 |
|
2490 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP469 |
0.0712226407778032 |
|
2491 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BCAS1 |
0.0713380178766366 |
|
2492 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4756 |
0.0713380178766366 |
|
2493 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CYP24A1 |
0.0713380178766366 |
|
2494 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZEB1 |
0.0713382686813435 |
|
2495 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ABCC10 |
0.0714259945893775 |
|
2496 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DLK2 |
0.0714259945893775 |
|
2497 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TJAP1 |
0.0714259945893775 |
|
2498 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRRC73 |
0.0714259945893775 |
|
2499 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
POLR1C |
0.0714259945893775 |
|
2500 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
YIPF3 |
0.0714259945893775 |
|
2501 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
XPO5 |
0.0714259945893775 |
|
2502 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCARNA15|ENSG00000252218.1 |
0.0714259945893775 |
|
2503 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCYL2 |
0.0714472455073125 |
|
2504 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP151 |
0.0714913948416769 |
|
2505 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GSTZ1 |
0.0715925383239592 |
|
2506 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMED8 |
0.0715925383239592 |
|
2507 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL137P |
0.0715925383239592 |
|
2508 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SAMD15 |
0.0715925383239592 |
|
2509 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NOXRED1 |
0.0715925383239592 |
|
2510 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FKSG61 |
0.0715925383239592 |
|
2511 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR920 |
0.0721178146956361 |
|
2512 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLA2G4D |
0.0721753727289796 |
|
2513 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLA2G4F |
0.0721753727289796 |
|
2514 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VPS39 |
0.0721753727289796 |
|
2515 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR627 |
0.0721753727289796 |
|
2516 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM87A |
0.0721753727289796 |
|
2517 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC37A3 |
0.07224084090547 |
|
2518 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAB19 |
0.07224084090547 |
|
2519 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP247 |
0.07224084090547 |
|
2520 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP248 |
0.07224084090547 |
|
2521 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238868.1 |
0.07224084090547 |
|
2522 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MKRN1 |
0.07224084090547 |
|
2523 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DENND2A |
0.07224084090547 |
|
2524 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL771P |
0.07224084090547 |
|
2525 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PTK7 |
0.0723506783568739 |
|
2526 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR422A |
0.0723616828634888 |
|
2527 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF100 |
0.0724287684279623 |
|
2528 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238763.1 |
0.0724373114040509 |
|
2529 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GTPBP2 |
0.0725020335906115 |
|
2530 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAD2L1BP |
0.0725020335906115 |
|
2531 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RSPH9 |
0.0725020335906115 |
|
2532 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MRPS18A |
0.0725020335906115 |
|
2533 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VEGFA |
0.0725020335906115 |
|
2534 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC17A8 |
0.0725394323058974 |
|
2535 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SYNDIG1 |
0.0725579334527081 |
|
2536 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GINS1 |
0.0725579334527081 |
|
2537 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NINL |
0.0725579334527081 |
|
2538 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNU6ATAC17P |
0.0725579334527081 |
|
2539 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NANP |
0.0725579334527081 |
|
2540 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL594P |
0.0725579334527081 |
|
2541 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF337 |
0.0725579334527081 |
|
2542 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C22orf43 |
0.0726075434457933 |
|
2543 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IGLL1 |
0.0726075434457933 |
|
2544 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ITGA5 |
0.0726098223845608 |
|
2545 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VWC2 |
0.072714516225177 |
|
2546 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZPBP |
0.072714516225177 |
|
2547 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
POLH |
0.0727149569500357 |
|
2548 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NR1H4 |
0.0727750885853302 |
|
2549 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TTI2 |
0.0731441410326777 |
|
2550 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAK16 |
0.0731441410326777 |
|
2551 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMED9 |
0.0731729658491365 |
|
2552 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
B4GALT7 |
0.0731729658491365 |
|
2553 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPM1F |
0.0733571559028515 |
|
2554 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BCR |
0.0733571559028515 |
|
2555 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CES5AP1 |
0.0733571559028515 |
|
2556 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GGTLC2 |
0.0733571559028515 |
|
2557 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GNAZ |
0.0733571559028515 |
|
2558 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IGLC1 |
0.0733571559028515 |
|
2559 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IGLC2 |
0.0733571559028515 |
|
2560 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IGLC3 |
0.0733571559028515 |
|
2561 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IGLC7 |
0.0733571559028515 |
|
2562 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IGLJ1 |
0.0733571559028515 |
|
2563 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IGLJ2 |
0.0733571559028515 |
|
2564 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IGLJ3 |
0.0733571559028515 |
|
2565 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IGLJ4 |
0.0733571559028515 |
|
2566 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IGLJ5 |
0.0733571559028515 |
|
2567 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IGLJ6 |
0.0733571559028515 |
|
2568 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IGLJ7 |
0.0733571559028515 |
|
2569 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IGLL5 |
0.0733571559028515 |
|
2570 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR650 |
0.0733571559028515 |
|
2571 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
POM121L1P |
0.0733571559028515 |
|
2572 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRAMEF24P |
0.0733571559028515 |
|
2573 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRAME |
0.0733571559028515 |
|
2574 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAB36 |
0.0733571559028515 |
|
2575 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL263P |
0.0733571559028515 |
|
2576 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RTDR1 |
0.0733571559028515 |
|
2577 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TOP3B |
0.0733571559028515 |
|
2578 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VPREB1 |
0.0733571559028515 |
|
2579 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZDHHC8P1 |
0.0733571559028515 |
|
2580 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF280A |
0.0733571559028515 |
|
2581 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF280B |
0.0733571559028515 |
|
2582 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000239066.1 |
0.0733571559028515 |
|
2583 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DOCK7 |
0.073733113346624 |
|
2584 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KLC2 |
0.0737918982016956 |
|
2585 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAB1B |
0.0737918982016956 |
|
2586 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CNIH2 |
0.0737918982016956 |
|
2587 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
YIF1A |
0.0737918982016956 |
|
2588 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FLRT3 |
0.0738448689204877 |
|
2589 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARHGAP29 |
0.0739655764177009 |
|
2590 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL440P |
0.0739655764177009 |
|
2591 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238389.1 |
0.0739655764177009 |
|
2592 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC7A2 |
0.0741180316144517 |
|
2593 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PDGFRL |
0.0741180316144517 |
|
2594 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MTUS1 |
0.0741180316144517 |
|
2595 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR548V |
0.0741180316144517 |
|
2596 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM222 |
0.074284152261947 |
|
2597 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SYTL1 |
0.074284152261947 |
|
2598 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAP3K6 |
0.074284152261947 |
|
2599 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FCN3 |
0.074284152261947 |
|
2600 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CD164L2 |
0.074284152261947 |
|
2601 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPR3 |
0.074284152261947 |
|
2602 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WASF2 |
0.074284152261947 |
|
2603 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MT4 |
0.0744713094651318 |
|
2604 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANO2 |
0.0745689209547542 |
|
2605 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
S1PR5 |
0.0748480957931428 |
|
2606 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SQRDL |
0.074891203650764 |
|
2607 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KRT18 |
0.0748969666119143 |
|
2608 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNF122 |
0.0748995274133529 |
|
2609 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF431 |
0.0755749324615813 |
|
2610 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL235P |
0.0756301754494699 |
|
2611 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BRDT |
0.0756301754494699 |
|
2612 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BTBD8 |
0.0756301754494699 |
|
2613 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FTSJD1 |
0.0756510676374663 |
|
2614 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CALB2 |
0.0756510676374663 |
|
2615 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF23 |
0.0756510676374663 |
|
2616 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF19 |
0.0756510676374663 |
|
2617 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CHST4 |
0.0756510676374663 |
|
2618 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TAT |
0.0756510676374663 |
|
2619 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MARVELD3 |
0.0756510676374663 |
|
2620 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PHLPP2 |
0.0756510676374663 |
|
2621 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA70D |
0.0756510676374663 |
|
2622 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AP1G1 |
0.0756510676374663 |
|
2623 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD71 |
0.0756510676374663 |
|
2624 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATXN1L |
0.0756510676374663 |
|
2625 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TBXA2R |
0.0758780825249817 |
|
2626 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CACTIN |
0.0758780825249817 |
|
2627 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PIP5K1C |
0.0758780825249817 |
|
2628 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TJP3 |
0.0758780825249817 |
|
2629 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
APBA3 |
0.0758780825249817 |
|
2630 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MRPL54 |
0.0758780825249817 |
|
2631 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAX2 |
0.0758780825249817 |
|
2632 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MATK |
0.0758780825249817 |
|
2633 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZFR2 |
0.0758780825249817 |
|
2634 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP475 |
0.0760978128754901 |
|
2635 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BLOC1S6 |
0.0761866594098531 |
|
2636 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PTPRT |
0.0762009643431131 |
|
2637 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TCTEX1D1 |
0.0765043518602584 |
|
2638 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
INSL5 |
0.0765043518602584 |
|
2639 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WDR78 |
0.0765043518602584 |
|
2640 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DMAP1 |
0.0766110482428125 |
|
2641 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ERI3 |
0.0766110482428125 |
|
2642 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DDX41 |
0.0767455166259148 |
|
2643 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPR61 |
0.0767947993891446 |
|
2644 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GNAI3 |
0.0767947993891446 |
|
2645 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNU6V |
0.0767947993891446 |
|
2646 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR197 |
0.0767947993891446 |
|
2647 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GNAT2 |
0.0767947993891446 |
|
2648 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AMPD2 |
0.0767947993891446 |
|
2649 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GSTM1 |
0.0767947993891446 |
|
2650 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GSTM2 |
0.0767947993891446 |
|
2651 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GSTM4 |
0.0767947993891446 |
|
2652 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GSTM5 |
0.0767947993891446 |
|
2653 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GSTM3 |
0.0767947993891446 |
|
2654 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EPS8L3 |
0.0767947993891446 |
|
2655 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARL2BP |
0.0770392488656575 |
|
2656 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLLP |
0.0770392488656575 |
|
2657 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCL22 |
0.0770392488656575 |
|
2658 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CX3CL1 |
0.0770392488656575 |
|
2659 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STMN4 |
0.0771413090640881 |
|
2660 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANGPTL3 |
0.0773413223873206 |
|
2661 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF106 |
0.0773948468105901 |
|
2662 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNAP23 |
0.0773948468105901 |
|
2663 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRRC57 |
0.0773948468105901 |
|
2664 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCNN1A |
0.0775673488658775 |
|
2665 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U3|ENSG00000200545.1 |
0.077628129713125 |
|
2666 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP303 |
0.077628129713125 |
|
2667 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KXD1 |
0.0777007272151147 |
|
2668 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CRLF1 |
0.0777007272151147 |
|
2669 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UBA52 |
0.0777007272151147 |
|
2670 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C19orf60 |
0.0777007272151147 |
|
2671 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM59L |
0.0777007272151147 |
|
2672 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL155P |
0.0777007272151147 |
|
2673 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KLHL26 |
0.0777007272151147 |
|
2674 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CRTC1 |
0.0777007272151147 |
|
2675 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COMP |
0.0777007272151147 |
|
2676 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UPF1 |
0.0777007272151147 |
|
2677 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CERS1 |
0.0777007272151147 |
|
2678 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GDF1 |
0.0777007272151147 |
|
2679 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR5100 |
0.0780578097493718 |
|
2680 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UNC13C |
0.0782906369063687 |
|
2681 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATP9A |
0.0783608180495065 |
|
2682 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SALL4 |
0.0783608180495065 |
|
2683 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL603P |
0.0783608180495065 |
|
2684 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SAMD4A |
0.0783669900902083 |
|
2685 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPR56 |
0.0783692980363949 |
|
2686 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPR97 |
0.0783692980363949 |
|
2687 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC135 |
0.0783692980363949 |
|
2688 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KATNB1 |
0.0783692980363949 |
|
2689 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIFC3 |
0.0783692980363949 |
|
2690 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CNGB1 |
0.0783692980363949 |
|
2691 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SUGP2 |
0.0783838840134425 |
|
2692 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARMC6 |
0.0783838840134425 |
|
2693 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DAPK2 |
0.0784507303480949 |
|
2694 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM96A |
0.0784507303480949 |
|
2695 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNX1 |
0.0784507303480949 |
|
2696 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNX22 |
0.0784507303480949 |
|
2697 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPIB |
0.0784507303480949 |
|
2698 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CSNK1G1 |
0.0784507303480949 |
|
2699 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR7A5 |
0.0788192424307462 |
|
2700 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR7A10 |
0.0788192424307462 |
|
2701 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238624.1 |
0.0790263640577411 |
|
2702 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CYP4Z2P |
0.0790689974748784 |
|
2703 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CYP4A11 |
0.0790689974748784 |
|
2704 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CYP4X1 |
0.0790689974748784 |
|
2705 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CYP4Z1 |
0.0790689974748784 |
|
2706 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CYP4A22 |
0.0790689974748784 |
|
2707 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00853 |
0.0790689974748784 |
|
2708 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PDZK1IP1 |
0.0790689974748784 |
|
2709 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TAL1 |
0.0790689974748784 |
|
2710 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STIL |
0.0790689974748784 |
|
2711 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CMPK1 |
0.0790689974748784 |
|
2712 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FOXE3 |
0.0790689974748784 |
|
2713 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FOXD2 |
0.0790689974748784 |
|
2714 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP264 |
0.0794699393031235 |
|
2715 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCNU1 |
0.0794699393031235 |
|
2716 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCL17 |
0.0797165461830072 |
|
2717 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CIAPIN1 |
0.0797165461830072 |
|
2718 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HERPUD1 |
0.0797383483543075 |
|
2719 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CETP |
0.0797383483543075 |
|
2720 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NLRC5 |
0.0797383483543075 |
|
2721 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAU2 |
0.0799807456603093 |
|
2722 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GATAD2A |
0.0799807456603093 |
|
2723 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KRT86 |
0.0799965487887145 |
|
2724 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GOLT1B |
0.0801055493741246 |
|
2725 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C12orf39 |
0.0801055493741246 |
|
2726 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GYS2 |
0.0801055493741246 |
|
2727 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GANC |
0.0801286735443774 |
|
2728 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CAPN3 |
0.0801286735443774 |
|
2729 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM138F |
0.0801389943205394 |
|
2730 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR4F17 |
0.0801389943205394 |
|
2731 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPAP2C |
0.0801389943205394 |
|
2732 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WASH5P |
0.0801389943205394 |
|
2733 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIER2 |
0.0801389943205394 |
|
2734 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
THEG |
0.0801389943205394 |
|
2735 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C2CD4C |
0.0801389943205394 |
|
2736 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SHC2 |
0.0801389943205394 |
|
2737 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP462 |
0.0801389943205394 |
|
2738 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ODF3L2 |
0.0801389943205394 |
|
2739 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TSHZ2 |
0.0801995070311163 |
|
2740 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF217 |
0.0801995070311163 |
|
2741 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF208 |
0.0802871575113234 |
|
2742 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GALNT8 |
0.0803737213365385 |
|
2743 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCNA6 |
0.0803737213365385 |
|
2744 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCNA1 |
0.0803737213365385 |
|
2745 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCNA5 |
0.0803737213365385 |
|
2746 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ELL |
0.0804594194352792 |
|
2747 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP247 |
0.0806034856859863 |
|
2748 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
INSC |
0.0808722886152925 |
|
2749 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LPAR3 |
0.0809107518876355 |
|
2750 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATCAY |
0.0809278415294024 |
|
2751 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL202P |
0.0809278415294024 |
|
2752 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NMRK2 |
0.0809278415294024 |
|
2753 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DAPK3 |
0.0809278415294024 |
|
2754 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR637 |
0.0809278415294024 |
|
2755 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EEF2 |
0.0809278415294024 |
|
2756 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD37|ENSG00000206775.1 |
0.0809278415294024 |
|
2757 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PIAS4 |
0.0809278415294024 |
|
2758 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM151B |
0.0811413902227223 |
|
2759 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KRT8 |
0.0812546840276358 |
|
2760 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIAA1107 |
0.0813824063945651 |
|
2761 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C1orf146 |
0.0813824063945651 |
|
2762 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACTBP12 |
0.0813824063945651 |
|
2763 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GLMN |
0.0813824063945651 |
|
2764 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPAP2 |
0.0813824063945651 |
|
2765 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL824P |
0.0813824063945651 |
|
2766 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C16orf74 |
0.0814017994582944 |
|
2767 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR1910 |
0.0814017994582944 |
|
2768 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EMC8 |
0.0814017994582944 |
|
2769 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COX4I1 |
0.0814017994582944 |
|
2770 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR5584 |
0.0814365169820862 |
|
2771 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MYO18B |
0.0816106980633733 |
|
2772 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LPHN2 |
0.0817464368116606 |
|
2773 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC146 |
0.0820178872480515 |
|
2774 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TCEA3 |
0.0820182261594035 |
|
2775 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ASAP3 |
0.0820182261594035 |
|
2776 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NME7 |
0.0820874899874648 |
|
2777 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BLZF1 |
0.0820874899874648 |
|
2778 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC181 |
0.0820874899874648 |
|
2779 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC19A2 |
0.0820874899874648 |
|
2780 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SELP |
0.0820874899874648 |
|
2781 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C1orf112 |
0.0820874899874648 |
|
2782 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SELL |
0.0820874899874648 |
|
2783 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SELE |
0.0820874899874648 |
|
2784 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
METTL18 |
0.0820874899874648 |
|
2785 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCYL3 |
0.0820874899874648 |
|
2786 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL333P |
0.0820874899874648 |
|
2787 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIFAP3 |
0.0820874899874648 |
|
2788 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL269P |
0.0820874899874648 |
|
2789 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
METTL11B |
0.0820874899874648 |
|
2790 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GORAB |
0.0820874899874648 |
|
2791 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD65|ENSG00000238936.1 |
0.0822552548978717 |
|
2792 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CACNA1H |
0.082262304767168 |
|
2793 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRSS29P |
0.082262304767168 |
|
2794 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TPSAB1 |
0.082262304767168 |
|
2795 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TPSB2 |
0.082262304767168 |
|
2796 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TPSD1 |
0.082262304767168 |
|
2797 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TPSG1 |
0.082262304767168 |
|
2798 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CASP14 |
0.0825993181362623 |
|
2799 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR1I1 |
0.0825993181362623 |
|
2800 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SYDE1 |
0.0825993181362623 |
|
2801 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ILVBL |
0.0825993181362623 |
|
2802 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AK4 |
0.0826194712870302 |
|
2803 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL69P |
0.0827018073079565 |
|
2804 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CD27 |
0.0827018073079565 |
|
2805 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA25|ENSG00000251735.1 |
0.0830407749530101 |
|
2806 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TAS2R40 |
0.0830729893199904 |
|
2807 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GSTK1 |
0.0830729893199904 |
|
2808 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM139 |
0.0830729893199904 |
|
2809 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CASP2 |
0.0830729893199904 |
|
2810 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL535P |
0.0830729893199904 |
|
2811 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL481P |
0.0830729893199904 |
|
2812 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLCN1 |
0.0830729893199904 |
|
2813 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM131B |
0.0830729893199904 |
|
2814 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZYX |
0.0830729893199904 |
|
2815 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EPHA1 |
0.0830729893199904 |
|
2816 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF714 |
0.0832546332632477 |
|
2817 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SSBP4 |
0.0833302483533584 |
|
2818 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ISYNA1 |
0.0833302483533584 |
|
2819 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GRID2 |
0.083360599215077 |
|
2820 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
INSM2 |
0.0833955581953603 |
|
2821 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COL5A3 |
0.0836334751867764 |
|
2822 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RDH8 |
0.0836334751867764 |
|
2823 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR5589 |
0.0836334751867764 |
|
2824 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
P2RY11 |
0.0836334751867764 |
|
2825 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD105B |
0.0836334751867764 |
|
2826 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EIF3G |
0.0836334751867764 |
|
2827 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DNMT1 |
0.0836334751867764 |
|
2828 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KRT16P3 |
0.0837928026780633 |
|
2829 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LGALS9B |
0.0837928026780633 |
|
2830 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NOS2P3 |
0.0837928026780633 |
|
2831 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDRT15L2 |
0.0837928026780633 |
|
2832 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC144NL |
0.0837928026780633 |
|
2833 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
USP22 |
0.0837928026780633 |
|
2834 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4425 |
0.0838519901787949 |
|
2835 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C10orf68 |
0.0840275559153942 |
|
2836 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA40|ENSG00000264043.2 |
0.0840830236264473 |
|
2837 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SSH1 |
0.0840830236264473 |
|
2838 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR619 |
0.0840830236264473 |
|
2839 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DAO |
0.0840830236264473 |
|
2840 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZFP64 |
0.0843137786343807 |
|
2841 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR640 |
0.0844413060766975 |
|
2842 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
POLD4 |
0.0844873293205328 |
|
2843 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP239 |
0.0844873293205328 |
|
2844 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLCF1 |
0.0844873293205328 |
|
2845 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAD9A |
0.0844873293205328 |
|
2846 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPP1CA |
0.0844873293205328 |
|
2847 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TBC1D10C |
0.0844873293205328 |
|
2848 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UBL4B |
0.084527401621877 |
|
2849 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZP3 |
0.0846158677589121 |
|
2850 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DTX2 |
0.0846158677589121 |
|
2851 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
POMZP3 |
0.0846158677589121 |
|
2852 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UPK3B |
0.0846158677589121 |
|
2853 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GLG1 |
0.0846165280759269 |
|
2854 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RFWD3 |
0.0846165280759269 |
|
2855 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MLKL |
0.0846165280759269 |
|
2856 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FA2H |
0.0846165280759269 |
|
2857 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238748.1 |
0.0847898466874257 |
|
2858 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CPNE2 |
0.0848187112983189 |
|
2859 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LTBR |
0.0848851372000624 |
|
2860 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR7A17 |
0.084999189296505 |
|
2861 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RSPRY1 |
0.0851060496073497 |
|
2862 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4693 |
0.0851734909236689 |
|
2863 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PDGFD |
0.0851734909236689 |
|
2864 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DDI1 |
0.0851734909236689 |
|
2865 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP348 |
0.0851734909236689 |
|
2866 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP164 |
0.0852579563324832 |
|
2867 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATOH1 |
0.0852579563324832 |
|
2868 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SMARCAD1 |
0.0852579563324832 |
|
2869 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IRF2BPL |
0.0852704912533218 |
|
2870 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF821 |
0.0853176967678194 |
|
2871 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IST1 |
0.0853176967678194 |
|
2872 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLEC18A |
0.0853286343166531 |
|
2873 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLEC18C |
0.0853286343166531 |
|
2874 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PDPR |
0.0853286343166531 |
|
2875 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PDXDC2P |
0.0853286343166531 |
|
2876 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PWP1 |
0.0856455184447195 |
|
2877 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRDM4 |
0.0856455184447195 |
|
2878 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ASCL4 |
0.0856455184447195 |
|
2879 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CRAMP1L |
0.085738431839862 |
|
2880 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TYK2 |
0.085762496485387 |
|
2881 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDC37 |
0.085762496485387 |
|
2882 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR1181 |
0.085762496485387 |
|
2883 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PDE4A |
0.085762496485387 |
|
2884 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SFXN2 |
0.085820935698374 |
|
2885 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DLGAP4 |
0.0858539545576932 |
|
2886 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
YWHAG |
0.0859452565532016 |
|
2887 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SRCRB4D |
0.0859452565532016 |
|
2888 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMED5 |
0.0859953605379106 |
|
2889 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DDX49 |
0.0861642994571929 |
|
2890 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HOMER3 |
0.0861642994571929 |
|
2891 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL70P |
0.0861642994571929 |
|
2892 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC25A42 |
0.0861642994571929 |
|
2893 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM161A |
0.0861642994571929 |
|
2894 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP301 |
0.0862144167221094 |
|
2895 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SHF |
0.0862833322376254 |
|
2896 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA11|ENSG00000261709.2 |
0.0862833322376254 |
|
2897 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RANBP10 |
0.0863237528096563 |
|
2898 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TSNAXIP1 |
0.0863237528096563 |
|
2899 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CENPT |
0.0863237528096563 |
|
2900 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
THAP11 |
0.0863237528096563 |
|
2901 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NUTF2 |
0.0863237528096563 |
|
2902 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EDC4 |
0.0863237528096563 |
|
2903 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NRN1L |
0.0863237528096563 |
|
2904 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PSKH1 |
0.0863237528096563 |
|
2905 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CTRL |
0.0863237528096563 |
|
2906 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PSMB10 |
0.0863237528096563 |
|
2907 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LCAT |
0.0863237528096563 |
|
2908 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC12A4 |
0.0863237528096563 |
|
2909 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DUS2L |
0.0863237528096563 |
|
2910 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NFATC3 |
0.0863237528096563 |
|
2911 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA48|ENSG00000212445.1 |
0.0863237528096563 |
|
2912 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ESRP2 |
0.0863237528096563 |
|
2913 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLA2G15 |
0.0863237528096563 |
|
2914 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC7A6 |
0.0863237528096563 |
|
2915 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC7A6OS |
0.0863237528096563 |
|
2916 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRMT7 |
0.0863237528096563 |
|
2917 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238343.1 |
0.0863237528096563 |
|
2918 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SMPD3 |
0.0863237528096563 |
|
2919 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIF2C |
0.0864435209278895 |
|
2920 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BEST4 |
0.0864435209278895 |
|
2921 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BTBD19 |
0.0864435209278895 |
|
2922 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLK3 |
0.0864435209278895 |
|
2923 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPS8 |
0.0864435209278895 |
|
2924 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD38A |
0.0864435209278895 |
|
2925 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD38B |
0.0864435209278895 |
|
2926 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD46|ENSG00000200913.1 |
0.0864435209278895 |
|
2927 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD55 |
0.0864435209278895 |
|
2928 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TCTEX1D4 |
0.0864435209278895 |
|
2929 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TESK2 |
0.0864435209278895 |
|
2930 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CNTNAP2 |
0.0865310153956782 |
|
2931 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MRPS33 |
0.0865776583950366 |
|
2932 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM178B |
0.0865776583950366 |
|
2933 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FTO |
0.0866036388500487 |
|
2934 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADAMTS18 |
0.0866963822469003 |
|
2935 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KRT81 |
0.0867109955862653 |
|
2936 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KRT83 |
0.0867109955862653 |
|
2937 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KRT84 |
0.0867109955862653 |
|
2938 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KRT85 |
0.0867109955862653 |
|
2939 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KRT82 |
0.0867109955862653 |
|
2940 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KRT6B |
0.0867109955862653 |
|
2941 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KRT6C |
0.0867109955862653 |
|
2942 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KRT75 |
0.0867109955862653 |
|
2943 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KRT6A |
0.0867109955862653 |
|
2944 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KRT5 |
0.0867109955862653 |
|
2945 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KRT71 |
0.0867109955862653 |
|
2946 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KRT74 |
0.0867109955862653 |
|
2947 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KRT72 |
0.0867109955862653 |
|
2948 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KRT73 |
0.0867109955862653 |
|
2949 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KRT2 |
0.0867109955862653 |
|
2950 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KRT1 |
0.0867109955862653 |
|
2951 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KRT77 |
0.0867109955862653 |
|
2952 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TGM5 |
0.0867911350986625 |
|
2953 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CSF1 |
0.0868755381096344 |
|
2954 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIAA0391 |
0.0869527409438901 |
|
2955 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EPB42 |
0.0870249196574625 |
|
2956 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM62 |
0.0870249196574625 |
|
2957 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NDUFA13 |
0.0871600330465391 |
|
2958 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
YJEFN3 |
0.0871600330465391 |
|
2959 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CILP2 |
0.0871600330465391 |
|
2960 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PBX4 |
0.0871600330465391 |
|
2961 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MTRNR2L6 |
0.0872425296482157 |
|
2962 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRSS1 |
0.0872425296482157 |
|
2963 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRSS3P2 |
0.0872425296482157 |
|
2964 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRSS3P3 |
0.0872425296482157 |
|
2965 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRBC2 |
0.0872425296482157 |
|
2966 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRBV19 |
0.0872425296482157 |
|
2967 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRBV27 |
0.0872425296482157 |
|
2968 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRBV28 |
0.0872425296482157 |
|
2969 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRBV2 |
0.0872425296482157 |
|
2970 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRBV9 |
0.0872425296482157 |
|
2971 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR7C2 |
0.0872450239961198 |
|
2972 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC1A6 |
0.0872450239961198 |
|
2973 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC105 |
0.0872450239961198 |
|
2974 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BIN2 |
0.0872760903020525 |
|
2975 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATF1 |
0.087277065952016 |
|
2976 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL519P |
0.087277065952016 |
|
2977 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMPRSS12 |
0.087277065952016 |
|
2978 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
METTL7A |
0.087277065952016 |
|
2979 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DENND4B |
0.087449940774134 |
|
2980 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CRTC2 |
0.087449940774134 |
|
2981 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC39A1 |
0.087449940774134 |
|
2982 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CREB3L4 |
0.087449940774134 |
|
2983 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
JTB |
0.087449940774134 |
|
2984 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAB13 |
0.087449940774134 |
|
2985 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NUP210L |
0.087449940774134 |
|
2986 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPS27 |
0.087449940774134 |
|
2987 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U3|ENSG00000252669.1 |
0.087449940774134 |
|
2988 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR5698 |
0.087449940774134 |
|
2989 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TPM3 |
0.087449940774134 |
|
2990 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL431P |
0.087449940774134 |
|
2991 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR190B |
0.087449940774134 |
|
2992 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C1orf189 |
0.087449940774134 |
|
2993 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C1orf43 |
0.087449940774134 |
|
2994 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UBAP2L |
0.087449940774134 |
|
2995 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA58|ENSG00000201129.1 |
0.087449940774134 |
|
2996 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HAX1 |
0.087449940774134 |
|
2997 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD59|ENSG00000252682.1 |
0.087449940774134 |
|
2998 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AQP10 |
0.087449940774134 |
|
2999 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATP8B2 |
0.087449940774134 |
|
3000 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TSSK6 |
0.0874536706873758 |
|
3001 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LPAR2 |
0.0874536706873758 |
|
3002 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GMIP |
0.0874536706873758 |
|
3003 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATP13A1 |
0.0874536706873758 |
|
3004 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF101 |
0.0874536706873758 |
|
3005 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00663 |
0.0874536706873758 |
|
3006 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF14 |
0.0874536706873758 |
|
3007 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF506 |
0.0874536706873758 |
|
3008 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238914.1 |
0.0878434873541085 |
|
3009 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA40|ENSG00000237002.2 |
0.0881173937363007 |
|
3010 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NAMPTL |
0.0881173937363007 |
|
3011 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
APAF1 |
0.0882152566340112 |
|
3012 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLCO1A2 |
0.0885176822606895 |
|
3013 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IAPP |
0.0885176822606895 |
|
3014 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PYROXD1 |
0.0885176822606895 |
|
3015 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RECQL |
0.0885176822606895 |
|
3016 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LDHB |
0.0885176822606895 |
|
3017 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCNJ8 |
0.0885176822606895 |
|
3018 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ABCC9 |
0.0885176822606895 |
|
3019 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DNAJC6 |
0.088548263738721 |
|
3020 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LEPROT |
0.088548263738721 |
|
3021 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LEPR |
0.088548263738721 |
|
3022 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TEX9 |
0.0885794803538338 |
|
3023 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MNS1 |
0.0885794803538338 |
|
3024 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COL11A1 |
0.0885920341812718 |
|
3025 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RBM4 |
0.0887528305058616 |
|
3026 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RBM4B |
0.0887528305058616 |
|
3027 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPTBN2 |
0.0887528305058616 |
|
3028 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL12P |
0.0887528305058616 |
|
3029 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C11orf80 |
0.0887528305058616 |
|
3030 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GOLGA7 |
0.0889774261701528 |
|
3031 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GINS4 |
0.0889774261701528 |
|
3032 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AKAP10 |
0.088978658312028 |
|
3033 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPECC1 |
0.088978658312028 |
|
3034 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC144CP |
0.088978658312028 |
|
3035 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL17P |
0.088978658312028 |
|
3036 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U6|ENSG00000266839.2 |
0.088978658312028 |
|
3037 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UPF3AP2 |
0.088978658312028 |
|
3038 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
USP32P3 |
0.088978658312028 |
|
3039 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRIM35 |
0.0891630047641145 |
|
3040 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PTK2B |
0.0891630047641145 |
|
3041 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CHRNA2 |
0.0891630047641145 |
|
3042 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLITRK6 |
0.0892713455394563 |
|
3043 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
XKR4 |
0.0893578682901528 |
|
3044 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR5190 |
0.089664903723911 |
|
3045 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UHRF1 |
0.0896887568833677 |
|
3046 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCNQ1 |
0.0898488423791906 |
|
3047 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
USP30 |
0.0899654151463571 |
|
3048 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP372 |
0.0899654151463571 |
|
3049 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ALKBH2 |
0.0899654151463571 |
|
3050 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UNG |
0.0899654151463571 |
|
3051 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACACB |
0.0899654151463571 |
|
3052 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MYO1H |
0.0899654151463571 |
|
3053 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCTD10 |
0.0899654151463571 |
|
3054 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZDHHC22 |
0.090029161831969 |
|
3055 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4704 |
0.0902972626933137 |
|
3056 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AGT |
0.0903602001184832 |
|
3057 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL467P |
0.0903602001184832 |
|
3058 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CAPN9 |
0.0903602001184832 |
|
3059 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP79 |
0.0903602001184832 |
|
3060 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KRT76 |
0.0903853829078277 |
|
3061 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KRT3 |
0.0903853829078277 |
|
3062 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KRT4 |
0.0903853829078277 |
|
3063 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KRT79 |
0.0903853829078277 |
|
3064 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KRT78 |
0.0903853829078277 |
|
3065 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HFM1 |
0.0905410272295031 |
|
3066 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIAA1737 |
0.0908210495551836 |
|
3067 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCNDBP1 |
0.0908338519765897 |
|
3068 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TGM7 |
0.0908338519765897 |
|
3069 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCDH9 |
0.0908765773634895 |
|
3070 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC27A3 |
0.0909990822334534 |
|
3071 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GATAD2B |
0.0909990822334534 |
|
3072 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PIWIL3 |
0.0910999419185363 |
|
3073 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SGSM1 |
0.0910999419185363 |
|
3074 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADRBK2 |
0.0910999419185363 |
|
3075 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CRYBB2P1 |
0.0910999419185363 |
|
3076 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRP5L |
0.0910999419185363 |
|
3077 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC25A3 |
0.091111768472028 |
|
3078 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA53 |
0.091111768472028 |
|
3079 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IKBIP |
0.091111768472028 |
|
3080 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4293 |
0.0911383044918954 |
|
3081 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WDTC1 |
0.0914608357818972 |
|
3082 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNF220 |
0.0917097581827455 |
|
3083 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM53 |
0.0917097581827455 |
|
3084 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C1orf228 |
0.0917097581827455 |
|
3085 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZFAND3 |
0.0918315381981942 |
|
3086 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C15orf43 |
0.0918334082240678 |
|
3087 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SORD |
0.0918334082240678 |
|
3088 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DUOX2 |
0.0918334082240678 |
|
3089 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DUOXA2 |
0.0918334082240678 |
|
3090 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DUOXA1 |
0.0918334082240678 |
|
3091 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DUOX1 |
0.0918334082240678 |
|
3092 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCARNA20|ENSG00000252778.1 |
0.0919072355322484 |
|
3093 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4675 |
0.0919748224804686 |
|
3094 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CMAS |
0.0922544378325315 |
|
3095 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM71C |
0.0923579187713907 |
|
3096 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AJAP1 |
0.0923916659388214 |
|
3097 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00364 |
0.0924507705674619 |
|
3098 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPBP1L1 |
0.0925288594257043 |
|
3099 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM69 |
0.0925288594257043 |
|
3100 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IPP |
0.0925288594257043 |
|
3101 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR548H4 |
0.0928043262207906 |
|
3102 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C1orf68 |
0.0930552369630698 |
|
3103 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KPRP |
0.0930552369630698 |
|
3104 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LCE1F |
0.0930552369630698 |
|
3105 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPRR2A |
0.0930552369630698 |
|
3106 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPRR2B |
0.0930552369630698 |
|
3107 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPRR2E |
0.0930552369630698 |
|
3108 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPRR2F |
0.0930552369630698 |
|
3109 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPRR2G |
0.0930552369630698 |
|
3110 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF333 |
0.0931269891662577 |
|
3111 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EMR2 |
0.0931269891662577 |
|
3112 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR7C1 |
0.0931269891662577 |
|
3113 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CD93 |
0.093233381751233 |
|
3114 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00656 |
0.093233381751233 |
|
3115 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP478 |
0.093233381751233 |
|
3116 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GZF1 |
0.093233381751233 |
|
3117 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NAPB |
0.093233381751233 |
|
3118 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP479 |
0.093233381751233 |
|
3119 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SEMA3A |
0.0934037024095133 |
|
3120 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RALGAPA1 |
0.093657364070963 |
|
3121 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADCK2 |
0.0937450639780406 |
|
3122 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NDUFB2 |
0.0937450639780406 |
|
3123 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BRAF |
0.0937450639780406 |
|
3124 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U6|ENSG00000271932.1 |
0.0937450639780406 |
|
3125 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C1orf63 |
0.0937668434035575 |
|
3126 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RHCE |
0.0937668434035575 |
|
3127 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RHD |
0.0937668434035575 |
|
3128 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SYF2 |
0.0937668434035575 |
|
3129 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM50A |
0.0937668434035575 |
|
3130 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238889.1 |
0.0937668434035575 |
|
3131 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U3|ENSG00000201368.1 |
0.0937767106409556 |
|
3132 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR125B1 |
0.0938184431871668 |
|
3133 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BLID |
0.0938184431871668 |
|
3134 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HEPACAM2 |
0.0938238275126726 |
|
3135 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC132 |
0.0938238275126726 |
|
3136 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CALCR |
0.0938238275126726 |
|
3137 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR489 |
0.0938238275126726 |
|
3138 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR653 |
0.0938238275126726 |
|
3139 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PSMA6 |
0.0938465079683695 |
|
3140 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DRD1 |
0.0938645231271964 |
|
3141 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000239026.1 |
0.0938645231271964 |
|
3142 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SFXN1 |
0.0938645231271964 |
|
3143 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP148 |
0.0938645231271964 |
|
3144 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HRH2 |
0.0938645231271964 |
|
3145 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00520 |
0.0939363421369862 |
|
3146 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPL13AP3 |
0.0939363421369862 |
|
3147 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP366 |
0.0939718254754236 |
|
3148 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC148 |
0.0940125105072532 |
|
3149 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL393P |
0.0940125105072532 |
|
3150 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KEAP1 |
0.0940154727546012 |
|
3151 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FOXA2 |
0.0940613410577744 |
|
3152 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STARD9 |
0.0942234969216926 |
|
3153 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000239025.1 |
0.0942234969216926 |
|
3154 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDAN1 |
0.0942234969216926 |
|
3155 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TTBK2 |
0.0942234969216926 |
|
3156 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UBR1 |
0.0942234969216926 |
|
3157 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IL18 |
0.0942513466144654 |
|
3158 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PTS |
0.0942513466144654 |
|
3159 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C11orf34 |
0.0942513466144654 |
|
3160 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL475P |
0.0943985654668268 |
|
3161 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C1orf87 |
0.0943985654668268 |
|
3162 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CBLN1 |
0.0944468484254104 |
|
3163 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238892.1 |
0.0945165890970288 |
|
3164 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADRBK1 |
0.0945165890970288 |
|
3165 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANKRD13D |
0.0945165890970288 |
|
3166 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SSH3 |
0.0945165890970288 |
|
3167 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CARNS1 |
0.0945165890970288 |
|
3168 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPS6KB2 |
0.0945165890970288 |
|
3169 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CORO1B |
0.0945165890970288 |
|
3170 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PTPRCAP |
0.0945165890970288 |
|
3171 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CABP4 |
0.0945165890970288 |
|
3172 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPR152 |
0.0945165890970288 |
|
3173 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM134 |
0.0945165890970288 |
|
3174 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AIP |
0.0945165890970288 |
|
3175 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PITPNM1 |
0.0945165890970288 |
|
3176 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDK2AP2 |
0.0945165890970288 |
|
3177 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CABP2 |
0.0945165890970288 |
|
3178 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCSK2 |
0.0946220850902666 |
|
3179 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAPRE1 |
0.0947080073955792 |
|
3180 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EFCAB8 |
0.0947080073955792 |
|
3181 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SUN5 |
0.0947080073955792 |
|
3182 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BPIFB2 |
0.0947080073955792 |
|
3183 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TBXAS1 |
0.0948513690857251 |
|
3184 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PARP12 |
0.0948513690857251 |
|
3185 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
JHDM1D |
0.0948513690857251 |
|
3186 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
B4GALNT3 |
0.0949293586496475 |
|
3187 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC77 |
0.0949293586496475 |
|
3188 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM138D |
0.0949293586496475 |
|
3189 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IQSEC3 |
0.0949293586496475 |
|
3190 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KDM5A |
0.0949293586496475 |
|
3191 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NINJ2 |
0.0949293586496475 |
|
3192 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNU4ATAC16P |
0.0949293586496475 |
|
3193 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC6A12 |
0.0949293586496475 |
|
3194 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC6A13 |
0.0949293586496475 |
|
3195 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WNK1 |
0.0949293586496475 |
|
3196 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EPHB2 |
0.0949382404764046 |
|
3197 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4684 |
0.0949382404764046 |
|
3198 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4253 |
0.0949382404764046 |
|
3199 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LACTBL1 |
0.0949382404764046 |
|
3200 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C1orf234 |
0.0949382404764046 |
|
3201 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KDM1A |
0.0949382404764046 |
|
3202 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3115 |
0.0949382404764046 |
|
3203 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4419A |
0.0949382404764046 |
|
3204 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LUZP1 |
0.0949382404764046 |
|
3205 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CMKLR1 |
0.0952169464537467 |
|
3206 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL552P |
0.0952937062175783 |
|
3207 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C2orf47 |
0.0953315440200083 |
|
3208 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLEKHG6 |
0.0953426010611899 |
|
3209 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TNFRSF1A |
0.0953426010611899 |
|
3210 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL391P |
0.0953426010611899 |
|
3211 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SAFB2 |
0.0955415145923578 |
|
3212 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA32|ENSG00000201384.1 |
0.0955648622462382 |
|
3213 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP494 |
0.0956029521268733 |
|
3214 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP169 |
0.0956029521268733 |
|
3215 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ELTD1 |
0.095687207240391 |
|
3216 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CST7 |
0.0958900897027698 |
|
3217 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
APMAP |
0.0958900897027698 |
|
3218 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACSS1 |
0.0958900897027698 |
|
3219 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PYGB |
0.0958900897027698 |
|
3220 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ABHD12 |
0.0958900897027698 |
|
3221 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCNYL2 |
0.0960254921668613 |
|
3222 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA73|ENSG00000252054.1 |
0.096085018101006 |
|
3223 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PAX1 |
0.0962037992035097 |
|
3224 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PIP |
0.0963121749554636 |
|
3225 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TAS2R39 |
0.0963121749554636 |
|
3226 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAD54L |
0.0964789915357256 |
|
3227 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRRC41 |
0.0964789915357256 |
|
3228 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UQCRH |
0.0964789915357256 |
|
3229 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NSUN4 |
0.0964789915357256 |
|
3230 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD13 |
0.0965202669416125 |
|
3231 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA70|ENSG00000252505.1 |
0.0965202669416125 |
|
3232 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MYLK2 |
0.0965527994350783 |
|
3233 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FOXS1 |
0.0965527994350783 |
|
3234 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MADCAM1 |
0.0966757319231812 |
|
3235 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TPGS1 |
0.0966757319231812 |
|
3236 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDC34 |
0.0966757319231812 |
|
3237 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GZMM |
0.0966757319231812 |
|
3238 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BSG |
0.0966757319231812 |
|
3239 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HCN2 |
0.0966757319231812 |
|
3240 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
POLRMT |
0.0966757319231812 |
|
3241 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FGF22 |
0.0966757319231812 |
|
3242 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNF126 |
0.0966757319231812 |
|
3243 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ABCA4 |
0.0967178876570866 |
|
3244 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UNC5D |
0.0967840662400284 |
|
3245 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NPR1 |
0.0968669246502043 |
|
3246 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
INTS3 |
0.0968669246502043 |
|
3247 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL372P |
0.0968669246502043 |
|
3248 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238511.1 |
0.0968669246502043 |
|
3249 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RIT1 |
0.0968764717626742 |
|
3250 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIAA0907 |
0.0968764717626742 |
|
3251 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP76 |
0.0970850112735016 |
|
3252 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PC |
0.0971300896364882 |
|
3253 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RCE1 |
0.0971300896364882 |
|
3254 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRFN4 |
0.0971300896364882 |
|
3255 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3163 |
0.0971300896364882 |
|
3256 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FUT10 |
0.0971485499544211 |
|
3257 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD56|ENSG00000199783.1 |
0.0972920049923816 |
|
3258 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM211 |
0.0972920049923816 |
|
3259 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIAA1671 |
0.0972920049923816 |
|
3260 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CRYBB3 |
0.0972920049923816 |
|
3261 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CRYBB2 |
0.0972920049923816 |
|
3262 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MGAM |
0.0973309259447762 |
|
3263 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TP73 |
0.0973936081518079 |
|
3264 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC27 |
0.0973936081518079 |
|
3265 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SMIM1 |
0.0973936081518079 |
|
3266 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRRC47 |
0.0973936081518079 |
|
3267 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL574P |
0.0973936081518079 |
|
3268 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CEP104 |
0.0973936081518079 |
|
3269 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DFFB |
0.0973936081518079 |
|
3270 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C1orf174 |
0.0973936081518079 |
|
3271 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCNN3 |
0.0975175485135159 |
|
3272 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AGBL4 |
0.0975378454864988 |
|
3273 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PFDN4 |
0.0978341320069072 |
|
3274 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DOK5 |
0.0978341320069072 |
|
3275 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC38A2 |
0.0980467118144316 |
|
3276 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DISC1 |
0.0980618653599113 |
|
3277 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP27 |
0.0980721711181287 |
|
3278 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KLHL29 |
0.0980721711181287 |
|
3279 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP484 |
0.0981269001439629 |
|
3280 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TOP1 |
0.0981269001439629 |
|
3281 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLCG1 |
0.0981269001439629 |
|
3282 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CST4 |
0.0982011411324298 |
|
3283 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CST1 |
0.0982011411324298 |
|
3284 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CST2 |
0.0982011411324298 |
|
3285 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CST5 |
0.0982011411324298 |
|
3286 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GGTLC1 |
0.0982011411324298 |
|
3287 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAD52 |
0.0984790759072167 |
|
3288 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ERC1 |
0.0984790759072167 |
|
3289 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL852P |
0.0984790759072167 |
|
3290 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL37P |
0.0985007793956177 |
|
3291 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NUP155 |
0.0985007793956177 |
|
3292 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WDR70 |
0.0985007793956177 |
|
3293 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GDNF |
0.0985007793956177 |
|
3294 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EGFLAM |
0.0985007793956177 |
|
3295 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL377P |
0.0986004074922321 |
|
3296 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL625P |
0.0986004074922321 |
|
3297 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TYW1B |
0.0986004074922321 |
|
3298 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EGFR |
0.0986014100912109 |
|
3299 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TEPP |
0.0986822399315753 |
|
3300 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
USB1 |
0.0986822399315753 |
|
3301 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF319 |
0.0986822399315753 |
|
3302 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MMP15 |
0.0986822399315753 |
|
3303 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C16orf80 |
0.0986822399315753 |
|
3304 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC113 |
0.0986822399315753 |
|
3305 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRSS54 |
0.0986822399315753 |
|
3306 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GINS3 |
0.0986822399315753 |
|
3307 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PSMA1 |
0.0987262618165046 |
|
3308 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PDE3B |
0.0987262618165046 |
|
3309 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CYP2R1 |
0.0987262618165046 |
|
3310 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CALCB |
0.0987262618165046 |
|
3311 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CALCA |
0.0987262618165046 |
|
3312 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP87 |
0.0987344233491056 |
|
3313 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00261 |
0.0987965533577173 |
|
3314 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C11orf86 |
0.0988255585109732 |
|
3315 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U3|ENSG00000252709.1 |
0.0988255585109732 |
|
3316 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SYT12 |
0.0988255585109732 |
|
3317 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RHOD |
0.0988255585109732 |
|
3318 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KDM2A |
0.0988255585109732 |
|
3319 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC82 |
0.0989083590998043 |
|
3320 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP346 |
0.0989083590998043 |
|
3321 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BAZ2B |
0.0989154490226258 |
|
3322 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LACRT |
0.0989223240426094 |
|
3323 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DCD |
0.0989223240426094 |
|
3324 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MUCL1 |
0.0989223240426094 |
|
3325 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GTSF1 |
0.0989374042498916 |
|
3326 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NCKAP1L |
0.0989374042498916 |
|
3327 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PDE1B |
0.0989374042498916 |
|
3328 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPP1R1A |
0.0989374042498916 |
|
3329 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GLYCAM1 |
0.0989374042498916 |
|
3330 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC7 |
0.0989957415736832 |
|
3331 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AHDC1 |
0.0991018041170225 |
|
3332 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FGR |
0.0991018041170225 |
|
3333 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IFI6 |
0.0991018041170225 |
|
3334 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GNG7 |
0.0992985005906576 |
|
3335 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LANCL2 |
0.0993223942778447 |
|
3336 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VOPP1 |
0.0993223942778447 |
|
3337 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FKBP9L |
0.0993223942778447 |
|
3338 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SEPT14 |
0.0993223942778447 |
|
3339 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MRPS17 |
0.0993223942778447 |
|
3340 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF713 |
0.0993223942778447 |
|
3341 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL64P |
0.0993223942778447 |
|
3342 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GBAS |
0.0993223942778447 |
|
3343 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NUPR1L |
0.0993223942778447 |
|
3344 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4747 |
0.09944965868591 |
|
3345 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NEBL |
0.0996851222934897 |
|
3346 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PGPEP1 |
0.0997413338431883 |
|
3347 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GDF15 |
0.0997413338431883 |
|
3348 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3189 |
0.0997413338431883 |
|
3349 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRRC25 |
0.0997413338431883 |
|
3350 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC163P |
0.0997980195614576 |
|
3351 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MMACHC |
0.0997980195614576 |
|
3352 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRDX1 |
0.0997980195614576 |
|
3353 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AKR1A1 |
0.0997980195614576 |
|
3354 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NASP |
0.0997980195614576 |
|
3355 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC17 |
0.0997980195614576 |
|
3356 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MVK |
0.0998961066394726 |
|
3357 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP250 |
0.0998961066394726 |
|
3358 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRPV4 |
0.0998961066394726 |
|
3359 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4497 |
0.0998961066394726 |
|
3360 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GLTP |
0.0998961066394726 |
|
3361 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL441P |
0.0998961066394726 |
|
3362 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PKP4 |
0.099958057083202 |
|
3363 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL252P |
0.100013377790926 |
|
3364 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP54 |
0.100025124586751 |
|
3365 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DRAM2 |
0.100025124586751 |
|
3366 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CEPT1 |
0.100025124586751 |
|
3367 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DENND2D |
0.100025124586751 |
|
3368 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CHI3L2 |
0.100025124586751 |
|
3369 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CHIAP2 |
0.100025124586751 |
|
3370 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CHIA |
0.100025124586751 |
|
3371 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RRAS2 |
0.100115178526271 |
|
3372 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
N4BP1 |
0.100275686358061 |
|
3373 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000239038.1 |
0.100275686358061 |
|
3374 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CBLN4 |
0.10060162233246 |
|
3375 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP487 |
0.10060162233246 |
|
3376 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MC3R |
0.10060162233246 |
|
3377 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM210B |
0.10060162233246 |
|
3378 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AURKA |
0.10060162233246 |
|
3379 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CSTF1 |
0.10060162233246 |
|
3380 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CASS4 |
0.10060162233246 |
|
3381 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238294.1 |
0.10060162233246 |
|
3382 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NR4A2 |
0.100646294009792 |
|
3383 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RANBP3L |
0.100716753306956 |
|
3384 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IRX3 |
0.100808731474324 |
|
3385 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP178 |
0.100944309042745 |
|
3386 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LIFR |
0.101025830539755 |
|
3387 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3650 |
0.101025830539755 |
|
3388 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNY3P10 |
0.101080416903843 |
|
3389 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SSPN |
0.101145124939991 |
|
3390 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP184 |
0.101183082801975 |
|
3391 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP431 |
0.101194067341568 |
|
3392 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAF |
0.101194067341568 |
|
3393 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COPB1 |
0.101247248374647 |
|
3394 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DLAT |
0.101677301124522 |
|
3395 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PIH1D2 |
0.101677301124522 |
|
3396 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C11orf57 |
0.101677301124522 |
|
3397 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TIMM8B |
0.101677301124522 |
|
3398 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MPZL1 |
0.101897911797797 |
|
3399 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADCY10 |
0.101897911797797 |
|
3400 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MPC2 |
0.101897911797797 |
|
3401 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPON1 |
0.101906946257522 |
|
3402 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EXOC1 |
0.101984831002134 |
|
3403 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C2CD5 |
0.102099547397899 |
|
3404 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ETNK1 |
0.102099547397899 |
|
3405 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PARD3B |
0.102105203074479 |
|
3406 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UBXN2A |
0.10212227945162 |
|
3407 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL610P |
0.10212227945162 |
|
3408 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MFSD2B |
0.10212227945162 |
|
3409 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C2orf44 |
0.10212227945162 |
|
3410 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FKBP1B |
0.10212227945162 |
|
3411 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR56A3 |
0.102185262867456 |
|
3412 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR52L1 |
0.102185262867456 |
|
3413 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR56A1 |
0.102185262867456 |
|
3414 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR56A4 |
0.102185262867456 |
|
3415 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR56B4 |
0.102185262867456 |
|
3416 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP329 |
0.102185262867456 |
|
3417 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLA2G4E |
0.102228861145545 |
|
3418 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DUSP15 |
0.102542621924829 |
|
3419 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TTLL9 |
0.102542621924829 |
|
3420 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PDRG1 |
0.102542621924829 |
|
3421 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
XKR7 |
0.102542621924829 |
|
3422 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C20orf203 |
0.102542621924829 |
|
3423 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COMMD7 |
0.102542621924829 |
|
3424 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DNMT3B |
0.102542621924829 |
|
3425 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD74|ENSG00000200897.1 |
0.102724606622549 |
|
3426 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP371 |
0.102724606622549 |
|
3427 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EPAS1 |
0.102740325586786 |
|
3428 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CST9 |
0.102765475543539 |
|
3429 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CST3 |
0.102765475543539 |
|
3430 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EXTL3 |
0.102842776516199 |
|
3431 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PSPH |
0.102912827084999 |
|
3432 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCT6A |
0.102912827084999 |
|
3433 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA15|ENSG00000207168.1 |
0.102912827084999 |
|
3434 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA22|ENSG00000206603.1 |
0.102912827084999 |
|
3435 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SUMF2 |
0.102912827084999 |
|
3436 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PHKG1 |
0.102912827084999 |
|
3437 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CHCHD2 |
0.102912827084999 |
|
3438 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238673.1 |
0.102912827084999 |
|
3439 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR383 |
0.102980306324911 |
|
3440 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MSR1 |
0.102992942938401 |
|
3441 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FKBP3 |
0.103050143660175 |
|
3442 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FANCM |
0.103050143660175 |
|
3443 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIS18BP1 |
0.103050143660175 |
|
3444 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KLHL14 |
0.103076784512996 |
|
3445 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SYT9 |
0.103268295409837 |
|
3446 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OLFML1 |
0.103268295409837 |
|
3447 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BCO2 |
0.103298984504466 |
|
3448 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL626P |
0.103381391856064 |
|
3449 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNRF4 |
0.103381391856064 |
|
3450 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TINCR |
0.103381391856064 |
|
3451 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARNTL |
0.103474330747189 |
|
3452 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BTBD10 |
0.103474330747189 |
|
3453 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PTH |
0.103474330747189 |
|
3454 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MEF2B |
0.103575294681907 |
|
3455 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MEF2BNB |
0.103575294681907 |
|
3456 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RFXANK |
0.103575294681907 |
|
3457 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NR2C2AP |
0.103575294681907 |
|
3458 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NUDC |
0.103687027730816 |
|
3459 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NR0B2 |
0.103687027730816 |
|
3460 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C1orf172 |
0.103687027730816 |
|
3461 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRNP1 |
0.103687027730816 |
|
3462 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM46B |
0.103687027730816 |
|
3463 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GLO1 |
0.104030408424365 |
|
3464 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DNAH8 |
0.104030408424365 |
|
3465 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL465P |
0.104030408424365 |
|
3466 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA8|ENSG00000212586.1 |
0.104030408424365 |
|
3467 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MICAL2 |
0.104043728763616 |
|
3468 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000239121.1 |
0.104054428875012 |
|
3469 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC38A7 |
0.104054428875012 |
|
3470 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GOT2 |
0.104054428875012 |
|
3471 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL143P |
0.104054428875012 |
|
3472 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C5orf42 |
0.104096895906834 |
|
3473 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DPEP3 |
0.104167061973448 |
|
3474 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DPEP2 |
0.104167061973448 |
|
3475 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DDX28 |
0.104167061973448 |
|
3476 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UGT3A2 |
0.104246483740927 |
|
3477 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CAMK1D |
0.104313279108224 |
|
3478 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4480 |
0.104313279108224 |
|
3479 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FRMD4A |
0.104313279108224 |
|
3480 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CGRRF1 |
0.104411963969442 |
|
3481 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WDHD1 |
0.104411963969442 |
|
3482 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SOCS4 |
0.104411963969442 |
|
3483 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARID2 |
0.104595701705397 |
|
3484 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL246P |
0.104595701705397 |
|
3485 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCAF11 |
0.104595701705397 |
|
3486 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC38A1 |
0.104595701705397 |
|
3487 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANKS1B |
0.104601727660378 |
|
3488 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRLR |
0.104816351542628 |
|
3489 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP44 |
0.104969651675241 |
|
3490 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRRC37A7P |
0.104969651675241 |
|
3491 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC25A52 |
0.104969651675241 |
|
3492 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CBX3P4 |
0.105068743806769 |
|
3493 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FKBP4 |
0.105068743806769 |
|
3494 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ITFG2 |
0.105068743806769 |
|
3495 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NRIP2 |
0.105068743806769 |
|
3496 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238384.1 |
0.105676799843772 |
|
3497 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PON1 |
0.105676799843772 |
|
3498 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PON3 |
0.105676799843772 |
|
3499 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PON2 |
0.105676799843772 |
|
3500 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NUAK1 |
0.105872095569399 |
|
3501 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CASC1 |
0.10591478603807 |
|
3502 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LYRM5 |
0.10591478603807 |
|
3503 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KRAS |
0.10591478603807 |
|
3504 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LMF1 |
0.105919871030536 |
|
3505 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF257 |
0.106169389935345 |
|
3506 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF676 |
0.106169389935345 |
|
3507 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF729 |
0.106169389935345 |
|
3508 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF423 |
0.106309664390527 |
|
3509 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DDHD1 |
0.106334550637958 |
|
3510 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR5580 |
0.106334550637958 |
|
3511 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BMP4 |
0.106334550637958 |
|
3512 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PDCD7 |
0.106362088653014 |
|
3513 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLPX |
0.106362088653014 |
|
3514 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CILP |
0.106362088653014 |
|
3515 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PARP16 |
0.106362088653014 |
|
3516 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA24|ENSG00000206903.1 |
0.106362088653014 |
|
3517 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IGDCC3 |
0.106362088653014 |
|
3518 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IGDCC4 |
0.106362088653014 |
|
3519 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DPP8 |
0.106362088653014 |
|
3520 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PTPLAD1 |
0.106362088653014 |
|
3521 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238715.1 |
0.106362088653014 |
|
3522 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VWA9 |
0.106362088653014 |
|
3523 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC24A1 |
0.106362088653014 |
|
3524 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DENND4A |
0.106362088653014 |
|
3525 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238311.1 |
0.106362088653014 |
|
3526 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4511 |
0.106362088653014 |
|
3527 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAB11A |
0.106362088653014 |
|
3528 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM192A |
0.106581548691833 |
|
3529 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00664 |
0.106592749405084 |
|
3530 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF429 |
0.106592749405084 |
|
3531 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM151A |
0.106751902977386 |
|
3532 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CD248 |
0.106751902977386 |
|
3533 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RIN1 |
0.106751902977386 |
|
3534 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BRMS1 |
0.106751902977386 |
|
3535 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
B3GNT1 |
0.106751902977386 |
|
3536 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC29A2 |
0.106751902977386 |
|
3537 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NPAS4 |
0.106751902977386 |
|
3538 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA43|ENSG00000201733.1 |
0.106751902977386 |
|
3539 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MRPL11 |
0.106751902977386 |
|
3540 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PELI3 |
0.106751902977386 |
|
3541 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DPP3 |
0.106751902977386 |
|
3542 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACAP3 |
0.106928854938946 |
|
3543 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACTRT2 |
0.106928854938946 |
|
3544 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AGRN |
0.106928854938946 |
|
3545 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANKRD65 |
0.106928854938946 |
|
3546 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATAD3A |
0.106928854938946 |
|
3547 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATAD3B |
0.106928854938946 |
|
3548 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATAD3C |
0.106928854938946 |
|
3549 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AURKAIP1 |
0.106928854938946 |
|
3550 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
B3GALT6 |
0.106928854938946 |
|
3551 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C1orf159 |
0.106928854938946 |
|
3552 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C1orf170 |
0.106928854938946 |
|
3553 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C1orf222 |
0.106928854938946 |
|
3554 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C1orf233 |
0.106928854938946 |
|
3555 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C1orf86 |
0.106928854938946 |
|
3556 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CALML6 |
0.106928854938946 |
|
3557 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCNL2 |
0.106928854938946 |
|
3558 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDK11A |
0.106928854938946 |
|
3559 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDK11B |
0.106928854938946 |
|
3560 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CPSF3L |
0.106928854938946 |
|
3561 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DDX11L1 |
0.106928854938946 |
|
3562 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DVL1 |
0.106928854938946 |
|
3563 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM132A |
0.106928854938946 |
|
3564 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM138A |
0.106928854938946 |
|
3565 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM213B |
0.106928854938946 |
|
3566 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM41C |
0.106928854938946 |
|
3567 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM87B |
0.106928854938946 |
|
3568 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GABRD |
0.106928854938946 |
|
3569 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GLTPD1 |
0.106928854938946 |
|
3570 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GNB1 |
0.106928854938946 |
|
3571 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HES4 |
0.106928854938946 |
|
3572 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HES5 |
0.106928854938946 |
|
3573 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ISG15 |
0.106928854938946 |
|
3574 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KLHL17 |
0.106928854938946 |
|
3575 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00115 |
0.106928854938946 |
|
3576 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00982 |
0.106928854938946 |
|
3577 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIB2 |
0.106928854938946 |
|
3578 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR200A |
0.106928854938946 |
|
3579 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR200B |
0.106928854938946 |
|
3580 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR429 |
0.106928854938946 |
|
3581 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MMEL1 |
0.106928854938946 |
|
3582 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MMP23B |
0.106928854938946 |
|
3583 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MORN1 |
0.106928854938946 |
|
3584 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MRPL20 |
0.106928854938946 |
|
3585 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MXRA8 |
0.106928854938946 |
|
3586 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NADK |
0.106928854938946 |
|
3587 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NOC2L |
0.106928854938946 |
|
3588 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR4F16 |
0.106928854938946 |
|
3589 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR4F29 |
0.106928854938946 |
|
3590 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR4F5 |
0.106928854938946 |
|
3591 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PANK4 |
0.106928854938946 |
|
3592 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PEX10 |
0.106928854938946 |
|
3593 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLCH2 |
0.106928854938946 |
|
3594 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLEKHN1 |
0.106928854938946 |
|
3595 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRDM16 |
0.106928854938946 |
|
3596 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRKCZ |
0.106928854938946 |
|
3597 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PUSL1 |
0.106928854938946 |
|
3598 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RER1 |
0.106928854938946 |
|
3599 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL657P |
0.106928854938946 |
|
3600 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNF223 |
0.106928854938946 |
|
3601 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SAMD11 |
0.106928854938946 |
|
3602 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCNN1D |
0.106928854938946 |
|
3603 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SDF4 |
0.106928854938946 |
|
3604 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SKI |
0.106928854938946 |
|
3605 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC35E2B |
0.106928854938946 |
|
3606 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC35E2 |
0.106928854938946 |
|
3607 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SSU72 |
0.106928854938946 |
|
3608 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TAS1R3 |
0.106928854938946 |
|
3609 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM240 |
0.106928854938946 |
|
3610 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM52 |
0.106928854938946 |
|
3611 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM88B |
0.106928854938946 |
|
3612 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TNFRSF14 |
0.106928854938946 |
|
3613 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TNFRSF18 |
0.106928854938946 |
|
3614 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TNFRSF4 |
0.106928854938946 |
|
3615 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TTC34 |
0.106928854938946 |
|
3616 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TTLL10 |
0.106928854938946 |
|
3617 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UBE2J2 |
0.106928854938946 |
|
3618 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VWA1 |
0.106928854938946 |
|
3619 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARHGEF16 |
0.106928854938946 |
|
3620 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MEGF6 |
0.106928854938946 |
|
3621 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR551A |
0.106928854938946 |
|
3622 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TPRG1L |
0.106928854938946 |
|
3623 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WRAP73 |
0.106928854938946 |
|
3624 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3622B |
0.106941383383325 |
|
3625 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR2A14 |
0.107149197428056 |
|
3626 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AHCYL1 |
0.107196125175856 |
|
3627 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STRIP1 |
0.107196125175856 |
|
3628 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ALX3 |
0.107196125175856 |
|
3629 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CTTNBP2NL |
0.107470429839219 |
|
3630 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF609 |
0.107708599566431 |
|
3631 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP86 |
0.107859618885735 |
|
3632 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RHOB |
0.107859618885735 |
|
3633 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HS1BP3 |
0.107859618885735 |
|
3634 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GDF7 |
0.107859618885735 |
|
3635 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C2orf43 |
0.107859618885735 |
|
3636 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
APOB |
0.107859618885735 |
|
3637 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TDRD15 |
0.107859618885735 |
|
3638 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PTGFR |
0.10805537177766 |
|
3639 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP23 |
0.10805537177766 |
|
3640 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRKCE |
0.108090260923517 |
|
3641 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL140P |
0.108096880834095 |
|
3642 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SDC1 |
0.108096880834095 |
|
3643 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PUM2 |
0.108096880834095 |
|
3644 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CSTF2T |
0.108375099584349 |
|
3645 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPP1R9A |
0.108692936968359 |
|
3646 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF32 |
0.108858571107533 |
|
3647 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00619 |
0.108858571107533 |
|
3648 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00840 |
0.108858571107533 |
|
3649 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SSTR5 |
0.109071774231646 |
|
3650 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C1QTNF8 |
0.109071774231646 |
|
3651 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR1265 |
0.109102842410066 |
|
3652 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM107B |
0.109102842410066 |
|
3653 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RET |
0.109177824070702 |
|
3654 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CSGALNACT2 |
0.109177824070702 |
|
3655 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RASGEF1A |
0.109177824070702 |
|
3656 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNU6ATAC11P |
0.109177824070702 |
|
3657 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FXYD4 |
0.109177824070702 |
|
3658 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF239 |
0.109177824070702 |
|
3659 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF485 |
0.109177824070702 |
|
3660 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM76B |
0.10919345946385 |
|
3661 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TET1 |
0.109491051091099 |
|
3662 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000251926.1 |
0.109491051091099 |
|
3663 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCAR1 |
0.109491051091099 |
|
3664 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD98 |
0.109491051091099 |
|
3665 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STOX1 |
0.109491051091099 |
|
3666 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DDX50 |
0.109491051091099 |
|
3667 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DDX21 |
0.109491051091099 |
|
3668 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL373P |
0.109491051091099 |
|
3669 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIAA1279 |
0.109491051091099 |
|
3670 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SRGN |
0.109491051091099 |
|
3671 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VPS26A |
0.109491051091099 |
|
3672 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SUPV3L1 |
0.109491051091099 |
|
3673 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HKDC1 |
0.109491051091099 |
|
3674 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDC7 |
0.10953460992939 |
|
3675 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TGFBR3 |
0.10953460992939 |
|
3676 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL653P |
0.10953460992939 |
|
3677 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RBM14 |
0.109651440536439 |
|
3678 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STXBP2 |
0.109671657526934 |
|
3679 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RETN |
0.109671657526934 |
|
3680 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LSM4 |
0.109685697994856 |
|
3681 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL513P |
0.109685697994856 |
|
3682 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NRP2 |
0.109764878611011 |
|
3683 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
Vault|ENSG00000252485.1 |
0.109872049379018 |
|
3684 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4417 |
0.109915358435724 |
|
3685 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
INO80D |
0.109956267605422 |
|
3686 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SOX6 |
0.110005315475817 |
|
3687 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CD247 |
0.110032179864695 |
|
3688 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CREG1 |
0.110032179864695 |
|
3689 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RCSD1 |
0.110032179864695 |
|
3690 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DCAF6 |
0.110032179864695 |
|
3691 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR1255B2 |
0.110032179864695 |
|
3692 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TBX19 |
0.110032179864695 |
|
3693 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR557 |
0.110032179864695 |
|
3694 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
XCL2 |
0.110032179864695 |
|
3695 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
XCL1 |
0.110032179864695 |
|
3696 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DPT |
0.110032179864695 |
|
3697 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00626 |
0.110032179864695 |
|
3698 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00970 |
0.110032179864695 |
|
3699 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP66 |
0.110032179864695 |
|
3700 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATP1B1 |
0.110032179864695 |
|
3701 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FMO3 |
0.110032179864695 |
|
3702 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR1295A |
0.110032179864695 |
|
3703 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FMO6P |
0.110032179864695 |
|
3704 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FMO2 |
0.110032179864695 |
|
3705 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FMO1 |
0.110032179864695 |
|
3706 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FMO4 |
0.110032179864695 |
|
3707 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BMF |
0.110205299073445 |
|
3708 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLEC2L |
0.110232792719795 |
|
3709 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HIPK2 |
0.110232792719795 |
|
3710 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CWF19L2 |
0.110381291681169 |
|
3711 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ALKBH8 |
0.110381291681169 |
|
3712 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL237P |
0.110843017213972 |
|
3713 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TGM2 |
0.110843017213972 |
|
3714 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIAA1755 |
0.110843017213972 |
|
3715 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BPI |
0.110843017213972 |
|
3716 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LBP |
0.110843017213972 |
|
3717 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNHG17 |
0.110843017213972 |
|
3718 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA71B |
0.110843017213972 |
|
3719 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA71A |
0.110843017213972 |
|
3720 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA71C |
0.110843017213972 |
|
3721 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA71D |
0.110843017213972 |
|
3722 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA71|ENSG00000201811.1 |
0.110843017213972 |
|
3723 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNHG11 |
0.110843017213972 |
|
3724 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA60 |
0.110843017213972 |
|
3725 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RALGAPB |
0.110843017213972 |
|
3726 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR548O2 |
0.110843017213972 |
|
3727 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADIG |
0.110843017213972 |
|
3728 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARHGAP40 |
0.110843017213972 |
|
3729 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL423P |
0.111282005377764 |
|
3730 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TANK |
0.111282005377764 |
|
3731 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
E2F2 |
0.111329293020819 |
|
3732 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ID3 |
0.111329293020819 |
|
3733 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MDS2 |
0.111329293020819 |
|
3734 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPL11 |
0.111329293020819 |
|
3735 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL532P |
0.111329293020819 |
|
3736 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NIPAL3 |
0.111329293020819 |
|
3737 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RCAN3 |
0.111329293020819 |
|
3738 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL857P |
0.111329293020819 |
|
3739 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NCMAP |
0.111329293020819 |
|
3740 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SRRM1 |
0.111329293020819 |
|
3741 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238986.1 |
0.111329293020819 |
|
3742 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ST7L |
0.111618870854677 |
|
3743 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CAPZA1 |
0.111618870854677 |
|
3744 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238975.1 |
0.111618870854677 |
|
3745 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238543.1 |
0.111636068533266 |
|
3746 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238481.1 |
0.111636068533266 |
|
3747 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPD2 |
0.111636068533266 |
|
3748 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC34A1 |
0.111830544761238 |
|
3749 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
F12 |
0.111830544761238 |
|
3750 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GRK6 |
0.111830544761238 |
|
3751 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PFN3 |
0.111830544761238 |
|
3752 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NCAN |
0.11184365435636 |
|
3753 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HAPLN4 |
0.11184365435636 |
|
3754 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TM6SF2 |
0.11184365435636 |
|
3755 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SUGP1 |
0.11184365435636 |
|
3756 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SRBD1 |
0.112106916190789 |
|
3757 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00841 |
0.112205431567804 |
|
3758 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ST8SIA1 |
0.112338134706284 |
|
3759 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LCE1C |
0.112340562677859 |
|
3760 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LCE1D |
0.112340562677859 |
|
3761 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LCE1E |
0.112340562677859 |
|
3762 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA31|ENSG00000252920.1 |
0.112340562677859 |
|
3763 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPRR1B |
0.112340562677859 |
|
3764 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPRR2D |
0.112340562677859 |
|
3765 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IL7R |
0.112353317804648 |
|
3766 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CAPSL |
0.112353317804648 |
|
3767 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UGT3A1 |
0.112353317804648 |
|
3768 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FTCDNL1 |
0.112388970720805 |
|
3769 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL717P |
0.112388970720805 |
|
3770 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C2orf69 |
0.112388970720805 |
|
3771 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TYW5 |
0.112388970720805 |
|
3772 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ECHDC3 |
0.112394411926182 |
|
3773 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PROSER2 |
0.112394411926182 |
|
3774 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HK1 |
0.112524953782853 |
|
3775 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DLX6 |
0.112682698702088 |
|
3776 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DLX5 |
0.112682698702088 |
|
3777 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACN9 |
0.112682698702088 |
|
3778 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CD302 |
0.112916966334637 |
|
3779 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LY75 |
0.112916966334637 |
|
3780 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLA2R1 |
0.112916966334637 |
|
3781 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ITGB6 |
0.112916966334637 |
|
3782 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RMRPP3 |
0.112916966334637 |
|
3783 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4785 |
0.112916966334637 |
|
3784 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KLRG2 |
0.112971030730761 |
|
3785 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EPC1 |
0.113238981362663 |
|
3786 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SF3B14 |
0.113269087337154 |
|
3787 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM228B |
0.113269087337154 |
|
3788 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TP53I3 |
0.113269087337154 |
|
3789 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PFN4 |
0.113269087337154 |
|
3790 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM228A |
0.113269087337154 |
|
3791 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ITSN2 |
0.113269087337154 |
|
3792 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCARNA21|ENSG00000251805.1 |
0.113269087337154 |
|
3793 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP88 |
0.113269087337154 |
|
3794 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SRC |
0.113364084922314 |
|
3795 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BLCAP |
0.113364084922314 |
|
3796 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NNAT |
0.113364084922314 |
|
3797 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00489 |
0.113364084922314 |
|
3798 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CTNNBL1 |
0.113364084922314 |
|
3799 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DKFZP667F0711 |
0.113570239179185 |
|
3800 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP347 |
0.113846607650725 |
|
3801 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC39A5 |
0.114116613773962 |
|
3802 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANKRD52 |
0.114116613773962 |
|
3803 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COQ10A |
0.114116613773962 |
|
3804 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CS |
0.114116613773962 |
|
3805 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GNGT1 |
0.114384273165378 |
|
3806 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AMACR |
0.114401183082403 |
|
3807 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C1QTNF3 |
0.114401183082403 |
|
3808 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAI14 |
0.114401183082403 |
|
3809 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC45A2 |
0.114401183082403 |
|
3810 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TTC23L |
0.114401183082403 |
|
3811 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAD1 |
0.114401183082403 |
|
3812 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BRIX1 |
0.114401183082403 |
|
3813 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DNAJC21 |
0.114401183082403 |
|
3814 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AGXT2 |
0.114401183082403 |
|
3815 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATAD2B |
0.114529838954672 |
|
3816 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MOXD2P |
0.114630681777994 |
|
3817 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRSS58 |
0.114630681777994 |
|
3818 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C3P1 |
0.114820478392737 |
|
3819 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C19orf66 |
0.114820478392737 |
|
3820 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANGPTL6 |
0.114820478392737 |
|
3821 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPAN |
0.114820478392737 |
|
3822 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD105 |
0.114820478392737 |
|
3823 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EPB41L1 |
0.114948154270882 |
|
3824 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AAR2 |
0.114948154270882 |
|
3825 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CEP192 |
0.115106325784319 |
|
3826 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MCOLN2 |
0.115184532963749 |
|
3827 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CTNNA3 |
0.115254991509199 |
|
3828 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C7orf72 |
0.115281180253116 |
|
3829 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPGRIP1L |
0.115424163568912 |
|
3830 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VSTM2L |
0.115486727117732 |
|
3831 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP185 |
0.115486727117732 |
|
3832 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TTI1 |
0.115486727117732 |
|
3833 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPRD1B |
0.115486727117732 |
|
3834 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
APBB2 |
0.115499771019951 |
|
3835 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LMBRD2 |
0.115735920639483 |
|
3836 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR580 |
0.115735920639483 |
|
3837 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SKP2 |
0.115735920639483 |
|
3838 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NADK2 |
0.115735920639483 |
|
3839 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DNMT3A |
0.11574187236131 |
|
3840 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR1301 |
0.11574187236131 |
|
3841 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC9A1 |
0.115765576024209 |
|
3842 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC3 |
0.115995242237812 |
|
3843 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC32A1 |
0.116042577086599 |
|
3844 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACTR5 |
0.116042577086599 |
|
3845 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP173 |
0.116042577086599 |
|
3846 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPP1R16B |
0.116042577086599 |
|
3847 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL116P |
0.116042577086599 |
|
3848 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM83D |
0.116042577086599 |
|
3849 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DHX35 |
0.116042577086599 |
|
3850 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL680P |
0.116042577086599 |
|
3851 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL194P |
0.116042577086599 |
|
3852 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SVOP |
0.11620017953381 |
|
3853 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FOXN4 |
0.11620017953381 |
|
3854 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C16orf78 |
0.116331370653686 |
|
3855 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00911 |
0.116540677540204 |
|
3856 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FLRT2 |
0.116540677540204 |
|
3857 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACSS2 |
0.116605229591167 |
|
3858 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UCHL1 |
0.116703947511096 |
|
3859 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NOTCH3 |
0.116721127619752 |
|
3860 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC6A17 |
0.11707338750026 |
|
3861 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCNC4 |
0.11707338750026 |
|
3862 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRR9 |
0.117141109642745 |
|
3863 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LOR |
0.117141109642745 |
|
3864 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PGLYRP3 |
0.117141109642745 |
|
3865 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PGLYRP4 |
0.117141109642745 |
|
3866 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
S100A12 |
0.117141109642745 |
|
3867 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
S100A8 |
0.117141109642745 |
|
3868 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
S100A9 |
0.117141109642745 |
|
3869 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
S100A7A |
0.117141109642745 |
|
3870 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
S100A7L2 |
0.117141109642745 |
|
3871 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
S100A7 |
0.117141109642745 |
|
3872 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL44P |
0.117141109642745 |
|
3873 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
S100A3 |
0.117141109642745 |
|
3874 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
S100A4 |
0.117141109642745 |
|
3875 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
S100A5 |
0.117141109642745 |
|
3876 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
S100A6 |
0.117141109642745 |
|
3877 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
S100A2 |
0.117141109642745 |
|
3878 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL146P |
0.117169523970484 |
|
3879 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP481 |
0.117226264345708 |
|
3880 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCM2L |
0.117226264345708 |
|
3881 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HCK |
0.117226264345708 |
|
3882 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP482 |
0.117226264345708 |
|
3883 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TM9SF4 |
0.117226264345708 |
|
3884 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TSPY26P |
0.117226264345708 |
|
3885 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLAGL2 |
0.117226264345708 |
|
3886 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
POFUT1 |
0.117226264345708 |
|
3887 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR1825 |
0.117226264345708 |
|
3888 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIF3B |
0.117226264345708 |
|
3889 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ASXL1 |
0.117226264345708 |
|
3890 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C20orf112 |
0.117226264345708 |
|
3891 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HNRNPF |
0.117306354574493 |
|
3892 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U3|ENSG00000221400.1 |
0.117306354574493 |
|
3893 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF487 |
0.117306354574493 |
|
3894 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WDFY3 |
0.117423560908269 |
|
3895 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
S1PR2 |
0.118090080018858 |
|
3896 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4322 |
0.118090080018858 |
|
3897 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MRPL4 |
0.118090080018858 |
|
3898 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ICAM1 |
0.118090080018858 |
|
3899 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ICAM4 |
0.118090080018858 |
|
3900 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ICAM5 |
0.118090080018858 |
|
3901 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPATA7 |
0.11810733139797 |
|
3902 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP325 |
0.118111553116252 |
|
3903 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3609 |
0.118174970773332 |
|
3904 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM130 |
0.118174970773332 |
|
3905 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRRAP |
0.118174970773332 |
|
3906 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238459.1 |
0.118174970773332 |
|
3907 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZMAT4 |
0.118208759773296 |
|
3908 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AFG3L2 |
0.118332191070399 |
|
3909 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WBSCR17 |
0.118427368309486 |
|
3910 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RBMS1 |
0.118464810367457 |
|
3911 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATG14 |
0.118580311380611 |
|
3912 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TBPL2 |
0.118580311380611 |
|
3913 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ELMOD1 |
0.118645538193435 |
|
3914 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLN |
0.118645538193435 |
|
3915 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATP8B4 |
0.118757878587331 |
|
3916 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRPM7 |
0.118757878587331 |
|
3917 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL354P |
0.118757878587331 |
|
3918 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPPL2A |
0.118757878587331 |
|
3919 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP75 |
0.118758490433149 |
|
3920 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FGF19 |
0.118973688883892 |
|
3921 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FGF4 |
0.118973688883892 |
|
3922 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FGF3 |
0.118973688883892 |
|
3923 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GLS2 |
0.119071187640529 |
|
3924 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RBMS2 |
0.119071187640529 |
|
3925 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SFRP1 |
0.119133802732536 |
|
3926 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR548AO |
0.119133802732536 |
|
3927 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoZ5 |
0.119267559232996 |
|
3928 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DSC2 |
0.119406602010636 |
|
3929 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DSC1 |
0.119406602010636 |
|
3930 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DSG1 |
0.119406602010636 |
|
3931 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DSG4 |
0.119406602010636 |
|
3932 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DSG3 |
0.119406602010636 |
|
3933 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DSG2 |
0.119406602010636 |
|
3934 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TTR |
0.119406602010636 |
|
3935 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
B4GALT6 |
0.119406602010636 |
|
3936 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AGPAT6 |
0.1195074445205 |
|
3937 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR486 |
0.1195074445205 |
|
3938 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM260 |
0.11967665860455 |
|
3939 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238376.1 |
0.119759143602281 |
|
3940 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NSD1 |
0.119860951536629 |
|
3941 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MXD3 |
0.119860951536629 |
|
3942 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAB24 |
0.119860951536629 |
|
3943 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRELID1 |
0.119860951536629 |
|
3944 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LMAN2 |
0.119860951536629 |
|
3945 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL562P |
0.119860951536629 |
|
3946 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RGS14 |
0.119860951536629 |
|
3947 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR1260B |
0.120421269286627 |
|
3948 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRMP |
0.120497866051926 |
|
3949 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STAB2 |
0.120660720516267 |
|
3950 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U8|ENSG00000212594.1 |
0.120660720516267 |
|
3951 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NT5DC3 |
0.120660720516267 |
|
3952 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3652 |
0.120660720516267 |
|
3953 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CD53 |
0.12072659601578 |
|
3954 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ABCB1 |
0.120952260969692 |
|
3955 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238587.1 |
0.120952260969692 |
|
3956 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RUNDC3B |
0.120952260969692 |
|
3957 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC25A40 |
0.120952260969692 |
|
3958 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANK1 |
0.120971612565788 |
|
3959 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNF112 |
0.12103912016402 |
|
3960 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC47A1 |
0.12103912016402 |
|
3961 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA59B |
0.12103912016402 |
|
3962 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ALDH3A2 |
0.12103912016402 |
|
3963 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA31|ENSG00000252349.1 |
0.12103912016402 |
|
3964 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL188P |
0.121041983395732 |
|
3965 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C11orf58 |
0.121041983395732 |
|
3966 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP90 |
0.121041983395732 |
|
3967 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF708 |
0.121078712800951 |
|
3968 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF738 |
0.121078712800951 |
|
3969 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF493 |
0.121078712800951 |
|
3970 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNU4ATAC7P |
0.121098777854568 |
|
3971 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RTFDC1 |
0.121098777854568 |
|
3972 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GCNT7 |
0.121098777854568 |
|
3973 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM209A |
0.121098777854568 |
|
3974 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM209B |
0.121098777854568 |
|
3975 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U3|ENSG00000252536.1 |
0.121098777854568 |
|
3976 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TFAP2C |
0.121098777854568 |
|
3977 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL170P |
0.121098777854568 |
|
3978 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BYSL |
0.121365318106807 |
|
3979 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCND3 |
0.121365318106807 |
|
3980 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DGKA |
0.121399687509973 |
|
3981 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PMEL |
0.121399687509973 |
|
3982 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDK2 |
0.121399687509973 |
|
3983 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAB5B |
0.121399687509973 |
|
3984 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SUOX |
0.121399687509973 |
|
3985 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C12orf42 |
0.121452363211026 |
|
3986 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNAPIN |
0.121596962524984 |
|
3987 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ILF2 |
0.121596962524984 |
|
3988 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NCOA6 |
0.121795937633249 |
|
3989 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GGT7 |
0.121795937633249 |
|
3990 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NPTX2 |
0.121868857254437 |
|
3991 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPRR4 |
0.121904686883843 |
|
3992 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPRR1A |
0.121904686883843 |
|
3993 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPRR3 |
0.121904686883843 |
|
3994 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM57 |
0.122068444290678 |
|
3995 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LDLRAP1 |
0.122068444290678 |
|
3996 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SATB2 |
0.12225457213352 |
|
3997 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
POLR2E |
0.122277895964145 |
|
3998 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPX4 |
0.122277895964145 |
|
3999 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SBNO2 |
0.122277895964145 |
|
4000 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STK11 |
0.122277895964145 |
|
4001 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATP5D |
0.122277895964145 |
|
4002 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C19orf26 |
0.122277895964145 |
|
4003 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CIRBP |
0.122277895964145 |
|
4004 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIDN |
0.122277895964145 |
|
4005 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C19orf24 |
0.122277895964145 |
|
4006 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EFNA2 |
0.122277895964145 |
|
4007 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MUM1 |
0.122277895964145 |
|
4008 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM222A |
0.122287033212541 |
|
4009 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GUCA1B |
0.122298843357822 |
|
4010 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MRPS10 |
0.122298843357822 |
|
4011 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4495 |
0.122319987499954 |
|
4012 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4303 |
0.122319987499954 |
|
4013 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC9A7P1 |
0.122319987499954 |
|
4014 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMPO |
0.122319987499954 |
|
4015 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL179P |
0.122319987499954 |
|
4016 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PTGFRN |
0.122430954542124 |
|
4017 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TAF8 |
0.122539290768408 |
|
4018 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C6orf132 |
0.122539290768408 |
|
4019 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GUCA1A |
0.122539290768408 |
|
4020 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FRS3 |
0.122608823358078 |
|
4021 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRICKLE4 |
0.122608823358078 |
|
4022 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TOMM6 |
0.122608823358078 |
|
4023 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
USP49 |
0.122608823358078 |
|
4024 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA8|ENSG00000206977.1 |
0.122608823358078 |
|
4025 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MED20 |
0.122608823358078 |
|
4026 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4689 |
0.122658130142271 |
|
4027 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NPHP4 |
0.122658130142271 |
|
4028 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCNAB2 |
0.122658130142271 |
|
4029 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CHD5 |
0.122658130142271 |
|
4030 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPL22 |
0.122658130142271 |
|
4031 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNF207 |
0.122658130142271 |
|
4032 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ICMT |
0.122658130142271 |
|
4033 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00337 |
0.122658130142271 |
|
4034 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U3|ENSG00000199370.1 |
0.122708071358865 |
|
4035 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SEMA3E |
0.122986390551456 |
|
4036 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FKSG63 |
0.12306757042127 |
|
4037 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238734.1 |
0.12306757042127 |
|
4038 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AARS |
0.12306757042127 |
|
4039 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EXOSC6 |
0.12306757042127 |
|
4040 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL407P |
0.12306757042127 |
|
4041 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL279P |
0.12306757042127 |
|
4042 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DDX19B |
0.12306757042127 |
|
4043 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DBF4 |
0.123130816832417 |
|
4044 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADAM22 |
0.123130816832417 |
|
4045 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM214A |
0.123229929969899 |
|
4046 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ONECUT1 |
0.123229929969899 |
|
4047 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL38P |
0.12331411687226 |
|
4048 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BCAT1 |
0.12331411687226 |
|
4049 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C12orf77 |
0.12331411687226 |
|
4050 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IL6R |
0.123315452071008 |
|
4051 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SHE |
0.123315452071008 |
|
4052 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TDRD10 |
0.123315452071008 |
|
4053 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UBE2Q1 |
0.123315452071008 |
|
4054 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CHRNB2 |
0.123315452071008 |
|
4055 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADAR |
0.123315452071008 |
|
4056 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL457P |
0.123410131349224 |
|
4057 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC1A3 |
0.123470845980603 |
|
4058 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TACR2 |
0.123485468700133 |
|
4059 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR9K2 |
0.123499829077537 |
|
4060 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CGGBP1 |
0.123500599507172 |
|
4061 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LIMCH1 |
0.123641441467673 |
|
4062 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000239111.1 |
0.123887976705153 |
|
4063 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238761.1 |
0.123887976705153 |
|
4064 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM76A |
0.123930589176892 |
|
4065 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STX12 |
0.123930589176892 |
|
4066 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPP1R8 |
0.123930589176892 |
|
4067 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCARNA1 |
0.123930589176892 |
|
4068 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
THEMIS2 |
0.123930589176892 |
|
4069 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC5A5 |
0.124136010524809 |
|
4070 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC124 |
0.124136010524809 |
|
4071 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP468 |
0.124136010524809 |
|
4072 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARRDC2 |
0.124136010524809 |
|
4073 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CNPY2 |
0.124138472038065 |
|
4074 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HEPHL1 |
0.124449061803892 |
|
4075 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PANX1 |
0.124449061803892 |
|
4076 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FOLR4 |
0.124449061803892 |
|
4077 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPR83 |
0.124449061803892 |
|
4078 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MRE11A |
0.124449061803892 |
|
4079 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR548L |
0.124449061803892 |
|
4080 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANKRD49 |
0.124449061803892 |
|
4081 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FUT4 |
0.124449061803892 |
|
4082 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PIWIL4 |
0.124449061803892 |
|
4083 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AMOTL1 |
0.124449061803892 |
|
4084 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CWC15 |
0.124449061803892 |
|
4085 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KDM4D |
0.124449061803892 |
|
4086 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KDM4E |
0.124449061803892 |
|
4087 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SRSF8 |
0.124449061803892 |
|
4088 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SESN3 |
0.124449061803892 |
|
4089 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00477 |
0.124487322334491 |
|
4090 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRABD2B |
0.124524321743651 |
|
4091 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC5A9 |
0.124524321743651 |
|
4092 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPATA6 |
0.124524321743651 |
|
4093 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BEND5 |
0.124524321743651 |
|
4094 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SYT11 |
0.124556978575879 |
|
4095 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA42|ENSG00000207475.1 |
0.124556978575879 |
|
4096 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCARNA4|ENSG00000252808.1 |
0.124556978575879 |
|
4097 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RXFP4 |
0.124556978575879 |
|
4098 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARHGEF2 |
0.124556978575879 |
|
4099 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SSR2 |
0.124556978575879 |
|
4100 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UBQLN4 |
0.124556978575879 |
|
4101 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LAMTOR2 |
0.124556978575879 |
|
4102 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAB25 |
0.124556978575879 |
|
4103 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MEX3A |
0.124556978575879 |
|
4104 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LMNA |
0.124556978575879 |
|
4105 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SEMA4A |
0.124556978575879 |
|
4106 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA26|ENSG00000252236.1 |
0.124556978575879 |
|
4107 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC25A44 |
0.124556978575879 |
|
4108 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PMF1 |
0.124556978575879 |
|
4109 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BGLAP |
0.124556978575879 |
|
4110 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PAQR6 |
0.124556978575879 |
|
4111 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SMG5 |
0.124556978575879 |
|
4112 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C1orf85 |
0.124556978575879 |
|
4113 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM79 |
0.124556978575879 |
|
4114 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VHLL |
0.124556978575879 |
|
4115 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCT3 |
0.124556978575879 |
|
4116 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TSACC |
0.124556978575879 |
|
4117 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RHBG |
0.124556978575879 |
|
4118 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
B9D1 |
0.124647160763848 |
|
4119 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR1180 |
0.124647160763848 |
|
4120 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAPK7 |
0.124647160763848 |
|
4121 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MFAP4 |
0.124647160763848 |
|
4122 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NDUFS7 |
0.124665356518123 |
|
4123 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DAZAP1 |
0.124665356518123 |
|
4124 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPS15 |
0.124665356518123 |
|
4125 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
APC2 |
0.124665356518123 |
|
4126 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C19orf25 |
0.124665356518123 |
|
4127 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCSK4 |
0.124665356518123 |
|
4128 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
REEP6 |
0.124665356518123 |
|
4129 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADAMTSL5 |
0.124665356518123 |
|
4130 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLK5 |
0.124665356518123 |
|
4131 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MEX3D |
0.124665356518123 |
|
4132 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MBD3 |
0.124665356518123 |
|
4133 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL477P |
0.124665356518123 |
|
4134 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UQCR11 |
0.124665356518123 |
|
4135 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL149P |
0.124905846753803 |
|
4136 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SART3 |
0.124981802532588 |
|
4137 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ISCU |
0.124981802532588 |
|
4138 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM119 |
0.124981802532588 |
|
4139 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SELPLG |
0.124981802532588 |
|
4140 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CORO1C |
0.124981802532588 |
|
4141 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GUCY1A2 |
0.125059236492647 |
|
4142 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MGST1 |
0.125113941470691 |
|
4143 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PGBD5 |
0.12521863514842 |
|
4144 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLXDC2 |
0.125319870765927 |
|
4145 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DPP9 |
0.125394945686284 |
|
4146 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CALN1 |
0.125512684982593 |
|
4147 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPFIBP2 |
0.12551687330494 |
|
4148 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CYB5R2 |
0.12551687330494 |
|
4149 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OVCH2 |
0.12551687330494 |
|
4150 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR10AB1P |
0.12551687330494 |
|
4151 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TTC37 |
0.125642067974276 |
|
4152 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNU3P3 |
0.12564472631944 |
|
4153 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AIM1L |
0.12576426152525 |
|
4154 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CD52 |
0.12576426152525 |
|
4155 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL490P |
0.12576426152525 |
|
4156 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF683 |
0.12576426152525 |
|
4157 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LIN28A |
0.12576426152525 |
|
4158 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARID1A |
0.125911950459164 |
|
4159 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL501P |
0.125911950459164 |
|
4160 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PIGV |
0.125911950459164 |
|
4161 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL165P |
0.125911950459164 |
|
4162 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZDHHC18 |
0.125911950459164 |
|
4163 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SFN |
0.125911950459164 |
|
4164 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPN2 |
0.125911950459164 |
|
4165 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPATCH3 |
0.125911950459164 |
|
4166 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM182A |
0.126180028994857 |
|
4167 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NCOR1P1 |
0.126180028994857 |
|
4168 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MOV10 |
0.12628737778326 |
|
4169 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RHOC |
0.12628737778326 |
|
4170 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPM1J |
0.12628737778326 |
|
4171 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM19A3 |
0.12628737778326 |
|
4172 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC16A1 |
0.12628737778326 |
|
4173 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRIG2 |
0.12628737778326 |
|
4174 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PMVK |
0.126294908096079 |
|
4175 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BBS1 |
0.126498392514973 |
|
4176 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MROH8 |
0.126624110958344 |
|
4177 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPN2 |
0.126624110958344 |
|
4178 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TCEB3 |
0.126684454166123 |
|
4179 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PITHD1 |
0.126684454166123 |
|
4180 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GALE |
0.126684454166123 |
|
4181 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HMGCL |
0.126684454166123 |
|
4182 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LYPLA2 |
0.126684454166123 |
|
4183 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FUCA1 |
0.126684454166123 |
|
4184 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CNR2 |
0.126684454166123 |
|
4185 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL24P |
0.126684454166123 |
|
4186 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238538.1 |
0.126684454166123 |
|
4187 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR378F |
0.126684454166123 |
|
4188 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PNRC2 |
0.126684454166123 |
|
4189 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SRSF10 |
0.126684454166123 |
|
4190 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C19orf59 |
0.126849042651895 |
|
4191 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAPPC5 |
0.126849042651895 |
|
4192 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FCER2 |
0.126849042651895 |
|
4193 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLEC4G |
0.126849042651895 |
|
4194 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CD209 |
0.126849042651895 |
|
4195 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIAA1731 |
0.126899669133427 |
|
4196 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIAA1324L |
0.126921413812558 |
|
4197 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DMTF1 |
0.126921413812558 |
|
4198 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM243 |
0.126921413812558 |
|
4199 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MARCH7 |
0.127120436589655 |
|
4200 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GHRH |
0.127319248027776 |
|
4201 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MANBAL |
0.127319248027776 |
|
4202 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR591 |
0.127515796917014 |
|
4203 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PTCH2 |
0.127905946386968 |
|
4204 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EIF2B3 |
0.127905946386968 |
|
4205 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP47 |
0.127905946386968 |
|
4206 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HECTD3 |
0.127905946386968 |
|
4207 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UROD |
0.127905946386968 |
|
4208 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZSWIM5 |
0.127905946386968 |
|
4209 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HPDL |
0.127905946386968 |
|
4210 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MUTYH |
0.127905946386968 |
|
4211 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TOE1 |
0.127905946386968 |
|
4212 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238945.1 |
0.127905946386968 |
|
4213 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP367 |
0.128116329605386 |
|
4214 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NXT1 |
0.128164734407912 |
|
4215 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PNOC |
0.12829309812946 |
|
4216 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF395 |
0.12829309812946 |
|
4217 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FBXO16 |
0.12829309812946 |
|
4218 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IKZF4 |
0.128334205986918 |
|
4219 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPS26 |
0.128334205986918 |
|
4220 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ERBB3 |
0.128334205986918 |
|
4221 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PIK3C3 |
0.128428780906649 |
|
4222 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP454 |
0.128428780906649 |
|
4223 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RFX2 |
0.128477208819045 |
|
4224 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EMR3 |
0.128504507277023 |
|
4225 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IP6K3 |
0.128570770454697 |
|
4226 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LEMD2 |
0.128570770454697 |
|
4227 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MLN |
0.128570770454697 |
|
4228 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP55 |
0.12863695804129 |
|
4229 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CD101 |
0.12863695804129 |
|
4230 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRPM5 |
0.128754380382783 |
|
4231 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TSSC4 |
0.128754380382783 |
|
4232 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCNQ1OT1 |
0.128754380382783 |
|
4233 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP326 |
0.128764190081196 |
|
4234 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CNOT2 |
0.128871090424418 |
|
4235 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCNMB4 |
0.128871090424418 |
|
4236 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR548Q |
0.128871581918162 |
|
4237 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP300 |
0.128871581918162 |
|
4238 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OPTN |
0.128871581918162 |
|
4239 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MCM10 |
0.128871581918162 |
|
4240 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UCMA |
0.128871581918162 |
|
4241 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PHYH |
0.128871581918162 |
|
4242 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SEPHS1 |
0.128871581918162 |
|
4243 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BEND7 |
0.128871581918162 |
|
4244 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRPF18 |
0.128871581918162 |
|
4245 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NFKBIA |
0.129102018288855 |
|
4246 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC25A13 |
0.129137704354736 |
|
4247 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DYNC2H1 |
0.129166412136394 |
|
4248 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ASXL3 |
0.129201517238118 |
|
4249 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDNF |
0.129231997503487 |
|
4250 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HSPA14 |
0.129231997503487 |
|
4251 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SUV39H2 |
0.129231997503487 |
|
4252 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DCLRE1C |
0.129231997503487 |
|
4253 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MEIG1 |
0.129231997503487 |
|
4254 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IGSF3 |
0.129341743885502 |
|
4255 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR320B1 |
0.129341743885502 |
|
4256 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C1orf137 |
0.129341743885502 |
|
4257 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CD2 |
0.129341743885502 |
|
4258 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00351 |
0.129459570456114 |
|
4259 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PAN2 |
0.129649798923217 |
|
4260 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IL23A |
0.129649798923217 |
|
4261 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STAT2 |
0.129649798923217 |
|
4262 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
APOF |
0.129649798923217 |
|
4263 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TIMELESS |
0.129649798923217 |
|
4264 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIP |
0.129649798923217 |
|
4265 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPRYD4 |
0.129649798923217 |
|
4266 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RIC8B |
0.129724598689962 |
|
4267 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CRY1 |
0.129724598689962 |
|
4268 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR6C4 |
0.129836716353989 |
|
4269 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR2AP1 |
0.129836716353989 |
|
4270 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR10P1 |
0.129836716353989 |
|
4271 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
METTL7B |
0.129836716353989 |
|
4272 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ITGA7 |
0.129836716353989 |
|
4273 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BLOC1S1 |
0.129836716353989 |
|
4274 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RDH5 |
0.129836716353989 |
|
4275 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CD63 |
0.129836716353989 |
|
4276 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GDF11 |
0.129836716353989 |
|
4277 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP181 |
0.12992223638665 |
|
4278 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NCOA1 |
0.130011004129904 |
|
4279 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLEKHG4 |
0.130088573072812 |
|
4280 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP118 |
0.130088573072812 |
|
4281 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRRC36 |
0.130088573072812 |
|
4282 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TPPP3 |
0.130088573072812 |
|
4283 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZDHHC1 |
0.130088573072812 |
|
4284 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HSD11B2 |
0.130088573072812 |
|
4285 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATP6V0D1 |
0.130088573072812 |
|
4286 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AGRP |
0.130088573072812 |
|
4287 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP232 |
0.13026472416173 |
|
4288 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TP53I11 |
0.130295903937515 |
|
4289 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TAS2R60 |
0.130307731349153 |
|
4290 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TAS2R41 |
0.130307731349153 |
|
4291 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL117P |
0.130361967931352 |
|
4292 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDH9 |
0.13040649728409 |
|
4293 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPS6KA5 |
0.130502059009262 |
|
4294 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C14orf159 |
0.130502059009262 |
|
4295 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA11B |
0.130502059009262 |
|
4296 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
JRKL |
0.130550059539716 |
|
4297 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA4|ENSG00000201133.1 |
0.130678346641532 |
|
4298 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PHF20 |
0.130712847486119 |
|
4299 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCAND1 |
0.130712847486119 |
|
4300 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00972 |
0.130993973686874 |
|
4301 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GRM3 |
0.131141877704847 |
|
4302 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CABP7 |
0.131180081364585 |
|
4303 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZMAT5 |
0.131180081364585 |
|
4304 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UQCR10 |
0.131180081364585 |
|
4305 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MACROD2 |
0.131390766579632 |
|
4306 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BAZ2A |
0.13147120876688 |
|
4307 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATP5B |
0.13147120876688 |
|
4308 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD59A |
0.13147120876688 |
|
4309 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PTGES3 |
0.13147120876688 |
|
4310 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL809P |
0.13147120876688 |
|
4311 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MON1B |
0.13150281958781 |
|
4312 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SYCE1L |
0.13150281958781 |
|
4313 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NUDT7 |
0.13150281958781 |
|
4314 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VAT1L |
0.13150281958781 |
|
4315 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLEC3A |
0.13150281958781 |
|
4316 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC24A3 |
0.131903835124967 |
|
4317 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL231P |
0.131997531869105 |
|
4318 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CD97 |
0.131997531869105 |
|
4319 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DDX39A |
0.131997531869105 |
|
4320 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PKN1 |
0.131997531869105 |
|
4321 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAN1C1 |
0.132019311950659 |
|
4322 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SEPN1 |
0.132019311950659 |
|
4323 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PTCHD4 |
0.132146357379842 |
|
4324 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
N4BP3 |
0.132327246503011 |
|
4325 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MTHFD2P1 |
0.132372386856205 |
|
4326 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD45|ENSG00000200706.1 |
0.132441867118679 |
|
4327 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GUSBP11 |
0.13247494539173 |
|
4328 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIF |
0.132671310557771 |
|
4329 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DDTL |
0.132671310557771 |
|
4330 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DDT |
0.132671310557771 |
|
4331 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GSTT1 |
0.132671310557771 |
|
4332 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GSTT2B |
0.132671310557771 |
|
4333 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GSTT2 |
0.132671310557771 |
|
4334 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GSTTP2 |
0.132671310557771 |
|
4335 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WNT2B |
0.132762536222237 |
|
4336 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CASC16 |
0.132789483535495 |
|
4337 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAAH |
0.13281743703099 |
|
4338 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00505 |
0.13281743703099 |
|
4339 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DMBX1 |
0.13281743703099 |
|
4340 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KNCN |
0.13281743703099 |
|
4341 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MKNK1 |
0.13281743703099 |
|
4342 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MOB3C |
0.13281743703099 |
|
4343 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATPAF1 |
0.13281743703099 |
|
4344 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EFCAB14 |
0.13281743703099 |
|
4345 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TEX38 |
0.13281743703099 |
|
4346 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CYP4B1 |
0.13281743703099 |
|
4347 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
USP6NL |
0.132889532448023 |
|
4348 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RGL4 |
0.132936653292348 |
|
4349 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VPREB3 |
0.132936653292348 |
|
4350 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF70 |
0.132936653292348 |
|
4351 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C22orf15 |
0.132936653292348 |
|
4352 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CHCHD10 |
0.132936653292348 |
|
4353 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MMP11 |
0.132936653292348 |
|
4354 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SMARCB1 |
0.132936653292348 |
|
4355 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DERL3 |
0.132936653292348 |
|
4356 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC2A11 |
0.132936653292348 |
|
4357 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL268P |
0.132936653292348 |
|
4358 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL223P |
0.133010165996504 |
|
4359 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BHLHE41 |
0.133019299530437 |
|
4360 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACCSL |
0.133033243601212 |
|
4361 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACCS |
0.133033243601212 |
|
4362 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EXT2 |
0.133033243601212 |
|
4363 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ALX4 |
0.133033243601212 |
|
4364 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CD82 |
0.133033243601212 |
|
4365 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TSPAN18 |
0.133033243601212 |
|
4366 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NCR3LG1 |
0.133113525618645 |
|
4367 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCNJ11 |
0.133113525618645 |
|
4368 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ABCC8 |
0.133113525618645 |
|
4369 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
USH1C |
0.133113525618645 |
|
4370 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OTOG |
0.133113525618645 |
|
4371 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MYOD1 |
0.133113525618645 |
|
4372 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCNC1 |
0.133113525618645 |
|
4373 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SERGEF |
0.133113525618645 |
|
4374 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TPH1 |
0.133113525618645 |
|
4375 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SAAL1 |
0.133113525618645 |
|
4376 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SAA3P |
0.133113525618645 |
|
4377 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MRGPRX3 |
0.133113525618645 |
|
4378 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MRGPRX4 |
0.133113525618645 |
|
4379 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SAA4 |
0.133113525618645 |
|
4380 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SAA2 |
0.133113525618645 |
|
4381 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP333 |
0.133113525618645 |
|
4382 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP334 |
0.133113525618645 |
|
4383 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SAA1 |
0.133113525618645 |
|
4384 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HPS5 |
0.133113525618645 |
|
4385 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GTF2H1 |
0.133113525618645 |
|
4386 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3159 |
0.133113525618645 |
|
4387 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LDHA |
0.133113525618645 |
|
4388 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LDHC |
0.133113525618645 |
|
4389 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LDHAL6A |
0.133113525618645 |
|
4390 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TSG101 |
0.133113525618645 |
|
4391 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UEVLD |
0.133113525618645 |
|
4392 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPTY2D1 |
0.133113525618645 |
|
4393 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM86A |
0.133113525618645 |
|
4394 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IGSF22 |
0.133113525618645 |
|
4395 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC38A4 |
0.133173032447289 |
|
4396 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VSX1 |
0.133193873182012 |
|
4397 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ENTPD6 |
0.133193873182012 |
|
4398 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLCN4 |
0.133500520887242 |
|
4399 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MID1 |
0.133500520887242 |
|
4400 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WWC3 |
0.133500520887242 |
|
4401 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SKINTL |
0.13354616437965 |
|
4402 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP140 |
0.133685807872297 |
|
4403 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRIF1 |
0.133717611040063 |
|
4404 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PIFO |
0.133717611040063 |
|
4405 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PGCP1 |
0.133717611040063 |
|
4406 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OVGP1 |
0.133717611040063 |
|
4407 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WDR77 |
0.133717611040063 |
|
4408 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATP5F1 |
0.133717611040063 |
|
4409 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C1orf162 |
0.133717611040063 |
|
4410 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADORA3 |
0.133717611040063 |
|
4411 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAP1A |
0.133717611040063 |
|
4412 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PALM3 |
0.133812011699903 |
|
4413 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C19orf67 |
0.133812011699903 |
|
4414 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRKACA |
0.133812011699903 |
|
4415 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SAMD1 |
0.133812011699903 |
|
4416 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ASF1B |
0.133812011699903 |
|
4417 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LPHN1 |
0.133812011699903 |
|
4418 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP430 |
0.133866825438248 |
|
4419 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CNTNAP4 |
0.133866825438248 |
|
4420 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP233 |
0.133866825438248 |
|
4421 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD33|ENSG00000252022.1 |
0.133866825438248 |
|
4422 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4719 |
0.133866825438248 |
|
4423 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANO1 |
0.133995006795988 |
|
4424 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRPF39 |
0.134035966044786 |
|
4425 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD127 |
0.134035966044786 |
|
4426 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRIM1 |
0.13426603076152 |
|
4427 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HSD17B6 |
0.13426603076152 |
|
4428 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA48|ENSG00000212383.1 |
0.13426603076152 |
|
4429 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP302 |
0.134352315131245 |
|
4430 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NUP153 |
0.134393208341869 |
|
4431 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OSMR |
0.134528329097843 |
|
4432 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COBL |
0.134595929954652 |
|
4433 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ASB4 |
0.134680176420654 |
|
4434 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PDK4 |
0.134680176420654 |
|
4435 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DYNC1I1 |
0.134680176420654 |
|
4436 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MTFR1L |
0.134762040664464 |
|
4437 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AUNIP |
0.134762040664464 |
|
4438 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PAQR7 |
0.134762040664464 |
|
4439 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STMN1 |
0.134762040664464 |
|
4440 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3917 |
0.134762040664464 |
|
4441 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PAFAH2 |
0.134762040664464 |
|
4442 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCARNA17|ENSG00000252190.1 |
0.134762040664464 |
|
4443 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCARNA18|ENSG00000252691.1 |
0.134762040664464 |
|
4444 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EXTL1 |
0.134762040664464 |
|
4445 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC30A2 |
0.134762040664464 |
|
4446 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRIM63 |
0.134762040664464 |
|
4447 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PDIK1L |
0.134762040664464 |
|
4448 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM110D |
0.134762040664464 |
|
4449 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF593 |
0.134762040664464 |
|
4450 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CNKSR1 |
0.134762040664464 |
|
4451 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CATSPER4 |
0.134762040664464 |
|
4452 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CEP85 |
0.134762040664464 |
|
4453 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SH3BGRL3 |
0.134762040664464 |
|
4454 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UBXN11 |
0.134762040664464 |
|
4455 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AMH |
0.135061431364879 |
|
4456 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
JSRP1 |
0.135061431364879 |
|
4457 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4321 |
0.135061431364879 |
|
4458 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C19orf35 |
0.135061431364879 |
|
4459 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OAZ1 |
0.135061431364879 |
|
4460 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINGO3 |
0.135061431364879 |
|
4461 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LSM7 |
0.135061431364879 |
|
4462 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPPL2B |
0.135061431364879 |
|
4463 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMPRSS9 |
0.135061431364879 |
|
4464 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LMNB2 |
0.135061431364879 |
|
4465 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TIMM13 |
0.135061431364879 |
|
4466 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GADD45B |
0.135061431364879 |
|
4467 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLMO1 |
0.135243648311614 |
|
4468 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPIRE1 |
0.135243648311614 |
|
4469 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238309.1 |
0.135243648311614 |
|
4470 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CEP76 |
0.135243648311614 |
|
4471 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PSMG2 |
0.135243648311614 |
|
4472 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNY4P28 |
0.135296860077872 |
|
4473 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00434 |
0.135296860077872 |
|
4474 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TDRD3 |
0.135296860077872 |
|
4475 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP31 |
0.135296860077872 |
|
4476 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00378 |
0.135296860077872 |
|
4477 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNY3P5 |
0.135296860077872 |
|
4478 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNY4P31 |
0.135296860077872 |
|
4479 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3169 |
0.135296860077872 |
|
4480 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCDH20 |
0.135296860077872 |
|
4481 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MSL3 |
0.135486097631364 |
|
4482 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLK1S1 |
0.135509558857483 |
|
4483 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP477 |
0.135509558857483 |
|
4484 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
XRN2 |
0.135509558857483 |
|
4485 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR8B2 |
0.135539456942903 |
|
4486 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ITIH5 |
0.135583465989763 |
|
4487 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ITIH2 |
0.135583465989763 |
|
4488 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIN |
0.135583465989763 |
|
4489 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATP5C1 |
0.135583465989763 |
|
4490 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GATA3 |
0.135583465989763 |
|
4491 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCNQ1DN |
0.13564961127608 |
|
4492 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDKN1C |
0.13564961127608 |
|
4493 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PDGFRA |
0.135672515651324 |
|
4494 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CYMP |
0.135753644376677 |
|
4495 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCNA10 |
0.135753644376677 |
|
4496 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCNA2 |
0.135753644376677 |
|
4497 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCNA3 |
0.135753644376677 |
|
4498 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NACA |
0.135956741628329 |
|
4499 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LELP1 |
0.135958021987915 |
|
4500 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FNBP1L |
0.136087284077728 |
|
4501 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BCAR3 |
0.136087284077728 |
|
4502 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC28A2 |
0.136211899882578 |
|
4503 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD112|ENSG00000252354.1 |
0.136485055295218 |
|
4504 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PIGC |
0.136485055295218 |
|
4505 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C1orf105 |
0.136485055295218 |
|
4506 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SUCO |
0.136485055295218 |
|
4507 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LAMA2 |
0.136556825781808 |
|
4508 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BTBD9 |
0.136740057870911 |
|
4509 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
API5 |
0.136759946943649 |
|
4510 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP287 |
0.136759946943649 |
|
4511 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HTR1F |
0.136859792487979 |
|
4512 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4490 |
0.136900883293848 |
|
4513 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ENDOD1 |
0.13693032851801 |
|
4514 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
APPL2 |
0.137045959876114 |
|
4515 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C12orf75 |
0.137045959876114 |
|
4516 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IFT81 |
0.137331053117284 |
|
4517 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM182B |
0.13741605382358 |
|
4518 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
XAF1 |
0.137532240373064 |
|
4519 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FBXO39 |
0.137532240373064 |
|
4520 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TEKT1 |
0.137532240373064 |
|
4521 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4802 |
0.137740593121362 |
|
4522 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238351.1 |
0.137740593121362 |
|
4523 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CASD1 |
0.137872074671815 |
|
4524 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SGCE |
0.137872074671815 |
|
4525 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PEG10 |
0.137872074671815 |
|
4526 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP129 |
0.137872074671815 |
|
4527 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IFNLR1 |
0.138106134635801 |
|
4528 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GRHL3 |
0.138106134635801 |
|
4529 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STPG1 |
0.138106134635801 |
|
4530 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DMRTA2 |
0.138304098979867 |
|
4531 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAF1 |
0.138304098979867 |
|
4532 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF99 |
0.138634270400427 |
|
4533 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238455.1 |
0.138641850625062 |
|
4534 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP6 |
0.138641850625062 |
|
4535 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRR20A |
0.138641850625062 |
|
4536 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRR20B |
0.138641850625062 |
|
4537 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRR20C |
0.138641850625062 |
|
4538 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRR20D |
0.138641850625062 |
|
4539 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRR20E |
0.138641850625062 |
|
4540 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCDH17 |
0.138641850625062 |
|
4541 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP30 |
0.138641850625062 |
|
4542 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNY4P29 |
0.138641850625062 |
|
4543 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ELAVL4 |
0.138803363486105 |
|
4544 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WDR62 |
0.138825108041712 |
|
4545 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FSTL3 |
0.138849254152618 |
|
4546 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRSS57 |
0.138849254152618 |
|
4547 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PALM |
0.138849254152618 |
|
4548 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MISP |
0.138849254152618 |
|
4549 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARID3A |
0.138849254152618 |
|
4550 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CFD |
0.138849254152618 |
|
4551 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ELANE |
0.138849254152618 |
|
4552 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KISS1R |
0.138849254152618 |
|
4553 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MED16 |
0.138849254152618 |
|
4554 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRTN3 |
0.138849254152618 |
|
4555 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
R3HDM4 |
0.138849254152618 |
|
4556 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WDR18 |
0.138849254152618 |
|
4557 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GRIN3B |
0.138849254152618 |
|
4558 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM259 |
0.138849254152618 |
|
4559 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CNN2 |
0.138849254152618 |
|
4560 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ABCA7 |
0.138849254152618 |
|
4561 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HMHA1 |
0.138849254152618 |
|
4562 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TUBB6 |
0.13896409992336 |
|
4563 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP235 |
0.139033508584849 |
|
4564 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TBCC |
0.139039293601166 |
|
4565 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPA2 |
0.139152473970911 |
|
4566 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DHX15 |
0.139242648197366 |
|
4567 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C8orf4 |
0.13925690188331 |
|
4568 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VWF |
0.13927994038707 |
|
4569 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP394 |
0.139299496386206 |
|
4570 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDK14 |
0.139392695066875 |
|
4571 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LMTK2 |
0.139397927545853 |
|
4572 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BHLHA15 |
0.139397927545853 |
|
4573 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TECPR1 |
0.139397927545853 |
|
4574 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BRI3 |
0.139397927545853 |
|
4575 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BAIAP2L1 |
0.139397927545853 |
|
4576 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRIM6 |
0.139432957265872 |
|
4577 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRIM34 |
0.139432957265872 |
|
4578 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRIM5 |
0.139432957265872 |
|
4579 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRIM22 |
0.139432957265872 |
|
4580 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR56B1 |
0.139432957265872 |
|
4581 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR52N4 |
0.139432957265872 |
|
4582 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR52N1 |
0.139432957265872 |
|
4583 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR52N5 |
0.139432957265872 |
|
4584 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR52N2 |
0.139432957265872 |
|
4585 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR52E6 |
0.139432957265872 |
|
4586 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR52E4 |
0.139432957265872 |
|
4587 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR52E8 |
0.139432957265872 |
|
4588 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR52B2 |
0.139432957265872 |
|
4589 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR52W1 |
0.139432957265872 |
|
4590 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C11orf42 |
0.139432957265872 |
|
4591 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM160A2 |
0.139432957265872 |
|
4592 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CNGA4 |
0.139432957265872 |
|
4593 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCKBR |
0.139432957265872 |
|
4594 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRKCDBP |
0.139432957265872 |
|
4595 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
APBB1 |
0.139432957265872 |
|
4596 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SMPD1 |
0.139432957265872 |
|
4597 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HPX |
0.139432957265872 |
|
4598 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRIM3 |
0.139432957265872 |
|
4599 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARFIP2 |
0.139432957265872 |
|
4600 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TIMM10B |
0.139432957265872 |
|
4601 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DNHD1 |
0.139432957265872 |
|
4602 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RRP8 |
0.139432957265872 |
|
4603 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KLHL1 |
0.139507476769985 |
|
4604 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATXN8OS |
0.139507476769985 |
|
4605 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C12orf68 |
0.139553382616336 |
|
4606 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DKFZP779L1853 |
0.139553382616336 |
|
4607 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR10AD1 |
0.139553382616336 |
|
4608 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TCHP |
0.14002434233297 |
|
4609 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GIT2 |
0.14002434233297 |
|
4610 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4652 |
0.140028519464166 |
|
4611 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TFPI2 |
0.140028519464166 |
|
4612 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GNG11 |
0.140028519464166 |
|
4613 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAB40C |
0.140031287514295 |
|
4614 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD112|ENSG00000252078.1 |
0.140197791236896 |
|
4615 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TPGS2 |
0.140197791236896 |
|
4616 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SRI |
0.140510740911477 |
|
4617 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EAPP |
0.140527836073015 |
|
4618 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPR161 |
0.140607375556818 |
|
4619 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TIPRL |
0.140607375556818 |
|
4620 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SFT2D2 |
0.140607375556818 |
|
4621 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANKRD36BP1 |
0.140607375556818 |
|
4622 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRRX1 |
0.140607375556818 |
|
4623 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MROH9 |
0.140607375556818 |
|
4624 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL756P |
0.140835518894069 |
|
4625 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR548D2 |
0.140835518894069 |
|
4626 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRKG1 |
0.140937132210237 |
|
4627 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C10orf113 |
0.140939459947798 |
|
4628 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HNRNPKP3 |
0.141021536118182 |
|
4629 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCNK17 |
0.141114059106616 |
|
4630 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCNK16 |
0.141114059106616 |
|
4631 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIF6 |
0.141114059106616 |
|
4632 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TCF3 |
0.141240343975311 |
|
4633 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EDEM2 |
0.141256419805948 |
|
4634 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MMP24 |
0.141256419805948 |
|
4635 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EIF6 |
0.141256419805948 |
|
4636 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM83C |
0.141256419805948 |
|
4637 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UQCC |
0.141256419805948 |
|
4638 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GDF5OS |
0.141256419805948 |
|
4639 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GDF5 |
0.141256419805948 |
|
4640 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CEP250 |
0.141256419805948 |
|
4641 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C20orf173 |
0.141256419805948 |
|
4642 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ERGIC3 |
0.141256419805948 |
|
4643 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FER1L4 |
0.141256419805948 |
|
4644 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MYEOV |
0.141437515735209 |
|
4645 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RIN2 |
0.141459829451845 |
|
4646 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NAA20 |
0.141459829451845 |
|
4647 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CRNKL1 |
0.141459829451845 |
|
4648 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAST2 |
0.141964669395025 |
|
4649 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PIK3R3 |
0.141964669395025 |
|
4650 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TSPAN1 |
0.141964669395025 |
|
4651 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
POMGNT1 |
0.141964669395025 |
|
4652 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LURAP1 |
0.141964669395025 |
|
4653 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDKN3 |
0.142449080790309 |
|
4654 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CNIH |
0.142449080790309 |
|
4655 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GMFB |
0.142449080790309 |
|
4656 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COL1A2 |
0.142527953468196 |
|
4657 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TGFBR3L |
0.142531646967245 |
|
4658 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNAPC2 |
0.142531646967245 |
|
4659 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CTXN1 |
0.142531646967245 |
|
4660 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ASNS |
0.142647200046187 |
|
4661 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR5692A1 |
0.142647200046187 |
|
4662 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR5692C2 |
0.142647200046187 |
|
4663 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OCM2 |
0.142647200046187 |
|
4664 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL478P |
0.142647200046187 |
|
4665 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL13P |
0.142647200046187 |
|
4666 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCARNA9 |
0.142671477563365 |
|
4667 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA25|ENSG00000207112.1 |
0.142671477563365 |
|
4668 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TAF1D |
0.142671477563365 |
|
4669 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA1|ENSG00000206834.1 |
0.142671477563365 |
|
4670 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA32|ENSG00000206799.1 |
0.142671477563365 |
|
4671 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA8|ENSG00000207304.1 |
0.142671477563365 |
|
4672 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD6 |
0.142671477563365 |
|
4673 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR1304 |
0.142671477563365 |
|
4674 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA18|ENSG00000207145.1 |
0.142671477563365 |
|
4675 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD5|ENSG00000239195.1 |
0.142671477563365 |
|
4676 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA40|ENSG00000210825.1 |
0.142671477563365 |
|
4677 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C11orf54 |
0.142671477563365 |
|
4678 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MED17 |
0.142671477563365 |
|
4679 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL195P |
0.142671477563365 |
|
4680 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238437.1 |
0.142671477563365 |
|
4681 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VSTM5 |
0.142671477563365 |
|
4682 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MTMR12 |
0.142739054056531 |
|
4683 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR579 |
0.142739054056531 |
|
4684 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C7orf76 |
0.142747128611284 |
|
4685 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COL2A1 |
0.142816932560743 |
|
4686 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SENP1 |
0.142816932560743 |
|
4687 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PFKM |
0.142816932560743 |
|
4688 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ASB8 |
0.142816932560743 |
|
4689 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SEMA3D |
0.142985349153771 |
|
4690 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATP8B3 |
0.143042932360207 |
|
4691 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KLF16 |
0.143042932360207 |
|
4692 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR1909 |
0.143042932360207 |
|
4693 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ONECUT3 |
0.143042932360207 |
|
4694 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
REXO1 |
0.143042932360207 |
|
4695 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ABHD17A |
0.143042932360207 |
|
4696 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADAT3 |
0.143042932360207 |
|
4697 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCAMP4 |
0.143042932360207 |
|
4698 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CSNK1G2 |
0.143042932360207 |
|
4699 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BTBD2 |
0.143042932360207 |
|
4700 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL226P |
0.143042932360207 |
|
4701 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MKNK2 |
0.143042932360207 |
|
4702 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MOB3A |
0.143042932360207 |
|
4703 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AP3D1 |
0.143042932360207 |
|
4704 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IZUMO4 |
0.143042932360207 |
|
4705 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DOT1L |
0.143042932360207 |
|
4706 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR1227 |
0.143042932360207 |
|
4707 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLEKHJ1 |
0.143042932360207 |
|
4708 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SF3A2 |
0.143042932360207 |
|
4709 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ISM1 |
0.143049127133484 |
|
4710 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TASP1 |
0.143049127133484 |
|
4711 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CACNA2D1 |
0.143070300807993 |
|
4712 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DYNLRB2 |
0.143197154420303 |
|
4713 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC130 |
0.143242497458723 |
|
4714 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MRI1 |
0.143242497458723 |
|
4715 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C19orf53 |
0.143242497458723 |
|
4716 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZSWIM4 |
0.143242497458723 |
|
4717 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL619P |
0.143242497458723 |
|
4718 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR27A |
0.143242497458723 |
|
4719 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR23A |
0.143242497458723 |
|
4720 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NANOS3 |
0.143242497458723 |
|
4721 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR181C |
0.143242497458723 |
|
4722 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR181D |
0.143242497458723 |
|
4723 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C19orf57 |
0.143242497458723 |
|
4724 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CC2D1A |
0.143242497458723 |
|
4725 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PODNL1 |
0.143242497458723 |
|
4726 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DCAF15 |
0.143242497458723 |
|
4727 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RFX1 |
0.143242497458723 |
|
4728 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IL27RA |
0.143242497458723 |
|
4729 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RLN3 |
0.143242497458723 |
|
4730 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
METAP2 |
0.143448384643066 |
|
4731 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
USP44 |
0.143448384643066 |
|
4732 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BFSP1 |
0.143458187194006 |
|
4733 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RRBP1 |
0.143458187194006 |
|
4734 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD112|ENSG00000252434.1 |
0.143496381990702 |
|
4735 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM212B |
0.143613224145418 |
|
4736 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DDX20 |
0.143613224145418 |
|
4737 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ASB13 |
0.143954948024539 |
|
4738 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL445P |
0.143954948024539 |
|
4739 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TTF2 |
0.143979207135088 |
|
4740 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR942 |
0.143979207135088 |
|
4741 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRIM45 |
0.143979207135088 |
|
4742 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VTCN1 |
0.143979207135088 |
|
4743 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GIPC1 |
0.144049470488985 |
|
4744 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PTGER1 |
0.144049470488985 |
|
4745 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DNAJB1 |
0.144049470488985 |
|
4746 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR639 |
0.144049470488985 |
|
4747 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TECR |
0.144049470488985 |
|
4748 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NDUFB7 |
0.144049470488985 |
|
4749 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLEC17A |
0.144049470488985 |
|
4750 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL337P |
0.144049470488985 |
|
4751 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL842P |
0.144049470488985 |
|
4752 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PTPN5 |
0.144402038731179 |
|
4753 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SEZ6L |
0.144558695635194 |
|
4754 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP495 |
0.144558695635194 |
|
4755 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ASPHD2 |
0.144558695635194 |
|
4756 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HPS4 |
0.144558695635194 |
|
4757 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SRRD |
0.144558695635194 |
|
4758 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TFIP11 |
0.144558695635194 |
|
4759 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TPST2 |
0.144558695635194 |
|
4760 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADIPOR2 |
0.144696362705735 |
|
4761 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FBXL14 |
0.144696362705735 |
|
4762 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00942 |
0.144696362705735 |
|
4763 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3649 |
0.144696362705735 |
|
4764 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WNT5B |
0.144696362705735 |
|
4765 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCIN |
0.144902223454399 |
|
4766 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARL4A |
0.144902223454399 |
|
4767 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA64|ENSG00000199470.1 |
0.144902223454399 |
|
4768 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP228 |
0.144902223454399 |
|
4769 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FOS |
0.144965343922323 |
|
4770 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BET1 |
0.144989053993689 |
|
4771 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OPN5 |
0.14501372634707 |
|
4772 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR2A12 |
0.14505135274326 |
|
4773 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR2A2 |
0.14505135274326 |
|
4774 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARHGEF35 |
0.14505135274326 |
|
4775 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARHGEF5 |
0.14505135274326 |
|
4776 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CTAGE4 |
0.14505135274326 |
|
4777 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CTAGE8 |
0.14505135274326 |
|
4778 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NOBOX |
0.14505135274326 |
|
4779 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR2A1 |
0.14505135274326 |
|
4780 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR2A20P |
0.14505135274326 |
|
4781 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR2A42 |
0.14505135274326 |
|
4782 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR2A7 |
0.14505135274326 |
|
4783 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR2A9P |
0.14505135274326 |
|
4784 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNU6ATAC40P |
0.14505135274326 |
|
4785 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BPIFB6 |
0.145119153160966 |
|
4786 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BPIFB3 |
0.145119153160966 |
|
4787 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BPIFB4 |
0.145119153160966 |
|
4788 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BPIFA2 |
0.145119153160966 |
|
4789 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ALDH1A2 |
0.145133070488036 |
|
4790 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PHOX2B |
0.145295932034428 |
|
4791 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00662 |
0.145349097504878 |
|
4792 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DHDDS |
0.145356231756137 |
|
4793 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HMGN2 |
0.145356231756137 |
|
4794 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPTLC3 |
0.145363451807497 |
|
4795 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GLTSCR1L |
0.145418977037881 |
|
4796 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPL7L1 |
0.145418977037881 |
|
4797 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C6orf226 |
0.145418977037881 |
|
4798 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PTCRA |
0.145418977037881 |
|
4799 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CNPY3 |
0.145418977037881 |
|
4800 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LYZL1 |
0.145460186396883 |
|
4801 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PTCHD3P1 |
0.145460186396883 |
|
4802 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR604 |
0.145460186396883 |
|
4803 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIAA1462 |
0.145460186396883 |
|
4804 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPCPD1 |
0.145615527994697 |
|
4805 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00654 |
0.145615527994697 |
|
4806 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00658 |
0.145615527994697 |
|
4807 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C20orf196 |
0.145615527994697 |
|
4808 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CHGB |
0.145615527994697 |
|
4809 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRMT6 |
0.145615527994697 |
|
4810 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MCM8 |
0.145615527994697 |
|
4811 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL498P |
0.145615527994697 |
|
4812 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CRLS1 |
0.145615527994697 |
|
4813 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRRN4 |
0.145615527994697 |
|
4814 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA25|ENSG00000200536.1 |
0.145693941113592 |
|
4815 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RBM15 |
0.145693941113592 |
|
4816 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC16A4 |
0.145693941113592 |
|
4817 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LAMTOR5 |
0.145693941113592 |
|
4818 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PROK1 |
0.145693941113592 |
|
4819 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OLAH |
0.145735375175383 |
|
4820 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACBD7 |
0.145735375175383 |
|
4821 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C10orf111 |
0.145735375175383 |
|
4822 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NMT2 |
0.145735375175383 |
|
4823 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPP38 |
0.145735375175383 |
|
4824 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM171A1 |
0.145735375175383 |
|
4825 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KLHDC1 |
0.145774437258688 |
|
4826 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KLHDC2 |
0.145774437258688 |
|
4827 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NEMF |
0.145774437258688 |
|
4828 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL3 |
0.145774437258688 |
|
4829 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL2 |
0.145774437258688 |
|
4830 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARF6 |
0.145774437258688 |
|
4831 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C14orf182 |
0.145774437258688 |
|
4832 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP193 |
0.145774437258688 |
|
4833 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C14orf183 |
0.145774437258688 |
|
4834 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00687 |
0.145960090640238 |
|
4835 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP111 |
0.145960090640238 |
|
4836 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BTBD3 |
0.145960090640238 |
|
4837 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NDRG4 |
0.145963898823792 |
|
4838 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TPK1 |
0.145987811429742 |
|
4839 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SMURF1 |
0.14614780281757 |
|
4840 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GLP1R |
0.146195862574052 |
|
4841 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SAYSD1 |
0.146195862574052 |
|
4842 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCNK5 |
0.146195862574052 |
|
4843 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP332 |
0.146322314612928 |
|
4844 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UHRF1BP1L |
0.146342714609726 |
|
4845 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARPP19 |
0.146378365764841 |
|
4846 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CTAGE5 |
0.146418780778181 |
|
4847 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RBM39 |
0.146464600216652 |
|
4848 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238549.1 |
0.146464600216652 |
|
4849 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238859.1 |
0.146694195248416 |
|
4850 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL425P |
0.146694195248416 |
|
4851 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WBP11P1 |
0.146733312450451 |
|
4852 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00907 |
0.146796388636285 |
|
4853 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UBR2 |
0.147000111269314 |
|
4854 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRPH2 |
0.147000111269314 |
|
4855 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPIL1 |
0.147053803744044 |
|
4856 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C6orf89 |
0.147053803744044 |
|
4857 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IL12RB1 |
0.147196538194711 |
|
4858 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAST3 |
0.147196538194711 |
|
4859 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PIK3R2 |
0.147196538194711 |
|
4860 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IFI30 |
0.147196538194711 |
|
4861 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MPV17L2 |
0.147196538194711 |
|
4862 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF254 |
0.147201523329915 |
|
4863 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF726 |
0.147201523329915 |
|
4864 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CEP135 |
0.147329543501201 |
|
4865 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP161 |
0.147329543501201 |
|
4866 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIAA1211 |
0.147329543501201 |
|
4867 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CNBD2 |
0.147346118300646 |
|
4868 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00657 |
0.147346118300646 |
|
4869 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000239089.1 |
0.147346118300646 |
|
4870 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR10A5 |
0.147390026542241 |
|
4871 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR10A2 |
0.147390026542241 |
|
4872 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR10A4 |
0.147390026542241 |
|
4873 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR2D2 |
0.147390026542241 |
|
4874 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR2D3 |
0.147390026542241 |
|
4875 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF215 |
0.147390026542241 |
|
4876 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF214 |
0.147390026542241 |
|
4877 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NLRP14 |
0.147390026542241 |
|
4878 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RBMXL2 |
0.147390026542241 |
|
4879 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR302E |
0.147390026542241 |
|
4880 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SAFB |
0.14749487274512 |
|
4881 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCED1B |
0.147534813529948 |
|
4882 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LCE1B |
0.147573730493243 |
|
4883 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LCE1A |
0.147573730493243 |
|
4884 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LCE6A |
0.147573730493243 |
|
4885 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PI16 |
0.148097408091806 |
|
4886 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MTCH1 |
0.148097408091806 |
|
4887 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FGD2 |
0.148097408091806 |
|
4888 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COX6A1P2 |
0.148097408091806 |
|
4889 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PIM1 |
0.148097408091806 |
|
4890 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD112|ENSG00000252687.1 |
0.148097408091806 |
|
4891 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM217 |
0.148097408091806 |
|
4892 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238375.1 |
0.148097408091806 |
|
4893 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TBC1D22B |
0.148097408091806 |
|
4894 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL273P |
0.148097408091806 |
|
4895 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNF8 |
0.148097408091806 |
|
4896 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FTSJD2 |
0.148097408091806 |
|
4897 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC167 |
0.148097408091806 |
|
4898 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4462 |
0.148097408091806 |
|
4899 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MDGA1 |
0.148097408091806 |
|
4900 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL285P |
0.148097408091806 |
|
4901 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238611.1 |
0.148214999248059 |
|
4902 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RP1 |
0.148243969100005 |
|
4903 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DLG2 |
0.148413160554229 |
|
4904 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GNMT |
0.148421323109464 |
|
4905 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PEX6 |
0.148421323109464 |
|
4906 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAFB |
0.148628717778718 |
|
4907 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EED |
0.148827451715633 |
|
4908 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C11orf73 |
0.148827451715633 |
|
4909 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL225P |
0.148827451715633 |
|
4910 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC81 |
0.148827451715633 |
|
4911 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF846 |
0.148973148827128 |
|
4912 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FBXL12 |
0.148973148827128 |
|
4913 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA70|ENSG00000200237.1 |
0.148973148827128 |
|
4914 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL94P |
0.148973148827128 |
|
4915 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UBL5 |
0.148973148827128 |
|
4916 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PIN1 |
0.148973148827128 |
|
4917 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OLFM2 |
0.148973148827128 |
|
4918 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AGAP6 |
0.148996353273813 |
|
4919 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ASAH2 |
0.148996353273813 |
|
4920 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM21A |
0.148996353273813 |
|
4921 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00843 |
0.148996353273813 |
|
4922 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RMRPP4 |
0.148996353273813 |
|
4923 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP317 |
0.148996353273813 |
|
4924 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SGMS1 |
0.148996353273813 |
|
4925 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA74|ENSG00000223111.1 |
0.148996353273813 |
|
4926 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TIMM23 |
0.148996353273813 |
|
4927 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ASAH2B |
0.148996353273813 |
|
4928 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
A1CF |
0.148996353273813 |
|
4929 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EVI5 |
0.149388743026915 |
|
4930 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAB3A |
0.149463311991971 |
|
4931 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PDE4C |
0.149463311991971 |
|
4932 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIAA1683 |
0.149463311991971 |
|
4933 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
JUND |
0.149463311991971 |
|
4934 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3188 |
0.149463311991971 |
|
4935 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL761P |
0.149485854594184 |
|
4936 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPS13 |
0.149500268738841 |
|
4937 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD14A |
0.149500268738841 |
|
4938 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD14B |
0.149500268738841 |
|
4939 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PIK3C2A |
0.149500268738841 |
|
4940 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NUCB2 |
0.149500268738841 |
|
4941 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00237 |
0.149609536196904 |
|
4942 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM8A1 |
0.149663994801253 |
|
4943 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLOCK |
0.149790758616804 |
|
4944 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP30 |
0.149790758616804 |
|
4945 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PDCL2 |
0.149790758616804 |
|
4946 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NMU |
0.149790758616804 |
|
4947 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPP2R5D |
0.149795672316545 |
|
4948 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CSNK2A2 |
0.149803648336054 |
|
4949 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL645P |
0.149803648336054 |
|
4950 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PEX11G |
0.149881140748315 |
|
4951 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C19orf45 |
0.149881140748315 |
|
4952 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF358 |
0.149881140748315 |
|
4953 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VSTM2A |
0.149913852695735 |
|
4954 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WDFY4 |
0.149928469354247 |
|
4955 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRRC18 |
0.149928469354247 |
|
4956 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4294 |
0.149928469354247 |
|
4957 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VSTM4 |
0.149928469354247 |
|
4958 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC13A5 |
0.150011988945979 |
|
4959 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARHGEF18 |
0.150156091238664 |
|
4960 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RIT2 |
0.150168067938995 |
|
4961 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GUCD1 |
0.150230075274524 |
|
4962 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNRPD3 |
0.150230075274524 |
|
4963 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM211B |
0.150230075274524 |
|
4964 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GGT1 |
0.150230075274524 |
|
4965 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IDO2 |
0.150315059829433 |
|
4966 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DCT |
0.150515274073682 |
|
4967 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TGDS |
0.150515274073682 |
|
4968 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPR180 |
0.150515274073682 |
|
4969 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP36 |
0.150515274073682 |
|
4970 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL585P |
0.150515274073682 |
|
4971 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00391 |
0.150515274073682 |
|
4972 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SOX21 |
0.150515274073682 |
|
4973 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NKD1 |
0.150547601088007 |
|
4974 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNX20 |
0.150547601088007 |
|
4975 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NOD2 |
0.150547601088007 |
|
4976 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CYLD |
0.150547601088007 |
|
4977 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP426 |
0.150547601088007 |
|
4978 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ST3GAL3 |
0.151310042520844 |
|
4979 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NCOA4 |
0.151363772530009 |
|
4980 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRRC17 |
0.151568485250922 |
|
4981 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DPY19L2P2 |
0.151568485250922 |
|
4982 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MYOM3 |
0.15174727990961 |
|
4983 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IL22RA1 |
0.15174727990961 |
|
4984 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LONP2 |
0.151831860117244 |
|
4985 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SIAH1 |
0.151831860117244 |
|
4986 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL54P |
0.151831860117244 |
|
4987 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000239013.1 |
0.151831860117244 |
|
4988 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATP1A1 |
0.151923677593409 |
|
4989 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATP1A1OS |
0.151923677593409 |
|
4990 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CD58 |
0.151923677593409 |
|
4991 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR548AC |
0.151923677593409 |
|
4992 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4657 |
0.15200164830299 |
|
4993 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MYO1G |
0.15200164830299 |
|
4994 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNHG15 |
0.15200164830299 |
|
4995 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCM2 |
0.15200164830299 |
|
4996 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NACAD |
0.15200164830299 |
|
4997 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TBRG4 |
0.15200164830299 |
|
4998 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA5A |
0.15200164830299 |
|
4999 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA5B |
0.15200164830299 |
|
5000 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA5C |
0.15200164830299 |
|
5001 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAMP3 |
0.15200164830299 |
|
5002 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IGFBP6 |
0.152390722508043 |
|
5003 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SOAT2 |
0.152390722508043 |
|
5004 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPRYD3 |
0.152390722508043 |
|
5005 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TENC1 |
0.152390722508043 |
|
5006 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PTPRS |
0.152526138382878 |
|
5007 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA48|ENSG00000252774.1 |
0.152582055777573 |
|
5008 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIAA0101 |
0.152582055777573 |
|
5009 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRIP4 |
0.152582055777573 |
|
5010 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL595P |
0.152582055777573 |
|
5011 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL707P |
0.152582055777573 |
|
5012 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLBD1 |
0.152601413685285 |
|
5013 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP134 |
0.152601413685285 |
|
5014 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GUCY2C |
0.152601413685285 |
|
5015 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
H2AFJ |
0.152601413685285 |
|
5016 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HIST4H4 |
0.152601413685285 |
|
5017 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WBP11 |
0.152601413685285 |
|
5018 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SMCO3 |
0.152601413685285 |
|
5019 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ART4 |
0.152601413685285 |
|
5020 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RCVRN |
0.152611687976502 |
|
5021 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C20orf26 |
0.15267513172905 |
|
5022 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL690P |
0.15267513172905 |
|
5023 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP162 |
0.15271740953406 |
|
5024 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DISC1FP1 |
0.152792798540863 |
|
5025 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TAC1 |
0.152984752493067 |
|
5026 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAPPC8 |
0.153088350533135 |
|
5027 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNF125 |
0.153088350533135 |
|
5028 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNF138 |
0.153088350533135 |
|
5029 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238982.1 |
0.153088350533135 |
|
5030 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GAREM |
0.153088350533135 |
|
5031 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP453 |
0.153088350533135 |
|
5032 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MEP1B |
0.153088350533135 |
|
5033 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00485 |
0.153101045810026 |
|
5034 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PAH |
0.153101045810026 |
|
5035 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ASCL1 |
0.153101045810026 |
|
5036 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KPNA7 |
0.153130064255565 |
|
5037 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MYH16 |
0.153130064255565 |
|
5038 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARPC1A |
0.153130064255565 |
|
5039 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EIF4B |
0.153151577185746 |
|
5040 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DIAPH3 |
0.153167446613926 |
|
5041 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL375P |
0.153167446613926 |
|
5042 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAPK1IP1L |
0.153172042564617 |
|
5043 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZDHHC24 |
0.153465632951648 |
|
5044 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACTN3 |
0.153465632951648 |
|
5045 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CTSF |
0.153465632951648 |
|
5046 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC87 |
0.153465632951648 |
|
5047 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCS |
0.153465632951648 |
|
5048 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SETD6 |
0.153491035209343 |
|
5049 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CNOT1 |
0.153491035209343 |
|
5050 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA46|ENSG00000207493.1 |
0.153491035209343 |
|
5051 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA50|ENSG00000206952.2 |
0.153491035209343 |
|
5052 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TAPBPL |
0.154052181235836 |
|
5053 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VAMP1 |
0.154052181235836 |
|
5054 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MRPL51 |
0.154052181235836 |
|
5055 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NCAPD2 |
0.154052181235836 |
|
5056 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCARNA10 |
0.154052181235836 |
|
5057 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GAPDH |
0.154052181235836 |
|
5058 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IFFO1 |
0.154052181235836 |
|
5059 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NOP2 |
0.154052181235836 |
|
5060 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CHD4 |
0.154052181235836 |
|
5061 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCARNA11|ENSG00000251898.1 |
0.154052181235836 |
|
5062 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LPAR5 |
0.154052181235836 |
|
5063 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACRBP |
0.154052181235836 |
|
5064 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ING4 |
0.154052181235836 |
|
5065 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF384 |
0.154052181235836 |
|
5066 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PIANP |
0.154052181235836 |
|
5067 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IKZF1 |
0.15460765940773 |
|
5068 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FIGNL1 |
0.15460765940773 |
|
5069 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DDC |
0.15460765940773 |
|
5070 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FASLG |
0.154681398822358 |
|
5071 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PTMAP5 |
0.154701590758533 |
|
5072 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SOS2 |
0.154729313900782 |
|
5073 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CEP57 |
0.154827590429483 |
|
5074 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MTMR2 |
0.154827590429483 |
|
5075 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP345 |
0.154827590429483 |
|
5076 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAML2 |
0.154827590429483 |
|
5077 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FOSB |
0.154966660228869 |
|
5078 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RTN2 |
0.154966660228869 |
|
5079 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPM1N |
0.154966660228869 |
|
5080 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VASP |
0.154966660228869 |
|
5081 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C10orf25 |
0.155045580524929 |
|
5082 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF22 |
0.155045580524929 |
|
5083 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM72 |
0.155078042174465 |
|
5084 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RASSF4 |
0.155078042174465 |
|
5085 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C10orf10 |
0.155078042174465 |
|
5086 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DSTN |
0.155111848496825 |
|
5087 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP69 |
0.155111848496825 |
|
5088 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KTN1 |
0.155166821829186 |
|
5089 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD112|ENSG00000252077.1 |
0.155236853600201 |
|
5090 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IFI44L |
0.155652745416474 |
|
5091 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IFI44 |
0.155652745416474 |
|
5092 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VWDE |
0.15581409747567 |
|
5093 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TAF3 |
0.155971662725356 |
|
5094 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CTCF |
0.156041692508548 |
|
5095 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RLTPR |
0.156041692508548 |
|
5096 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACD |
0.156041692508548 |
|
5097 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C16orf86 |
0.156041692508548 |
|
5098 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ENKD1 |
0.156041692508548 |
|
5099 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PARD6A |
0.156041692508548 |
|
5100 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GFOD2 |
0.156041692508548 |
|
5101 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ME3 |
0.156059449014338 |
|
5102 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC35F2 |
0.156323184486355 |
|
5103 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CUL5 |
0.156323184486355 |
|
5104 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAB39A |
0.156323184486355 |
|
5105 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACAT1 |
0.156323184486355 |
|
5106 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NPAT |
0.156323184486355 |
|
5107 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATM |
0.156323184486355 |
|
5108 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C11orf65 |
0.156323184486355 |
|
5109 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KDELC2 |
0.156323184486355 |
|
5110 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EXPH5 |
0.156323184486355 |
|
5111 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DDX10 |
0.156323184486355 |
|
5112 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP349 |
0.156323184486355 |
|
5113 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL636P |
0.156585442796887 |
|
5114 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FGL2 |
0.156617402346813 |
|
5115 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM106B |
0.156739555840408 |
|
5116 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C10orf137 |
0.156780285277337 |
|
5117 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MMP21 |
0.156780285277337 |
|
5118 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UROS |
0.156780285277337 |
|
5119 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4484 |
0.156780285277337 |
|
5120 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BCCIP |
0.156780285277337 |
|
5121 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DNAJC11 |
0.156882830271456 |
|
5122 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000239166.1 |
0.156882830271456 |
|
5123 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAP4K5 |
0.157090544852859 |
|
5124 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATL1 |
0.157090544852859 |
|
5125 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FGFR4 |
0.157377256936949 |
|
5126 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP249 |
0.15740050077761 |
|
5127 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL456P |
0.15740050077761 |
|
5128 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLITRK1 |
0.157486959815968 |
|
5129 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CD9 |
0.157588930370254 |
|
5130 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C12orf60 |
0.157629612229248 |
|
5131 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MGP |
0.157629612229248 |
|
5132 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ERP27 |
0.157629612229248 |
|
5133 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARHGDIB |
0.157629612229248 |
|
5134 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PDE6H |
0.157629612229248 |
|
5135 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CAMSAP3 |
0.157715862100911 |
|
5136 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
XAB2 |
0.157715862100911 |
|
5137 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCP2 |
0.157715862100911 |
|
5138 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PET100 |
0.157715862100911 |
|
5139 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNX6 |
0.157856264999053 |
|
5140 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AMIGO2 |
0.157904653935843 |
|
5141 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SDHD |
0.157924341136476 |
|
5142 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HOXC5 |
0.157975769959228 |
|
5143 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HOXC4 |
0.157975769959228 |
|
5144 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GSS |
0.158105614019639 |
|
5145 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MYH7B |
0.158105614019639 |
|
5146 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR499A |
0.158105614019639 |
|
5147 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRPC4AP |
0.158105614019639 |
|
5148 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD56|ENSG00000201151.1 |
0.158105614019639 |
|
5149 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PROCR |
0.158105614019639 |
|
5150 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP483 |
0.158105614019639 |
|
5151 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPAG4 |
0.158105614019639 |
|
5152 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CPNE1 |
0.158105614019639 |
|
5153 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NFS1 |
0.158105614019639 |
|
5154 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP271 |
0.158105614019639 |
|
5155 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RBM12 |
0.158105614019639 |
|
5156 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ROMO1 |
0.158105614019639 |
|
5157 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BMS1 |
0.158120878319099 |
|
5158 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238732.1 |
0.158120878319099 |
|
5159 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPIH |
0.1581512576327 |
|
5160 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR1261 |
0.158169883550443 |
|
5161 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP35 |
0.158208964986893 |
|
5162 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GON4L |
0.158240126386187 |
|
5163 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KARS |
0.158494676578188 |
|
5164 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TERF2IP |
0.158494676578188 |
|
5165 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL520P |
0.158494676578188 |
|
5166 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR605 |
0.158521886330662 |
|
5167 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DHX32 |
0.158531189173344 |
|
5168 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U3|ENSG00000253091.1 |
0.158562760993664 |
|
5169 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HOXC13 |
0.158875198909094 |
|
5170 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HOXC12 |
0.158875198909094 |
|
5171 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HOTAIR |
0.159017124603065 |
|
5172 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HOXC11 |
0.159017124603065 |
|
5173 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SEC23A |
0.159116625013957 |
|
5174 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GEMIN2 |
0.159116625013957 |
|
5175 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAPPC6B |
0.159116625013957 |
|
5176 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PNN |
0.159116625013957 |
|
5177 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GDF2 |
0.159141318130919 |
|
5178 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GDF10 |
0.159141318130919 |
|
5179 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BMS1P5 |
0.159141318130919 |
|
5180 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM25C |
0.159141318130919 |
|
5181 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GLUD1P2 |
0.159141318130919 |
|
5182 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PTPN20B |
0.159141318130919 |
|
5183 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL527P |
0.159141318130919 |
|
5184 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP314 |
0.159141318130919 |
|
5185 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP315 |
0.159141318130919 |
|
5186 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RERG |
0.159269403281056 |
|
5187 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SMCP |
0.159272467469804 |
|
5188 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IVL |
0.159272467469804 |
|
5189 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KDM4A |
0.159273145167629 |
|
5190 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PTBP1 |
0.159433438654155 |
|
5191 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4745 |
0.159433438654155 |
|
5192 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AZU1 |
0.159433438654155 |
|
5193 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LPPR3 |
0.159433438654155 |
|
5194 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3187 |
0.159433438654155 |
|
5195 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF641 |
0.159513082777281 |
|
5196 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CTAGE15 |
0.159581357932234 |
|
5197 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CTAGE6 |
0.159581357932234 |
|
5198 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM115A |
0.159581357932234 |
|
5199 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM115C |
0.159581357932234 |
|
5200 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR2F2 |
0.159581357932234 |
|
5201 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR2F1 |
0.159581357932234 |
|
5202 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR6B1 |
0.159581357932234 |
|
5203 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR2A5 |
0.159581357932234 |
|
5204 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR2A25 |
0.159581357932234 |
|
5205 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AHCY |
0.159599607044009 |
|
5206 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ITCH |
0.159599607044009 |
|
5207 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR644A |
0.159599607044009 |
|
5208 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DYNLRB1 |
0.159599607044009 |
|
5209 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAP1LC3A |
0.159599607044009 |
|
5210 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PIGU |
0.159599607044009 |
|
5211 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TP53INP2 |
0.159599607044009 |
|
5212 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IFLTD1 |
0.159648223375184 |
|
5213 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP262 |
0.159648223375184 |
|
5214 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RASSF9 |
0.159652296275475 |
|
5215 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRKCQ |
0.159727414320522 |
|
5216 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00707 |
0.159727414320522 |
|
5217 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATP5G2 |
0.15979158009568 |
|
5218 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238739.1 |
0.159820959911222 |
|
5219 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP104 |
0.160020966891657 |
|
5220 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FBXO33 |
0.160025429946597 |
|
5221 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GSX2 |
0.160213280889834 |
|
5222 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238753.1 |
0.160213280889834 |
|
5223 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TESPA1 |
0.160287140420761 |
|
5224 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NEUROD4 |
0.160287140420761 |
|
5225 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR6C6 |
0.160287140420761 |
|
5226 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR6C1 |
0.160287140420761 |
|
5227 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR6C3 |
0.160287140420761 |
|
5228 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR6C75 |
0.160287140420761 |
|
5229 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR6C65 |
0.160287140420761 |
|
5230 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR6C76 |
0.160287140420761 |
|
5231 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR6C2 |
0.160287140420761 |
|
5232 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR6C70 |
0.160287140420761 |
|
5233 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR6C68 |
0.160287140420761 |
|
5234 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MICAL3 |
0.160332521634242 |
|
5235 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR10A7 |
0.160518085930971 |
|
5236 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR6C74 |
0.160518085930971 |
|
5237 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARMC10 |
0.160664827387232 |
|
5238 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NAPEPLD |
0.160664827387232 |
|
5239 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LGALS3 |
0.160667757136398 |
|
5240 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DLGAP5 |
0.160667757136398 |
|
5241 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF354A |
0.160668665119813 |
|
5242 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AACSP1 |
0.160668665119813 |
|
5243 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U3|ENSG00000251749.1 |
0.160691513893707 |
|
5244 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CASC10 |
0.160691513893707 |
|
5245 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR1915 |
0.160691513893707 |
|
5246 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SKIDA1 |
0.160691513893707 |
|
5247 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC39A6 |
0.160848375679191 |
|
5248 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ELP2 |
0.160848375679191 |
|
5249 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MOCOS |
0.160848375679191 |
|
5250 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CACNA2D4 |
0.161089718179169 |
|
5251 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA31|ENSG00000252537.1 |
0.161156550821707 |
|
5252 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238552.1 |
0.161156550821707 |
|
5253 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RSU1 |
0.161156550821707 |
|
5254 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CUBN |
0.161156550821707 |
|
5255 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRDMT1 |
0.161156550821707 |
|
5256 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VIM |
0.161156550821707 |
|
5257 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ST8SIA6 |
0.161156550821707 |
|
5258 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GATM |
0.161172996508128 |
|
5259 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPATA5L1 |
0.161172996508128 |
|
5260 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C15orf48 |
0.161172996508128 |
|
5261 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR147B |
0.161172996508128 |
|
5262 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC30A4 |
0.161172996508128 |
|
5263 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238583.1 |
0.161172996508128 |
|
5264 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HMGN2P46 |
0.161172996508128 |
|
5265 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA41|ENSG00000207516.1 |
0.161172996508128 |
|
5266 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIA2 |
0.161330790439576 |
|
5267 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM68 |
0.16138288904124 |
|
5268 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP265 |
0.16138288904124 |
|
5269 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TGS1 |
0.16138288904124 |
|
5270 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LYN |
0.16138288904124 |
|
5271 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA1|ENSG00000199405.1 |
0.16138288904124 |
|
5272 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL798P |
0.16138288904124 |
|
5273 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL323P |
0.16138288904124 |
|
5274 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPS20 |
0.16138288904124 |
|
5275 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD54 |
0.16138288904124 |
|
5276 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MOS |
0.16138288904124 |
|
5277 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA3|ENSG00000221093.1 |
0.16138288904124 |
|
5278 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ASXL2 |
0.161451937697929 |
|
5279 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIF3C |
0.161451937697929 |
|
5280 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA40|ENSG00000252049.1 |
0.16162980790614 |
|
5281 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PTF1A |
0.16162980790614 |
|
5282 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C10orf115 |
0.16162980790614 |
|
5283 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C10orf67 |
0.16162980790614 |
|
5284 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238515.1 |
0.16162980790614 |
|
5285 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL618P |
0.1618011149055 |
|
5286 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00558 |
0.1618011149055 |
|
5287 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00879 |
0.161810707559878 |
|
5288 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC41A2 |
0.161856022289878 |
|
5289 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00682 |
0.161908115187694 |
|
5290 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM33 |
0.161908115187694 |
|
5291 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ITPR3 |
0.162016232098635 |
|
5292 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP174 |
0.162026056744266 |
|
5293 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CSAD |
0.162079110340748 |
|
5294 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF740 |
0.162079110340748 |
|
5295 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ITGB7 |
0.162079110340748 |
|
5296 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RARG |
0.162079110340748 |
|
5297 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MFSD5 |
0.162079110340748 |
|
5298 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ESPL1 |
0.162079110340748 |
|
5299 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PFDN5 |
0.162079110340748 |
|
5300 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C12orf10 |
0.162079110340748 |
|
5301 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AAAS |
0.162079110340748 |
|
5302 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SP7 |
0.162079110340748 |
|
5303 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SP1 |
0.162079110340748 |
|
5304 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AMHR2 |
0.162079110340748 |
|
5305 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCBP2 |
0.162079110340748 |
|
5306 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRR13 |
0.162079110340748 |
|
5307 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAP3K12 |
0.162079110340748 |
|
5308 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TARBP2 |
0.162079110340748 |
|
5309 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NPFF |
0.162079110340748 |
|
5310 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATF7 |
0.162079110340748 |
|
5311 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STAM |
0.162166912580149 |
|
5312 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoR442|ENSG00000251959.1 |
0.162166912580149 |
|
5313 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MRC1L1 |
0.162166912580149 |
|
5314 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MRC1 |
0.162166912580149 |
|
5315 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC39A12 |
0.162166912580149 |
|
5316 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM236|ENSG00000148483.7 |
0.162166912580149 |
|
5317 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM236|ENSG00000184040.7 |
0.162166912580149 |
|
5318 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANP32D |
0.162396689000365 |
|
5319 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C12orf54 |
0.162396689000365 |
|
5320 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR8S1 |
0.162396689000365 |
|
5321 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADCY1 |
0.16244033391642 |
|
5322 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SEPT7P2 |
0.16244033391642 |
|
5323 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IGFBP1 |
0.16244033391642 |
|
5324 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RMND5B |
0.162480617785103 |
|
5325 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NHP2 |
0.162480617785103 |
|
5326 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COL23A1 |
0.162480617785103 |
|
5327 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL646P |
0.162480617785103 |
|
5328 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLK4 |
0.162480617785103 |
|
5329 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP70 |
0.162480617785103 |
|
5330 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HOXC10 |
0.162487008234409 |
|
5331 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HOXC6 |
0.162487008234409 |
|
5332 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR196A2 |
0.162487008234409 |
|
5333 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HOXC9 |
0.162487008234409 |
|
5334 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HOXC8 |
0.162487008234409 |
|
5335 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR615 |
0.162487008234409 |
|
5336 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3173 |
0.162787267752464 |
|
5337 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLMN |
0.162787267752464 |
|
5338 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00341 |
0.162787267752464 |
|
5339 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SYNE3 |
0.162787267752464 |
|
5340 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNHG10 |
0.162787267752464 |
|
5341 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCARNA13 |
0.162787267752464 |
|
5342 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GLRX5 |
0.162787267752464 |
|
5343 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TCL6 |
0.162787267752464 |
|
5344 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TCL1B |
0.162787267752464 |
|
5345 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TCL1A |
0.162787267752464 |
|
5346 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00617 |
0.162787267752464 |
|
5347 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C14orf132 |
0.162787267752464 |
|
5348 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BDKRB2 |
0.162787267752464 |
|
5349 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BDKRB1 |
0.162787267752464 |
|
5350 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DKFZP434O1614 |
0.162787267752464 |
|
5351 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATG2B |
0.162787267752464 |
|
5352 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238776.1 |
0.162787267752464 |
|
5353 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GSKIP |
0.162787267752464 |
|
5354 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AK7 |
0.162787267752464 |
|
5355 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PAPOLA |
0.162787267752464 |
|
5356 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP108 |
0.162787267752464 |
|
5357 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VRK1 |
0.162787267752464 |
|
5358 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00618 |
0.162787267752464 |
|
5359 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TSPAN15 |
0.162811269382641 |
|
5360 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRSS23 |
0.162827474096233 |
|
5361 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FZD4 |
0.162827474096233 |
|
5362 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM135 |
0.162827474096233 |
|
5363 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HK3 |
0.162874963881878 |
|
5364 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UIMC1 |
0.162874963881878 |
|
5365 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF346 |
0.162874963881878 |
|
5366 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SYTL2 |
0.162879442067547 |
|
5367 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CAP2 |
0.163122262473783 |
|
5368 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CXCL12 |
0.163507513084714 |
|
5369 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD112|ENSG00000251824.1 |
0.163567829049193 |
|
5370 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CHTF18 |
0.163669167125786 |
|
5371 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GNG13 |
0.163669167125786 |
|
5372 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR662 |
0.163669167125786 |
|
5373 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MSLNL |
0.163669167125786 |
|
5374 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MSLN |
0.163669167125786 |
|
5375 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRR25 |
0.163669167125786 |
|
5376 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPUSD1 |
0.163669167125786 |
|
5377 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAT3 |
0.163678831346473 |
|
5378 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000239086.1 |
0.163678831346473 |
|
5379 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PTPN2 |
0.163689026384651 |
|
5380 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SEH1L |
0.163689026384651 |
|
5381 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LTBP4 |
0.16379284638687 |
|
5382 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL758P |
0.16379284638687 |
|
5383 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SHKBP1 |
0.16379284638687 |
|
5384 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NUMBL |
0.16379284638687 |
|
5385 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADCK4 |
0.16379284638687 |
|
5386 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IGFBP3 |
0.163947165668028 |
|
5387 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TOX3 |
0.164030139613633 |
|
5388 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CELF2 |
0.164436698583435 |
|
5389 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HES3 |
0.164477766111402 |
|
5390 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FHOD3 |
0.164521164902689 |
|
5391 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RANBP3 |
0.164756167987222 |
|
5392 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SMUG1 |
0.165061356719822 |
|
5393 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CBX5 |
0.165061356719822 |
|
5394 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD81|ENSG00000223213.1 |
0.165097233454542 |
|
5395 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP289 |
0.165097233454542 |
|
5396 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC94 |
0.165443020141711 |
|
5397 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SHD |
0.165443020141711 |
|
5398 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMIGD2 |
0.165443020141711 |
|
5399 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FSD1 |
0.165443020141711 |
|
5400 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STAP2 |
0.165443020141711 |
|
5401 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MPND |
0.165443020141711 |
|
5402 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SH3GL1 |
0.165443020141711 |
|
5403 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD14 |
0.165538924645529 |
|
5404 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EFR3B |
0.165538924645529 |
|
5405 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL856P |
0.165538924645529 |
|
5406 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
POMC |
0.165538924645529 |
|
5407 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DTNB |
0.165538924645529 |
|
5408 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRFN3 |
0.165572420487752 |
|
5409 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SDHAF1 |
0.165572420487752 |
|
5410 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SYNE4 |
0.165572420487752 |
|
5411 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ALKBH6 |
0.165572420487752 |
|
5412 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLIP3 |
0.165572420487752 |
|
5413 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
THAP8 |
0.165572420487752 |
|
5414 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OVOL3 |
0.165572420487752 |
|
5415 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
POLR2I |
0.165572420487752 |
|
5416 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TBCB |
0.165572420487752 |
|
5417 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
POU4F1 |
0.165621620789266 |
|
5418 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNF219 |
0.165621620789266 |
|
5419 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00331 |
0.165621620789266 |
|
5420 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STX8 |
0.165838705339622 |
|
5421 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ST6GALNAC5 |
0.165893820249727 |
|
5422 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238507.1 |
0.166115340492145 |
|
5423 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANKRD13A |
0.166118407907737 |
|
5424 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C12orf76 |
0.166118407907737 |
|
5425 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00871 |
0.166326862374037 |
|
5426 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPL10L |
0.166326862374037 |
|
5427 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AK5 |
0.166437103929097 |
|
5428 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TIAM1 |
0.166496454370569 |
|
5429 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCND1 |
0.166578382526791 |
|
5430 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ORAOV1 |
0.166578382526791 |
|
5431 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC25A41 |
0.166637662422966 |
|
5432 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC25A23 |
0.166637662422966 |
|
5433 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CTXN2 |
0.166649094904203 |
|
5434 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC12A1 |
0.166649094904203 |
|
5435 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ASCL2 |
0.166916779868848 |
|
5436 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C11orf21 |
0.166916779868848 |
|
5437 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TSPAN32 |
0.166916779868848 |
|
5438 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPL26P30 |
0.166916779868848 |
|
5439 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CD81 |
0.166916779868848 |
|
5440 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL860P |
0.166967656278568 |
|
5441 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF492 |
0.166967656278568 |
|
5442 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C18orf21 |
0.167095929267529 |
|
5443 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPRD1A |
0.167095929267529 |
|
5444 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC35C1 |
0.167131821098566 |
|
5445 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CRY2 |
0.167131821098566 |
|
5446 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RACGAP1 |
0.167332896636845 |
|
5447 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP299 |
0.167579964614815 |
|
5448 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPIC |
0.167597299789829 |
|
5449 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MDGA2 |
0.167634853557988 |
|
5450 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CPNE5 |
0.167756183358133 |
|
5451 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MYBPC1 |
0.167972586932597 |
|
5452 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CHPT1 |
0.167972586932597 |
|
5453 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SYCP3 |
0.167972586932597 |
|
5454 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GNPTAB |
0.167972586932597 |
|
5455 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP368 |
0.167972586932597 |
|
5456 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238940.1 |
0.167972586932597 |
|
5457 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP369 |
0.167972586932597 |
|
5458 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DRAM1 |
0.167972586932597 |
|
5459 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PARPBP |
0.167972586932597 |
|
5460 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PMCH |
0.167972586932597 |
|
5461 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL793P |
0.167972586932597 |
|
5462 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IGF1 |
0.167972586932597 |
|
5463 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATP6V1H |
0.167972692493692 |
|
5464 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDYL2 |
0.168379416905923 |
|
5465 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CMC2 |
0.168379416905923 |
|
5466 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CENPN |
0.168379416905923 |
|
5467 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATMIN |
0.168379416905923 |
|
5468 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C16orf46 |
0.168379416905923 |
|
5469 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GCSH |
0.168379416905923 |
|
5470 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PKD1L2 |
0.168379416905923 |
|
5471 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BCMO1 |
0.168379416905923 |
|
5472 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CRB3 |
0.168778887143812 |
|
5473 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DENND1C |
0.168778887143812 |
|
5474 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TUBB4A |
0.168778887143812 |
|
5475 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C12orf36 |
0.168857388328303 |
|
5476 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP353 |
0.168857388328303 |
|
5477 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GRIN2B |
0.168857388328303 |
|
5478 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRRC4 |
0.168991917129947 |
|
5479 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HSF2 |
0.169181944881379 |
|
5480 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MUT |
0.169285729602734 |
|
5481 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CENPQ |
0.169285729602734 |
|
5482 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GLYATL3 |
0.169285729602734 |
|
5483 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GLCCI1 |
0.169362859146573 |
|
5484 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ALG10B |
0.169457951902141 |
|
5485 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ALG10 |
0.169457951902141 |
|
5486 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP358 |
0.169457951902141 |
|
5487 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP359 |
0.169457951902141 |
|
5488 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SYT10 |
0.169457951902141 |
|
5489 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00708 |
0.169498646114401 |
|
5490 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CABIN1 |
0.169651628281997 |
|
5491 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FHOD1 |
0.169691165307814 |
|
5492 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC9A5 |
0.169691165307814 |
|
5493 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SUSD2 |
0.169802047479581 |
|
5494 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GGT5 |
0.169802047479581 |
|
5495 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
POM121L9P |
0.169802047479581 |
|
5496 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA31|ENSG00000253028.1 |
0.169977761748781 |
|
5497 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238506.1 |
0.169977761748781 |
|
5498 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DHFRL1 |
0.170002989488925 |
|
5499 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NSUN3 |
0.170002989488925 |
|
5500 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC15A5 |
0.17019952988557 |
|
5501 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C10orf71 |
0.170372336819545 |
|
5502 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPEF2 |
0.170438282681229 |
|
5503 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM247 |
0.170717671640244 |
|
5504 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL817P |
0.170717671640244 |
|
5505 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATP6V1E2 |
0.170717671640244 |
|
5506 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RHOQ |
0.170717671640244 |
|
5507 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PIGF |
0.170717671640244 |
|
5508 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CRIPT |
0.170717671640244 |
|
5509 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SOCS5 |
0.170717671640244 |
|
5510 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MCFD2 |
0.170717671640244 |
|
5511 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TTC7A |
0.170717671640244 |
|
5512 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CALM2 |
0.170717671640244 |
|
5513 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C2orf61 |
0.170717671640244 |
|
5514 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BCYRN1 |
0.170717671640244 |
|
5515 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EPCAM |
0.170717671640244 |
|
5516 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP119 |
0.170717671640244 |
|
5517 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR559 |
0.170717671640244 |
|
5518 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRDM11 |
0.171028519454287 |
|
5519 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ITGA8 |
0.171068632444635 |
|
5520 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM188A |
0.171068632444635 |
|
5521 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000239130.1 |
0.171068632444635 |
|
5522 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLEC4M |
0.171175483928482 |
|
5523 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EVI5L |
0.171175483928482 |
|
5524 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRRC8E |
0.171175483928482 |
|
5525 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP463 |
0.171175483928482 |
|
5526 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAP2K7 |
0.171175483928482 |
|
5527 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL115P |
0.171175483928482 |
|
5528 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADAM2 |
0.171236370233671 |
|
5529 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IDO1 |
0.171236370233671 |
|
5530 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MADD |
0.171376105881521 |
|
5531 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MYBPC3 |
0.171376105881521 |
|
5532 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPI1 |
0.171376105881521 |
|
5533 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL16P |
0.171710436634053 |
|
5534 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
USP24 |
0.171715919439378 |
|
5535 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4422 |
0.171715919439378 |
|
5536 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP291 |
0.171715919439378 |
|
5537 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PTPRO |
0.171723741445761 |
|
5538 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EPS8 |
0.171723741445761 |
|
5539 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STRAP |
0.171723741445761 |
|
5540 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DERA |
0.171723741445761 |
|
5541 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RND3 |
0.171789395630723 |
|
5542 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RSBN1L |
0.171830778995302 |
|
5543 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM60 |
0.171830778995302 |
|
5544 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL390P |
0.171889517047021 |
|
5545 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HNRNPA1 |
0.171889517047021 |
|
5546 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NFE2 |
0.171889517047021 |
|
5547 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LAMP5 |
0.172311433528355 |
|
5548 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CBFA2T2 |
0.172409845154799 |
|
5549 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NECAB3 |
0.172409845154799 |
|
5550 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C20orf144 |
0.172409845154799 |
|
5551 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACTL10 |
0.172409845154799 |
|
5552 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
E2F1 |
0.172409845154799 |
|
5553 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PXMP4 |
0.172409845154799 |
|
5554 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF341 |
0.172409845154799 |
|
5555 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SORCS1 |
0.172597045940594 |
|
5556 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRRIQ1 |
0.172773633211978 |
|
5557 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SAV1 |
0.17291368391935 |
|
5558 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL452P |
0.17291368391935 |
|
5559 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NIN |
0.17291368391935 |
|
5560 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PYGL |
0.17291368391935 |
|
5561 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ABHD12B |
0.17291368391935 |
|
5562 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC67 |
0.172920639717204 |
|
5563 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC36A4 |
0.172920639717204 |
|
5564 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SMCO4 |
0.172920639717204 |
|
5565 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRIM9 |
0.173002270805481 |
|
5566 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA70|ENSG00000201376.1 |
0.173002270805481 |
|
5567 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMX1 |
0.173002270805481 |
|
5568 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00519 |
0.173002270805481 |
|
5569 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00640 |
0.173002270805481 |
|
5570 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL239P |
0.173023283264599 |
|
5571 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MSH2 |
0.173132339490212 |
|
5572 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCNK12 |
0.173132339490212 |
|
5573 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FBXO34 |
0.173192917607089 |
|
5574 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP210 |
0.173201175770666 |
|
5575 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA70|ENSG00000206886.1 |
0.173201175770666 |
|
5576 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PHTF1 |
0.173222717323209 |
|
5577 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RSBN1 |
0.173222717323209 |
|
5578 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PTPN22 |
0.173222717323209 |
|
5579 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DR1 |
0.173243172811266 |
|
5580 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP53 |
0.173243172811266 |
|
5581 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCT8L2 |
0.173308380459967 |
|
5582 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HSFY1P1 |
0.173308380459967 |
|
5583 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCNMB3P1 |
0.173308380459967 |
|
5584 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR11H1 |
0.173308380459967 |
|
5585 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
POTEH |
0.173308380459967 |
|
5586 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TPTEP1 |
0.173308380459967 |
|
5587 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
XKR3 |
0.173308380459967 |
|
5588 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GAB4 |
0.173308380459967 |
|
5589 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CECR7 |
0.173308380459967 |
|
5590 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IL17RA |
0.173308380459967 |
|
5591 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CECR6 |
0.173308380459967 |
|
5592 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CECR5 |
0.173308380459967 |
|
5593 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CECR1 |
0.173308380459967 |
|
5594 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SIX3 |
0.173401890248102 |
|
5595 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SIX2 |
0.173401890248102 |
|
5596 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL414P |
0.173401890248102 |
|
5597 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP204 |
0.173432841845614 |
|
5598 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIF13A |
0.173432841845614 |
|
5599 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NHLRC1 |
0.173432841845614 |
|
5600 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TPMT |
0.173432841845614 |
|
5601 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KDM1B |
0.173432841845614 |
|
5602 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DEK |
0.173432841845614 |
|
5603 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF98 |
0.173452574160212 |
|
5604 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00648 |
0.173463497864836 |
|
5605 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR548Y |
0.173463497864836 |
|
5606 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DHX57 |
0.173468536743419 |
|
5607 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MORN2 |
0.173468536743419 |
|
5608 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL96P |
0.173468536743419 |
|
5609 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM178A |
0.173468536743419 |
|
5610 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
THUMPD2 |
0.173468536743419 |
|
5611 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoR442|ENSG00000252203.1 |
0.173840678485376 |
|
5612 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000239000.1 |
0.173840678485376 |
|
5613 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RASGEF1B |
0.173859516635887 |
|
5614 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CIDEA |
0.173984667359288 |
|
5615 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DDIT4L |
0.174033375231618 |
|
5616 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPCS2 |
0.174133186424659 |
|
5617 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NEU3 |
0.174133186424659 |
|
5618 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR2AT4 |
0.174133186424659 |
|
5619 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLCO2B1 |
0.174133186424659 |
|
5620 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TPBGL |
0.174133186424659 |
|
5621 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARRB1 |
0.174133186424659 |
|
5622 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR326 |
0.174133186424659 |
|
5623 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPS3 |
0.174133186424659 |
|
5624 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD15A |
0.174133186424659 |
|
5625 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD15B |
0.174133186424659 |
|
5626 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KLHL35 |
0.174133186424659 |
|
5627 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GDPD5 |
0.174133186424659 |
|
5628 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MNF1 |
0.174522240278656 |
|
5629 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SBP1 |
0.174522240278656 |
|
5630 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3934 |
0.174522240278656 |
|
5631 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA64|ENSG00000199566.1 |
0.174559607654305 |
|
5632 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C11orf87 |
0.174858558704543 |
|
5633 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZC3H12C |
0.174858558704543 |
|
5634 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RDX |
0.174858558704543 |
|
5635 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPL34 |
0.174893583246352 |
|
5636 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OSTC |
0.174893583246352 |
|
5637 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNU4ATAC10P |
0.174934655059663 |
|
5638 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNU4ATAC5P |
0.174934655059663 |
|
5639 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DIS3 |
0.175028806830291 |
|
5640 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PIBF1 |
0.175028806830291 |
|
5641 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KLF5 |
0.175028806830291 |
|
5642 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SEL1L2 |
0.175151571234256 |
|
5643 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DNM3 |
0.175235348905011 |
|
5644 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIAA1549 |
0.175242093137714 |
|
5645 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZC3HAV1L |
0.175242093137714 |
|
5646 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZC3HAV1 |
0.175242093137714 |
|
5647 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PICALM |
0.175270914438389 |
|
5648 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD112|ENSG00000252566.1 |
0.175322268012238 |
|
5649 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CNEP1R1 |
0.175358579556769 |
|
5650 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HEATR3 |
0.175358579556769 |
|
5651 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNY4P3 |
0.175358579556769 |
|
5652 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA70|ENSG00000252526.1 |
0.175358579556769 |
|
5653 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PAPD5 |
0.175358579556769 |
|
5654 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADCY7 |
0.175358579556769 |
|
5655 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BRD7 |
0.175358579556769 |
|
5656 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238544.1 |
0.175358579556769 |
|
5657 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BAK1 |
0.17553836853269 |
|
5658 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GGNBP1 |
0.17553836853269 |
|
5659 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00336 |
0.17553836853269 |
|
5660 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DCUN1D5 |
0.175575245199594 |
|
5661 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPATA8 |
0.175612424788876 |
|
5662 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U3|ENSG00000221040.1 |
0.175619776628929 |
|
5663 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MMP8 |
0.175667164783941 |
|
5664 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WTAPP1 |
0.175667164783941 |
|
5665 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MMP10 |
0.175667164783941 |
|
5666 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MMP1 |
0.175667164783941 |
|
5667 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MMP3 |
0.175667164783941 |
|
5668 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MMP12 |
0.175667164783941 |
|
5669 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MMP13 |
0.175667164783941 |
|
5670 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SOD3 |
0.175785239388989 |
|
5671 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
INTS5 |
0.175929974188929 |
|
5672 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C11orf48 |
0.175929974188929 |
|
5673 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C11orf83 |
0.175929974188929 |
|
5674 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
METTL12 |
0.175929974188929 |
|
5675 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA57|ENSG00000206597.1 |
0.175929974188929 |
|
5676 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UBXN1 |
0.175929974188929 |
|
5677 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRRN4CL |
0.175929974188929 |
|
5678 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BSCL2 |
0.175929974188929 |
|
5679 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GNG3 |
0.175929974188929 |
|
5680 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HNRNPUL2 |
0.175929974188929 |
|
5681 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TTC9C |
0.175929974188929 |
|
5682 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
POLR2G |
0.175929974188929 |
|
5683 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZBTB3 |
0.175929974188929 |
|
5684 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TAF6L |
0.175929974188929 |
|
5685 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM223 |
0.175929974188929 |
|
5686 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SYT13 |
0.175991966452355 |
|
5687 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DICER1 |
0.176009168957883 |
|
5688 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL750P |
0.176232557844397 |
|
5689 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC12A9 |
0.176232557844397 |
|
5690 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRIP6 |
0.176232557844397 |
|
5691 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SRRT |
0.176232557844397 |
|
5692 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACHE |
0.176232557844397 |
|
5693 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UFSP1 |
0.176232557844397 |
|
5694 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL549P |
0.176232557844397 |
|
5695 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KDR |
0.17631646272209 |
|
5696 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADORA2A |
0.176368198611885 |
|
5697 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UPB1 |
0.176368198611885 |
|
5698 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SIK2 |
0.176698632415326 |
|
5699 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP273 |
0.176698632415326 |
|
5700 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPP2R1B |
0.176698632415326 |
|
5701 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ALG9 |
0.176698632415326 |
|
5702 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FDXACB1 |
0.176698632415326 |
|
5703 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C11orf1 |
0.176698632415326 |
|
5704 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIAA1328 |
0.176706155749077 |
|
5705 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM9B |
0.176744457056144 |
|
5706 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP499 |
0.176744457056144 |
|
5707 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ASH1L |
0.176842858969877 |
|
5708 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR555 |
0.176842858969877 |
|
5709 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238805.1 |
0.176842858969877 |
|
5710 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C16orf13 |
0.17685188614502 |
|
5711 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM195A |
0.17685188614502 |
|
5712 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WDR90 |
0.17685188614502 |
|
5713 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WFIKKN1 |
0.17685188614502 |
|
5714 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RHOT2 |
0.17685188614502 |
|
5715 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RHBDL1 |
0.17685188614502 |
|
5716 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00348 |
0.176873143199638 |
|
5717 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP33 |
0.176953801541281 |
|
5718 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ALX1 |
0.177088497615907 |
|
5719 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NTS |
0.177088497615907 |
|
5720 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ITPR2 |
0.177094028279038 |
|
5721 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238430.1 |
0.177165590364873 |
|
5722 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KLHL20 |
0.177165590364873 |
|
5723 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP160 |
0.177165590364873 |
|
5724 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CENPL |
0.177165590364873 |
|
5725 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PHKB |
0.177207590980037 |
|
5726 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ABCC12 |
0.177207590980037 |
|
5727 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PTPRR |
0.177660946752083 |
|
5728 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DKK2 |
0.177676650877834 |
|
5729 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPECC1L |
0.17768539543558 |
|
5730 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SGCZ |
0.17783886795423 |
|
5731 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NKAIN3 |
0.177920002800646 |
|
5732 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4698 |
0.177953859327075 |
|
5733 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL207P |
0.17812689740808 |
|
5734 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MYO9A |
0.178551006439785 |
|
5735 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TTC26 |
0.178642435273152 |
|
5736 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UBN2 |
0.178642435273152 |
|
5737 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C7orf55 |
0.178642435273152 |
|
5738 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LUC7L2 |
0.178642435273152 |
|
5739 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR573 |
0.178854087583608 |
|
5740 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZDHHC7 |
0.178997835858866 |
|
5741 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIAA0513 |
0.178997835858866 |
|
5742 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM92B |
0.178997835858866 |
|
5743 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR52A4 |
0.17902906996756 |
|
5744 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR52A5 |
0.17902906996756 |
|
5745 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR52A1 |
0.17902906996756 |
|
5746 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR51V1 |
0.17902906996756 |
|
5747 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HBB |
0.17902906996756 |
|
5748 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HBD |
0.17902906996756 |
|
5749 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HBBP1 |
0.17902906996756 |
|
5750 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HBG1 |
0.17902906996756 |
|
5751 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR51B4 |
0.17902906996756 |
|
5752 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR51B2 |
0.17902906996756 |
|
5753 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR51B5 |
0.17902906996756 |
|
5754 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR51B6 |
0.17902906996756 |
|
5755 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR51M1 |
0.17902906996756 |
|
5756 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR51J1 |
0.17902906996756 |
|
5757 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR51Q1 |
0.17902906996756 |
|
5758 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR51I1 |
0.17902906996756 |
|
5759 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ILK |
0.17902906996756 |
|
5760 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TAF10 |
0.17902906996756 |
|
5761 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TPP1 |
0.17902906996756 |
|
5762 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DCHS1 |
0.17902906996756 |
|
5763 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MRPL17 |
0.17902906996756 |
|
5764 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GVINP1 |
0.17902906996756 |
|
5765 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR2AG2 |
0.17902906996756 |
|
5766 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR2AG1 |
0.17902906996756 |
|
5767 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR6A2 |
0.17902906996756 |
|
5768 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC24 |
0.179239968434048 |
|
5769 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC6A9 |
0.179239968434048 |
|
5770 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KLF17 |
0.179239968434048 |
|
5771 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL479P |
0.179239968434048 |
|
5772 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
INSM1 |
0.179321898680687 |
|
5773 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RALGAPA2 |
0.179321898680687 |
|
5774 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCG3 |
0.17953948127363 |
|
5775 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LYSMD2 |
0.17953948127363 |
|
5776 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMOD2 |
0.17953948127363 |
|
5777 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMOD3 |
0.17953948127363 |
|
5778 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U6|ENSG00000272337.1 |
0.17953948127363 |
|
5779 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LEO1 |
0.17953948127363 |
|
5780 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAPK6 |
0.17953948127363 |
|
5781 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BCL2L10 |
0.17953948127363 |
|
5782 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GNB5 |
0.17953948127363 |
|
5783 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR1266 |
0.17953948127363 |
|
5784 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238938.1 |
0.179548594445237 |
|
5785 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
METTL21D |
0.179716128104447 |
|
5786 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMTC4 |
0.179962769508166 |
|
5787 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FGF14 |
0.179962769508166 |
|
5788 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NR2E3 |
0.180001072785893 |
|
5789 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR187 |
0.180053929840233 |
|
5790 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3929 |
0.180053929840233 |
|
5791 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MCOLN1 |
0.18010217291138 |
|
5792 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PNPLA6 |
0.18010217291138 |
|
5793 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
INO80C |
0.180138885367114 |
|
5794 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GALNT1 |
0.180138885367114 |
|
5795 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ASIP |
0.180507173059753 |
|
5796 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC8A1 |
0.180515812472172 |
|
5797 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CYP2U1 |
0.180518617433685 |
|
5798 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HADH |
0.180518617433685 |
|
5799 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LEF1 |
0.180518617433685 |
|
5800 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NRDE2 |
0.180582911087888 |
|
5801 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CALM1 |
0.180582911087888 |
|
5802 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00642 |
0.180582911087888 |
|
5803 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GGACT |
0.180680263157665 |
|
5804 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00411 |
0.180680263157665 |
|
5805 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NALCN |
0.180680263157665 |
|
5806 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ITGBL1 |
0.180680263157665 |
|
5807 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR2681 |
0.180680263157665 |
|
5808 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNY1P2 |
0.180680263157665 |
|
5809 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4705 |
0.180680263157665 |
|
5810 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4252 |
0.180763434575363 |
|
5811 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZBTB48 |
0.180763434575363 |
|
5812 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KLHL21 |
0.180763434575363 |
|
5813 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PHF13 |
0.180763434575363 |
|
5814 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
THAP3 |
0.180763434575363 |
|
5815 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PAPSS1 |
0.18085944914686 |
|
5816 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TTC7B |
0.180961666701384 |
|
5817 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PHACTR3 |
0.18097890348776 |
|
5818 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KDM4B |
0.181072779247099 |
|
5819 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCNJ9 |
0.181081327657516 |
|
5820 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IGSF8 |
0.181081327657516 |
|
5821 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATP1A2 |
0.181081327657516 |
|
5822 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP350 |
0.181138228455717 |
|
5823 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C11orf53 |
0.181138228455717 |
|
5824 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C11orf92 |
0.181138228455717 |
|
5825 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C11orf93 |
0.181138228455717 |
|
5826 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4491 |
0.181138228455717 |
|
5827 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
POU2AF1 |
0.181138228455717 |
|
5828 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BTG4 |
0.181138228455717 |
|
5829 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C11orf88 |
0.181138228455717 |
|
5830 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR34B |
0.181138228455717 |
|
5831 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR34C |
0.181138228455717 |
|
5832 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LAYN |
0.181138228455717 |
|
5833 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC53 |
0.181147512436649 |
|
5834 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NUP37 |
0.181147512436649 |
|
5835 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SDR16C6P |
0.181169267342072 |
|
5836 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PENK |
0.181169267342072 |
|
5837 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00968 |
0.181169267342072 |
|
5838 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IMPAD1 |
0.181169267342072 |
|
5839 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP266 |
0.181169267342072 |
|
5840 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4311 |
0.181196110027091 |
|
5841 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP354 |
0.18163502791762 |
|
5842 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FMO9P |
0.181660198059524 |
|
5843 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
POGK |
0.181660198059524 |
|
5844 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TADA1 |
0.181660198059524 |
|
5845 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ILDR2 |
0.181660198059524 |
|
5846 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAEL |
0.181660198059524 |
|
5847 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP65 |
0.181660198059524 |
|
5848 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238325.1 |
0.181660198059524 |
|
5849 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPA33 |
0.181660198059524 |
|
5850 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DUSP27 |
0.181660198059524 |
|
5851 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
POU2F1 |
0.181660198059524 |
|
5852 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PTER |
0.181753216689936 |
|
5853 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C1QL3 |
0.181753216689936 |
|
5854 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PTPLA |
0.181753216689936 |
|
5855 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RBM47 |
0.181933341973043 |
|
5856 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NSUN7 |
0.181933341973043 |
|
5857 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00402 |
0.181993015152757 |
|
5858 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNY1P5 |
0.181993015152757 |
|
5859 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00381 |
0.181993015152757 |
|
5860 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00347 |
0.181993015152757 |
|
5861 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DAAM2 |
0.182116634715326 |
|
5862 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MOCS1 |
0.182116634715326 |
|
5863 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TDRG1 |
0.182116634715326 |
|
5864 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00951 |
0.182116634715326 |
|
5865 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HADHA |
0.182129096246329 |
|
5866 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DSC3 |
0.182155436497347 |
|
5867 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA9|ENSG00000199282.1 |
0.182180322529258 |
|
5868 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MZT1 |
0.182180322529258 |
|
5869 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BORA |
0.182180322529258 |
|
5870 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCNK10 |
0.182223329085509 |
|
5871 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PTPN21 |
0.182223329085509 |
|
5872 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZC3H14 |
0.182223329085509 |
|
5873 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EML5 |
0.182223329085509 |
|
5874 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TTC8 |
0.182223329085509 |
|
5875 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FADD |
0.18223190635969 |
|
5876 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR548K |
0.18223190635969 |
|
5877 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AIPL1 |
0.182347023523331 |
|
5878 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM64A |
0.182347023523331 |
|
5879 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIAA0753 |
0.182347023523331 |
|
5880 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MED31 |
0.182347023523331 |
|
5881 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TXNDC17 |
0.182347023523331 |
|
5882 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C17orf100 |
0.182347023523331 |
|
5883 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4520B |
0.182347023523331 |
|
5884 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP162 |
0.182490478255979 |
|
5885 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AASDH |
0.182490478255979 |
|
5886 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPAT |
0.182490478255979 |
|
5887 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PAICS |
0.182490478255979 |
|
5888 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SRP72 |
0.182490478255979 |
|
5889 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARL9 |
0.182490478255979 |
|
5890 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
THEGL |
0.182490478255979 |
|
5891 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C12orf45 |
0.182492148781085 |
|
5892 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ALDH1L2 |
0.182492148781085 |
|
5893 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIAA1033 |
0.182492148781085 |
|
5894 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RXRB |
0.182535480053087 |
|
5895 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HSD17B8 |
0.182535480053087 |
|
5896 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNY4P10 |
0.182535480053087 |
|
5897 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC39A7 |
0.182535480053087 |
|
5898 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RING1 |
0.182535480053087 |
|
5899 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HCG25 |
0.182535480053087 |
|
5900 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VPS52 |
0.182535480053087 |
|
5901 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPS18 |
0.182535480053087 |
|
5902 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
B3GALT4 |
0.182535480053087 |
|
5903 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WDR46 |
0.182535480053087 |
|
5904 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PFDN6 |
0.182535480053087 |
|
5905 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RGL2 |
0.182535480053087 |
|
5906 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TAPBP |
0.182535480053087 |
|
5907 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DAXX |
0.182535480053087 |
|
5908 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZBTB22 |
0.182535480053087 |
|
5909 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIFC1 |
0.182535480053087 |
|
5910 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CUTA |
0.182535480053087 |
|
5911 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PHF1 |
0.182535480053087 |
|
5912 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SYNGAP1 |
0.182535480053087 |
|
5913 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR5004 |
0.182535480053087 |
|
5914 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL26P |
0.182535480053087 |
|
5915 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANKRD2 |
0.182561858052317 |
|
5916 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARHGEF33 |
0.182591466799177 |
|
5917 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SOS1 |
0.182591466799177 |
|
5918 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00564 |
0.182635861039181 |
|
5919 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
YY1AP1 |
0.182665115473558 |
|
5920 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DAP3 |
0.182665115473558 |
|
5921 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HELZ |
0.182676166401925 |
|
5922 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SGMS2 |
0.1826832333983 |
|
5923 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AMPD1 |
0.182747259599964 |
|
5924 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL432P |
0.182747259599964 |
|
5925 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NRAS |
0.182747259599964 |
|
5926 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC18 |
0.182776370212981 |
|
5927 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PTPRM |
0.182853073471589 |
|
5928 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OAZ2 |
0.183041960671527 |
|
5929 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RBPMS2 |
0.183041960671527 |
|
5930 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR1272 |
0.183041960671527 |
|
5931 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PIF1 |
0.183041960671527 |
|
5932 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLEKHO2 |
0.183041960671527 |
|
5933 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL348P |
0.183041960671527 |
|
5934 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANKDD1A |
0.183041960671527 |
|
5935 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPG21 |
0.183041960671527 |
|
5936 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MTFMT |
0.183041960671527 |
|
5937 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC51B |
0.183041960671527 |
|
5938 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RASL12 |
0.183041960671527 |
|
5939 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KBTBD13 |
0.183041960671527 |
|
5940 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UBAP1L |
0.183041960671527 |
|
5941 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FZD1 |
0.183091020509308 |
|
5942 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF354B |
0.183181799485428 |
|
5943 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZFP2 |
0.183181799485428 |
|
5944 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF454 |
0.183181799485428 |
|
5945 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GRM6 |
0.183181799485428 |
|
5946 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RGS20 |
0.183255528581151 |
|
5947 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TCEA1 |
0.183255528581151 |
|
5948 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP424 |
0.18334843085841 |
|
5949 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TSPAN19 |
0.183568431090519 |
|
5950 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C12orf63 |
0.18378227466936 |
|
5951 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IFI27L1 |
0.183846715298897 |
|
5952 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IFI27 |
0.183846715298897 |
|
5953 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IFI27L2 |
0.183846715298897 |
|
5954 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPP4R4 |
0.183846715298897 |
|
5955 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SERPINA10 |
0.183846715298897 |
|
5956 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SERPINA6 |
0.183846715298897 |
|
5957 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SERPINA1 |
0.183846715298897 |
|
5958 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SERPINA11 |
0.183846715298897 |
|
5959 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SERPINA9 |
0.183846715298897 |
|
5960 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SERPINA12 |
0.183846715298897 |
|
5961 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SERPINA4 |
0.183846715298897 |
|
5962 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SERPINA5 |
0.183846715298897 |
|
5963 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SERPINA3 |
0.183846715298897 |
|
5964 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SERPINA13P |
0.183846715298897 |
|
5965 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GSC |
0.183846715298897 |
|
5966 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNY4P11 |
0.183881803476742 |
|
5967 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00851 |
0.183881803476742 |
|
5968 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP476 |
0.183881803476742 |
|
5969 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL816P |
0.183947649582276 |
|
5970 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF479 |
0.183947649582276 |
|
5971 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238666.1 |
0.184246155462397 |
|
5972 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDKL4 |
0.184297236098505 |
|
5973 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAP4K3 |
0.184297236098505 |
|
5974 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA67|ENSG00000252473.1 |
0.184297236098505 |
|
5975 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00440 |
0.184330853257485 |
|
5976 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRFN5 |
0.184362515631159 |
|
5977 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GAS7 |
0.184362852768833 |
|
5978 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000239144.1 |
0.18437968004851 |
|
5979 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR568 |
0.184426472420165 |
|
5980 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MEGF11 |
0.184725719728686 |
|
5981 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DIS3L |
0.184725719728686 |
|
5982 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TIPIN |
0.184725719728686 |
|
5983 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCARNA14 |
0.184725719728686 |
|
5984 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAP2K1 |
0.184725719728686 |
|
5985 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RASSF8 |
0.184750688032481 |
|
5986 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GREB1L |
0.184936615582284 |
|
5987 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC83 |
0.185053380498208 |
|
5988 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP224 |
0.185153532731206 |
|
5989 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FOXN2 |
0.185153532731206 |
|
5990 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MSH6 |
0.185209165925611 |
|
5991 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FBXO11 |
0.185209165925611 |
|
5992 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPP1R21 |
0.185214834673377 |
|
5993 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STON1 |
0.185214834673377 |
|
5994 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GTF2A1L |
0.185214834673377 |
|
5995 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LHCGR |
0.185214834673377 |
|
5996 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCND3 |
0.185281649828108 |
|
5997 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PBXIP1 |
0.18541541350399 |
|
5998 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PYGO2 |
0.18541541350399 |
|
5999 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SHC1 |
0.18541541350399 |
|
6000 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CKS1B|ENSG00000173207.8 |
0.18541541350399 |
|
6001 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4258 |
0.18541541350399 |
|
6002 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FLAD1 |
0.18541541350399 |
|
6003 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LENEP |
0.18541541350399 |
|
6004 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZBTB7B |
0.18541541350399 |
|
6005 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238458.1 |
0.185609277213413 |
|
6006 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP37 |
0.185824719470484 |
|
6007 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EBLN1 |
0.185824719470484 |
|
6008 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BMI1 |
0.185824719470484 |
|
6009 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COMMD3 |
0.185824719470484 |
|
6010 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPAG6 |
0.185824719470484 |
|
6011 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PIP4K2A |
0.185824719470484 |
|
6012 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARMC3 |
0.185824719470484 |
|
6013 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP304 |
0.185824719470484 |
|
6014 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MSRB2 |
0.185824719470484 |
|
6015 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CHMP4B |
0.185827464044768 |
|
6016 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RALY |
0.185827464044768 |
|
6017 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4755 |
0.185827464044768 |
|
6018 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EIF2S2 |
0.185827464044768 |
|
6019 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CPNE8 |
0.185903441613265 |
|
6020 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238563.1 |
0.185907215379286 |
|
6021 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MARCKS |
0.185907215379286 |
|
6022 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP213 |
0.185907215379286 |
|
6023 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF730 |
0.186088455731364 |
|
6024 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GAMT |
0.186372132929218 |
|
6025 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ABI3BP |
0.186662616877652 |
|
6026 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP160 |
0.186677893686375 |
|
6027 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
POM121L12 |
0.186825155253783 |
|
6028 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP218 |
0.186825155253783 |
|
6029 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRERF1 |
0.186957356624375 |
|
6030 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U3|ENSG00000221252.1 |
0.186957356624375 |
|
6031 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COL11A2 |
0.18725002549442 |
|
6032 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRFN2 |
0.188148035650202 |
|
6033 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00847 |
0.188252607108146 |
|
6034 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZFP62 |
0.188252607108146 |
|
6035 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BTNL8 |
0.188252607108146 |
|
6036 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BTNL3 |
0.188252607108146 |
|
6037 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BTNL9 |
0.188252607108146 |
|
6038 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GNB2L1 |
0.188252607108146 |
|
6039 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4638 |
0.188252607108146 |
|
6040 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR2V1 |
0.188252607108146 |
|
6041 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR2V2 |
0.188252607108146 |
|
6042 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR4F3 |
0.188252607108146 |
|
6043 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD95|ENSG00000264549.1 |
0.188252607108146 |
|
6044 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD96A |
0.188252607108146 |
|
6045 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRIM41 |
0.188252607108146 |
|
6046 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRIM52 |
0.188252607108146 |
|
6047 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRIM7 |
0.188252607108146 |
|
6048 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP220 |
0.188289614029431 |
|
6049 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TFEB |
0.188315702462108 |
|
6050 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PGC |
0.188315702462108 |
|
6051 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RIF1 |
0.188361184877975 |
|
6052 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
THEMIS |
0.188699660239328 |
|
6053 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL292P |
0.188778258082708 |
|
6054 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CECR3 |
0.189038887550616 |
|
6055 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CECR9 |
0.189038887550616 |
|
6056 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL843P |
0.189038887550616 |
|
6057 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PGBD3 |
0.189158869479943 |
|
6058 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CHAT |
0.189158869479943 |
|
6059 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC18A3 |
0.189158869479943 |
|
6060 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C10orf53 |
0.189158869479943 |
|
6061 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OGDHL |
0.189158869479943 |
|
6062 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PARG |
0.189158869479943 |
|
6063 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AGAP7 |
0.189158869479943 |
|
6064 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AGAP8 |
0.189158869479943 |
|
6065 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM21D |
0.189158869479943 |
|
6066 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM25D |
0.189158869479943 |
|
6067 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MSMB |
0.189158869479943 |
|
6068 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP316 |
0.189158869479943 |
|
6069 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA74|ENSG00000223182.1 |
0.189158869479943 |
|
6070 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TIMM23B |
0.189158869479943 |
|
6071 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TTC17 |
0.189239477646691 |
|
6072 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAPK8IP1 |
0.189267056401891 |
|
6073 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C11orf94 |
0.189267056401891 |
|
6074 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PEX16 |
0.189267056401891 |
|
6075 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GYLTL1B |
0.189267056401891 |
|
6076 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PHF21A |
0.189267056401891 |
|
6077 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAB10 |
0.189465759007036 |
|
6078 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GAREML |
0.189465759007036 |
|
6079 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ASF1A |
0.189537140650374 |
|
6080 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM184A |
0.189537140650374 |
|
6081 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR548B |
0.189537140650374 |
|
6082 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAN1A1 |
0.189537140650374 |
|
6083 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPR68 |
0.189796569707159 |
|
6084 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC88C |
0.189796569707159 |
|
6085 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SMEK1 |
0.189796569707159 |
|
6086 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM126B |
0.189840944413365 |
|
6087 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM126A |
0.189840944413365 |
|
6088 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CREBZF |
0.189840944413365 |
|
6089 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC89 |
0.189840944413365 |
|
6090 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RIMKLB |
0.189963063430587 |
|
6091 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PHC1 |
0.189963063430587 |
|
6092 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
M6PR |
0.189963063430587 |
|
6093 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KLRG1 |
0.189963063430587 |
|
6094 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00612 |
0.189963063430587 |
|
6095 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
A2M |
0.189963063430587 |
|
6096 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PZP |
0.189963063430587 |
|
6097 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
A2MP1 |
0.189963063430587 |
|
6098 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00987 |
0.189963063430587 |
|
6099 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA75|ENSG00000212432.1 |
0.189963063430587 |
|
6100 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA75|ENSG00000212440.1 |
0.189963063430587 |
|
6101 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KLRB1 |
0.189963063430587 |
|
6102 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLEC2D |
0.189963063430587 |
|
6103 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLECL1 |
0.189963063430587 |
|
6104 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CD69 |
0.189963063430587 |
|
6105 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KLRF1 |
0.189963063430587 |
|
6106 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLEC2B |
0.189963063430587 |
|
6107 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPS10 |
0.190079089103248 |
|
6108 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR548X2 |
0.190108497364572 |
|
6109 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OPRD1 |
0.190321627793318 |
|
6110 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EPB41 |
0.190321627793318 |
|
6111 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RASA3 |
0.190357539151213 |
|
6112 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MGAT4C |
0.190414126792234 |
|
6113 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF675 |
0.190639719898546 |
|
6114 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR548J |
0.190778349746757 |
|
6115 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CRYBB1 |
0.190778349746757 |
|
6116 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CRYBA4 |
0.190778349746757 |
|
6117 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIAT |
0.190778349746757 |
|
6118 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00333 |
0.190865640458745 |
|
6119 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCNK13 |
0.190898321901734 |
|
6120 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PSMC1 |
0.190898321901734 |
|
6121 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARHGAP22 |
0.190928623823743 |
|
6122 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARPC1B |
0.191060425024239 |
|
6123 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PDAP1 |
0.191060425024239 |
|
6124 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BUD31 |
0.191060425024239 |
|
6125 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000239133.1 |
0.191060425024239 |
|
6126 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CPSF4 |
0.191060425024239 |
|
6127 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CHRNA9 |
0.191132490276822 |
|
6128 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COG2 |
0.191149474714462 |
|
6129 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C1orf198 |
0.191149474714462 |
|
6130 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL837P |
0.191149474714462 |
|
6131 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238985.1 |
0.191149474714462 |
|
6132 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL506P |
0.191228254137056 |
|
6133 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIRLET7A2 |
0.191334063858924 |
|
6134 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR100 |
0.191334063858924 |
|
6135 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C12orf23 |
0.191847980846606 |
|
6136 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MTERFD3 |
0.191847980846606 |
|
6137 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLAG1 |
0.191901863233849 |
|
6138 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CHCHD7 |
0.191901863233849 |
|
6139 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SDR16C5 |
0.191901863233849 |
|
6140 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARTN |
0.191981625222999 |
|
6141 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IPO13 |
0.191981625222999 |
|
6142 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DPH2 |
0.191981625222999 |
|
6143 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATP6V0B |
0.191981625222999 |
|
6144 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
B4GALT2 |
0.191981625222999 |
|
6145 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FSCB |
0.192256461201147 |
|
6146 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238501.1 |
0.192256461201147 |
|
6147 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C14orf28 |
0.192256461201147 |
|
6148 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KLHL28 |
0.192256461201147 |
|
6149 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM179B |
0.192256461201147 |
|
6150 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD58 |
0.192256461201147 |
|
6151 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNY3P3 |
0.192373004213633 |
|
6152 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPRY2 |
0.192373004213633 |
|
6153 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FRMPD2 |
0.192480704121214 |
|
6154 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAPK8 |
0.192480704121214 |
|
6155 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACER1 |
0.192484479243529 |
|
6156 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLPP |
0.192484479243529 |
|
6157 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ALKBH7 |
0.192484479243529 |
|
6158 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GTF2F1 |
0.192484479243529 |
|
6159 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PSPN |
0.192484479243529 |
|
6160 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KHSRP |
0.192484479243529 |
|
6161 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3940 |
0.192484479243529 |
|
6162 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF724P |
0.192538672480286 |
|
6163 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PTRHD1 |
0.192559815832675 |
|
6164 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CENPO |
0.192559815832675 |
|
6165 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADCY3 |
0.192559815832675 |
|
6166 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DNAJC27 |
0.192559815832675 |
|
6167 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SFTA1P |
0.19256033843886 |
|
6168 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00710 |
0.19256033843886 |
|
6169 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CEBPB |
0.192724318938888 |
|
6170 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM170B |
0.192749301683659 |
|
6171 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C10orf128 |
0.192749301683659 |
|
6172 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CSRP2BP |
0.192881803905982 |
|
6173 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PET117 |
0.192881803905982 |
|
6174 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL14P |
0.192881803905982 |
|
6175 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF133 |
0.192881803905982 |
|
6176 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP74 |
0.192881803905982 |
|
6177 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DZANK1 |
0.192881803905982 |
|
6178 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
POLR3F |
0.192881803905982 |
|
6179 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3192 |
0.192881803905982 |
|
6180 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00652 |
0.192881803905982 |
|
6181 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C20orf78 |
0.192881803905982 |
|
6182 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCP2D1 |
0.192881803905982 |
|
6183 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KANSL2 |
0.193042527313757 |
|
6184 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA34 |
0.193042527313757 |
|
6185 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA2A |
0.193042527313757 |
|
6186 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA2B |
0.193042527313757 |
|
6187 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TNFSF18 |
0.193526175437403 |
|
6188 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TNFSF4 |
0.193526175437403 |
|
6189 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000251817.1 |
0.193526175437403 |
|
6190 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRDX6 |
0.193526175437403 |
|
6191 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC9C2 |
0.193526175437403 |
|
6192 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANKRD45 |
0.193526175437403 |
|
6193 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LYPD6 |
0.19357297914703 |
|
6194 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COG5 |
0.193654057563153 |
|
6195 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPR22 |
0.193654057563153 |
|
6196 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DUS4L |
0.193654057563153 |
|
6197 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BCAP29 |
0.193654057563153 |
|
6198 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU109|ENSG00000238832.1 |
0.193654057563153 |
|
6199 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC26A4 |
0.193654057563153 |
|
6200 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CBLL1 |
0.193654057563153 |
|
6201 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC26A3 |
0.193654057563153 |
|
6202 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DLD |
0.193654057563153 |
|
6203 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
POU5F1B |
0.193737580940055 |
|
6204 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CHMP1B |
0.19374262899667 |
|
6205 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MPPE1 |
0.19374262899667 |
|
6206 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IMPA2 |
0.19374262899667 |
|
6207 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANKRD62 |
0.19374262899667 |
|
6208 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PSMC2 |
0.193942047530658 |
|
6209 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC26A5 |
0.193942047530658 |
|
6210 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP86 |
0.193942047530658 |
|
6211 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DEF6 |
0.19405891551824 |
|
6212 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPARD |
0.19405891551824 |
|
6213 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FANCE |
0.19405891551824 |
|
6214 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPL10A |
0.19405891551824 |
|
6215 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TEAD3 |
0.19405891551824 |
|
6216 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TULP1 |
0.19405891551824 |
|
6217 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MNDA |
0.194064612977959 |
|
6218 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VAMP4 |
0.194114379962075 |
|
6219 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCARNA20|ENSG00000253060.1 |
0.194114379962075 |
|
6220 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
METTL13 |
0.194114379962075 |
|
6221 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDK17 |
0.194254523981122 |
|
6222 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP11 |
0.194254523981122 |
|
6223 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C12orf55 |
0.194254523981122 |
|
6224 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NEDD1 |
0.194254523981122 |
|
6225 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00433 |
0.194363113495983 |
|
6226 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00560 |
0.194363113495983 |
|
6227 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DARS2 |
0.194627699724828 |
|
6228 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GAS5 |
0.194627699724828 |
|
6229 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD78|ENSG00000208317.1 |
0.194627699724828 |
|
6230 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZBTB37 |
0.194627699724828 |
|
6231 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SERPINC1 |
0.194627699724828 |
|
6232 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP67 |
0.194627699724828 |
|
6233 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RC3H1 |
0.194627699724828 |
|
6234 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP68 |
0.194627699724828 |
|
6235 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR34A |
0.194716463383445 |
|
6236 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
H6PD |
0.194716463383445 |
|
6237 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPSB1 |
0.194716463383445 |
|
6238 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CHMP2B |
0.194787032429176 |
|
6239 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4795 |
0.194787032429176 |
|
6240 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
POU1F1 |
0.194787032429176 |
|
6241 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00458 |
0.194874619947601 |
|
6242 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA40|ENSG00000212579.1 |
0.194952077031634 |
|
6243 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR5690 |
0.194952077031634 |
|
6244 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR548F4 |
0.195322347669581 |
|
6245 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BMP2 |
0.195525020808224 |
|
6246 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoR26 |
0.195525020808224 |
|
6247 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CHIC2 |
0.195829601478691 |
|
6248 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC30A9 |
0.195913811106952 |
|
6249 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BEND4 |
0.195913811106952 |
|
6250 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
L2HGDH |
0.196120858467287 |
|
6251 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4504 |
0.196120858467287 |
|
6252 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATP5S |
0.196120858467287 |
|
6253 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BANF2 |
0.196247208177383 |
|
6254 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARHGDIG |
0.196267103182288 |
|
6255 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AXIN1 |
0.196267103182288 |
|
6256 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C16orf11 |
0.196267103182288 |
|
6257 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CAPN15 |
0.196267103182288 |
|
6258 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DDX11L10 |
0.196267103182288 |
|
6259 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DECR2 |
0.196267103182288 |
|
6260 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HBA1 |
0.196267103182288 |
|
6261 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HBA2 |
0.196267103182288 |
|
6262 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HBM |
0.196267103182288 |
|
6263 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HBQ1 |
0.196267103182288 |
|
6264 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HBZ |
0.196267103182288 |
|
6265 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ITFG3 |
0.196267103182288 |
|
6266 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LUC7L |
0.196267103182288 |
|
6267 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3176 |
0.196267103182288 |
|
6268 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR5587 |
0.196267103182288 |
|
6269 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MPG |
0.196267103182288 |
|
6270 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MRPL28 |
0.196267103182288 |
|
6271 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NHLRC4 |
0.196267103182288 |
|
6272 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NME4 |
0.196267103182288 |
|
6273 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NPRL3 |
0.196267103182288 |
|
6274 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PDIA2 |
0.196267103182288 |
|
6275 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PIGQ |
0.196267103182288 |
|
6276 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
POLR3K |
0.196267103182288 |
|
6277 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAB11FIP3 |
0.196267103182288 |
|
6278 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RGS11 |
0.196267103182288 |
|
6279 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RHBDF1 |
0.196267103182288 |
|
6280 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNRNP25 |
0.196267103182288 |
|
6281 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM8A |
0.196267103182288 |
|
6282 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WASH4P |
0.196267103182288 |
|
6283 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WASIR2 |
0.196267103182288 |
|
6284 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DKK1 |
0.196313823559822 |
|
6285 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRRC2C |
0.19634251003229 |
|
6286 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4500HG |
0.196388476286352 |
|
6287 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4500 |
0.196388476286352 |
|
6288 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLITRK5 |
0.196388476286352 |
|
6289 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF76 |
0.196505812344432 |
|
6290 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAB21L3 |
0.196899161968304 |
|
6291 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACSBG2 |
0.196908068103319 |
|
6292 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MLLT1 |
0.196908068103319 |
|
6293 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DNM3OS |
0.197119504865291 |
|
6294 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR214 |
0.197119504865291 |
|
6295 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR199A2 |
0.197119504865291 |
|
6296 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCTD19 |
0.19714155009275 |
|
6297 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM65A |
0.19714155009275 |
|
6298 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANGPTL5 |
0.197205349634583 |
|
6299 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIAA1377 |
0.197205349634583 |
|
6300 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C11orf70 |
0.197205349634583 |
|
6301 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000252679.1 |
0.197205349634583 |
|
6302 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000239154.1 |
0.197205349634583 |
|
6303 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PBX1 |
0.197354901485528 |
|
6304 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CECR2 |
0.197418504167826 |
|
6305 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC25A18 |
0.197418504167826 |
|
6306 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD39|ENSG00000264997.1 |
0.197500320229665 |
|
6307 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PTCD1 |
0.197528975731598 |
|
6308 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATP5J2 |
0.197528975731598 |
|
6309 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF789 |
0.197528975731598 |
|
6310 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF394 |
0.197528975731598 |
|
6311 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZKSCAN5 |
0.197528975731598 |
|
6312 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM200A |
0.197528975731598 |
|
6313 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF655 |
0.197528975731598 |
|
6314 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZSCAN25 |
0.197528975731598 |
|
6315 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CYP3A5 |
0.197528975731598 |
|
6316 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CYP3A7 |
0.197528975731598 |
|
6317 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CYP3A4 |
0.197528975731598 |
|
6318 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CYP3A43 |
0.197528975731598 |
|
6319 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TIMM44 |
0.197543710611615 |
|
6320 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ELAVL1 |
0.197543710611615 |
|
6321 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FKBP5 |
0.197580255359435 |
|
6322 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARMC12 |
0.197580255359435 |
|
6323 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLPSL1 |
0.197580255359435 |
|
6324 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLPSL2 |
0.197580255359435 |
|
6325 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLPS |
0.197580255359435 |
|
6326 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LHFPL5 |
0.197580255359435 |
|
6327 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SRPK1 |
0.197580255359435 |
|
6328 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAB28 |
0.197616492345357 |
|
6329 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIT |
0.197632465672278 |
|
6330 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C1orf61 |
0.197751986122447 |
|
6331 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MEF2D |
0.197751986122447 |
|
6332 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238843.1 |
0.197751986122447 |
|
6333 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OIP5 |
0.197896969899436 |
|
6334 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STMND1 |
0.197913272355359 |
|
6335 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RBM24 |
0.197913272355359 |
|
6336 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL250P |
0.198018935768771 |
|
6337 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SOX17 |
0.198018935768771 |
|
6338 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CRYAB |
0.198151381497746 |
|
6339 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HSPB2 |
0.198151381497746 |
|
6340 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C11orf52 |
0.198151381497746 |
|
6341 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DIXDC1 |
0.198151381497746 |
|
6342 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP351 |
0.198151381497746 |
|
6343 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANKEF1 |
0.198210234080291 |
|
6344 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3664 |
0.198403190198329 |
|
6345 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRRC52 |
0.19840949768405 |
|
6346 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MGST3 |
0.19840949768405 |
|
6347 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ALDH9A1 |
0.19840949768405 |
|
6348 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMCO1 |
0.19840949768405 |
|
6349 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UCK2 |
0.19840949768405 |
|
6350 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR921 |
0.19840949768405 |
|
6351 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDH11 |
0.1985136759794 |
|
6352 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR586 |
0.198542273871365 |
|
6353 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LCMT2 |
0.198628089791703 |
|
6354 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADAL |
0.198628089791703 |
|
6355 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FOLH1B |
0.198695561278284 |
|
6356 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRIM49C |
0.198695561278284 |
|
6357 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRIM49D1 |
0.198695561278284 |
|
6358 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRIM49 |
0.198695561278284 |
|
6359 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRIM64B |
0.198695561278284 |
|
6360 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRIM77 |
0.198695561278284 |
|
6361 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD56|ENSG00000207299.1 |
0.198695561278284 |
|
6362 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NAALAD2 |
0.198695561278284 |
|
6363 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CHORDC1 |
0.198695561278284 |
|
6364 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NDUFAF5 |
0.199059698676906 |
|
6365 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL864P |
0.199059698676906 |
|
6366 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238316.1 |
0.199279192343867 |
|
6367 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ESF1 |
0.19931548199807 |
|
6368 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDKL1 |
0.199524312886411 |
|
6369 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AHNAK |
0.199566567457399 |
|
6370 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MTX1 |
0.199683834036527 |
|
6371 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GBAP1 |
0.199683834036527 |
|
6372 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GBA |
0.199683834036527 |
|
6373 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM189B |
0.199683834036527 |
|
6374 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCAMP3 |
0.199683834036527 |
|
6375 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCUBE3 |
0.199715100966653 |
|
6376 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COPA |
0.199862317124597 |
|
6377 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NCSTN |
0.199862317124597 |
|
6378 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NHLH1 |
0.199862317124597 |
|
6379 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VANGL2 |
0.199862317124597 |
|
6380 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LIF |
0.199903558035809 |
|
6381 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MGC20647 |
0.199903558035809 |
|
6382 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZBTB7A |
0.199962021274715 |
|
6383 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAP2K2 |
0.199962021274715 |
|
6384 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM46A |
0.200030428065644 |
|
6385 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPR111 |
0.200076317986612 |
|
6386 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPR115 |
0.200076317986612 |
|
6387 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP116 |
0.200076317986612 |
|
6388 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
A4GALT |
0.20009977290424 |
|
6389 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATP10D |
0.200131374523494 |
|
6390 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CORIN |
0.200131374523494 |
|
6391 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP215 |
0.200131374523494 |
|
6392 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NFXL1 |
0.200131374523494 |
|
6393 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NIPAL1 |
0.200131374523494 |
|
6394 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CNGA1 |
0.200131374523494 |
|
6395 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TGM3 |
0.20033235436605 |
|
6396 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SIGLECP3 |
0.200457340822753 |
|
6397 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GJA1 |
0.200457340822753 |
|
6398 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ALKBH3 |
0.200459110350914 |
|
6399 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C11orf96 |
0.200459110350914 |
|
6400 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL547P |
0.200460955072511 |
|
6401 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDH8 |
0.200580117868193 |
|
6402 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PATZ1 |
0.200711696759019 |
|
6403 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EIF4ENIF1 |
0.200711696759019 |
|
6404 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00589 |
0.200759642691605 |
|
6405 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM183CP |
0.200759642691605 |
|
6406 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3148 |
0.200759642691605 |
|
6407 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GTF2E2 |
0.200759642691605 |
|
6408 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SMIM18 |
0.200759642691605 |
|
6409 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GSR |
0.200759642691605 |
|
6410 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UBXN8 |
0.200759642691605 |
|
6411 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPP2CB |
0.200759642691605 |
|
6412 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TEX15 |
0.200759642691605 |
|
6413 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PURG |
0.200759642691605 |
|
6414 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WRN |
0.200759642691605 |
|
6415 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STK35 |
0.201018290272693 |
|
6416 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC25A16 |
0.201319242176086 |
|
6417 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNF144B |
0.201337141393402 |
|
6418 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR548A1 |
0.201337141393402 |
|
6419 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PBLD |
0.201338232210776 |
|
6420 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HNRNPH3 |
0.201338232210776 |
|
6421 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HMGA1 |
0.201373695148678 |
|
6422 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C6orf1 |
0.201373695148678 |
|
6423 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FZD3 |
0.20140738984458 |
|
6424 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4288 |
0.20140738984458 |
|
6425 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP259 |
0.20140738984458 |
|
6426 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
INTS9 |
0.20140738984458 |
|
6427 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C6orf141 |
0.201448532543965 |
|
6428 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AZGP1P1 |
0.201483838297497 |
|
6429 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZKSCAN1 |
0.201483838297497 |
|
6430 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZSCAN21 |
0.201483838297497 |
|
6431 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF3 |
0.201483838297497 |
|
6432 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COPS6 |
0.201483838297497 |
|
6433 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MCM7 |
0.201483838297497 |
|
6434 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR106B |
0.201483838297497 |
|
6435 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR25 |
0.201483838297497 |
|
6436 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR93 |
0.201483838297497 |
|
6437 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AP4M1 |
0.201483838297497 |
|
6438 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TAF6 |
0.201483838297497 |
|
6439 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CNPY4 |
0.201483838297497 |
|
6440 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MBLAC1 |
0.201483838297497 |
|
6441 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LAMTOR4 |
0.201483838297497 |
|
6442 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C7orf43 |
0.201483838297497 |
|
6443 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GAL3ST4 |
0.201483838297497 |
|
6444 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4658 |
0.201483838297497 |
|
6445 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPC2 |
0.201483838297497 |
|
6446 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STAG3 |
0.201483838297497 |
|
6447 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GATS |
0.201483838297497 |
|
6448 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PVRIG |
0.201483838297497 |
|
6449 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR1275 |
0.20157435994348 |
|
6450 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GRM4 |
0.20157435994348 |
|
6451 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
A2ML1 |
0.20160681321262 |
|
6452 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HGF |
0.20166136433947 |
|
6453 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PIEZO2 |
0.201713320834302 |
|
6454 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
JAG1 |
0.201759183096936 |
|
6455 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C20orf187 |
0.201759183096936 |
|
6456 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP427 |
0.201823883915821 |
|
6457 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238645.1 |
0.201823883915821 |
|
6458 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RBL2 |
0.201823883915821 |
|
6459 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AKTIP |
0.201823883915821 |
|
6460 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLYBL |
0.201956226733292 |
|
6461 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U3|ENSG00000199856.1 |
0.202201341514272 |
|
6462 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM81B |
0.202304836724214 |
|
6463 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC34A2 |
0.202327051382025 |
|
6464 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM179B |
0.202417834247535 |
|
6465 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NXF1 |
0.202417834247535 |
|
6466 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STX5 |
0.202417834247535 |
|
6467 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL119P |
0.202417834247535 |
|
6468 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WDR74 |
0.202417834247535 |
|
6469 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNHG1 |
0.202417834247535 |
|
6470 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC3A2 |
0.202417834247535 |
|
6471 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC22A8 |
0.202417834247535 |
|
6472 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP278 |
0.202441289622725 |
|
6473 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CRNN |
0.202723589933318 |
|
6474 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LCE5A |
0.202723589933318 |
|
6475 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CRCT1 |
0.202723589933318 |
|
6476 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LCE3B |
0.202723589933318 |
|
6477 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LCE3C |
0.202723589933318 |
|
6478 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LCE3D |
0.202723589933318 |
|
6479 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LCE3E |
0.202723589933318 |
|
6480 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LCE3A |
0.202723589933318 |
|
6481 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LCE2D |
0.202723589933318 |
|
6482 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00302 |
0.202723589933318 |
|
6483 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LCE2B |
0.202723589933318 |
|
6484 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LCE2C |
0.202723589933318 |
|
6485 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LCE2A |
0.202723589933318 |
|
6486 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LCE4A |
0.202723589933318 |
|
6487 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NPY2R |
0.202753028465082 |
|
6488 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CHD9 |
0.202868008285594 |
|
6489 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DIP2B |
0.203051650729726 |
|
6490 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL50P |
0.20308552983132 |
|
6491 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAB12 |
0.20308552983132 |
|
6492 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SOGA2 |
0.20308552983132 |
|
6493 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NDUFV2 |
0.20308552983132 |
|
6494 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANKRD12 |
0.20308552983132 |
|
6495 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRIM33 |
0.203095360145605 |
|
6496 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BCAS2 |
0.203095360145605 |
|
6497 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DENND2C |
0.203095360145605 |
|
6498 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MDFI |
0.203115767482842 |
|
6499 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RBM26 |
0.203411418640926 |
|
6500 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NDFIP2 |
0.203411418640926 |
|
6501 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CYP1B1 |
0.203457142920671 |
|
6502 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATL2 |
0.203457142920671 |
|
6503 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HNRNPLL |
0.203457142920671 |
|
6504 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GALM |
0.203457142920671 |
|
6505 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GEMIN6 |
0.203457142920671 |
|
6506 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SRSF7 |
0.203457142920671 |
|
6507 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NIPSNAP1 |
0.203530546242224 |
|
6508 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR1255B1 |
0.203537714589635 |
|
6509 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NF2 |
0.20356892902028 |
|
6510 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANAPC4 |
0.203576832457384 |
|
6511 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP262 |
0.203594921066207 |
|
6512 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FRMD6 |
0.203682381612617 |
|
6513 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP385 |
0.203682381612617 |
|
6514 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GNG2 |
0.203682381612617 |
|
6515 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CPEB4 |
0.203744015445416 |
|
6516 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C5orf47 |
0.203744015445416 |
|
6517 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NSG2 |
0.203744015445416 |
|
6518 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4634 |
0.203744015445416 |
|
6519 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MSX2 |
0.203744015445416 |
|
6520 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LDLRAD4 |
0.203763822613266 |
|
6521 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
N4BP2 |
0.2037933166377 |
|
6522 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA51|ENSG00000201863.1 |
0.2037933166377 |
|
6523 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RHOH |
0.2037933166377 |
|
6524 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDC42EP3 |
0.203992625919688 |
|
6525 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00211 |
0.203992625919688 |
|
6526 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RMDN2 |
0.203992625919688 |
|
6527 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CAMKMT |
0.204175913355806 |
|
6528 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP182 |
0.204187967670956 |
|
6529 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNU11 |
0.204258159223479 |
|
6530 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GMEB1 |
0.204258159223479 |
|
6531 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCARNA24|ENSG00000252777.1 |
0.204258159223479 |
|
6532 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
YTHDF2 |
0.204258159223479 |
|
6533 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC35E4 |
0.204340270452197 |
|
6534 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DUSP18 |
0.204340270452197 |
|
6535 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3200 |
0.204340270452197 |
|
6536 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR648 |
0.204377262486737 |
|
6537 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC2A5 |
0.204557541104543 |
|
6538 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCARNA16|ENSG00000252404.1 |
0.204557541104543 |
|
6539 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPR157 |
0.204557541104543 |
|
6540 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPL26L1 |
0.204585503531717 |
|
6541 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATP6V0E1 |
0.204585503531717 |
|
6542 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA74B |
0.204585503531717 |
|
6543 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CREBRF |
0.204585503531717 |
|
6544 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BNIP1 |
0.204585503531717 |
|
6545 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP200 |
0.204585503531717 |
|
6546 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STC2 |
0.204585503531717 |
|
6547 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BOD1 |
0.204585503531717 |
|
6548 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TCTN1 |
0.204597434522077 |
|
6549 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HVCN1 |
0.204597434522077 |
|
6550 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EEF1G |
0.204704789923191 |
|
6551 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3654 |
0.204704789923191 |
|
6552 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TUT1 |
0.204704789923191 |
|
6553 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MTA2 |
0.204704789923191 |
|
6554 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EML3 |
0.204704789923191 |
|
6555 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ROM1 |
0.204704789923191 |
|
6556 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
B3GAT3 |
0.204704789923191 |
|
6557 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GANAB |
0.204704789923191 |
|
6558 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RUFY2 |
0.204787124355639 |
|
6559 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DNA2 |
0.204787124355639 |
|
6560 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP319 |
0.204787124355639 |
|
6561 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00849 |
0.204787124355639 |
|
6562 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR52D1 |
0.204943829206326 |
|
6563 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UBQLN3 |
0.204943829206326 |
|
6564 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UBQLNL |
0.204943829206326 |
|
6565 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR52H1 |
0.204943829206326 |
|
6566 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR52B6 |
0.204943829206326 |
|
6567 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNU6ATAC6P |
0.205041946861425 |
|
6568 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PREX1 |
0.20508018682814 |
|
6569 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNY1P8 |
0.205244478100494 |
|
6570 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00392 |
0.205244478100494 |
|
6571 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP263 |
0.205256325021714 |
|
6572 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DCHS2 |
0.205390001446968 |
|
6573 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLRG1 |
0.205390001446968 |
|
6574 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FGB |
0.205390001446968 |
|
6575 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FGA |
0.205390001446968 |
|
6576 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FGG |
0.205390001446968 |
|
6577 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRAT |
0.205390001446968 |
|
6578 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RBM46 |
0.205390001446968 |
|
6579 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPR153 |
0.205473969919008 |
|
6580 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACOT7 |
0.205473969919008 |
|
6581 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HES2 |
0.205473969919008 |
|
6582 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MMP20 |
0.205738989136877 |
|
6583 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MMP27 |
0.205738989136877 |
|
6584 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNX5 |
0.205770154441884 |
|
6585 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD17 |
0.205770154441884 |
|
6586 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MGME1 |
0.205770154441884 |
|
6587 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STYX |
0.20582533912603 |
|
6588 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GNPNAT1 |
0.20582533912603 |
|
6589 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL588P |
0.20582533912603 |
|
6590 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SF3B4 |
0.205875794239333 |
|
6591 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MTMR11 |
0.205875794239333 |
|
6592 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OTUD7B |
0.205875794239333 |
|
6593 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VPS45 |
0.205875794239333 |
|
6594 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLEKHO1 |
0.205875794239333 |
|
6595 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL480P |
0.205875794239333 |
|
6596 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANP32E |
0.205875794239333 |
|
6597 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC22A15 |
0.2060960402374 |
|
6598 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HMBOX1 |
0.206370089873703 |
|
6599 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP260 |
0.206370089873703 |
|
6600 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIF13B |
0.206370089873703 |
|
6601 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL781P |
0.206370089873703 |
|
6602 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF654 |
0.206370818054961 |
|
6603 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C3orf38 |
0.206370818054961 |
|
6604 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DAPL1 |
0.20652176917836 |
|
6605 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
XPNPEP1 |
0.206544793532024 |
|
6606 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U4|ENSG00000272160.1 |
0.206544793532024 |
|
6607 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CEACAM8 |
0.20654680271442 |
|
6608 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SIRT1 |
0.206593197913875 |
|
6609 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ABCG5 |
0.206702915167427 |
|
6610 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ABCG8 |
0.206702915167427 |
|
6611 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRPPRC |
0.206702915167427 |
|
6612 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPM1B |
0.206746448655463 |
|
6613 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000239052.1 |
0.206746448655463 |
|
6614 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC3A1 |
0.206746448655463 |
|
6615 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PREPL |
0.206746448655463 |
|
6616 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANKRD30B |
0.206879053862678 |
|
6617 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL662P |
0.206879053862678 |
|
6618 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ROCK1 |
0.206879053862678 |
|
6619 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SV2A |
0.206884893647821 |
|
6620 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KAL1 |
0.206893069048808 |
|
6621 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VCX3B |
0.206893069048808 |
|
6622 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM9A |
0.206893069048808 |
|
6623 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CEP170 |
0.207212711432955 |
|
6624 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SDCCAG8 |
0.207212711432955 |
|
6625 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4677 |
0.207212711432955 |
|
6626 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZBTB18 |
0.207212711432955 |
|
6627 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL148P |
0.207212711432955 |
|
6628 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C1orf100 |
0.207212711432955 |
|
6629 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADSS |
0.207212711432955 |
|
6630 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IKZF3 |
0.207220591206565 |
|
6631 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRKD3 |
0.207446647868949 |
|
6632 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
QPCT |
0.207446647868949 |
|
6633 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
7SK|ENSG00000260682.2 |
0.20757219139592 |
|
6634 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SDR42E1 |
0.20757219139592 |
|
6635 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HSD17B2 |
0.20757219139592 |
|
6636 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MPHOSPH6 |
0.20757219139592 |
|
6637 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP190 |
0.20757219139592 |
|
6638 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238321.1 |
0.20757219139592 |
|
6639 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDH13 |
0.20757219139592 |
|
6640 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL134P |
0.20757219139592 |
|
6641 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3182 |
0.20757219139592 |
|
6642 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HSBP1 |
0.20757219139592 |
|
6643 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MLYCD |
0.20757219139592 |
|
6644 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OSGIN1 |
0.20757219139592 |
|
6645 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NECAB2 |
0.20757219139592 |
|
6646 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MBTPS1 |
0.20757219139592 |
|
6647 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP432 |
0.20757219139592 |
|
6648 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC38A8 |
0.20757219139592 |
|
6649 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HSDL1 |
0.20757219139592 |
|
6650 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DNAAF1 |
0.20757219139592 |
|
6651 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GOLGA2B |
0.207604745259776 |
|
6652 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL176P |
0.207604745259776 |
|
6653 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACTR6 |
0.207604745259776 |
|
6654 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DEPDC4 |
0.207604745259776 |
|
6655 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL569P |
0.20770933458368 |
|
6656 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BCKDHB |
0.207776838376604 |
|
6657 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TTK |
0.207847923338363 |
|
6658 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MLLT10 |
0.208206735876899 |
|
6659 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DNAJC1 |
0.208206735876899 |
|
6660 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP219 |
0.208206735876899 |
|
6661 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP261 |
0.208218818220955 |
|
6662 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EEF1B2 |
0.208341855159444 |
|
6663 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA41|ENSG00000207406.1 |
0.208341855159444 |
|
6664 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD51|ENSG00000207047.2 |
0.208341855159444 |
|
6665 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPR1 |
0.208341855159444 |
|
6666 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP200 |
0.208343249918931 |
|
6667 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP260 |
0.208343249918931 |
|
6668 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZDBF2 |
0.208343249918931 |
|
6669 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ORC5 |
0.208363016021344 |
|
6670 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DBX2 |
0.208474394799724 |
|
6671 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP361 |
0.208474394799724 |
|
6672 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLEKHA8P1 |
0.208474394799724 |
|
6673 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GAS2L3 |
0.208508977577318 |
|
6674 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LMOD2 |
0.2086812275686 |
|
6675 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WASL |
0.2086812275686 |
|
6676 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC6 |
0.208691409255264 |
|
6677 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C10orf40 |
0.208691409255264 |
|
6678 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EMP1 |
0.208820231482998 |
|
6679 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UBE2D1 |
0.208996898989489 |
|
6680 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TFAM |
0.208996898989489 |
|
6681 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BICC1 |
0.208996898989489 |
|
6682 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP196 |
0.208996898989489 |
|
6683 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00844 |
0.208996898989489 |
|
6684 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM123 |
0.209124774219055 |
|
6685 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNRF3 |
0.20918082856534 |
|
6686 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IBTK |
0.209190376551831 |
|
6687 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TPBG |
0.209190376551831 |
|
6688 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MMP7 |
0.209215212178136 |
|
6689 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MMP26 |
0.209291927733636 |
|
6690 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA62|ENSG00000201980.1 |
0.209291927733636 |
|
6691 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR51F1 |
0.209291927733636 |
|
6692 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR52R1 |
0.209291927733636 |
|
6693 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR51F2 |
0.209291927733636 |
|
6694 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR51S1 |
0.209291927733636 |
|
6695 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR51H1P |
0.209291927733636 |
|
6696 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR51T1 |
0.209291927733636 |
|
6697 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR51A7 |
0.209291927733636 |
|
6698 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR51G2 |
0.209291927733636 |
|
6699 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR51G1 |
0.209291927733636 |
|
6700 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR51A2 |
0.209291927733636 |
|
6701 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR51A4 |
0.209291927733636 |
|
6702 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR51L1 |
0.209291927733636 |
|
6703 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR52J3 |
0.209291927733636 |
|
6704 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR52E2 |
0.209291927733636 |
|
6705 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OSBP2 |
0.209419397647094 |
|
6706 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MTNR1B |
0.209434750412357 |
|
6707 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NOTCH2 |
0.20968813680094 |
|
6708 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAB38 |
0.209816388764636 |
|
6709 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3166 |
0.209816388764636 |
|
6710 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CTSC |
0.209816388764636 |
|
6711 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BCL2L13 |
0.209843497083456 |
|
6712 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000251737.1 |
0.209843497083456 |
|
6713 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL72P |
0.209890763790489 |
|
6714 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C7orf33 |
0.209890763790489 |
|
6715 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNY5 |
0.209890763790489 |
|
6716 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNY1 |
0.209890763790489 |
|
6717 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNY3 |
0.209890763790489 |
|
6718 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNY4 |
0.209890763790489 |
|
6719 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PDIA4 |
0.209890763790489 |
|
6720 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF425 |
0.209890763790489 |
|
6721 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF786 |
0.209890763790489 |
|
6722 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL521P |
0.209890763790489 |
|
6723 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF398 |
0.209890763790489 |
|
6724 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF282 |
0.209890763790489 |
|
6725 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF212 |
0.209890763790489 |
|
6726 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF783 |
0.209890763790489 |
|
6727 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD112|ENSG00000252557.1 |
0.209890763790489 |
|
6728 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF777 |
0.209890763790489 |
|
6729 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF746 |
0.209890763790489 |
|
6730 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00449 |
0.210032268581645 |
|
6731 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TM9SF2 |
0.210032268581645 |
|
6732 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNY3P6 |
0.210032268581645 |
|
6733 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA25|ENSG00000201245.1 |
0.210032268581645 |
|
6734 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238305.1 |
0.210032268581645 |
|
6735 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZIC5 |
0.210032268581645 |
|
6736 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZIC2 |
0.210032268581645 |
|
6737 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00554 |
0.210032268581645 |
|
6738 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CRP |
0.210087006987808 |
|
6739 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DUSP23 |
0.210087006987808 |
|
6740 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FCRL6 |
0.210087006987808 |
|
6741 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CASQ1 |
0.210087006987808 |
|
6742 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PEA15 |
0.210087006987808 |
|
6743 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DCAF8 |
0.210087006987808 |
|
6744 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PAK7 |
0.210385085123586 |
|
6745 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC4A10 |
0.210451451581928 |
|
6746 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FYN |
0.210462194744776 |
|
6747 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LYST |
0.210692413897695 |
|
6748 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR1537 |
0.210692413897695 |
|
6749 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NOL9 |
0.210793598992367 |
|
6750 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TAS1R1 |
0.210793598992367 |
|
6751 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR1251 |
0.211034337443149 |
|
6752 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
JDP2 |
0.211082755229854 |
|
6753 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PAGE4 |
0.211229965650778 |
|
6754 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
USP27X |
0.211229965650778 |
|
6755 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLCN5 |
0.211229965650778 |
|
6756 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR532 |
0.211229965650778 |
|
6757 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR188 |
0.211229965650778 |
|
6758 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR362 |
0.211229965650778 |
|
6759 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR500A |
0.211229965650778 |
|
6760 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR500B |
0.211229965650778 |
|
6761 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR501 |
0.211229965650778 |
|
6762 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR660 |
0.211229965650778 |
|
6763 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR502 |
0.211229965650778 |
|
6764 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NR3C2 |
0.211591455514487 |
|
6765 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NDUFA11 |
0.2118331322871 |
|
6766 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CAPS |
0.2118331322871 |
|
6767 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VMAC |
0.2118331322871 |
|
6768 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SMNDC1 |
0.211870056625615 |
|
6769 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MEGF8 |
0.211999823317693 |
|
6770 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CNFN |
0.211999823317693 |
|
6771 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LIPE |
0.211999823317693 |
|
6772 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CXCL17 |
0.211999823317693 |
|
6773 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CEACAM1 |
0.211999823317693 |
|
6774 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NEUROG3 |
0.212049442014093 |
|
6775 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C10orf35 |
0.212049442014093 |
|
6776 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COL13A1 |
0.212049442014093 |
|
6777 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
H2AFY2 |
0.212049442014093 |
|
6778 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AIFM2 |
0.212049442014093 |
|
6779 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TYSND1 |
0.212049442014093 |
|
6780 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SAR1A |
0.212049442014093 |
|
6781 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPA1 |
0.212049442014093 |
|
6782 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00709 |
0.21220714851315 |
|
6783 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SEC14L6 |
0.212315605761515 |
|
6784 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GAL3ST1 |
0.212315605761515 |
|
6785 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PES1 |
0.212315605761515 |
|
6786 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TCN2 |
0.212315605761515 |
|
6787 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP306 |
0.212483191340783 |
|
6788 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BID |
0.212560109037945 |
|
6789 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00528 |
0.212560109037945 |
|
6790 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM189 |
0.21256102091563 |
|
6791 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNAP25 |
0.212709657857377 |
|
6792 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CHST1 |
0.21281401622158 |
|
6793 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MYO5A |
0.212829281952966 |
|
6794 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNF41 |
0.21298279449756 |
|
6795 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NPFFR1 |
0.212988580351057 |
|
6796 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRRC20 |
0.212988580351057 |
|
6797 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EIF4EBP2 |
0.212988580351057 |
|
6798 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NODAL |
0.212988580351057 |
|
6799 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PTPRK |
0.213006162875983 |
|
6800 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PIK3IP1 |
0.213079722238578 |
|
6801 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP496 |
0.213079722238578 |
|
6802 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RXRG |
0.213218891660628 |
|
6803 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDH18 |
0.21323814837831 |
|
6804 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP205 |
0.213373505903655 |
|
6805 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLX4IP |
0.2135455086101 |
|
6806 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PACS1 |
0.213654846731849 |
|
6807 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZZZ3 |
0.213726423235951 |
|
6808 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
USP33 |
0.213726423235951 |
|
6809 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNF113B |
0.213845162954958 |
|
6810 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP8 |
0.213845162954958 |
|
6811 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00839 |
0.213874577553216 |
|
6812 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF37BP |
0.213874577553216 |
|
6813 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF33B |
0.213874577553216 |
|
6814 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARHGAP6 |
0.213900900330759 |
|
6815 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MSTO1 |
0.213902088052547 |
|
6816 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AMELX |
0.213946620371322 |
|
6817 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR548AX |
0.213946620371322 |
|
6818 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACP6 |
0.214130930068697 |
|
6819 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANKRD20A12P |
0.214130930068697 |
|
6820 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANKRD34A |
0.214130930068697 |
|
6821 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANKRD35 |
0.214130930068697 |
|
6822 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BCL9 |
0.214130930068697 |
|
6823 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BOLA1 |
0.214130930068697 |
|
6824 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CD160 |
0.214130930068697 |
|
6825 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CHD1L |
0.214130930068697 |
|
6826 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM72B |
0.214130930068697 |
|
6827 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM72C |
0.214130930068697 |
|
6828 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM72D |
0.214130930068697 |
|
6829 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FCGR1A |
0.214130930068697 |
|
6830 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FCGR1B |
0.214130930068697 |
|
6831 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FCGR1C |
0.214130930068697 |
|
6832 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FMO5 |
0.214130930068697 |
|
6833 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GJA5 |
0.214130930068697 |
|
6834 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GJA8 |
0.214130930068697 |
|
6835 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GNRHR2 |
0.214130930068697 |
|
6836 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPR89A |
0.214130930068697 |
|
6837 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPR89B |
0.214130930068697 |
|
6838 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPR89C |
0.214130930068697 |
|
6839 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HFE2 |
0.214130930068697 |
|
6840 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HIST2H2AA3 |
0.214130930068697 |
|
6841 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HIST2H2AA4 |
0.214130930068697 |
|
6842 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HIST2H2AB |
0.214130930068697 |
|
6843 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HIST2H2AC |
0.214130930068697 |
|
6844 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HIST2H2BA |
0.214130930068697 |
|
6845 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HIST2H2BE |
0.214130930068697 |
|
6846 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HIST2H2BF |
0.214130930068697 |
|
6847 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HIST2H3A |
0.214130930068697 |
|
6848 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HIST2H3C |
0.214130930068697 |
|
6849 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HIST2H3D |
0.214130930068697 |
|
6850 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HIST2H4A |
0.214130930068697 |
|
6851 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HIST2H4B |
0.214130930068697 |
|
6852 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HYDIN2 |
0.214130930068697 |
|
6853 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ITGA10 |
0.214130930068697 |
|
6854 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00623 |
0.214130930068697 |
|
6855 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00624 |
0.214130930068697 |
|
6856 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LIX1L |
0.214130930068697 |
|
6857 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NBPF10 |
0.214130930068697 |
|
6858 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NBPF11 |
0.214130930068697 |
|
6859 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NBPF12 |
0.214130930068697 |
|
6860 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NBPF14 |
0.214130930068697 |
|
6861 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NBPF15 |
0.214130930068697 |
|
6862 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NBPF16 |
0.214130930068697 |
|
6863 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NBPF20 |
0.214130930068697 |
|
6864 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NBPF24 |
0.214130930068697 |
|
6865 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NBPF8 |
0.214130930068697 |
|
6866 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NBPF9 |
0.214130930068697 |
|
6867 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NOTCH2NL |
0.214130930068697 |
|
6868 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NUDT17 |
0.214130930068697 |
|
6869 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PDE4DIP |
0.214130930068697 |
|
6870 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PDZK1P1 |
0.214130930068697 |
|
6871 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PDZK1 |
0.214130930068697 |
|
6872 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PEX11B |
0.214130930068697 |
|
6873 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PIAS3 |
0.214130930068697 |
|
6874 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
POLR3C |
0.214130930068697 |
|
6875 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
POLR3GL |
0.214130930068697 |
|
6876 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPIAL4A |
0.214130930068697 |
|
6877 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPIAL4B |
0.214130930068697 |
|
6878 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPIAL4C |
0.214130930068697 |
|
6879 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPIAL4D |
0.214130930068697 |
|
6880 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPIAL4G |
0.214130930068697 |
|
6881 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRKAB2 |
0.214130930068697 |
|
6882 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RBM8A |
0.214130930068697 |
|
6883 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP88 |
0.214130930068697 |
|
6884 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL261P |
0.214130930068697 |
|
6885 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP57 |
0.214130930068697 |
|
6886 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP58 |
0.214130930068697 |
|
6887 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP59 |
0.214130930068697 |
|
6888 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNF115 |
0.214130930068697 |
|
6889 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SEC22B |
0.214130930068697 |
|
6890 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SRGAP2B |
0.214130930068697 |
|
6891 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TXNIP |
0.214130930068697 |
|
6892 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MORC2 |
0.214324389309557 |
|
6893 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TUG1 |
0.214324389309557 |
|
6894 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL633P |
0.214324389309557 |
|
6895 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SMTN |
0.214324389309557 |
|
6896 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
INPP5J |
0.214324389309557 |
|
6897 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLA2G3 |
0.214324389309557 |
|
6898 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3928 |
0.214324389309557 |
|
6899 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNF185 |
0.214324389309557 |
|
6900 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LIMK2 |
0.214324389309557 |
|
6901 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DCST2 |
0.214421372004795 |
|
6902 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DCST1 |
0.214421372004795 |
|
6903 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADAM15 |
0.214421372004795 |
|
6904 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EFNA3 |
0.214421372004795 |
|
6905 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EFNA4 |
0.214421372004795 |
|
6906 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EFNA1 |
0.214421372004795 |
|
6907 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DPM3 |
0.214421372004795 |
|
6908 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC50A1 |
0.214421372004795 |
|
6909 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KRTCAP2 |
0.214421372004795 |
|
6910 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRIM46 |
0.214421372004795 |
|
6911 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR92B |
0.214421372004795 |
|
6912 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MUC1 |
0.214421372004795 |
|
6913 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
THBS3 |
0.214421372004795 |
|
6914 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLK2 |
0.214421372004795 |
|
6915 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HCN3 |
0.214421372004795 |
|
6916 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PKLR |
0.214421372004795 |
|
6917 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPFIBP1 |
0.214684488065738 |
|
6918 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HSCB |
0.214974180894415 |
|
6919 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TANC2 |
0.215026362999522 |
|
6920 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238354.1 |
0.215039273253264 |
|
6921 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OPA3 |
0.215192451834288 |
|
6922 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3147 |
0.215854868214686 |
|
6923 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF716 |
0.215854868214686 |
|
6924 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
YAF2 |
0.215922913274126 |
|
6925 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238407.1 |
0.215978078216154 |
|
6926 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IPO5 |
0.215978078216154 |
|
6927 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNU6ATAC22P |
0.216355852902596 |
|
6928 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC134 |
0.216355852902596 |
|
6929 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SREBF2 |
0.216355852902596 |
|
6930 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CENPM |
0.216355852902596 |
|
6931 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00634 |
0.216355852902596 |
|
6932 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR33A |
0.216355852902596 |
|
6933 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR378I |
0.216355852902596 |
|
6934 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SEPT3 |
0.216355852902596 |
|
6935 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SHISA8 |
0.216355852902596 |
|
6936 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TNFRSF13C |
0.216355852902596 |
|
6937 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WBP2NL |
0.216355852902596 |
|
6938 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NAGA |
0.216355852902596 |
|
6939 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM109B |
0.216355852902596 |
|
6940 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238498.1 |
0.216355852902596 |
|
6941 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SMDT1 |
0.216355852902596 |
|
6942 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NDUFA6 |
0.216355852902596 |
|
6943 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CYP2D6 |
0.216355852902596 |
|
6944 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CYP2D7P1 |
0.216355852902596 |
|
6945 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C19orf70 |
0.216383532794641 |
|
6946 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CTBP2 |
0.216496802221613 |
|
6947 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4296 |
0.216496802221613 |
|
6948 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00669 |
0.216546116546462 |
|
6949 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
REP15 |
0.216550357310669 |
|
6950 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MRPS35 |
0.216550357310669 |
|
6951 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MANSC4 |
0.216550357310669 |
|
6952 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KLHL42 |
0.216550357310669 |
|
6953 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP15 |
0.216550357310669 |
|
6954 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C15orf41 |
0.216646302173753 |
|
6955 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CSNK1A1P1 |
0.216646302173753 |
|
6956 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U3|ENSG00000212511.1 |
0.216646302173753 |
|
6957 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MEIS2 |
0.216646302173753 |
|
6958 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMCO5A |
0.216646302173753 |
|
6959 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPRED1 |
0.216646302173753 |
|
6960 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANKS1A |
0.216896773770564 |
|
6961 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNRPC |
0.216896773770564 |
|
6962 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TAF11 |
0.216896773770564 |
|
6963 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UHRF1BP1 |
0.216896773770564 |
|
6964 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ISX |
0.216954203981996 |
|
6965 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00555 |
0.217084396506803 |
|
6966 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TPP2 |
0.217084396506803 |
|
6967 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
METTL21C |
0.217084396506803 |
|
6968 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HBG2 |
0.217518892189593 |
|
6969 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HBE1 |
0.217518892189593 |
|
6970 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARFGEF2 |
0.217665046090901 |
|
6971 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CSE1L |
0.217665046090901 |
|
6972 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STAU1 |
0.217665046090901 |
|
6973 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SYCP2 |
0.217665219628815 |
|
6974 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM217B |
0.217665219628815 |
|
6975 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPP1R3D |
0.217665219628815 |
|
6976 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDH26 |
0.217665219628815 |
|
6977 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C20orf197 |
0.217665219628815 |
|
6978 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CREB3L2 |
0.217773350401242 |
|
6979 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AKR1D1 |
0.217773350401242 |
|
6980 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP223 |
0.217773350401242 |
|
6981 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000239145.1 |
0.217773350401242 |
|
6982 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4468 |
0.217773350401242 |
|
6983 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA51|ENSG00000201465.1 |
0.217773350401242 |
|
6984 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238984.1 |
0.217773350401242 |
|
6985 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRIM24 |
0.217773350401242 |
|
6986 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000239123.1 |
0.217773350401242 |
|
6987 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CYP51A1 |
0.217949444169301 |
|
6988 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRRD1 |
0.217949444169301 |
|
6989 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SYCP1 |
0.218140135894499 |
|
6990 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TSHB |
0.218140135894499 |
|
6991 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TSPAN2 |
0.218140135894499 |
|
6992 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NGF |
0.218140135894499 |
|
6993 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL420P |
0.218140135894499 |
|
6994 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA42|ENSG00000207502.1 |
0.218140135894499 |
|
6995 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VANGL1 |
0.218140135894499 |
|
6996 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CASQ2 |
0.218140135894499 |
|
6997 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANKRD30A |
0.218421865921264 |
|
6998 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP53 |
0.218429758312857 |
|
6999 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SALL1 |
0.218525708189725 |
|
7000 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HNRNPA1P48 |
0.218525708189725 |
|
7001 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP142 |
0.218525708189725 |
|
7002 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C16orf97 |
0.218525708189725 |
|
7003 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00919 |
0.218525708189725 |
|
7004 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC6A15 |
0.218607943217601 |
|
7005 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TEX36 |
0.218659600739249 |
|
7006 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNAPC5 |
0.219175538071661 |
|
7007 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4512 |
0.219175538071661 |
|
7008 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPL4 |
0.219175538071661 |
|
7009 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD18C |
0.219175538071661 |
|
7010 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD16 |
0.219175538071661 |
|
7011 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD18A |
0.219175538071661 |
|
7012 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD18B |
0.219175538071661 |
|
7013 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZWILCH |
0.219175538071661 |
|
7014 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LCTL |
0.219175538071661 |
|
7015 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SMAD6 |
0.219175538071661 |
|
7016 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM66 |
0.219262446487687 |
|
7017 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LEPROTL1 |
0.219262446487687 |
|
7018 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MBOAT4 |
0.219262446487687 |
|
7019 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DCTN6 |
0.219262446487687 |
|
7020 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TUBBP1 |
0.219262446487687 |
|
7021 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RBPMS |
0.219262446487687 |
|
7022 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAP2A |
0.219294826822479 |
|
7023 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NHLH2 |
0.21930244822708 |
|
7024 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BPIFA4P |
0.219357695578557 |
|
7025 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BPIFA3 |
0.219357695578557 |
|
7026 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BPIFA1 |
0.219357695578557 |
|
7027 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP444 |
0.219445379877709 |
|
7028 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LYPLA1 |
0.219684273692299 |
|
7029 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ISPD |
0.219792195117269 |
|
7030 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR1228 |
0.219856791843909 |
|
7031 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DGKI |
0.219857072971593 |
|
7032 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PTPRB |
0.220339805393269 |
|
7033 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U3|ENSG00000212538.1 |
0.220565570974905 |
|
7034 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC35F1 |
0.220567451049306 |
|
7035 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UGGT2 |
0.22057787417428 |
|
7036 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HS6ST3 |
0.22057787417428 |
|
7037 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL164P |
0.22057787417428 |
|
7038 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00359 |
0.22057787417428 |
|
7039 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP7 |
0.22057787417428 |
|
7040 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD112|ENSG00000252154.1 |
0.22057787417428 |
|
7041 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OXGR1 |
0.22057787417428 |
|
7042 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238522.1 |
0.22057787417428 |
|
7043 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C11orf49 |
0.220752086231105 |
|
7044 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARFGAP2 |
0.220752086231105 |
|
7045 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PACSIN3 |
0.220752086231105 |
|
7046 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL772P |
0.220752086231105 |
|
7047 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DDB2 |
0.220752086231105 |
|
7048 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACP2 |
0.220752086231105 |
|
7049 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NR1H3 |
0.220752086231105 |
|
7050 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4487 |
0.220752086231105 |
|
7051 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC39A13 |
0.220752086231105 |
|
7052 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PSMC3 |
0.220752086231105 |
|
7053 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAPSN |
0.220752086231105 |
|
7054 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CELF1 |
0.220752086231105 |
|
7055 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL652P |
0.220752086231105 |
|
7056 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NDUFS3 |
0.220752086231105 |
|
7057 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PTPMT1 |
0.220752086231105 |
|
7058 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KBTBD4 |
0.220752086231105 |
|
7059 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C1QTNF4 |
0.220752086231105 |
|
7060 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM180B |
0.220752086231105 |
|
7061 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MTCH2 |
0.220752086231105 |
|
7062 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLEKHA7 |
0.220885741018196 |
|
7063 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR7E14P |
0.220885741018196 |
|
7064 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP455 |
0.221064275509479 |
|
7065 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LALBA |
0.221398192386362 |
|
7066 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AKR1C7P |
0.221526961673093 |
|
7067 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UCN3 |
0.221526961673093 |
|
7068 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TUBAL3 |
0.221526961673093 |
|
7069 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NET1 |
0.221526961673093 |
|
7070 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CALML5 |
0.221526961673093 |
|
7071 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CALML3 |
0.221526961673093 |
|
7072 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM208B |
0.221526961673093 |
|
7073 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GDI2 |
0.221526961673093 |
|
7074 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANKRD16 |
0.221526961673093 |
|
7075 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IL15RA |
0.221526961673093 |
|
7076 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IL2RA |
0.221526961673093 |
|
7077 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA14 |
0.221526961673093 |
|
7078 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238371.1 |
0.221594189567221 |
|
7079 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCNT1 |
0.221637934572628 |
|
7080 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00935 |
0.221637934572628 |
|
7081 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADCY6 |
0.221637934572628 |
|
7082 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4701 |
0.221637934572628 |
|
7083 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARF3 |
0.221637934572628 |
|
7084 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC65 |
0.221637934572628 |
|
7085 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FKBP11 |
0.221637934572628 |
|
7086 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238395.1 |
0.221637934572628 |
|
7087 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WNT10B |
0.221637934572628 |
|
7088 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WNT1 |
0.221637934572628 |
|
7089 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DDN |
0.221637934572628 |
|
7090 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRKAG1 |
0.221637934572628 |
|
7091 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KMT2D |
0.221637934572628 |
|
7092 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RHEBL1 |
0.221637934572628 |
|
7093 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DHH |
0.221637934572628 |
|
7094 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LMBR1L |
0.221637934572628 |
|
7095 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC22A18AS |
0.221836407311036 |
|
7096 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC22A18 |
0.221836407311036 |
|
7097 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PHLDA2 |
0.221836407311036 |
|
7098 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NAP1L4 |
0.221836407311036 |
|
7099 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA54 |
0.221836407311036 |
|
7100 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PSMD14 |
0.221990945000044 |
|
7101 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TBR1 |
0.221990945000044 |
|
7102 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238570.1 |
0.221990945000044 |
|
7103 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPRC5A |
0.22199280679953 |
|
7104 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPRC5D |
0.22199280679953 |
|
7105 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GSG1 |
0.22199280679953 |
|
7106 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HEBP1 |
0.22199280679953 |
|
7107 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HTR7P1 |
0.22199280679953 |
|
7108 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIAA1467 |
0.22199280679953 |
|
7109 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR614 |
0.22199280679953 |
|
7110 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD88 |
0.22199280679953 |
|
7111 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CELF4 |
0.222147182341878 |
|
7112 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4318 |
0.222147182341878 |
|
7113 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP20 |
0.222172771079464 |
|
7114 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL370P |
0.222172771079464 |
|
7115 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM73A |
0.222172771079464 |
|
7116 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP21 |
0.222172771079464 |
|
7117 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NEXN |
0.222172771079464 |
|
7118 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FUBP1 |
0.222172771079464 |
|
7119 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DNAJB4 |
0.222172771079464 |
|
7120 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GIPC2 |
0.222172771079464 |
|
7121 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP22 |
0.222172771079464 |
|
7122 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C2orf91 |
0.222240995734498 |
|
7123 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PKDCC |
0.222240995734498 |
|
7124 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EML4 |
0.222240995734498 |
|
7125 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HCCS |
0.222309977579104 |
|
7126 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SERPINH1 |
0.222560743486458 |
|
7127 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAP6 |
0.222560743486458 |
|
7128 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MOGAT2 |
0.222560743486458 |
|
7129 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FBXO18 |
0.222609171542233 |
|
7130 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PMPCB |
0.222651703880816 |
|
7131 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DNAJC2 |
0.222651703880816 |
|
7132 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OVOL2 |
0.222671296183016 |
|
7133 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
XRCC6 |
0.22295434715479 |
|
7134 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NHP2L1 |
0.22295434715479 |
|
7135 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C22orf46 |
0.22295434715479 |
|
7136 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MEI1 |
0.22295434715479 |
|
7137 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPP1CC |
0.223221918205726 |
|
7138 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLEKHG5 |
0.223509506055825 |
|
7139 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TNFRSF25 |
0.223509506055825 |
|
7140 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BRD2 |
0.22355108208688 |
|
7141 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC178 |
0.223574249146034 |
|
7142 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CD109 |
0.223614452853171 |
|
7143 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DHCR7 |
0.223662302960225 |
|
7144 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NADSYN1 |
0.223662302960225 |
|
7145 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UNC93B6 |
0.223662302960225 |
|
7146 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ENPP7P8 |
0.223662302960225 |
|
7147 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM86C1 |
0.223662302960225 |
|
7148 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF705E |
0.223662302960225 |
|
7149 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DEFB108B |
0.223662302960225 |
|
7150 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP342 |
0.223662302960225 |
|
7151 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNF121 |
0.223662302960225 |
|
7152 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IL18BP |
0.223662302960225 |
|
7153 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CHST10 |
0.223680063989436 |
|
7154 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NDUFS1 |
0.223735694649359 |
|
7155 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPATA2 |
0.223808065364971 |
|
7156 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNF114 |
0.223808065364971 |
|
7157 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000239157.1 |
0.223808065364971 |
|
7158 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNAI1 |
0.223808065364971 |
|
7159 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00651 |
0.223808065364971 |
|
7160 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UBE2V1 |
0.223808065364971 |
|
7161 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ITGAV |
0.22395621749234 |
|
7162 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR5H14 |
0.223977409448589 |
|
7163 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR5H15 |
0.223977409448589 |
|
7164 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR5H6 |
0.223977409448589 |
|
7165 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR5H2 |
0.223977409448589 |
|
7166 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR5H8P |
0.223977409448589 |
|
7167 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATP6V1E1 |
0.224120166813263 |
|
7168 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNU4ATAC14P |
0.22429097559704 |
|
7169 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WDR16 |
0.224604176755119 |
|
7170 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
USP43 |
0.224604176755119 |
|
7171 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DHRS7C |
0.224604176755119 |
|
7172 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP447 |
0.224714886770352 |
|
7173 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA8|ENSG00000207410.1 |
0.224714886770352 |
|
7174 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PSMD12 |
0.224714886770352 |
|
7175 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238612.1 |
0.224714886770352 |
|
7176 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DTX1 |
0.224841899582974 |
|
7177 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RASAL1 |
0.224841899582974 |
|
7178 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC42B |
0.224841899582974 |
|
7179 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DDX54 |
0.224841899582974 |
|
7180 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C12orf52 |
0.224841899582974 |
|
7181 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IQCD |
0.224841899582974 |
|
7182 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TPCN1 |
0.224841899582974 |
|
7183 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COX7A2L |
0.224921895794603 |
|
7184 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCNG3 |
0.224921895794603 |
|
7185 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD75|ENSG00000221300.1 |
0.224921895794603 |
|
7186 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoZ247 |
0.225011538774122 |
|
7187 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCNN4 |
0.225151556012659 |
|
7188 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LYPD5 |
0.225151556012659 |
|
7189 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF283 |
0.225151556012659 |
|
7190 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF404 |
0.225151556012659 |
|
7191 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF45 |
0.225151556012659 |
|
7192 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WWOX |
0.225162410641533 |
|
7193 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MINA |
0.225328734732165 |
|
7194 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GABRR3 |
0.225328734732165 |
|
7195 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR5AC1 |
0.225328734732165 |
|
7196 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR5AC2 |
0.225328734732165 |
|
7197 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR5H1 |
0.225328734732165 |
|
7198 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LUCAT1 |
0.225493721028954 |
|
7199 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NIM1 |
0.225614901382859 |
|
7200 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HMGCS1 |
0.225614901382859 |
|
7201 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COL28A1 |
0.225732916619363 |
|
7202 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIOS |
0.225732916619363 |
|
7203 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPA3 |
0.225732916619363 |
|
7204 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BATF |
0.225807497978925 |
|
7205 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FLVCR2 |
0.225807497978925 |
|
7206 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU83B |
0.225816557062487 |
|
7207 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPFIA1 |
0.225991554170208 |
|
7208 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PUS7L |
0.226002240557959 |
|
7209 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLCB4 |
0.226144832919286 |
|
7210 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TCP11 |
0.226175049379604 |
|
7211 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GXYLT1 |
0.226240577906413 |
|
7212 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ERRFI1 |
0.226282628774805 |
|
7213 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RELN |
0.226311176946397 |
|
7214 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SYT6 |
0.226341376089611 |
|
7215 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TUBA1B |
0.226502801763097 |
|
7216 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TUBA1A |
0.226502801763097 |
|
7217 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TUBA1C |
0.226502801763097 |
|
7218 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRPH |
0.226502801763097 |
|
7219 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C1QL4 |
0.226502801763097 |
|
7220 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TROAP |
0.226502801763097 |
|
7221 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DNAJC22 |
0.226502801763097 |
|
7222 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPATS2 |
0.226502801763097 |
|
7223 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCNH3 |
0.226502801763097 |
|
7224 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MCRS1 |
0.226502801763097 |
|
7225 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRPF40B |
0.226502801763097 |
|
7226 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM186B |
0.226502801763097 |
|
7227 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FMNL3 |
0.226502801763097 |
|
7228 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMBIM6 |
0.226502801763097 |
|
7229 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NCKAP5L |
0.226502801763097 |
|
7230 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BCDIN3D |
0.226502801763097 |
|
7231 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAIM2 |
0.226502801763097 |
|
7232 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AQP2 |
0.226502801763097 |
|
7233 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AQP5 |
0.226502801763097 |
|
7234 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AQP6 |
0.226502801763097 |
|
7235 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LIMA1 |
0.226502801763097 |
|
7236 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR1293 |
0.226502801763097 |
|
7237 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM186A |
0.226502801763097 |
|
7238 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LARP4 |
0.226502801763097 |
|
7239 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SMLR1 |
0.226793357239097 |
|
7240 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRIQK |
0.226850780352863 |
|
7241 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C6orf52 |
0.226876528204894 |
|
7242 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GCNT6 |
0.226876528204894 |
|
7243 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PAK1IP1 |
0.226876528204894 |
|
7244 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM14C |
0.226876528204894 |
|
7245 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP203 |
0.226876528204894 |
|
7246 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANKRD32 |
0.226954984096555 |
|
7247 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPL36 |
0.226978873317381 |
|
7248 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HSD11B1L |
0.226978873317381 |
|
7249 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DUS3L |
0.226978873317381 |
|
7250 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRR22 |
0.226978873317381 |
|
7251 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NRTN |
0.226978873317381 |
|
7252 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FUT3 |
0.226978873317381 |
|
7253 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FUT5 |
0.226978873317381 |
|
7254 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FUT6 |
0.226978873317381 |
|
7255 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANO6 |
0.227134391080299 |
|
7256 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
S100A16 |
0.227159545127788 |
|
7257 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CHAF1A |
0.227382577504146 |
|
7258 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C19orf10 |
0.227382577504146 |
|
7259 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HDGFRP2 |
0.227382577504146 |
|
7260 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRG1 |
0.227382577504146 |
|
7261 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4746 |
0.227382577504146 |
|
7262 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLIN4 |
0.227382577504146 |
|
7263 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLIN5 |
0.227382577504146 |
|
7264 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL121P |
0.227382577504146 |
|
7265 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL528P |
0.227382577504146 |
|
7266 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SEMA6B |
0.227382577504146 |
|
7267 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TNFAIP8L1 |
0.227382577504146 |
|
7268 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UBXN6 |
0.227382577504146 |
|
7269 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ICA1 |
0.227439053053265 |
|
7270 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NXPH1 |
0.227439053053265 |
|
7271 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLAMF6 |
0.227525790332257 |
|
7272 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF728 |
0.227560627222483 |
|
7273 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C22orf24 |
0.227561370874253 |
|
7274 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OARD1 |
0.227777604932644 |
|
7275 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UNC5CL |
0.227777604932644 |
|
7276 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TSPO2 |
0.227777604932644 |
|
7277 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
APOBEC2 |
0.227777604932644 |
|
7278 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NFYA |
0.227777604932644 |
|
7279 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADCY10P1 |
0.227777604932644 |
|
7280 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TREML1 |
0.227777604932644 |
|
7281 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TREM2 |
0.227777604932644 |
|
7282 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TREML2 |
0.227777604932644 |
|
7283 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TREML3P |
0.227777604932644 |
|
7284 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TREML4 |
0.227777604932644 |
|
7285 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP207 |
0.227777604932644 |
|
7286 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TREM1 |
0.227777604932644 |
|
7287 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NCR2 |
0.227777604932644 |
|
7288 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HCG24 |
0.227780109486608 |
|
7289 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PIGK |
0.227892150195089 |
|
7290 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CEP57L1 |
0.228088961049224 |
|
7291 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
YLPM1 |
0.2281704672419 |
|
7292 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PROX2 |
0.2281704672419 |
|
7293 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DLST |
0.2281704672419 |
|
7294 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPS6KL1 |
0.2281704672419 |
|
7295 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NDUFA4 |
0.228331947236733 |
|
7296 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RFC5 |
0.228478465749737 |
|
7297 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NABP2 |
0.228538785130238 |
|
7298 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL162P |
0.228659596575687 |
|
7299 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CHEK2 |
0.228659596575687 |
|
7300 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HSP90B1 |
0.228711523086763 |
|
7301 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C12orf73 |
0.228711523086763 |
|
7302 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TDG |
0.228711523086763 |
|
7303 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GLT8D2 |
0.228711523086763 |
|
7304 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EID3 |
0.228711523086763 |
|
7305 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZFAND4 |
0.228731310428503 |
|
7306 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AGAP10 |
0.228731310428503 |
|
7307 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AGAP4 |
0.228731310428503 |
|
7308 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AGAP9 |
0.228731310428503 |
|
7309 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANTXRLP1 |
0.228731310428503 |
|
7310 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANTXRL |
0.228731310428503 |
|
7311 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANXA8L1 |
0.228731310428503 |
|
7312 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANXA8L2 |
0.228731310428503 |
|
7313 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANXA8 |
0.228731310428503 |
|
7314 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ASAH2C |
0.228731310428503 |
|
7315 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BMS1P1 |
0.228731310428503 |
|
7316 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BMS1P2 |
0.228731310428503 |
|
7317 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C10orf43 |
0.228731310428503 |
|
7318 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM21B |
0.228731310428503 |
|
7319 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM21C |
0.228731310428503 |
|
7320 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM25B |
0.228731310428503 |
|
7321 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM25E |
0.228731310428503 |
|
7322 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM25G |
0.228731310428503 |
|
7323 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM35BP |
0.228731310428503 |
|
7324 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPRIN2 |
0.228731310428503 |
|
7325 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00842 |
0.228731310428503 |
|
7326 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NPY4R |
0.228731310428503 |
|
7327 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PTPN20A |
0.228731310428503 |
|
7328 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RBP3 |
0.228731310428503 |
|
7329 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL248P |
0.228731310428503 |
|
7330 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL453P |
0.228731310428503 |
|
7331 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP310 |
0.228731310428503 |
|
7332 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP311 |
0.228731310428503 |
|
7333 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP312 |
0.228731310428503 |
|
7334 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP313 |
0.228731310428503 |
|
7335 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SYT15 |
0.228731310428503 |
|
7336 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF488 |
0.228731310428503 |
|
7337 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SEC61G |
0.229000509896503 |
|
7338 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FOXP4 |
0.229109180220245 |
|
7339 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4641 |
0.229109180220245 |
|
7340 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TBC1D4 |
0.229155567159403 |
|
7341 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COMMD6 |
0.229155567159403 |
|
7342 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UCHL3 |
0.229155567159403 |
|
7343 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LMO7 |
0.229155567159403 |
|
7344 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C13orf45 |
0.229155567159403 |
|
7345 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00561 |
0.229155567159403 |
|
7346 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL571P |
0.229155567159403 |
|
7347 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCTD12 |
0.229155567159403 |
|
7348 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IRG1 |
0.229155567159403 |
|
7349 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLN5 |
0.229155567159403 |
|
7350 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FBXL3 |
0.229155567159403 |
|
7351 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MYCBP2 |
0.229155567159403 |
|
7352 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IPMK |
0.229304095844982 |
|
7353 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238970.1 |
0.229304095844982 |
|
7354 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CISD1 |
0.229304095844982 |
|
7355 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PITPNC1 |
0.229448444861589 |
|
7356 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HNRNPA1P57 |
0.229681380115998 |
|
7357 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HADHB |
0.229826699791058 |
|
7358 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EPT1 |
0.229826699791058 |
|
7359 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPR113 |
0.229826699791058 |
|
7360 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DRC1 |
0.229826699791058 |
|
7361 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OTOF |
0.229826699791058 |
|
7362 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCGB3A1 |
0.23076062601036 |
|
7363 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM184B |
0.23081411596505 |
|
7364 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MKKS |
0.231160734961936 |
|
7365 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LONP1 |
0.231170566076255 |
|
7366 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CATSPERD |
0.231170566076255 |
|
7367 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AKR1C4 |
0.231180881296121 |
|
7368 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U8|ENSG00000251909.1 |
0.231180881296121 |
|
7369 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CACNB3 |
0.231186553959665 |
|
7370 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DDX23 |
0.231186553959665 |
|
7371 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RND1 |
0.231186553959665 |
|
7372 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP399 |
0.23120496003477 |
|
7373 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDKN1A |
0.231353036183697 |
|
7374 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAB44 |
0.231353036183697 |
|
7375 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00393 |
0.231384317471316 |
|
7376 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KLF12 |
0.231384317471316 |
|
7377 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GATAD1 |
0.231507860297942 |
|
7378 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PEX1 |
0.231507860297942 |
|
7379 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RBM48 |
0.231507860297942 |
|
7380 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PGAP2 |
0.231532742043536 |
|
7381 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WDR72 |
0.231746990722709 |
|
7382 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPS4XP16 |
0.231928691017017 |
|
7383 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL320P |
0.231928691017017 |
|
7384 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CTDSPL2 |
0.232109022816002 |
|
7385 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL347P |
0.232109022816002 |
|
7386 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EIF3J |
0.232109022816002 |
|
7387 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPG11 |
0.232109022816002 |
|
7388 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PATL2 |
0.232109022816002 |
|
7389 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ELK3 |
0.232138107343106 |
|
7390 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00557 |
0.232366668888936 |
|
7391 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FIP1L1 |
0.23242735805402 |
|
7392 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLBD2 |
0.232578673786411 |
|
7393 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SDS |
0.232578673786411 |
|
7394 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SDSL |
0.232578673786411 |
|
7395 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LHX5 |
0.232578673786411 |
|
7396 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TTC28 |
0.232613275639907 |
|
7397 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FLT4 |
0.232753447954317 |
|
7398 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MGAT1 |
0.232753447954317 |
|
7399 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR2Y1 |
0.232753447954317 |
|
7400 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARSK |
0.232960547128258 |
|
7401 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPR150 |
0.232960547128258 |
|
7402 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RFESD |
0.232960547128258 |
|
7403 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPATA9 |
0.232960547128258 |
|
7404 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RHOBTB3 |
0.232960547128258 |
|
7405 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GLRX |
0.232960547128258 |
|
7406 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C5orf27 |
0.232960547128258 |
|
7407 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ELL2 |
0.232960547128258 |
|
7408 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR583 |
0.232960547128258 |
|
7409 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FDX1 |
0.2330087248504 |
|
7410 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARHGAP20 |
0.2330087248504 |
|
7411 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNY3P8 |
0.233078537952764 |
|
7412 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNY4P27 |
0.233078537952764 |
|
7413 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLDN10 |
0.233078537952764 |
|
7414 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LAPTM4A |
0.233157020421053 |
|
7415 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA18|ENSG00000252601.1 |
0.233273072382391 |
|
7416 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL602P |
0.233307339243359 |
|
7417 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
YWHAH |
0.23371792712275 |
|
7418 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238910.1 |
0.23371792712275 |
|
7419 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL305P |
0.23371792712275 |
|
7420 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC5A1 |
0.23371792712275 |
|
7421 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL607P |
0.233721999056886 |
|
7422 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HEXA |
0.233881506208843 |
|
7423 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
S100A14 |
0.233969041512954 |
|
7424 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
S100A13 |
0.233969041512954 |
|
7425 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
S100A1 |
0.233969041512954 |
|
7426 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CHTOP |
0.233969041512954 |
|
7427 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR51I2 |
0.23430123981648 |
|
7428 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NOL11 |
0.234427159940149 |
|
7429 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA38B |
0.234427159940149 |
|
7430 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00674 |
0.234427159940149 |
|
7431 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRRC37A16P |
0.234427159940149 |
|
7432 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SMG9 |
0.234525453266646 |
|
7433 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PHYHIPL |
0.234535507462203 |
|
7434 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C1GALT1 |
0.234536777534799 |
|
7435 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FOXN3 |
0.234785144754552 |
|
7436 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP107 |
0.234785144754552 |
|
7437 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP255 |
0.234785144754552 |
|
7438 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EFCAB11 |
0.234785144754552 |
|
7439 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM200B |
0.234862063421054 |
|
7440 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SRSF4 |
0.234862063421054 |
|
7441 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MECR |
0.234862063421054 |
|
7442 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM220A |
0.234916147316128 |
|
7443 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GRID2IP |
0.234916147316128 |
|
7444 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZDHHC4 |
0.234916147316128 |
|
7445 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C7orf26 |
0.234916147316128 |
|
7446 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF853 |
0.234916147316128 |
|
7447 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF12 |
0.234916147316128 |
|
7448 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR2AE1 |
0.235144626735676 |
|
7449 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRIM4 |
0.235144626735676 |
|
7450 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GJC3 |
0.235144626735676 |
|
7451 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA40|ENSG00000222966.1 |
0.235144626735676 |
|
7452 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AZGP1 |
0.235144626735676 |
|
7453 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ASCC2 |
0.235223454586699 |
|
7454 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA31|ENSG00000251858.1 |
0.235268609403996 |
|
7455 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCEL |
0.235272340430452 |
|
7456 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNY3P7 |
0.235272340430452 |
|
7457 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3665 |
0.235272340430452 |
|
7458 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLAIN1 |
0.235272340430452 |
|
7459 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EDNRB |
0.235272340430452 |
|
7460 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL810P |
0.235272340430452 |
|
7461 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00446 |
0.235272340430452 |
|
7462 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00311 |
0.23536404426083 |
|
7463 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR5093 |
0.23536404426083 |
|
7464 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GSE1 |
0.23536404426083 |
|
7465 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDK5RAP2 |
0.235382612027498 |
|
7466 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DZIP1 |
0.23552226651033 |
|
7467 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DNAJC3 |
0.23552226651033 |
|
7468 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snR65|ENSG00000251901.1 |
0.23552226651033 |
|
7469 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00948 |
0.235766969557881 |
|
7470 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CSDE1 |
0.235788146233886 |
|
7471 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SENP8 |
0.235921302897275 |
|
7472 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TBX5 |
0.235921785122933 |
|
7473 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP216 |
0.235921785122933 |
|
7474 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM45A |
0.236000547375405 |
|
7475 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ESCO1 |
0.236036110760427 |
|
7476 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ABCC4 |
0.236189953740578 |
|
7477 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM13C |
0.236355125371068 |
|
7478 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCAT2 |
0.236390347446576 |
|
7479 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCAT1 |
0.236390347446576 |
|
7480 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MBNL2 |
0.236635017087848 |
|
7481 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP37 |
0.236635017087848 |
|
7482 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
YAP1 |
0.236671011423396 |
|
7483 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BIRC2 |
0.236671011423396 |
|
7484 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BIRC3 |
0.236671011423396 |
|
7485 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00922 |
0.236708537185033 |
|
7486 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MXI1 |
0.236816108207841 |
|
7487 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EIF2AK2 |
0.23682926083719 |
|
7488 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM153A |
0.236966344132549 |
|
7489 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PROP1 |
0.236966344132549 |
|
7490 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM153C |
0.236966344132549 |
|
7491 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP384 |
0.237066784146317 |
|
7492 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPS29 |
0.237066784146317 |
|
7493 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL1 |
0.237066784146317 |
|
7494 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRR1 |
0.237066784146317 |
|
7495 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MGAT2 |
0.237066784146317 |
|
7496 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPL36AL |
0.237066784146317 |
|
7497 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DNAAF2 |
0.237066784146317 |
|
7498 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
POLE2 |
0.237066784146317 |
|
7499 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNU6ATAC30P |
0.237066784146317 |
|
7500 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VDR |
0.23728736247378 |
|
7501 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM106C |
0.23728736247378 |
|
7502 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF879 |
0.237298937607684 |
|
7503 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF354C |
0.237298937607684 |
|
7504 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD37|ENSG00000212377.1 |
0.237395079813155 |
|
7505 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA68|ENSG00000251715.1 |
0.237395079813155 |
|
7506 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PTGIS |
0.237482713535691 |
|
7507 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
B4GALT5 |
0.237482713535691 |
|
7508 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC16A9 |
0.237497287130332 |
|
7509 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARIH1 |
0.237502430837564 |
|
7510 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DDX27 |
0.237530857106816 |
|
7511 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNFX1 |
0.237530857106816 |
|
7512 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD12B |
0.237530857106816 |
|
7513 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD12C |
0.237530857106816 |
|
7514 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD12 |
0.237530857106816 |
|
7515 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZFAS1 |
0.237530857106816 |
|
7516 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCNB1 |
0.237530857106816 |
|
7517 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDC42BPG |
0.237740353185869 |
|
7518 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AP5B1 |
0.237740353185869 |
|
7519 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARL2 |
0.237740353185869 |
|
7520 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATG2A |
0.237740353185869 |
|
7521 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BATF2 |
0.237740353185869 |
|
7522 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C11orf85 |
0.237740353185869 |
|
7523 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CAPN1 |
0.237740353185869 |
|
7524 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC85B |
0.237740353185869 |
|
7525 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDC42EP2 |
0.237740353185869 |
|
7526 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDCA5 |
0.237740353185869 |
|
7527 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CFL1 |
0.237740353185869 |
|
7528 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CTSW |
0.237740353185869 |
|
7529 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DPF2 |
0.237740353185869 |
|
7530 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EFEMP2 |
0.237740353185869 |
|
7531 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EHBP1L1 |
0.237740353185869 |
|
7532 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EHD1 |
0.237740353185869 |
|
7533 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM89B |
0.237740353185869 |
|
7534 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAU |
0.237740353185869 |
|
7535 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FIBP |
0.237740353185869 |
|
7536 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FOSL1 |
0.237740353185869 |
|
7537 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FRMD8 |
0.237740353185869 |
|
7538 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPHA2 |
0.237740353185869 |
|
7539 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KAT5 |
0.237740353185869 |
|
7540 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCNK7 |
0.237740353185869 |
|
7541 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LTBP3 |
0.237740353185869 |
|
7542 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MALAT1 |
0.237740353185869 |
|
7543 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAP3K11 |
0.237740353185869 |
|
7544 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR192 |
0.237740353185869 |
|
7545 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4489 |
0.237740353185869 |
|
7546 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4690 |
0.237740353185869 |
|
7547 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MRPL49 |
0.237740353185869 |
|
7548 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MUS81 |
0.237740353185869 |
|
7549 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NAALADL1 |
0.237740353185869 |
|
7550 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NEAT1 |
0.237740353185869 |
|
7551 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OVOL1 |
0.237740353185869 |
|
7552 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCNXL3 |
0.237740353185869 |
|
7553 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
POLA2 |
0.237740353185869 |
|
7554 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPP2R5B |
0.237740353185869 |
|
7555 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RELA |
0.237740353185869 |
|
7556 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL114P |
0.237740353185869 |
|
7557 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL309P |
0.237740353185869 |
|
7558 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNASEH2C |
0.237740353185869 |
|
7559 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SAC3D1 |
0.237740353185869 |
|
7560 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCYL1 |
0.237740353185869 |
|
7561 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SIPA1 |
0.237740353185869 |
|
7562 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC22A20 |
0.237740353185869 |
|
7563 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC25A45 |
0.237740353185869 |
|
7564 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNX15 |
0.237740353185869 |
|
7565 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNX32 |
0.237740353185869 |
|
7566 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPDYC |
0.237740353185869 |
|
7567 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SSSCA1 |
0.237740353185869 |
|
7568 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SYVN1 |
0.237740353185869 |
|
7569 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TIGD3 |
0.237740353185869 |
|
7570 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TM7SF2 |
0.237740353185869 |
|
7571 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VPS51 |
0.237740353185869 |
|
7572 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZFPL1 |
0.237740353185869 |
|
7573 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNHIT2 |
0.237740353185869 |
|
7574 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RXFP3 |
0.238016021581381 |
|
7575 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAPRE2 |
0.23823737665118 |
|
7576 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF397 |
0.23823737665118 |
|
7577 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZSCAN30 |
0.23823737665118 |
|
7578 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF271 |
0.23823737665118 |
|
7579 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF24 |
0.23823737665118 |
|
7580 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF396 |
0.23823737665118 |
|
7581 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ALOX12P2 |
0.238249532303473 |
|
7582 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ALOX12 |
0.238249532303473 |
|
7583 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C17orf49 |
0.238249532303473 |
|
7584 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR497HG |
0.238249532303473 |
|
7585 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNASEK |
0.238249532303473 |
|
7586 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BCL6B |
0.238249532303473 |
|
7587 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC16A11 |
0.238249532303473 |
|
7588 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC16A13 |
0.238249532303473 |
|
7589 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL200P |
0.238277048789423 |
|
7590 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000239059.1 |
0.238277048789423 |
|
7591 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238484.1 |
0.238277048789423 |
|
7592 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF221 |
0.238481487978917 |
|
7593 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DNAJC12 |
0.238529718141311 |
|
7594 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL394P |
0.238529718141311 |
|
7595 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRKAG2 |
0.238552884262979 |
|
7596 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GALNTL5 |
0.238552884262979 |
|
7597 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SIAE |
0.239400180385819 |
|
7598 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPA17 |
0.239400180385819 |
|
7599 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NRGN |
0.239400180385819 |
|
7600 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VSIG2 |
0.239400180385819 |
|
7601 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ESAM |
0.239400180385819 |
|
7602 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MSANTD2 |
0.239400180385819 |
|
7603 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CD84 |
0.239492961517878 |
|
7604 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLAMF1 |
0.239492961517878 |
|
7605 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CD48 |
0.239492961517878 |
|
7606 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLAMF7 |
0.239492961517878 |
|
7607 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LY9 |
0.239492961517878 |
|
7608 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CD244 |
0.239492961517878 |
|
7609 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ITLN1 |
0.239492961517878 |
|
7610 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAF3IP2 |
0.239538742972309 |
|
7611 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C6orf3 |
0.239538742972309 |
|
7612 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DHODH |
0.239637420822892 |
|
7613 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TXNL4B |
0.239637420822892 |
|
7614 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HPR |
0.239637420822892 |
|
7615 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HP |
0.239637420822892 |
|
7616 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DHX38 |
0.239637420822892 |
|
7617 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PMFBP1 |
0.239637420822892 |
|
7618 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CSNK2A1 |
0.239682716619514 |
|
7619 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR548AD |
0.239756522609009 |
|
7620 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PKD1L3 |
0.239785500478573 |
|
7621 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPS6KA1 |
0.239823471023151 |
|
7622 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR1976 |
0.239823471023151 |
|
7623 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL679P |
0.239823471023151 |
|
7624 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP64 |
0.239871454861389 |
|
7625 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM78B |
0.239871454861389 |
|
7626 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL387P |
0.240047383309596 |
|
7627 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DIP2C |
0.240104623094171 |
|
7628 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TSPAN8 |
0.240128014237024 |
|
7629 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DACH1 |
0.240198960959868 |
|
7630 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FRK |
0.240242966285479 |
|
7631 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NT5DC1 |
0.240242966285479 |
|
7632 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COL10A1 |
0.240242966285479 |
|
7633 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPR158 |
0.240394060494063 |
|
7634 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPDEF |
0.240514973727152 |
|
7635 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C6orf106 |
0.240514973727152 |
|
7636 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HARBI1 |
0.240797469497142 |
|
7637 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATG13 |
0.240797469497142 |
|
7638 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARHGAP1 |
0.240797469497142 |
|
7639 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF408 |
0.240797469497142 |
|
7640 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
F2 |
0.240797469497142 |
|
7641 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CKAP5 |
0.240797469497142 |
|
7642 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR5582 |
0.240797469497142 |
|
7643 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD67|ENSG00000252427.1 |
0.240797469497142 |
|
7644 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD67|ENSG00000212135.1 |
0.240797469497142 |
|
7645 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SEPP1 |
0.24084709105667 |
|
7646 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANXA2R |
0.24084709105667 |
|
7647 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF131 |
0.24084709105667 |
|
7648 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C11orf68 |
0.240870009549441 |
|
7649 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DRAP1 |
0.240870009549441 |
|
7650 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TSGA10IP |
0.240870009549441 |
|
7651 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SART1 |
0.240870009549441 |
|
7652 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EIF1AD |
0.240870009549441 |
|
7653 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BANF1 |
0.240870009549441 |
|
7654 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CST6 |
0.240870009549441 |
|
7655 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CATSPER1 |
0.240870009549441 |
|
7656 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GAL3ST3 |
0.240870009549441 |
|
7657 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SF3B2 |
0.240870009549441 |
|
7658 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238752.1 |
0.240870009549441 |
|
7659 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BPIFB1 |
0.241115945077148 |
|
7660 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDK5RAP1 |
0.241115945077148 |
|
7661 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNTA1 |
0.241115945077148 |
|
7662 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL511P |
0.241115945077148 |
|
7663 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SUPT3H |
0.241146990536523 |
|
7664 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RUNX2 |
0.241146990536523 |
|
7665 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RASGEF1C |
0.241320430753656 |
|
7666 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAPK9 |
0.241320430753656 |
|
7667 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GFPT2 |
0.241320430753656 |
|
7668 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAGI3 |
0.241356013446569 |
|
7669 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SEMA6D |
0.241381956587411 |
|
7670 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MBIP |
0.241426479570389 |
|
7671 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DPPA3P2 |
0.241426479570389 |
|
7672 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SFTA3 |
0.241426479570389 |
|
7673 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP257 |
0.241426479570389 |
|
7674 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PAX9 |
0.241426479570389 |
|
7675 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HSP90AB2P |
0.241504326607184 |
|
7676 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR5K4 |
0.241522123006412 |
|
7677 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR5K3 |
0.241522123006412 |
|
7678 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR5K1 |
0.241522123006412 |
|
7679 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLDND1 |
0.241522123006412 |
|
7680 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR5K2 |
0.241522123006412 |
|
7681 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CPOX |
0.241522123006412 |
|
7682 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPR15 |
0.241522123006412 |
|
7683 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RCAN2 |
0.241595283247035 |
|
7684 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CYP39A1 |
0.241595283247035 |
|
7685 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PGAP3 |
0.24163921473049 |
|
7686 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ERBB2 |
0.24163921473049 |
|
7687 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4728 |
0.24163921473049 |
|
7688 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIEN1 |
0.24163921473049 |
|
7689 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GRB7 |
0.24163921473049 |
|
7690 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TNFSF9 |
0.241643622274096 |
|
7691 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA31|ENSG00000251838.1 |
0.241695354650519 |
|
7692 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP139 |
0.241807575529628 |
|
7693 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CACNG1 |
0.241808841956704 |
|
7694 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDC16 |
0.241876222329607 |
|
7695 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CHAMP1 |
0.241876222329607 |
|
7696 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4502 |
0.241876222329607 |
|
7697 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR548AR |
0.241876222329607 |
|
7698 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UPF3A |
0.241876222329607 |
|
7699 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CEACAM19 |
0.241914335359855 |
|
7700 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CEACAM16 |
0.241914335359855 |
|
7701 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD11|ENSG00000238819.1 |
0.241934453862358 |
|
7702 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FKSG62 |
0.242230001380288 |
|
7703 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLIC5 |
0.242316882476625 |
|
7704 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EIF2B2 |
0.242436021899656 |
|
7705 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MLH3 |
0.242436021899656 |
|
7706 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACYP1 |
0.242436021899656 |
|
7707 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZC2HC1C |
0.242436021899656 |
|
7708 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NEK9 |
0.242436021899656 |
|
7709 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLRN2 |
0.242438530226481 |
|
7710 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238536.1 |
0.242438530226481 |
|
7711 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238925.1 |
0.242633969429755 |
|
7712 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR52K2 |
0.242985315680057 |
|
7713 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR52K1 |
0.242985315680057 |
|
7714 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR52M1 |
0.242985315680057 |
|
7715 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C11orf40 |
0.242985315680057 |
|
7716 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR52I2 |
0.242985315680057 |
|
7717 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR52I1 |
0.242985315680057 |
|
7718 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRIM68 |
0.242985315680057 |
|
7719 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR51D1 |
0.242985315680057 |
|
7720 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR51E1 |
0.242985315680057 |
|
7721 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR51E2 |
0.242985315680057 |
|
7722 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR51C1P |
0.242985315680057 |
|
7723 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
THSD4 |
0.242988171659025 |
|
7724 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BIVM |
0.243002135624746 |
|
7725 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ERCC5 |
0.243002135624746 |
|
7726 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
METTL21EP |
0.243002135624746 |
|
7727 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC10A2 |
0.243002135624746 |
|
7728 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PMS2CL |
0.243156200136524 |
|
7729 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RSPH10B2 |
0.243156200136524 |
|
7730 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCZ1B |
0.243156200136524 |
|
7731 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3683 |
0.243156200136524 |
|
7732 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
JMJD8 |
0.243293364803945 |
|
7733 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STUB1 |
0.243293364803945 |
|
7734 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FBXL16 |
0.243293364803945 |
|
7735 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WDR24 |
0.243293364803945 |
|
7736 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
METRN |
0.243293364803945 |
|
7737 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC78 |
0.243293364803945 |
|
7738 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM173A |
0.243293364803945 |
|
7739 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HAGHL |
0.243293364803945 |
|
7740 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NARFL |
0.243293364803945 |
|
7741 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL10P |
0.243311607545227 |
|
7742 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BCL2L15 |
0.243496391851382 |
|
7743 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AP4B1 |
0.243496391851382 |
|
7744 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DCLRE1B |
0.243496391851382 |
|
7745 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HIPK1 |
0.243496391851382 |
|
7746 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OLFML3 |
0.243496391851382 |
|
7747 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MCTP1 |
0.243797929610034 |
|
7748 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00358 |
0.243913876874643 |
|
7749 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00459 |
0.243913876874643 |
|
7750 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PDYN |
0.243966666091417 |
|
7751 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238869.1 |
0.244341890833933 |
|
7752 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC168 |
0.244341890833933 |
|
7753 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00283 |
0.244341890833933 |
|
7754 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TEX30 |
0.244341890833933 |
|
7755 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KDELC1 |
0.244341890833933 |
|
7756 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNY5P8 |
0.244341890833933 |
|
7757 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MTMR3 |
0.244603598920078 |
|
7758 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CASP12 |
0.244646215433655 |
|
7759 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CASP4 |
0.244646215433655 |
|
7760 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPPL3 |
0.244688325270164 |
|
7761 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FENDRR |
0.244824347129021 |
|
7762 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FOXF1 |
0.244824347129021 |
|
7763 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MTHFSD |
0.244824347129021 |
|
7764 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FOXC2 |
0.244824347129021 |
|
7765 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FOXL1 |
0.244824347129021 |
|
7766 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC27A2 |
0.244898350431108 |
|
7767 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HDC |
0.244898350431108 |
|
7768 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL494P |
0.244898350431108 |
|
7769 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GABPB1 |
0.244898350431108 |
|
7770 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U6|ENSG00000271819.1 |
0.244898350431108 |
|
7771 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4712 |
0.244898350431108 |
|
7772 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AP4E1 |
0.244898350431108 |
|
7773 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TNFAIP8L3 |
0.244898350431108 |
|
7774 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CYP19A1 |
0.244898350431108 |
|
7775 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4713 |
0.244898350431108 |
|
7776 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GLDN |
0.244898350431108 |
|
7777 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SOGA3 |
0.24493553842589 |
|
7778 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C6orf58 |
0.24493553842589 |
|
7779 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ASB7 |
0.24522442055291 |
|
7780 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPR108 |
0.24532727203328 |
|
7781 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRIP10 |
0.24532727203328 |
|
7782 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MUC3A |
0.245408214573937 |
|
7783 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MUC12 |
0.245408214573937 |
|
7784 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MUC17 |
0.245408214573937 |
|
7785 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP54 |
0.245408214573937 |
|
7786 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRIM56 |
0.245408214573937 |
|
7787 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SERPINE1 |
0.245408214573937 |
|
7788 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AP1S1 |
0.245408214573937 |
|
7789 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4653 |
0.245408214573937 |
|
7790 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VGF |
0.245408214573937 |
|
7791 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NAT16 |
0.245408214573937 |
|
7792 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MOGAT3 |
0.245408214573937 |
|
7793 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLOD3 |
0.245408214573937 |
|
7794 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNHIT1 |
0.245408214573937 |
|
7795 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLDN15 |
0.245408214573937 |
|
7796 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FIS1 |
0.245408214573937 |
|
7797 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COL26A1 |
0.245408214573937 |
|
7798 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RABL5 |
0.245408214573937 |
|
7799 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MYL10 |
0.245408214573937 |
|
7800 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PA2G4 |
0.245418141092018 |
|
7801 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPL41 |
0.245418141092018 |
|
7802 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ESYT1 |
0.245418141092018 |
|
7803 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZC3H10 |
0.245418141092018 |
|
7804 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MYL6B |
0.245418141092018 |
|
7805 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MYL6 |
0.245418141092018 |
|
7806 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SMARCC2 |
0.245418141092018 |
|
7807 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL770P |
0.245418141092018 |
|
7808 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TYR |
0.245457259113003 |
|
7809 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NOX4 |
0.245457259113003 |
|
7810 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MRPL24 |
0.245580157064643 |
|
7811 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HDGF |
0.245580157064643 |
|
7812 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRCC |
0.245580157064643 |
|
7813 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SH2D2A |
0.245580157064643 |
|
7814 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NTRK1 |
0.245580157064643 |
|
7815 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
INSRR |
0.245580157064643 |
|
7816 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PEAR1 |
0.245580157064643 |
|
7817 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GATSL3 |
0.245693336956705 |
|
7818 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TBC1D10A |
0.245693336956705 |
|
7819 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SF3A1 |
0.245693336956705 |
|
7820 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC157 |
0.245693336956705 |
|
7821 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNF215 |
0.245693336956705 |
|
7822 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SEC14L2 |
0.245693336956705 |
|
7823 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIAA1658 |
0.245693336956705 |
|
7824 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MTFP1 |
0.245693336956705 |
|
7825 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SEC14L3 |
0.245693336956705 |
|
7826 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SEC14L4 |
0.245693336956705 |
|
7827 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ENPP4 |
0.245727399525645 |
|
7828 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ENPP5 |
0.245727399525645 |
|
7829 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UQCRFS1 |
0.245905109546273 |
|
7830 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL340P |
0.245905109546273 |
|
7831 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MCM9 |
0.246008720133582 |
|
7832 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM233 |
0.246015401886681 |
|
7833 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP197 |
0.246015401886681 |
|
7834 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRKAB1 |
0.246015401886681 |
|
7835 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MSANTD4 |
0.246083447220614 |
|
7836 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KBTBD3 |
0.246083447220614 |
|
7837 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MYOC |
0.246133346138707 |
|
7838 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OPRK1 |
0.24635636109184 |
|
7839 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DNAJC14 |
0.246449744766512 |
|
7840 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ORMDL2 |
0.246449744766512 |
|
7841 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM198B |
0.246449744766512 |
|
7842 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MMP19 |
0.246449744766512 |
|
7843 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PUS7 |
0.24647087366362 |
|
7844 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RINT1 |
0.24647087366362 |
|
7845 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EFCAB10 |
0.24647087366362 |
|
7846 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATXN7L1 |
0.24647087366362 |
|
7847 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDHR3 |
0.24647087366362 |
|
7848 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UBE3D |
0.246527714721295 |
|
7849 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DOPEY1 |
0.246527714721295 |
|
7850 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PGM3 |
0.246527714721295 |
|
7851 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RWDD2A |
0.246527714721295 |
|
7852 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ME1 |
0.246527714721295 |
|
7853 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRSS35 |
0.246527714721295 |
|
7854 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RIPPLY2 |
0.246527714721295 |
|
7855 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CYB5R4 |
0.246527714721295 |
|
7856 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MRAP2 |
0.246527714721295 |
|
7857 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIAA1009 |
0.246527714721295 |
|
7858 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NNT |
0.246553506930476 |
|
7859 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CACNB2 |
0.246629063125311 |
|
7860 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HCFC2 |
0.24667206851165 |
|
7861 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NFYB |
0.24667206851165 |
|
7862 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP370 |
0.24667206851165 |
|
7863 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TXNRD1 |
0.24667206851165 |
|
7864 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RHAG |
0.246835591054167 |
|
7865 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AGBL2 |
0.246926451694897 |
|
7866 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FNBP4 |
0.246926451694897 |
|
7867 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000252447.1 |
0.246926451694897 |
|
7868 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NUP160 |
0.246926451694897 |
|
7869 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP340 |
0.246926451694897 |
|
7870 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL487P |
0.247058918218801 |
|
7871 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR646 |
0.247097460294289 |
|
7872 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4533 |
0.247097460294289 |
|
7873 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR548AG2 |
0.247097460294289 |
|
7874 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4526 |
0.247127731883996 |
|
7875 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM210A |
0.247127731883996 |
|
7876 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL362P |
0.247127731883996 |
|
7877 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNMT |
0.247127731883996 |
|
7878 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MC5R |
0.247127731883996 |
|
7879 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MC2R |
0.247127731883996 |
|
7880 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SHISA3 |
0.247496075441706 |
|
7881 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATP8A1 |
0.247496075441706 |
|
7882 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GRXCR1 |
0.247496075441706 |
|
7883 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP82 |
0.247496075441706 |
|
7884 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HAO1 |
0.247560514505215 |
|
7885 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PYHIN1 |
0.247795642435916 |
|
7886 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CADM3 |
0.247795642435916 |
|
7887 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP60 |
0.247795642435916 |
|
7888 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DARC |
0.247795642435916 |
|
7889 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DCAF16 |
0.247812160742451 |
|
7890 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NCAPG |
0.247812160742451 |
|
7891 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LACE1 |
0.2480314909035 |
|
7892 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238463.1 |
0.248085053364086 |
|
7893 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PGF |
0.248149652048209 |
|
7894 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC9A8 |
0.248284806396375 |
|
7895 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FDPS |
0.248385291982532 |
|
7896 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RUSC1 |
0.248385291982532 |
|
7897 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP445 |
0.248449369285735 |
|
7898 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ABTB2 |
0.248666046146042 |
|
7899 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CREB3L3 |
0.248684865562528 |
|
7900 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SIRT6 |
0.248684865562528 |
|
7901 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANKRD24 |
0.248684865562528 |
|
7902 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL84P |
0.248684865562528 |
|
7903 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EBI3 |
0.248684865562528 |
|
7904 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C19orf47 |
0.24871504635772 |
|
7905 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLD3 |
0.24871504635772 |
|
7906 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLEC14A |
0.248946288306832 |
|
7907 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HORMAD2 |
0.249061437421624 |
|
7908 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OSM |
0.249061437421624 |
|
7909 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP181 |
0.249138910493053 |
|
7910 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL677P |
0.249138910493053 |
|
7911 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP401 |
0.249138910493053 |
|
7912 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00923 |
0.249138910493053 |
|
7913 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARRDC4 |
0.249138910493053 |
|
7914 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPIP5K1 |
0.249152026660893 |
|
7915 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CATSPER2P1 |
0.249152026660893 |
|
7916 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CATSPER2 |
0.249152026660893 |
|
7917 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CKMT1A |
0.249152026660893 |
|
7918 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CKMT1B |
0.249152026660893 |
|
7919 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STRC |
0.249152026660893 |
|
7920 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238494.1 |
0.249152026660893 |
|
7921 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238535.1 |
0.249152026660893 |
|
7922 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PDIA3 |
0.249152026660893 |
|
7923 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ELL3 |
0.249152026660893 |
|
7924 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SERF2 |
0.249152026660893 |
|
7925 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HYPK |
0.249152026660893 |
|
7926 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR1282 |
0.249152026660893 |
|
7927 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SERINC4 |
0.249152026660893 |
|
7928 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MFAP1 |
0.249152026660893 |
|
7929 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WDR76 |
0.249152026660893 |
|
7930 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRIG3 |
0.249497306992111 |
|
7931 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC16A7 |
0.249497306992111 |
|
7932 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TAF12 |
0.249547676669944 |
|
7933 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAB42 |
0.249547676669944 |
|
7934 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TTC6 |
0.249567532286782 |
|
7935 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP425 |
0.249640209484494 |
|
7936 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ABCC11 |
0.249640209484494 |
|
7937 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AMZ2 |
0.249657005540201 |
|
7938 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC16A6 |
0.249657005540201 |
|
7939 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRKAR1A |
0.249657005540201 |
|
7940 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WIPI1 |
0.249657005540201 |
|
7941 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR635 |
0.249657005540201 |
|
7942 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM20A |
0.249657005540201 |
|
7943 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HDAC2 |
0.249691430753179 |
|
7944 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR148B |
0.249767745136352 |
|
7945 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL744P |
0.249767745136352 |
|
7946 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPR84 |
0.249767745136352 |
|
7947 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF385A |
0.249767745136352 |
|
7948 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TGFB1I1 |
0.249790205165168 |
|
7949 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC5A2 |
0.249790205165168 |
|
7950 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C16orf58 |
0.249790205165168 |
|
7951 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AHSP |
0.249790205165168 |
|
7952 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLUHP3 |
0.249790205165168 |
|
7953 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF720 |
0.249790205165168 |
|
7954 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CEP164P1 |
0.249952122294586 |
|
7955 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RSU1P2 |
0.249952122294586 |
|
7956 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPP30 |
0.249960974895057 |
|
7957 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANKRD1 |
0.249960974895057 |
|
7958 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL424P |
0.250030229311963 |
|
7959 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C12orf79 |
0.250063228217544 |
|
7960 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BTG1 |
0.250063228217544 |
|
7961 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLLU1OS |
0.250063228217544 |
|
7962 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLLU1 |
0.250063228217544 |
|
7963 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238865.1 |
0.250063228217544 |
|
7964 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DPF3 |
0.250113053330081 |
|
7965 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CEP85L |
0.250157433614493 |
|
7966 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLN |
0.250157433614493 |
|
7967 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NUDT3 |
0.25021062633394 |
|
7968 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PACSIN1 |
0.25021062633394 |
|
7969 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
THBS1 |
0.250345185708275 |
|
7970 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPR176 |
0.250345185708275 |
|
7971 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BUB1B |
0.250345185708275 |
|
7972 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PAK6 |
0.250345185708275 |
|
7973 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C15orf56 |
0.250345185708275 |
|
7974 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLCB2 |
0.250345185708275 |
|
7975 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANKRD63 |
0.250345185708275 |
|
7976 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00984 |
0.250345185708275 |
|
7977 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C15orf52 |
0.250345185708275 |
|
7978 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP392 |
0.250345185708275 |
|
7979 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PHGR1 |
0.250345185708275 |
|
7980 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DISP2 |
0.250345185708275 |
|
7981 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00594 |
0.250345185708275 |
|
7982 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KNSTRN |
0.250345185708275 |
|
7983 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IVD |
0.250345185708275 |
|
7984 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BAHD1 |
0.250345185708275 |
|
7985 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CAPNS1 |
0.250396545002546 |
|
7986 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COX7A1 |
0.250396545002546 |
|
7987 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNY1P6 |
0.250409683121832 |
|
7988 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WDFY2 |
0.250409683121832 |
|
7989 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL413P |
0.250409683121832 |
|
7990 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DHRS12 |
0.250409683121832 |
|
7991 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC70 |
0.250409683121832 |
|
7992 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATP7B |
0.250409683121832 |
|
7993 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ALG11 |
0.250409683121832 |
|
7994 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UTP14C |
0.250409683121832 |
|
7995 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NEK5 |
0.250409683121832 |
|
7996 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NEK3 |
0.250409683121832 |
|
7997 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
THSD1 |
0.250409683121832 |
|
7998 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNY4P24 |
0.250409683121832 |
|
7999 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VPS36 |
0.250409683121832 |
|
8000 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CKAP2 |
0.250409683121832 |
|
8001 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00345 |
0.250409683121832 |
|
8002 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HNRNPA1L2 |
0.250409683121832 |
|
8003 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SUGT1 |
0.250409683121832 |
|
8004 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LECT1 |
0.250409683121832 |
|
8005 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR759 |
0.250409683121832 |
|
8006 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCDH8 |
0.250409683121832 |
|
8007 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OLFM4 |
0.250409683121832 |
|
8008 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF622 |
0.250411940676165 |
|
8009 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM134B |
0.250411940676165 |
|
8010 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MYO10 |
0.250411940676165 |
|
8011 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP179 |
0.250411940676165 |
|
8012 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BASP1 |
0.250411940676165 |
|
8013 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP180 |
0.250411940676165 |
|
8014 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FTH1P10 |
0.250411940676165 |
|
8015 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP133 |
0.250411940676165 |
|
8016 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PGAM1P5 |
0.25044114613376 |
|
8017 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NTN4 |
0.25044114613376 |
|
8018 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNRPF |
0.25044114613376 |
|
8019 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC38 |
0.25044114613376 |
|
8020 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AMDHD1 |
0.25044114613376 |
|
8021 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HAL |
0.25044114613376 |
|
8022 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LTA4H |
0.25044114613376 |
|
8023 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL88P |
0.25044114613376 |
|
8024 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RMST |
0.25044114613376 |
|
8025 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR135A2 |
0.25044114613376 |
|
8026 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TP53BP1 |
0.250448089928979 |
|
8027 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAP1A |
0.250448089928979 |
|
8028 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
B2M |
0.250497145029617 |
|
8029 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRIM69 |
0.250497145029617 |
|
8030 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ABHD16A |
0.25056490160611 |
|
8031 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AGER |
0.25056490160611 |
|
8032 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AGPAT1 |
0.25056490160611 |
|
8033 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AIF1 |
0.25056490160611 |
|
8034 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
APOM |
0.25056490160611 |
|
8035 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATF6B |
0.25056490160611 |
|
8036 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATP6V1G2 |
0.25056490160611 |
|
8037 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BAG6 |
0.25056490160611 |
|
8038 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BTNL2 |
0.25056490160611 |
|
8039 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C2 |
0.25056490160611 |
|
8040 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C4A |
0.25056490160611 |
|
8041 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C4B |
0.25056490160611 |
|
8042 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C6orf10 |
0.25056490160611 |
|
8043 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C6orf25 |
0.25056490160611 |
|
8044 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C6orf47 |
0.25056490160611 |
|
8045 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C6orf48 |
0.25056490160611 |
|
8046 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CFB |
0.25056490160611 |
|
8047 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLIC1 |
0.25056490160611 |
|
8048 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CSNK2B |
0.25056490160611 |
|
8049 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CYP21A1P |
0.25056490160611 |
|
8050 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CYP21A2 |
0.25056490160611 |
|
8051 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DDAH2 |
0.25056490160611 |
|
8052 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DDX39B |
0.25056490160611 |
|
8053 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DOM3Z |
0.25056490160611 |
|
8054 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EGFL8 |
0.25056490160611 |
|
8055 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EHMT2 |
0.25056490160611 |
|
8056 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FKBPL |
0.25056490160611 |
|
8057 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPANK1 |
0.25056490160611 |
|
8058 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPSM3 |
0.25056490160611 |
|
8059 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HCG23 |
0.25056490160611 |
|
8060 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HCP5 |
0.25056490160611 |
|
8061 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HSPA1A |
0.25056490160611 |
|
8062 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HSPA1B |
0.25056490160611 |
|
8063 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HSPA1L |
0.25056490160611 |
|
8064 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LSM2 |
0.25056490160611 |
|
8065 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LST1 |
0.25056490160611 |
|
8066 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LTA |
0.25056490160611 |
|
8067 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LTB |
0.25056490160611 |
|
8068 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LY6G5B |
0.25056490160611 |
|
8069 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LY6G5C |
0.25056490160611 |
|
8070 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LY6G6C |
0.25056490160611 |
|
8071 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LY6G6D |
0.25056490160611 |
|
8072 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LY6G6E |
0.25056490160611 |
|
8073 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LY6G6F |
0.25056490160611 |
|
8074 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MCCD1 |
0.25056490160611 |
|
8075 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MEGT1 |
0.25056490160611 |
|
8076 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MICA |
0.25056490160611 |
|
8077 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MICB |
0.25056490160611 |
|
8078 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR1236 |
0.25056490160611 |
|
8079 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3135B |
0.25056490160611 |
|
8080 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4646 |
0.25056490160611 |
|
8081 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MSH5 |
0.25056490160611 |
|
8082 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NCR3 |
0.25056490160611 |
|
8083 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NELFE |
0.25056490160611 |
|
8084 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NEU1 |
0.25056490160611 |
|
8085 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NFKBIL1 |
0.25056490160611 |
|
8086 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NOTCH4 |
0.25056490160611 |
|
8087 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PBX2 |
0.25056490160611 |
|
8088 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPP1R2P1 |
0.25056490160611 |
|
8089 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPT2 |
0.25056490160611 |
|
8090 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRRC2A |
0.25056490160611 |
|
8091 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRRT1 |
0.25056490160611 |
|
8092 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PSMB8 |
0.25056490160611 |
|
8093 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PSMB9 |
0.25056490160611 |
|
8094 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP206 |
0.25056490160611 |
|
8095 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNF5 |
0.25056490160611 |
|
8096 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SAPCD1 |
0.25056490160611 |
|
8097 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SKIV2L |
0.25056490160611 |
|
8098 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC44A4 |
0.25056490160611 |
|
8099 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA38|ENSG00000200816.1 |
0.25056490160611 |
|
8100 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD117 |
0.25056490160611 |
|
8101 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD48 |
0.25056490160611 |
|
8102 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD52 |
0.25056490160611 |
|
8103 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD84 |
0.25056490160611 |
|
8104 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STK19 |
0.25056490160611 |
|
8105 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TAP1 |
0.25056490160611 |
|
8106 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TAP2 |
0.25056490160611 |
|
8107 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TNF |
0.25056490160611 |
|
8108 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TNXB |
0.25056490160611 |
|
8109 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VARS |
0.25056490160611 |
|
8110 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VWA7 |
0.25056490160611 |
|
8111 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZBTB12 |
0.25056490160611 |
|
8112 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00353 |
0.250573342609251 |
|
8113 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TAOK3 |
0.250652193350272 |
|
8114 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SUDS3 |
0.250652193350272 |
|
8115 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP374 |
0.250652193350272 |
|
8116 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL381P |
0.250827777881701 |
|
8117 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GINS2 |
0.250827777881701 |
|
8118 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IRF8 |
0.250827777881701 |
|
8119 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BAAT |
0.250871633959151 |
|
8120 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MRPL50 |
0.250871633959151 |
|
8121 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF189 |
0.250871633959151 |
|
8122 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLAMF8 |
0.251079793375925 |
|
8123 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C1orf204 |
0.251079793375925 |
|
8124 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD64|ENSG00000212161.1 |
0.251079793375925 |
|
8125 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VSIG8 |
0.251079793375925 |
|
8126 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC19 |
0.251079793375925 |
|
8127 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TAGLN2 |
0.251079793375925 |
|
8128 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IGSF9 |
0.251079793375925 |
|
8129 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLAMF9 |
0.251079793375925 |
|
8130 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATP1A4 |
0.251079793375925 |
|
8131 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL729P |
0.251122834177161 |
|
8132 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC45A1 |
0.251122834177161 |
|
8133 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
APOH |
0.251458158273896 |
|
8134 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADAMTS2 |
0.251488355409551 |
|
8135 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL71P |
0.251488355409551 |
|
8136 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RUFY1 |
0.251488355409551 |
|
8137 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TTLL5 |
0.251525500719342 |
|
8138 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PROKR2 |
0.251544687526153 |
|
8139 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COMMD8 |
0.251557961611723 |
|
8140 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF519 |
0.251672271529139 |
|
8141 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANKRD20A5P |
0.251672271529139 |
|
8142 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CYP4F35P |
0.251672271529139 |
|
8143 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RASSF2 |
0.251675905072714 |
|
8144 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC23A2 |
0.251675905072714 |
|
8145 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA31|ENSG00000252096.1 |
0.251675905072714 |
|
8146 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000252058.1 |
0.251675905072714 |
|
8147 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL514P |
0.251675905072714 |
|
8148 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP474 |
0.251675905072714 |
|
8149 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM230 |
0.251675905072714 |
|
8150 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCNA |
0.251675905072714 |
|
8151 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA26|ENSG00000212517.1 |
0.251675905072714 |
|
8152 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDS2 |
0.251675905072714 |
|
8153 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ENO1 |
0.251920669225047 |
|
8154 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CA6 |
0.251920669225047 |
|
8155 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL451P |
0.251920669225047 |
|
8156 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC2A7 |
0.251920669225047 |
|
8157 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WISP3 |
0.252193100650152 |
|
8158 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TUBE1 |
0.252193100650152 |
|
8159 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD112|ENSG00000252740.1 |
0.252540152210817 |
|
8160 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP62 |
0.252540152210817 |
|
8161 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP63 |
0.252540152210817 |
|
8162 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EDDM3A |
0.252586913283773 |
|
8163 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HOPX |
0.252679357483031 |
|
8164 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL492P |
0.252679357483031 |
|
8165 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL357P |
0.252679357483031 |
|
8166 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPINK2 |
0.252679357483031 |
|
8167 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
REST |
0.252679357483031 |
|
8168 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NOA1 |
0.252679357483031 |
|
8169 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
POLR2B |
0.252679357483031 |
|
8170 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238579.1 |
0.252679357483031 |
|
8171 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoZ6|ENSG00000252200.1 |
0.252810657579962 |
|
8172 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BCL3 |
0.252810657579962 |
|
8173 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA70|ENSG00000253027.1 |
0.252810657579962 |
|
8174 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CBLC |
0.252810657579962 |
|
8175 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BCAM |
0.252810657579962 |
|
8176 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM26D |
0.252870825258603 |
|
8177 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RWDD1 |
0.252870825258603 |
|
8178 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RSPH4A |
0.252870825258603 |
|
8179 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZUFSP |
0.252870825258603 |
|
8180 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KPNA5 |
0.252870825258603 |
|
8181 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM162B |
0.252870825258603 |
|
8182 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPRC6A |
0.252870825258603 |
|
8183 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP214 |
0.252870825258603 |
|
8184 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VGLL2 |
0.252870825258603 |
|
8185 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ROS1 |
0.252870825258603 |
|
8186 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP18 |
0.252870825258603 |
|
8187 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP51 |
0.252870825258603 |
|
8188 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DCBLD1 |
0.252870825258603 |
|
8189 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SYPL1 |
0.253131123383147 |
|
8190 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NAMPT |
0.253131123383147 |
|
8191 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ASIC1 |
0.253404155099324 |
|
8192 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SMARCD1 |
0.253404155099324 |
|
8193 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COX14 |
0.253404155099324 |
|
8194 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPD1 |
0.253404155099324 |
|
8195 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CERS5 |
0.253404155099324 |
|
8196 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00917 |
0.253424282278177 |
|
8197 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EIF2S3L |
0.253772808133141 |
|
8198 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KLRAP1 |
0.253772808133141 |
|
8199 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAGOHB |
0.253772808133141 |
|
8200 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STYK1 |
0.253772808133141 |
|
8201 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
YBX3 |
0.253772808133141 |
|
8202 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ESPN |
0.254063900552464 |
|
8203 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRP4 |
0.254596094335387 |
|
8204 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00702 |
0.254670832508806 |
|
8205 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ALDOB |
0.254819168763825 |
|
8206 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM246 |
0.254819168763825 |
|
8207 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNF20 |
0.254819168763825 |
|
8208 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPP3R2 |
0.254819168763825 |
|
8209 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LDOC1L |
0.254864664318443 |
|
8210 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TBX18 |
0.254953071106756 |
|
8211 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP360 |
0.255315509605011 |
|
8212 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM30C |
0.255400949917984 |
|
8213 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD61|ENSG00000238377.1 |
0.255400949917984 |
|
8214 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TBC1D23 |
0.255400949917984 |
|
8215 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NIT2 |
0.255400949917984 |
|
8216 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TOMM70A |
0.255400949917984 |
|
8217 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LNP1 |
0.255400949917984 |
|
8218 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COPZ1 |
0.255415742265412 |
|
8219 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMED10 |
0.255567616968387 |
|
8220 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4306 |
0.255613008489469 |
|
8221 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EPB41L2 |
0.25596102795387 |
|
8222 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MTMR10 |
0.256017573682961 |
|
8223 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238301.1 |
0.25614104677466 |
|
8224 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PARP6 |
0.256188863663316 |
|
8225 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CELF6 |
0.256188863663316 |
|
8226 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SDR9C7 |
0.256394019786902 |
|
8227 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TSPYL4 |
0.256429456699848 |
|
8228 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DSE |
0.256429456699848 |
|
8229 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TSPYL1 |
0.256429456699848 |
|
8230 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM26F |
0.256429456699848 |
|
8231 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAPPC3L |
0.256429456699848 |
|
8232 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM26E |
0.256429456699848 |
|
8233 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC149 |
0.2564761483961 |
|
8234 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DUSP4 |
0.256500244173447 |
|
8235 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR629 |
0.256603642460428 |
|
8236 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CRYBG3|ENSG00000080200.5 |
0.256783967780319 |
|
8237 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NEGR1 |
0.256946662922012 |
|
8238 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CREB3L1 |
0.257192680954983 |
|
8239 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SMAD3 |
0.25722593751699 |
|
8240 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AAGAB |
0.25722593751699 |
|
8241 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF767 |
0.257311927977815 |
|
8242 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STX17 |
0.257529726062813 |
|
8243 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ITPK1 |
0.257554992414881 |
|
8244 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MOAP1 |
0.257554992414881 |
|
8245 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM251 |
0.257554992414881 |
|
8246 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C14orf142 |
0.257554992414881 |
|
8247 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UBR7 |
0.257554992414881 |
|
8248 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PIGM |
0.257579558933167 |
|
8249 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCNJ10 |
0.257579558933167 |
|
8250 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPR182 |
0.25776606128736 |
|
8251 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HBCBP |
0.25776606128736 |
|
8252 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZBTB39 |
0.25776606128736 |
|
8253 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TAC3 |
0.25776606128736 |
|
8254 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MYO1A |
0.25776606128736 |
|
8255 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM194A |
0.25776606128736 |
|
8256 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NAB2 |
0.25776606128736 |
|
8257 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STAT6 |
0.25776606128736 |
|
8258 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC25A27 |
0.25785861720111 |
|
8259 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TDRD6 |
0.25785861720111 |
|
8260 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLA2G7 |
0.25785861720111 |
|
8261 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANKRD66 |
0.25785861720111 |
|
8262 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MEP1A |
0.25785861720111 |
|
8263 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPR116 |
0.25785861720111 |
|
8264 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPR110 |
0.25785861720111 |
|
8265 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARHGAP18 |
0.258154607850546 |
|
8266 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM244 |
0.258154607850546 |
|
8267 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CAMTA1 |
0.258300500344982 |
|
8268 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPARCL1 |
0.25886408266926 |
|
8269 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CYP7B1 |
0.258900854478803 |
|
8270 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SVOPL |
0.259015156414412 |
|
8271 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA40|ENSG00000252188.1 |
0.259015156414412 |
|
8272 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATP6V0A4 |
0.259015156414412 |
|
8273 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM213 |
0.259015156414412 |
|
8274 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ICA1L |
0.259256275514518 |
|
8275 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRP1 |
0.259262605963762 |
|
8276 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NXPH4 |
0.259262605963762 |
|
8277 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SHMT2 |
0.259262605963762 |
|
8278 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NDUFA4L2 |
0.259262605963762 |
|
8279 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STAC3 |
0.259262605963762 |
|
8280 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR26A2 |
0.259262605963762 |
|
8281 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
XRCC6BP1 |
0.259262605963762 |
|
8282 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP65 |
0.259262605963762 |
|
8283 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AKR1E2 |
0.259420419444532 |
|
8284 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ABCA5 |
0.259426145262952 |
|
8285 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA40|ENSG00000252352.1 |
0.259426145262952 |
|
8286 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAP2K6 |
0.259426145262952 |
|
8287 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCNJ16 |
0.259426145262952 |
|
8288 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCNJ2 |
0.259426145262952 |
|
8289 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPR4 |
0.259465329376479 |
|
8290 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EML2 |
0.259465329376479 |
|
8291 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR330 |
0.259465329376479 |
|
8292 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL836P |
0.259465329376479 |
|
8293 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR642A |
0.259465329376479 |
|
8294 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SS18 |
0.259505684095541 |
|
8295 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP267 |
0.259675239402429 |
|
8296 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TSTD1 |
0.25985526333734 |
|
8297 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
USF1 |
0.25985526333734 |
|
8298 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARHGAP30 |
0.25985526333734 |
|
8299 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PVRL4 |
0.25985526333734 |
|
8300 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KLHDC9 |
0.25985526333734 |
|
8301 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PFDN2 |
0.25985526333734 |
|
8302 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NIT1 |
0.25985526333734 |
|
8303 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DEDD |
0.25985526333734 |
|
8304 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACA64|ENSG00000238934.1 |
0.25985526333734 |
|
8305 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UFC1 |
0.25985526333734 |
|
8306 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
USP21 |
0.25985526333734 |
|
8307 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MMADHC |
0.260277912345472 |
|
8308 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNAP91 |
0.260429904692429 |
|
8309 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA77|ENSG00000221083.1 |
0.260657131825361 |
|
8310 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C22orf31 |
0.260711005475187 |
|
8311 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SIKE1 |
0.260718075005468 |
|
8312 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CTTN |
0.260805302889056 |
|
8313 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANKIB1 |
0.261006006848814 |
|
8314 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AP1B1 |
0.261025680121778 |
|
8315 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RFPL1S |
0.261025680121778 |
|
8316 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RFPL1 |
0.261025680121778 |
|
8317 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NEFH |
0.261025680121778 |
|
8318 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
THOC5 |
0.261025680121778 |
|
8319 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BTBD7 |
0.261252372998876 |
|
8320 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UNC79 |
0.261252372998876 |
|
8321 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COX8C |
0.261252372998876 |
|
8322 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRIMA1 |
0.261252372998876 |
|
8323 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM181A |
0.261252372998876 |
|
8324 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ASB2 |
0.261252372998876 |
|
8325 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4506 |
0.261252372998876 |
|
8326 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00521 |
0.261252372998876 |
|
8327 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OTUB2 |
0.261252372998876 |
|
8328 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DDX24 |
0.261252372998876 |
|
8329 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FBLN5 |
0.261399023146594 |
|
8330 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRIP11 |
0.261399023146594 |
|
8331 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATXN3 |
0.261399023146594 |
|
8332 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NDUFB1 |
0.261399023146594 |
|
8333 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CPSF2 |
0.261399023146594 |
|
8334 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC24A4 |
0.261399023146594 |
|
8335 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RIN3 |
0.261399023146594 |
|
8336 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LGMN |
0.261399023146594 |
|
8337 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GOLGA5 |
0.261399023146594 |
|
8338 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CHGA |
0.261399023146594 |
|
8339 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ST3GAL6 |
0.261487284519741 |
|
8340 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DCBLD2 |
0.261487284519741 |
|
8341 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00973 |
0.261487284519741 |
|
8342 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COL8A1 |
0.261487284519741 |
|
8343 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADAD2 |
0.261541723020124 |
|
8344 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATP2C2 |
0.261541723020124 |
|
8345 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COTL1 |
0.261541723020124 |
|
8346 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CRISPLD2 |
0.261541723020124 |
|
8347 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCNG4 |
0.261541723020124 |
|
8348 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KLHL36 |
0.261541723020124 |
|
8349 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP433 |
0.261541723020124 |
|
8350 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TAF1C |
0.261541723020124 |
|
8351 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TLDC1 |
0.261541723020124 |
|
8352 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
USP10 |
0.261541723020124 |
|
8353 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WFDC1 |
0.261541723020124 |
|
8354 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VAMP3 |
0.261598921232129 |
|
8355 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PER3 |
0.261598921232129 |
|
8356 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UTS2 |
0.261598921232129 |
|
8357 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TNFRSF9 |
0.261598921232129 |
|
8358 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PARK7 |
0.261598921232129 |
|
8359 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MGAT5 |
0.261845912212792 |
|
8360 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00517 |
0.261863166804988 |
|
8361 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SSTR1 |
0.261863166804988 |
|
8362 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00639 |
0.261863166804988 |
|
8363 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C12orf74 |
0.261890819026302 |
|
8364 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLEKHG7 |
0.261890819026302 |
|
8365 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL643P |
0.262013300604521 |
|
8366 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CREB5 |
0.262178621318716 |
|
8367 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CD177 |
0.262260111688225 |
|
8368 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CEACAMP10 |
0.262260111688225 |
|
8369 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PSG10P |
0.262260111688225 |
|
8370 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PSG11 |
0.262260111688225 |
|
8371 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PSG1 |
0.262260111688225 |
|
8372 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PSG2 |
0.262260111688225 |
|
8373 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PSG3 |
0.262260111688225 |
|
8374 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PSG4 |
0.262260111688225 |
|
8375 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PSG5 |
0.262260111688225 |
|
8376 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PSG6 |
0.262260111688225 |
|
8377 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PSG7 |
0.262260111688225 |
|
8378 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PSG8 |
0.262260111688225 |
|
8379 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PSG9 |
0.262260111688225 |
|
8380 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TEX101 |
0.262260111688225 |
|
8381 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NEB |
0.262821956891632 |
|
8382 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RDH16 |
0.262840602300255 |
|
8383 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADAMTS20 |
0.2628946631801 |
|
8384 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR10J5 |
0.2631575124824 |
|
8385 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
APCS |
0.2631575124824 |
|
8386 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PEX19 |
0.2631575124824 |
|
8387 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL197P |
0.26316683741483 |
|
8388 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF526 |
0.263283949720517 |
|
8389 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GSK3A |
0.263283949720517 |
|
8390 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ERF |
0.263283949720517 |
|
8391 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC47A2 |
0.263381134687431 |
|
8392 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ALDH3A1 |
0.263381134687431 |
|
8393 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ULK2 |
0.263381134687431 |
|
8394 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MTERF |
0.263533930984216 |
|
8395 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AKAP9 |
0.263533930984216 |
|
8396 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UBASH3B |
0.263563095411836 |
|
8397 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000239079.1 |
0.263563095411836 |
|
8398 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CRTAM |
0.263563095411836 |
|
8399 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C11orf63 |
0.263563095411836 |
|
8400 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BSX |
0.263563095411836 |
|
8401 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HSPA8 |
0.263563095411836 |
|
8402 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD14E |
0.263563095411836 |
|
8403 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD14C |
0.263563095411836 |
|
8404 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD14D |
0.263563095411836 |
|
8405 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLMP |
0.263563095411836 |
|
8406 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U8|ENSG00000200496.1 |
0.263563095411836 |
|
8407 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4493 |
0.263563095411836 |
|
8408 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GRAMD1B |
0.263563095411836 |
|
8409 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCN3B |
0.263563095411836 |
|
8410 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF202 |
0.263563095411836 |
|
8411 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR6X1 |
0.263563095411836 |
|
8412 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR6M1 |
0.263563095411836 |
|
8413 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM225 |
0.263563095411836 |
|
8414 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR8D4 |
0.263563095411836 |
|
8415 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR10G4 |
0.263563095411836 |
|
8416 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR10G9 |
0.263563095411836 |
|
8417 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR10G8 |
0.263563095411836 |
|
8418 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR10G7 |
0.263563095411836 |
|
8419 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VWA5A |
0.263563095411836 |
|
8420 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR10D3 |
0.263563095411836 |
|
8421 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR8D1 |
0.263563095411836 |
|
8422 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR8D2 |
0.263563095411836 |
|
8423 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR8B3 |
0.263563095411836 |
|
8424 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR8B4 |
0.263563095411836 |
|
8425 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR8B8 |
0.263563095411836 |
|
8426 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR8B12 |
0.263563095411836 |
|
8427 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR8A1 |
0.263563095411836 |
|
8428 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PANX3 |
0.263563095411836 |
|
8429 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TBRG1 |
0.263563095411836 |
|
8430 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP352 |
0.263563095411836 |
|
8431 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000239087.1 |
0.263635382799177 |
|
8432 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TWSG1 |
0.263635382799177 |
|
8433 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RALBP1 |
0.263635382799177 |
|
8434 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPP4R1 |
0.263635382799177 |
|
8435 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAB31 |
0.263635382799177 |
|
8436 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL862P |
0.263635382799177 |
|
8437 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP449 |
0.263635382799177 |
|
8438 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TXNDC2 |
0.263635382799177 |
|
8439 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VAPA |
0.263635382799177 |
|
8440 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP450 |
0.263635382799177 |
|
8441 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000239031.1 |
0.263635382799177 |
|
8442 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRDN |
0.263652761378117 |
|
8443 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NKAIN2 |
0.263652761378117 |
|
8444 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TLE1 |
0.264077392446866 |
|
8445 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NUDCD3 |
0.264112919284119 |
|
8446 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NPC1L1 |
0.264112919284119 |
|
8447 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DDX56 |
0.264112919284119 |
|
8448 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMED4 |
0.264112919284119 |
|
8449 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FCER1A |
0.264184149552299 |
|
8450 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR10J3 |
0.264184149552299 |
|
8451 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR10J4 |
0.264184149552299 |
|
8452 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR10J1 |
0.264184149552299 |
|
8453 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCTD1 |
0.264184648689039 |
|
8454 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MN1 |
0.264344182029627 |
|
8455 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PITPNB |
0.264344182029627 |
|
8456 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL757P |
0.264344182029627 |
|
8457 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000239015.1 |
0.264419690214595 |
|
8458 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL7P |
0.264779783920145 |
|
8459 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SAMD9 |
0.264779783920145 |
|
8460 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SAMD9L |
0.264779783920145 |
|
8461 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GABBR2 |
0.26479458122758 |
|
8462 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NEO1 |
0.264909180883 |
|
8463 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LDB2 |
0.265180201119364 |
|
8464 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LIPA |
0.265332208222979 |
|
8465 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IFIT2 |
0.265332208222979 |
|
8466 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IFIT3 |
0.265332208222979 |
|
8467 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DCAF4L1 |
0.265404586252986 |
|
8468 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR13A1 |
0.265407823337077 |
|
8469 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ALOX5 |
0.265407823337077 |
|
8470 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MARCH8 |
0.265407823337077 |
|
8471 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC71L |
0.26561388978373 |
|
8472 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP236 |
0.26561388978373 |
|
8473 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA38|ENSG00000201042.1 |
0.265808197467446 |
|
8474 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WDR12 |
0.265961519010374 |
|
8475 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CARF |
0.265961519010374 |
|
8476 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NBEAL1 |
0.265961519010374 |
|
8477 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA1|ENSG00000202059.1 |
0.265961519010374 |
|
8478 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CYP20A1 |
0.265961519010374 |
|
8479 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL670P |
0.265961519010374 |
|
8480 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ABI2 |
0.265961519010374 |
|
8481 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAPH1 |
0.265961519010374 |
|
8482 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CD28 |
0.265961519010374 |
|
8483 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CTLA4 |
0.265961519010374 |
|
8484 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C6orf203 |
0.266022848676178 |
|
8485 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BEND3 |
0.266022848676178 |
|
8486 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VSTM2B |
0.266032261030977 |
|
8487 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
POP4 |
0.266032261030977 |
|
8488 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAB3IP |
0.266151236829802 |
|
8489 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MYRFL |
0.266151236829802 |
|
8490 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RSPO3 |
0.266178103052509 |
|
8491 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNF146 |
0.266178103052509 |
|
8492 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ECHDC1 |
0.266178103052509 |
|
8493 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP217 |
0.266178103052509 |
|
8494 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
L3MBTL3 |
0.26654209362564 |
|
8495 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SAMD3 |
0.26654209362564 |
|
8496 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM200A |
0.26654209362564 |
|
8497 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCCA |
0.26654602270141 |
|
8498 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLEC10A |
0.266777553903948 |
|
8499 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ASGR2 |
0.266777553903948 |
|
8500 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KRIT1 |
0.26679671062946 |
|
8501 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TAS2R7 |
0.266973334706687 |
|
8502 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TAS2R8 |
0.266973334706687 |
|
8503 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TAS2R9 |
0.266973334706687 |
|
8504 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRR4 |
0.266973334706687 |
|
8505 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TAS2R10 |
0.266973334706687 |
|
8506 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRH1 |
0.266973334706687 |
|
8507 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TAS2R13 |
0.266973334706687 |
|
8508 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRH2 |
0.266973334706687 |
|
8509 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TAS2R14 |
0.266973334706687 |
|
8510 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TAS2R50 |
0.266973334706687 |
|
8511 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TAS2R20 |
0.266973334706687 |
|
8512 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TAS2R19 |
0.266973334706687 |
|
8513 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TAS2R30 |
0.266973334706687 |
|
8514 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TAS2R31 |
0.266973334706687 |
|
8515 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TAS2R42 |
0.266973334706687 |
|
8516 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TAS2R43 |
0.266973334706687 |
|
8517 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TAS2R46 |
0.266973334706687 |
|
8518 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TAS2R64P |
0.266973334706687 |
|
8519 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CWH43 |
0.267304440672489 |
|
8520 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FRYL |
0.267304440672489 |
|
8521 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OCIAD1 |
0.267304440672489 |
|
8522 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OCIAD2 |
0.267304440672489 |
|
8523 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLAIN2 |
0.267304440672489 |
|
8524 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC10A4 |
0.267304440672489 |
|
8525 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TEC |
0.267304440672489 |
|
8526 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZAR1 |
0.267304440672489 |
|
8527 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U3|ENSG00000212422.1 |
0.267361266652564 |
|
8528 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PHF14 |
0.267361266652564 |
|
8529 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR4D5 |
0.267656874165646 |
|
8530 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR6T1 |
0.267656874165646 |
|
8531 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR10S1 |
0.267656874165646 |
|
8532 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HNRNPH1 |
0.267677710489994 |
|
8533 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C5orf60 |
0.267677710489994 |
|
8534 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CANX |
0.267677710489994 |
|
8535 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CBY3 |
0.267677710489994 |
|
8536 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HMGB3P22 |
0.267677710489994 |
|
8537 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAML1 |
0.267677710489994 |
|
8538 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LTC4S |
0.267677710489994 |
|
8539 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MGAT4B |
0.267677710489994 |
|
8540 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR1229 |
0.267677710489994 |
|
8541 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SQSTM1 |
0.267677710489994 |
|
8542 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C5orf45 |
0.267677710489994 |
|
8543 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP150 |
0.267677710489994 |
|
8544 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TBC1D9B |
0.267677710489994 |
|
8545 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNF130 |
0.267677710489994 |
|
8546 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR340 |
0.267677710489994 |
|
8547 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DEPDC5 |
0.267685695093348 |
|
8548 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL785P |
0.267745298264571 |
|
8549 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238729.1 |
0.267745298264571 |
|
8550 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF157 |
0.267745298264571 |
|
8551 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA11C |
0.267745298264571 |
|
8552 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF41 |
0.267745298264571 |
|
8553 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CXorf24 |
0.267745298264571 |
|
8554 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARAF |
0.267745298264571 |
|
8555 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SYN1 |
0.267745298264571 |
|
8556 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TIMP1 |
0.267745298264571 |
|
8557 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4769 |
0.267745298264571 |
|
8558 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CFP |
0.267745298264571 |
|
8559 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ELK1 |
0.267745298264571 |
|
8560 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UXT |
0.267745298264571 |
|
8561 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CXXC1P1 |
0.267745298264571 |
|
8562 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF81 |
0.267745298264571 |
|
8563 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPACA5B |
0.267745298264571 |
|
8564 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPACA5 |
0.267745298264571 |
|
8565 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SSX6 |
0.267745298264571 |
|
8566 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF182 |
0.267745298264571 |
|
8567 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF630 |
0.267745298264571 |
|
8568 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238473.1 |
0.267745298264571 |
|
8569 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SSX5 |
0.267745298264571 |
|
8570 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP503 |
0.267745298264571 |
|
8571 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SSX1 |
0.267745298264571 |
|
8572 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SSX3 |
0.267745298264571 |
|
8573 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SSX4B |
0.267745298264571 |
|
8574 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SSX4 |
0.267745298264571 |
|
8575 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SSX9 |
0.267745298264571 |
|
8576 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC38A5 |
0.267745298264571 |
|
8577 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FTSJ1 |
0.267745298264571 |
|
8578 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PORCN |
0.267745298264571 |
|
8579 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EBP |
0.267745298264571 |
|
8580 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UPK3A |
0.267754688022501 |
|
8581 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM118A |
0.267754688022501 |
|
8582 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SUB1 |
0.2677853796496 |
|
8583 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RFX6 |
0.267858775104791 |
|
8584 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC91 |
0.268111110641266 |
|
8585 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BMP7 |
0.268453959331448 |
|
8586 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4325 |
0.268453959331448 |
|
8587 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPO11 |
0.268453959331448 |
|
8588 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAE1 |
0.268453959331448 |
|
8589 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MTRNR2L3 |
0.268453959331448 |
|
8590 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RBM38 |
0.268453959331448 |
|
8591 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAB22A |
0.268453959331448 |
|
8592 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SHANK2 |
0.268484359121185 |
|
8593 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANXA10 |
0.268562164665565 |
|
8594 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM98B |
0.268866691780743 |
|
8595 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RASGRP1 |
0.268866691780743 |
|
8596 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C15orf53 |
0.268866691780743 |
|
8597 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C15orf54 |
0.268866691780743 |
|
8598 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NR4A3 |
0.26889100125557 |
|
8599 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FEZ2 |
0.26891770263589 |
|
8600 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VIT |
0.26891770263589 |
|
8601 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EEA1 |
0.2689274781329 |
|
8602 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD74|ENSG00000201502.1 |
0.2689274781329 |
|
8603 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238361.1 |
0.2689274781329 |
|
8604 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000239073.1 |
0.2689274781329 |
|
8605 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NUDT4 |
0.2689274781329 |
|
8606 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UBE2N |
0.2689274781329 |
|
8607 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MRPL42 |
0.2689274781329 |
|
8608 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL737P |
0.2689274781329 |
|
8609 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COL18A1 |
0.269045523399482 |
|
8610 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00205 |
0.269045523399482 |
|
8611 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00315 |
0.269045523399482 |
|
8612 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00316 |
0.269045523399482 |
|
8613 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00334 |
0.269045523399482 |
|
8614 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCBP3 |
0.269045523399482 |
|
8615 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
POFUT2 |
0.269045523399482 |
|
8616 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC19A1 |
0.269045523399482 |
|
8617 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARL5A |
0.269049167048121 |
|
8618 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CACNB4 |
0.269049167048121 |
|
8619 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PISD |
0.269581254873259 |
|
8620 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRR14L |
0.269581254873259 |
|
8621 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL20P |
0.269581254873259 |
|
8622 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIPOL1 |
0.269827037559021 |
|
8623 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDH6 |
0.269984439529388 |
|
8624 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C5orf22 |
0.269984439529388 |
|
8625 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PDZD2 |
0.269984439529388 |
|
8626 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SESN1 |
0.270003913817171 |
|
8627 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PAIP1 |
0.270006058846841 |
|
8628 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPL13AP17 |
0.270008404978048 |
|
8629 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
QRSL1 |
0.270018451092288 |
|
8630 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR587 |
0.270018451092288 |
|
8631 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CEP95 |
0.270050028132236 |
|
8632 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SMURF2 |
0.270050028132236 |
|
8633 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AKAP4 |
0.270267650558147 |
|
8634 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCNB3 |
0.270267650558147 |
|
8635 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238388.1 |
0.270270043035195 |
|
8636 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COA1 |
0.27058392063955 |
|
8637 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BLVRA |
0.27058392063955 |
|
8638 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CASP5 |
0.270718530371355 |
|
8639 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CASP1 |
0.270718530371355 |
|
8640 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CARD16 |
0.270718530371355 |
|
8641 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LYPD3 |
0.270727923596805 |
|
8642 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PHLDB3 |
0.270727923596805 |
|
8643 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ETHE1 |
0.270727923596805 |
|
8644 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF575 |
0.270727923596805 |
|
8645 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
XRCC1 |
0.270727923596805 |
|
8646 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PINLYP |
0.270727923596805 |
|
8647 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IRGQ |
0.270727923596805 |
|
8648 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SRRM5 |
0.270727923596805 |
|
8649 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF576 |
0.270727923596805 |
|
8650 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF428 |
0.270727923596805 |
|
8651 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CADM4 |
0.270727923596805 |
|
8652 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLAUR |
0.270727923596805 |
|
8653 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL368P |
0.270727923596805 |
|
8654 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KLRC1 |
0.270787401492375 |
|
8655 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KLRC2 |
0.270787401492375 |
|
8656 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KLRC3 |
0.270787401492375 |
|
8657 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BRPF3 |
0.27080760094959 |
|
8658 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PNPLA1 |
0.27080760094959 |
|
8659 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C6orf222 |
0.27080760094959 |
|
8660 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ETV7 |
0.27080760094959 |
|
8661 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PXT1 |
0.27080760094959 |
|
8662 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
APCDD1 |
0.270814542159543 |
|
8663 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NAPG |
0.270814542159543 |
|
8664 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL538P |
0.270847556814013 |
|
8665 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PIN1P1 |
0.270847556814013 |
|
8666 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRRC40 |
0.270847556814013 |
|
8667 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL242P |
0.270847556814013 |
|
8668 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MANBA |
0.270859543966372 |
|
8669 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MORN3 |
0.270956850838364 |
|
8670 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MATN3 |
0.271042599888451 |
|
8671 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BHLHE22 |
0.271098302341185 |
|
8672 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL735P |
0.271333775480918 |
|
8673 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KITLG |
0.271348838184934 |
|
8674 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238872.1 |
0.271583345021724 |
|
8675 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPR52 |
0.271583345021724 |
|
8676 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TC2N |
0.271653401376283 |
|
8677 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR490 |
0.271741520358174 |
|
8678 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PTN |
0.271741520358174 |
|
8679 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD81|ENSG00000202023.1 |
0.271741520358174 |
|
8680 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GTPBP10 |
0.271763669681252 |
|
8681 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLDN12 |
0.271763669681252 |
|
8682 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WDR35 |
0.27180331677701 |
|
8683 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MBL2 |
0.271808774262406 |
|
8684 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZC3H15 |
0.272032431481876 |
|
8685 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF521 |
0.272052551592864 |
|
8686 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL46P |
0.272112032025664 |
|
8687 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL676P |
0.272112032025664 |
|
8688 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPL30P11 |
0.272112032025664 |
|
8689 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATF7IP |
0.272112032025664 |
|
8690 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM202 |
0.272146103507568 |
|
8691 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR630 |
0.272146103507568 |
|
8692 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GOLGA6B |
0.272146103507568 |
|
8693 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL485P |
0.272146103507568 |
|
8694 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL853P |
0.272146103507568 |
|
8695 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HIGD2B |
0.272146103507568 |
|
8696 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PTPN12 |
0.272301904712029 |
|
8697 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BEAN1 |
0.272509753028259 |
|
8698 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TK2 |
0.272509753028259 |
|
8699 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CKLF |
0.272509753028259 |
|
8700 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CMTM1 |
0.272509753028259 |
|
8701 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CMTM2 |
0.272509753028259 |
|
8702 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CMTM3 |
0.272509753028259 |
|
8703 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CMTM4 |
0.272509753028259 |
|
8704 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DRGX |
0.272651603116134 |
|
8705 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00703 |
0.272775311670981 |
|
8706 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00704 |
0.272775311670981 |
|
8707 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00705 |
0.272775311670981 |
|
8708 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LYPD6B |
0.273012660972876 |
|
8709 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C5orf28 |
0.273100047713601 |
|
8710 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C5orf34 |
0.273100047713601 |
|
8711 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00898 |
0.273137140922305 |
|
8712 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP32 |
0.27329057834288 |
|
8713 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCL28 |
0.273365664309655 |
|
8714 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD81|ENSG00000212278.1 |
0.27341179330413 |
|
8715 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL58P |
0.27341179330413 |
|
8716 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238674.1 |
0.27341179330413 |
|
8717 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NUP50 |
0.27345680355968 |
|
8718 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIAA0930 |
0.27345680355968 |
|
8719 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR1249 |
0.27345680355968 |
|
8720 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SMC1B |
0.27345680355968 |
|
8721 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PHTF2 |
0.273594442876463 |
|
8722 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GSAP |
0.27373874932476 |
|
8723 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OGDH |
0.273849101502063 |
|
8724 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
H2AFV |
0.273849101502063 |
|
8725 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM51 |
0.274000761195365 |
|
8726 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C1orf195 |
0.274000761195365 |
|
8727 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FHAD1 |
0.274000761195365 |
|
8728 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EFHD2 |
0.274000761195365 |
|
8729 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CTRC |
0.274000761195365 |
|
8730 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CELA2A |
0.274000761195365 |
|
8731 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CELA2B |
0.274000761195365 |
|
8732 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CASP9 |
0.274000761195365 |
|
8733 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DNAJC16 |
0.274000761195365 |
|
8734 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCARNA21|ENSG00000251866.1 |
0.274000761195365 |
|
8735 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AGMAT |
0.274000761195365 |
|
8736 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238453.1 |
0.274119517010919 |
|
8737 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCER1 |
0.274241460551937 |
|
8738 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00615 |
0.274241460551937 |
|
8739 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EPYC |
0.274241460551937 |
|
8740 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KERA |
0.274241460551937 |
|
8741 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LUM |
0.274241460551937 |
|
8742 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DCN |
0.274241460551937 |
|
8743 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ELOVL4 |
0.274517033892729 |
|
8744 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRB3 |
0.274564391440698 |
|
8745 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRB4 |
0.274564391440698 |
|
8746 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRB1 |
0.274564391440698 |
|
8747 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRB2 |
0.274564391440698 |
|
8748 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMX4 |
0.274755445559676 |
|
8749 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238488.1 |
0.274803401907993 |
|
8750 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CHRM2 |
0.274803401907993 |
|
8751 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NRG1 |
0.274887540447779 |
|
8752 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HRK |
0.275225311663788 |
|
8753 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FBXW8 |
0.275225311663788 |
|
8754 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TESC |
0.275225311663788 |
|
8755 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FBXO21 |
0.275225311663788 |
|
8756 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NOS1 |
0.275225311663788 |
|
8757 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL448P |
0.275261436818634 |
|
8758 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC176 |
0.275339579135844 |
|
8759 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ALDH6A1 |
0.275339579135844 |
|
8760 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LIN52 |
0.275339579135844 |
|
8761 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PIK3CG |
0.275491888249857 |
|
8762 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRKAR2B |
0.275491888249857 |
|
8763 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HBP1 |
0.275491888249857 |
|
8764 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP207 |
0.275835489632367 |
|
8765 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC25A21 |
0.275903414442461 |
|
8766 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DUSP6 |
0.276002850673412 |
|
8767 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
POC1B |
0.276002850673412 |
|
8768 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GALNT4 |
0.276002850673412 |
|
8769 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPHLN1 |
0.276040263648508 |
|
8770 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZCRB1 |
0.276040263648508 |
|
8771 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA74|ENSG00000252917.1 |
0.276040263648508 |
|
8772 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRICKLE1 |
0.276040263648508 |
|
8773 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00453 |
0.276056254647707 |
|
8774 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00452 |
0.276056254647707 |
|
8775 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00565 |
0.276056254647707 |
|
8776 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PSMA8 |
0.276504856786507 |
|
8777 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TAF4B |
0.276504856786507 |
|
8778 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U3|ENSG00000252921.1 |
0.276504856786507 |
|
8779 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RHOBTB1 |
0.276610073476553 |
|
8780 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SULT4A1 |
0.276871679204903 |
|
8781 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PNPLA5 |
0.276871679204903 |
|
8782 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PNPLA3 |
0.276871679204903 |
|
8783 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SAMM50 |
0.276871679204903 |
|
8784 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PARVB |
0.276871679204903 |
|
8785 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PARVG |
0.276871679204903 |
|
8786 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIAA1644 |
0.276871679204903 |
|
8787 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00207 |
0.276871679204903 |
|
8788 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00229 |
0.276871679204903 |
|
8789 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRR5 |
0.276871679204903 |
|
8790 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA48|ENSG00000252824.1 |
0.276874374325983 |
|
8791 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FBXL13 |
0.276874374325983 |
|
8792 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP198 |
0.276874374325983 |
|
8793 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZMIZ2 |
0.277011962951518 |
|
8794 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPIA |
0.277011962951518 |
|
8795 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD56|ENSG00000200112.1 |
0.277052806615118 |
|
8796 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CNTN5 |
0.277125103472028 |
|
8797 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TCHHL1 |
0.277292864288458 |
|
8798 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TCHH |
0.277292864288458 |
|
8799 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPTN |
0.277292864288458 |
|
8800 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HRNR |
0.277292864288458 |
|
8801 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FLG |
0.277292864288458 |
|
8802 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FLG2 |
0.277292864288458 |
|
8803 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATG5 |
0.277321386203323 |
|
8804 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL47P |
0.277321386203323 |
|
8805 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD112|ENSG00000252359.1 |
0.277369779111851 |
|
8806 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LMX1A |
0.277369779111851 |
|
8807 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GMPR |
0.277412508968485 |
|
8808 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PURB |
0.277504835732804 |
|
8809 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NOS1AP |
0.277707150064267 |
|
8810 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP287 |
0.277730116290393 |
|
8811 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD95|ENSG00000200969.1 |
0.277730116290393 |
|
8812 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPATA31D5P |
0.277730116290393 |
|
8813 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPATA31D4 |
0.277730116290393 |
|
8814 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPATA31D3 |
0.277730116290393 |
|
8815 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPATA31D1 |
0.277730116290393 |
|
8816 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP211 |
0.277910409623541 |
|
8817 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AIM1 |
0.277910409623541 |
|
8818 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RTN4IP1 |
0.277910409623541 |
|
8819 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MANSC1 |
0.277990823372245 |
|
8820 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LOH12CR2 |
0.277990823372245 |
|
8821 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LOH12CR1 |
0.277990823372245 |
|
8822 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DUSP16 |
0.277990823372245 |
|
8823 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CRIM1 |
0.278003962596749 |
|
8824 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATXN10 |
0.278010964373916 |
|
8825 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ETV1 |
0.278265316526298 |
|
8826 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM133B |
0.278423592093227 |
|
8827 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDK6 |
0.278423592093227 |
|
8828 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DDX5 |
0.278526380834376 |
|
8829 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3064 |
0.278526380834376 |
|
8830 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR5047 |
0.278526380834376 |
|
8831 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
INVS |
0.278618479772856 |
|
8832 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EP300 |
0.278692943688013 |
|
8833 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL97P |
0.278756143375701 |
|
8834 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PTGR2 |
0.278804331284595 |
|
8835 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF410 |
0.278804331284595 |
|
8836 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM161B |
0.278804331284595 |
|
8837 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COQ6 |
0.278804331284595 |
|
8838 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ENTPD5 |
0.278804331284595 |
|
8839 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC17A5 |
0.278877830043151 |
|
8840 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GCC1 |
0.278935617128261 |
|
8841 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARF5 |
0.278935617128261 |
|
8842 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FSCN3 |
0.278935617128261 |
|
8843 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PAX4 |
0.278935617128261 |
|
8844 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WSB2 |
0.27893901636799 |
|
8845 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VSIG10 |
0.27893901636799 |
|
8846 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PEBP1 |
0.27893901636799 |
|
8847 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00587 |
0.27902917691657 |
|
8848 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CREBL2 |
0.279057065589869 |
|
8849 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPR19 |
0.279057065589869 |
|
8850 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM110B |
0.279362600735484 |
|
8851 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM120AOS |
0.279650918990239 |
|
8852 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4494 |
0.279687380273135 |
|
8853 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FERMT2 |
0.279793596934598 |
|
8854 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KRBA1 |
0.27984315473638 |
|
8855 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF467 |
0.27984315473638 |
|
8856 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SSPO |
0.27984315473638 |
|
8857 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATP6V0E2 |
0.27984315473638 |
|
8858 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF862 |
0.27984315473638 |
|
8859 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACTR3C |
0.27984315473638 |
|
8860 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRRC61 |
0.27984315473638 |
|
8861 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZBED6CL |
0.27984315473638 |
|
8862 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RARRES2 |
0.27984315473638 |
|
8863 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
REPIN1 |
0.27984315473638 |
|
8864 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF775 |
0.27984315473638 |
|
8865 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GIMAP8 |
0.27984315473638 |
|
8866 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GIMAP7 |
0.27984315473638 |
|
8867 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GIMAP4 |
0.27984315473638 |
|
8868 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GIMAP6 |
0.27984315473638 |
|
8869 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GIMAP2 |
0.27984315473638 |
|
8870 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GIMAP1 |
0.27984315473638 |
|
8871 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GIMAP5 |
0.27984315473638 |
|
8872 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM176B |
0.27984315473638 |
|
8873 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM176A |
0.27984315473638 |
|
8874 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AOC1 |
0.27984315473638 |
|
8875 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCNH2 |
0.27984315473638 |
|
8876 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NUB1 |
0.27984315473638 |
|
8877 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WDR86 |
0.27984315473638 |
|
8878 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CRYGN |
0.27984315473638 |
|
8879 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3907 |
0.27984315473638 |
|
8880 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RHEB |
0.27984315473638 |
|
8881 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL76P |
0.27984315473638 |
|
8882 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATXN1 |
0.279921109999347 |
|
8883 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VPS35 |
0.279996030902499 |
|
8884 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ORC6 |
0.279996030902499 |
|
8885 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4639 |
0.280038471441783 |
|
8886 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATP2B1 |
0.280174366222486 |
|
8887 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00936 |
0.280174366222486 |
|
8888 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP365 |
0.280174366222486 |
|
8889 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STRN |
0.280192218076436 |
|
8890 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HEATR5B |
0.280192218076436 |
|
8891 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPATCH11 |
0.280192218076436 |
|
8892 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SULT6B1 |
0.280192218076436 |
|
8893 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CEBPZ |
0.280192218076436 |
|
8894 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NDUFAF7 |
0.280192218076436 |
|
8895 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA40|ENSG00000251704.1 |
0.280427669304796 |
|
8896 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDKN1B |
0.280550558524907 |
|
8897 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
APOLD1 |
0.280550558524907 |
|
8898 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR613 |
0.280550558524907 |
|
8899 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DDX47 |
0.280550558524907 |
|
8900 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GRM5 |
0.280589582272812 |
|
8901 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CYLC2 |
0.280907977758591 |
|
8902 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP291 |
0.280907977758591 |
|
8903 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDH2 |
0.280968642046223 |
|
8904 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CD276 |
0.28133146898219 |
|
8905 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C15orf59 |
0.28133146898219 |
|
8906 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MARK4 |
0.281791792593864 |
|
8907 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NOL4 |
0.281808656382377 |
|
8908 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EIF2AK4 |
0.281868885495102 |
|
8909 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238564.1 |
0.281868885495102 |
|
8910 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SRP14 |
0.281868885495102 |
|
8911 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CIC |
0.281976861371815 |
|
8912 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PAFAH1B3 |
0.281976861371815 |
|
8913 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRR19 |
0.281976861371815 |
|
8914 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM145 |
0.281976861371815 |
|
8915 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC16A10 |
0.282481749227427 |
|
8916 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIAA1919 |
0.282481749227427 |
|
8917 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM124A |
0.28248408742397 |
|
8918 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SERPINE3 |
0.28248408742397 |
|
8919 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR5693 |
0.28248408742397 |
|
8920 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
INTS6 |
0.28248408742397 |
|
8921 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RASAL2 |
0.282667827244401 |
|
8922 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARHGEF17 |
0.282719425999486 |
|
8923 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RELT |
0.282719425999486 |
|
8924 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM168A |
0.282719425999486 |
|
8925 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PHF16 |
0.282869598036677 |
|
8926 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RGN |
0.282869598036677 |
|
8927 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NDUFB11 |
0.282869598036677 |
|
8928 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RBM10 |
0.282869598036677 |
|
8929 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CARS |
0.2829151589319 |
|
8930 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238860.1 |
0.282938553788914 |
|
8931 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SRPX2 |
0.282994577367323 |
|
8932 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SYTL4 |
0.282994577367323 |
|
8933 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TNMD |
0.283003920730748 |
|
8934 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TSPAN6 |
0.283003920730748 |
|
8935 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CTCFL |
0.283015263394017 |
|
8936 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCK1 |
0.283015263394017 |
|
8937 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZBP1 |
0.283015263394017 |
|
8938 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PMEPA1 |
0.283015263394017 |
|
8939 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4532 |
0.283015263394017 |
|
8940 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C20orf85 |
0.283015263394017 |
|
8941 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANKRD60 |
0.283015263394017 |
|
8942 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPP4R1L |
0.283015263394017 |
|
8943 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM91A1 |
0.283084742677051 |
|
8944 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC22A11 |
0.283130216580431 |
|
8945 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CALCOCO1 |
0.28320716180433 |
|
8946 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PSMC6 |
0.283255773345124 |
|
8947 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IPO8 |
0.283293082428792 |
|
8948 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CAPRIN2 |
0.283293082428792 |
|
8949 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ASRGL1 |
0.283455634568763 |
|
8950 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCGB1A1 |
0.283455634568763 |
|
8951 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HSD17B12 |
0.283760437518297 |
|
8952 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR670 |
0.283760437518297 |
|
8953 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
POU2F2 |
0.283941385309886 |
|
8954 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4323 |
0.283941385309886 |
|
8955 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD112|ENSG00000252356.1 |
0.283941385309886 |
|
8956 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DEDD2 |
0.283941385309886 |
|
8957 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BPTF |
0.2839957787755 |
|
8958 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL622P |
0.2839957787755 |
|
8959 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C17orf58 |
0.2839957787755 |
|
8960 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KPNA2 |
0.2839957787755 |
|
8961 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4510 |
0.284149780291756 |
|
8962 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KREMEN1 |
0.284581295120426 |
|
8963 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SRPK2 |
0.28469059531077 |
|
8964 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANP32B |
0.284761020145792 |
|
8965 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CHST14 |
0.284818902871085 |
|
8966 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C15orf57 |
0.284818902871085 |
|
8967 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPUSD2 |
0.284818902871085 |
|
8968 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CASC5 |
0.284818902871085 |
|
8969 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238559.1 |
0.284818902871085 |
|
8970 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL376P |
0.284818902871085 |
|
8971 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IRGC |
0.28485113670298 |
|
8972 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CHST11 |
0.284968213996383 |
|
8973 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3922 |
0.284968213996383 |
|
8974 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRF1 |
0.285136040102354 |
|
8975 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADAMTS14 |
0.285136040102354 |
|
8976 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TBATA |
0.285136040102354 |
|
8977 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SGPL1 |
0.285136040102354 |
|
8978 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DTNA |
0.285198471440966 |
|
8979 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRKCA |
0.28527254191879 |
|
8980 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR634 |
0.28527254191879 |
|
8981 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CACNG5 |
0.28527254191879 |
|
8982 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP446 |
0.28527254191879 |
|
8983 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RBM43 |
0.285385063197958 |
|
8984 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NMI |
0.285385063197958 |
|
8985 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TNFAIP6 |
0.285385063197958 |
|
8986 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL124P |
0.285385063197958 |
|
8987 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD42|ENSG00000201209.1 |
0.285434529909011 |
|
8988 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DIRAS2 |
0.285677567215661 |
|
8989 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SYK |
0.285677567215661 |
|
8990 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00484 |
0.285677567215661 |
|
8991 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AUH |
0.285677567215661 |
|
8992 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NFIL3 |
0.285677567215661 |
|
8993 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C14orf166 |
0.286123671122908 |
|
8994 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NID2 |
0.286123671122908 |
|
8995 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PTGDR |
0.286123671122908 |
|
8996 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PTGER2 |
0.286123671122908 |
|
8997 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP225 |
0.286175994169125 |
|
8998 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLEKHH2 |
0.286325208389618 |
|
8999 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRRC4C |
0.286409985277758 |
|
9000 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM133 |
0.286433338101516 |
|
9001 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MYLIP |
0.287003024231967 |
|
9002 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U3|ENSG00000251793.1 |
0.287003024231967 |
|
9003 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC26A8 |
0.287145843388778 |
|
9004 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAPK14 |
0.287145843388778 |
|
9005 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAPK13 |
0.287145843388778 |
|
9006 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP297 |
0.287270214604434 |
|
9007 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CHRDL2 |
0.287270214604434 |
|
9008 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD43|ENSG00000212277.1 |
0.287270214604434 |
|
9009 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4696 |
0.287270214604434 |
|
9010 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNF169 |
0.287270214604434 |
|
9011 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TEX10 |
0.287484830523102 |
|
9012 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KLF6 |
0.287508111946733 |
|
9013 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00621 |
0.287813300127249 |
|
9014 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD36|ENSG00000253094.1 |
0.287813300127249 |
|
9015 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CELF3 |
0.287874845968044 |
|
9016 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RIIAD1 |
0.287874845968044 |
|
9017 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MRPL9 |
0.287874845968044 |
|
9018 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OAZ3 |
0.287874845968044 |
|
9019 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TDRKH |
0.287874845968044 |
|
9020 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINGO4 |
0.287874845968044 |
|
9021 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RORC |
0.287874845968044 |
|
9022 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C2CD4D |
0.287874845968044 |
|
9023 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
THEM5 |
0.287874845968044 |
|
9024 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
THEM4 |
0.287874845968044 |
|
9025 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HYDIN |
0.28791991707089 |
|
9026 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FCHSD2 |
0.288101448748373 |
|
9027 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDH10 |
0.288306146902783 |
|
9028 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CD70 |
0.288379180549737 |
|
9029 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRRC69 |
0.288434166042355 |
|
9030 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL777P |
0.288434166042355 |
|
9031 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4661 |
0.288434166042355 |
|
9032 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC26A7 |
0.288434166042355 |
|
9033 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000239134.1 |
0.288434166042355 |
|
9034 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
XRRA1 |
0.288470278132423 |
|
9035 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ITLN2 |
0.288731649394339 |
|
9036 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
F11R |
0.288731649394339 |
|
9037 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
B4GALT3 |
0.288731649394339 |
|
9038 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPOX |
0.288731649394339 |
|
9039 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADAMTS4 |
0.288731649394339 |
|
9040 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NDUFS2 |
0.288731649394339 |
|
9041 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FCER1G |
0.288731649394339 |
|
9042 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
APOA2 |
0.288731649394339 |
|
9043 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR5187 |
0.288731649394339 |
|
9044 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NR1I3 |
0.288731649394339 |
|
9045 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TOMM40L |
0.288731649394339 |
|
9046 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCP4L1 |
0.288731649394339 |
|
9047 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MPZ |
0.288731649394339 |
|
9048 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SDHC |
0.288731649394339 |
|
9049 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C1orf192 |
0.288731649394339 |
|
9050 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FCGR2A |
0.288731649394339 |
|
9051 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FCGR2B |
0.288731649394339 |
|
9052 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FCGR2C |
0.288731649394339 |
|
9053 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FCGR3A |
0.288731649394339 |
|
9054 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FCGR3B |
0.288731649394339 |
|
9055 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HSPA6 |
0.288731649394339 |
|
9056 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPL31P11 |
0.288731649394339 |
|
9057 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FCRLA |
0.288731649394339 |
|
9058 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FCRLB |
0.288731649394339 |
|
9059 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL466P |
0.288731649394339 |
|
9060 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
POLD3 |
0.288830978897646 |
|
9061 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CRABP2 |
0.289221683294589 |
|
9062 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ISG20L2 |
0.289221683294589 |
|
9063 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RRNAD1 |
0.289221683294589 |
|
9064 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EPB41L3 |
0.289300299316233 |
|
9065 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snR65|ENSG00000252576.1 |
0.289300299316233 |
|
9066 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD112|ENSG00000252572.1 |
0.289300299316233 |
|
9067 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FBN3 |
0.289312900626113 |
|
9068 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CRISP2 |
0.289337047120507 |
|
9069 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CRISP3 |
0.289337047120507 |
|
9070 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PGK2 |
0.289337047120507 |
|
9071 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CRISP1 |
0.289337047120507 |
|
9072 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DEFB133 |
0.289337047120507 |
|
9073 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DEFB114 |
0.289337047120507 |
|
9074 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DEFB113 |
0.289337047120507 |
|
9075 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HIPK4 |
0.289422502335851 |
|
9076 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRX |
0.289422502335851 |
|
9077 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SERTAD1 |
0.289422502335851 |
|
9078 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SERTAD3 |
0.289422502335851 |
|
9079 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BLVRB |
0.289422502335851 |
|
9080 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPTBN4 |
0.289422502335851 |
|
9081 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C22orf42 |
0.289547197784804 |
|
9082 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RFPL2 |
0.289547197784804 |
|
9083 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC5A4 |
0.289547197784804 |
|
9084 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FBXO7 |
0.289547197784804 |
|
9085 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C20orf96 |
0.289653901265134 |
|
9086 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DEFB125 |
0.289653901265134 |
|
9087 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DEFB126 |
0.289653901265134 |
|
9088 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DEFB127 |
0.289653901265134 |
|
9089 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DEFB128 |
0.289653901265134 |
|
9090 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DEFB129 |
0.289653901265134 |
|
9091 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DEFB132 |
0.289653901265134 |
|
9092 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NRSN2 |
0.289653901265134 |
|
9093 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RBCK1 |
0.289653901265134 |
|
9094 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SOX12 |
0.289653901265134 |
|
9095 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TBC1D20 |
0.289653901265134 |
|
9096 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRIB3 |
0.289653901265134 |
|
9097 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZCCHC3 |
0.289653901265134 |
|
9098 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SRXN1 |
0.289653901265134 |
|
9099 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCRT2 |
0.289653901265134 |
|
9100 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC52A3 |
0.289653901265134 |
|
9101 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM110A |
0.289653901265134 |
|
9102 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANGPT4 |
0.289653901265134 |
|
9103 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RSPO4 |
0.289653901265134 |
|
9104 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C20orf202 |
0.289653901265134 |
|
9105 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PSMF1 |
0.289653901265134 |
|
9106 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM74B |
0.289653901265134 |
|
9107 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAD21L1 |
0.289653901265134 |
|
9108 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNPH |
0.289653901265134 |
|
9109 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SDCBP2 |
0.289653901265134 |
|
9110 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FKBP1A |
0.289653901265134 |
|
9111 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NSFL1C |
0.289653901265134 |
|
9112 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MPPED1 |
0.289817817817819 |
|
9113 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EFCAB6 |
0.289817817817819 |
|
9114 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BBS4 |
0.289930048291018 |
|
9115 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADPGK |
0.289930048291018 |
|
9116 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IFI16 |
0.289974443384999 |
|
9117 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AIM2 |
0.289974443384999 |
|
9118 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP318 |
0.29011210792968 |
|
9119 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IMPACT |
0.290242291347463 |
|
9120 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HRH4 |
0.290242291347463 |
|
9121 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CA14 |
0.29027850413147 |
|
9122 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238526.1 |
0.29027850413147 |
|
9123 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
APH1A |
0.29027850413147 |
|
9124 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C1orf54 |
0.29027850413147 |
|
9125 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C1orf51 |
0.29027850413147 |
|
9126 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MRPS21 |
0.29027850413147 |
|
9127 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIS12 |
0.290427284632278 |
|
9128 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCTD20 |
0.290459462904865 |
|
9129 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL502P |
0.290459462904865 |
|
9130 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STK38 |
0.290459462904865 |
|
9131 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL748P |
0.290459462904865 |
|
9132 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
USP8 |
0.290472957152008 |
|
9133 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP395 |
0.290472957152008 |
|
9134 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
USP50 |
0.290472957152008 |
|
9135 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PHF21B |
0.290532259676988 |
|
9136 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL728P |
0.290556587549319 |
|
9137 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MILR1 |
0.2906419011947 |
|
9138 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
POLG2 |
0.2906419011947 |
|
9139 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OSTM1 |
0.29068874855769 |
|
9140 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPC5 |
0.290778805355422 |
|
9141 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STIM1 |
0.290856204029478 |
|
9142 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GOLPH3 |
0.290880648174934 |
|
9143 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STAM2 |
0.29092147009012 |
|
9144 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LCORL |
0.291077740585451 |
|
9145 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNU105C |
0.29111044145209 |
|
9146 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NEUROD2 |
0.291147985517471 |
|
9147 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPP1R1B |
0.291147985517471 |
|
9148 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STARD3 |
0.291147985517471 |
|
9149 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TCAP |
0.291147985517471 |
|
9150 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PNMT |
0.291147985517471 |
|
9151 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GLP2R |
0.291455303384663 |
|
9152 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARHGAP8 |
0.291484467789082 |
|
9153 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238312.1 |
0.291537769335828 |
|
9154 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IMPG2 |
0.291537769335828 |
|
9155 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SENP7 |
0.291537769335828 |
|
9156 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238525.1 |
0.291537769335828 |
|
9157 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRMT10C |
0.291537769335828 |
|
9158 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCNP |
0.291537769335828 |
|
9159 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDH5 |
0.291558095821622 |
|
9160 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00920 |
0.291558095821622 |
|
9161 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADD3 |
0.2917057134822 |
|
9162 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL450P |
0.2917057134822 |
|
9163 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MEN1 |
0.291719554339347 |
|
9164 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ICOS |
0.291810458730394 |
|
9165 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PDSS2 |
0.291852985423828 |
|
9166 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NUP98 |
0.291894355405432 |
|
9167 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF91 |
0.291990511366404 |
|
9168 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RIBC2 |
0.292382917188575 |
|
9169 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FBLN1 |
0.292382917188575 |
|
9170 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ID4 |
0.292452769832942 |
|
9171 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FH |
0.292524134778936 |
|
9172 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KMO |
0.292524134778936 |
|
9173 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OPN3 |
0.292524134778936 |
|
9174 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CHML |
0.292524134778936 |
|
9175 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WDR64 |
0.292524134778936 |
|
9176 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EXO1 |
0.292524134778936 |
|
9177 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAP1LC3C |
0.292524134778936 |
|
9178 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLD5 |
0.292524134778936 |
|
9179 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP81 |
0.292524134778936 |
|
9180 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP12 |
0.292524134778936 |
|
9181 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IGF1R |
0.292604106994549 |
|
9182 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4714 |
0.292604106994549 |
|
9183 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SYNM |
0.292604106994549 |
|
9184 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DKFZP779J2370 |
0.292604106994549 |
|
9185 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LYSMD4 |
0.292604106994549 |
|
9186 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DNM1P46 |
0.292604106994549 |
|
9187 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL484P |
0.292604106994549 |
|
9188 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD23|ENSG00000221139.1 |
0.292607028247552 |
|
9189 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GNL1 |
0.292654368012518 |
|
9190 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRR3 |
0.292654368012518 |
|
9191 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MRPL15 |
0.29269125629541 |
|
9192 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNU6ATAC32P |
0.29269125629541 |
|
9193 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CABYR |
0.292850703477249 |
|
9194 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP452 |
0.292850703477249 |
|
9195 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL247P |
0.292850703477249 |
|
9196 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR320C2 |
0.292850703477249 |
|
9197 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLVS2 |
0.292992706972852 |
|
9198 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VAPB |
0.293081487215233 |
|
9199 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
APCDD1L |
0.293081487215233 |
|
9200 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MGC4294 |
0.293081487215233 |
|
9201 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STX16 |
0.293081487215233 |
|
9202 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NPEPL1 |
0.293081487215233 |
|
9203 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR296 |
0.293081487215233 |
|
9204 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR298 |
0.293081487215233 |
|
9205 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GNAS |
0.293081487215233 |
|
9206 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TNFSF14 |
0.293093232628653 |
|
9207 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLEC2A |
0.293321244412737 |
|
9208 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLEC12A |
0.293321244412737 |
|
9209 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLEC1B |
0.293321244412737 |
|
9210 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLEC12B |
0.293321244412737 |
|
9211 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLEC9A |
0.293321244412737 |
|
9212 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLEC1A |
0.293321244412737 |
|
9213 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP161 |
0.293321244412737 |
|
9214 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLEC7A |
0.293321244412737 |
|
9215 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OLR1 |
0.293321244412737 |
|
9216 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM52B |
0.293321244412737 |
|
9217 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GABARAPL1 |
0.293321244412737 |
|
9218 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KLRD1 |
0.293321244412737 |
|
9219 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KLRK1 |
0.293321244412737 |
|
9220 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KLRC4 |
0.293321244412737 |
|
9221 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PTPRU |
0.293437822710563 |
|
9222 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF229 |
0.293441502510039 |
|
9223 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PVR |
0.293441502510039 |
|
9224 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IL34 |
0.293549162749419 |
|
9225 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FLJ00418 |
0.293549162749419 |
|
9226 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MTSS1L |
0.293549162749419 |
|
9227 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VAC14 |
0.293549162749419 |
|
9228 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNU6ATAC25P |
0.293549162749419 |
|
9229 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD112|ENSG00000251700.1 |
0.293549162749419 |
|
9230 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NFYC |
0.293650476388253 |
|
9231 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF565 |
0.293697727232099 |
|
9232 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL287P |
0.293697727232099 |
|
9233 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF146 |
0.293697727232099 |
|
9234 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SIRPB2 |
0.293733192543096 |
|
9235 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SIRPD |
0.293733192543096 |
|
9236 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SIRPB1 |
0.293733192543096 |
|
9237 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SIRPG |
0.293733192543096 |
|
9238 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL561P |
0.293733192543096 |
|
9239 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR2Z1 |
0.293841313531997 |
|
9240 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EEF1A1 |
0.293926582531089 |
|
9241 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OVCH1 |
0.293931504616304 |
|
9242 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MARCH1 |
0.293992898011498 |
|
9243 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZFR |
0.294029528945392 |
|
9244 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NPR3 |
0.294029528945392 |
|
9245 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00636 |
0.294408712081713 |
|
9246 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TKTL2 |
0.294470174260338 |
|
9247 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMA16 |
0.294470174260338 |
|
9248 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TGFBR1 |
0.294486710683998 |
|
9249 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL794P |
0.294486710683998 |
|
9250 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ALG2 |
0.294486710683998 |
|
9251 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SEC61B |
0.294486710683998 |
|
9252 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DDX11 |
0.29449579175313 |
|
9253 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM60A |
0.29449579175313 |
|
9254 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238661.1 |
0.29449579175313 |
|
9255 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DENND5B |
0.29449579175313 |
|
9256 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000239033.1 |
0.29449579175313 |
|
9257 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HERC4 |
0.294503563817352 |
|
9258 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MYPN |
0.294503563817352 |
|
9259 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA3|ENSG00000221148.1 |
0.294562058764928 |
|
9260 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL220P |
0.294589536943431 |
|
9261 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP202 |
0.294589536943431 |
|
9262 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCMTD1 |
0.294664887428453 |
|
9263 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TINAGL1 |
0.294690961126986 |
|
9264 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HCRTR1 |
0.294690961126986 |
|
9265 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PEF1 |
0.294690961126986 |
|
9266 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COL16A1 |
0.294690961126986 |
|
9267 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BAI2 |
0.294690961126986 |
|
9268 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4254 |
0.294690961126986 |
|
9269 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPOCD1 |
0.294690961126986 |
|
9270 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PTP4A2 |
0.294690961126986 |
|
9271 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KHDRBS1 |
0.294690961126986 |
|
9272 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CARD17 |
0.294762496867633 |
|
9273 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CARD18 |
0.294762496867633 |
|
9274 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GRIA4 |
0.294762496867633 |
|
9275 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PROM1 |
0.294869821352949 |
|
9276 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TAPT1 |
0.294869821352949 |
|
9277 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZEB2P1 |
0.294869821352949 |
|
9278 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZFP82 |
0.295160718937415 |
|
9279 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SND1 |
0.295200442201683 |
|
9280 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MARS2 |
0.295217509545838 |
|
9281 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BOLL |
0.295217509545838 |
|
9282 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRPF3 |
0.295218273504936 |
|
9283 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPRD2 |
0.295218273504936 |
|
9284 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TARS2 |
0.295218273504936 |
|
9285 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ECM1 |
0.295218273504936 |
|
9286 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00568 |
0.295218273504936 |
|
9287 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADAMTSL4 |
0.295218273504936 |
|
9288 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4257 |
0.295218273504936 |
|
9289 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C1orf138 |
0.295218273504936 |
|
9290 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL473P |
0.295218273504936 |
|
9291 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL600P |
0.295218273504936 |
|
9292 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MCL1 |
0.295218273504936 |
|
9293 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ENSA |
0.295218273504936 |
|
9294 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA40|ENSG00000253047.1 |
0.295218273504936 |
|
9295 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LAP3 |
0.295354338473156 |
|
9296 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL315P |
0.295354338473156 |
|
9297 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MED28 |
0.295354338473156 |
|
9298 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PVRL2 |
0.295423776595899 |
|
9299 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANXA3 |
0.295516341763045 |
|
9300 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238816.1 |
0.295516341763045 |
|
9301 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BMP2K |
0.295516341763045 |
|
9302 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR5096 |
0.295516341763045 |
|
9303 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PAQR3 |
0.295516341763045 |
|
9304 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL127P |
0.295516341763045 |
|
9305 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLEKHM1P |
0.295864630307276 |
|
9306 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL409P |
0.295864630307276 |
|
9307 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRRC37A3 |
0.295864630307276 |
|
9308 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL404P |
0.295864630307276 |
|
9309 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC16A6P1 |
0.295864630307276 |
|
9310 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AMZ2P1 |
0.295864630307276 |
|
9311 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GNA13 |
0.295864630307276 |
|
9312 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP168 |
0.295917647886552 |
|
9313 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP387 |
0.295920467034656 |
|
9314 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C14orf1 |
0.295920467034656 |
|
9315 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IFT43 |
0.295920467034656 |
|
9316 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TGFB3 |
0.295920467034656 |
|
9317 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PALD1 |
0.296049518527603 |
|
9318 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD112|ENSG00000252883.1 |
0.296056892853294 |
|
9319 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ABCA8 |
0.296185446864128 |
|
9320 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ABCA9 |
0.296185446864128 |
|
9321 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ABCA6 |
0.296185446864128 |
|
9322 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4524B |
0.296185446864128 |
|
9323 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ABCA10 |
0.296185446864128 |
|
9324 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD29 |
0.296462330654088 |
|
9325 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MYO5C |
0.296595246164685 |
|
9326 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EMID1 |
0.296907268543299 |
|
9327 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RHBDD3 |
0.296907268543299 |
|
9328 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EWSR1 |
0.296907268543299 |
|
9329 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF253 |
0.297029997518437 |
|
9330 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF430 |
0.297029997518437 |
|
9331 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF486 |
0.297029997518437 |
|
9332 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF626 |
0.297029997518437 |
|
9333 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF66 |
0.297029997518437 |
|
9334 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF682 |
0.297029997518437 |
|
9335 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF737 |
0.297029997518437 |
|
9336 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF826P |
0.297029997518437 |
|
9337 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF85 |
0.297029997518437 |
|
9338 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF90 |
0.297029997518437 |
|
9339 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF93 |
0.297029997518437 |
|
9340 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNY3P4 |
0.297089243928262 |
|
9341 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00362 |
0.297089243928262 |
|
9342 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDK19 |
0.297261374140237 |
|
9343 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA40|ENSG00000212587.1 |
0.297261374140237 |
|
9344 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CUX1 |
0.297335601963868 |
|
9345 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4285 |
0.297335601963868 |
|
9346 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SH2B2 |
0.297335601963868 |
|
9347 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRKRIP1 |
0.297335601963868 |
|
9348 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR548O |
0.297335601963868 |
|
9349 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ORAI2 |
0.297335601963868 |
|
9350 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ALKBH4 |
0.297335601963868 |
|
9351 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM185A |
0.297335601963868 |
|
9352 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRWD1 |
0.297335601963868 |
|
9353 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4467 |
0.297335601963868 |
|
9354 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR5090 |
0.297335601963868 |
|
9355 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
POLR2J2 |
0.297335601963868 |
|
9356 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
POLR2J3 |
0.297335601963868 |
|
9357 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
POLR2J |
0.297335601963868 |
|
9358 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RASA4B |
0.297335601963868 |
|
9359 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RASA4 |
0.297335601963868 |
|
9360 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPDYE2B |
0.297335601963868 |
|
9361 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPDYE2 |
0.297335601963868 |
|
9362 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UPK3BL |
0.297335601963868 |
|
9363 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC24A5 |
0.297386839218465 |
|
9364 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MYEF2 |
0.297386839218465 |
|
9365 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CXXC4 |
0.297398112358118 |
|
9366 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR633 |
0.297431184921576 |
|
9367 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC9A7 |
0.297467914396869 |
|
9368 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BCAS3 |
0.297589345271466 |
|
9369 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM19 |
0.297654870228236 |
|
9370 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAB21 |
0.297654870228236 |
|
9371 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TBC1D15 |
0.297654870228236 |
|
9372 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TPH2 |
0.297654870228236 |
|
9373 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZCCHC8 |
0.2977333224318 |
|
9374 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA9|ENSG00000252192.1 |
0.2977333224318 |
|
9375 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RSRC2 |
0.2977333224318 |
|
9376 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KNTC1 |
0.2977333224318 |
|
9377 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HCAR2 |
0.2977333224318 |
|
9378 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HIP1R |
0.2977333224318 |
|
9379 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VPS37B |
0.2977333224318 |
|
9380 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZRANB2 |
0.297801040917752 |
|
9381 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR186 |
0.297801040917752 |
|
9382 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ABCB9 |
0.297840223295367 |
|
9383 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARL6IP4 |
0.297840223295367 |
|
9384 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OGFOD2 |
0.297840223295367 |
|
9385 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PITPNM2 |
0.297840223295367 |
|
9386 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4304 |
0.297840223295367 |
|
9387 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL133P |
0.297840223295367 |
|
9388 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MPHOSPH9 |
0.297840223295367 |
|
9389 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STK24 |
0.297980518807038 |
|
9390 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4503 |
0.298094323256962 |
|
9391 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FNTA |
0.298163350413365 |
|
9392 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HGSNAT |
0.298163350413365 |
|
9393 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
POTEA |
0.298163350413365 |
|
9394 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP41 |
0.298163350413365 |
|
9395 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SGK196 |
0.298163350413365 |
|
9396 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U3|ENSG00000201329.1 |
0.298163350413365 |
|
9397 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PHF2 |
0.298787881639992 |
|
9398 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4291 |
0.298787881639992 |
|
9399 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BARX1 |
0.298787881639992 |
|
9400 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PTPDC1 |
0.298787881639992 |
|
9401 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TARS |
0.299073262643378 |
|
9402 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GALNT11 |
0.299164188327642 |
|
9403 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4470 |
0.299166830995718 |
|
9404 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZFPM1 |
0.29921697199472 |
|
9405 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
INSR |
0.299223207712197 |
|
9406 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RICTOR |
0.299296147055912 |
|
9407 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FYB |
0.299296147055912 |
|
9408 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TEX2 |
0.299328623375683 |
|
9409 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPP1R37 |
0.299328874029862 |
|
9410 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RBM17 |
0.299434220905089 |
|
9411 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PFKFB3 |
0.299434220905089 |
|
9412 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP78 |
0.299434220905089 |
|
9413 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3155A |
0.299434220905089 |
|
9414 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC39A8 |
0.299579257190728 |
|
9415 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NFKB1 |
0.299579257190728 |
|
9416 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SRSF3 |
0.299886738162621 |
|
9417 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3925 |
0.299886738162621 |
|
9418 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KLRF2 |
0.300351664640403 |
|
9419 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238972.1 |
0.300380386608096 |
|
9420 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DCAF4 |
0.300380386608096 |
|
9421 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZFYVE1 |
0.300380386608096 |
|
9422 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL586P |
0.300380386608096 |
|
9423 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NUMB |
0.300380386608096 |
|
9424 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HEATR4 |
0.300380386608096 |
|
9425 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C14orf169 |
0.300380386608096 |
|
9426 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATOH7 |
0.300551047172966 |
|
9427 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLCB1 |
0.300557361624539 |
|
9428 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC35E3 |
0.300625700324764 |
|
9429 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MDM2 |
0.300625700324764 |
|
9430 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CPM |
0.300625700324764 |
|
9431 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CTSK |
0.300749708036932 |
|
9432 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARNT |
0.300749708036932 |
|
9433 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SETDB1 |
0.300749708036932 |
|
9434 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CERS2 |
0.300749708036932 |
|
9435 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANXA9 |
0.300749708036932 |
|
9436 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM63A |
0.300749708036932 |
|
9437 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRUNE |
0.300749708036932 |
|
9438 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BNIPL |
0.300749708036932 |
|
9439 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C1orf56 |
0.300749708036932 |
|
9440 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDC42SE1 |
0.300749708036932 |
|
9441 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MLLT11 |
0.300749708036932 |
|
9442 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GABPB2 |
0.300749708036932 |
|
9443 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LARP4B |
0.300800650249513 |
|
9444 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GTPBP4 |
0.300800650249513 |
|
9445 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADARB2 |
0.300800650249513 |
|
9446 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IDI1 |
0.300800650249513 |
|
9447 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IDI2 |
0.300800650249513 |
|
9448 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00200 |
0.300800650249513 |
|
9449 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WDR37 |
0.300800650249513 |
|
9450 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIB1 |
0.30086469536018 |
|
9451 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA73|ENSG00000199977.1 |
0.30086469536018 |
|
9452 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RFX4 |
0.301151334481062 |
|
9453 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CELSR1 |
0.301251248579025 |
|
9454 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR548AJ1 |
0.301275844489154 |
|
9455 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MOXD1 |
0.301275844489154 |
|
9456 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZBTB20 |
0.301298253146825 |
|
9457 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238864.1 |
0.301375727306314 |
|
9458 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4279 |
0.301375727306314 |
|
9459 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF831 |
0.3013966122187 |
|
9460 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EDN3 |
0.3013966122187 |
|
9461 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AASDHPPT |
0.301868532584526 |
|
9462 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACSF3 |
0.301911919485883 |
|
9463 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
APRT |
0.301911919485883 |
|
9464 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CBFA2T3 |
0.301911919485883 |
|
9465 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDH15 |
0.301911919485883 |
|
9466 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDT1 |
0.301911919485883 |
|
9467 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CTU2 |
0.301911919485883 |
|
9468 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CYBA |
0.301911919485883 |
|
9469 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GALNS |
0.301911919485883 |
|
9470 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IL17C |
0.301911919485883 |
|
9471 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00304 |
0.301911919485883 |
|
9472 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4722 |
0.301911919485883 |
|
9473 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR5189 |
0.301911919485883 |
|
9474 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MVD |
0.301911919485883 |
|
9475 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PABPN1L |
0.301911919485883 |
|
9476 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PIEZO1 |
0.301911919485883 |
|
9477 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNF166 |
0.301911919485883 |
|
9478 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC22A31 |
0.301911919485883 |
|
9479 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNAI3 |
0.301911919485883 |
|
9480 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAPPC2L |
0.301911919485883 |
|
9481 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZC3H18 |
0.301911919485883 |
|
9482 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF778 |
0.301911919485883 |
|
9483 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LEP |
0.301966379887612 |
|
9484 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RBM28 |
0.301966379887612 |
|
9485 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRRT4 |
0.301966379887612 |
|
9486 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IMPDH1 |
0.301966379887612 |
|
9487 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRRTM3 |
0.301999672682426 |
|
9488 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GIGYF1 |
0.302120169323134 |
|
9489 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GNB2 |
0.302120169323134 |
|
9490 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
POP7 |
0.302120169323134 |
|
9491 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EPO |
0.302120169323134 |
|
9492 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZAN |
0.302120169323134 |
|
9493 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EPHB4 |
0.302120169323134 |
|
9494 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCD5 |
0.302297206952606 |
|
9495 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SEC31A |
0.302297206952606 |
|
9496 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
THAP9 |
0.302297206952606 |
|
9497 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LIN54 |
0.302297206952606 |
|
9498 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoR442|ENSG00000252834.1 |
0.302297206952606 |
|
9499 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COPS4 |
0.302297206952606 |
|
9500 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CHRNA6 |
0.302384109655057 |
|
9501 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
METTL20 |
0.302385596894408 |
|
9502 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AMN1 |
0.302385596894408 |
|
9503 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PTHLH |
0.302394756355761 |
|
9504 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C7orf62 |
0.302420808329193 |
|
9505 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C7orf63 |
0.302420808329193 |
|
9506 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DPY19L2P4 |
0.302420808329193 |
|
9507 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STEAP1 |
0.302420808329193 |
|
9508 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STEAP2 |
0.302420808329193 |
|
9509 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF804B |
0.302420808329193 |
|
9510 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HCG9 |
0.302451024090388 |
|
9511 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNRD1 |
0.302451024090388 |
|
9512 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPP1R11 |
0.302451024090388 |
|
9513 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNF39 |
0.302451024090388 |
|
9514 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRIM31 |
0.302451024090388 |
|
9515 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA48|ENSG00000252228.1 |
0.302451024090388 |
|
9516 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRIM40 |
0.302451024090388 |
|
9517 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRIM10 |
0.302451024090388 |
|
9518 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRIM15 |
0.302451024090388 |
|
9519 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRIM26 |
0.302451024090388 |
|
9520 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DDRGK1 |
0.302631994377215 |
|
9521 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ITPA |
0.302631994377215 |
|
9522 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC4A11 |
0.302631994377215 |
|
9523 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C20orf194 |
0.302631994377215 |
|
9524 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL839P |
0.302631994377215 |
|
9525 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U3|ENSG00000201346.1 |
0.302631994377215 |
|
9526 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GFRA4 |
0.302631994377215 |
|
9527 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADAM33 |
0.302631994377215 |
|
9528 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SIGLEC1 |
0.302631994377215 |
|
9529 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00954 |
0.302915623717098 |
|
9530 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TTC32 |
0.302915623717098 |
|
9531 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC24A6 |
0.303003534500664 |
|
9532 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP115 |
0.303113905380516 |
|
9533 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRPC6 |
0.303113905380516 |
|
9534 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3920 |
0.303113905380516 |
|
9535 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPL9 |
0.303261470336982 |
|
9536 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LIAS |
0.303261470336982 |
|
9537 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UGDH |
0.303261470336982 |
|
9538 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SMIM14 |
0.303261470336982 |
|
9539 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC117 |
0.30327130984377 |
|
9540 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
XBP1 |
0.30327130984377 |
|
9541 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM26 |
0.303607620720928 |
|
9542 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ERCC6 |
0.303621742888121 |
|
9543 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SOST |
0.303789161105151 |
|
9544 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DUSP3 |
0.303789161105151 |
|
9545 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C17orf105 |
0.303789161105151 |
|
9546 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MPP3 |
0.303789161105151 |
|
9547 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CD300LG |
0.303789161105151 |
|
9548 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MPP2 |
0.303789161105151 |
|
9549 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM215A |
0.303789161105151 |
|
9550 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPY |
0.303789161105151 |
|
9551 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PYY |
0.303789161105151 |
|
9552 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NAGS |
0.303789161105151 |
|
9553 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM101 |
0.303789161105151 |
|
9554 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U3|ENSG00000221044.1 |
0.303789161105151 |
|
9555 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CD200R1 |
0.303830264111655 |
|
9556 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RBM19 |
0.303847201643769 |
|
9557 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PAGE1 |
0.303853848486354 |
|
9558 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM71F1 |
0.303854444039175 |
|
9559 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM71F2 |
0.303854444039175 |
|
9560 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HILPDA |
0.303854444039175 |
|
9561 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
METTL2B |
0.303854444039175 |
|
9562 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP242 |
0.303854444039175 |
|
9563 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP243 |
0.303854444039175 |
|
9564 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CALU |
0.303854444039175 |
|
9565 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL81P |
0.303854444039175 |
|
9566 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OPN1SW |
0.303854444039175 |
|
9567 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC136 |
0.303854444039175 |
|
9568 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FLNC |
0.303854444039175 |
|
9569 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATP6V1F |
0.303854444039175 |
|
9570 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
USP31 |
0.303915066686911 |
|
9571 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCNN1G |
0.303915066686911 |
|
9572 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCNN1B |
0.303915066686911 |
|
9573 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COG7 |
0.303915066686911 |
|
9574 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP23 |
0.303915066686911 |
|
9575 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRRC71 |
0.304105650886263 |
|
9576 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARHGEF11 |
0.304105650886263 |
|
9577 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR765 |
0.304105650886263 |
|
9578 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL612P |
0.304105650886263 |
|
9579 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ETV3L |
0.304105650886263 |
|
9580 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ETV3 |
0.304105650886263 |
|
9581 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FCRL5 |
0.304105650886263 |
|
9582 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FCRL4 |
0.304105650886263 |
|
9583 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FCRL3 |
0.304105650886263 |
|
9584 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FCRL2 |
0.304105650886263 |
|
9585 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FCRL1 |
0.304105650886263 |
|
9586 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CD5L |
0.304105650886263 |
|
9587 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIRREL |
0.304105650886263 |
|
9588 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CD1D |
0.304105650886263 |
|
9589 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CD1E |
0.304105650886263 |
|
9590 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR10K2 |
0.304105650886263 |
|
9591 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR10K1 |
0.304105650886263 |
|
9592 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR10R2 |
0.304105650886263 |
|
9593 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR10X1 |
0.304105650886263 |
|
9594 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR6P1 |
0.304105650886263 |
|
9595 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR6Y1 |
0.304105650886263 |
|
9596 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR10Z1 |
0.304105650886263 |
|
9597 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPTA1 |
0.304105650886263 |
|
9598 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR6K2 |
0.304105650886263 |
|
9599 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR6K3 |
0.304105650886263 |
|
9600 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR6K6 |
0.304105650886263 |
|
9601 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR6N1 |
0.304105650886263 |
|
9602 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR6N2 |
0.304105650886263 |
|
9603 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CNP |
0.304172842568446 |
|
9604 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DNAJC7 |
0.304172842568446 |
|
9605 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL508P |
0.304257614546332 |
|
9606 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACOT1 |
0.304296579415898 |
|
9607 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACOT2 |
0.304296579415898 |
|
9608 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACOT4 |
0.304296579415898 |
|
9609 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACOT6 |
0.304296579415898 |
|
9610 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238330.1 |
0.304296579415898 |
|
9611 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GOPC |
0.30448492215141 |
|
9612 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NUS1 |
0.30448492215141 |
|
9613 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3121 |
0.304631857406248 |
|
9614 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LNX1 |
0.30467251422859 |
|
9615 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NPIPB1P |
0.304681472661304 |
|
9616 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GNAL |
0.304681472661304 |
|
9617 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CATSPERB |
0.304766510857045 |
|
9618 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U3|ENSG00000200042.1 |
0.304766510857045 |
|
9619 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TXK |
0.30478809680299 |
|
9620 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FERMT1 |
0.304823518804895 |
|
9621 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HCAR1 |
0.304867318900406 |
|
9622 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HCAR3 |
0.304867318900406 |
|
9623 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DENR |
0.304867318900406 |
|
9624 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC62 |
0.304867318900406 |
|
9625 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TBC1D32 |
0.305174912713761 |
|
9626 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C18orf42 |
0.305224294442184 |
|
9627 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00667 |
0.305224294442184 |
|
9628 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00526 |
0.305224294442184 |
|
9629 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZBTB14 |
0.305224294442184 |
|
9630 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3976 |
0.305262997462343 |
|
9631 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM200C |
0.305262997462343 |
|
9632 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ERP44 |
0.305316076527689 |
|
9633 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL75P |
0.305316076527689 |
|
9634 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IL1RAPL2 |
0.305495916953088 |
|
9635 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRR5L |
0.30563999548789 |
|
9636 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GOLPH3L |
0.305800423858628 |
|
9637 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HORMAD1 |
0.305800423858628 |
|
9638 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CTSS |
0.305800423858628 |
|
9639 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANK3 |
0.305850501512991 |
|
9640 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EPHA5 |
0.306179496791141 |
|
9641 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4762 |
0.306211173584537 |
|
9642 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WNT7B |
0.306211173584537 |
|
9643 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00899 |
0.306211173584537 |
|
9644 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C22orf26 |
0.306211173584537 |
|
9645 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ETNPPL |
0.306323733986128 |
|
9646 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARHGAP10 |
0.306328810669633 |
|
9647 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP166 |
0.306328810669633 |
|
9648 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ST13 |
0.306341631939836 |
|
9649 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DNAJB7 |
0.306341631939836 |
|
9650 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
XPNPEP3 |
0.306341631939836 |
|
9651 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238887.1 |
0.306341631939836 |
|
9652 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIAA0408 |
0.306567032708794 |
|
9653 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CYYR1 |
0.30675967424057 |
|
9654 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAPGEF3 |
0.306770707908034 |
|
9655 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC48A1 |
0.306770707908034 |
|
9656 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HDAC7 |
0.306770707908034 |
|
9657 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ROBO3 |
0.306858944815913 |
|
9658 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ROBO4 |
0.306858944815913 |
|
9659 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HEPACAM |
0.306858944815913 |
|
9660 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HEPN1 |
0.306858944815913 |
|
9661 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC15 |
0.306858944815913 |
|
9662 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC37A2 |
0.306858944815913 |
|
9663 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM218 |
0.306858944815913 |
|
9664 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KRT18P59 |
0.306858944815913 |
|
9665 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CMIP |
0.306987554921741 |
|
9666 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLCG2 |
0.306987554921741 |
|
9667 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPATCH2L |
0.307235264544073 |
|
9668 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PAPPA2 |
0.307359466852688 |
|
9669 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ASTN1 |
0.307359466852688 |
|
9670 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR488 |
0.307359466852688 |
|
9671 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM5B |
0.307359466852688 |
|
9672 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPLP0P2 |
0.307438813243894 |
|
9673 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DAGLA |
0.307438813243894 |
|
9674 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MYRF |
0.307438813243894 |
|
9675 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM258 |
0.307438813243894 |
|
9676 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FADS2 |
0.307438813243894 |
|
9677 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FEN1 |
0.307438813243894 |
|
9678 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR611 |
0.307438813243894 |
|
9679 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FADS1 |
0.307438813243894 |
|
9680 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR1908 |
0.307438813243894 |
|
9681 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FADS3 |
0.307438813243894 |
|
9682 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAB3IL1 |
0.307438813243894 |
|
9683 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GGH |
0.307480689839865 |
|
9684 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TTPA |
0.307480689839865 |
|
9685 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
YTHDF3 |
0.307480689839865 |
|
9686 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL135P |
0.307480689839865 |
|
9687 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP135 |
0.307480689839865 |
|
9688 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00966 |
0.307480689839865 |
|
9689 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP2 |
0.307539834437097 |
|
9690 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00598 |
0.307539834437097 |
|
9691 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HCN4 |
0.307560592092338 |
|
9692 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C15orf60 |
0.307560592092338 |
|
9693 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NPTN |
0.307560592092338 |
|
9694 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GARS |
0.307664047852341 |
|
9695 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CRHR2 |
0.307664047852341 |
|
9696 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM188B |
0.307664047852341 |
|
9697 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AQP1 |
0.307664047852341 |
|
9698 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GHRHR |
0.307664047852341 |
|
9699 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SOBP |
0.307670235729656 |
|
9700 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCML4 |
0.307670235729656 |
|
9701 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SEC63 |
0.307670235729656 |
|
9702 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SMPDL3B |
0.307739537076554 |
|
9703 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
XKR8 |
0.307739537076554 |
|
9704 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EYA3 |
0.307739537076554 |
|
9705 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL559P |
0.307739537076554 |
|
9706 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP373 |
0.307951205187484 |
|
9707 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM109A |
0.307951205187484 |
|
9708 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SH2B3 |
0.307951205187484 |
|
9709 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00395 |
0.308303099532217 |
|
9710 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PTAFR |
0.308316790704539 |
|
9711 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DNAJC8 |
0.308316790704539 |
|
9712 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATPIF1 |
0.308316790704539 |
|
9713 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SESN2 |
0.308316790704539 |
|
9714 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MED18 |
0.308316790704539 |
|
9715 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HACE1 |
0.309100751995362 |
|
9716 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00577 |
0.309100751995362 |
|
9717 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LIN28B |
0.309100751995362 |
|
9718 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BVES |
0.309100751995362 |
|
9719 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
POPDC3 |
0.309100751995362 |
|
9720 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FRMPD4 |
0.309101771743525 |
|
9721 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
7SK|ENSG00000271814.1 |
0.309101771743525 |
|
9722 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRPS2 |
0.309101771743525 |
|
9723 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AHR |
0.309178577464369 |
|
9724 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA63|ENSG00000199473.1 |
0.309178577464369 |
|
9725 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00355 |
0.309312090166733 |
|
9726 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIAA1239 |
0.309330764119239 |
|
9727 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CACNG4 |
0.309408710627618 |
|
9728 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CETN3 |
0.309437627947535 |
|
9729 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MBLAC2 |
0.309437627947535 |
|
9730 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
POLR3G |
0.309437627947535 |
|
9731 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LYSMD3 |
0.309437627947535 |
|
9732 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARRDC3 |
0.309437627947535 |
|
9733 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DMXL2 |
0.309546772662871 |
|
9734 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NR2F1 |
0.309574548373705 |
|
9735 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM172A |
0.309574548373705 |
|
9736 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR2277 |
0.309574548373705 |
|
9737 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
POU5F2 |
0.309574548373705 |
|
9738 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PREP |
0.310316553675949 |
|
9739 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR10T2 |
0.310648260217763 |
|
9740 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DRG1 |
0.310694975689198 |
|
9741 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SFI1 |
0.310694975689198 |
|
9742 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C4orf32 |
0.310929678774864 |
|
9743 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR1281 |
0.311175615575854 |
|
9744 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC63 |
0.311242223390136 |
|
9745 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MYL2 |
0.311242223390136 |
|
9746 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CUX2 |
0.311242223390136 |
|
9747 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EFCAB2 |
0.311249071612917 |
|
9748 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ESRRB |
0.311351352825577 |
|
9749 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DDX1 |
0.311437992968796 |
|
9750 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MYCNOS |
0.311437992968796 |
|
9751 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MYCN |
0.311437992968796 |
|
9752 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL104P |
0.311437992968796 |
|
9753 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HCG17 |
0.311505353965211 |
|
9754 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HCG18 |
0.311505353965211 |
|
9755 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPP21 |
0.311505353965211 |
|
9756 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRIM39 |
0.311505353965211 |
|
9757 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RFC1 |
0.311521994295138 |
|
9758 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KLB |
0.311521994295138 |
|
9759 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR5591 |
0.311521994295138 |
|
9760 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CACYBP |
0.311586294027961 |
|
9761 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MRPS14 |
0.311586294027961 |
|
9762 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRIL |
0.311593453653041 |
|
9763 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00083 |
0.311623246359124 |
|
9764 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TEX35 |
0.311623246359124 |
|
9765 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C1ORF220 |
0.311623246359124 |
|
9766 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C1orf220 |
0.311623246359124 |
|
9767 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP69 |
0.311623246359124 |
|
9768 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4424 |
0.311623246359124 |
|
9769 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RALGPS2 |
0.311623246359124 |
|
9770 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA63|ENSG00000201791.1 |
0.311623246359124 |
|
9771 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANGPTL1 |
0.311623246359124 |
|
9772 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM20B |
0.311623246359124 |
|
9773 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TOR3A |
0.311623246359124 |
|
9774 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TNN |
0.311643629731078 |
|
9775 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIAA0040 |
0.311643629731078 |
|
9776 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TNR |
0.311643629731078 |
|
9777 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C1orf110 |
0.311870124998589 |
|
9778 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RGS4 |
0.311870124998589 |
|
9779 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RGS5 |
0.311870124998589 |
|
9780 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ENPP3 |
0.311914455362646 |
|
9781 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR548H5 |
0.311914455362646 |
|
9782 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ENPP1 |
0.311914455362646 |
|
9783 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP245 |
0.311914455362646 |
|
9784 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00486 |
0.311931733247272 |
|
9785 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LTBP1 |
0.311931733247272 |
|
9786 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4765 |
0.311931733247272 |
|
9787 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR558 |
0.311931733247272 |
|
9788 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD112|ENSG00000252502.1 |
0.311931733247272 |
|
9789 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TTC27 |
0.311931733247272 |
|
9790 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP91 |
0.311931733247272 |
|
9791 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP92 |
0.311931733247272 |
|
9792 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CHST9 |
0.312059123792225 |
|
9793 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GRAMD4 |
0.312186835466266 |
|
9794 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CERK |
0.312186835466266 |
|
9795 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C12orf50 |
0.312273273792816 |
|
9796 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C12orf29 |
0.312273273792816 |
|
9797 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CEP290 |
0.312273273792816 |
|
9798 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP364 |
0.312273273792816 |
|
9799 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMTC3 |
0.312273273792816 |
|
9800 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4692 |
0.312442360276915 |
|
9801 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATG16L2 |
0.312442360276915 |
|
9802 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FGFR1OP2 |
0.312486033957463 |
|
9803 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TM7SF3 |
0.312486033957463 |
|
9804 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MED21 |
0.312486033957463 |
|
9805 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C12orf71 |
0.312486033957463 |
|
9806 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STK38L |
0.312486033957463 |
|
9807 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARNTL2 |
0.312486033957463 |
|
9808 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SMCO2 |
0.312486033957463 |
|
9809 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPR128 |
0.312543135433709 |
|
9810 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA31|ENSG00000252989.1 |
0.312543135433709 |
|
9811 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TFG |
0.312543135433709 |
|
9812 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM120B |
0.313409109664906 |
|
9813 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RHOF |
0.313409109664906 |
|
9814 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SETD1B |
0.313409109664906 |
|
9815 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HPD |
0.313409109664906 |
|
9816 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PSMD9 |
0.313409109664906 |
|
9817 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WDR66 |
0.313409109664906 |
|
9818 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BCL7A |
0.313409109664906 |
|
9819 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MLXIP |
0.313409109664906 |
|
9820 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IL31 |
0.313409109664906 |
|
9821 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNF34 |
0.313449938001079 |
|
9822 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KDM2B |
0.313449938001079 |
|
9823 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ORAI1 |
0.313449938001079 |
|
9824 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNY3P9 |
0.313599347597583 |
|
9825 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VGLL3 |
0.313753553956065 |
|
9826 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCP |
0.3137569872787 |
|
9827 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IRF5 |
0.3137569872787 |
|
9828 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP97 |
0.313811918079621 |
|
9829 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OLFML2B |
0.313910338956048 |
|
9830 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4654 |
0.313910338956048 |
|
9831 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP61 |
0.313910338956048 |
|
9832 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR556 |
0.313910338956048 |
|
9833 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C1orf226 |
0.313910338956048 |
|
9834 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C1orf111 |
0.313910338956048 |
|
9835 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SH2D1B |
0.313910338956048 |
|
9836 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UHMK1 |
0.313910338956048 |
|
9837 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UAP1 |
0.313910338956048 |
|
9838 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DDR2 |
0.313910338956048 |
|
9839 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL861P |
0.313910338956048 |
|
9840 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HSD17B7 |
0.313910338956048 |
|
9841 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NUF2 |
0.313910338956048 |
|
9842 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CIT |
0.314121574494894 |
|
9843 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR1178 |
0.314121574494894 |
|
9844 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC64 |
0.314121574494894 |
|
9845 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000272464.1 |
0.314121574494894 |
|
9846 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAB35 |
0.314121574494894 |
|
9847 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GCN1L1 |
0.314121574494894 |
|
9848 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MSI1 |
0.314121574494894 |
|
9849 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPS27P25 |
0.314121574494894 |
|
9850 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COX6A1 |
0.314121574494894 |
|
9851 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GATC |
0.314121574494894 |
|
9852 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRIAP1 |
0.314121574494894 |
|
9853 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SRSF9 |
0.314121574494894 |
|
9854 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DYNLL1 |
0.314121574494894 |
|
9855 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COQ5 |
0.314121574494894 |
|
9856 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNF10 |
0.314121574494894 |
|
9857 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
POP5 |
0.314121574494894 |
|
9858 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CABP1 |
0.314121574494894 |
|
9859 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MLEC |
0.314121574494894 |
|
9860 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UNC119B |
0.314121574494894 |
|
9861 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4700 |
0.314121574494894 |
|
9862 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACADS |
0.314121574494894 |
|
9863 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA70|ENSG00000201945.1 |
0.314121574494894 |
|
9864 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
P2RX7 |
0.314121574494894 |
|
9865 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
P2RX4 |
0.314121574494894 |
|
9866 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CAMKK2 |
0.314121574494894 |
|
9867 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANAPC5 |
0.314121574494894 |
|
9868 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP284 |
0.314296449369017 |
|
9869 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA19|ENSG00000251822.1 |
0.314315873215684 |
|
9870 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HS3ST5 |
0.314404864046699 |
|
9871 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM55A |
0.31442301092855 |
|
9872 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OTUD6B |
0.31442301092855 |
|
9873 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP231 |
0.31442301092855 |
|
9874 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR620 |
0.314428260357976 |
|
9875 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF562 |
0.314568262185074 |
|
9876 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DGKZ |
0.314611967284777 |
|
9877 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CHRM4 |
0.314611967284777 |
|
9878 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MDK |
0.314611967284777 |
|
9879 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4688 |
0.314611967284777 |
|
9880 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MSANTD3 |
0.314698439836612 |
|
9881 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEFF1 |
0.314698439836612 |
|
9882 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MURC |
0.314698439836612 |
|
9883 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP87 |
0.314698439836612 |
|
9884 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA31|ENSG00000253041.1 |
0.314698439836612 |
|
9885 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GAS2L1 |
0.31483782580777 |
|
9886 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RASL10A |
0.31483782580777 |
|
9887 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD125 |
0.31483782580777 |
|
9888 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TBX3 |
0.314854518080243 |
|
9889 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA27|ENSG00000252459.1 |
0.314854518080243 |
|
9890 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC109B |
0.314956470828313 |
|
9891 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4703 |
0.315016535024702 |
|
9892 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COMMD9 |
0.315398010926502 |
|
9893 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00610 |
0.315398010926502 |
|
9894 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GUCY2GP |
0.315724869380763 |
|
9895 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACSL5 |
0.315724869380763 |
|
9896 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA75|ENSG00000206780.1 |
0.315747789138418 |
|
9897 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
QDPR |
0.315747789138418 |
|
9898 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
JMJD1C |
0.315757167323009 |
|
9899 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR1296 |
0.315757167323009 |
|
9900 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
REEP3 |
0.315757167323009 |
|
9901 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TLR7 |
0.316101385269386 |
|
9902 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TLR8 |
0.316101385269386 |
|
9903 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMSB4X |
0.316101385269386 |
|
9904 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM9C |
0.316101385269386 |
|
9905 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BOD1L1 |
0.316131411226675 |
|
9906 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR5091 |
0.316131411226675 |
|
9907 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA63|ENSG00000202449.1 |
0.316131411226675 |
|
9908 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TBC1D25 |
0.31615834604566 |
|
9909 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000239017.1 |
0.31615834604566 |
|
9910 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GLOD5 |
0.31615834604566 |
|
9911 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GATA1 |
0.31615834604566 |
|
9912 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HDAC6 |
0.31615834604566 |
|
9913 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ERAS |
0.31615834604566 |
|
9914 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCSK1N |
0.31615834604566 |
|
9915 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TIMM17B |
0.31615834604566 |
|
9916 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PQBP1 |
0.31615834604566 |
|
9917 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LGR5 |
0.316336746078704 |
|
9918 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EPHA3 |
0.316364321766206 |
|
9919 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRRTM4 |
0.316554341468214 |
|
9920 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HS3ST2 |
0.316555720393978 |
|
9921 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARFGAP3 |
0.316571650919135 |
|
9922 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PACSIN2 |
0.316571650919135 |
|
9923 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RGS21 |
0.317381537256024 |
|
9924 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCL25 |
0.317382746085158 |
|
9925 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U3|ENSG00000252241.1 |
0.317797249953561 |
|
9926 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RGS18 |
0.317798784164404 |
|
9927 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL419P |
0.317814875756809 |
|
9928 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SMTNL2 |
0.317929383670601 |
|
9929 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ALOX15 |
0.317929383670601 |
|
9930 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PELP1 |
0.317929383670601 |
|
9931 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TXNDC16 |
0.317964549434311 |
|
9932 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPR137C |
0.317964549434311 |
|
9933 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADAMTS17 |
0.31805964618627 |
|
9934 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP402 |
0.31805964618627 |
|
9935 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CERS3 |
0.31805964618627 |
|
9936 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPATA41 |
0.31805964618627 |
|
9937 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINS |
0.31805964618627 |
|
9938 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPR37 |
0.318172474530896 |
|
9939 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
POT1 |
0.318172474530896 |
|
9940 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RGS1 |
0.318226094890788 |
|
9941 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RGS13 |
0.318226094890788 |
|
9942 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP40 |
0.318407564822494 |
|
9943 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4789 |
0.318407564822494 |
|
9944 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000271842.1 |
0.318407564822494 |
|
9945 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COL25A1 |
0.318482516916703 |
|
9946 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SEC24B |
0.318482516916703 |
|
9947 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL55P |
0.318482516916703 |
|
9948 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR576 |
0.318482516916703 |
|
9949 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL865P |
0.318537144046109 |
|
9950 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RBFOX2 |
0.318576905557466 |
|
9951 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HSPH1 |
0.318639084706132 |
|
9952 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
B3GALTL |
0.318639084706132 |
|
9953 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MYADML |
0.319020584298164 |
|
9954 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRELID1P1 |
0.319103924403847 |
|
9955 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCBD1 |
0.319150917977094 |
|
9956 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RASGRP3 |
0.319184745930913 |
|
9957 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM98A |
0.319184745930913 |
|
9958 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
YIPF7 |
0.319203389697217 |
|
9959 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FMNL2 |
0.319512377539486 |
|
9960 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRPF40A |
0.319512377539486 |
|
9961 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARL6IP6 |
0.319512377539486 |
|
9962 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FCF1 |
0.319684995451301 |
|
9963 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA7|ENSG00000222604.1 |
0.319684995451301 |
|
9964 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RBM25 |
0.319975261862118 |
|
9965 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PSEN1 |
0.319975261862118 |
|
9966 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PAPLN |
0.319975261862118 |
|
9967 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP211 |
0.320373461841459 |
|
9968 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRDM1 |
0.320373461841459 |
|
9969 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3144 |
0.320850267608738 |
|
9970 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UBE2K |
0.320933749032369 |
|
9971 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM218A |
0.320965109712349 |
|
9972 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRIM61 |
0.320965109712349 |
|
9973 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRIM60 |
0.320965109712349 |
|
9974 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM192 |
0.320965109712349 |
|
9975 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KLHL2 |
0.320965109712349 |
|
9976 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MSMO1 |
0.320965109712349 |
|
9977 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR578 |
0.320965109712349 |
|
9978 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DNAL1 |
0.320973494006429 |
|
9979 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PNMA1 |
0.320973494006429 |
|
9980 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ELMSAN1 |
0.320973494006429 |
|
9981 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4505 |
0.320973494006429 |
|
9982 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR14J1 |
0.321043851657691 |
|
9983 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR5V1 |
0.321043851657691 |
|
9984 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR12D3 |
0.321043851657691 |
|
9985 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR12D2 |
0.321043851657691 |
|
9986 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR12D1P |
0.321043851657691 |
|
9987 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR11A1 |
0.321043851657691 |
|
9988 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR10C1 |
0.321043851657691 |
|
9989 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR2H1 |
0.321043851657691 |
|
9990 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAS1L |
0.321043851657691 |
|
9991 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GABBR1 |
0.321043851657691 |
|
9992 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UBD |
0.321043851657691 |
|
9993 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR2H2 |
0.321043851657691 |
|
9994 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD32B |
0.321043851657691 |
|
9995 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MOG |
0.321043851657691 |
|
9996 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZFP57 |
0.321043851657691 |
|
9997 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TDP1 |
0.321262786681404 |
|
9998 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BEST1 |
0.321272629457841 |
|
9999 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FTH1 |
0.321272629457841 |
|
10000 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCGB1D1 |
0.321272629457841 |
|
10001 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCGB2A1 |
0.321272629457841 |
|
10002 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCGB1D2 |
0.321272629457841 |
|
10003 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCGB2A2 |
0.321272629457841 |
|
10004 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCGB1D4 |
0.321272629457841 |
|
10005 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CAPN8 |
0.32155831997748 |
|
10006 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CAPN2 |
0.32155831997748 |
|
10007 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TP53BP2 |
0.32155831997748 |
|
10008 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP159 |
0.321562347803811 |
|
10009 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TBC1D22A |
0.321572860443567 |
|
10010 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UACA |
0.321819743528559 |
|
10011 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPL29P30 |
0.321819743528559 |
|
10012 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LARP6 |
0.321819743528559 |
|
10013 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRRC49 |
0.321819743528559 |
|
10014 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
THAP10 |
0.321819743528559 |
|
10015 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CT62 |
0.321819743528559 |
|
10016 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U3|ENSG00000265369.2 |
0.321884690286369 |
|
10017 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AQP4 |
0.321884690286369 |
|
10018 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR7E19P |
0.322060806919981 |
|
10019 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WDR20 |
0.322655624433505 |
|
10020 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MOK |
0.322655624433505 |
|
10021 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF839 |
0.322655624433505 |
|
10022 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CINP |
0.322655624433505 |
|
10023 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000239061.1 |
0.322655624433505 |
|
10024 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TECPR2 |
0.322655624433505 |
|
10025 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DYNC1LI2 |
0.322739833679544 |
|
10026 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR593 |
0.322937818881932 |
|
10027 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDK1 |
0.322975863545431 |
|
10028 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00845 |
0.322975863545431 |
|
10029 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GRIP1 |
0.323025432232208 |
|
10030 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IFNG |
0.323025432232208 |
|
10031 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IL26 |
0.323025432232208 |
|
10032 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IL22 |
0.323025432232208 |
|
10033 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MDM1 |
0.323025432232208 |
|
10034 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP428 |
0.323199905524697 |
|
10035 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CHRM1 |
0.323281167737545 |
|
10036 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL259P |
0.323281167737545 |
|
10037 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC22A6 |
0.323281167737545 |
|
10038 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C6orf183 |
0.323341524209685 |
|
10039 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM229B |
0.323699177361858 |
|
10040 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LAMA4 |
0.323699177361858 |
|
10041 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SERINC1 |
0.323790778691625 |
|
10042 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD38|ENSG00000200733.1 |
0.323937144846233 |
|
10043 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00559 |
0.323937144846233 |
|
10044 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLDN19 |
0.324066597408878 |
|
10045 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AP1B1P1 |
0.324132949041428 |
|
10046 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C1orf101 |
0.324133485243107 |
|
10047 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DESI2 |
0.324133485243107 |
|
10048 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COX20 |
0.324133485243107 |
|
10049 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HNRNPU |
0.324133485243107 |
|
10050 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP55 |
0.324133485243107 |
|
10051 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CPE |
0.32416781642723 |
|
10052 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238433.1 |
0.324457963909879 |
|
10053 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LGALS12 |
0.32448627346694 |
|
10054 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RARRES3 |
0.32448627346694 |
|
10055 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HRASLS2 |
0.32448627346694 |
|
10056 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLA2G16 |
0.32448627346694 |
|
10057 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATL3 |
0.32448627346694 |
|
10058 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAGEB18 |
0.324615891960895 |
|
10059 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAGEB6 |
0.324615891960895 |
|
10060 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAGEB5 |
0.324615891960895 |
|
10061 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR30C1 |
0.324710324824769 |
|
10062 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCNQ4 |
0.324710324824769 |
|
10063 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL326P |
0.324710324824769 |
|
10064 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CITED4 |
0.324710324824769 |
|
10065 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CD1A |
0.324746508996887 |
|
10066 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CD1C |
0.324746508996887 |
|
10067 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CD1B |
0.324746508996887 |
|
10068 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF561 |
0.325041055741081 |
|
10069 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C19orf82 |
0.325041055741081 |
|
10070 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAB21L2 |
0.325068234540233 |
|
10071 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SH3D19 |
0.325068234540233 |
|
10072 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRSS48 |
0.325068234540233 |
|
10073 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FOXO3 |
0.325149570631329 |
|
10074 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PTPRJ |
0.325185328457246 |
|
10075 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GHR |
0.325294812867576 |
|
10076 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC152 |
0.325294812867576 |
|
10077 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GUCY2EP |
0.325323880719822 |
|
10078 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TSKU |
0.325323880719822 |
|
10079 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AKAP7 |
0.325357469669874 |
|
10080 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TGIF1 |
0.325399333507007 |
|
10081 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238863.1 |
0.325399333507007 |
|
10082 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL39P |
0.325399333507007 |
|
10083 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238445.1 |
0.325399333507007 |
|
10084 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
P4HA1 |
0.32540531027125 |
|
10085 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPSAP52 |
0.325597902526757 |
|
10086 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HMGA2 |
0.325597902526757 |
|
10087 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP362 |
0.325597902526757 |
|
10088 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LLPH |
0.325597902526757 |
|
10089 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMBIM4 |
0.325597902526757 |
|
10090 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IRAK3 |
0.325597902526757 |
|
10091 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP166 |
0.325597902526757 |
|
10092 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HELB |
0.325597902526757 |
|
10093 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238528.1 |
0.325597902526757 |
|
10094 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SIRPA |
0.325684047497611 |
|
10095 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MED13L |
0.32606839286155 |
|
10096 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SRRM4 |
0.326126865239656 |
|
10097 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HSPB8 |
0.326126865239656 |
|
10098 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC60 |
0.326126865239656 |
|
10099 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRRC7 |
0.326167733447221 |
|
10100 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UBA1 |
0.32617529792714 |
|
10101 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
INE1 |
0.32617529792714 |
|
10102 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDK16 |
0.32617529792714 |
|
10103 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
USP11 |
0.32617529792714 |
|
10104 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LAMA1 |
0.326553009776323 |
|
10105 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL537P |
0.326553009776323 |
|
10106 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRRC30 |
0.326553009776323 |
|
10107 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA48|ENSG00000212626.1 |
0.326553009776323 |
|
10108 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CXADRP3 |
0.326604933725771 |
|
10109 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
POTEC |
0.326604933725771 |
|
10110 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GABRA4 |
0.326700657438613 |
|
10111 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GABRB1 |
0.326700657438613 |
|
10112 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
THADA |
0.326717798013015 |
|
10113 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL472P |
0.326927406500807 |
|
10114 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HSP90AA1 |
0.326927406500807 |
|
10115 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANKRD9 |
0.326927406500807 |
|
10116 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4309 |
0.326927406500807 |
|
10117 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL546P |
0.326927406500807 |
|
10118 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VENTXP1 |
0.327050243273098 |
|
10119 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
S100A10 |
0.327382680752829 |
|
10120 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NBPF18P |
0.327382680752829 |
|
10121 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
S100A11 |
0.327382680752829 |
|
10122 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL371P |
0.327487175268329 |
|
10123 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ABL2 |
0.327490619546941 |
|
10124 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA67|ENSG00000201619.1 |
0.327490619546941 |
|
10125 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA67|ENSG00000212338.1 |
0.327490619546941 |
|
10126 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SOAT1 |
0.327490619546941 |
|
10127 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AXDND1 |
0.327490619546941 |
|
10128 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL374P |
0.327490619546941 |
|
10129 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NPHS2 |
0.327490619546941 |
|
10130 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TDRD5 |
0.327490619546941 |
|
10131 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RCOR1 |
0.327505819937314 |
|
10132 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RFPL3 |
0.327627965396146 |
|
10133 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RFPL3S |
0.327627965396146 |
|
10134 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RTCB |
0.327627965396146 |
|
10135 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BPIFC |
0.327627965396146 |
|
10136 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PGPEP1L |
0.32775254321405 |
|
10137 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP215 |
0.327926020759524 |
|
10138 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IQGAP3 |
0.327966642664882 |
|
10139 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PUM1 |
0.328085649096504 |
|
10140 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL745P |
0.328242842751383 |
|
10141 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
INCENP |
0.328529233221222 |
|
10142 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRNAU1AP |
0.328530494205106 |
|
10143 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNHG12 |
0.328530494205106 |
|
10144 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD99 |
0.328530494205106 |
|
10145 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ETV6 |
0.328538354218932 |
|
10146 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CHST3 |
0.328643453047371 |
|
10147 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PXDNL |
0.328743156799899 |
|
10148 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC92 |
0.328884971789658 |
|
10149 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DNAH10OS |
0.328884971789658 |
|
10150 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF664 |
0.328884971789658 |
|
10151 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RERE |
0.328925602023411 |
|
10152 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SOSTDC1 |
0.329130029637868 |
|
10153 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRRC72 |
0.329130029637868 |
|
10154 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANKMY2 |
0.329130029637868 |
|
10155 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BZW2 |
0.329130029637868 |
|
10156 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TSPAN13 |
0.329130029637868 |
|
10157 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AGR2 |
0.329130029637868 |
|
10158 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AGR3 |
0.329130029637868 |
|
10159 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MARCH2 |
0.329167174882917 |
|
10160 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM46C |
0.329232386554191 |
|
10161 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WDSUB1 |
0.329310190863304 |
|
10162 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRED60 |
0.329417620993857 |
|
10163 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRED62 |
0.329417620993857 |
|
10164 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COL6A1 |
0.329417620993857 |
|
10165 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MCM3AP |
0.329417620993857 |
|
10166 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C21orf58 |
0.329417620993857 |
|
10167 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DIP2A |
0.329417620993857 |
|
10168 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCNT |
0.329417620993857 |
|
10169 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRMT2 |
0.329417620993857 |
|
10170 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
S100B |
0.329417620993857 |
|
10171 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
YBEY |
0.329417620993857 |
|
10172 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UNC5B |
0.329489774985315 |
|
10173 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC29A3 |
0.329489774985315 |
|
10174 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238918.1 |
0.329489774985315 |
|
10175 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SYT4 |
0.329497974964022 |
|
10176 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DUSP12 |
0.329569929338132 |
|
10177 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATF6 |
0.329569929338132 |
|
10178 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NUDT13 |
0.329613902746715 |
|
10179 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA11|ENSG00000221164.1 |
0.329613902746715 |
|
10180 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ECD |
0.329613902746715 |
|
10181 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM149B1 |
0.329613902746715 |
|
10182 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DNAJC9 |
0.329613902746715 |
|
10183 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MRPS16 |
0.329613902746715 |
|
10184 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HNRNPM |
0.329689774988461 |
|
10185 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRAM1 |
0.329689774988461 |
|
10186 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF414 |
0.329689774988461 |
|
10187 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MYO1F |
0.329689774988461 |
|
10188 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADAMTS10 |
0.329689774988461 |
|
10189 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANKS6 |
0.329734143844097 |
|
10190 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GALNT12 |
0.329734143844097 |
|
10191 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COL15A1 |
0.329734143844097 |
|
10192 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP290 |
0.329734143844097 |
|
10193 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TBX2 |
0.329781527670929 |
|
10194 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C17orf82 |
0.329781527670929 |
|
10195 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NACA2 |
0.329781527670929 |
|
10196 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DYNC2LI1 |
0.329931148464081 |
|
10197 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ROR2 |
0.330020124841095 |
|
10198 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPTLC1 |
0.330020124841095 |
|
10199 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00475 |
0.330020124841095 |
|
10200 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238996.1 |
0.330020124841095 |
|
10201 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IARS |
0.330020124841095 |
|
10202 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA84 |
0.330020124841095 |
|
10203 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NOL8 |
0.330020124841095 |
|
10204 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ASPN |
0.330020124841095 |
|
10205 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CENPP |
0.330020124841095 |
|
10206 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ECM2 |
0.330020124841095 |
|
10207 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4670 |
0.330020124841095 |
|
10208 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OGN |
0.330020124841095 |
|
10209 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OMD |
0.330020124841095 |
|
10210 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ABCF1 |
0.330127754370696 |
|
10211 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR877 |
0.330127754370696 |
|
10212 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPP1R10 |
0.330127754370696 |
|
10213 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MRPS18B |
0.330127754370696 |
|
10214 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATAT1 |
0.330127754370696 |
|
10215 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C6orf136 |
0.330127754370696 |
|
10216 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DHX16 |
0.330127754370696 |
|
10217 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NRM |
0.330127754370696 |
|
10218 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPP1R18 |
0.330127754370696 |
|
10219 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MDC1 |
0.330127754370696 |
|
10220 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TUBB |
0.330127754370696 |
|
10221 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FLOT1 |
0.330127754370696 |
|
10222 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IER3 |
0.330127754370696 |
|
10223 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL353P |
0.330127754370696 |
|
10224 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HCG20 |
0.330127754370696 |
|
10225 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00243 |
0.330127754370696 |
|
10226 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DDR1 |
0.330127754370696 |
|
10227 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP186 |
0.330127754370696 |
|
10228 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4640 |
0.330127754370696 |
|
10229 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GTF2H4 |
0.330127754370696 |
|
10230 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL175P |
0.330127754370696 |
|
10231 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VARS2 |
0.330127754370696 |
|
10232 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SFTA2 |
0.330127754370696 |
|
10233 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DPCR1 |
0.330127754370696 |
|
10234 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HCG21 |
0.330127754370696 |
|
10235 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FGF10 |
0.330209636085379 |
|
10236 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM39B |
0.330261998407583 |
|
10237 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR5585 |
0.330261998407583 |
|
10238 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NUTM2F |
0.330358534713105 |
|
10239 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SARNP |
0.330447986233883 |
|
10240 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WIBG |
0.330447986233883 |
|
10241 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLIP1 |
0.330565687506888 |
|
10242 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LGALS16 |
0.33073582927419 |
|
10243 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LGALS17A |
0.33073582927419 |
|
10244 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LGALS14 |
0.33073582927419 |
|
10245 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLC |
0.33073582927419 |
|
10246 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LEUTX |
0.33073582927419 |
|
10247 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DYRK1B |
0.33073582927419 |
|
10248 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FBL |
0.33073582927419 |
|
10249 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FCGBP |
0.33073582927419 |
|
10250 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
REV3L |
0.330738912269262 |
|
10251 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4498 |
0.330791462125894 |
|
10252 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPLP0 |
0.330791462125894 |
|
10253 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PXN |
0.330791462125894 |
|
10254 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SIRT4 |
0.330791462125894 |
|
10255 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLA2G1B |
0.330791462125894 |
|
10256 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HNF1A |
0.330791462125894 |
|
10257 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C12orf43 |
0.330791462125894 |
|
10258 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OASL |
0.330791462125894 |
|
10259 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NFAM1 |
0.330839060980107 |
|
10260 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
POLDIP3 |
0.330839060980107 |
|
10261 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP80 |
0.330839060980107 |
|
10262 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RRP7A |
0.330839060980107 |
|
10263 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RRP7B |
0.330839060980107 |
|
10264 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SERHL2 |
0.330839060980107 |
|
10265 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SERHL |
0.330839060980107 |
|
10266 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNU12 |
0.330839060980107 |
|
10267 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CYB5R3 |
0.330839060980107 |
|
10268 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATP5L2 |
0.330839060980107 |
|
10269 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACTL9 |
0.330993561835186 |
|
10270 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OSBPL1A |
0.331013008503649 |
|
10271 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C12orf65 |
0.331200888456708 |
|
10272 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDK2AP1 |
0.331200888456708 |
|
10273 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP375 |
0.331200888456708 |
|
10274 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SBNO1 |
0.331200888456708 |
|
10275 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SETD8 |
0.331200888456708 |
|
10276 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM169B |
0.331435678406474 |
|
10277 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MS4A6E |
0.331485232069106 |
|
10278 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MUC19 |
0.331620147542531 |
|
10279 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COX6B1 |
0.331694879811009 |
|
10280 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL765P |
0.331694879811009 |
|
10281 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UPK1A |
0.331694879811009 |
|
10282 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZBTB32 |
0.331694879811009 |
|
10283 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KMT2B |
0.331694879811009 |
|
10284 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WBP7 |
0.331694879811009 |
|
10285 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IGFLR1 |
0.331694879811009 |
|
10286 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LIN37 |
0.331694879811009 |
|
10287 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PSENEN |
0.331694879811009 |
|
10288 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U2AF1L4 |
0.331694879811009 |
|
10289 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C19orf55 |
0.331694879811009 |
|
10290 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HSPB6 |
0.331694879811009 |
|
10291 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARHGAP33 |
0.331694879811009 |
|
10292 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRODH2 |
0.331694879811009 |
|
10293 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NPHS1 |
0.331694879811009 |
|
10294 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIRREL2 |
0.331694879811009 |
|
10295 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
APLP1 |
0.331694879811009 |
|
10296 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL402P |
0.331694879811009 |
|
10297 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NFKBID |
0.331694879811009 |
|
10298 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4757 |
0.331788449712781 |
|
10299 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OSR1 |
0.331788449712781 |
|
10300 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OSBP |
0.331959018649946 |
|
10301 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IPPK |
0.332117824482992 |
|
10302 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BICD2 |
0.332117824482992 |
|
10303 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARHGAP42 |
0.332293198806409 |
|
10304 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
POLR3B |
0.332307081009597 |
|
10305 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZFC3H1 |
0.332321074392379 |
|
10306 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA17|ENSG00000212461.1 |
0.332321074392379 |
|
10307 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
THAP2 |
0.332321074392379 |
|
10308 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PSMC4 |
0.332563550696357 |
|
10309 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF546 |
0.332563550696357 |
|
10310 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA75|ENSG00000212533.1 |
0.332647491706299 |
|
10311 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MUC21 |
0.332697699883032 |
|
10312 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MUC22 |
0.332697699883032 |
|
10313 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HCG22 |
0.332697699883032 |
|
10314 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C6orf15 |
0.332697699883032 |
|
10315 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDSN |
0.332697699883032 |
|
10316 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PSORS1C1 |
0.332697699883032 |
|
10317 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PSORS1C2 |
0.332697699883032 |
|
10318 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCHCR1 |
0.332697699883032 |
|
10319 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TCF19 |
0.332697699883032 |
|
10320 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
POU5F1 |
0.332697699883032 |
|
10321 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PSORS1C3 |
0.332697699883032 |
|
10322 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HCG27 |
0.332697699883032 |
|
10323 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00448 |
0.332712331543026 |
|
10324 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL384P |
0.332799783856349 |
|
10325 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRUB1 |
0.332799783856349 |
|
10326 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PTCHD1 |
0.332886909351175 |
|
10327 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238327.1 |
0.332886909351175 |
|
10328 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNRPD1 |
0.333078411544104 |
|
10329 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ABHD3 |
0.333078411544104 |
|
10330 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR320C1 |
0.333078411544104 |
|
10331 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA81|ENSG00000252677.1 |
0.333078411544104 |
|
10332 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL233P |
0.333078411544104 |
|
10333 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR4D6 |
0.333109251904606 |
|
10334 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR4D10 |
0.333109251904606 |
|
10335 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR4D11 |
0.333109251904606 |
|
10336 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3162 |
0.333109251904606 |
|
10337 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPP3CB |
0.333194931477246 |
|
10338 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RBM3 |
0.333238090487618 |
|
10339 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WDR13 |
0.333238090487618 |
|
10340 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WAS |
0.333238090487618 |
|
10341 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SUV39H1 |
0.333238090487618 |
|
10342 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF812 |
0.333347746425801 |
|
10343 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP355 |
0.333413255809448 |
|
10344 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SEC16B |
0.333464978395121 |
|
10345 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC41 |
0.333656604681641 |
|
10346 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL330P |
0.333656604681641 |
|
10347 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL483P |
0.333656604681641 |
|
10348 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR5700 |
0.333656604681641 |
|
10349 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMCC3 |
0.333656604681641 |
|
10350 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NDUFA12 |
0.333656604681641 |
|
10351 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NR2C1 |
0.333656604681641 |
|
10352 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FGD6 |
0.333656604681641 |
|
10353 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
R3HDM2 |
0.333856885341523 |
|
10354 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
INHBC |
0.333856885341523 |
|
10355 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
INHBE |
0.333856885341523 |
|
10356 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GLI1 |
0.333856885341523 |
|
10357 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARHGAP9 |
0.333856885341523 |
|
10358 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DTX3 |
0.333856885341523 |
|
10359 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARHGEF25 |
0.333856885341523 |
|
10360 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
B4GALNT1 |
0.333856885341523 |
|
10361 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC26A10 |
0.333856885341523 |
|
10362 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238436.1 |
0.333856885341523 |
|
10363 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OS9 |
0.333856885341523 |
|
10364 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AGAP2 |
0.333856885341523 |
|
10365 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TSPAN31 |
0.333856885341523 |
|
10366 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDK4 |
0.333856885341523 |
|
10367 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MARCH9 |
0.333856885341523 |
|
10368 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CYP27B1 |
0.333856885341523 |
|
10369 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
METTL1 |
0.333856885341523 |
|
10370 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
METTL21B |
0.333856885341523 |
|
10371 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TSFM |
0.333856885341523 |
|
10372 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AVIL |
0.333856885341523 |
|
10373 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CTDSP2 |
0.333856885341523 |
|
10374 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UCP3 |
0.333994860939225 |
|
10375 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C2CD3 |
0.333994860939225 |
|
10376 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM117B |
0.33401377725616 |
|
10377 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3123 |
0.334053413498635 |
|
10378 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RP2 |
0.334526345799762 |
|
10379 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CXorf31 |
0.334526345799762 |
|
10380 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ITPKC |
0.334823395002155 |
|
10381 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C19orf54 |
0.334823395002155 |
|
10382 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNRPA |
0.334823395002155 |
|
10383 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIA |
0.334823395002155 |
|
10384 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAB4B |
0.334823395002155 |
|
10385 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EGLN2 |
0.334823395002155 |
|
10386 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CYP2A6 |
0.334823395002155 |
|
10387 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CYP2A7 |
0.334823395002155 |
|
10388 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CYP2G1P |
0.334823395002155 |
|
10389 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL530P |
0.33484104211234 |
|
10390 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VSX2 |
0.33484104211234 |
|
10391 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ABCD4 |
0.33484104211234 |
|
10392 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VRTN |
0.33484104211234 |
|
10393 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SYNDIG1L |
0.33484104211234 |
|
10394 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NPC2 |
0.33484104211234 |
|
10395 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4709 |
0.33484104211234 |
|
10396 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ISCA2 |
0.33484104211234 |
|
10397 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LTBP2 |
0.33484104211234 |
|
10398 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AREL1 |
0.33484104211234 |
|
10399 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PHEX |
0.334917699460908 |
|
10400 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF645 |
0.334917699460908 |
|
10401 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRIM2 |
0.334949429302811 |
|
10402 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MND1 |
0.334949429302811 |
|
10403 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WASF1 |
0.335485161960435 |
|
10404 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDC40 |
0.335485161960435 |
|
10405 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
METTL24 |
0.335485161960435 |
|
10406 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DDO |
0.335485161960435 |
|
10407 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC22A16 |
0.335485161960435 |
|
10408 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL617P |
0.335485161960435 |
|
10409 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SYNCRIP |
0.335603170440434 |
|
10410 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNHG5 |
0.335603170440434 |
|
10411 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00354 |
0.335735072565406 |
|
10412 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD44 |
0.335735072565406 |
|
10413 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SOX1 |
0.335735072565406 |
|
10414 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00403 |
0.335735072565406 |
|
10415 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00404 |
0.335735072565406 |
|
10416 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GRAMD2 |
0.335766505621907 |
|
10417 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PTGER3 |
0.336047637544948 |
|
10418 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
YIPF4 |
0.336064436901879 |
|
10419 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HRH3 |
0.336090082548857 |
|
10420 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OSBPL2 |
0.336090082548857 |
|
10421 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADRM1 |
0.336090082548857 |
|
10422 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LAMA5 |
0.336090082548857 |
|
10423 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BHLHE23 |
0.336090082548857 |
|
10424 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00029 |
0.336090082548857 |
|
10425 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HAR1A |
0.336090082548857 |
|
10426 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HAR1B |
0.336090082548857 |
|
10427 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
YTHDF1 |
0.336090082548857 |
|
10428 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BIRC7 |
0.336090082548857 |
|
10429 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3196 |
0.336090082548857 |
|
10430 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NKAIN4 |
0.336090082548857 |
|
10431 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARFGAP1 |
0.336090082548857 |
|
10432 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4326 |
0.336090082548857 |
|
10433 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COL20A1 |
0.336090082548857 |
|
10434 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CHRNA4 |
0.336090082548857 |
|
10435 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCNQ2 |
0.336090082548857 |
|
10436 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EEF1A2 |
0.336090082548857 |
|
10437 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPDPF |
0.336090082548857 |
|
10438 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C20orf195 |
0.336090082548857 |
|
10439 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PTK6 |
0.336090082548857 |
|
10440 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SRMS |
0.336090082548857 |
|
10441 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HELZ2 |
0.336090082548857 |
|
10442 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GMEB2 |
0.336090082548857 |
|
10443 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ABHD16B |
0.336090082548857 |
|
10444 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARFRP1 |
0.336090082548857 |
|
10445 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C20ORF135 |
0.336090082548857 |
|
10446 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C20orf201 |
0.336090082548857 |
|
10447 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DNAJC5 |
0.336090082548857 |
|
10448 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LIME1 |
0.336090082548857 |
|
10449 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00176 |
0.336090082548857 |
|
10450 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR1914 |
0.336090082548857 |
|
10451 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR647 |
0.336090082548857 |
|
10452 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MYT1 |
0.336090082548857 |
|
10453 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NPBWR2 |
0.336090082548857 |
|
10454 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OPRL1 |
0.336090082548857 |
|
10455 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCMTD2 |
0.336090082548857 |
|
10456 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRPF6 |
0.336090082548857 |
|
10457 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RGS19 |
0.336090082548857 |
|
10458 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RTEL1 |
0.336090082548857 |
|
10459 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SAMD10 |
0.336090082548857 |
|
10460 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC2A4RG |
0.336090082548857 |
|
10461 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SOX18 |
0.336090082548857 |
|
10462 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STMN3 |
0.336090082548857 |
|
10463 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TCEA2 |
0.336090082548857 |
|
10464 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TNFRSF6B |
0.336090082548857 |
|
10465 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TPD52L2 |
0.336090082548857 |
|
10466 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UCKL1 |
0.336090082548857 |
|
10467 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZBTB46 |
0.336090082548857 |
|
10468 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZGPAT |
0.336090082548857 |
|
10469 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF512B |
0.336090082548857 |
|
10470 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPAST |
0.336117886682852 |
|
10471 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZCCHC4 |
0.336590332259593 |
|
10472 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCDH19 |
0.336673301686579 |
|
10473 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TAX1BP1 |
0.337001526818889 |
|
10474 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL365P |
0.337001526818889 |
|
10475 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RHOG |
0.337275604704466 |
|
10476 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238537.1 |
0.337300954342723 |
|
10477 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4741 |
0.337300954342723 |
|
10478 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CD47 |
0.337314010670614 |
|
10479 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C1QTNF7 |
0.337380915017888 |
|
10480 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CC2D2A |
0.337380915017888 |
|
10481 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BOC |
0.337514240462266 |
|
10482 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM163A |
0.337535086443856 |
|
10483 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TOR1AIP2 |
0.337535086443856 |
|
10484 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IFRG15 |
0.337535086443856 |
|
10485 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TOR1AIP1 |
0.337535086443856 |
|
10486 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL230P |
0.337535086443856 |
|
10487 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CEP350 |
0.337535086443856 |
|
10488 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
QSOX1 |
0.337535086443856 |
|
10489 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LHX4 |
0.337535086443856 |
|
10490 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACBD6 |
0.337535086443856 |
|
10491 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KHDC1L |
0.337548600858458 |
|
10492 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KHDC1 |
0.337548600858458 |
|
10493 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DPPA5 |
0.337548600858458 |
|
10494 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA73|ENSG00000253090.1 |
0.337950744438824 |
|
10495 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WLS |
0.338048657349169 |
|
10496 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPE65 |
0.338048657349169 |
|
10497 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DEPDC1 |
0.338048657349169 |
|
10498 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM101A |
0.338099222899511 |
|
10499 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FOXA1 |
0.338185309369077 |
|
10500 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA42|ENSG00000200385.1 |
0.338185309369077 |
|
10501 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GIPR |
0.33834375579218 |
|
10502 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNRPD2 |
0.33834375579218 |
|
10503 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
QPCTL |
0.33834375579218 |
|
10504 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FBXO46 |
0.33834375579218 |
|
10505 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DMPK |
0.33834375579218 |
|
10506 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SIX5 |
0.33834375579218 |
|
10507 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
APOL6 |
0.338456601563596 |
|
10508 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MB |
0.338456601563596 |
|
10509 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
APOL5 |
0.338456601563596 |
|
10510 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PDS5A |
0.338503270796 |
|
10511 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RCOR2 |
0.33855432510056 |
|
10512 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NAA40 |
0.33855432510056 |
|
10513 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COX8A |
0.33855432510056 |
|
10514 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OTUB1 |
0.33855432510056 |
|
10515 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FLRT1 |
0.33855432510056 |
|
10516 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA70G |
0.338663806055665 |
|
10517 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NUP107 |
0.338663806055665 |
|
10518 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CHST12 |
0.338790909061085 |
|
10519 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EIF3B |
0.338790909061085 |
|
10520 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C1QTNF6 |
0.338816426974291 |
|
10521 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SSTR3 |
0.338816426974291 |
|
10522 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNY4P17 |
0.339061446067417 |
|
10523 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CTH |
0.339152474362719 |
|
10524 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF536 |
0.33917508435024 |
|
10525 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CORO2B |
0.339241962245388 |
|
10526 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EIF2B1 |
0.339441805860928 |
|
10527 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATP6V0A2 |
0.339441805860928 |
|
10528 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GTF2H3 |
0.339441805860928 |
|
10529 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TCTN2 |
0.339441805860928 |
|
10530 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATP4B |
0.339537870172613 |
|
10531 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLEKHB1 |
0.339627665817888 |
|
10532 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAB6A |
0.339627665817888 |
|
10533 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MRPL48 |
0.339627665817888 |
|
10534 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP243 |
0.339627665817888 |
|
10535 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COA4 |
0.339627665817888 |
|
10536 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PAAF1 |
0.339627665817888 |
|
10537 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DNAJB13 |
0.339627665817888 |
|
10538 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UCP2 |
0.339627665817888 |
|
10539 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COX7A2 |
0.339810920217473 |
|
10540 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM30A |
0.339810920217473 |
|
10541 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FILIP1 |
0.339810920217473 |
|
10542 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BEND2 |
0.34011934211063 |
|
10543 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCML2 |
0.34011934211063 |
|
10544 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GAS6 |
0.34015836166946 |
|
10545 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GRK1 |
0.34015836166946 |
|
10546 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00454 |
0.34015836166946 |
|
10547 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM255B |
0.34015836166946 |
|
10548 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF699 |
0.340579501236202 |
|
10549 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPR6 |
0.340614879175651 |
|
10550 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZPBP2 |
0.340846204661034 |
|
10551 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GSDMB |
0.340846204661034 |
|
10552 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LONRF2 |
0.340911122866633 |
|
10553 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HIVEP1 |
0.341079989731084 |
|
10554 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EDN1 |
0.341079989731084 |
|
10555 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP293 |
0.341079989731084 |
|
10556 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PHACTR1 |
0.341079989731084 |
|
10557 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C10orf112 |
0.34112511421915 |
|
10558 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CH25H |
0.341196855054269 |
|
10559 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPR143 |
0.341288168774473 |
|
10560 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SHROOM2 |
0.341288168774473 |
|
10561 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDH23 |
0.341333134034991 |
|
10562 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RBBP8 |
0.341398975456746 |
|
10563 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SRSF11 |
0.341479394501526 |
|
10564 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANKRD13C |
0.341479394501526 |
|
10565 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HHLA3 |
0.341479394501526 |
|
10566 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMTC2 |
0.341493188777624 |
|
10567 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CUL1 |
0.341517416786016 |
|
10568 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATG3 |
0.341868616306493 |
|
10569 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC35A5 |
0.341868616306493 |
|
10570 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4662B |
0.341972485551098 |
|
10571 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCRN1 |
0.342108865622988 |
|
10572 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FKBP14 |
0.342108865622988 |
|
10573 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLEKHA8 |
0.342108865622988 |
|
10574 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ASPH |
0.342220454311273 |
|
10575 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM216B |
0.342252412482111 |
|
10576 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DNAJC15 |
0.342252412482111 |
|
10577 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ENOX1 |
0.342252412482111 |
|
10578 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EPSTI1 |
0.342252412482111 |
|
10579 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00400 |
0.342252412482111 |
|
10580 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CABLES1 |
0.342423754085211 |
|
10581 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AFP |
0.342493061987064 |
|
10582 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CSDC2 |
0.342643040422267 |
|
10583 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PMM1 |
0.342643040422267 |
|
10584 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HYAL4 |
0.342699442397803 |
|
10585 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPAM1 |
0.342699442397803 |
|
10586 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
JAZF1 |
0.342827296551779 |
|
10587 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3170 |
0.343125112777038 |
|
10588 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAC1 |
0.343137505071519 |
|
10589 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DAGLB |
0.343137505071519 |
|
10590 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KDELR2 |
0.343137505071519 |
|
10591 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FLJ20306 |
0.343137505071519 |
|
10592 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC59 |
0.343139591209048 |
|
10593 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
METTL25 |
0.343139591209048 |
|
10594 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GRIN2D |
0.343192045406682 |
|
10595 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GRWD1 |
0.343192045406682 |
|
10596 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCNJ14 |
0.343192045406682 |
|
10597 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CYTH2 |
0.343192045406682 |
|
10598 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LMTK3 |
0.343192045406682 |
|
10599 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SULT2B1 |
0.343192045406682 |
|
10600 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM83E |
0.343192045406682 |
|
10601 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPACA4 |
0.343192045406682 |
|
10602 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPL18 |
0.343192045406682 |
|
10603 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TENM4 |
0.343203144852078 |
|
10604 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KAT6A |
0.343561923788578 |
|
10605 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD112|ENSG00000238966.1 |
0.343561923788578 |
|
10606 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TACO1 |
0.343640747985884 |
|
10607 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAP3K3 |
0.343640747985884 |
|
10608 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LIMD2 |
0.343640747985884 |
|
10609 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FTSJ3 |
0.343640747985884 |
|
10610 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PSMC5 |
0.343640747985884 |
|
10611 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SMARCD2 |
0.343640747985884 |
|
10612 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL805P |
0.343640747985884 |
|
10613 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C17orf72 |
0.343640747985884 |
|
10614 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ICAM2 |
0.343640747985884 |
|
10615 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ERN1 |
0.343640747985884 |
|
10616 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA76|ENSG00000266402.2 |
0.343640747985884 |
|
10617 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD104 |
0.343640747985884 |
|
10618 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPR125 |
0.343732270457713 |
|
10619 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP101 |
0.344064483344195 |
|
10620 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HMGXB4 |
0.344067087946727 |
|
10621 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAC2 |
0.344514777906471 |
|
10622 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CYTH4 |
0.344514777906471 |
|
10623 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SGCG |
0.344595356165945 |
|
10624 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SACS |
0.344595356165945 |
|
10625 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DRD3 |
0.344618140162256 |
|
10626 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF80 |
0.344618140162256 |
|
10627 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TIGIT |
0.344618140162256 |
|
10628 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LBR |
0.344756166684508 |
|
10629 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL383P |
0.344963174548687 |
|
10630 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MRPS30 |
0.344963174548687 |
|
10631 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FGD3 |
0.345058177651763 |
|
10632 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MEGF9 |
0.345313558563824 |
|
10633 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000239045.1 |
0.345409732473679 |
|
10634 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KMT2C |
0.345409732473679 |
|
10635 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FABP5P3 |
0.345409732473679 |
|
10636 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP250 |
0.345409732473679 |
|
10637 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238557.1 |
0.345409732473679 |
|
10638 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA26|ENSG00000212590.1 |
0.345409732473679 |
|
10639 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
XRCC2 |
0.345409732473679 |
|
10640 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL811P |
0.345409732473679 |
|
10641 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL845P |
0.345409732473679 |
|
10642 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACTR3B |
0.345409732473679 |
|
10643 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRKAR1B |
0.345532225696982 |
|
10644 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HEATR2 |
0.345532225696982 |
|
10645 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SUN1 |
0.345532225696982 |
|
10646 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GET4 |
0.345532225696982 |
|
10647 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADAP1 |
0.345532225696982 |
|
10648 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C7orf50 |
0.345532225696982 |
|
10649 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COX19 |
0.345532225696982 |
|
10650 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CYP2W1 |
0.345532225696982 |
|
10651 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPER |
0.345532225696982 |
|
10652 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPR146 |
0.345532225696982 |
|
10653 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR339 |
0.345532225696982 |
|
10654 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZFAND2A |
0.345532225696982 |
|
10655 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ROCK1P1 |
0.345631763578731 |
|
10656 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
THOC1 |
0.345631763578731 |
|
10657 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
USP14 |
0.345631763578731 |
|
10658 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PKIB |
0.345659307903118 |
|
10659 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL564P |
0.345659307903118 |
|
10660 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FABP7 |
0.345659307903118 |
|
10661 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SMPDL3A |
0.345659307903118 |
|
10662 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCSK1 |
0.345664709833319 |
|
10663 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ABCD2 |
0.345897600467487 |
|
10664 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C12orf40 |
0.345897600467487 |
|
10665 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC2A13 |
0.345897600467487 |
|
10666 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPAM |
0.34596216778526 |
|
10667 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TECTB |
0.34596216778526 |
|
10668 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZDHHC6 |
0.34596216778526 |
|
10669 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4295 |
0.34596216778526 |
|
10670 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TTC24 |
0.346040107696588 |
|
10671 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
APOA1BP |
0.346040107696588 |
|
10672 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPATCH4 |
0.346040107696588 |
|
10673 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HAPLN2 |
0.346040107696588 |
|
10674 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BCAN |
0.346040107696588 |
|
10675 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SYCP2L |
0.346093694433383 |
|
10676 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM14B |
0.346093694433383 |
|
10677 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAK |
0.346093694433383 |
|
10678 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CNTD2 |
0.346511488008792 |
|
10679 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AKT2 |
0.346511488008792 |
|
10680 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C14orf177 |
0.346636675930327 |
|
10681 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAP1B |
0.346682218153941 |
|
10682 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP91 |
0.346692436223615 |
|
10683 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SDC3 |
0.346692436223615 |
|
10684 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NKAIN1 |
0.346692436223615 |
|
10685 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPARGC1A |
0.346712365238016 |
|
10686 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRRC43 |
0.346906033477958 |
|
10687 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
B3GNT4 |
0.346906033477958 |
|
10688 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DIABLO |
0.346906033477958 |
|
10689 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VPS33A |
0.346906033477958 |
|
10690 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PFKP |
0.347013870834176 |
|
10691 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL558P |
0.347039095655705 |
|
10692 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GSTA3 |
0.347079362284153 |
|
10693 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANXA13 |
0.347152572270707 |
|
10694 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADTRP |
0.347182572833767 |
|
10695 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GFOD1 |
0.347182572833767 |
|
10696 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP204 |
0.347182572833767 |
|
10697 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SIRT5 |
0.347182572833767 |
|
10698 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NOL7 |
0.347182572833767 |
|
10699 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RANBP9 |
0.347182572833767 |
|
10700 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LAMB1 |
0.34725304173401 |
|
10701 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U3|ENSG00000238297.1 |
0.34725304173401 |
|
10702 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL332P |
0.347370224659483 |
|
10703 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
JARID2 |
0.347370224659483 |
|
10704 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DTNBP1 |
0.347370224659483 |
|
10705 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMPRSS6 |
0.347601993788277 |
|
10706 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IL2RB |
0.347601993788277 |
|
10707 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PROS1 |
0.347608147923676 |
|
10708 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CD200R1L |
0.347709765200448 |
|
10709 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SHPK |
0.347814979946743 |
|
10710 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRPV1 |
0.347814979946743 |
|
10711 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CTNS |
0.347814979946743 |
|
10712 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EMC6 |
0.347814979946743 |
|
10713 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
P2RX5 |
0.347814979946743 |
|
10714 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TAX1BP3 |
0.347814979946743 |
|
10715 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MSRB3 |
0.347976634674151 |
|
10716 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATRNL1 |
0.348135718973809 |
|
10717 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR125B2 |
0.348281796445165 |
|
10718 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR4D9 |
0.348650428549335 |
|
10719 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C8orf76 |
0.348816315785944 |
|
10720 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZHX1 |
0.348816315785944 |
|
10721 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238422.1 |
0.348816315785944 |
|
10722 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATAD2 |
0.348816315785944 |
|
10723 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR548AA1 |
0.348816315785944 |
|
10724 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WDYHV1 |
0.348816315785944 |
|
10725 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FBXO32 |
0.348816315785944 |
|
10726 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP155 |
0.348816315785944 |
|
10727 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DPH6 |
0.348908922036028 |
|
10728 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3921 |
0.349121215330127 |
|
10729 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DGKB |
0.349224579348252 |
|
10730 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TTC39C |
0.349235590147156 |
|
10731 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4758 |
0.349332779786901 |
|
10732 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPS21 |
0.349332779786901 |
|
10733 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CABLES2 |
0.349332779786901 |
|
10734 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RBBP8NL |
0.349332779786901 |
|
10735 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GATA5 |
0.349332779786901 |
|
10736 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C20orf166 |
0.349332779786901 |
|
10737 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR133A2 |
0.349332779786901 |
|
10738 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLCO4A1 |
0.349332779786901 |
|
10739 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00686 |
0.349332779786901 |
|
10740 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NTSR1 |
0.349332779786901 |
|
10741 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00659 |
0.349332779786901 |
|
10742 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MRGBP |
0.349332779786901 |
|
10743 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OGFR |
0.349332779786901 |
|
10744 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COL9A3 |
0.349332779786901 |
|
10745 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TCFL5 |
0.349332779786901 |
|
10746 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CTAGE1 |
0.349411023995045 |
|
10747 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CAND1 |
0.34949024570038 |
|
10748 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DYRK2 |
0.34949024570038 |
|
10749 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CKAP4 |
0.349539753864811 |
|
10750 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TCP11L2 |
0.349539753864811 |
|
10751 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDKAL1 |
0.349581969415033 |
|
10752 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GMDS |
0.34962826150952 |
|
10753 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAG1 |
0.349654591264858 |
|
10754 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAG2 |
0.349654591264858 |
|
10755 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C11orf74 |
0.349654591264858 |
|
10756 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ALB |
0.349803322782989 |
|
10757 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NBN |
0.349827917966536 |
|
10758 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DECR1 |
0.349827917966536 |
|
10759 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CALB1 |
0.349827917966536 |
|
10760 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PIM2 |
0.349884712981319 |
|
10761 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC35A2 |
0.349884712981319 |
|
10762 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OTUD5 |
0.349884712981319 |
|
10763 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCND1 |
0.349884712981319 |
|
10764 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GRIPAP1 |
0.349884712981319 |
|
10765 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL139P |
0.349884712981319 |
|
10766 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TFE3 |
0.349884712981319 |
|
10767 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC120 |
0.349884712981319 |
|
10768 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRAF2 |
0.349884712981319 |
|
10769 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WDR45 |
0.349884712981319 |
|
10770 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPKOW |
0.349884712981319 |
|
10771 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL262P |
0.349884712981319 |
|
10772 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAGIX |
0.349884712981319 |
|
10773 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLP2 |
0.349884712981319 |
|
10774 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPP1R3F |
0.349884712981319 |
|
10775 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GAGE10 |
0.349884712981319 |
|
10776 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GAGE12B |
0.349884712981319 |
|
10777 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GAGE12C |
0.349884712981319 |
|
10778 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GAGE12D |
0.349884712981319 |
|
10779 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GAGE12E |
0.349884712981319 |
|
10780 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GAGE12F |
0.349884712981319 |
|
10781 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GAGE12G |
0.349884712981319 |
|
10782 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GAGE12H |
0.349884712981319 |
|
10783 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GAGE12I |
0.349884712981319 |
|
10784 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GAGE12J |
0.349884712981319 |
|
10785 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GAGE13 |
0.349884712981319 |
|
10786 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GAGE2A |
0.349884712981319 |
|
10787 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GAGE2B |
0.349884712981319 |
|
10788 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GAGE2C |
0.349884712981319 |
|
10789 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GAGE2D |
0.349884712981319 |
|
10790 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GAGE2E |
0.349884712981319 |
|
10791 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP163 |
0.350028366230303 |
|
10792 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MYO6 |
0.350028366230303 |
|
10793 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OSBPL5 |
0.350155056198296 |
|
10794 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NKTR |
0.350241118150286 |
|
10795 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR2C3 |
0.350311450535604 |
|
10796 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRKCG |
0.350462404356136 |
|
10797 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CACNG7 |
0.350462404356136 |
|
10798 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CACNG8 |
0.350462404356136 |
|
10799 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CACNG6 |
0.350462404356136 |
|
10800 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR935 |
0.350462404356136 |
|
10801 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VSTM1 |
0.350462404356136 |
|
10802 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TARM1 |
0.350462404356136 |
|
10803 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HIF1AN |
0.350523648853138 |
|
10804 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ALDH1A3 |
0.350836664639448 |
|
10805 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRRK1 |
0.350836664639448 |
|
10806 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RBBP6 |
0.351066434812203 |
|
10807 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRR15 |
0.351190095914886 |
|
10808 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR550A3 |
0.351190095914886 |
|
10809 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WIPF3 |
0.351190095914886 |
|
10810 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238906.1 |
0.351190095914886 |
|
10811 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C7orf41 |
0.351190095914886 |
|
10812 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR550A1 |
0.351190095914886 |
|
10813 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNRF2 |
0.351190095914886 |
|
10814 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NOD1 |
0.351190095914886 |
|
10815 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GGCT |
0.351190095914886 |
|
10816 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DBP |
0.351344946110627 |
|
10817 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CA11 |
0.351344946110627 |
|
10818 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MKRN9P |
0.35134792953089 |
|
10819 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OXCT1 |
0.351401388122371 |
|
10820 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C5orf51 |
0.351401388122371 |
|
10821 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FBXO4 |
0.351401388122371 |
|
10822 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C4orf19 |
0.351703640861573 |
|
10823 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RELL1 |
0.351703640861573 |
|
10824 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PGM2 |
0.351703640861573 |
|
10825 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TBC1D1 |
0.351703640861573 |
|
10826 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PTTG2 |
0.351703640861573 |
|
10827 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238514.1 |
0.351771241341921 |
|
10828 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00906 |
0.351771241341921 |
|
10829 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP470 |
0.351771241341921 |
|
10830 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FBP1 |
0.351908597000408 |
|
10831 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MYO15B |
0.351936382489193 |
|
10832 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RECQL5 |
0.351936382489193 |
|
10833 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SAP30BP |
0.351936382489193 |
|
10834 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC30A6 |
0.352224909226854 |
|
10835 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
INMT |
0.352228532113166 |
|
10836 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CTGF |
0.352297856413829 |
|
10837 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STX7 |
0.352297856413829 |
|
10838 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TAAR9 |
0.352297856413829 |
|
10839 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TAAR8 |
0.352297856413829 |
|
10840 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TAAR6 |
0.352297856413829 |
|
10841 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TAAR5 |
0.352297856413829 |
|
10842 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TAAR3 |
0.352297856413829 |
|
10843 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TAAR2 |
0.352297856413829 |
|
10844 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TAAR1 |
0.352297856413829 |
|
10845 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VNN1 |
0.352297856413829 |
|
10846 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VNN3 |
0.352297856413829 |
|
10847 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VNN2 |
0.352297856413829 |
|
10848 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC18B1 |
0.352297856413829 |
|
10849 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPS12 |
0.352297856413829 |
|
10850 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA33|ENSG00000200534.1 |
0.352297856413829 |
|
10851 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD100 |
0.352297856413829 |
|
10852 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD101 |
0.352297856413829 |
|
10853 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MCUR1 |
0.352511152413894 |
|
10854 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNF182 |
0.352511152413894 |
|
10855 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CD83 |
0.352511152413894 |
|
10856 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NEDD9 |
0.352553542332228 |
|
10857 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM170B |
0.352553542332228 |
|
10858 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARMC2 |
0.352684313077229 |
|
10859 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA67|ENSG00000207419.1 |
0.353048673175113 |
|
10860 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STIM2 |
0.353063451391972 |
|
10861 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC25A53 |
0.353389315771914 |
|
10862 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM199X |
0.353389315771914 |
|
10863 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ESX1 |
0.353389315771914 |
|
10864 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TEX13A |
0.353389315771914 |
|
10865 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NRK |
0.353389315771914 |
|
10866 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SERPINA7 |
0.353389315771914 |
|
10867 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MUM1L1 |
0.353389315771914 |
|
10868 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
USP54 |
0.353426544723882 |
|
10869 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCFD2 |
0.353447954363323 |
|
10870 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
POGZ |
0.353453635725952 |
|
10871 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AGMO |
0.353541605911894 |
|
10872 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TBC1D19 |
0.353723674287679 |
|
10873 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD74|ENSG00000200999.1 |
0.353723674287679 |
|
10874 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HCST |
0.353819213438895 |
|
10875 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TYROBP |
0.353819213438895 |
|
10876 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NOS3 |
0.353883505233197 |
|
10877 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATG9B |
0.353883505233197 |
|
10878 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ABCB8 |
0.353883505233197 |
|
10879 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ASIC3 |
0.353883505233197 |
|
10880 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDK5 |
0.353883505233197 |
|
10881 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC4A2 |
0.353883505233197 |
|
10882 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FASTK |
0.353883505233197 |
|
10883 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMUB1 |
0.353883505233197 |
|
10884 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AGAP3 |
0.353883505233197 |
|
10885 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GBX1 |
0.353883505233197 |
|
10886 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ASB10 |
0.353883505233197 |
|
10887 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IQCA1P1 |
0.353883505233197 |
|
10888 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ABCF2 |
0.353883505233197 |
|
10889 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CHPF2 |
0.353883505233197 |
|
10890 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR671 |
0.353883505233197 |
|
10891 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SMARCD3 |
0.353883505233197 |
|
10892 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MBOAT1 |
0.353895264823454 |
|
10893 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
E2F3 |
0.353895264823454 |
|
10894 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL128P |
0.353895264823454 |
|
10895 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MTG2 |
0.354018869811054 |
|
10896 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U3|ENSG00000212598.1 |
0.354040955452937 |
|
10897 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM241 |
0.354047659545297 |
|
10898 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RIOK3 |
0.354047659545297 |
|
10899 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C18orf8 |
0.354047659545297 |
|
10900 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NPC1 |
0.354047659545297 |
|
10901 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANKRD29 |
0.354047659545297 |
|
10902 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RTN3 |
0.354052746779227 |
|
10903 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C11orf95 |
0.354052746779227 |
|
10904 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL596P |
0.354052746779227 |
|
10905 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C11orf84 |
0.354052746779227 |
|
10906 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MARK2 |
0.354052746779227 |
|
10907 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoZ40 |
0.354205426469708 |
|
10908 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD59|ENSG00000252517.1 |
0.354210346156753 |
|
10909 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238907.1 |
0.355153030323218 |
|
10910 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CNTN1 |
0.35570372784353 |
|
10911 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL647P |
0.355707241218833 |
|
10912 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP61 |
0.355707241218833 |
|
10913 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FARP1 |
0.35578888243276 |
|
10914 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GCM2 |
0.355807552399383 |
|
10915 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ELOVL2 |
0.355807552399383 |
|
10916 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238896.1 |
0.355807552399383 |
|
10917 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SMIM13 |
0.355807552399383 |
|
10918 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MEOX2 |
0.355987486637291 |
|
10919 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MRGPRE |
0.356007230038302 |
|
10920 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF195 |
0.356007230038302 |
|
10921 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TSSC2 |
0.356007230038302 |
|
10922 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRPC2 |
0.356007230038302 |
|
10923 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ART1 |
0.356007230038302 |
|
10924 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ART5 |
0.356007230038302 |
|
10925 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CHRNA10 |
0.356007230038302 |
|
10926 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238686.1 |
0.356007230038302 |
|
10927 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MYH13 |
0.356052443548861 |
|
10928 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPME1 |
0.356066729121602 |
|
10929 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP343 |
0.356066729121602 |
|
10930 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
P4HA3 |
0.356066729121602 |
|
10931 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA7|ENSG00000206913.1 |
0.356066729121602 |
|
10932 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PGM2L1 |
0.356066729121602 |
|
10933 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR548AL |
0.356066729121602 |
|
10934 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCNE3 |
0.356066729121602 |
|
10935 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LIPT2 |
0.356066729121602 |
|
10936 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CYB561 |
0.356087465919784 |
|
10937 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACE |
0.356087465919784 |
|
10938 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCNH6 |
0.356087465919784 |
|
10939 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DCAF7 |
0.356087465919784 |
|
10940 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RXFP2 |
0.35661332580948 |
|
10941 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EEF1DP3 |
0.35661332580948 |
|
10942 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAF6 |
0.356786501514686 |
|
10943 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TBC1D7 |
0.356945826644578 |
|
10944 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARRB2 |
0.357091805475569 |
|
10945 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MED11 |
0.357091805475569 |
|
10946 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CXCL16 |
0.357091805475569 |
|
10947 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM229A |
0.357098788990543 |
|
10948 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LAMA3 |
0.357150009970551 |
|
10949 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRRC66 |
0.35724270222677 |
|
10950 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SGCB |
0.35724270222677 |
|
10951 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPATA18 |
0.35724270222677 |
|
10952 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4739 |
0.357325224432873 |
|
10953 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000239173.1 |
0.357325224432873 |
|
10954 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ENPP7 |
0.357325224432873 |
|
10955 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CBX2 |
0.357325224432873 |
|
10956 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CBX8 |
0.357325224432873 |
|
10957 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CBX4 |
0.357325224432873 |
|
10958 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COX7B2 |
0.357412293807642 |
|
10959 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C10orf107 |
0.357675849333416 |
|
10960 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARID5B |
0.357675849333416 |
|
10961 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SDK2 |
0.357716556852645 |
|
10962 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NUMA1 |
0.357840134616576 |
|
10963 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3165 |
0.357840134616576 |
|
10964 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRTOMT |
0.357840134616576 |
|
10965 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LAMTOR1 |
0.357840134616576 |
|
10966 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238768.1 |
0.357840134616576 |
|
10967 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANAPC15 |
0.357840134616576 |
|
10968 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FOLR3 |
0.357840134616576 |
|
10969 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FOLR1 |
0.357840134616576 |
|
10970 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FOLR2 |
0.357840134616576 |
|
10971 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
INPPL1 |
0.357840134616576 |
|
10972 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PHOX2A |
0.357840134616576 |
|
10973 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLPB |
0.357840134616576 |
|
10974 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RIPK2 |
0.357858130431256 |
|
10975 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DPY30 |
0.357976057602858 |
|
10976 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MEMO1 |
0.357976057602858 |
|
10977 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BRIP1 |
0.358027419092368 |
|
10978 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
INTS2 |
0.358027419092368 |
|
10979 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MED13 |
0.358027419092368 |
|
10980 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL800P |
0.358027419092368 |
|
10981 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARL13B |
0.358040148268473 |
|
10982 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STX19 |
0.358040148268473 |
|
10983 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UBXN2B |
0.358328901278379 |
|
10984 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CYP7A1 |
0.358328901278379 |
|
10985 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CD38 |
0.358429594049166 |
|
10986 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FGFBP1 |
0.358429594049166 |
|
10987 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FGFBP2 |
0.358429594049166 |
|
10988 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZBTB9 |
0.358557661945434 |
|
10989 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIAA2018 |
0.358661601272854 |
|
10990 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NAA50 |
0.358661601272854 |
|
10991 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATP6V1A |
0.358661601272854 |
|
10992 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GRAMD1C |
0.358661601272854 |
|
10993 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ASUN |
0.358723044123406 |
|
10994 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FOLH1 |
0.358796773194457 |
|
10995 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM200B |
0.358834128103022 |
|
10996 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BST1 |
0.358834128103022 |
|
10997 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR1E1 |
0.358848812052125 |
|
10998 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR3A3 |
0.358848812052125 |
|
10999 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR1E2 |
0.358848812052125 |
|
11000 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPATA22 |
0.358848812052125 |
|
11001 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ASPA |
0.358848812052125 |
|
11002 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRPV3 |
0.358848812052125 |
|
11003 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ENDOU |
0.358871194539941 |
|
11004 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00504 |
0.358898851571282 |
|
11005 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CPEB2 |
0.358898851571282 |
|
11006 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP170 |
0.358898851571282 |
|
11007 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U6|ENSG00000272292.1 |
0.358931743163103 |
|
11008 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIAA1614 |
0.358931743163103 |
|
11009 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STX6 |
0.358931743163103 |
|
11010 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C3 |
0.358968735227039 |
|
11011 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IKBKB |
0.358987096412644 |
|
11012 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
F13A1 |
0.359075893986349 |
|
11013 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR5683 |
0.359075893986349 |
|
11014 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM167A |
0.359109711312688 |
|
11015 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCARNA18|ENSG00000238835.1 |
0.359109711312688 |
|
11016 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NQO2 |
0.359359963646818 |
|
11017 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PDLIM5 |
0.359682561250169 |
|
11018 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GBF1 |
0.359694868408017 |
|
11019 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00941 |
0.359878054844295 |
|
11020 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TSPAN11 |
0.359878054844295 |
|
11021 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TCEAL2 |
0.359943287190571 |
|
11022 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TCEAL6 |
0.359943287190571 |
|
11023 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BEX5 |
0.359943287190571 |
|
11024 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TCP11X3P |
0.359943287190571 |
|
11025 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAB40AL |
0.359943287190571 |
|
11026 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BEX1 |
0.359943287190571 |
|
11027 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NXF3 |
0.359943287190571 |
|
11028 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRIM49B |
0.36025128052595 |
|
11029 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRIM64C |
0.36025128052595 |
|
11030 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HAO2 |
0.360364565331401 |
|
11031 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HSD3B2 |
0.360364565331401 |
|
11032 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HSD3B1 |
0.360364565331401 |
|
11033 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00622 |
0.360364565331401 |
|
11034 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF697 |
0.360364565331401 |
|
11035 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PHGDH |
0.360364565331401 |
|
11036 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HMGCS2 |
0.360364565331401 |
|
11037 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
REG4 |
0.360364565331401 |
|
11038 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PAM |
0.360406202025401 |
|
11039 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCNS3 |
0.36045530652802 |
|
11040 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIRLET7A1 |
0.36052128004124 |
|
11041 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIRLET7DHG |
0.36052128004124 |
|
11042 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIRLET7F1 |
0.36052128004124 |
|
11043 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIRLET7D |
0.36052128004124 |
|
11044 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238792.1 |
0.36052128004124 |
|
11045 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF169 |
0.36052128004124 |
|
11046 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C3orf52 |
0.360551535786121 |
|
11047 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GCSAM |
0.360551535786121 |
|
11048 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC9C1 |
0.360551535786121 |
|
11049 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BTLA |
0.360551535786121 |
|
11050 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC80 |
0.360551535786121 |
|
11051 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4530 |
0.360558831792388 |
|
11052 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLEKHG2 |
0.360558831792388 |
|
11053 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZFP36 |
0.360558831792388 |
|
11054 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPS16 |
0.360558831792388 |
|
11055 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SUPT5H |
0.360558831792388 |
|
11056 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DLL3 |
0.360558831792388 |
|
11057 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TIMM50 |
0.360558831792388 |
|
11058 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SELV |
0.360558831792388 |
|
11059 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EID2B |
0.360558831792388 |
|
11060 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EID2 |
0.360558831792388 |
|
11061 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C9orf3 |
0.360649027477229 |
|
11062 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPS19 |
0.360688655150818 |
|
11063 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CD79A |
0.360688655150818 |
|
11064 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR4B1 |
0.360917295016273 |
|
11065 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR4X2 |
0.360917295016273 |
|
11066 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR4X1 |
0.360917295016273 |
|
11067 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CXorf22 |
0.360976575844463 |
|
11068 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM19A2 |
0.360998335295927 |
|
11069 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FER1L6 |
0.361075054882315 |
|
11070 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM65 |
0.361075054882315 |
|
11071 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRMT12 |
0.361075054882315 |
|
11072 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNF139 |
0.361075054882315 |
|
11073 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TATDN1 |
0.361075054882315 |
|
11074 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NDUFB9 |
0.361075054882315 |
|
11075 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MTSS1 |
0.361075054882315 |
|
11076 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPDYE3 |
0.361130306020569 |
|
11077 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PILRB |
0.361130306020569 |
|
11078 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STAG3L5P |
0.361130306020569 |
|
11079 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PILRA |
0.361130306020569 |
|
11080 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZCWPW1 |
0.361130306020569 |
|
11081 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MEPCE |
0.361130306020569 |
|
11082 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPP1R35 |
0.361130306020569 |
|
11083 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C7orf61 |
0.361130306020569 |
|
11084 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL161P |
0.361130306020569 |
|
11085 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TSC22D4 |
0.361130306020569 |
|
11086 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NYAP1 |
0.361130306020569 |
|
11087 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL416P |
0.361130306020569 |
|
11088 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AGFG2 |
0.361130306020569 |
|
11089 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRCH4 |
0.361130306020569 |
|
11090 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SAP25 |
0.361130306020569 |
|
11091 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FBXO24 |
0.361130306020569 |
|
11092 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MOSPD3 |
0.361130306020569 |
|
11093 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCOLCE |
0.361130306020569 |
|
11094 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TFR2 |
0.361130306020569 |
|
11095 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACTL6B |
0.361130306020569 |
|
11096 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
L3MBTL4 |
0.361262012341323 |
|
11097 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL282P |
0.361262012341323 |
|
11098 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL723P |
0.361262012341323 |
|
11099 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPL6P27 |
0.361262012341323 |
|
11100 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARHGAP28 |
0.361262012341323 |
|
11101 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00668 |
0.361262012341323 |
|
11102 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL60P |
0.361560450829642 |
|
11103 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC15A1 |
0.361560450829642 |
|
11104 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DOCK9 |
0.361560450829642 |
|
11105 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UBAC2 |
0.361560450829642 |
|
11106 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP9 |
0.361560450829642 |
|
11107 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPR18 |
0.361560450829642 |
|
11108 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPR183 |
0.361560450829642 |
|
11109 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR623 |
0.361560450829642 |
|
11110 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TCF20 |
0.361671041509973 |
|
11111 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
JPH3 |
0.361701286744478 |
|
11112 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BANP |
0.361701286744478 |
|
11113 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF469 |
0.361701286744478 |
|
11114 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM64 |
0.36174555150094 |
|
11115 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA31|ENSG00000252136.1 |
0.361965264919993 |
|
11116 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TET2 |
0.361965264919993 |
|
11117 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPA2 |
0.361965264919993 |
|
11118 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SEPSECS |
0.362038506813963 |
|
11119 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PI4K2B |
0.362038506813963 |
|
11120 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCOC |
0.362120389056708 |
|
11121 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD112|ENSG00000252300.1 |
0.362120389056708 |
|
11122 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLGN |
0.362120389056708 |
|
11123 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ELMOD2 |
0.362120389056708 |
|
11124 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UCP1 |
0.362120389056708 |
|
11125 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL152P |
0.362120389056708 |
|
11126 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TBC1D9 |
0.362120389056708 |
|
11127 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ERO1L |
0.362143708734809 |
|
11128 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATP2A2 |
0.362194718642544 |
|
11129 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL89P |
0.362260847264937 |
|
11130 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL741P |
0.36241337601042 |
|
11131 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNY1P3 |
0.36241337601042 |
|
11132 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDK8 |
0.36241337601042 |
|
11133 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NMS |
0.362447935329287 |
|
11134 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL611P |
0.362447935329287 |
|
11135 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00593 |
0.362466157901833 |
|
11136 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TLE3 |
0.362466157901833 |
|
11137 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP157 |
0.362652058263169 |
|
11138 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PKM |
0.362754586875863 |
|
11139 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC16A12 |
0.362905014030388 |
|
11140 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FARS2 |
0.3629211114774 |
|
11141 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL221P |
0.3629211114774 |
|
11142 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NRN1 |
0.3629211114774 |
|
11143 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FLJ27365 |
0.363195612792809 |
|
11144 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3619 |
0.363195612792809 |
|
11145 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCF11 |
0.363318427880681 |
|
11146 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANKRD42 |
0.363318427880681 |
|
11147 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC90B |
0.363318427880681 |
|
11148 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SARS2 |
0.3635202074023 |
|
11149 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FBXO17 |
0.3635202074023 |
|
11150 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FBXO27 |
0.3635202074023 |
|
11151 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AP1AR |
0.363725743819515 |
|
11152 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TCF15 |
0.36387155321288 |
|
11153 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA51|ENSG00000206853.1 |
0.363996425778112 |
|
11154 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZRANB1 |
0.364113394720178 |
|
11155 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RB1 |
0.364154712445955 |
|
11156 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DUSP22 |
0.364203323674444 |
|
11157 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EXOC2 |
0.364203323674444 |
|
11158 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HUS1B |
0.364203323674444 |
|
11159 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IRF4 |
0.364203323674444 |
|
11160 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238438.1 |
0.364203323674444 |
|
11161 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FOXQ1 |
0.364203323674444 |
|
11162 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FOXF2 |
0.364203323674444 |
|
11163 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL352P |
0.364203323674444 |
|
11164 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FOXC1 |
0.364203323674444 |
|
11165 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NR2E1 |
0.36421574294823 |
|
11166 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNX3 |
0.36421574294823 |
|
11167 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238974.1 |
0.36421574294823 |
|
11168 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP212 |
0.36421574294823 |
|
11169 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM221A |
0.364549564156479 |
|
11170 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ICK |
0.364663165914263 |
|
11171 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FBXO9 |
0.364663165914263 |
|
11172 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL244P |
0.364663165914263 |
|
11173 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP106 |
0.364684819705765 |
|
11174 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACVR2A |
0.364684819705765 |
|
11175 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ORC4 |
0.364684819705765 |
|
11176 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BEX4 |
0.364791176396407 |
|
11177 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TCEAL8 |
0.364791176396407 |
|
11178 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TCEAL5 |
0.364791176396407 |
|
11179 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BEX2 |
0.364791176396407 |
|
11180 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TCEAL7 |
0.364791176396407 |
|
11181 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WBP5 |
0.364791176396407 |
|
11182 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NGFRAP1 |
0.364791176396407 |
|
11183 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAB40A |
0.364791176396407 |
|
11184 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TCEAL4 |
0.364791176396407 |
|
11185 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TCEAL3 |
0.364791176396407 |
|
11186 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TCEAL1 |
0.364791176396407 |
|
11187 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MORF4L2 |
0.364791176396407 |
|
11188 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GLRA4 |
0.364791176396407 |
|
11189 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM31 |
0.364791176396407 |
|
11190 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLP1 |
0.364791176396407 |
|
11191 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAB9B |
0.364791176396407 |
|
11192 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP511 |
0.364791176396407 |
|
11193 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMSB15B |
0.364791176396407 |
|
11194 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
H2BFM |
0.364791176396407 |
|
11195 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
H2BFWT |
0.364791176396407 |
|
11196 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZCCHC18 |
0.364791176396407 |
|
11197 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNF150 |
0.364900764418405 |
|
11198 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC25A17 |
0.365025694328755 |
|
11199 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4766 |
0.365025694328755 |
|
11200 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PSAP |
0.36512104387994 |
|
11201 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238853.1 |
0.36514985149573 |
|
11202 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ITGB8 |
0.365629802113709 |
|
11203 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIF26B |
0.365645976399082 |
|
11204 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NLRC4 |
0.365694741092979 |
|
11205 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C16orf95 |
0.365749424785486 |
|
11206 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000239186.1 |
0.365749424785486 |
|
11207 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FBXO31 |
0.365749424785486 |
|
11208 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAP1LC3B |
0.365749424785486 |
|
11209 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
METTL4 |
0.365869513070302 |
|
11210 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CBX3P2 |
0.365869513070302 |
|
11211 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NDC80 |
0.365869513070302 |
|
11212 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU109|ENSG00000238575.1 |
0.365869513070302 |
|
11213 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238425.1 |
0.365869513070302 |
|
11214 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C10orf105 |
0.366465726275101 |
|
11215 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C10orf54 |
0.366465726275101 |
|
11216 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL74P |
0.366555202511744 |
|
11217 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WNT8B |
0.366661611489242 |
|
11218 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SEC31B |
0.366661611489242 |
|
11219 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NDUFB8 |
0.366661611489242 |
|
11220 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TANC1 |
0.366945024639655 |
|
11221 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARMCX1 |
0.366967605186678 |
|
11222 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARMCX6 |
0.366967605186678 |
|
11223 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARMCX3 |
0.366967605186678 |
|
11224 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARMCX2 |
0.366967605186678 |
|
11225 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NXF5 |
0.366967605186678 |
|
11226 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZMAT1 |
0.366967605186678 |
|
11227 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VIPR1 |
0.366975829753167 |
|
11228 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SEC22C |
0.366975829753167 |
|
11229 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SS18L2 |
0.366975829753167 |
|
11230 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
THSD7A |
0.367006345673736 |
|
11231 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RFPL4B |
0.367154005585201 |
|
11232 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FSHR |
0.367190088310867 |
|
11233 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DLGAP1 |
0.367224665754178 |
|
11234 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MRPS24 |
0.367455151309324 |
|
11235 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
URGCP |
0.367455151309324 |
|
11236 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UBE2D4 |
0.367455151309324 |
|
11237 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
POLR2J4 |
0.367455151309324 |
|
11238 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZCCHC14 |
0.36762759181808 |
|
11239 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PITRM1 |
0.367660317843641 |
|
11240 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FREM2 |
0.367785873893259 |
|
11241 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DNAH10 |
0.367947576707386 |
|
11242 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF668 |
0.367963519892695 |
|
11243 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRSS53 |
0.367963519892695 |
|
11244 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF646 |
0.367963519892695 |
|
11245 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VKORC1 |
0.367963519892695 |
|
11246 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BCKDK |
0.367963519892695 |
|
11247 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KAT8 |
0.367963519892695 |
|
11248 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRSS8 |
0.367963519892695 |
|
11249 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRSS36 |
0.367963519892695 |
|
11250 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FUS |
0.367963519892695 |
|
11251 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C16orf98 |
0.367963519892695 |
|
11252 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PYCARD |
0.367963519892695 |
|
11253 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PYDC1 |
0.367963519892695 |
|
11254 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRIM72 |
0.367963519892695 |
|
11255 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ITGAM |
0.367963519892695 |
|
11256 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ITGAX |
0.367963519892695 |
|
11257 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ITGAD |
0.367963519892695 |
|
11258 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COX6A2 |
0.367963519892695 |
|
11259 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF843 |
0.367963519892695 |
|
11260 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARMC5 |
0.367963519892695 |
|
11261 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NBPF22P |
0.368139563457081 |
|
11262 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VEZT |
0.368169705236297 |
|
11263 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR331 |
0.368169705236297 |
|
11264 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3685 |
0.368169705236297 |
|
11265 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL710P |
0.368181386750622 |
|
11266 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C14orf64 |
0.368181386750622 |
|
11267 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMTC1 |
0.368200273455215 |
|
11268 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U3|ENSG00000253052.1 |
0.368200273455215 |
|
11269 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NCBP1 |
0.368345716440006 |
|
11270 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
XPA |
0.368345716440006 |
|
11271 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FOXE1 |
0.368345716440006 |
|
11272 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C9orf156 |
0.368345716440006 |
|
11273 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HEMGN |
0.368345716440006 |
|
11274 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NANS |
0.368345716440006 |
|
11275 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRIM14 |
0.368345716440006 |
|
11276 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CORO2A |
0.368345716440006 |
|
11277 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TBC1D2 |
0.368345716440006 |
|
11278 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR1257 |
0.36845857670023 |
|
11279 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TAF4 |
0.36845857670023 |
|
11280 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LSM14B |
0.36845857670023 |
|
11281 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PSMA7 |
0.36845857670023 |
|
11282 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SS18L1 |
0.36845857670023 |
|
11283 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP191 |
0.368639706101825 |
|
11284 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF568 |
0.368665988085976 |
|
11285 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF420 |
0.368665988085976 |
|
11286 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LGALS13 |
0.368796069590174 |
|
11287 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLDN8 |
0.36889865771556 |
|
11288 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL222P |
0.369055648755235 |
|
11289 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM49A |
0.369119122227283 |
|
11290 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR595 |
0.369258033198821 |
|
11291 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR5707 |
0.369258033198821 |
|
11292 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ESYT2 |
0.369258033198821 |
|
11293 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00689 |
0.369258033198821 |
|
11294 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NCAPG2 |
0.369258033198821 |
|
11295 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VIPR2 |
0.369258033198821 |
|
11296 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WDR60 |
0.369258033198821 |
|
11297 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SMC2 |
0.369332740210379 |
|
11298 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR13C4 |
0.369332740210379 |
|
11299 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR13C3 |
0.369332740210379 |
|
11300 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR13C8 |
0.369514973977116 |
|
11301 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR13C2 |
0.369514973977116 |
|
11302 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR13C5 |
0.369514973977116 |
|
11303 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR13C9 |
0.369514973977116 |
|
11304 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR13D1 |
0.369514973977116 |
|
11305 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NIPSNAP3A |
0.369514973977116 |
|
11306 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NIPSNAP3B |
0.369514973977116 |
|
11307 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ABCA1 |
0.369514973977116 |
|
11308 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LGI2 |
0.369806646922801 |
|
11309 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FBXL5 |
0.370092770956018 |
|
11310 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IREB2 |
0.370374274554637 |
|
11311 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HYKK |
0.370374274554637 |
|
11312 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PSMA4 |
0.370374274554637 |
|
11313 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CHRNA5 |
0.370374274554637 |
|
11314 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FABP3 |
0.370614777830796 |
|
11315 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SERINC2 |
0.370614777830796 |
|
11316 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TBL1X |
0.37073079033545 |
|
11317 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4419B |
0.370914327737703 |
|
11318 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3612 |
0.370914327737703 |
|
11319 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238895.1 |
0.370914327737703 |
|
11320 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HABP2 |
0.370937695379187 |
|
11321 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD112|ENSG00000252592.1 |
0.370953046064691 |
|
11322 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C11orf82 |
0.370953046064691 |
|
11323 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAB30 |
0.370953046064691 |
|
11324 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA70E |
0.370953046064691 |
|
11325 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCNQ5 |
0.370970469832217 |
|
11326 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4282 |
0.370970469832217 |
|
11327 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WDR52 |
0.371006291904058 |
|
11328 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPICE1 |
0.371006291904058 |
|
11329 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SIDT1 |
0.371006291904058 |
|
11330 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNU105B |
0.371046444884371 |
|
11331 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD22 |
0.371152115110469 |
|
11332 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FRAS1 |
0.371337497369366 |
|
11333 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LPPR1 |
0.371341674494112 |
|
11334 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UBFD1 |
0.371404249078553 |
|
11335 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NDUFAB1 |
0.371404249078553 |
|
11336 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C10orf76 |
0.371593908931858 |
|
11337 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DESI1 |
0.371896709984923 |
|
11338 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GTPBP8 |
0.372013359368603 |
|
11339 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C3orf17 |
0.372013359368603 |
|
11340 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD112|ENSG00000253076.1 |
0.372013359368603 |
|
11341 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RABAC1 |
0.372357536907235 |
|
11342 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATP1A3 |
0.372357536907235 |
|
11343 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GRIK5 |
0.372357536907235 |
|
11344 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DNAJC5B |
0.372578748013288 |
|
11345 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AEBP1 |
0.372699226711274 |
|
11346 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4649 |
0.372699226711274 |
|
11347 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
POLD2 |
0.372699226711274 |
|
11348 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP230 |
0.372699226711274 |
|
11349 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MYL7 |
0.372699226711274 |
|
11350 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GCK |
0.372699226711274 |
|
11351 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP209 |
0.372763551389233 |
|
11352 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000239132.1 |
0.372763551389233 |
|
11353 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IMPG1 |
0.372763551389233 |
|
11354 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NIPBL |
0.372959689280946 |
|
11355 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NDUFA7 |
0.372989307881106 |
|
11356 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPS28 |
0.372989307881106 |
|
11357 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KANK3 |
0.372989307881106 |
|
11358 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANGPTL4 |
0.372989307881106 |
|
11359 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4999 |
0.372989307881106 |
|
11360 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAB11B |
0.372989307881106 |
|
11361 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATP8A2 |
0.373097455771785 |
|
11362 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SH2D3A |
0.373171174977179 |
|
11363 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PGR |
0.373293652783048 |
|
11364 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3615 |
0.373557943213194 |
|
11365 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC9A3R1 |
0.373557943213194 |
|
11366 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NAT9 |
0.373557943213194 |
|
11367 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM104 |
0.373557943213194 |
|
11368 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IMMP2L |
0.373604500111809 |
|
11369 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLK |
0.373651998909977 |
|
11370 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CALML4 |
0.373830446755435 |
|
11371 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLN6 |
0.373830446755435 |
|
11372 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FEM1B |
0.373830446755435 |
|
11373 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANO4 |
0.37395982444149 |
|
11374 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C4orf46 |
0.373982400402656 |
|
11375 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ETFDH |
0.373982400402656 |
|
11376 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U3|ENSG00000271817.1 |
0.373982400402656 |
|
11377 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPID |
0.373982400402656 |
|
11378 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FNIP2 |
0.373982400402656 |
|
11379 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C4orf45 |
0.373982400402656 |
|
11380 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACER3 |
0.374122227998181 |
|
11381 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
B3GNT6 |
0.374122227998181 |
|
11382 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CAPN5 |
0.374122227998181 |
|
11383 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OMP |
0.374122227998181 |
|
11384 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MYO7A |
0.374122227998181 |
|
11385 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GDPD4 |
0.374122227998181 |
|
11386 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PAK1 |
0.374122227998181 |
|
11387 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DKFZP434E1119 |
0.374122227998181 |
|
11388 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLNS1A |
0.374122227998181 |
|
11389 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AQP11 |
0.374122227998181 |
|
11390 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RSF1 |
0.374122227998181 |
|
11391 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR1267 |
0.374383138706011 |
|
11392 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TNFRSF21 |
0.374499668899433 |
|
11393 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CD2AP |
0.374499668899433 |
|
11394 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIAA0922 |
0.374519575259666 |
|
11395 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TLR2 |
0.374519575259666 |
|
11396 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNF175 |
0.374519575259666 |
|
11397 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SFRP2 |
0.374519575259666 |
|
11398 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDS1 |
0.374709005723746 |
|
11399 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRICKLE3 |
0.374856513811956 |
|
11400 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SYP |
0.374856513811956 |
|
11401 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CACNA1F |
0.374856513811956 |
|
11402 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC22 |
0.374856513811956 |
|
11403 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FOXP3 |
0.374856513811956 |
|
11404 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PXDC1 |
0.374901336560823 |
|
11405 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM50B |
0.374901336560823 |
|
11406 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARG1 |
0.375014724525722 |
|
11407 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MED23 |
0.375014724525722 |
|
11408 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR2A4 |
0.375014724525722 |
|
11409 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CTAGE9 |
0.375014724525722 |
|
11410 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LCA5 |
0.375093107883747 |
|
11411 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SH3BGRL2 |
0.375093107883747 |
|
11412 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LEPRE1 |
0.375704441563877 |
|
11413 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C1orf50 |
0.375704441563877 |
|
11414 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DBNL |
0.375748888912441 |
|
11415 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PGAM2 |
0.375748888912441 |
|
11416 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
POLM |
0.375748888912441 |
|
11417 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FANK1 |
0.375839118038556 |
|
11418 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA75|ENSG00000212593.1 |
0.376078880737119 |
|
11419 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SHCBP1 |
0.376219363579701 |
|
11420 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3973 |
0.376502614880304 |
|
11421 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DTWD2 |
0.37655807733954 |
|
11422 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DMXL1 |
0.37655807733954 |
|
11423 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000239011.1 |
0.37655807733954 |
|
11424 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR5706 |
0.37655807733954 |
|
11425 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZFP36L2 |
0.376670409827516 |
|
11426 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00534 |
0.376715554893493 |
|
11427 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP273 |
0.376715554893493 |
|
11428 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NECAB1 |
0.376715554893493 |
|
11429 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACADM |
0.376846253646483 |
|
11430 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RABGGTB |
0.376846253646483 |
|
11431 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD45C |
0.376846253646483 |
|
11432 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD45A |
0.376846253646483 |
|
11433 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD45B |
0.376846253646483 |
|
11434 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NRBF2 |
0.377306866495605 |
|
11435 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SERPINB6 |
0.377334180195304 |
|
11436 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RIPK1 |
0.377334180195304 |
|
11437 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP201 |
0.377334180195304 |
|
11438 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BPHL |
0.377334180195304 |
|
11439 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TUBB2A |
0.377334180195304 |
|
11440 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TUBB2B |
0.377334180195304 |
|
11441 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PSMG4 |
0.377334180195304 |
|
11442 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C8orf87 |
0.377352304453499 |
|
11443 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD112|ENSG00000252961.1 |
0.377437215786738 |
|
11444 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATXN2 |
0.377476989061754 |
|
11445 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CD320 |
0.377562648665397 |
|
11446 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARAP1 |
0.377635781462727 |
|
11447 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STARD10 |
0.377635781462727 |
|
11448 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANKRD19P |
0.377642637865806 |
|
11449 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF484 |
0.377642637865806 |
|
11450 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
APOC1 |
0.377711499808374 |
|
11451 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
APOC1P1 |
0.377711499808374 |
|
11452 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDH12 |
0.377991647346037 |
|
11453 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KLF8 |
0.378011628618563 |
|
11454 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CPSF6 |
0.378045861189234 |
|
11455 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZDHHC23 |
0.378073686533853 |
|
11456 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF559 |
0.378378091285561 |
|
11457 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TBC1D3P2 |
0.378457346953092 |
|
11458 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EFCAB3 |
0.378457346953092 |
|
11459 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AP3M2 |
0.37857100761322 |
|
11460 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLAT |
0.37857100761322 |
|
11461 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP231 |
0.378735397479724 |
|
11462 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LYZ |
0.379021525157889 |
|
11463 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
YEATS4 |
0.379021525157889 |
|
11464 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL804P |
0.379021525157889 |
|
11465 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FRS2 |
0.379021525157889 |
|
11466 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR548E |
0.379035059699538 |
|
11467 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADRA2A |
0.379035059699538 |
|
11468 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC162P |
0.379141007031598 |
|
11469 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238474.1 |
0.379141007031598 |
|
11470 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TGM6 |
0.379282063773277 |
|
11471 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GCNT2 |
0.379286563909187 |
|
11472 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AMD1 |
0.379323869156082 |
|
11473 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GTF3C6 |
0.379323869156082 |
|
11474 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238775.1 |
0.379323869156082 |
|
11475 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPF2 |
0.379323869156082 |
|
11476 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRNP |
0.379806550215589 |
|
11477 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRND |
0.379806550215589 |
|
11478 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRNT |
0.379806550215589 |
|
11479 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TCAM1P |
0.379809129310858 |
|
11480 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CSH1 |
0.379809129310858 |
|
11481 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CSH2 |
0.379809129310858 |
|
11482 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CSHL1 |
0.379809129310858 |
|
11483 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GH2 |
0.379809129310858 |
|
11484 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GH1 |
0.379809129310858 |
|
11485 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CD79B |
0.379809129310858 |
|
11486 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCN4A |
0.379809129310858 |
|
11487 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF155 |
0.379810784117325 |
|
11488 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF230 |
0.379810784117325 |
|
11489 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF222 |
0.379810784117325 |
|
11490 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF223 |
0.379810784117325 |
|
11491 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF235 |
0.379810784117325 |
|
11492 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF233 |
0.379810784117325 |
|
11493 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF112 |
0.379810784117325 |
|
11494 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF285 |
0.379810784117325 |
|
11495 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF180 |
0.379810784117325 |
|
11496 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CEACAM20 |
0.379810784117325 |
|
11497 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CEACAM22P |
0.379810784117325 |
|
11498 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IGSF23 |
0.379810784117325 |
|
11499 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UBE2D3 |
0.379863830605898 |
|
11500 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CISD2 |
0.379863830605898 |
|
11501 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238948.1 |
0.379863830605898 |
|
11502 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC9B1 |
0.379863830605898 |
|
11503 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC9B2 |
0.379863830605898 |
|
11504 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BDH2 |
0.379863830605898 |
|
11505 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CENPE |
0.379863830605898 |
|
11506 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00478 |
0.379915278788179 |
|
11507 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD74|ENSG00000201025.1 |
0.379915278788179 |
|
11508 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR99A |
0.379915278788179 |
|
11509 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIRLET7C |
0.379915278788179 |
|
11510 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00461 |
0.380040815277512 |
|
11511 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MEF2C |
0.380040815277512 |
|
11512 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3660 |
0.380040815277512 |
|
11513 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNRNP40 |
0.380095579974474 |
|
11514 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCR4 |
0.380131291328986 |
|
11515 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GLB1 |
0.380131291328986 |
|
11516 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMPPE |
0.380131291328986 |
|
11517 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL296P |
0.380131291328986 |
|
11518 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CRTAP |
0.380131291328986 |
|
11519 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SUSD5 |
0.380131291328986 |
|
11520 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIF4A |
0.380595326975036 |
|
11521 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNY4P23 |
0.380595326975036 |
|
11522 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GDPD2 |
0.380595326975036 |
|
11523 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DLG3 |
0.380595326975036 |
|
11524 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SYT1 |
0.380608264313252 |
|
11525 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR1252 |
0.380608264313252 |
|
11526 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL696P |
0.380608264313252 |
|
11527 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PAWR |
0.380608264313252 |
|
11528 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MARCKSL1 |
0.380640791051155 |
|
11529 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TSSK3 |
0.380640791051155 |
|
11530 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BSDC1 |
0.380640791051155 |
|
11531 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM229A |
0.380640791051155 |
|
11532 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00371 |
0.381198399070692 |
|
11533 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP356 |
0.381254601624034 |
|
11534 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4446 |
0.381263053970407 |
|
11535 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL767P |
0.381263053970407 |
|
11536 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C9orf47 |
0.381335194108302 |
|
11537 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
S1PR3 |
0.381335194108302 |
|
11538 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SHC3 |
0.381335194108302 |
|
11539 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LPAR6 |
0.381480633121166 |
|
11540 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
USP46 |
0.381486270847268 |
|
11541 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DANCR |
0.381486270847268 |
|
11542 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4449 |
0.381486270847268 |
|
11543 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA26|ENSG00000212588.1 |
0.381486270847268 |
|
11544 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA26|ENSG00000212490.1 |
0.381486270847268 |
|
11545 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RASL11B |
0.381486270847268 |
|
11546 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPDYE1 |
0.381614702738334 |
|
11547 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RASA4CP |
0.381614702738334 |
|
11548 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00957 |
0.381614702738334 |
|
11549 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL714P |
0.381658367244862 |
|
11550 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LHFPL3 |
0.38213448496788 |
|
11551 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPHK2 |
0.382135285461432 |
|
11552 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CAP1 |
0.382146316600263 |
|
11553 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPT1 |
0.382146316600263 |
|
11554 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RLF |
0.382146316600263 |
|
11555 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMCO2 |
0.382146316600263 |
|
11556 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZMPSTE24 |
0.382146316600263 |
|
11557 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COL9A2 |
0.382146316600263 |
|
11558 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SMAP2 |
0.382146316600263 |
|
11559 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZFP69B |
0.382146316600263 |
|
11560 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZFP69 |
0.382146316600263 |
|
11561 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EXO5 |
0.382146316600263 |
|
11562 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF684 |
0.382146316600263 |
|
11563 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RIMS3 |
0.382146316600263 |
|
11564 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EMR1 |
0.382317978212406 |
|
11565 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EMR4P |
0.382317978212406 |
|
11566 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MBD3L2 |
0.382317978212406 |
|
11567 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MBD3L3 |
0.382317978212406 |
|
11568 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MBD3L4 |
0.382317978212406 |
|
11569 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MBD3L5 |
0.382317978212406 |
|
11570 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF557 |
0.382317978212406 |
|
11571 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RILPL2 |
0.382864507903132 |
|
11572 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNRNP35 |
0.382864507903132 |
|
11573 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RILPL1 |
0.382864507903132 |
|
11574 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3908 |
0.382864507903132 |
|
11575 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMED2 |
0.382864507903132 |
|
11576 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DDX55 |
0.382864507903132 |
|
11577 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA9|ENSG00000206897.1 |
0.382864507903132 |
|
11578 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF260 |
0.382991194098483 |
|
11579 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF365 |
0.383000175598868 |
|
11580 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADO |
0.383000175598868 |
|
11581 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EGR2 |
0.383000175598868 |
|
11582 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
XRCC4 |
0.383035994170228 |
|
11583 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VCAN |
0.383035994170228 |
|
11584 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NOLC1 |
0.383185528078921 |
|
11585 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR641 |
0.383252949062457 |
|
11586 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LSM12 |
0.383255970341755 |
|
11587 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
G6PC3 |
0.383255970341755 |
|
11588 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HDAC5 |
0.383255970341755 |
|
11589 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C17orf53 |
0.383255970341755 |
|
11590 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DDX19A |
0.383601112809675 |
|
11591 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ST3GAL2 |
0.383601112809675 |
|
11592 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FUK |
0.383601112809675 |
|
11593 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DUSP10 |
0.383632676427652 |
|
11594 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CD164 |
0.383636041232979 |
|
11595 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPIL6 |
0.383636041232979 |
|
11596 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SMPD2 |
0.383636041232979 |
|
11597 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MICAL1 |
0.383636041232979 |
|
11598 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZBTB24 |
0.383636041232979 |
|
11599 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AK9 |
0.383636041232979 |
|
11600 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AKR1CL1 |
0.383782817228879 |
|
11601 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNAPC3 |
0.383918136820214 |
|
11602 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PSIP1 |
0.383918136820214 |
|
11603 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL98P |
0.383918136820214 |
|
11604 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAR2 |
0.383970386911777 |
|
11605 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ERGIC2 |
0.383970386911777 |
|
11606 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCT2 |
0.383975993442647 |
|
11607 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRRC10 |
0.383975993442647 |
|
11608 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BEST3 |
0.383975993442647 |
|
11609 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM161B |
0.384103194438231 |
|
11610 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP187 |
0.384103194438231 |
|
11611 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA70|ENSG00000206958.1 |
0.384103194438231 |
|
11612 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TOMM40 |
0.384273624865061 |
|
11613 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
APOE |
0.384273624865061 |
|
11614 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADPRHL1 |
0.384316195630027 |
|
11615 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DCUN1D2 |
0.384316195630027 |
|
11616 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP107 |
0.384355127413684 |
|
11617 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCNJ3 |
0.384355127413684 |
|
11618 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000239068.1 |
0.38449371558966 |
|
11619 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AFAP1L2 |
0.38484579763374 |
|
11620 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COX18 |
0.385179978712581 |
|
11621 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANKRD17 |
0.385179978712581 |
|
11622 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CTSL |
0.385281384505761 |
|
11623 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CTSL3P |
0.385281384505761 |
|
11624 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPATA31E1 |
0.385281384505761 |
|
11625 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPATA31C1 |
0.385281384505761 |
|
11626 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDK20 |
0.385281384505761 |
|
11627 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U6|ENSG00000271923.1 |
0.385281384505761 |
|
11628 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HCN1 |
0.385508845730168 |
|
11629 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PHACTR4 |
0.385759136777855 |
|
11630 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNU6ATAC27P |
0.385759136777855 |
|
11631 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RCC1 |
0.385759136777855 |
|
11632 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNHG3 |
0.385759136777855 |
|
11633 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA73B |
0.385759136777855 |
|
11634 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238821.1 |
0.385759136777855 |
|
11635 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EPHA6 |
0.385873647411777 |
|
11636 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARL6 |
0.385873647411777 |
|
11637 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BIRC6 |
0.385954831171619 |
|
11638 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR21 |
0.386047244852173 |
|
11639 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TUBD1 |
0.386047244852173 |
|
11640 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPS6KB1 |
0.386047244852173 |
|
11641 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNFT1 |
0.386047244852173 |
|
11642 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HEATR6 |
0.386047244852173 |
|
11643 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4737 |
0.386047244852173 |
|
11644 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C6ORF50 |
0.386065966489708 |
|
11645 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRPF4B |
0.386065966489708 |
|
11646 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM217A |
0.386065966489708 |
|
11647 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000252668.1 |
0.386065966489708 |
|
11648 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C6orf201 |
0.386065966489708 |
|
11649 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ECI2 |
0.386065966489708 |
|
11650 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C7orf13 |
0.386261885207475 |
|
11651 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNF32 |
0.386261885207475 |
|
11652 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP248 |
0.386278215104123 |
|
11653 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL786P |
0.386303728815546 |
|
11654 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DGAT2 |
0.386303728815546 |
|
11655 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CACNG3 |
0.386375566131442 |
|
11656 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA1|ENSG00000201541.1 |
0.386375566131442 |
|
11657 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DDX53 |
0.386440422423608 |
|
11658 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CHST7 |
0.386763757771826 |
|
11659 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDKL5 |
0.38740383845655 |
|
11660 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RS1 |
0.38740383845655 |
|
11661 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4763 |
0.38763528930097 |
|
11662 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIRLET7A3 |
0.38763528930097 |
|
11663 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIRLET7B |
0.38763528930097 |
|
11664 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KLC1 |
0.387742600641159 |
|
11665 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPAP3 |
0.387830467232879 |
|
11666 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
H1FNT |
0.387841460766987 |
|
11667 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARHGEF1 |
0.387881396459733 |
|
11668 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MRGPRG |
0.387979129611202 |
|
11669 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TEX11 |
0.388011163620107 |
|
11670 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00462 |
0.388067955384707 |
|
11671 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PKHD1 |
0.388382820463011 |
|
11672 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL580P |
0.388382820463011 |
|
11673 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR206 |
0.388382820463011 |
|
11674 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR133B |
0.388382820463011 |
|
11675 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IL17A |
0.388382820463011 |
|
11676 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AMBRA1 |
0.388390548649234 |
|
11677 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SMIM20 |
0.388404430741323 |
|
11678 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MRPL47 |
0.388660617135761 |
|
11679 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NDUFB5 |
0.388660617135761 |
|
11680 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000239096.1 |
0.388660617135761 |
|
11681 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CERS4 |
0.388714162198668 |
|
11682 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF292 |
0.388768095077624 |
|
11683 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GJB7 |
0.388768095077624 |
|
11684 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SMIM8 |
0.388768095077624 |
|
11685 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C6orf163 |
0.388768095077624 |
|
11686 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C6orf164 |
0.388768095077624 |
|
11687 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C6ORF165 |
0.388768095077624 |
|
11688 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C6orf165 |
0.388768095077624 |
|
11689 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC35A1 |
0.388768095077624 |
|
11690 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RARS2 |
0.388768095077624 |
|
11691 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ORC3 |
0.388768095077624 |
|
11692 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPL12P38 |
0.388906787331959 |
|
11693 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
APPBP2 |
0.388906787331959 |
|
11694 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPM1D |
0.388906787331959 |
|
11695 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL606P |
0.388906787331959 |
|
11696 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR548AS |
0.388966303732926 |
|
11697 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CNOT4 |
0.388988009118359 |
|
11698 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NUP205 |
0.388988009118359 |
|
11699 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C7orf73 |
0.388988009118359 |
|
11700 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC13A4 |
0.388988009118359 |
|
11701 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM180A |
0.388988009118359 |
|
11702 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LUZP6 |
0.388988009118359 |
|
11703 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MTPN |
0.388988009118359 |
|
11704 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
XRCC3 |
0.388998485247168 |
|
11705 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZFYVE21 |
0.388998485247168 |
|
11706 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPP1R13B |
0.388998485247168 |
|
11707 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD51|ENSG00000202275.1 |
0.388998485247168 |
|
11708 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00637 |
0.388998485247168 |
|
11709 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C14orf2 |
0.388998485247168 |
|
11710 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RD3L |
0.388998485247168 |
|
11711 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRGUK |
0.389047341896757 |
|
11712 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF585B |
0.389060758711959 |
|
11713 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM181B |
0.389068884397871 |
|
11714 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRCP |
0.389068884397871 |
|
11715 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238995.1 |
0.389068884397871 |
|
11716 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPP1R12A |
0.389143254238351 |
|
11717 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP363 |
0.389143254238351 |
|
11718 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP261 |
0.389143254238351 |
|
11719 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PTPRQ |
0.389143254238351 |
|
11720 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MYF6 |
0.389143254238351 |
|
11721 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MYF5 |
0.389143254238351 |
|
11722 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LIN7A |
0.389143254238351 |
|
11723 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR617 |
0.389143254238351 |
|
11724 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACSS3 |
0.389143254238351 |
|
11725 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR618 |
0.389143254238351 |
|
11726 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4699 |
0.389143254238351 |
|
11727 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PVRL3 |
0.38926574821801 |
|
11728 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CD96 |
0.38926574821801 |
|
11729 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZBED2 |
0.38926574821801 |
|
11730 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLCXD2 |
0.38926574821801 |
|
11731 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ENPEP |
0.389296155101527 |
|
11732 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR548AG1 |
0.389301630308143 |
|
11733 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MCU |
0.389315545796098 |
|
11734 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4676 |
0.389315545796098 |
|
11735 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OIT3 |
0.389315545796098 |
|
11736 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLA2G12B |
0.389315545796098 |
|
11737 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NOXO1 |
0.389449713892934 |
|
11738 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GFER |
0.389449713892934 |
|
11739 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SYNGR3 |
0.389449713892934 |
|
11740 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NPW |
0.389449713892934 |
|
11741 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF598 |
0.389449713892934 |
|
11742 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL219P |
0.389449713892934 |
|
11743 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC9A3R2 |
0.389449713892934 |
|
11744 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NTHL1 |
0.389449713892934 |
|
11745 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U3|ENSG00000221345.1 |
0.389644904966965 |
|
11746 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HIATL1 |
0.389724638645108 |
|
11747 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCAT7 |
0.389724638645108 |
|
11748 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FBP2 |
0.389724638645108 |
|
11749 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRNAI6 |
0.390338604454271 |
|
11750 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP34 |
0.390418732847332 |
|
11751 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR622 |
0.390418732847332 |
|
11752 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TDRD9 |
0.390428314630201 |
|
11753 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL634P |
0.390428314630201 |
|
11754 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ASPG |
0.390428314630201 |
|
11755 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR203 |
0.390428314630201 |
|
11756 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIF26A |
0.390428314630201 |
|
11757 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CPVL |
0.390483316690967 |
|
11758 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CHN2 |
0.390483316690967 |
|
11759 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ABLIM1 |
0.390504633593172 |
|
11760 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238577.1 |
0.390504633593172 |
|
11761 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM160B1 |
0.390504633593172 |
|
11762 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00173 |
0.390537075083243 |
|
11763 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAP1LC3B2 |
0.390537075083243 |
|
11764 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C12orf49 |
0.390537075083243 |
|
11765 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNFT2 |
0.390537075083243 |
|
11766 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00943 |
0.390593764814046 |
|
11767 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00944 |
0.390593764814046 |
|
11768 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLDN17 |
0.390593814818772 |
|
11769 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00307 |
0.390593814818772 |
|
11770 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF529 |
0.390634709700795 |
|
11771 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF382 |
0.390634709700795 |
|
11772 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF461 |
0.390634709700795 |
|
11773 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCARNA3 |
0.390647083660743 |
|
11774 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NFKB2 |
0.390941106275126 |
|
11775 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PSD |
0.390941106275126 |
|
11776 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CUEDC2 |
0.390941106275126 |
|
11777 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FBXL15 |
0.390941106275126 |
|
11778 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR146B |
0.390941106275126 |
|
11779 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C10orf95 |
0.390941106275126 |
|
11780 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM180 |
0.390941106275126 |
|
11781 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238714.1 |
0.391316719727116 |
|
11782 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OFCC1 |
0.391475608234251 |
|
11783 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM132C |
0.39175108735153 |
|
11784 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC15A4 |
0.39175108735153 |
|
11785 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GLT1D1 |
0.39175108735153 |
|
11786 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RBM42 |
0.39182462256889 |
|
11787 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ETV2 |
0.39182462256889 |
|
11788 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD65|ENSG00000212229.1 |
0.391909636190654 |
|
11789 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP208 |
0.391909636190654 |
|
11790 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC30 |
0.392053329327434 |
|
11791 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIAA0825 |
0.392091638453559 |
|
11792 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC22A9 |
0.392287435843696 |
|
11793 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4445 |
0.392383704080901 |
|
11794 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PHLDB2 |
0.392461750395954 |
|
11795 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ABHD10 |
0.392461750395954 |
|
11796 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TAGLN3 |
0.392461750395954 |
|
11797 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMPRSS7 |
0.392461750395954 |
|
11798 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR567 |
0.392461750395954 |
|
11799 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00472 |
0.392692340668146 |
|
11800 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR30A |
0.392692340668146 |
|
11801 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IRAK1BP1 |
0.392764135720674 |
|
11802 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PHIP |
0.392764135720674 |
|
11803 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HMGN3 |
0.392764135720674 |
|
11804 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FOXK2 |
0.393015395589128 |
|
11805 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ST18 |
0.393032688997608 |
|
11806 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM150A |
0.393032688997608 |
|
11807 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RB1CC1 |
0.393032688997608 |
|
11808 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZCCHC17 |
0.393058918052054 |
|
11809 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
METTL2A |
0.393094751112754 |
|
11810 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TLK2 |
0.393094751112754 |
|
11811 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MRC2 |
0.393094751112754 |
|
11812 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MARCH10 |
0.393094751112754 |
|
11813 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF574 |
0.393133193435802 |
|
11814 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATP11A |
0.39319460038147 |
|
11815 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MCF2L |
0.39319460038147 |
|
11816 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
F7 |
0.39319460038147 |
|
11817 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
F10 |
0.39319460038147 |
|
11818 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PROZ |
0.39319460038147 |
|
11819 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCID2 |
0.39319460038147 |
|
11820 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CUL4A |
0.39319460038147 |
|
11821 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LAMP1 |
0.39319460038147 |
|
11822 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GRTP1 |
0.39319460038147 |
|
11823 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IFT57 |
0.393235474571252 |
|
11824 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TTLL1 |
0.393303997973504 |
|
11825 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BIK |
0.393303997973504 |
|
11826 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MCAT |
0.393303997973504 |
|
11827 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TSPO |
0.393303997973504 |
|
11828 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TTLL12 |
0.393303997973504 |
|
11829 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCUBE1 |
0.393303997973504 |
|
11830 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPFIA2 |
0.393306021250407 |
|
11831 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U6|ENSG00000272445.1 |
0.393388818151497 |
|
11832 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KLHL38 |
0.393390758175151 |
|
11833 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PARP4 |
0.393411543462407 |
|
11834 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TPTE2P6 |
0.393411543462407 |
|
11835 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATP12A |
0.393411543462407 |
|
11836 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNY1P7 |
0.393411543462407 |
|
11837 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SEMA6A |
0.393428342830652 |
|
11838 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL575P |
0.393459552513805 |
|
11839 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAL |
0.393459552513805 |
|
11840 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PTPLAD2 |
0.39351627227428 |
|
11841 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CHRNB3 |
0.393686247267725 |
|
11842 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
S100PBP |
0.393717950351746 |
|
11843 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FNDC5 |
0.393717950351746 |
|
11844 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HPCA |
0.393717950351746 |
|
11845 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM54 |
0.393717950351746 |
|
11846 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNF19B |
0.393717950351746 |
|
11847 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FKSG48 |
0.393717950351746 |
|
11848 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AK2 |
0.393717950351746 |
|
11849 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADC |
0.393717950351746 |
|
11850 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRIM62 |
0.393717950351746 |
|
11851 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GALNT13 |
0.393836916417899 |
|
11852 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF790 |
0.393911731555306 |
|
11853 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF345 |
0.393911731555306 |
|
11854 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF829 |
0.393911731555306 |
|
11855 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF585A |
0.393911731555306 |
|
11856 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP254 |
0.393930390526874 |
|
11857 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TNPO3 |
0.394257943642808 |
|
11858 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL491P |
0.394311312215836 |
|
11859 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SDCBP |
0.394908835507831 |
|
11860 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NSMAF |
0.394908835507831 |
|
11861 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DDIT4 |
0.395019179167641 |
|
11862 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DNAJB12 |
0.395019179167641 |
|
11863 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MICU1 |
0.395019179167641 |
|
11864 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZC3H7B |
0.395499508931642 |
|
11865 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STMN1P1 |
0.39570557965877 |
|
11866 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
H3F3C |
0.39570557965877 |
|
11867 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA25|ENSG00000252204.1 |
0.39570557965877 |
|
11868 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR708 |
0.395741907951937 |
|
11869 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR5579 |
0.395741907951937 |
|
11870 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CA4 |
0.395966190094043 |
|
11871 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
USP32 |
0.395966190094043 |
|
11872 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCARNA20|ENSG00000252577.1 |
0.395966190094043 |
|
11873 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C17orf64 |
0.395966190094043 |
|
11874 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC22A12 |
0.396057738214931 |
|
11875 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NRXN2 |
0.396057738214931 |
|
11876 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RASGRP2 |
0.396057738214931 |
|
11877 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PYGM |
0.396057738214931 |
|
11878 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SF1 |
0.396057738214931 |
|
11879 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAP4K2 |
0.396057738214931 |
|
11880 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPH3A |
0.396076407219067 |
|
11881 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GRM8 |
0.396139848964627 |
|
11882 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR572 |
0.396372172950895 |
|
11883 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HS3ST1 |
0.396372172950895 |
|
11884 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP156 |
0.396372172950895 |
|
11885 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CEACAMP3 |
0.396494241358396 |
|
11886 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CEACAM4 |
0.396494241358396 |
|
11887 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CEACAM7 |
0.396494241358396 |
|
11888 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CEACAM5 |
0.396494241358396 |
|
11889 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CEA |
0.396494241358396 |
|
11890 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CEACAM3 |
0.396494241358396 |
|
11891 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CEACAM6 |
0.396494241358396 |
|
11892 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LYPD4 |
0.396494241358396 |
|
11893 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DMRTC2 |
0.396494241358396 |
|
11894 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238790.1 |
0.396526025733943 |
|
11895 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNU6ATAC15P |
0.396530325275167 |
|
11896 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP19 |
0.396639620305109 |
|
11897 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COG4 |
0.396652742954254 |
|
11898 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SF3B3 |
0.396652742954254 |
|
11899 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD111B |
0.396652742954254 |
|
11900 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD111|ENSG00000221066.1 |
0.396652742954254 |
|
11901 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANP32A |
0.396950211015082 |
|
11902 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4312 |
0.396950211015082 |
|
11903 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPESP1 |
0.396950211015082 |
|
11904 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NOX5 |
0.396950211015082 |
|
11905 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00277 |
0.396950211015082 |
|
11906 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM116 |
0.397079692764898 |
|
11907 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ERP29 |
0.397079692764898 |
|
11908 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3657 |
0.397079692764898 |
|
11909 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MYLK3 |
0.397080523899974 |
|
11910 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C16orf87 |
0.397080523899974 |
|
11911 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZKSCAN4 |
0.397419266990507 |
|
11912 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NKAPL |
0.397419266990507 |
|
11913 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF391 |
0.397790246528581 |
|
11914 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF184 |
0.397790246528581 |
|
11915 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3161 |
0.397898190461332 |
|
11916 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP71 |
0.398345580416662 |
|
11917 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PTPN11 |
0.398345580416662 |
|
11918 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPL6 |
0.398345580416662 |
|
11919 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OAS1 |
0.398345580416662 |
|
11920 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OAS3 |
0.398345580416662 |
|
11921 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OAS2 |
0.398345580416662 |
|
11922 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ITM2B |
0.398427072408954 |
|
11923 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00441 |
0.398427072408954 |
|
11924 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IL17F |
0.39848316325027 |
|
11925 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MCM3 |
0.39848316325027 |
|
11926 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PAQR8 |
0.39848316325027 |
|
11927 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EFHC1 |
0.39848316325027 |
|
11928 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAM2 |
0.39848316325027 |
|
11929 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM14A |
0.39848316325027 |
|
11930 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GSTA2 |
0.39848316325027 |
|
11931 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SYN3 |
0.398617511451855 |
|
11932 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP497 |
0.398617511451855 |
|
11933 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TIMP3 |
0.398617511451855 |
|
11934 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DCAF8L1 |
0.398653253143701 |
|
11935 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FLJ00104 |
0.39874976857431 |
|
11936 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KLHDC4 |
0.39874976857431 |
|
11937 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC7A5 |
0.39874976857431 |
|
11938 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CA5A |
0.39874976857431 |
|
11939 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DUSP5 |
0.398893033179411 |
|
11940 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RBM20 |
0.398893033179411 |
|
11941 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PDCD4 |
0.398893033179411 |
|
11942 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BBIP1 |
0.398893033179411 |
|
11943 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4680 |
0.398893033179411 |
|
11944 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SHOC2 |
0.398893033179411 |
|
11945 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GDF6 |
0.399456640054582 |
|
11946 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BMPR1B |
0.399510346732558 |
|
11947 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WDR45B |
0.399619556527254 |
|
11948 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TBX4 |
0.399643621014975 |
|
11949 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U3|ENSG00000252299.1 |
0.399684953175735 |
|
11950 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPIN1 |
0.399684953175735 |
|
11951 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA67|ENSG00000207094.1 |
0.399858547109259 |
|
11952 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HTR1E |
0.400021691806403 |
|
11953 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP209 |
0.400021691806403 |
|
11954 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CGA |
0.400021691806403 |
|
11955 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AKIRIN2 |
0.400021691806403 |
|
11956 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238628.1 |
0.400021691806403 |
|
11957 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL183P |
0.400021691806403 |
|
11958 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EDIL3 |
0.400120873672023 |
|
11959 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
USP13 |
0.400274917804552 |
|
11960 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PEX5L |
0.400274917804552 |
|
11961 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DTX4 |
0.400718383078406 |
|
11962 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MPEG1 |
0.400718383078406 |
|
11963 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL42P |
0.400718383078406 |
|
11964 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL435P |
0.400718383078406 |
|
11965 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR5AN1 |
0.400718383078406 |
|
11966 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR5A2 |
0.400718383078406 |
|
11967 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR5A1 |
0.400718383078406 |
|
11968 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HTR5A |
0.4009009507316 |
|
11969 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA22|ENSG00000199571.1 |
0.400949141325664 |
|
11970 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SENP6 |
0.401261065157011 |
|
11971 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RGS9 |
0.401262699389829 |
|
11972 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RTKN2 |
0.40131622329194 |
|
11973 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL591P |
0.40131622329194 |
|
11974 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LAPTM5 |
0.401341453916327 |
|
11975 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MATN1 |
0.401341453916327 |
|
11976 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4420 |
0.401341453916327 |
|
11977 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL566P |
0.401380328995633 |
|
11978 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PAF1 |
0.401380328995633 |
|
11979 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MED29 |
0.401380328995633 |
|
11980 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF266 |
0.401401364476718 |
|
11981 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF560 |
0.401401364476718 |
|
11982 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF426 |
0.401401364476718 |
|
11983 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF121 |
0.401401364476718 |
|
11984 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL700P |
0.401426226621377 |
|
11985 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00444 |
0.401426226621377 |
|
11986 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00562 |
0.401426226621377 |
|
11987 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SUCLA2 |
0.401426226621377 |
|
11988 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NUDT15 |
0.401426226621377 |
|
11989 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MED4 |
0.401426226621377 |
|
11990 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RCBTB2 |
0.401426226621377 |
|
11991 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF566 |
0.401583098312001 |
|
11992 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIAA1407 |
0.401671714607303 |
|
11993 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
QTRTD1 |
0.401671714607303 |
|
11994 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MS4A4A |
0.401740156286446 |
|
11995 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MS4A14 |
0.401740156286446 |
|
11996 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MS4A7 |
0.401740156286446 |
|
11997 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADAMTS12 |
0.401964277289082 |
|
11998 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
P2RY2 |
0.40203729816382 |
|
11999 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
P2RY6 |
0.40203729816382 |
|
12000 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATG10 |
0.402102210214329 |
|
12001 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL378P |
0.402102210214329 |
|
12002 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPS23 |
0.402102210214329 |
|
12003 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATP6AP1L |
0.402102210214329 |
|
12004 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP234 |
0.402148038986264 |
|
12005 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL802P |
0.402181248901655 |
|
12006 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP188 |
0.402181248901655 |
|
12007 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00492 |
0.402181248901655 |
|
12008 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00491 |
0.402181248901655 |
|
12009 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GIN1 |
0.402181248901655 |
|
12010 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPIP5K2 |
0.402181248901655 |
|
12011 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C5orf30 |
0.402181248901655 |
|
12012 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STOML1 |
0.402213295843308 |
|
12013 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PML |
0.402213295843308 |
|
12014 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GOLGA6A |
0.402213295843308 |
|
12015 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ISLR2 |
0.402213295843308 |
|
12016 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL429P |
0.402213295843308 |
|
12017 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ISLR |
0.402213295843308 |
|
12018 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STRA6 |
0.402213295843308 |
|
12019 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TTC23 |
0.402349703134678 |
|
12020 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRRC28 |
0.402349703134678 |
|
12021 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MEF2A |
0.402349703134678 |
|
12022 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STX2 |
0.402956311945343 |
|
12023 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238822.1 |
0.402956311945343 |
|
12024 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAN |
0.402956311945343 |
|
12025 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPR133 |
0.402956311945343 |
|
12026 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MYL12B |
0.403074145588903 |
|
12027 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP202 |
0.403379703368222 |
|
12028 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
YBX1 |
0.403409716387572 |
|
12029 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CNNM2 |
0.403770585233197 |
|
12030 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL8P |
0.403829583589283 |
|
12031 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD112|ENSG00000251911.1 |
0.403829583589283 |
|
12032 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00507 |
0.403918331818099 |
|
12033 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00508 |
0.403918331818099 |
|
12034 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF284 |
0.404002453904822 |
|
12035 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL53P |
0.404002453904822 |
|
12036 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF224 |
0.404002453904822 |
|
12037 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF225 |
0.404002453904822 |
|
12038 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF234 |
0.404002453904822 |
|
12039 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF226 |
0.404002453904822 |
|
12040 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF227 |
0.404002453904822 |
|
12041 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADAM30 |
0.404053588146825 |
|
12042 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LGALS4 |
0.4041435659832 |
|
12043 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ECH1 |
0.4041435659832 |
|
12044 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HNRNPL |
0.4041435659832 |
|
12045 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RINL |
0.4041435659832 |
|
12046 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SIRT2 |
0.4041435659832 |
|
12047 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NFKBIB |
0.4041435659832 |
|
12048 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MRPS12 |
0.4041435659832 |
|
12049 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TECRL |
0.404225304547217 |
|
12050 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GRK5 |
0.404231726733106 |
|
12051 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4681 |
0.404231726733106 |
|
12052 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HPYR1 |
0.40451449773348 |
|
12053 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OSGIN2 |
0.404679024566091 |
|
12054 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNX13 |
0.404692343673202 |
|
12055 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRPS1L1 |
0.404692343673202 |
|
12056 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HDAC9 |
0.404692343673202 |
|
12057 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NELL2 |
0.404821639314901 |
|
12058 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FIG4 |
0.405091846173074 |
|
12059 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WNT11 |
0.405259921029636 |
|
12060 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRKRIR |
0.405259921029636 |
|
12061 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C11orf30 |
0.405259921029636 |
|
12062 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRRC32 |
0.405259921029636 |
|
12063 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NT5C2 |
0.405338294124358 |
|
12064 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
INA |
0.405338294124358 |
|
12065 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCGF6 |
0.405338294124358 |
|
12066 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TAF5 |
0.405338294124358 |
|
12067 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CALHM1 |
0.405338294124358 |
|
12068 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CALHM2 |
0.405338294124358 |
|
12069 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR1307 |
0.405338294124358 |
|
12070 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PDCD11 |
0.405338294124358 |
|
12071 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
USMG5 |
0.405338294124358 |
|
12072 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CALHM3 |
0.405338294124358 |
|
12073 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NEURL |
0.405338294124358 |
|
12074 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SH3PXD2A |
0.405338294124358 |
|
12075 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OBFC1 |
0.405338294124358 |
|
12076 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000239095.1 |
0.405491068916959 |
|
12077 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COPRS |
0.405529505590061 |
|
12078 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UTP6 |
0.405529505590061 |
|
12079 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SUZ12 |
0.405529505590061 |
|
12080 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP437 |
0.405529505590061 |
|
12081 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRRC37B |
0.405529505590061 |
|
12082 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SH3GL1P1 |
0.405529505590061 |
|
12083 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TBX15 |
0.40590524014965 |
|
12084 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WARS2 |
0.40590524014965 |
|
12085 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238679.1 |
0.40590524014965 |
|
12086 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADAM1A |
0.405960564972522 |
|
12087 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAPKAPK5 |
0.406059342310963 |
|
12088 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRIM21 |
0.406065567346572 |
|
12089 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CKS2 |
0.406145016105055 |
|
12090 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3153 |
0.406145016105055 |
|
12091 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SECISBP2 |
0.406145016105055 |
|
12092 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SEMA4D |
0.406145016105055 |
|
12093 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GADD45G |
0.406145016105055 |
|
12094 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4290 |
0.406145016105055 |
|
12095 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HHLA2 |
0.406503417287565 |
|
12096 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MYH15 |
0.406503417287565 |
|
12097 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIAA1524 |
0.406503417287565 |
|
12098 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA70|ENSG00000202379.1 |
0.406503417287565 |
|
12099 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DZIP3 |
0.406503417287565 |
|
12100 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RETNLB |
0.406503417287565 |
|
12101 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAT1 |
0.406503417287565 |
|
12102 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DPPA2 |
0.406503417287565 |
|
12103 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GUCA1C |
0.406503417287565 |
|
12104 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00488 |
0.406503417287565 |
|
12105 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MORC1 |
0.406503417287565 |
|
12106 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U3|ENSG00000221633.1 |
0.406503417287565 |
|
12107 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DPPA4 |
0.406503417287565 |
|
12108 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ENTPD3 |
0.406597270187636 |
|
12109 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPL14 |
0.406597270187636 |
|
12110 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF619 |
0.406597270187636 |
|
12111 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF620 |
0.406597270187636 |
|
12112 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF621 |
0.406597270187636 |
|
12113 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR1292 |
0.406615659410745 |
|
12114 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NOP56 |
0.406615659410745 |
|
12115 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA51|ENSG00000271798.1 |
0.406615659410745 |
|
12116 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD110 |
0.406615659410745 |
|
12117 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD86 |
0.406615659410745 |
|
12118 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD56|ENSG00000229686.1 |
0.406615659410745 |
|
12119 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD57 |
0.406615659410745 |
|
12120 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IDH3B |
0.406615659410745 |
|
12121 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EBF4 |
0.406615659410745 |
|
12122 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CPXM1 |
0.406615659410745 |
|
12123 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C20orf141 |
0.406615659410745 |
|
12124 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM239 |
0.406615659410745 |
|
12125 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCED1A |
0.406615659410745 |
|
12126 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VPS16 |
0.406615659410745 |
|
12127 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PTPRA |
0.406615659410745 |
|
12128 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GNRH2 |
0.406615659410745 |
|
12129 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MRPS26 |
0.406615659410745 |
|
12130 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UBOX5 |
0.406615659410745 |
|
12131 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FASTKD5 |
0.406615659410745 |
|
12132 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LZTS3 |
0.406615659410745 |
|
12133 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPARA |
0.406648781183703 |
|
12134 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDPF1 |
0.406648781183703 |
|
12135 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PKDREJ |
0.406648781183703 |
|
12136 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TTC38 |
0.406648781183703 |
|
12137 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GTSE1 |
0.406648781183703 |
|
12138 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GAS1 |
0.406656783219002 |
|
12139 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C9orf170 |
0.406656783219002 |
|
12140 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA26|ENSG00000212421.1 |
0.406656783219002 |
|
12141 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00240 |
0.406698139444147 |
|
12142 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HIST1H2BJ |
0.406698139444147 |
|
12143 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HIST1H2AG |
0.406698139444147 |
|
12144 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HIST1H2BK |
0.406698139444147 |
|
12145 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HIST1H4I |
0.406698139444147 |
|
12146 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HIST1H2AH |
0.406698139444147 |
|
12147 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3143 |
0.406698139444147 |
|
12148 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRSS16 |
0.406698139444147 |
|
12149 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
POM121L2 |
0.406698139444147 |
|
12150 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNLS |
0.406774439625955 |
|
12151 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LIPJ |
0.406774439625955 |
|
12152 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LIPF |
0.406774439625955 |
|
12153 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LIPK |
0.406774439625955 |
|
12154 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LIPN |
0.406774439625955 |
|
12155 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LIPM |
0.406774439625955 |
|
12156 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANKRD22 |
0.406774439625955 |
|
12157 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NPBWR1 |
0.406871942549275 |
|
12158 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FFAR2 |
0.407073242001979 |
|
12159 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KRTDAP |
0.407073242001979 |
|
12160 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DMKN |
0.407073242001979 |
|
12161 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00571 |
0.407320432786493 |
|
12162 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UFM1 |
0.407320432786493 |
|
12163 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00366 |
0.407320432786493 |
|
12164 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TGFB1 |
0.407324584728865 |
|
12165 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM120A |
0.407575841735358 |
|
12166 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL306P |
0.407578415829269 |
|
12167 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NELFCD |
0.407708898672443 |
|
12168 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CTSZ |
0.407708898672443 |
|
12169 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TUBB1 |
0.407708898672443 |
|
12170 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATP5E |
0.407708898672443 |
|
12171 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLMO2 |
0.407708898672443 |
|
12172 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SSR4P1 |
0.407832527344376 |
|
12173 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRED57 |
0.407832527344376 |
|
12174 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIF5C |
0.407952688591141 |
|
12175 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP66 |
0.408117407532015 |
|
12176 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HPS6 |
0.40811979738953 |
|
12177 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ELOVL3 |
0.40811979738953 |
|
12178 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PITX3 |
0.40811979738953 |
|
12179 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COL12A1 |
0.408382210597203 |
|
12180 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIF21A |
0.408495788372406 |
|
12181 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AK8 |
0.408643917625939 |
|
12182 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OGFRL1 |
0.408664427383823 |
|
12183 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR30C2 |
0.408664427383823 |
|
12184 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCZ1 |
0.408745543398072 |
|
12185 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OCM |
0.408745543398072 |
|
12186 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PMS2 |
0.408745543398072 |
|
12187 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL556P |
0.408745543398072 |
|
12188 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RSPH10B |
0.408745543398072 |
|
12189 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF815P |
0.408745543398072 |
|
12190 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4264 |
0.408763972665181 |
|
12191 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C9orf129 |
0.408772900136439 |
|
12192 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCTD8 |
0.408835679845532 |
|
12193 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF567 |
0.408957125965534 |
|
12194 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DNAJA2 |
0.409018017417124 |
|
12195 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CNNM1 |
0.409028013098999 |
|
12196 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GOT1 |
0.409028013098999 |
|
12197 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238588.1 |
0.409028013098999 |
|
12198 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC25A28 |
0.409028013098999 |
|
12199 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ENTPD7 |
0.409028013098999 |
|
12200 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CUTC |
0.409028013098999 |
|
12201 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COX15 |
0.409028013098999 |
|
12202 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ABCC2 |
0.409028013098999 |
|
12203 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DNMBP |
0.409028013098999 |
|
12204 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238472.1 |
0.409028013098999 |
|
12205 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CPN1 |
0.409028013098999 |
|
12206 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ERLIN1 |
0.409028013098999 |
|
12207 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GUCY2F |
0.409104093626913 |
|
12208 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CYTH3 |
0.409137034641816 |
|
12209 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DIDO1 |
0.409142660671634 |
|
12210 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GID8 |
0.409142660671634 |
|
12211 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC17A9 |
0.409142660671634 |
|
12212 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WDR96 |
0.40969758792384 |
|
12213 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRNAI2 |
0.409719635426546 |
|
12214 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ULK4 |
0.409750434203266 |
|
12215 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ELF5 |
0.409905332997769 |
|
12216 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PDE2A |
0.409939107354142 |
|
12217 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR139 |
0.409939107354142 |
|
12218 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP50 |
0.409941880247027 |
|
12219 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAGI2 |
0.410027117385195 |
|
12220 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FUT9 |
0.41011274101003 |
|
12221 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL797P |
0.41011274101003 |
|
12222 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WSCD1 |
0.410132283808677 |
|
12223 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AKR1C1 |
0.410198145255841 |
|
12224 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACTRT3 |
0.410225826972588 |
|
12225 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TERC |
0.410225826972588 |
|
12226 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MYNN |
0.410225826972588 |
|
12227 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRRC34 |
0.410225826972588 |
|
12228 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRRIQ4 |
0.410225826972588 |
|
12229 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRRC31 |
0.410225826972588 |
|
12230 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UFL1 |
0.410353182053219 |
|
12231 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FHL5 |
0.410353182053219 |
|
12232 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CHP2 |
0.410841103856537 |
|
12233 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4300 |
0.410928284477021 |
|
12234 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SAMD7 |
0.411171373483795 |
|
12235 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SEC62 |
0.411171373483795 |
|
12236 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPC6 |
0.41122005575082 |
|
12237 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COL17A1 |
0.411266275137593 |
|
12238 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR936 |
0.411266275137593 |
|
12239 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SFR1 |
0.411266275137593 |
|
12240 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CEACAM21 |
0.411593136935223 |
|
12241 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000239054.1 |
0.411639075621654 |
|
12242 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BRCA2 |
0.41173848044251 |
|
12243 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
N4BP2L1 |
0.41173848044251 |
|
12244 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA16|ENSG00000212293.1 |
0.41173848044251 |
|
12245 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
N4BP2L2 |
0.41173848044251 |
|
12246 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAPGEF5 |
0.411760681702746 |
|
12247 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP227 |
0.411760681702746 |
|
12248 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EMB |
0.411843839051066 |
|
12249 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PACRGL |
0.411995361383557 |
|
12250 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238801.1 |
0.412225744034298 |
|
12251 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDYL |
0.412225744034298 |
|
12252 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPP40 |
0.412225744034298 |
|
12253 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RMRPP2 |
0.412225744034298 |
|
12254 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPP1R3G |
0.412225744034298 |
|
12255 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LYRM4 |
0.412225744034298 |
|
12256 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3691 |
0.412225744034298 |
|
12257 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LY86 |
0.412225744034298 |
|
12258 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL554P |
0.412225744034298 |
|
12259 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000251762.1 |
0.412225744034298 |
|
12260 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RREB1 |
0.412225744034298 |
|
12261 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SSR1 |
0.412225744034298 |
|
12262 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CAGE1 |
0.412225744034298 |
|
12263 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RIOK1 |
0.412225744034298 |
|
12264 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DSP |
0.412225744034298 |
|
12265 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BLOC1S5 |
0.412225744034298 |
|
12266 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EEF1E1 |
0.412225744034298 |
|
12267 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PAX5 |
0.412334968320105 |
|
12268 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA3|ENSG00000221639.1 |
0.412414119122231 |
|
12269 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZFP14 |
0.412879543541191 |
|
12270 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NLGN1 |
0.413187681963908 |
|
12271 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP234 |
0.413187681963908 |
|
12272 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD112|ENSG00000253068.1 |
0.413323431680146 |
|
12273 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LDB1 |
0.413323431680146 |
|
12274 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPRC1 |
0.413323431680146 |
|
12275 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DCUN1D4 |
0.413390300399989 |
|
12276 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM20C |
0.413451385677187 |
|
12277 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PDGFA |
0.413451385677187 |
|
12278 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CRYBG3|ENSG00000233280.2 |
0.413660929018887 |
|
12279 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CSMD2 |
0.4138437681362 |
|
12280 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZSCAN29 |
0.413865545265695 |
|
12281 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TUBGCP4 |
0.413865545265695 |
|
12282 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRA2A |
0.41404992853321 |
|
12283 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GUSBP1 |
0.414060272999648 |
|
12284 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC126 |
0.414206517321356 |
|
12285 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PAX2 |
0.41427574469322 |
|
12286 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DLEU1 |
0.414339671491529 |
|
12287 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DLEU2 |
0.414339671491529 |
|
12288 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DLEU7 |
0.414339671491529 |
|
12289 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCNRG |
0.414339671491529 |
|
12290 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3613 |
0.414339671491529 |
|
12291 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP28 |
0.414339671491529 |
|
12292 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP29 |
0.414339671491529 |
|
12293 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNASEH2B |
0.414339671491529 |
|
12294 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRIM13 |
0.414339671491529 |
|
12295 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAHD1 |
0.414543283308411 |
|
12296 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MEIOB |
0.414543283308411 |
|
12297 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL367P |
0.414543283308411 |
|
12298 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HS3ST6 |
0.414543283308411 |
|
12299 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MSRB1 |
0.414543283308411 |
|
12300 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPL3L |
0.414543283308411 |
|
12301 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NDUFB10 |
0.414543283308411 |
|
12302 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNF151 |
0.414543283308411 |
|
12303 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPS2 |
0.414543283308411 |
|
12304 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNHG9 |
0.414543283308411 |
|
12305 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA10 |
0.414543283308411 |
|
12306 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA64|ENSG00000207405.1 |
0.414543283308411 |
|
12307 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TBL3 |
0.414543283308411 |
|
12308 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TSC2 |
0.414543283308411 |
|
12309 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR1225 |
0.414543283308411 |
|
12310 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PKD1 |
0.414543283308411 |
|
12311 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CASKIN1 |
0.414543283308411 |
|
12312 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4516 |
0.414543283308411 |
|
12313 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAB26 |
0.414543283308411 |
|
12314 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD60|ENSG00000206630.1 |
0.414543283308411 |
|
12315 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAF7 |
0.414543283308411 |
|
12316 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MLST8 |
0.414543283308411 |
|
12317 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BRICD5 |
0.414543283308411 |
|
12318 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PGP |
0.414543283308411 |
|
12319 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DNASE1L2 |
0.414543283308411 |
|
12320 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
E4F1 |
0.414543283308411 |
|
12321 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ECI1 |
0.414543283308411 |
|
12322 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNPS1 |
0.414543283308411 |
|
12323 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RFWD2 |
0.414662356611336 |
|
12324 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL691P |
0.414757381339772 |
|
12325 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NT5E |
0.414776693393188 |
|
12326 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNX14 |
0.414776693393188 |
|
12327 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF165 |
0.414986322623757 |
|
12328 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZSCAN12P1 |
0.414986322623757 |
|
12329 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZSCAN16 |
0.414986322623757 |
|
12330 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZKSCAN8 |
0.414986322623757 |
|
12331 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF192P1 |
0.414986322623757 |
|
12332 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZSCAN9 |
0.414986322623757 |
|
12333 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
APOL1 |
0.415041569269426 |
|
12334 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
APOL2 |
0.415041569269426 |
|
12335 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MYH9 |
0.415041569269426 |
|
12336 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL349P |
0.415041569269426 |
|
12337 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SORCS3 |
0.415117550161555 |
|
12338 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPACA7 |
0.415329551574226 |
|
12339 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TUBGCP3 |
0.415329551574226 |
|
12340 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C13orf35 |
0.415329551574226 |
|
12341 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACTL6A |
0.415377844252115 |
|
12342 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238329.1 |
0.415456347156252 |
|
12343 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMC7 |
0.415456347156252 |
|
12344 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COQ7 |
0.415456347156252 |
|
12345 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
B9D2 |
0.415512766598779 |
|
12346 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BCKDHA |
0.415512766598779 |
|
12347 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM91 |
0.415512766598779 |
|
12348 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EXOSC5 |
0.415512766598779 |
|
12349 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
B3GNT8 |
0.415512766598779 |
|
12350 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATP5SL |
0.415512766598779 |
|
12351 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C19orf69 |
0.415512766598779 |
|
12352 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNU4ATAC3P |
0.415626227081458 |
|
12353 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EHF |
0.415992007345234 |
|
12354 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
APIP |
0.415992007345234 |
|
12355 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIAA0195 |
0.416156187270625 |
|
12356 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CASKIN2 |
0.416156187270625 |
|
12357 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TSEN54 |
0.416156187270625 |
|
12358 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LLGL2 |
0.416156187270625 |
|
12359 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZDHHC21 |
0.416367031189521 |
|
12360 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CER1 |
0.416367031189521 |
|
12361 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FREM1 |
0.416367031189521 |
|
12362 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CYP17A1 |
0.416436875407688 |
|
12363 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C10ORF32 |
0.416436875407688 |
|
12364 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C10orf32 |
0.416436875407688 |
|
12365 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AS3MT |
0.416436875407688 |
|
12366 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00222 |
0.416522130184598 |
|
12367 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF259P1 |
0.416522130184598 |
|
12368 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OTOGL |
0.416525942858875 |
|
12369 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MRGPRX1 |
0.41654974505073 |
|
12370 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZDHHC13 |
0.41654974505073 |
|
12371 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CSRP3 |
0.41654974505073 |
|
12372 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IRAK4 |
0.416619062945356 |
|
12373 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TWF1 |
0.416619062945356 |
|
12374 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U3|ENSG00000221332.1 |
0.416777160667546 |
|
12375 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4463 |
0.416777160667546 |
|
12376 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR7D2 |
0.416810600610879 |
|
12377 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR7D4 |
0.416810600610879 |
|
12378 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR7E24 |
0.416810600610879 |
|
12379 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ITGAE |
0.416929856277643 |
|
12380 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GSG2 |
0.416929856277643 |
|
12381 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C17orf85 |
0.416929856277643 |
|
12382 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C6orf195 |
0.417210060893358 |
|
12383 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MYLK4 |
0.417210060893358 |
|
12384 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WRNIP1 |
0.417210060893358 |
|
12385 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SERPINB1 |
0.417210060893358 |
|
12386 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4645 |
0.417210060893358 |
|
12387 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SERPINB9 |
0.417210060893358 |
|
12388 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IGFBP7 |
0.417247255527277 |
|
12389 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238541.1 |
0.417247255527277 |
|
12390 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4694 |
0.417259201376729 |
|
12391 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DBX1 |
0.417259201376729 |
|
12392 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR609 |
0.417327322552568 |
|
12393 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GSTO1 |
0.417327322552568 |
|
12394 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GGA2 |
0.417401627922731 |
|
12395 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EARS2 |
0.417401627922731 |
|
12396 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AFF3 |
0.417509200399273 |
|
12397 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR30E |
0.417515493218653 |
|
12398 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CTPS1 |
0.417515493218653 |
|
12399 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLFNL1 |
0.417515493218653 |
|
12400 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL122P |
0.417882421918531 |
|
12401 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZBTB8B |
0.417882421918531 |
|
12402 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CD200 |
0.417921849063649 |
|
12403 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL855P |
0.417953077250361 |
|
12404 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF733P |
0.417953077250361 |
|
12405 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STAMBPL1 |
0.417995863996513 |
|
12406 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACTA2 |
0.417995863996513 |
|
12407 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAS |
0.417995863996513 |
|
12408 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238991.1 |
0.417995863996513 |
|
12409 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GSTO2 |
0.418008406447869 |
|
12410 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ITPRIP |
0.418008406447869 |
|
12411 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC147 |
0.418008406447869 |
|
12412 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238620.1 |
0.418008406447869 |
|
12413 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LHFP |
0.418245773748273 |
|
12414 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CAV2 |
0.418269739510099 |
|
12415 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CAV1 |
0.418269739510099 |
|
12416 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCNIP4 |
0.418669383019091 |
|
12417 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF177 |
0.41867315904941 |
|
12418 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STK31 |
0.418778227966297 |
|
12419 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238849.1 |
0.418778227966297 |
|
12420 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRRTM1 |
0.418833546814379 |
|
12421 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00410 |
0.418840933942827 |
|
12422 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00379 |
0.418840933942827 |
|
12423 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR17HG |
0.418840933942827 |
|
12424 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
APOC4 |
0.418899290922893 |
|
12425 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
APOC2 |
0.418899290922893 |
|
12426 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLPTM1 |
0.418899290922893 |
|
12427 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RELB |
0.418899290922893 |
|
12428 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLASRP |
0.418899290922893 |
|
12429 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF296 |
0.418899290922893 |
|
12430 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GEMIN7 |
0.418899290922893 |
|
12431 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TXLNG |
0.418984742874838 |
|
12432 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RBBP7 |
0.418984742874838 |
|
12433 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCML1 |
0.419196732982077 |
|
12434 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAI2 |
0.419196732982077 |
|
12435 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPSAP58 |
0.419301752133639 |
|
12436 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
THAP1 |
0.419390097606128 |
|
12437 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LNPEP |
0.419683949520475 |
|
12438 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LIX1 |
0.419683949520475 |
|
12439 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BNC2 |
0.419820729528757 |
|
12440 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL720P |
0.419820729528757 |
|
12441 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CNTLN |
0.419820729528757 |
|
12442 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FFAR3 |
0.419835774373104 |
|
12443 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPR42 |
0.419835774373104 |
|
12444 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LMBR1 |
0.41994673775554 |
|
12445 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MBOAT7 |
0.419973628895971 |
|
12446 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TSEN34 |
0.419973628895971 |
|
12447 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HIST1H2AI |
0.419980061590338 |
|
12448 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HIST1H2AJ |
0.419980061590338 |
|
12449 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HIST1H2BL |
0.419980061590338 |
|
12450 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HIST1H2BM |
0.419980061590338 |
|
12451 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HIST1H3H |
0.419980061590338 |
|
12452 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HIST1H4J |
0.419980061590338 |
|
12453 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HIST1H4K |
0.419980061590338 |
|
12454 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HIST1H2AK |
0.419980061590338 |
|
12455 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HIST1H2BN |
0.419980061590338 |
|
12456 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HIST1H2AL |
0.419980061590338 |
|
12457 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HIST1H1B |
0.419980061590338 |
|
12458 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HIST1H3I |
0.419980061590338 |
|
12459 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HIST1H4L |
0.419980061590338 |
|
12460 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HIST1H3J |
0.419980061590338 |
|
12461 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HIST1H2AM |
0.419980061590338 |
|
12462 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HIST1H2BO |
0.419980061590338 |
|
12463 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR2B2 |
0.419980061590338 |
|
12464 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR2B6 |
0.419980061590338 |
|
12465 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U3|ENSG00000199851.1 |
0.419980061590338 |
|
12466 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NXT2 |
0.42008150499383 |
|
12467 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCNE1L |
0.42008150499383 |
|
12468 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACSL4 |
0.42008150499383 |
|
12469 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM164 |
0.42008150499383 |
|
12470 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR652 |
0.42008150499383 |
|
12471 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3978 |
0.42008150499383 |
|
12472 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD96B |
0.42008150499383 |
|
12473 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4687 |
0.420380055558804 |
|
12474 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA7|ENSG00000206976.1 |
0.420380055558804 |
|
12475 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RBX1 |
0.420423568859546 |
|
12476 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U8|ENSG00000200191.1 |
0.420538583199473 |
|
12477 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MSC |
0.420538583199473 |
|
12478 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRPA1 |
0.420538583199473 |
|
12479 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP271 |
0.420538583199473 |
|
12480 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPL7 |
0.420538583199473 |
|
12481 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RDH10 |
0.420538583199473 |
|
12482 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STAU2 |
0.420538583199473 |
|
12483 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MRPS5 |
0.420553935306663 |
|
12484 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF514 |
0.420553935306663 |
|
12485 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF2 |
0.420553935306663 |
|
12486 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PROM2 |
0.420553935306663 |
|
12487 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCNIP3 |
0.420553935306663 |
|
12488 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STK17A |
0.420573527285834 |
|
12489 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA25|ENSG00000252296.1 |
0.420609398990311 |
|
12490 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP344 |
0.42061757419671 |
|
12491 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNY4P30 |
0.42068754455345 |
|
12492 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNY4P9 |
0.42068754455345 |
|
12493 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPRYD7 |
0.42068754455345 |
|
12494 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VCL |
0.420699412276438 |
|
12495 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AP3M1 |
0.420699412276438 |
|
12496 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CD3EAP |
0.420972552737773 |
|
12497 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ERCC1 |
0.420972552737773 |
|
12498 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACTL7B |
0.421062419216319 |
|
12499 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACTL7A |
0.421062419216319 |
|
12500 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HSPA12B |
0.421092731296042 |
|
12501 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C20orf27 |
0.421092731296042 |
|
12502 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPEF1 |
0.421092731296042 |
|
12503 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDC25B |
0.421092731296042 |
|
12504 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CENPB |
0.421092731296042 |
|
12505 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AP5S1 |
0.421092731296042 |
|
12506 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAVS |
0.421092731296042 |
|
12507 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR103A2 |
0.421092731296042 |
|
12508 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PANK2 |
0.421092731296042 |
|
12509 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNF24 |
0.421092731296042 |
|
12510 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DPCD |
0.421111435584207 |
|
12511 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
POLL |
0.421111435584207 |
|
12512 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FBXW4 |
0.421111435584207 |
|
12513 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NAT10 |
0.421294629726798 |
|
12514 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CD44 |
0.421294629726798 |
|
12515 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC1A2 |
0.421294629726798 |
|
12516 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PAMR1 |
0.421294629726798 |
|
12517 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FJX1 |
0.421294629726798 |
|
12518 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPOCK2 |
0.42160970977217 |
|
12519 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MTRNR2L12 |
0.42161717037584 |
|
12520 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SMC6 |
0.421640932746338 |
|
12521 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GEN1 |
0.421640932746338 |
|
12522 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MSGN1 |
0.421640932746338 |
|
12523 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TTC39B |
0.421647792389568 |
|
12524 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL157P |
0.421647792389568 |
|
12525 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OSBPL8 |
0.421716652957733 |
|
12526 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZDHHC17 |
0.421716652957733 |
|
12527 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CSRP2 |
0.421716652957733 |
|
12528 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
E2F7 |
0.421716652957733 |
|
12529 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238769.1 |
0.421716652957733 |
|
12530 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TNPO1 |
0.421749859003925 |
|
12531 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4804 |
0.421749859003925 |
|
12532 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FCHO2 |
0.421749859003925 |
|
12533 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM171 |
0.421749859003925 |
|
12534 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM174 |
0.421749859003925 |
|
12535 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC44A5 |
0.421924134969234 |
|
12536 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PTPRN2 |
0.422307888295051 |
|
12537 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NCOR2 |
0.422351180963774 |
|
12538 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MTA3 |
0.422405048922874 |
|
12539 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OXER1 |
0.422405048922874 |
|
12540 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCNK4 |
0.4224862855059 |
|
12541 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TEX40 |
0.4224862855059 |
|
12542 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ESRRA |
0.4224862855059 |
|
12543 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRDX5 |
0.4224862855059 |
|
12544 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRMT112 |
0.4224862855059 |
|
12545 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PGBD1 |
0.422601613161417 |
|
12546 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZSCAN31 |
0.422601613161417 |
|
12547 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZKSCAN3 |
0.422601613161417 |
|
12548 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZSCAN12 |
0.422601613161417 |
|
12549 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZSCAN23 |
0.422601613161417 |
|
12550 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPX6 |
0.422601613161417 |
|
12551 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPX5 |
0.422601613161417 |
|
12552 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCAND3 |
0.422601613161417 |
|
12553 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00533 |
0.422601613161417 |
|
12554 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR2J1 |
0.422601613161417 |
|
12555 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR2J2 |
0.422601613161417 |
|
12556 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR2J3 |
0.422601613161417 |
|
12557 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SRD5A2 |
0.422652943599286 |
|
12558 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LGALS7B |
0.422696400499198 |
|
12559 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WBP4 |
0.422792979918014 |
|
12560 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3168 |
0.422792979918014 |
|
12561 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL597P |
0.422792979918014 |
|
12562 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KBTBD6 |
0.422792979918014 |
|
12563 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238651.1 |
0.422792979918014 |
|
12564 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KBTBD7 |
0.422792979918014 |
|
12565 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KHDC3L |
0.422886060015509 |
|
12566 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OOEP |
0.422886060015509 |
|
12567 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DDX43 |
0.422886060015509 |
|
12568 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238464.1 |
0.422886060015509 |
|
12569 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MB21D1 |
0.422886060015509 |
|
12570 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MTO1 |
0.422886060015509 |
|
12571 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLIT2 |
0.423012053217609 |
|
12572 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GRIN2C |
0.42318178016694 |
|
12573 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FDXR |
0.42318178016694 |
|
12574 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC16A5 |
0.42318178016694 |
|
12575 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SMOX |
0.423353136286197 |
|
12576 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADRA1D |
0.423353136286197 |
|
12577 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRRC6 |
0.423481334194875 |
|
12578 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SUMO1 |
0.423526220217513 |
|
12579 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD70|ENSG00000212534.1 |
0.423526220217513 |
|
12580 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD70|ENSG00000212309.1 |
0.423526220217513 |
|
12581 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TSC22D3 |
0.423576223445417 |
|
12582 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NCBP2L |
0.423576223445417 |
|
12583 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AMMECR1 |
0.423649651068207 |
|
12584 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GNG5P2 |
0.423649651068207 |
|
12585 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RGAG1 |
0.423649651068207 |
|
12586 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TDGF1P3 |
0.423649651068207 |
|
12587 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CHRDL1 |
0.423649651068207 |
|
12588 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR2276 |
0.423938928776572 |
|
12589 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCNB2 |
0.423950535146452 |
|
12590 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GAGE1 |
0.423961650133013 |
|
12591 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRKCB |
0.424044130279639 |
|
12592 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAD51AP2 |
0.424286925602682 |
|
12593 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VSNL1 |
0.424286925602682 |
|
12594 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA40|ENSG00000212455.1 |
0.424286925602682 |
|
12595 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NT5C1B |
0.424286925602682 |
|
12596 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RDH14 |
0.424286925602682 |
|
12597 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL493P |
0.424644291356549 |
|
12598 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CTNNB1 |
0.424768997179368 |
|
12599 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCARNA21|ENSG00000252409.1 |
0.424768997179368 |
|
12600 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KSR2 |
0.42479098418624 |
|
12601 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SUSD3 |
0.424980574214324 |
|
12602 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C9orf89 |
0.424980574214324 |
|
12603 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NINJ1 |
0.424980574214324 |
|
12604 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WNK2 |
0.424980574214324 |
|
12605 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRMU |
0.425066209337484 |
|
12606 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MID2 |
0.425381513409695 |
|
12607 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SMCHD1 |
0.425570815505131 |
|
12608 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TAF7L |
0.425941118720683 |
|
12609 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BTK |
0.425941118720683 |
|
12610 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TIMM8A |
0.425941118720683 |
|
12611 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPL36A |
0.425941118720683 |
|
12612 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GLA |
0.425941118720683 |
|
12613 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HNRNPH2 |
0.425941118720683 |
|
12614 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CSTF2 |
0.42631992844069 |
|
12615 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA9|ENSG00000202231.1 |
0.42631992844069 |
|
12616 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NOX1 |
0.42631992844069 |
|
12617 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARL13A |
0.42631992844069 |
|
12618 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM35 |
0.42631992844069 |
|
12619 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRMT2B |
0.42631992844069 |
|
12620 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
XKRX |
0.42631992844069 |
|
12621 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CENPI |
0.42631992844069 |
|
12622 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DRP2 |
0.42631992844069 |
|
12623 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARMCX4 |
0.42631992844069 |
|
12624 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FEM1C |
0.426331392143147 |
|
12625 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TICAM2 |
0.426331392143147 |
|
12626 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMED7 |
0.426331392143147 |
|
12627 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDO1 |
0.426331392143147 |
|
12628 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATG12 |
0.426331392143147 |
|
12629 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AP3S1 |
0.426331392143147 |
|
12630 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AQPEP |
0.426331392143147 |
|
12631 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARL14EPL |
0.426331392143147 |
|
12632 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COMMD10 |
0.426331392143147 |
|
12633 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IFIT1B |
0.426390149345615 |
|
12634 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IFIT1 |
0.426390149345615 |
|
12635 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IFIT5 |
0.426390149345615 |
|
12636 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP266 |
0.426411683798481 |
|
12637 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DKK4 |
0.426429390594548 |
|
12638 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC5A8 |
0.426457073991208 |
|
12639 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UTP20 |
0.426457073991208 |
|
12640 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238800.1 |
0.426457073991208 |
|
12641 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARL1 |
0.426457073991208 |
|
12642 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CYP2B7P1 |
0.426490172324239 |
|
12643 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CYP2B6 |
0.426490172324239 |
|
12644 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CYP2A13 |
0.426490172324239 |
|
12645 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CYP2F1 |
0.426490172324239 |
|
12646 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZBTB47 |
0.426643019870954 |
|
12647 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL567P |
0.426643019870954 |
|
12648 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KLHL40 |
0.426643019870954 |
|
12649 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HHATL |
0.426643019870954 |
|
12650 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TOMM5 |
0.426668646001907 |
|
12651 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IFT27 |
0.426849678992026 |
|
12652 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PVALB |
0.426849678992026 |
|
12653 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NCF4 |
0.426849678992026 |
|
12654 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EIF1B |
0.42690808682396 |
|
12655 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD31 |
0.427159147514528 |
|
12656 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CALD1 |
0.427418215703399 |
|
12657 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
POLB |
0.427469511746416 |
|
12658 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DYNC1H1 |
0.427537873039445 |
|
12659 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U8|ENSG00000201810.1 |
0.427661440489916 |
|
12660 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EYA4 |
0.427749129397695 |
|
12661 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TCF21 |
0.427749129397695 |
|
12662 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00326 |
0.427888553389925 |
|
12663 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FBXW11 |
0.428054217514921 |
|
12664 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EFCAB9 |
0.428054217514921 |
|
12665 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STK10 |
0.428054217514921 |
|
12666 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UBTD2 |
0.428054217514921 |
|
12667 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA57|ENSG00000212529.1 |
0.428054217514921 |
|
12668 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SH3PXD2B |
0.428054217514921 |
|
12669 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EMILIN2 |
0.428270169233273 |
|
12670 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LPIN2 |
0.428270169233273 |
|
12671 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP49 |
0.428359561856703 |
|
12672 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FBXO28 |
0.428359561856703 |
|
12673 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DEGS1 |
0.428359561856703 |
|
12674 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA72|ENSG00000201898.1 |
0.428359561856703 |
|
12675 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NVL |
0.428359561856703 |
|
12676 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR320B2 |
0.428359561856703 |
|
12677 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238856.1 |
0.428359561856703 |
|
12678 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CNIH4 |
0.428359561856703 |
|
12679 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WDR26 |
0.428359561856703 |
|
12680 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4742 |
0.428359561856703 |
|
12681 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CSF2RB |
0.428593294257296 |
|
12682 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000239056.1 |
0.428593294257296 |
|
12683 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TEX33 |
0.428593294257296 |
|
12684 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TST |
0.428593294257296 |
|
12685 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MPST |
0.428593294257296 |
|
12686 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCTD17 |
0.428593294257296 |
|
12687 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP214 |
0.428593294257296 |
|
12688 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238702.1 |
0.428740173302598 |
|
12689 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ISL1 |
0.428740173302598 |
|
12690 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RABEP1 |
0.42878785619455 |
|
12691 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NUP88 |
0.42878785619455 |
|
12692 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPAIN |
0.42878785619455 |
|
12693 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C1QBP |
0.42878785619455 |
|
12694 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DHX33 |
0.42878785619455 |
|
12695 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DERL2 |
0.42878785619455 |
|
12696 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NLRP1 |
0.42878785619455 |
|
12697 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SBSN |
0.428884305426907 |
|
12698 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GAPDHS |
0.428884305426907 |
|
12699 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM147 |
0.428884305426907 |
|
12700 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATP4A |
0.428884305426907 |
|
12701 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HAUS5 |
0.428884305426907 |
|
12702 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD2|ENSG00000238707.1 |
0.429067275277519 |
|
12703 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IFNL3 |
0.429101597721631 |
|
12704 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IFNL4 |
0.429101597721631 |
|
12705 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IFNL2 |
0.429101597721631 |
|
12706 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IFNL1 |
0.429101597721631 |
|
12707 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRFN1 |
0.429101597721631 |
|
12708 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GMFG |
0.429101597721631 |
|
12709 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SAMD4B |
0.429101597721631 |
|
12710 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DUSP1 |
0.429186482422236 |
|
12711 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ERGIC1 |
0.429186482422236 |
|
12712 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL516P |
0.429186911817684 |
|
12713 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ASB16 |
0.429333544365322 |
|
12714 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMUB2 |
0.429333544365322 |
|
12715 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATXN7L3 |
0.429333544365322 |
|
12716 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UBTF |
0.429333544365322 |
|
12717 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC22A24 |
0.429432803138925 |
|
12718 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC22A10 |
0.429432803138925 |
|
12719 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC22A25 |
0.429432803138925 |
|
12720 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIAA1468 |
0.429678278549204 |
|
12721 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GSTA1 |
0.429739708058393 |
|
12722 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GSTA5 |
0.429739708058393 |
|
12723 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ELOVL5 |
0.429739708058393 |
|
12724 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR5685 |
0.429739708058393 |
|
12725 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP147 |
0.429888975304456 |
|
12726 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MET |
0.430223453207846 |
|
12727 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CAPZA2 |
0.430223453207846 |
|
12728 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TLR5 |
0.430245698104927 |
|
12729 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SUSD4 |
0.430245698104927 |
|
12730 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C1orf65 |
0.430245698104927 |
|
12731 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NSUN6 |
0.430339345287932 |
|
12732 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARL5B |
0.430339345287932 |
|
12733 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CA8 |
0.430530197622315 |
|
12734 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
YPEL5 |
0.430567860171232 |
|
12735 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA64|ENSG00000207187.1 |
0.430567860171232 |
|
12736 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR548F1 |
0.430604626198066 |
|
12737 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PNPLA8 |
0.430709736274938 |
|
12738 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
THAP5 |
0.430709736274938 |
|
12739 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DNAJB9 |
0.430709736274938 |
|
12740 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C7orf66 |
0.430709736274938 |
|
12741 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FLJ00325 |
0.430709736274938 |
|
12742 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HTATIP2 |
0.430727232385444 |
|
12743 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRMT3 |
0.430727232385444 |
|
12744 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARHGEF7 |
0.431079408571446 |
|
12745 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TEX29 |
0.431079408571446 |
|
12746 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNU6ATAC21P |
0.431201572324626 |
|
12747 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TFAP2A |
0.431201572324626 |
|
12748 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00518 |
0.431201572324626 |
|
12749 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR5689 |
0.431201572324626 |
|
12750 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3923 |
0.431282349081004 |
|
12751 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HTR2A |
0.431513667771396 |
|
12752 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP239 |
0.43159817520324 |
|
12753 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ST7 |
0.43159817520324 |
|
12754 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WNT2 |
0.43159817520324 |
|
12755 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NACAP1 |
0.431660749835858 |
|
12756 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL563P |
0.431660749835858 |
|
12757 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GRHL2 |
0.431660749835858 |
|
12758 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NCALD |
0.431660749835858 |
|
12759 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238372.1 |
0.431660749835858 |
|
12760 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HMGB1 |
0.431721422955515 |
|
12761 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
USPL1 |
0.431721422955515 |
|
12762 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ALOX5AP |
0.431721422955515 |
|
12763 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00398 |
0.431721422955515 |
|
12764 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00545 |
0.431721422955515 |
|
12765 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MEDAG |
0.431721422955515 |
|
12766 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TEX26 |
0.431721422955515 |
|
12767 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD74|ENSG00000201666.1 |
0.431855226432634 |
|
12768 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF800 |
0.431922631255072 |
|
12769 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C5orf50 |
0.432002296402102 |
|
12770 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CWF19L1 |
0.432305244655443 |
|
12771 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA12|ENSG00000212464.1 |
0.432305244655443 |
|
12772 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BLOC1S2 |
0.432305244655443 |
|
12773 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PKD2L1 |
0.432305244655443 |
|
12774 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCD |
0.432305244655443 |
|
12775 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00263 |
0.432305244655443 |
|
12776 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HAAO |
0.432413553490386 |
|
12777 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MSH4 |
0.432479039242826 |
|
12778 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP451 |
0.432495529941291 |
|
12779 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNU6ATAC20P |
0.432495529941291 |
|
12780 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GATA6 |
0.432495529941291 |
|
12781 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRSAM1 |
0.432671935107527 |
|
12782 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238355.1 |
0.432903839888369 |
|
12783 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP168 |
0.432906622239125 |
|
12784 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPS3A |
0.432906622239125 |
|
12785 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD73A |
0.432906622239125 |
|
12786 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD73 |
0.432906622239125 |
|
12787 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KRT19P2 |
0.43290677545013 |
|
12788 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR492 |
0.43290677545013 |
|
12789 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZBTB8OS |
0.432914322194 |
|
12790 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RBBP4 |
0.432914322194 |
|
12791 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SYNC |
0.432914322194 |
|
12792 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIAA1522 |
0.432914322194 |
|
12793 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
YARS |
0.432914322194 |
|
12794 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MED1 |
0.433032352414406 |
|
12795 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC22A23 |
0.433106183809935 |
|
12796 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SRGAP1 |
0.433207630935685 |
|
12797 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA72|ENSG00000200355.1 |
0.433450770428662 |
|
12798 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000239141.1 |
0.433450770428662 |
|
12799 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRIB2 |
0.433566173379402 |
|
12800 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3125 |
0.433566173379402 |
|
12801 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AGBL3 |
0.433677846594492 |
|
12802 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C7orf49 |
0.433677846594492 |
|
12803 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM140 |
0.433677846594492 |
|
12804 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WDR91 |
0.433677846594492 |
|
12805 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STRA8 |
0.433677846594492 |
|
12806 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BRAP |
0.433891912076047 |
|
12807 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACAD10 |
0.433891912076047 |
|
12808 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ALDH2 |
0.433891912076047 |
|
12809 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANKRD20A11P |
0.433979231469246 |
|
12810 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANKRD30BP2 |
0.433979231469246 |
|
12811 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BAGE2 |
0.433979231469246 |
|
12812 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CYP4F29P |
0.433979231469246 |
|
12813 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3648 |
0.433979231469246 |
|
12814 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3687 |
0.433979231469246 |
|
12815 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
POTED |
0.433979231469246 |
|
12816 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL52P |
0.433979231469246 |
|
12817 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA70|ENSG00000252199.1 |
0.433979231469246 |
|
12818 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TEKT4P2 |
0.433979231469246 |
|
12819 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TPTE |
0.433979231469246 |
|
12820 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP488 |
0.433979231469246 |
|
12821 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LIPI |
0.433979231469246 |
|
12822 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RBM11 |
0.433979231469246 |
|
12823 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ABCC13 |
0.433979231469246 |
|
12824 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HSPA13 |
0.433979231469246 |
|
12825 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TBL1XR1 |
0.434043257676153 |
|
12826 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00501 |
0.434043257676153 |
|
12827 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00578 |
0.434043257676153 |
|
12828 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP52 |
0.434043257676153 |
|
12829 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA18|ENSG00000200288.1 |
0.434043257676153 |
|
12830 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SAMSN1 |
0.434064878100264 |
|
12831 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KPNA6 |
0.434143748776559 |
|
12832 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TXLNA |
0.434143748776559 |
|
12833 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR5007 |
0.43438174328058 |
|
12834 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DAOA |
0.434424141646551 |
|
12835 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00343 |
0.434424141646551 |
|
12836 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00344 |
0.434424141646551 |
|
12837 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U3|ENSG00000199769.1 |
0.434827687017386 |
|
12838 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC7A3 |
0.434827687017386 |
|
12839 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNX12 |
0.434827687017386 |
|
12840 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL746P |
0.434827687017386 |
|
12841 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CXorf65 |
0.434827687017386 |
|
12842 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FOXO4 |
0.434827687017386 |
|
12843 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IL2RG |
0.434827687017386 |
|
12844 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRRK2 |
0.434945314053461 |
|
12845 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LSR |
0.435080440228255 |
|
12846 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
USF2 |
0.435080440228255 |
|
12847 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HAMP |
0.435080440228255 |
|
12848 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAG |
0.435080440228255 |
|
12849 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DERL1 |
0.435113024172865 |
|
12850 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM117 |
0.435240757327384 |
|
12851 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LIG4 |
0.435472618456271 |
|
12852 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ABHD13 |
0.435472618456271 |
|
12853 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TNFSF13B |
0.435472618456271 |
|
12854 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP39 |
0.435472618456271 |
|
12855 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GBA3 |
0.435494764112002 |
|
12856 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF674 |
0.435686866794581 |
|
12857 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM111B |
0.435812804753704 |
|
12858 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM111A |
0.435812804753704 |
|
12859 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CTNNA2 |
0.435825286836011 |
|
12860 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PIK3R1 |
0.435945706162881 |
|
12861 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EPC2 |
0.436006311429079 |
|
12862 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZBTB8A |
0.436147333094229 |
|
12863 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CTTNBP2 |
0.436242991157739 |
|
12864 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA63|ENSG00000199552.1 |
0.436244037590305 |
|
12865 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PTGER4 |
0.436244037590305 |
|
12866 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TTC33 |
0.436244037590305 |
|
12867 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRKAA1 |
0.436244037590305 |
|
12868 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EIF2S3 |
0.436390239821181 |
|
12869 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ASCC1 |
0.436790067397863 |
|
12870 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA36|ENSG00000200294.1 |
0.436790067397863 |
|
12871 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANAPC16 |
0.436790067397863 |
|
12872 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLVS1 |
0.436803771005699 |
|
12873 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SOX9 |
0.436933088242987 |
|
12874 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL436P |
0.436978482345722 |
|
12875 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC33 |
0.437083527274876 |
|
12876 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC44A1 |
0.437447383459707 |
|
12877 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC35B4 |
0.437605078372164 |
|
12878 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AKR1B1 |
0.437605078372164 |
|
12879 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AKR1B10 |
0.437605078372164 |
|
12880 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AKR1B15 |
0.437605078372164 |
|
12881 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BPGM |
0.437605078372164 |
|
12882 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCNMB2 |
0.437790694534528 |
|
12883 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP148 |
0.437790694534528 |
|
12884 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZMAT3 |
0.437790694534528 |
|
12885 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PIK3CA |
0.437790694534528 |
|
12886 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA25|ENSG00000201957.1 |
0.437790694534528 |
|
12887 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCNMB3 |
0.437790694534528 |
|
12888 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF639 |
0.437790694534528 |
|
12889 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MFN1 |
0.437790694534528 |
|
12890 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GNB4 |
0.437790694534528 |
|
12891 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FLJ45079 |
0.437794813199516 |
|
12892 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF681 |
0.437812557931713 |
|
12893 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC20A2 |
0.437930610029603 |
|
12894 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SMIM19 |
0.437930610029603 |
|
12895 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ASZ1 |
0.438062342280473 |
|
12896 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CFTR |
0.438062342280473 |
|
12897 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP149 |
0.438330230395495 |
|
12898 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TNFAIP8 |
0.438535580351544 |
|
12899 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL174P |
0.438535580351544 |
|
12900 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP190 |
0.438535580351544 |
|
12901 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HSD17B4 |
0.438535580351544 |
|
12902 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000239084.1 |
0.438535580351544 |
|
12903 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000239067.1 |
0.438535580351544 |
|
12904 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM170A |
0.438535580351544 |
|
12905 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
S100P |
0.439129498576653 |
|
12906 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MRFAP1L1 |
0.439129498576653 |
|
12907 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BLOC1S4 |
0.439129498576653 |
|
12908 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIAA0232 |
0.439129498576653 |
|
12909 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SEC14L1 |
0.43915167686152 |
|
12910 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SEPT9 |
0.43915167686152 |
|
12911 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238901.1 |
0.439194792364352 |
|
12912 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZHX2 |
0.439194792364352 |
|
12913 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNY4P5 |
0.439194792364352 |
|
12914 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TBC1D31 |
0.439194792364352 |
|
12915 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM83A |
0.439194792364352 |
|
12916 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U3|ENSG00000221461.1 |
0.439194792364352 |
|
12917 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4663 |
0.439194792364352 |
|
12918 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PIAS1 |
0.439290572767383 |
|
12919 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ITGA11 |
0.439290572767383 |
|
12920 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AIMP2 |
0.439295362725873 |
|
12921 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA42|ENSG00000207217.1 |
0.439295362725873 |
|
12922 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EIF2AK1 |
0.439295362725873 |
|
12923 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANKRD61 |
0.439295362725873 |
|
12924 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL851P |
0.439295362725873 |
|
12925 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
USP42 |
0.439295362725873 |
|
12926 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ORMDL3 |
0.439410180186649 |
|
12927 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PAPL |
0.439826660357162 |
|
12928 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000251709.1 |
0.439826660357162 |
|
12929 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PAK4 |
0.439826660357162 |
|
12930 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NCCRP1 |
0.439826660357162 |
|
12931 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SYCN |
0.439826660357162 |
|
12932 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NEUROD6 |
0.440024347245125 |
|
12933 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FSD1L |
0.440563256150607 |
|
12934 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP376 |
0.440732124193887 |
|
12935 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HCG14 |
0.44073405783598 |
|
12936 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRIM27 |
0.44073405783598 |
|
12937 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C6orf100 |
0.44073405783598 |
|
12938 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL471P |
0.44073405783598 |
|
12939 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HCG15 |
0.44073405783598 |
|
12940 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HCG16 |
0.44073405783598 |
|
12941 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF311 |
0.44073405783598 |
|
12942 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR2W1 |
0.44073405783598 |
|
12943 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR2B3 |
0.44073405783598 |
|
12944 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DCLK3 |
0.441058054941785 |
|
12945 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HSPD1P6 |
0.441058054941785 |
|
12946 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL294P |
0.441344940332847 |
|
12947 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM86DP |
0.441344940332847 |
|
12948 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FRG2C |
0.441344940332847 |
|
12949 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00960 |
0.441344940332847 |
|
12950 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR1324 |
0.441344940332847 |
|
12951 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4273 |
0.441344940332847 |
|
12952 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL92P |
0.441344940332847 |
|
12953 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF717 |
0.441344940332847 |
|
12954 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EZH2 |
0.441387796440452 |
|
12955 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RABGAP1L |
0.441529266791928 |
|
12956 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COL19A1 |
0.44175108124904 |
|
12957 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COL9A1 |
0.44175108124904 |
|
12958 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM135A |
0.44175108124904 |
|
12959 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C6orf57 |
0.44175108124904 |
|
12960 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SEC1P |
0.441811170097521 |
|
12961 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NTN5 |
0.441811170097521 |
|
12962 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FUT2 |
0.441811170097521 |
|
12963 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL345P |
0.441811170097521 |
|
12964 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAMSTR |
0.441811170097521 |
|
12965 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RASIP1 |
0.441811170097521 |
|
12966 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IZUMO1 |
0.441811170097521 |
|
12967 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CAT |
0.442077830999426 |
|
12968 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SOX4 |
0.442641217929983 |
|
12969 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00340 |
0.442641217929983 |
|
12970 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP240 |
0.442641217929983 |
|
12971 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRL |
0.442641217929983 |
|
12972 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADARB1 |
0.442692658694034 |
|
12973 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRED58 |
0.442692658694034 |
|
12974 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TEF |
0.442745884039468 |
|
12975 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TOB2 |
0.442745884039468 |
|
12976 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NEURL1B |
0.442800721319902 |
|
12977 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR5003 |
0.442800721319902 |
|
12978 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BBC3 |
0.442870267700554 |
|
12979 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3191 |
0.442870267700554 |
|
12980 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC9 |
0.442870267700554 |
|
12981 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRR24 |
0.442870267700554 |
|
12982 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C5AR1 |
0.442870267700554 |
|
12983 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C5AR2 |
0.442870267700554 |
|
12984 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DHX34 |
0.442870267700554 |
|
12985 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MEIS3 |
0.442870267700554 |
|
12986 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC8A2 |
0.442870267700554 |
|
12987 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KPTN |
0.442870267700554 |
|
12988 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NAPA |
0.442870267700554 |
|
12989 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF541 |
0.442870267700554 |
|
12990 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL322P |
0.442870267700554 |
|
12991 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GLTSCR1 |
0.442870267700554 |
|
12992 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EHD2 |
0.442870267700554 |
|
12993 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GLTSCR2 |
0.442870267700554 |
|
12994 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD23|ENSG00000221803.1 |
0.442870267700554 |
|
12995 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SEPW1 |
0.442870267700554 |
|
12996 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TPRX1 |
0.442870267700554 |
|
12997 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CRX |
0.442870267700554 |
|
12998 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TPRX2P |
0.442870267700554 |
|
12999 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SULT2A1 |
0.442870267700554 |
|
13000 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BSPH1 |
0.442870267700554 |
|
13001 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ELSPBP1 |
0.442870267700554 |
|
13002 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CABP5 |
0.442870267700554 |
|
13003 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLA2G4C |
0.442870267700554 |
|
13004 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LIG1 |
0.442870267700554 |
|
13005 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C19orf68 |
0.442870267700554 |
|
13006 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DOCK4 |
0.443100754263493 |
|
13007 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CKM |
0.443106422953991 |
|
13008 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ERCC2 |
0.443106422953991 |
|
13009 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KLC3 |
0.443106422953991 |
|
13010 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPP1R13L |
0.443106422953991 |
|
13011 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPP2R5C |
0.443158660962519 |
|
13012 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
XAGE2B |
0.443257071449696 |
|
13013 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
XAGE1A |
0.443257071449696 |
|
13014 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
XAGE1B |
0.443257071449696 |
|
13015 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
XAGE2 |
0.443257071449696 |
|
13016 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD66|ENSG00000212532.1 |
0.443266936432324 |
|
13017 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CD22 |
0.443345759331302 |
|
13018 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR5196 |
0.443345759331302 |
|
13019 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FFAR1 |
0.443345759331302 |
|
13020 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MR1 |
0.443467770290367 |
|
13021 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADCYAP1R1 |
0.443519393592177 |
|
13022 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PSMB4 |
0.44356234465884 |
|
13023 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SELENBP1 |
0.44356234465884 |
|
13024 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNY4P25 |
0.44356234465884 |
|
13025 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FOXP2 |
0.443667565630674 |
|
13026 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4316 |
0.444304716989988 |
|
13027 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NES |
0.444361064261016 |
|
13028 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAGED4B |
0.444533465982913 |
|
13029 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAGED4 |
0.444533465982913 |
|
13030 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA11D |
0.444533465982913 |
|
13031 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA11E |
0.444533465982913 |
|
13032 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
B3GAT2 |
0.44459185555675 |
|
13033 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF780B |
0.444605035857441 |
|
13034 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF780A |
0.444605035857441 |
|
13035 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WIF1 |
0.444685280963445 |
|
13036 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SRCAP |
0.444713135954493 |
|
13037 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA30|ENSG00000206755.1 |
0.444713135954493 |
|
13038 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PHKG2 |
0.444713135954493 |
|
13039 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C16orf93 |
0.444713135954493 |
|
13040 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNF40 |
0.444713135954493 |
|
13041 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF629 |
0.444713135954493 |
|
13042 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ALK |
0.444791606119199 |
|
13043 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GCLC |
0.444876286458621 |
|
13044 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MACC1 |
0.444998315786501 |
|
13045 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MYRIP |
0.445002703794743 |
|
13046 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL411P |
0.445002703794743 |
|
13047 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA64|ENSG00000202517.1 |
0.445002703794743 |
|
13048 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDH4 |
0.445185507563185 |
|
13049 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TTC18 |
0.445371339601861 |
|
13050 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238983.1 |
0.445371339601861 |
|
13051 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANXA7 |
0.445371339601861 |
|
13052 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MSS51 |
0.445371339601861 |
|
13053 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD56|ENSG00000200377.1 |
0.445677767213493 |
|
13054 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPRM |
0.445677767213493 |
|
13055 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VDAC3 |
0.44585068973529 |
|
13056 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SEMA6C |
0.445872835170156 |
|
13057 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LYSMD1 |
0.445872835170156 |
|
13058 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCNM1 |
0.445872835170156 |
|
13059 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TNFAIP8L2 |
0.445872835170156 |
|
13060 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMOD4 |
0.445872835170156 |
|
13061 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VPS72 |
0.445872835170156 |
|
13062 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PIP5K1A |
0.445872835170156 |
|
13063 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CENPH |
0.445948468967358 |
|
13064 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MRPS36 |
0.445948468967358 |
|
13065 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC125 |
0.445948468967358 |
|
13066 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TAF9 |
0.445948468967358 |
|
13067 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAD17 |
0.445948468967358 |
|
13068 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MARVELD2 |
0.445948468967358 |
|
13069 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FERD3L |
0.446300548858124 |
|
13070 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3146 |
0.446300548858124 |
|
13071 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM196 |
0.446300548858124 |
|
13072 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TWIST1 |
0.446300548858124 |
|
13073 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TWISTNB |
0.446300548858124 |
|
13074 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00469 |
0.446433555670884 |
|
13075 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BTBD17 |
0.446433555670884 |
|
13076 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C17orf77 |
0.446433555670884 |
|
13077 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CD300A |
0.446433555670884 |
|
13078 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CD300C |
0.446433555670884 |
|
13079 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CD300E |
0.446433555670884 |
|
13080 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CD300LB |
0.446433555670884 |
|
13081 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CD300LD |
0.446433555670884 |
|
13082 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CD300LF |
0.446433555670884 |
|
13083 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DNAI2 |
0.446433555670884 |
|
13084 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPR142 |
0.446433555670884 |
|
13085 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPRC5C |
0.446433555670884 |
|
13086 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIF19 |
0.446433555670884 |
|
13087 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAB37 |
0.446433555670884 |
|
13088 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP448 |
0.446433555670884 |
|
13089 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPL38 |
0.446433555670884 |
|
13090 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TTYH2 |
0.446433555670884 |
|
13091 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPP2R2C |
0.446647618048548 |
|
13092 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAN2B2 |
0.446647618048548 |
|
13093 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MRFAP1 |
0.446647618048548 |
|
13094 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3942 |
0.446706055892749 |
|
13095 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KLF3 |
0.446751416149997 |
|
13096 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP158 |
0.446751416149997 |
|
13097 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TLR10 |
0.446751416149997 |
|
13098 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TLR1 |
0.446751416149997 |
|
13099 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TLR6 |
0.446751416149997 |
|
13100 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM114A1 |
0.446751416149997 |
|
13101 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR574 |
0.446751416149997 |
|
13102 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM156 |
0.446751416149997 |
|
13103 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KLHL5 |
0.446751416149997 |
|
13104 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U8|ENSG00000212145.2 |
0.446762296872366 |
|
13105 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LYZL4 |
0.446762296872366 |
|
13106 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SHBG |
0.446807675689951 |
|
13107 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000251860.1 |
0.446807675689951 |
|
13108 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SAT2 |
0.446807675689951 |
|
13109 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATP1B2 |
0.446807675689951 |
|
13110 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TP53 |
0.446807675689951 |
|
13111 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WRAP53 |
0.446807675689951 |
|
13112 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EFNB3 |
0.446807675689951 |
|
13113 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPL29P2 |
0.446807675689951 |
|
13114 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WWTR1 |
0.446855541424706 |
|
13115 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPNS3 |
0.446952611982308 |
|
13116 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KLF10 |
0.447040562469209 |
|
13117 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AZIN1 |
0.447040562469209 |
|
13118 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATP6V1C1 |
0.447040562469209 |
|
13119 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C8orf56 |
0.447040562469209 |
|
13120 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BAALC |
0.447040562469209 |
|
13121 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3151 |
0.447040562469209 |
|
13122 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FZD6 |
0.447040562469209 |
|
13123 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CTHRC1 |
0.447040562469209 |
|
13124 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC25A32 |
0.447040562469209 |
|
13125 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DCAF13 |
0.447040562469209 |
|
13126 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZSCAN20 |
0.447057897414245 |
|
13127 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SH3GL2 |
0.447205495140285 |
|
13128 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ERN2 |
0.447344305666253 |
|
13129 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANTXR2 |
0.447581099466876 |
|
13130 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRDM8 |
0.447581099466876 |
|
13131 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FGF5 |
0.447581099466876 |
|
13132 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C4orf22 |
0.447581099466876 |
|
13133 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STK17B |
0.447620267252421 |
|
13134 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HECW2 |
0.447620267252421 |
|
13135 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000239161.1 |
0.447620267252421 |
|
13136 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL820P |
0.447620267252421 |
|
13137 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EFHC2 |
0.447675706784665 |
|
13138 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KMT2E |
0.447705644014506 |
|
13139 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C10orf55 |
0.447708912732415 |
|
13140 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLAU |
0.447708912732415 |
|
13141 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3924 |
0.447763772829545 |
|
13142 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4474 |
0.44777813744416 |
|
13143 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA57|ENSG00000212567.1 |
0.448183761693503 |
|
13144 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPL37 |
0.448183761693503 |
|
13145 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD72 |
0.448183761693503 |
|
13146 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CARD6 |
0.448183761693503 |
|
13147 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C7 |
0.448183761693503 |
|
13148 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MROH2B |
0.448183761693503 |
|
13149 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CHRNB4 |
0.448239365121508 |
|
13150 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PDHX |
0.448318829669787 |
|
13151 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR1343 |
0.448318829669787 |
|
13152 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238408.1 |
0.448361929975982 |
|
13153 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FOXO1 |
0.448361929975982 |
|
13154 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR320D1 |
0.448361929975982 |
|
13155 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MRPS31 |
0.448361929975982 |
|
13156 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC25A15 |
0.448361929975982 |
|
13157 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR621 |
0.448361929975982 |
|
13158 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TPTE2P5 |
0.448361929975982 |
|
13159 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SUGT1P3 |
0.448361929975982 |
|
13160 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ELF1 |
0.448361929975982 |
|
13161 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP169 |
0.44879552324932 |
|
13162 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL446P |
0.44879552324932 |
|
13163 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FBXW7 |
0.44879552324932 |
|
13164 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3140 |
0.44879552324932 |
|
13165 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4453 |
0.44879552324932 |
|
13166 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM154 |
0.44879552324932 |
|
13167 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HHIPL2 |
0.4487963181816 |
|
13168 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TAF1A |
0.4487963181816 |
|
13169 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BROX |
0.4487963181816 |
|
13170 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL276P |
0.4487963181816 |
|
13171 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM177B |
0.4487963181816 |
|
13172 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LBH |
0.449035545121316 |
|
13173 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LCLAT1 |
0.449035545121316 |
|
13174 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPNS2 |
0.449202575714092 |
|
13175 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MYBBP1A |
0.449202575714092 |
|
13176 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DPRX |
0.449431928827415 |
|
13177 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR1323 |
0.449431928827415 |
|
13178 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR371A |
0.449431928827415 |
|
13179 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR371B |
0.449431928827415 |
|
13180 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR372 |
0.449431928827415 |
|
13181 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR373 |
0.449431928827415 |
|
13182 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR498 |
0.449431928827415 |
|
13183 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR516A1 |
0.449431928827415 |
|
13184 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR516A2 |
0.449431928827415 |
|
13185 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR516B1 |
0.449431928827415 |
|
13186 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR516B2 |
0.449431928827415 |
|
13187 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR517A |
0.449431928827415 |
|
13188 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR517B |
0.449431928827415 |
|
13189 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR517C |
0.449431928827415 |
|
13190 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR518A1 |
0.449431928827415 |
|
13191 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR518A2 |
0.449431928827415 |
|
13192 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR518B |
0.449431928827415 |
|
13193 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR518C |
0.449431928827415 |
|
13194 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR518D |
0.449431928827415 |
|
13195 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR518E |
0.449431928827415 |
|
13196 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR518F |
0.449431928827415 |
|
13197 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR519A1 |
0.449431928827415 |
|
13198 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR519A2 |
0.449431928827415 |
|
13199 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR519B |
0.449431928827415 |
|
13200 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR519C |
0.449431928827415 |
|
13201 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR519D |
0.449431928827415 |
|
13202 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR519E |
0.449431928827415 |
|
13203 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR520A |
0.449431928827415 |
|
13204 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR520B |
0.449431928827415 |
|
13205 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR520C |
0.449431928827415 |
|
13206 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR520D |
0.449431928827415 |
|
13207 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR520E |
0.449431928827415 |
|
13208 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR520F |
0.449431928827415 |
|
13209 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR520G |
0.449431928827415 |
|
13210 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR520H |
0.449431928827415 |
|
13211 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR522 |
0.449431928827415 |
|
13212 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR523 |
0.449431928827415 |
|
13213 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR524 |
0.449431928827415 |
|
13214 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR525 |
0.449431928827415 |
|
13215 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR526A1 |
0.449431928827415 |
|
13216 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR526A2 |
0.449431928827415 |
|
13217 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR526B |
0.449431928827415 |
|
13218 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR527 |
0.449431928827415 |
|
13219 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NLRP12 |
0.449431928827415 |
|
13220 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL317P |
0.449431928827415 |
|
13221 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDH20 |
0.4495631746189 |
|
13222 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNF152 |
0.4495631746189 |
|
13223 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PIGN |
0.4495631746189 |
|
13224 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GLTPD2 |
0.449644408174079 |
|
13225 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TM4SF5 |
0.449644408174079 |
|
13226 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VMO1 |
0.449644408174079 |
|
13227 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLD2 |
0.449644408174079 |
|
13228 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PSMB6 |
0.449644408174079 |
|
13229 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MINK1 |
0.449644408174079 |
|
13230 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL171P |
0.449644408174079 |
|
13231 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL784P |
0.449644408174079 |
|
13232 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CHRNE |
0.449644408174079 |
|
13233 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C17orf107 |
0.449644408174079 |
|
13234 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GP1BA |
0.449644408174079 |
|
13235 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC25A11 |
0.449644408174079 |
|
13236 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNF167 |
0.449644408174079 |
|
13237 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ENO3 |
0.449644408174079 |
|
13238 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PFN1 |
0.449644408174079 |
|
13239 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPAG7 |
0.449644408174079 |
|
13240 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CAMTA2 |
0.449644408174079 |
|
13241 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
INCA1 |
0.449644408174079 |
|
13242 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FKTN |
0.449650744634309 |
|
13243 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CAPN13 |
0.449944702387374 |
|
13244 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CAPN14 |
0.449944702387374 |
|
13245 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP90 |
0.449944702387374 |
|
13246 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EHD3 |
0.449944702387374 |
|
13247 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
XDH |
0.449944702387374 |
|
13248 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPM1H |
0.450140407633272 |
|
13249 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LDHAL6CP |
0.450140407633272 |
|
13250 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AVPR1A |
0.450140407633272 |
|
13251 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SMC3 |
0.450156639049971 |
|
13252 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000239125.1 |
0.450156639049971 |
|
13253 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL686P |
0.450156639049971 |
|
13254 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP288 |
0.450156639049971 |
|
13255 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP327 |
0.450156639049971 |
|
13256 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WDR27 |
0.450223243929838 |
|
13257 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C6orf120 |
0.450223243929838 |
|
13258 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PHF10 |
0.450223243929838 |
|
13259 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TCTE3 |
0.450223243929838 |
|
13260 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C6orf70 |
0.450223243929838 |
|
13261 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00242 |
0.450223243929838 |
|
13262 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00574 |
0.450223243929838 |
|
13263 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIA3 |
0.45029903719849 |
|
13264 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AIDA |
0.45029903719849 |
|
13265 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL438P |
0.450351824649255 |
|
13266 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC114 |
0.450364731524554 |
|
13267 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EMP3 |
0.450364731524554 |
|
13268 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM143 |
0.450364731524554 |
|
13269 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SYNGR4 |
0.450364731524554 |
|
13270 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KDELR1 |
0.450364731524554 |
|
13271 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIAA0196 |
0.450406740823664 |
|
13272 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MACROD1 |
0.450529161452047 |
|
13273 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STIP1 |
0.450529161452047 |
|
13274 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FERMT3 |
0.450529161452047 |
|
13275 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRPT1 |
0.450529161452047 |
|
13276 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NUDT22 |
0.450529161452047 |
|
13277 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DNAJC4 |
0.450529161452047 |
|
13278 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VEGFB |
0.450529161452047 |
|
13279 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FKBP2 |
0.450529161452047 |
|
13280 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLCB3 |
0.450529161452047 |
|
13281 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPP1R14B |
0.450529161452047 |
|
13282 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BAD |
0.450529161452047 |
|
13283 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPR137 |
0.450529161452047 |
|
13284 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC88B |
0.450529161452047 |
|
13285 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPS6KA4 |
0.450529161452047 |
|
13286 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR1237 |
0.450529161452047 |
|
13287 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCDH7 |
0.450896495634786 |
|
13288 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DGKK |
0.451506725402782 |
|
13289 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL524P |
0.451518795624606 |
|
13290 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HDGFL1 |
0.451652465006091 |
|
13291 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4801 |
0.451950838470612 |
|
13292 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
REG1A |
0.451955217686683 |
|
13293 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
REG1B |
0.451955217686683 |
|
13294 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
REG1P |
0.451955217686683 |
|
13295 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
REG3A |
0.451955217686683 |
|
13296 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
REG3G |
0.451955217686683 |
|
13297 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4486 |
0.451955420977413 |
|
13298 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA1|ENSG00000207407.1 |
0.451955420977413 |
|
13299 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00882 |
0.451964280967655 |
|
13300 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNRNP48 |
0.451986165218157 |
|
13301 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BMP6 |
0.451986165218157 |
|
13302 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TXNDC5 |
0.451986165218157 |
|
13303 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIF1C |
0.452409916333987 |
|
13304 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC52A1 |
0.452409916333987 |
|
13305 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZFP3 |
0.452409916333987 |
|
13306 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
USP6 |
0.452409916333987 |
|
13307 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF232 |
0.452409916333987 |
|
13308 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF594 |
0.452409916333987 |
|
13309 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCIMP |
0.452409916333987 |
|
13310 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COG6 |
0.452491032198912 |
|
13311 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNY4P14 |
0.452491032198912 |
|
13312 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD116|ENSG00000212553.1 |
0.452491032198912 |
|
13313 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00332 |
0.452491032198912 |
|
13314 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VAV1 |
0.452585515240075 |
|
13315 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KLHL7 |
0.452745701914763 |
|
13316 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
YKT6 |
0.452922908406286 |
|
13317 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CAMK2B |
0.452922908406286 |
|
13318 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238693.1 |
0.452984526220791 |
|
13319 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EVC |
0.453093813757922 |
|
13320 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SMAP1 |
0.453151931470974 |
|
13321 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DSCC1 |
0.453281085471952 |
|
13322 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL396P |
0.453281085471952 |
|
13323 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DEPTOR |
0.453281085471952 |
|
13324 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP277 |
0.453281085471952 |
|
13325 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ABLIM2 |
0.453351167269234 |
|
13326 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR95 |
0.453351167269234 |
|
13327 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SH3TC1 |
0.453351167269234 |
|
13328 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HTRA3 |
0.453351167269234 |
|
13329 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACOX3 |
0.453351167269234 |
|
13330 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP152 |
0.453351167269234 |
|
13331 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRMT44 |
0.453351167269234 |
|
13332 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPR78 |
0.453351167269234 |
|
13333 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CPZ |
0.453351167269234 |
|
13334 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HMOX1 |
0.453423932994923 |
|
13335 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MCM5 |
0.453423932994923 |
|
13336 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ITFG1 |
0.453458397338264 |
|
13337 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC28B |
0.453505794839022 |
|
13338 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IQCC |
0.453505794839022 |
|
13339 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DCDC2B |
0.453505794839022 |
|
13340 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM234 |
0.453505794839022 |
|
13341 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EIF3I |
0.453505794839022 |
|
13342 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MTMR9LP |
0.453505794839022 |
|
13343 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM167B |
0.453505794839022 |
|
13344 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LCK |
0.453505794839022 |
|
13345 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HDAC1 |
0.453505794839022 |
|
13346 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA48|ENSG00000212181.1 |
0.453521990134438 |
|
13347 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HSPD1 |
0.453551923440586 |
|
13348 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HSPE1 |
0.453551923440586 |
|
13349 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MOB4 |
0.453551923440586 |
|
13350 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RFTN2 |
0.453551923440586 |
|
13351 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AP5Z1 |
0.453589143976602 |
|
13352 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4656 |
0.453589143976602 |
|
13353 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RADIL |
0.453589143976602 |
|
13354 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM132D |
0.4536279787647 |
|
13355 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FZD10 |
0.4536279787647 |
|
13356 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PIWIL1 |
0.4536279787647 |
|
13357 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RIMBP2 |
0.4536279787647 |
|
13358 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL534P |
0.4536279787647 |
|
13359 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL658P |
0.453687391507591 |
|
13360 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CTPS2 |
0.453687391507591 |
|
13361 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR548AM |
0.453687391507591 |
|
13362 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
S100G |
0.453687391507591 |
|
13363 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SYAP1 |
0.453687391507591 |
|
13364 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
REPS2 |
0.453687391507591 |
|
13365 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA16|ENSG00000201467.1 |
0.453687391507591 |
|
13366 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4768 |
0.453687391507591 |
|
13367 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NHS |
0.453687391507591 |
|
13368 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238764.1 |
0.453687391507591 |
|
13369 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MYADM |
0.453762866798249 |
|
13370 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL5P |
0.453970808177615 |
|
13371 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GRB10 |
0.45406322031052 |
|
13372 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATF7IP2 |
0.454166865381038 |
|
13373 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STEAP1B |
0.454745979526375 |
|
13374 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IL6 |
0.454745979526375 |
|
13375 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TOMM7 |
0.454745979526375 |
|
13376 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD93 |
0.454745979526375 |
|
13377 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM126A |
0.454745979526375 |
|
13378 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
B3GNTL1 |
0.454768186052517 |
|
13379 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
METRNL |
0.454768186052517 |
|
13380 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DCAF8L2 |
0.454842483756755 |
|
13381 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF518B |
0.454993238636769 |
|
13382 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLNK |
0.454993238636769 |
|
13383 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPS9 |
0.455291516363771 |
|
13384 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LILRA3 |
0.455291516363771 |
|
13385 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LILRA4 |
0.455291516363771 |
|
13386 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LILRA5 |
0.455291516363771 |
|
13387 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LILRA6 |
0.455291516363771 |
|
13388 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LILRB2 |
0.455291516363771 |
|
13389 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LILRB3 |
0.455291516363771 |
|
13390 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LILRB5 |
0.455291516363771 |
|
13391 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4752 |
0.455291516363771 |
|
13392 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EFCAB1 |
0.45552225680112 |
|
13393 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNAI2 |
0.45552225680112 |
|
13394 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C8orf22 |
0.45552225680112 |
|
13395 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
YWHAZ |
0.455878716944293 |
|
13396 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TOM1 |
0.456176306680239 |
|
13397 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3909 |
0.456176306680239 |
|
13398 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C10orf131 |
0.456194150180683 |
|
13399 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF362 |
0.456283668858136 |
|
13400 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
A3GALT2 |
0.456283668858136 |
|
13401 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RUNX1T1 |
0.456580215094258 |
|
13402 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP274 |
0.456628551619718 |
|
13403 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NAA11 |
0.456991594892076 |
|
13404 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GK2 |
0.456991594892076 |
|
13405 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00989 |
0.456991594892076 |
|
13406 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR7E94P |
0.456991594892076 |
|
13407 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCAT4 |
0.456991594892076 |
|
13408 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA75|ENSG00000212620.1 |
0.456991594892076 |
|
13409 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CYP2S1 |
0.457167547521344 |
|
13410 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL718P |
0.457167547521344 |
|
13411 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LAMB4 |
0.457190783415299 |
|
13412 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NRCAM |
0.457190783415299 |
|
13413 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VTI1A |
0.457345090848206 |
|
13414 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RBPJ |
0.457384787370834 |
|
13415 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPP1R3C |
0.457553641341598 |
|
13416 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TNKS2 |
0.457553641341598 |
|
13417 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TARDBP |
0.457607754333948 |
|
13418 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MASP2 |
0.457607754333948 |
|
13419 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C1QTNF9 |
0.457772715274199 |
|
13420 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00566 |
0.457772715274199 |
|
13421 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PANK1 |
0.457984225726111 |
|
13422 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR107 |
0.457984225726111 |
|
13423 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIF20B |
0.457984225726111 |
|
13424 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00865 |
0.457984225726111 |
|
13425 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP143 |
0.457984225726111 |
|
13426 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HTR7 |
0.457984225726111 |
|
13427 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00502 |
0.457984225726111 |
|
13428 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCGF5 |
0.457984225726111 |
|
13429 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HECTD2 |
0.457984225726111 |
|
13430 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FGFBP3 |
0.457984225726111 |
|
13431 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BTAF1 |
0.457984225726111 |
|
13432 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COX7C |
0.458015423318052 |
|
13433 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3607 |
0.458015423318052 |
|
13434 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RASA1 |
0.458015423318052 |
|
13435 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL629P |
0.458015423318052 |
|
13436 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCNH |
0.458015423318052 |
|
13437 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BCL11B |
0.458059513388166 |
|
13438 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SMIM5 |
0.458162790553732 |
|
13439 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SMIM6 |
0.458162790553732 |
|
13440 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ITGB4 |
0.458162790553732 |
|
13441 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GALK1 |
0.458162790553732 |
|
13442 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TEN1 |
0.458162790553732 |
|
13443 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDK3 |
0.458162790553732 |
|
13444 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EVPL |
0.458162790553732 |
|
13445 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SRP68 |
0.458162790553732 |
|
13446 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OSCAR |
0.458186096508165 |
|
13447 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NDUFA3 |
0.458186096508165 |
|
13448 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TFPT |
0.458186096508165 |
|
13449 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRPF31 |
0.458186096508165 |
|
13450 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CNOT3 |
0.458186096508165 |
|
13451 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LENG1 |
0.458186096508165 |
|
13452 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMC4 |
0.458186096508165 |
|
13453 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADAM23 |
0.458287593499993 |
|
13454 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DNAJB6 |
0.45845473027459 |
|
13455 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCK |
0.458529430767261 |
|
13456 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP58 |
0.458875314270402 |
|
13457 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CHD7 |
0.45903450932569 |
|
13458 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4274 |
0.459144833433524 |
|
13459 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PSAPL1 |
0.459144833433524 |
|
13460 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AFAP1 |
0.459144833433524 |
|
13461 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRLHR |
0.459243636127402 |
|
13462 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CACUL1 |
0.459243636127402 |
|
13463 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U3|ENSG00000251836.1 |
0.459243636127402 |
|
13464 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NCAM2 |
0.459289983405955 |
|
13465 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA25|ENSG00000252550.1 |
0.459378680418913 |
|
13466 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP38 |
0.459378680418913 |
|
13467 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00460 |
0.459378680418913 |
|
13468 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EFNB2 |
0.459378680418913 |
|
13469 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARGLU1 |
0.459378680418913 |
|
13470 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00551 |
0.459378680418913 |
|
13471 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00443 |
0.459378680418913 |
|
13472 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAK1 |
0.4594368259545 |
|
13473 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RIMS1 |
0.459546931527232 |
|
13474 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDK7 |
0.459627070740759 |
|
13475 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AGO1 |
0.459660114077892 |
|
13476 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARAP2 |
0.459777334758971 |
|
13477 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DTHD1 |
0.459777334758971 |
|
13478 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C9 |
0.45983610301793 |
|
13479 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DAB2 |
0.45983610301793 |
|
13480 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
USP15 |
0.460027739756181 |
|
13481 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NPLOC4 |
0.460395954047551 |
|
13482 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NXF2 |
0.46071094581151 |
|
13483 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TCP11X1 |
0.46071094581151 |
|
13484 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NXF2B |
0.46071094581151 |
|
13485 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TCP11X2 |
0.46071094581151 |
|
13486 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMSB15A |
0.46071094581151 |
|
13487 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NXF4 |
0.46071094581151 |
|
13488 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARMCX5 |
0.46071094581151 |
|
13489 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPRASP1 |
0.46071094581151 |
|
13490 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00630 |
0.46071094581151 |
|
13491 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AKAP11 |
0.460824676626144 |
|
13492 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AAMDC |
0.461036980479883 |
|
13493 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPIN3 |
0.461091261929211 |
|
13494 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIAA0895 |
0.461148846726846 |
|
13495 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANLN |
0.461148846726846 |
|
13496 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C21orf37 |
0.46141354618118 |
|
13497 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL163P |
0.46141354618118 |
|
13498 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CXADR |
0.46141354618118 |
|
13499 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BTG3 |
0.46141354618118 |
|
13500 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C21orf91 |
0.46141354618118 |
|
13501 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CHODL |
0.46141354618118 |
|
13502 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AGTR1 |
0.461424679481945 |
|
13503 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CPA3 |
0.461424679481945 |
|
13504 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GYG1 |
0.461424679481945 |
|
13505 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HLTF |
0.461424679481945 |
|
13506 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HPS3 |
0.461424679481945 |
|
13507 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CP |
0.461424679481945 |
|
13508 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CPHL1P |
0.461424679481945 |
|
13509 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TM4SF18 |
0.461424679481945 |
|
13510 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TM4SF1 |
0.461424679481945 |
|
13511 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TM4SF4 |
0.461424679481945 |
|
13512 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EXOC7 |
0.461634804107113 |
|
13513 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GALR2 |
0.461634804107113 |
|
13514 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZACN |
0.461634804107113 |
|
13515 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FOXJ1 |
0.461634804107113 |
|
13516 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNF157 |
0.461634804107113 |
|
13517 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
QRICH2 |
0.461634804107113 |
|
13518 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UBALD2 |
0.461634804107113 |
|
13519 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ITGA9 |
0.462209035688013 |
|
13520 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TBCD |
0.462289210037007 |
|
13521 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TSSK1B |
0.462404713721164 |
|
13522 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNU4ATAC13P |
0.462404713721164 |
|
13523 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
YTHDC2 |
0.462404713721164 |
|
13524 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP89 |
0.462404713721164 |
|
13525 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCNN2 |
0.462404713721164 |
|
13526 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIAA1551 |
0.462473513765427 |
|
13527 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC30A10 |
0.463097524032526 |
|
13528 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP76 |
0.463097524032526 |
|
13529 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U3|ENSG00000221673.1 |
0.463097524032526 |
|
13530 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EPRS |
0.463097524032526 |
|
13531 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238798.1 |
0.463097524032526 |
|
13532 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR215 |
0.463097524032526 |
|
13533 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238576.1 |
0.463097524032526 |
|
13534 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAB3GAP2 |
0.463097524032526 |
|
13535 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA36B |
0.463097524032526 |
|
13536 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MARK1 |
0.463097524032526 |
|
13537 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL464P |
0.463097524032526 |
|
13538 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HDAC1P2 |
0.463097524032526 |
|
13539 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C1orf115 |
0.463097524032526 |
|
13540 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MARC2 |
0.463097524032526 |
|
13541 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MARC1 |
0.463097524032526 |
|
13542 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNU6ATAC35P |
0.463097524032526 |
|
13543 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HLX |
0.463097524032526 |
|
13544 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR13F1 |
0.463128501636725 |
|
13545 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPATA19 |
0.463279452873644 |
|
13546 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4697 |
0.463279452873644 |
|
13547 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IGSF9B |
0.463279452873644 |
|
13548 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
JAM3 |
0.463279452873644 |
|
13549 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NCAPD3 |
0.463279452873644 |
|
13550 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VPS26B |
0.463279452873644 |
|
13551 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
THYN1 |
0.463279452873644 |
|
13552 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACAD8 |
0.463279452873644 |
|
13553 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
B3GAT1 |
0.463279452873644 |
|
13554 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GLB1L2 |
0.463279452873644 |
|
13555 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GLB1L3 |
0.463279452873644 |
|
13556 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZMYND12 |
0.463433953809677 |
|
13557 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPCS |
0.463433953809677 |
|
13558 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COMMD2 |
0.463498208237664 |
|
13559 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANKUB1 |
0.463498208237664 |
|
13560 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNF13 |
0.463498208237664 |
|
13561 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PFN2 |
0.463498208237664 |
|
13562 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000243321.2 |
0.463498208237664 |
|
13563 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAF3 |
0.463513491205456 |
|
13564 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AMN |
0.463513491205456 |
|
13565 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDC42BPB |
0.463513491205456 |
|
13566 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KDM6A |
0.463521531110259 |
|
13567 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CXorf36 |
0.463521531110259 |
|
13568 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD18|ENSG00000238503.1 |
0.463627386389485 |
|
13569 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3681 |
0.463627386389485 |
|
13570 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
USP25 |
0.464133781354434 |
|
13571 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238591.1 |
0.464133781354434 |
|
13572 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00276 |
0.464243872651444 |
|
13573 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BCL7C |
0.464317896131268 |
|
13574 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4519 |
0.464317896131268 |
|
13575 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP34 |
0.464593802438986 |
|
13576 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4280 |
0.464593802438986 |
|
13577 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FOXK1 |
0.464626811703376 |
|
13578 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NRG2 |
0.464821149454691 |
|
13579 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PURA |
0.464821149454691 |
|
13580 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IGIP |
0.464821149454691 |
|
13581 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CYSTM1 |
0.464821149454691 |
|
13582 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PFDN1 |
0.464821149454691 |
|
13583 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HBEGF |
0.464821149454691 |
|
13584 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC4A9 |
0.464821149454691 |
|
13585 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANKHD1 |
0.464821149454691 |
|
13586 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TBPL1 |
0.464849538256838 |
|
13587 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC2A12 |
0.464849538256838 |
|
13588 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PTEN |
0.465103834550498 |
|
13589 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MYOZ1 |
0.465152091823092 |
|
13590 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SYNPO2L |
0.465152091823092 |
|
13591 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AGAP5 |
0.465152091823092 |
|
13592 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP320 |
0.465152091823092 |
|
13593 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BMS1P4 |
0.465152091823092 |
|
13594 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GLUD1P3 |
0.465152091823092 |
|
13595 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SEC24C |
0.465152091823092 |
|
13596 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FUT11 |
0.465152091823092 |
|
13597 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RMRPP1 |
0.465152091823092 |
|
13598 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CHCHD1 |
0.465152091823092 |
|
13599 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZSWIM8 |
0.465152091823092 |
|
13600 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NDST2 |
0.465152091823092 |
|
13601 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CAMK2G |
0.465152091823092 |
|
13602 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IKBKAP |
0.465262725203185 |
|
13603 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM206A |
0.465262725203185 |
|
13604 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CTNNAL1 |
0.465262725203185 |
|
13605 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM245 |
0.465262725203185 |
|
13606 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR32 |
0.465262725203185 |
|
13607 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FZD7 |
0.465432786909764 |
|
13608 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238770.1 |
0.465432786909764 |
|
13609 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ELFN2 |
0.46550698177059 |
|
13610 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR10AG1 |
0.465519128804266 |
|
13611 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR4A15 |
0.465519128804266 |
|
13612 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR4A16 |
0.465519128804266 |
|
13613 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR4A5 |
0.465519128804266 |
|
13614 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR4C11 |
0.465519128804266 |
|
13615 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR4C15 |
0.465519128804266 |
|
13616 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR4C16 |
0.465519128804266 |
|
13617 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR4C46 |
0.465519128804266 |
|
13618 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR4C6 |
0.465519128804266 |
|
13619 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR4P4 |
0.465519128804266 |
|
13620 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR4S2 |
0.465519128804266 |
|
13621 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR5AS1 |
0.465519128804266 |
|
13622 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR5D13 |
0.465519128804266 |
|
13623 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR5D14 |
0.465519128804266 |
|
13624 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR5D16 |
0.465519128804266 |
|
13625 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR5D18 |
0.465519128804266 |
|
13626 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR5F1 |
0.465519128804266 |
|
13627 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR5I1 |
0.465519128804266 |
|
13628 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR5J2 |
0.465519128804266 |
|
13629 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR5L1 |
0.465519128804266 |
|
13630 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR5L2 |
0.465519128804266 |
|
13631 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR5T2 |
0.465519128804266 |
|
13632 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR5W2 |
0.465519128804266 |
|
13633 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR8H2 |
0.465519128804266 |
|
13634 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR8H3 |
0.465519128804266 |
|
13635 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR8I2 |
0.465519128804266 |
|
13636 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR8J3 |
0.465519128804266 |
|
13637 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR8K5 |
0.465519128804266 |
|
13638 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRIM48 |
0.465519128804266 |
|
13639 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRIM51HP |
0.465519128804266 |
|
13640 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRIM51 |
0.465519128804266 |
|
13641 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HS3ST3A1 |
0.465684640288461 |
|
13642 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL289P |
0.46582674920365 |
|
13643 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MGAT5B |
0.465972256642527 |
|
13644 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP147 |
0.466423530748648 |
|
13645 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NARF |
0.466459544925193 |
|
13646 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC7A1 |
0.466526573278879 |
|
13647 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4327 |
0.466782129227831 |
|
13648 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C1orf127 |
0.466820955974959 |
|
13649 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM84A |
0.466827343779271 |
|
13650 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMPRSS15 |
0.466912251472356 |
|
13651 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR548X |
0.466912251472356 |
|
13652 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UVRAG |
0.466919646776022 |
|
13653 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAP3K10 |
0.466949657765277 |
|
13654 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TTC9B |
0.466949657765277 |
|
13655 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
POLE4 |
0.466953474720027 |
|
13656 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR5000 |
0.466953474720027 |
|
13657 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRIM71 |
0.466975581207506 |
|
13658 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCSER1 |
0.46752296379348 |
|
13659 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRDM9 |
0.467563110933439 |
|
13660 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NETO2 |
0.467600645225266 |
|
13661 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238834.1 |
0.467600645225266 |
|
13662 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD103A |
0.467719524393429 |
|
13663 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD103B |
0.467719524393429 |
|
13664 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD85 |
0.467719524393429 |
|
13665 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACTR1A |
0.468163335311298 |
|
13666 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SUFU |
0.468163335311298 |
|
13667 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL21P |
0.468163335311298 |
|
13668 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRIM8 |
0.468163335311298 |
|
13669 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARL3 |
0.468163335311298 |
|
13670 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPUSD4 |
0.468184973599117 |
|
13671 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM118B |
0.468184973599117 |
|
13672 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FRMPD1 |
0.4683826573587 |
|
13673 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP171 |
0.4683826573587 |
|
13674 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRMT10B |
0.4683826573587 |
|
13675 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EXOSC3 |
0.4683826573587 |
|
13676 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DCAF10 |
0.4683826573587 |
|
13677 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNRPB |
0.468661526650413 |
|
13678 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD119 |
0.468661526650413 |
|
13679 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF343 |
0.468661526650413 |
|
13680 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
E2F8 |
0.468942372028476 |
|
13681 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP335 |
0.468942372028476 |
|
13682 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAD23B |
0.469110039723442 |
|
13683 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KLF4 |
0.469110039723442 |
|
13684 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL659P |
0.469110039723442 |
|
13685 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP293 |
0.469110039723442 |
|
13686 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADAMTS3 |
0.469138001352819 |
|
13687 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TCF7L2 |
0.46940077815138 |
|
13688 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3679 |
0.470229359090239 |
|
13689 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AFM |
0.470753363194297 |
|
13690 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RASSF6 |
0.470753363194297 |
|
13691 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IL8 |
0.470753363194297 |
|
13692 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ROBO2 |
0.47079049196106 |
|
13693 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACO2 |
0.470901481570159 |
|
13694 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
POLR3H |
0.470901481570159 |
|
13695 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C5orf17 |
0.471128894283541 |
|
13696 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA40|ENSG00000252083.1 |
0.471128894283541 |
|
13697 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NOP58 |
0.471398510600863 |
|
13698 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD11B |
0.471398510600863 |
|
13699 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD11|ENSG00000238317.1 |
0.471398510600863 |
|
13700 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL753P |
0.471398510600863 |
|
13701 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL40P |
0.471398510600863 |
|
13702 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
XPR1 |
0.471497565391284 |
|
13703 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00588 |
0.471572658422628 |
|
13704 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRIM55 |
0.471615049443438 |
|
13705 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CRH |
0.471615049443438 |
|
13706 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00967 |
0.471615049443438 |
|
13707 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM178A |
0.471868910872154 |
|
13708 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FSCN1 |
0.472147333906921 |
|
13709 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNF216 |
0.472147333906921 |
|
13710 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TLX3 |
0.472368895359922 |
|
13711 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL339P |
0.472368895359922 |
|
13712 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA70|ENSG00000206909.1 |
0.472368895359922 |
|
13713 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNU4ATAC8P |
0.473127192845161 |
|
13714 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRRIQ3 |
0.473127192845161 |
|
13715 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FPGT |
0.473127192845161 |
|
13716 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238428.1 |
0.473155877169261 |
|
13717 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARPC2 |
0.473155877169261 |
|
13718 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL769P |
0.473158074774922 |
|
13719 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANAPC7 |
0.473158074774922 |
|
13720 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARPC3 |
0.473158074774922 |
|
13721 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPN3 |
0.473158074774922 |
|
13722 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM216A |
0.473158074774922 |
|
13723 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VPS29 |
0.473158074774922 |
|
13724 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD50|ENSG00000202335.1 |
0.473158074774922 |
|
13725 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAD9B |
0.473158074774922 |
|
13726 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPTC7 |
0.473158074774922 |
|
13727 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AHRR |
0.473240135879281 |
|
13728 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BRD9 |
0.473240135879281 |
|
13729 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C5orf55 |
0.473240135879281 |
|
13730 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC127 |
0.473240135879281 |
|
13731 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CEP72 |
0.473240135879281 |
|
13732 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EXOC3 |
0.473240135879281 |
|
13733 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRRC14B |
0.473240135879281 |
|
13734 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4456 |
0.473240135879281 |
|
13735 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PDCD6 |
0.473240135879281 |
|
13736 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLEKHG4B |
0.473240135879281 |
|
13737 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SDHA |
0.473240135879281 |
|
13738 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC9A3 |
0.473240135879281 |
|
13739 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TPPP |
0.473240135879281 |
|
13740 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRIP13 |
0.473240135879281 |
|
13741 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZDHHC11B |
0.473240135879281 |
|
13742 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZDHHC11 |
0.473240135879281 |
|
13743 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4635 |
0.473240135879281 |
|
13744 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC12A7 |
0.473240135879281 |
|
13745 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC6A18 |
0.473240135879281 |
|
13746 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC6A19 |
0.473240135879281 |
|
13747 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TERT |
0.473240135879281 |
|
13748 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4457 |
0.473240135879281 |
|
13749 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLPTM1L |
0.473240135879281 |
|
13750 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC6A3 |
0.473240135879281 |
|
13751 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IRX4 |
0.473240135879281 |
|
13752 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LPCAT1 |
0.473240135879281 |
|
13753 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4277 |
0.473240135879281 |
|
13754 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MRPL36 |
0.473240135879281 |
|
13755 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NDUFS6 |
0.473240135879281 |
|
13756 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SDHAP3 |
0.473240135879281 |
|
13757 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DOK6 |
0.473286307024325 |
|
13758 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CD226 |
0.473286307024325 |
|
13759 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RTTN |
0.473286307024325 |
|
13760 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TIGD4 |
0.473294217765174 |
|
13761 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARFIP1 |
0.473294217765174 |
|
13762 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FHDC1 |
0.473294217765174 |
|
13763 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BCL2 |
0.473364856498111 |
|
13764 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238988.1 |
0.473364856498111 |
|
13765 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF383 |
0.473462954144432 |
|
13766 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238694.1 |
0.473572238113908 |
|
13767 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRIM36 |
0.473672435185582 |
|
13768 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PGGT1B |
0.473672435185582 |
|
13769 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC112 |
0.473672435185582 |
|
13770 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SORCS2 |
0.473738727569917 |
|
13771 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4798 |
0.473738727569917 |
|
13772 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EML6 |
0.473798532133969 |
|
13773 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM216 |
0.473805815322401 |
|
13774 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CPSF7 |
0.473805815322401 |
|
13775 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SDHAF2 |
0.473805815322401 |
|
13776 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL23P |
0.473805815322401 |
|
13777 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPP1R32 |
0.473805815322401 |
|
13778 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRRC10B |
0.473805815322401 |
|
13779 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4488 |
0.473805815322401 |
|
13780 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SYT7 |
0.473805815322401 |
|
13781 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM179 |
0.473940539126367 |
|
13782 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C14orf180 |
0.473940539126367 |
|
13783 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CNOT6L |
0.473951490687665 |
|
13784 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MRPL1 |
0.473951490687665 |
|
13785 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HULC |
0.473959099643503 |
|
13786 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RTN4 |
0.47412663926786 |
|
13787 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD75|ENSG00000221711.1 |
0.474296713855896 |
|
13788 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HDHD1 |
0.474428577963273 |
|
13789 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4767 |
0.474428577963273 |
|
13790 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR651 |
0.474428577963273 |
|
13791 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PNPLA4 |
0.474428577963273 |
|
13792 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STS |
0.474428577963273 |
|
13793 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VCX2 |
0.474428577963273 |
|
13794 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VCX3A |
0.474428577963273 |
|
13795 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VCX |
0.474428577963273 |
|
13796 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
L3MBTL2 |
0.47445863671519 |
|
13797 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AKT3 |
0.474475861051838 |
|
13798 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GLIPR1 |
0.474602001153603 |
|
13799 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KRR1 |
0.474602001153603 |
|
13800 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PVT1 |
0.474722878086926 |
|
13801 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR1208 |
0.474722878086926 |
|
13802 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP226 |
0.474722878086926 |
|
13803 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NXNL2 |
0.474765611332073 |
|
13804 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4289 |
0.474765611332073 |
|
13805 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPTBN1 |
0.474828000388095 |
|
13806 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GABRG1 |
0.474976605551474 |
|
13807 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GABRA2 |
0.474976605551474 |
|
13808 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM75 |
0.475107811247289 |
|
13809 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR1205 |
0.475107811247289 |
|
13810 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR1207 |
0.475107811247289 |
|
13811 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD112|ENSG00000251863.1 |
0.475394417191402 |
|
13812 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HRASLS5 |
0.475448206744398 |
|
13813 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KLF13 |
0.475882062764396 |
|
13814 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TBC1D12 |
0.47594587731646 |
|
13815 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HELLS |
0.47594587731646 |
|
13816 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CYP2C18 |
0.47594587731646 |
|
13817 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CYP2C19 |
0.47594587731646 |
|
13818 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NKD2 |
0.475980756040884 |
|
13819 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FBXL2 |
0.47609806115351 |
|
13820 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UBP1 |
0.47609806115351 |
|
13821 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP128 |
0.47609806115351 |
|
13822 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLASP2 |
0.47609806115351 |
|
13823 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ETFA |
0.476214582129009 |
|
13824 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ISL2 |
0.476214582129009 |
|
13825 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIF27 |
0.47621505342032 |
|
13826 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238403.1 |
0.476291492210697 |
|
13827 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WDR48 |
0.476656734761801 |
|
13828 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GORASP1 |
0.476656734761801 |
|
13829 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GRIN3A |
0.476890819907049 |
|
13830 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLEKHF1 |
0.477062854387411 |
|
13831 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C19orf12 |
0.477062854387411 |
|
13832 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCNE1 |
0.477062854387411 |
|
13833 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
URI1 |
0.477062854387411 |
|
13834 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLCO5A1 |
0.477163338469098 |
|
13835 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP29 |
0.477163338469098 |
|
13836 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL675P |
0.477163338469098 |
|
13837 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP270 |
0.477163338469098 |
|
13838 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SYMPK |
0.477524035929062 |
|
13839 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FOXA3 |
0.477524035929062 |
|
13840 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IRF2BP1 |
0.477524035929062 |
|
13841 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MYPOP |
0.477524035929062 |
|
13842 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NANOS2 |
0.477524035929062 |
|
13843 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NOVA2 |
0.477524035929062 |
|
13844 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC61 |
0.477524035929062 |
|
13845 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR769 |
0.477524035929062 |
|
13846 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PGLYRP1 |
0.477524035929062 |
|
13847 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IGFL4 |
0.477524035929062 |
|
13848 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IGFL3 |
0.477524035929062 |
|
13849 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IGFL2 |
0.477524035929062 |
|
13850 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UNCX |
0.47762639022851 |
|
13851 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MICALL2 |
0.47762639022851 |
|
13852 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
INTS1 |
0.47762639022851 |
|
13853 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAFK |
0.47762639022851 |
|
13854 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM184A |
0.47762639022851 |
|
13855 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PSMG3 |
0.47762639022851 |
|
13856 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ELFN1 |
0.47762639022851 |
|
13857 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAD1L1 |
0.47762639022851 |
|
13858 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4655 |
0.47762639022851 |
|
13859 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FTSJ2 |
0.47762639022851 |
|
13860 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NUDT1 |
0.47762639022851 |
|
13861 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNX8 |
0.47762639022851 |
|
13862 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GRIFIN |
0.47762639022851 |
|
13863 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LFNG |
0.47762639022851 |
|
13864 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4648 |
0.47762639022851 |
|
13865 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BRAT1 |
0.47762639022851 |
|
13866 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238857.1 |
0.47762639022851 |
|
13867 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IQCE |
0.47762639022851 |
|
13868 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SORBS1 |
0.477642278897772 |
|
13869 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ALDH18A1 |
0.477642278897772 |
|
13870 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TCTN3 |
0.477642278897772 |
|
13871 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ENTPD1 |
0.477642278897772 |
|
13872 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CXorf30 |
0.477779420565587 |
|
13873 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MSL1 |
0.478034587645841 |
|
13874 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CASC3 |
0.478034587645841 |
|
13875 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAPGEFL1 |
0.478034587645841 |
|
13876 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAFD1 |
0.478130409718129 |
|
13877 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNF17 |
0.478133889892113 |
|
13878 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CENPJ |
0.478133889892113 |
|
13879 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TPTE2P1 |
0.478133889892113 |
|
13880 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LSP1|ENSG00000269099.1 |
0.478133889892113 |
|
13881 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PABPC3 |
0.478133889892113 |
|
13882 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AMER2 |
0.478133889892113 |
|
13883 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MTMR6 |
0.478133889892113 |
|
13884 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NUPL1 |
0.478133889892113 |
|
13885 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR2G2 |
0.478283376810008 |
|
13886 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR2G3 |
0.478283376810008 |
|
13887 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LYPD8 |
0.478283376810008 |
|
13888 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3124 |
0.478283376810008 |
|
13889 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR11L1 |
0.478283376810008 |
|
13890 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR13G1 |
0.478283376810008 |
|
13891 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR14A16 |
0.478283376810008 |
|
13892 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR14A2 |
0.478283376810008 |
|
13893 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR14C36 |
0.478283376810008 |
|
13894 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR14I1 |
0.478283376810008 |
|
13895 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR14K1 |
0.478283376810008 |
|
13896 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR1C1 |
0.478283376810008 |
|
13897 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR2AJ1 |
0.478283376810008 |
|
13898 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR2AK2 |
0.478283376810008 |
|
13899 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR2G6 |
0.478283376810008 |
|
13900 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR2L13 |
0.478283376810008 |
|
13901 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR2L2 |
0.478283376810008 |
|
13902 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR2L3 |
0.478283376810008 |
|
13903 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR2L5 |
0.478283376810008 |
|
13904 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR2L8 |
0.478283376810008 |
|
13905 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR2M2 |
0.478283376810008 |
|
13906 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR2M3 |
0.478283376810008 |
|
13907 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR2M4 |
0.478283376810008 |
|
13908 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR2M5 |
0.478283376810008 |
|
13909 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR2M7 |
0.478283376810008 |
|
13910 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR2T10 |
0.478283376810008 |
|
13911 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR2T11 |
0.478283376810008 |
|
13912 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR2T12 |
0.478283376810008 |
|
13913 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR2T1 |
0.478283376810008 |
|
13914 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR2T27 |
0.478283376810008 |
|
13915 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR2T29 |
0.478283376810008 |
|
13916 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR2T2 |
0.478283376810008 |
|
13917 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR2T33 |
0.478283376810008 |
|
13918 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR2T34 |
0.478283376810008 |
|
13919 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR2T35 |
0.478283376810008 |
|
13920 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR2T3 |
0.478283376810008 |
|
13921 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR2T4 |
0.478283376810008 |
|
13922 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR2T5 |
0.478283376810008 |
|
13923 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR2T6 |
0.478283376810008 |
|
13924 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR2T7 |
0.478283376810008 |
|
13925 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR2T8 |
0.478283376810008 |
|
13926 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR2W3 |
0.478283376810008 |
|
13927 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR6F1 |
0.478283376810008 |
|
13928 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PGBD2 |
0.478283376810008 |
|
13929 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SH3BP5L |
0.478283376810008 |
|
13930 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRIM58 |
0.478283376810008 |
|
13931 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF672 |
0.478283376810008 |
|
13932 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF692 |
0.478283376810008 |
|
13933 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PAXIP1 |
0.478528274731898 |
|
13934 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP280 |
0.478528274731898 |
|
13935 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
INSIG1 |
0.478528274731898 |
|
13936 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BLACE |
0.478528274731898 |
|
13937 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EN2 |
0.478528274731898 |
|
13938 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CNPY1 |
0.478528274731898 |
|
13939 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RBM33 |
0.478528274731898 |
|
13940 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SHH |
0.478528274731898 |
|
13941 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DNAH14 |
0.478535287615127 |
|
13942 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ENAH |
0.478535287615127 |
|
13943 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ASB17 |
0.478985155471141 |
|
13944 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SAE1 |
0.479045679003506 |
|
13945 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPIN2A |
0.479080308876033 |
|
13946 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPIN2B |
0.479080308876033 |
|
13947 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC35B3 |
0.479130868246555 |
|
13948 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMCO3 |
0.479172354372101 |
|
13949 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR762 |
0.47925621278977 |
|
13950 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CTF1 |
0.47925621278977 |
|
13951 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FBXL19 |
0.47925621278977 |
|
13952 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ORAI3 |
0.47925621278977 |
|
13953 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SETD1A |
0.47925621278977 |
|
13954 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HSD3B7 |
0.47925621278977 |
|
13955 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STX1B |
0.47925621278977 |
|
13956 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STX4 |
0.47925621278977 |
|
13957 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TYW1 |
0.479429178928461 |
|
13958 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PMS2P4 |
0.479429178928461 |
|
13959 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STAG3L4 |
0.479429178928461 |
|
13960 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TOX |
0.479497707958632 |
|
13961 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MELK |
0.479522172616532 |
|
13962 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PALB2 |
0.479664540912701 |
|
13963 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DCTN5 |
0.479664540912701 |
|
13964 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLK1 |
0.479664540912701 |
|
13965 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LARGE |
0.479690052909755 |
|
13966 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA76|ENSG00000253007.2 |
0.479690052909755 |
|
13967 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UBR5 |
0.47971056044173 |
|
13968 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238533.1 |
0.47971056044173 |
|
13969 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNU6ATAC8P |
0.47971056044173 |
|
13970 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ODF1 |
0.47971056044173 |
|
13971 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RGMB |
0.479819594993702 |
|
13972 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CHD1 |
0.479819594993702 |
|
13973 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM174A |
0.479819594993702 |
|
13974 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP62 |
0.479819594993702 |
|
13975 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ST8SIA4 |
0.479819594993702 |
|
13976 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR548P |
0.479819594993702 |
|
13977 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMPRSS2 |
0.479959390887236 |
|
13978 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM105A |
0.479971631243857 |
|
13979 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM105B |
0.479971631243857 |
|
13980 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANKH |
0.479971631243857 |
|
13981 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4637 |
0.479971631243857 |
|
13982 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HPSE2 |
0.480021769808194 |
|
13983 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRPSAP1 |
0.480029722754287 |
|
13984 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238418.1 |
0.480029722754287 |
|
13985 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPHK1 |
0.480029722754287 |
|
13986 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UBE2O |
0.480029722754287 |
|
13987 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AANAT |
0.480029722754287 |
|
13988 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RHBDF2 |
0.480029722754287 |
|
13989 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CYGB |
0.480029722754287 |
|
13990 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRCD |
0.480029722754287 |
|
13991 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNHG16 |
0.480029722754287 |
|
13992 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD1B |
0.480029722754287 |
|
13993 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ST6GALNAC2 |
0.480029722754287 |
|
13994 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MFSD11 |
0.480029722754287 |
|
13995 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00868 |
0.480029722754287 |
|
13996 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RASD2 |
0.480166144844328 |
|
13997 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PHF5A |
0.480205035614597 |
|
13998 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OTUD7A |
0.480292661719883 |
|
13999 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARHGAP11A |
0.480292661719883 |
|
14000 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CHRNA7 |
0.480292661719883 |
|
14001 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GOLGA8K |
0.480292661719883 |
|
14002 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GOLGA8N |
0.480292661719883 |
|
14003 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GOLGA8O |
0.480292661719883 |
|
14004 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL185P |
0.480292661719883 |
|
14005 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL286P |
0.480292661719883 |
|
14006 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL539P |
0.480292661719883 |
|
14007 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA18|ENSG00000206849.1 |
0.480292661719883 |
|
14008 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U8|ENSG00000206987.1 |
0.480292661719883 |
|
14009 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ULK4P1 |
0.480292661719883 |
|
14010 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U8|ENSG00000238840.1 |
0.480296721880659 |
|
14011 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AKR1C2 |
0.480296721880659 |
|
14012 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U8|ENSG00000239148.1 |
0.480296721880659 |
|
14013 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AKR1C3 |
0.480296721880659 |
|
14014 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U8|ENSG00000251740.1 |
0.480296721880659 |
|
14015 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U8|ENSG00000239142.1 |
0.480296721880659 |
|
14016 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UBQLN2 |
0.48037794933744 |
|
14017 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FSHB |
0.480394884286853 |
|
14018 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARL14EP |
0.480394884286853 |
|
14019 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRRC53 |
0.480407099877945 |
|
14020 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C1orf173 |
0.480407099877945 |
|
14021 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CRYZ |
0.480407099877945 |
|
14022 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TYW3 |
0.480407099877945 |
|
14023 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LHX8 |
0.480407099877945 |
|
14024 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PBX3 |
0.480470084816658 |
|
14025 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL685P |
0.480579898220816 |
|
14026 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP249 |
0.480579898220816 |
|
14027 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF706 |
0.480579898220816 |
|
14028 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR5680 |
0.480579898220816 |
|
14029 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RRM2B |
0.480579898220816 |
|
14030 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HERC2 |
0.480632274962784 |
|
14031 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL542P |
0.480842402567028 |
|
14032 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCNC2 |
0.480854893950856 |
|
14033 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CAPS2 |
0.480854893950856 |
|
14034 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GLIPR1L1 |
0.480854893950856 |
|
14035 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GLIPR1L2 |
0.480854893950856 |
|
14036 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ST6GALNAC1 |
0.481004804332776 |
|
14037 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MXRA7 |
0.481004804332776 |
|
14038 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
INTS4 |
0.481109998318361 |
|
14039 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SP4 |
0.48113284450356 |
|
14040 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR1183 |
0.48113284450356 |
|
14041 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DNAH11 |
0.48113284450356 |
|
14042 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDCA7L |
0.48113284450356 |
|
14043 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MTRNR2L13 |
0.481245804129731 |
|
14044 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR52B4 |
0.481324739650376 |
|
14045 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP256 |
0.481361117054096 |
|
14046 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRRC1 |
0.481361117054096 |
|
14047 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MLIP |
0.481361117054096 |
|
14048 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HECTD4 |
0.481386031534601 |
|
14049 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HN1L |
0.481403216888421 |
|
14050 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAPK8IP3 |
0.481403216888421 |
|
14051 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3177 |
0.481403216888421 |
|
14052 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF665 |
0.481585477801536 |
|
14053 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NAA25 |
0.481749190432444 |
|
14054 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCNT2 |
0.481781865346535 |
|
14055 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CFHR5 |
0.481781865346535 |
|
14056 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AWAT2 |
0.481937571580506 |
|
14057 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DGAT2L6 |
0.481937571580506 |
|
14058 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IGBP1 |
0.481937571580506 |
|
14059 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR676 |
0.481937571580506 |
|
14060 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OTUD6A |
0.481937571580506 |
|
14061 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FBXO43 |
0.481957550831488 |
|
14062 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
POLR2K |
0.481957550831488 |
|
14063 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPAG1 |
0.481957550831488 |
|
14064 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNF19A |
0.481957550831488 |
|
14065 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4471 |
0.481957550831488 |
|
14066 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANKRD46 |
0.481957550831488 |
|
14067 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNX31 |
0.481957550831488 |
|
14068 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PABPC1 |
0.481957550831488 |
|
14069 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNU6ATAC41P |
0.481957550831488 |
|
14070 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM155A |
0.48198742614532 |
|
14071 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PAPD4 |
0.48221585765177 |
|
14072 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CMYA5 |
0.48221585765177 |
|
14073 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KAZN |
0.482642906339254 |
|
14074 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BPNT1 |
0.48264666359235 |
|
14075 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IARS2 |
0.48264666359235 |
|
14076 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC129 |
0.482712946290709 |
|
14077 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL832P |
0.482850600754883 |
|
14078 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATP6V1C2 |
0.482850600754883 |
|
14079 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PDIA6 |
0.482850600754883 |
|
14080 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCNF1 |
0.482850600754883 |
|
14081 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C2orf50 |
0.482850600754883 |
|
14082 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PQLC3 |
0.482850600754883 |
|
14083 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NTSR2 |
0.482850600754883 |
|
14084 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LPIN1 |
0.482850600754883 |
|
14085 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR548S |
0.482850600754883 |
|
14086 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4262 |
0.482850600754883 |
|
14087 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD50|ENSG00000199857.1 |
0.483016299658271 |
|
14088 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FBRS |
0.483081391441816 |
|
14089 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRR14 |
0.483081391441816 |
|
14090 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BTBD16 |
0.483220458530976 |
|
14091 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3941 |
0.483220458530976 |
|
14092 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PDZRN4 |
0.483265596121575 |
|
14093 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC23 |
0.48331591491745 |
|
14094 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ERMAP |
0.48331591491745 |
|
14095 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF691 |
0.48331591491745 |
|
14096 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC2A1 |
0.48331591491745 |
|
14097 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM183A |
0.48331591491745 |
|
14098 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDK12 |
0.483583020559414 |
|
14099 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3663 |
0.483853515537024 |
|
14100 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCNK18 |
0.483853515537024 |
|
14101 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC18A2 |
0.483853515537024 |
|
14102 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PDZD8 |
0.483853515537024 |
|
14103 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EMX2OS |
0.483853515537024 |
|
14104 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EMX2 |
0.483853515537024 |
|
14105 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAB11FIP2 |
0.483853515537024 |
|
14106 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CASC2 |
0.483853515537024 |
|
14107 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM204A |
0.483853515537024 |
|
14108 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00867 |
0.483853515537024 |
|
14109 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CNIH3 |
0.483858486710635 |
|
14110 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DISP1 |
0.483989034134147 |
|
14111 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C1orf53 |
0.484077112031454 |
|
14112 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LHX9 |
0.484077112031454 |
|
14113 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD56|ENSG00000200753.1 |
0.484231308618263 |
|
14114 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TNFSF11 |
0.484242119242054 |
|
14115 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DAPK1 |
0.484302148163483 |
|
14116 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SEPHS2 |
0.484311280064545 |
|
14117 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ITGAL |
0.484311280064545 |
|
14118 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4518 |
0.484311280064545 |
|
14119 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF747 |
0.484311280064545 |
|
14120 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF768 |
0.484311280064545 |
|
14121 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF764 |
0.484311280064545 |
|
14122 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF688 |
0.484311280064545 |
|
14123 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF785 |
0.484311280064545 |
|
14124 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MTOR |
0.484353672542519 |
|
14125 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000271794.1 |
0.484353672542519 |
|
14126 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANGPTL7 |
0.484353672542519 |
|
14127 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
F13B |
0.484466869268034 |
|
14128 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ASPM |
0.484466869268034 |
|
14129 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZBTB41 |
0.484466869268034 |
|
14130 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CRB1 |
0.484466869268034 |
|
14131 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DENND1B |
0.484466869268034 |
|
14132 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATXN7L3B |
0.48479537049483 |
|
14133 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GALNT14 |
0.484957267709815 |
|
14134 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4710 |
0.48515785982738 |
|
14135 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
INF2 |
0.48515785982738 |
|
14136 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADSSL1 |
0.48515785982738 |
|
14137 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SIVA1 |
0.48515785982738 |
|
14138 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AKT1 |
0.48515785982738 |
|
14139 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZBTB42 |
0.48515785982738 |
|
14140 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00638 |
0.48515785982738 |
|
14141 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CEP170B |
0.48515785982738 |
|
14142 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLD4 |
0.48515785982738 |
|
14143 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AHNAK2 |
0.48515785982738 |
|
14144 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4735 |
0.485188348469017 |
|
14145 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CFH |
0.485188348469017 |
|
14146 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CFHR1 |
0.485188348469017 |
|
14147 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CFHR2 |
0.485188348469017 |
|
14148 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CFHR3 |
0.485188348469017 |
|
14149 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CFHR4 |
0.485188348469017 |
|
14150 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C14orf144 |
0.48538604252434 |
|
14151 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FUNDC1 |
0.485389690296844 |
|
14152 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL291P |
0.485389690296844 |
|
14153 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DUSP21 |
0.485389690296844 |
|
14154 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SOCS2 |
0.486256813561899 |
|
14155 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CRADD |
0.486256813561899 |
|
14156 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL630P |
0.486256813561899 |
|
14157 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP263 |
0.486256813561899 |
|
14158 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLXNC1 |
0.486256813561899 |
|
14159 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
POU6F2 |
0.486563818975189 |
|
14160 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
YAE1D1 |
0.486563818975189 |
|
14161 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RALA |
0.486563818975189 |
|
14162 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00665 |
0.486594068689074 |
|
14163 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OXT |
0.486634866493938 |
|
14164 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AVP |
0.486634866493938 |
|
14165 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL555P |
0.486634866493938 |
|
14166 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AQR |
0.486697998570223 |
|
14167 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF770 |
0.486697998570223 |
|
14168 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANP32AP1 |
0.486697998570223 |
|
14169 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DUPD1 |
0.486943227417525 |
|
14170 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DUSP13 |
0.486943227417525 |
|
14171 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SAMD8 |
0.486943227417525 |
|
14172 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GCSAML |
0.4872682915802 |
|
14173 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HDDC2 |
0.487345314589205 |
|
14174 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TFDP1 |
0.487431681977899 |
|
14175 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ABCB5 |
0.487477940208195 |
|
14176 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SP8 |
0.487477940208195 |
|
14177 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GNAT3 |
0.487667989907375 |
|
14178 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FRMPD3 |
0.487743027729867 |
|
14179 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRPS1 |
0.487743027729867 |
|
14180 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCN11A |
0.487818311678159 |
|
14181 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238799.1 |
0.487947871749613 |
|
14182 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00604 |
0.487989271280593 |
|
14183 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RGCC |
0.488061825325392 |
|
14184 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VWA8 |
0.488061825325392 |
|
14185 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR5006 |
0.488061825325392 |
|
14186 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL515P |
0.488061825325392 |
|
14187 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
REXO4 |
0.488263393792699 |
|
14188 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRP6 |
0.48831119985965 |
|
14189 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UBL3 |
0.48837608355236 |
|
14190 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00572 |
0.48837608355236 |
|
14191 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00544 |
0.48837608355236 |
|
14192 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00365 |
0.48837608355236 |
|
14193 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KATNAL1 |
0.48837608355236 |
|
14194 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00427 |
0.48837608355236 |
|
14195 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00426 |
0.48837608355236 |
|
14196 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TYRP1 |
0.488396414271598 |
|
14197 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL849P |
0.488396414271598 |
|
14198 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LURAP1L |
0.488396414271598 |
|
14199 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MPDZ |
0.488396414271598 |
|
14200 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WASF3 |
0.48848074853319 |
|
14201 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPR12 |
0.48848074853319 |
|
14202 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AR |
0.488842544910507 |
|
14203 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCMH1 |
0.488953613231487 |
|
14204 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WDR3 |
0.489187726230947 |
|
14205 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPAG17 |
0.489187726230947 |
|
14206 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP56 |
0.489187726230947 |
|
14207 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
APBA2 |
0.489406325911471 |
|
14208 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARHGAP11B |
0.489406325911471 |
|
14209 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CHRFAM7A |
0.489406325911471 |
|
14210 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM189A1 |
0.489406325911471 |
|
14211 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GOLGA6L7P |
0.489406325911471 |
|
14212 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GOLGA8F |
0.489406325911471 |
|
14213 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GOLGA8G |
0.489406325911471 |
|
14214 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GOLGA8H |
0.489406325911471 |
|
14215 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GOLGA8J |
0.489406325911471 |
|
14216 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GOLGA8M |
0.489406325911471 |
|
14217 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GOLGA8Q |
0.489406325911471 |
|
14218 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GOLGA8R |
0.489406325911471 |
|
14219 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GOLGA8T |
0.489406325911471 |
|
14220 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HERC2P9 |
0.489406325911471 |
|
14221 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NDNL2 |
0.489406325911471 |
|
14222 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL196P |
0.489406325911471 |
|
14223 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL238P |
0.489406325911471 |
|
14224 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL469P |
0.489406325911471 |
|
14225 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL628P |
0.489406325911471 |
|
14226 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL673P |
0.489406325911471 |
|
14227 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL719P |
0.489406325911471 |
|
14228 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL796P |
0.489406325911471 |
|
14229 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL829P |
0.489406325911471 |
|
14230 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL82P |
0.489406325911471 |
|
14231 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TJP1 |
0.489406325911471 |
|
14232 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U8|ENSG00000207430.1 |
0.489406325911471 |
|
14233 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U8|ENSG00000207432.1 |
0.489406325911471 |
|
14234 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U8|ENSG00000238519.1 |
0.489406325911471 |
|
14235 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U8|ENSG00000252602.1 |
0.489406325911471 |
|
14236 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ULK4P2 |
0.489406325911471 |
|
14237 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ULK4P3 |
0.489406325911471 |
|
14238 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WHAMMP2 |
0.489406325911471 |
|
14239 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoZ278 |
0.489406325911471 |
|
14240 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAN1 |
0.489406325911471 |
|
14241 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRPM1 |
0.489406325911471 |
|
14242 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR211 |
0.489406325911471 |
|
14243 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WDR19 |
0.489550173832601 |
|
14244 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C2orf70 |
0.48987817058974 |
|
14245 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CIB4 |
0.48987817058974 |
|
14246 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRDX4 |
0.489952616829785 |
|
14247 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACOT9 |
0.489952616829785 |
|
14248 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SAT1 |
0.489952616829785 |
|
14249 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
APOO |
0.489952616829785 |
|
14250 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CXorf58 |
0.489952616829785 |
|
14251 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KLHL15 |
0.489952616829785 |
|
14252 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCT6P1 |
0.48995838799641 |
|
14253 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA15|ENSG00000206785.1 |
0.48995838799641 |
|
14254 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA22|ENSG00000206634.1 |
0.48995838799641 |
|
14255 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VKORC1L1 |
0.48995838799641 |
|
14256 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GUSB |
0.48995838799641 |
|
14257 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ASL |
0.48995838799641 |
|
14258 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CRCP |
0.48995838799641 |
|
14259 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00676 |
0.490220603572122 |
|
14260 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IRS2 |
0.490220603572122 |
|
14261 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP10 |
0.490220603572122 |
|
14262 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL783P |
0.490220603572122 |
|
14263 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COL4A1 |
0.490220603572122 |
|
14264 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COL4A2 |
0.490220603572122 |
|
14265 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238629.1 |
0.490220603572122 |
|
14266 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAB20 |
0.490220603572122 |
|
14267 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CARKD |
0.490220603572122 |
|
14268 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CARS2 |
0.490220603572122 |
|
14269 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ING1 |
0.490220603572122 |
|
14270 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00567 |
0.490220603572122 |
|
14271 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00346 |
0.490220603572122 |
|
14272 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANKRD10 |
0.490220603572122 |
|
14273 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CHADL |
0.490449792621605 |
|
14274 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RANGAP1 |
0.490449792621605 |
|
14275 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAEA |
0.490535036055069 |
|
14276 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CRIPAK |
0.490535036055069 |
|
14277 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UVSSA |
0.490535036055069 |
|
14278 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FGF8 |
0.490887277685435 |
|
14279 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MGEA5 |
0.490887277685435 |
|
14280 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NPM3 |
0.490887277685435 |
|
14281 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCNIP2 |
0.490887277685435 |
|
14282 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRHDE |
0.491105299733528 |
|
14283 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRP1B |
0.491348505563514 |
|
14284 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD74|ENSG00000200891.1 |
0.491586775193701 |
|
14285 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FADS6 |
0.491694219336364 |
|
14286 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
USH1G |
0.491694219336364 |
|
14287 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OTOP2 |
0.491694219336364 |
|
14288 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OTOP3 |
0.491694219336364 |
|
14289 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HID1 |
0.491694219336364 |
|
14290 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDR2L |
0.491694219336364 |
|
14291 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ICT1 |
0.491694219336364 |
|
14292 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCTD2 |
0.491694219336364 |
|
14293 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATP5H |
0.491694219336364 |
|
14294 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL573P |
0.491694219336364 |
|
14295 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U7|ENSG00000272215.1 |
0.491704563639965 |
|
14296 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CHSY1 |
0.491899871753227 |
|
14297 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VIMP |
0.491899871753227 |
|
14298 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNRPA1 |
0.491899871753227 |
|
14299 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCSK6 |
0.491899871753227 |
|
14300 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DDX11L9 |
0.491899871753227 |
|
14301 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DNM1P47 |
0.491899871753227 |
|
14302 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM138E |
0.491899871753227 |
|
14303 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR4F13P |
0.491899871753227 |
|
14304 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR4F15 |
0.491899871753227 |
|
14305 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR4F4 |
0.491899871753227 |
|
14306 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR4F6 |
0.491899871753227 |
|
14307 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL209P |
0.491899871753227 |
|
14308 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TARSL2 |
0.491899871753227 |
|
14309 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TM2D3 |
0.491899871753227 |
|
14310 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WASH3P |
0.491899871753227 |
|
14311 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238502.1 |
0.491899871753227 |
|
14312 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BAIAP2 |
0.491941231794198 |
|
14313 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR592 |
0.49199152105496 |
|
14314 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SEMA3C |
0.492006328972203 |
|
14315 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FRAT1 |
0.49214759715513 |
|
14316 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FRAT2 |
0.49214759715513 |
|
14317 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RRP12 |
0.49214759715513 |
|
14318 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADRB1 |
0.492161275074307 |
|
14319 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C10orf118 |
0.492161275074307 |
|
14320 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR2110 |
0.492161275074307 |
|
14321 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TDRD1 |
0.492161275074307 |
|
14322 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VWA2 |
0.492161275074307 |
|
14323 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DMWD |
0.492214128161591 |
|
14324 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RSPH6A |
0.492214128161591 |
|
14325 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C8orf34 |
0.49261934931698 |
|
14326 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PTPRD |
0.492626020208198 |
|
14327 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP36 |
0.492673086104488 |
|
14328 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RRAS |
0.492714462676836 |
|
14329 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCAF1 |
0.492714462676836 |
|
14330 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADM5 |
0.492714462676836 |
|
14331 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BCL2L12 |
0.492714462676836 |
|
14332 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CPT1C |
0.492714462676836 |
|
14333 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IRF3 |
0.492714462676836 |
|
14334 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR5088 |
0.492714462676836 |
|
14335 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRMT1 |
0.492714462676836 |
|
14336 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA7|ENSG00000201316.1 |
0.492726366333539 |
|
14337 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SHISA9 |
0.492764666060822 |
|
14338 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EIF3A |
0.493226977368324 |
|
14339 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NANOS1 |
0.493226977368324 |
|
14340 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA19|ENSG00000207468.1 |
0.493226977368324 |
|
14341 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA19|ENSG00000222588.1 |
0.493226977368324 |
|
14342 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM45A |
0.493226977368324 |
|
14343 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SFXN4 |
0.493226977368324 |
|
14344 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRDX3 |
0.493226977368324 |
|
14345 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA70|ENSG00000252258.1 |
0.493227837055858 |
|
14346 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TEX13B |
0.49326135986938 |
|
14347 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VSIG1 |
0.49326135986938 |
|
14348 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PSMD10 |
0.49326135986938 |
|
14349 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATG4A |
0.49326135986938 |
|
14350 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AXL |
0.493451330269625 |
|
14351 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HNRNPUL1 |
0.493451330269625 |
|
14352 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL34P |
0.493451330269625 |
|
14353 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238899.1 |
0.493596490113936 |
|
14354 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF689 |
0.493663849635147 |
|
14355 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MED12 |
0.493775069825979 |
|
14356 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NLGN3 |
0.493775069825979 |
|
14357 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GJB1 |
0.493775069825979 |
|
14358 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ITGB1BP2 |
0.493775069825979 |
|
14359 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD118 |
0.493824596277438 |
|
14360 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM107 |
0.493824596277438 |
|
14361 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C17orf59 |
0.493824596277438 |
|
14362 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3676 |
0.493824596277438 |
|
14363 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AURKB |
0.493824596277438 |
|
14364 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00324 |
0.493824596277438 |
|
14365 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CTC1 |
0.493824596277438 |
|
14366 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF890P |
0.493857862946079 |
|
14367 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WIPI2 |
0.493857862946079 |
|
14368 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC29A4 |
0.493857862946079 |
|
14369 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TNRC18 |
0.493857862946079 |
|
14370 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARHGEF15 |
0.494448421324554 |
|
14371 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CYP2C9 |
0.494475868485812 |
|
14372 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CYP2C8 |
0.494475868485812 |
|
14373 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C10orf129 |
0.494475868485812 |
|
14374 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PDLIM1 |
0.494475868485812 |
|
14375 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADNP2 |
0.494585984509449 |
|
14376 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CTDP1 |
0.494585984509449 |
|
14377 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HSBP1L1 |
0.494585984509449 |
|
14378 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCNG2 |
0.494585984509449 |
|
14379 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NFATC1 |
0.494585984509449 |
|
14380 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PARD6G |
0.494585984509449 |
|
14381 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PQLC1 |
0.494585984509449 |
|
14382 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RBFADN |
0.494585984509449 |
|
14383 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RBFA |
0.494585984509449 |
|
14384 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TXNL4A |
0.494585984509449 |
|
14385 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SRM |
0.494610822858018 |
|
14386 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EXOSC10 |
0.494610822858018 |
|
14387 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARSG |
0.494706875349836 |
|
14388 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM47A |
0.494949811430037 |
|
14389 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM47 |
0.494949811430037 |
|
14390 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM47B |
0.494949811430037 |
|
14391 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAGEB16 |
0.494949811430037 |
|
14392 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CHDC2 |
0.494949811430037 |
|
14393 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EME2 |
0.495378385642484 |
|
14394 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MRPS34 |
0.495378385642484 |
|
14395 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NME3 |
0.495378385642484 |
|
14396 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NUBP2 |
0.495378385642484 |
|
14397 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPSB3 |
0.495378385642484 |
|
14398 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HAGH |
0.495378385642484 |
|
14399 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IGFALS |
0.495378385642484 |
|
14400 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM187B |
0.495641407386194 |
|
14401 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TBC1D14 |
0.495714989690224 |
|
14402 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP292 |
0.495714989690224 |
|
14403 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC96 |
0.495714989690224 |
|
14404 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TADA2B |
0.495714989690224 |
|
14405 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GRPEL1 |
0.495714989690224 |
|
14406 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SHISA2 |
0.495833713776158 |
|
14407 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00415 |
0.495833713776158 |
|
14408 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNF6 |
0.495833713776158 |
|
14409 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NR2F2 |
0.496010264209591 |
|
14410 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR1469 |
0.496010264209591 |
|
14411 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TPD52L1 |
0.496206319930812 |
|
14412 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MTTP |
0.496440662864064 |
|
14413 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DAPP1 |
0.496440662864064 |
|
14414 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LAMTOR3 |
0.496440662864064 |
|
14415 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DNAJB14 |
0.496440662864064 |
|
14416 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
H2AFZ |
0.496440662864064 |
|
14417 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EMCN |
0.496440662864064 |
|
14418 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA75|ENSG00000212580.1 |
0.496586368552274 |
|
14419 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NRXN1 |
0.496586368552274 |
|
14420 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CHRNA3 |
0.496812760688892 |
|
14421 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TES |
0.497170680768765 |
|
14422 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoZ185 |
0.497170680768765 |
|
14423 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FSCN2 |
0.497174600776213 |
|
14424 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C17orf70 |
0.497174600776213 |
|
14425 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADAMTSL3 |
0.497242618288346 |
|
14426 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC97 |
0.497365274009855 |
|
14427 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ALCAM |
0.497496612582727 |
|
14428 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CBLB |
0.497496612582727 |
|
14429 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GTF2H2B |
0.497702411299836 |
|
14430 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GTF2H2C |
0.497702411299836 |
|
14431 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GTF2H2 |
0.497702411299836 |
|
14432 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GUSBP3 |
0.497702411299836 |
|
14433 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NAIP |
0.497702411299836 |
|
14434 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OCLN |
0.497702411299836 |
|
14435 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL476P |
0.497702411299836 |
|
14436 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL616P |
0.497702411299836 |
|
14437 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL9P |
0.497702411299836 |
|
14438 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SERF1A |
0.497702411299836 |
|
14439 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SERF1B |
0.497702411299836 |
|
14440 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SMN1 |
0.497702411299836 |
|
14441 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SMN2 |
0.497702411299836 |
|
14442 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238451.1 |
0.497702411299836 |
|
14443 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238740.1 |
0.497702411299836 |
|
14444 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4431 |
0.497987897748547 |
|
14445 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCARNA16|ENSG00000251942.1 |
0.498019220939956 |
|
14446 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4261 |
0.498109589617841 |
|
14447 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL66P |
0.498109589617841 |
|
14448 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA51|ENSG00000206898.1 |
0.498109589617841 |
|
14449 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HPCAL1 |
0.498109589617841 |
|
14450 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ODC1 |
0.498109589617841 |
|
14451 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA80B |
0.498109589617841 |
|
14452 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NOL10 |
0.498109589617841 |
|
14453 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GGT6 |
0.498139058761568 |
|
14454 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WBP1L |
0.498362481557627 |
|
14455 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZXDA |
0.498365711697439 |
|
14456 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HTR1B |
0.498628870481675 |
|
14457 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EBNA1BP2 |
0.498698601280984 |
|
14458 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PHC2 |
0.498737486047437 |
|
14459 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3605 |
0.498737486047437 |
|
14460 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP16 |
0.498737486047437 |
|
14461 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SETBP1 |
0.498790475834996 |
|
14462 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4319 |
0.498790475834996 |
|
14463 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TNRC6C |
0.498885091605336 |
|
14464 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL101P |
0.499012312950462 |
|
14465 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NRAP |
0.499139757732711 |
|
14466 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CASP7 |
0.499139757732711 |
|
14467 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLEKHS1 |
0.499139757732711 |
|
14468 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA17|ENSG00000212589.1 |
0.499139757732711 |
|
14469 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DCLRE1A |
0.499139757732711 |
|
14470 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NHLRC2 |
0.499139757732711 |
|
14471 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NOM1 |
0.499140879899848 |
|
14472 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MNX1 |
0.499140879899848 |
|
14473 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SEL1L3 |
0.499355981531035 |
|
14474 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARMC7 |
0.499363742542587 |
|
14475 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HN1 |
0.499363742542587 |
|
14476 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NT5C |
0.499363742542587 |
|
14477 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SUMO2 |
0.499363742542587 |
|
14478 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NUP85 |
0.499363742542587 |
|
14479 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GGA3 |
0.499363742542587 |
|
14480 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MRPS7 |
0.499363742542587 |
|
14481 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIF4GD |
0.499363742542587 |
|
14482 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC25A19 |
0.499363742542587 |
|
14483 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SKOR1 |
0.499529365397786 |
|
14484 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C6 |
0.499881277762882 |
|
14485 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OSBPL10 |
0.500084132326113 |
|
14486 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL83P |
0.500169597526433 |
|
14487 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM183B |
0.500169597526433 |
|
14488 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VPS41 |
0.500169597526433 |
|
14489 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAHD2A |
0.500405093594007 |
|
14490 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FLJ14082 |
0.500405093594007 |
|
14491 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00342 |
0.500405093594007 |
|
14492 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRIM43 |
0.500405093594007 |
|
14493 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM53A |
0.500557982894626 |
|
14494 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FGFR3 |
0.500557982894626 |
|
14495 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LETM1 |
0.500557982894626 |
|
14496 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL671P |
0.500557982894626 |
|
14497 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WHSC1 |
0.500557982894626 |
|
14498 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BMPR1A |
0.50077682687135 |
|
14499 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MMRN2 |
0.50077682687135 |
|
14500 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNCG |
0.50077682687135 |
|
14501 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADIRF |
0.50077682687135 |
|
14502 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AGAP11 |
0.50077682687135 |
|
14503 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM25A |
0.50077682687135 |
|
14504 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HOXB6 |
0.501344756809359 |
|
14505 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TBC1D16 |
0.501403341480724 |
|
14506 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC40 |
0.501403341480724 |
|
14507 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAOA |
0.501540966935009 |
|
14508 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAOB |
0.501540966935009 |
|
14509 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NDP |
0.501540966935009 |
|
14510 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3201 |
0.50157457780386 |
|
14511 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM19A5 |
0.50157457780386 |
|
14512 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4535 |
0.50157457780386 |
|
14513 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACR |
0.50157457780386 |
|
14514 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADM2 |
0.50157457780386 |
|
14515 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ALG12 |
0.50157457780386 |
|
14516 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARSA |
0.50157457780386 |
|
14517 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BRD1 |
0.50157457780386 |
|
14518 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C22orf34 |
0.50157457780386 |
|
14519 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CHKB |
0.50157457780386 |
|
14520 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CPT1B |
0.50157457780386 |
|
14521 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CRELD2 |
0.50157457780386 |
|
14522 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DENND6B |
0.50157457780386 |
|
14523 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HDAC10 |
0.50157457780386 |
|
14524 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IL17REL |
0.50157457780386 |
|
14525 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KLHDC7B |
0.50157457780386 |
|
14526 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LMF2 |
0.50157457780386 |
|
14527 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAPK11 |
0.50157457780386 |
|
14528 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAPK12 |
0.50157457780386 |
|
14529 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAPK8IP2 |
0.50157457780386 |
|
14530 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIOX |
0.50157457780386 |
|
14531 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3667 |
0.50157457780386 |
|
14532 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MLC1 |
0.50157457780386 |
|
14533 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MOV10L1 |
0.50157457780386 |
|
14534 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NCAPH2 |
0.50157457780386 |
|
14535 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ODF3B |
0.50157457780386 |
|
14536 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PANX2 |
0.50157457780386 |
|
14537 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PIM3 |
0.50157457780386 |
|
14538 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLXNB2 |
0.50157457780386 |
|
14539 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPP6R2 |
0.50157457780386 |
|
14540 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RABL2B |
0.50157457780386 |
|
14541 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP252 |
0.50157457780386 |
|
14542 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL500P |
0.50157457780386 |
|
14543 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SBF1 |
0.50157457780386 |
|
14544 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCO2 |
0.50157457780386 |
|
14545 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SHANK3 |
0.50157457780386 |
|
14546 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SYCE3 |
0.50157457780386 |
|
14547 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRABD |
0.50157457780386 |
|
14548 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TTLL8 |
0.50157457780386 |
|
14549 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TUBGCP6 |
0.50157457780386 |
|
14550 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TYMP |
0.50157457780386 |
|
14551 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZBED4 |
0.50157457780386 |
|
14552 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BICD1 |
0.501602049559214 |
|
14553 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AAMP |
0.501751483402606 |
|
14554 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPBAR1 |
0.501751483402606 |
|
14555 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PNKD |
0.501751483402606 |
|
14556 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMBIM1 |
0.501751483402606 |
|
14557 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238736.1 |
0.501751483402606 |
|
14558 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C2orf62 |
0.501751483402606 |
|
14559 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC11A1 |
0.501751483402606 |
|
14560 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR26A1 |
0.501990284996564 |
|
14561 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VILL |
0.501990284996564 |
|
14562 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLCD1 |
0.501990284996564 |
|
14563 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DLEC1 |
0.501990284996564 |
|
14564 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACAA1 |
0.501990284996564 |
|
14565 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MYD88 |
0.501990284996564 |
|
14566 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OXSR1 |
0.501990284996564 |
|
14567 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC22A13 |
0.501990284996564 |
|
14568 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC22A14 |
0.501990284996564 |
|
14569 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
XYLB |
0.501990284996564 |
|
14570 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACVR2B |
0.501990284996564 |
|
14571 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EXOG |
0.501990284996564 |
|
14572 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCN5A |
0.501990284996564 |
|
14573 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCN10A |
0.501990284996564 |
|
14574 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EXOC3L4 |
0.502250184170576 |
|
14575 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00677 |
0.502250184170576 |
|
14576 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TNFAIP2 |
0.502250184170576 |
|
14577 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
APOBEC3A |
0.502289506686065 |
|
14578 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
APOBEC3B |
0.502289506686065 |
|
14579 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
APOBEC3C |
0.502289506686065 |
|
14580 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
APOBEC3D |
0.502289506686065 |
|
14581 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
APOBEC3F |
0.502289506686065 |
|
14582 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
APOBEC3G |
0.502289506686065 |
|
14583 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
APOBEC3H |
0.502289506686065 |
|
14584 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CBX7 |
0.502289506686065 |
|
14585 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PDGFB |
0.502289506686065 |
|
14586 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPL3 |
0.502289506686065 |
|
14587 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD83B |
0.502289506686065 |
|
14588 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD83A |
0.502289506686065 |
|
14589 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD43|ENSG00000263764.1 |
0.502289506686065 |
|
14590 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SYNGR1 |
0.502289506686065 |
|
14591 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TAB1 |
0.502289506686065 |
|
14592 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MGAT3 |
0.502289506686065 |
|
14593 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SMCR7L |
0.502289506686065 |
|
14594 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATF4 |
0.502289506686065 |
|
14595 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPS19BP1 |
0.502289506686065 |
|
14596 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CACNA1I |
0.502289506686065 |
|
14597 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ENTHD1 |
0.502289506686065 |
|
14598 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP210 |
0.502289506686065 |
|
14599 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GRAP2 |
0.502289506686065 |
|
14600 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM83F |
0.502289506686065 |
|
14601 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C16orf90 |
0.502422268247585 |
|
14602 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLX4 |
0.502422268247585 |
|
14603 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DNASE1 |
0.502422268247585 |
|
14604 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRGC1 |
0.502438416815062 |
|
14605 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRGC2 |
0.502438416815062 |
|
14606 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRGJ1 |
0.502438416815062 |
|
14607 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRGJ2 |
0.502438416815062 |
|
14608 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRGJP1 |
0.502438416815062 |
|
14609 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRGJP2 |
0.502438416815062 |
|
14610 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRGJP |
0.502438416815062 |
|
14611 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRGV10 |
0.502438416815062 |
|
14612 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRGV11 |
0.502438416815062 |
|
14613 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRGV1 |
0.502438416815062 |
|
14614 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRGV2 |
0.502438416815062 |
|
14615 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRGV3 |
0.502438416815062 |
|
14616 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRGV4 |
0.502438416815062 |
|
14617 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRGV5 |
0.502438416815062 |
|
14618 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRGV8 |
0.502438416815062 |
|
14619 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRGV9 |
0.502438416815062 |
|
14620 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AMPH |
0.502438416815062 |
|
14621 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00605 |
0.502602016803289 |
|
14622 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EIF5 |
0.502602016803289 |
|
14623 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA28 |
0.502602016803289 |
|
14624 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MARK3 |
0.502602016803289 |
|
14625 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CKB |
0.502602016803289 |
|
14626 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRMT61A |
0.502602016803289 |
|
14627 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BAG5 |
0.502602016803289 |
|
14628 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
APOPT1 |
0.502602016803289 |
|
14629 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NKPD1 |
0.502603806664379 |
|
14630 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAPPC6A |
0.502603806664379 |
|
14631 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BLOC1S3 |
0.502603806664379 |
|
14632 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EXOC3L2 |
0.502603806664379 |
|
14633 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CASC8 |
0.502607987366596 |
|
14634 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL193P |
0.502947144235236 |
|
14635 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL35P |
0.503089252279105 |
|
14636 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MVB12B |
0.503181014962178 |
|
14637 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GTF2IRD1P1 |
0.503490031527043 |
|
14638 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM248 |
0.503490031527043 |
|
14639 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL43P |
0.503490031527043 |
|
14640 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SBDS |
0.503490031527043 |
|
14641 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NAA38 |
0.503567342123986 |
|
14642 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANKRD7 |
0.503567342123986 |
|
14643 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA25|ENSG00000202377.1 |
0.503576481061924 |
|
14644 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TFEC |
0.503576481061924 |
|
14645 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BMPR2 |
0.504515905236466 |
|
14646 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UGGT1 |
0.504586791307008 |
|
14647 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL206P |
0.504586791307008 |
|
14648 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA20|ENSG00000206947.1 |
0.504747491252993 |
|
14649 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GSTA4 |
0.504908016170425 |
|
14650 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SK |
0.504908016170425 |
|
14651 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GCM1 |
0.504908016170425 |
|
14652 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U3|ENSG00000251930.1 |
0.504908016170425 |
|
14653 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EPDR1 |
0.505130858318725 |
|
14654 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPR141 |
0.505130858318725 |
|
14655 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NME8 |
0.505130858318725 |
|
14656 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SFRP4 |
0.505130858318725 |
|
14657 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STARD3NL |
0.505130858318725 |
|
14658 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL65P |
0.505276087837789 |
|
14659 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00174 |
0.505577021537306 |
|
14660 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000252265.1 |
0.505577021537306 |
|
14661 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCTD7 |
0.505577021537306 |
|
14662 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RABGEF1 |
0.505577021537306 |
|
14663 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238841.1 |
0.505577021537306 |
|
14664 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TSPAN10 |
0.505642001046358 |
|
14665 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PDE6G |
0.505642001046358 |
|
14666 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OXLD1 |
0.505642001046358 |
|
14667 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC137 |
0.505642001046358 |
|
14668 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARL16 |
0.505642001046358 |
|
14669 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HGS |
0.505642001046358 |
|
14670 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MRPL12 |
0.505642001046358 |
|
14671 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC25A10 |
0.505642001046358 |
|
14672 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM195B |
0.505642001046358 |
|
14673 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GCGR |
0.505642001046358 |
|
14674 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
P4HB |
0.505642001046358 |
|
14675 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPP1R27 |
0.505642001046358 |
|
14676 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARHGDIA |
0.505642001046358 |
|
14677 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ALYREF |
0.505642001046358 |
|
14678 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANAPC11 |
0.505642001046358 |
|
14679 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NPB |
0.505642001046358 |
|
14680 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCYT2 |
0.505642001046358 |
|
14681 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SIRT7 |
0.505642001046358 |
|
14682 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAFG |
0.505642001046358 |
|
14683 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MYADML2 |
0.505642001046358 |
|
14684 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PYCR1 |
0.505642001046358 |
|
14685 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM198B |
0.505701206318529 |
|
14686 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM144 |
0.505701206318529 |
|
14687 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RXFP1 |
0.505701206318529 |
|
14688 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TNFRSF8 |
0.505843831229002 |
|
14689 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SMG1 |
0.505927674556317 |
|
14690 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IER5 |
0.506493461911004 |
|
14691 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DPY19L2 |
0.506605497805094 |
|
14692 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM5 |
0.506605497805094 |
|
14693 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C12orf66 |
0.506605497805094 |
|
14694 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPS11P6 |
0.506605497805094 |
|
14695 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C12orf56 |
0.506605497805094 |
|
14696 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238440.1 |
0.506605497805094 |
|
14697 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
XPOT |
0.506605497805094 |
|
14698 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TBK1 |
0.506605497805094 |
|
14699 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD83 |
0.506605497805094 |
|
14700 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RASSF3 |
0.506605497805094 |
|
14701 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR548C |
0.506605497805094 |
|
14702 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GNS |
0.506605497805094 |
|
14703 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238592.1 |
0.506605497805094 |
|
14704 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TBC1D30 |
0.506605497805094 |
|
14705 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNU6ATAC42P |
0.506605497805094 |
|
14706 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LEMD3 |
0.506605497805094 |
|
14707 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238383.1 |
0.50670812154285 |
|
14708 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HIST1H2BC |
0.506949373664068 |
|
14709 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HIST1H2AC |
0.506949373664068 |
|
14710 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HIST1H1E |
0.506949373664068 |
|
14711 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HIST1H2BD |
0.506949373664068 |
|
14712 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HIST1H2BE |
0.506949373664068 |
|
14713 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC13 |
0.507132552057595 |
|
14714 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HIGD1A |
0.507132552057595 |
|
14715 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C14orf79 |
0.507207582008101 |
|
14716 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLDN6 |
0.507277923311613 |
|
14717 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLDN9 |
0.507277923311613 |
|
14718 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC64B |
0.507277923311613 |
|
14719 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HCFC1R1 |
0.507277923311613 |
|
14720 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
THOC6 |
0.507277923311613 |
|
14721 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TNFRSF12A |
0.507277923311613 |
|
14722 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MMP25 |
0.507277923311613 |
|
14723 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IL32 |
0.507277923311613 |
|
14724 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZSCAN10 |
0.507277923311613 |
|
14725 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF205 |
0.507277923311613 |
|
14726 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF213 |
0.507277923311613 |
|
14727 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CASP16 |
0.507277923311613 |
|
14728 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR1F1 |
0.507277923311613 |
|
14729 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZMYM3 |
0.507334133737238 |
|
14730 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NONO |
0.507334133737238 |
|
14731 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLCL1 |
0.507642583899193 |
|
14732 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SIGLEC15 |
0.507658992953492 |
|
14733 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NLRP3 |
0.507769290163545 |
|
14734 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR2B11 |
0.507769290163545 |
|
14735 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR2W5 |
0.507769290163545 |
|
14736 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TPST1 |
0.508027269296774 |
|
14737 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DCSTAMP |
0.508041570744989 |
|
14738 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRKDC |
0.508172707523917 |
|
14739 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MCM4 |
0.508172707523917 |
|
14740 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MTHFD2L |
0.508495849734466 |
|
14741 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EPGN |
0.508495849734466 |
|
14742 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EREG |
0.508495849734466 |
|
14743 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCARNA23 |
0.508594766371026 |
|
14744 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CNOT10 |
0.508900535863426 |
|
14745 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PSMD4 |
0.508992728186323 |
|
14746 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00700 |
0.50915743580604 |
|
14747 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CD36 |
0.509188446506427 |
|
14748 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LMBRD1 |
0.509191075283105 |
|
14749 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EIF4A1 |
0.509248180290275 |
|
14750 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA67|ENSG00000264772.2 |
0.509248180290275 |
|
14751 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD10 |
0.509248180290275 |
|
14752 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CD68 |
0.509248180290275 |
|
14753 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FXR2 |
0.509248180290275 |
|
14754 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MPDU1 |
0.509248180290275 |
|
14755 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SOX15 |
0.509248180290275 |
|
14756 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PAN3 |
0.509337551466808 |
|
14757 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FLT1 |
0.509337551466808 |
|
14758 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
POMP |
0.509337551466808 |
|
14759 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MBD5 |
0.509518352195103 |
|
14760 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TTYH3 |
0.509894769657854 |
|
14761 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AMZ1 |
0.509894769657854 |
|
14762 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GNA12 |
0.509894769657854 |
|
14763 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CARD11 |
0.509894769657854 |
|
14764 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP130 |
0.509894769657854 |
|
14765 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GNAI1 |
0.509946775291693 |
|
14766 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL869P |
0.509946775291693 |
|
14767 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IL33 |
0.510082945706471 |
|
14768 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C9orf38 |
0.510082945706471 |
|
14769 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GLDC |
0.510082945706471 |
|
14770 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KDM4C |
0.510082945706471 |
|
14771 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL123P |
0.510082945706471 |
|
14772 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL25P |
0.510082945706471 |
|
14773 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TPD52L3 |
0.510082945706471 |
|
14774 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UHRF2 |
0.510082945706471 |
|
14775 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000252110.1 |
0.510082945706471 |
|
14776 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CIDEC |
0.510350408923607 |
|
14777 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NAV2 |
0.510441810153044 |
|
14778 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNRK |
0.510582913840194 |
|
14779 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL517P |
0.510582913840194 |
|
14780 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PKHD1L1 |
0.51111535543152 |
|
14781 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA72|ENSG00000252158.1 |
0.511212367569165 |
|
14782 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCBE1 |
0.511216761028391 |
|
14783 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PMAIP1 |
0.511216761028391 |
|
14784 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL342P |
0.511216761028391 |
|
14785 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CMSS1 |
0.511419315054961 |
|
14786 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FILIP1L |
0.511419315054961 |
|
14787 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NRG3 |
0.51142704140513 |
|
14788 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PDP1 |
0.5115786090662 |
|
14789 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR378D2 |
0.5115786090662 |
|
14790 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AKAP17A|ENSG00000197976.6 |
0.511597408639388 |
|
14791 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARSD |
0.511597408639388 |
|
14792 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARSE |
0.511597408639388 |
|
14793 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARSF |
0.511597408639388 |
|
14794 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARSH |
0.511597408639388 |
|
14795 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ASMTL|ENSG00000169093.10 |
0.511597408639388 |
|
14796 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ASMT|ENSG00000196433.6 |
0.511597408639388 |
|
14797 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CD99P1|ENSG00000223773.2 |
0.511597408639388 |
|
14798 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CD99|ENSG00000002586.13 |
0.511597408639388 |
|
14799 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CRLF2|ENSG00000205755.6 |
0.511597408639388 |
|
14800 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CSF2RA|ENSG00000198223.9 |
0.511597408639388 |
|
14801 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DHRSX|ENSG00000169084.8 |
0.511597408639388 |
|
14802 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GTPBP6|ENSG00000178605.8 |
0.511597408639388 |
|
14803 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GYG2 |
0.511597408639388 |
|
14804 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IL3RA|ENSG00000185291.6 |
0.511597408639388 |
|
14805 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00102|ENSG00000230542.1 |
0.511597408639388 |
|
14806 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00106|ENSG00000236871.2 |
0.511597408639388 |
|
14807 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00685|ENSG00000226179.1 |
0.511597408639388 |
|
14808 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3690|ENSG00000265658.1 |
0.511597408639388 |
|
14809 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
P2RY8|ENSG00000182162.5 |
0.511597408639388 |
|
14810 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLCXD1|ENSG00000182378.8 |
0.511597408639388 |
|
14811 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPP2R3B|ENSG00000167393.12 |
0.511597408639388 |
|
14812 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL355P|ENSG00000265350.1 |
0.511597408639388 |
|
14813 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL578P |
0.511597408639388 |
|
14814 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP498|ENSG00000223274.1 |
0.511597408639388 |
|
14815 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SHOX|ENSG00000185960.8 |
0.511597408639388 |
|
14816 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC25A6|ENSG00000169100.8 |
0.511597408639388 |
|
14817 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
XG |
0.511597408639388 |
|
14818 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZBED1|ENSG00000214717.4 |
0.511597408639388 |
|
14819 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000251848.1 |
0.511597408639388 |
|
14820 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CXorf28 |
0.511597408639388 |
|
14821 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MXRA5 |
0.511597408639388 |
|
14822 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA48|ENSG00000212214.1 |
0.511597408639388 |
|
14823 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRKX |
0.511597408639388 |
|
14824 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF850 |
0.511905303239953 |
|
14825 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MYL12A |
0.51204060823384 |
|
14826 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ABT1 |
0.512445067635616 |
|
14827 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF322 |
0.512445067635616 |
|
14828 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GUSBP2 |
0.512445067635616 |
|
14829 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ROCK2 |
0.512689360570467 |
|
14830 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00570 |
0.512689360570467 |
|
14831 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
E2F6 |
0.512689360570467 |
|
14832 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP84 |
0.512689360570467 |
|
14833 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GREB1 |
0.512689360570467 |
|
14834 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4429 |
0.512689360570467 |
|
14835 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP85 |
0.512689360570467 |
|
14836 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL674P |
0.512689360570467 |
|
14837 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACSBG1 |
0.512927258879477 |
|
14838 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DNAJA4 |
0.512927258879477 |
|
14839 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WDR61 |
0.512927258879477 |
|
14840 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CRABP1 |
0.512927258879477 |
|
14841 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF200 |
0.513098252456898 |
|
14842 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MEFV |
0.513098252456898 |
|
14843 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF263 |
0.513098252456898 |
|
14844 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TIGD7 |
0.513098252456898 |
|
14845 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF75A |
0.513098252456898 |
|
14846 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR2C1 |
0.513098252456898 |
|
14847 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MTRNR2L4 |
0.513098252456898 |
|
14848 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZSCAN32 |
0.513098252456898 |
|
14849 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF174 |
0.513098252456898 |
|
14850 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADCY9 |
0.513362862104722 |
|
14851 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLCO4C1 |
0.513559489359915 |
|
14852 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP68 |
0.513559489359915 |
|
14853 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLCO6A1 |
0.513559489359915 |
|
14854 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NUDT12 |
0.513559489359915 |
|
14855 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL255P |
0.513559489359915 |
|
14856 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF496 |
0.513704776561458 |
|
14857 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPR63 |
0.513951009111711 |
|
14858 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NDUFAF4 |
0.513951009111711 |
|
14859 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL509P |
0.513951009111711 |
|
14860 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM92A1 |
0.514354088465706 |
|
14861 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RBM12B |
0.514354088465706 |
|
14862 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM67 |
0.514354088465706 |
|
14863 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDH17 |
0.514354088465706 |
|
14864 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GEM |
0.514354088465706 |
|
14865 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FSBP |
0.514354088465706 |
|
14866 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAD54B |
0.514354088465706 |
|
14867 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIAA1429 |
0.514354088465706 |
|
14868 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C8orf37 |
0.514354088465706 |
|
14869 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PTPRF |
0.514378161120571 |
|
14870 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ASIC2 |
0.514511071943674 |
|
14871 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C17orf102 |
0.514511071943674 |
|
14872 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCL11 |
0.514511071943674 |
|
14873 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCL13 |
0.514511071943674 |
|
14874 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCL1 |
0.514511071943674 |
|
14875 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCL2 |
0.514511071943674 |
|
14876 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCL7 |
0.514511071943674 |
|
14877 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCL8 |
0.514511071943674 |
|
14878 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP438 |
0.514511071943674 |
|
14879 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LHFPL4 |
0.514523417371266 |
|
14880 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MTMR14 |
0.514523417371266 |
|
14881 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CPNE9 |
0.514523417371266 |
|
14882 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BRPF1 |
0.514523417371266 |
|
14883 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MYOM1 |
0.514650669557024 |
|
14884 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SKAP2 |
0.514756485005134 |
|
14885 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IQCH |
0.514842087195782 |
|
14886 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C15orf61 |
0.514842087195782 |
|
14887 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAP2K5 |
0.514842087195782 |
|
14888 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR221 |
0.5149767122601 |
|
14889 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR222 |
0.5149767122601 |
|
14890 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD77|ENSG00000212347.2 |
0.5149767122601 |
|
14891 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KRBOX4 |
0.5149767122601 |
|
14892 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCDHGA1 |
0.515092167860291 |
|
14893 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCDHGA2 |
0.515092167860291 |
|
14894 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCDHGA3 |
0.515092167860291 |
|
14895 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCDHGB1 |
0.515092167860291 |
|
14896 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCDHGA4 |
0.515092167860291 |
|
14897 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCDHGB2 |
0.515092167860291 |
|
14898 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCDHGA5 |
0.515092167860291 |
|
14899 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCDHGB3 |
0.515092167860291 |
|
14900 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCDHGA6 |
0.515092167860291 |
|
14901 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCDHGA7 |
0.515092167860291 |
|
14902 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCDHGB4 |
0.515092167860291 |
|
14903 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCDHGA8 |
0.515092167860291 |
|
14904 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCDHGA9 |
0.515092167860291 |
|
14905 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCDHGA10 |
0.515092167860291 |
|
14906 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCDHGA11 |
0.515092167860291 |
|
14907 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCDHGB6 |
0.515092167860291 |
|
14908 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCDHGB7 |
0.515092167860291 |
|
14909 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCDHGA12 |
0.515092167860291 |
|
14910 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCDHGC3 |
0.515092167860291 |
|
14911 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL68P |
0.515092167860291 |
|
14912 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCDHGC4 |
0.515092167860291 |
|
14913 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCDHGC5 |
0.515092167860291 |
|
14914 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAN1A2 |
0.515438203766776 |
|
14915 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MTRF1 |
0.515614758262168 |
|
14916 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NAA16 |
0.515614758262168 |
|
14917 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DGKH |
0.515614758262168 |
|
14918 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BCAT2 |
0.515618676044768 |
|
14919 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HSD17B14 |
0.515618676044768 |
|
14920 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLEKHA4 |
0.515618676044768 |
|
14921 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPP1R15A |
0.515618676044768 |
|
14922 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TULP2 |
0.515618676044768 |
|
14923 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NUCB1 |
0.515618676044768 |
|
14924 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DMD |
0.515638567172848 |
|
14925 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPRASP2 |
0.515886320841711 |
|
14926 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BHLHB9 |
0.515886320841711 |
|
14927 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA40|ENSG00000212266.1 |
0.516227084889285 |
|
14928 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GDAP2 |
0.516227084889285 |
|
14929 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PSMD8 |
0.516295571943435 |
|
14930 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GGN |
0.516295571943435 |
|
14931 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPRED3 |
0.516295571943435 |
|
14932 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM98C |
0.516295571943435 |
|
14933 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RASGRP4 |
0.516295571943435 |
|
14934 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RYR1 |
0.516295571943435 |
|
14935 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAP4K1 |
0.516295571943435 |
|
14936 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EIF3K |
0.516295571943435 |
|
14937 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACTN4 |
0.516295571943435 |
|
14938 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CAPN12 |
0.516295571943435 |
|
14939 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LGALS7 |
0.516295571943435 |
|
14940 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PACRG |
0.516329816681473 |
|
14941 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC122 |
0.516397980499117 |
|
14942 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LACC1 |
0.516397980499117 |
|
14943 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SETD3 |
0.516648362922228 |
|
14944 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CXCL6 |
0.516688209299803 |
|
14945 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PF4V1 |
0.516688209299803 |
|
14946 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CXCL1 |
0.516688209299803 |
|
14947 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PF4 |
0.516688209299803 |
|
14948 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPBP |
0.516688209299803 |
|
14949 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CXCL5 |
0.516688209299803 |
|
14950 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL218P |
0.516688209299803 |
|
14951 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CXCL3 |
0.516688209299803 |
|
14952 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPBPP2 |
0.516688209299803 |
|
14953 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CXCL2 |
0.516688209299803 |
|
14954 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL774P |
0.516918442256134 |
|
14955 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4796 |
0.517105458254862 |
|
14956 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HAPLN1 |
0.517447827478175 |
|
14957 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP295 |
0.517447827478175 |
|
14958 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLCXD3 |
0.517542229444857 |
|
14959 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP203 |
0.517568122083571 |
|
14960 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP164 |
0.517568122083571 |
|
14961 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP98 |
0.517568122083571 |
|
14962 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PYROXD2 |
0.517580273576704 |
|
14963 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR1287 |
0.517580273576704 |
|
14964 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HPS1 |
0.517580273576704 |
|
14965 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4685 |
0.517580273576704 |
|
14966 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GFRA1 |
0.517600326774686 |
|
14967 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNU4ATAC9P |
0.517633620933873 |
|
14968 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNU6ATAC5P |
0.517633620933873 |
|
14969 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GTF3C3 |
0.518401569621238 |
|
14970 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C2orf66 |
0.518401569621238 |
|
14971 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PGAP1 |
0.518401569621238 |
|
14972 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANKRD44 |
0.518401569621238 |
|
14973 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ERCC6L |
0.518987674728141 |
|
14974 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL264P |
0.518987674728141 |
|
14975 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CAMKK1 |
0.518988870190386 |
|
14976 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
P2RX1 |
0.518988870190386 |
|
14977 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATP2A3 |
0.518988870190386 |
|
14978 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZZEF1 |
0.518988870190386 |
|
14979 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP434 |
0.518988870190386 |
|
14980 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238807.1 |
0.518988870190386 |
|
14981 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CYB5D2 |
0.518988870190386 |
|
14982 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANKFY1 |
0.518988870190386 |
|
14983 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UBE2G1 |
0.518988870190386 |
|
14984 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA32|ENSG00000206776.1 |
0.519105016841455 |
|
14985 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NOV |
0.519105016841455 |
|
14986 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ENPP2 |
0.519105016841455 |
|
14987 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZIC4 |
0.519144714165049 |
|
14988 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZIC1 |
0.519144714165049 |
|
14989 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
R3HCC1L |
0.519196463618435 |
|
14990 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LOXL4 |
0.519196463618435 |
|
14991 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SGCD |
0.519534246139099 |
|
14992 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PARM1 |
0.519537936100245 |
|
14993 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C15orf27 |
0.519550669110595 |
|
14994 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NRON |
0.519703639964624 |
|
14995 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD116|ENSG00000252985.1 |
0.519703639964624 |
|
14996 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BCL2L14 |
0.519735398217505 |
|
14997 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CHUK |
0.520017145436151 |
|
14998 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PDE7A |
0.520090708853785 |
|
14999 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAB6C |
0.520116272276405 |
|
15000 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP77 |
0.520159729684209 |
|
15001 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP292 |
0.520159729684209 |
|
15002 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF462 |
0.520159729684209 |
|
15003 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNF170 |
0.52026190997031 |
|
15004 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL806P |
0.52026190997031 |
|
15005 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4469 |
0.52026190997031 |
|
15006 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCG5 |
0.520339076351859 |
|
15007 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GREM1 |
0.520339076351859 |
|
15008 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FMN1 |
0.520339076351859 |
|
15009 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238342.1 |
0.520339076351859 |
|
15010 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD77|ENSG00000212415.1 |
0.520339076351859 |
|
15011 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AVEN |
0.520339076351859 |
|
15012 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CHRM5 |
0.520339076351859 |
|
15013 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EMC7 |
0.520339076351859 |
|
15014 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PGBD4 |
0.520339076351859 |
|
15015 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KATNBL1 |
0.520339076351859 |
|
15016 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EMC4 |
0.520339076351859 |
|
15017 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC12A6 |
0.520339076351859 |
|
15018 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NOP10 |
0.520339076351859 |
|
15019 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NUTM1 |
0.520339076351859 |
|
15020 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LPCAT4 |
0.520339076351859 |
|
15021 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GOLGA8A |
0.520339076351859 |
|
15022 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GOLGA8B |
0.520339076351859 |
|
15023 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA18|ENSG00000252425.1 |
0.520339076351859 |
|
15024 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GJD2 |
0.520339076351859 |
|
15025 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACTC1 |
0.520339076351859 |
|
15026 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMCO5B |
0.520419057051551 |
|
15027 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RYR3 |
0.520419057051551 |
|
15028 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STOML3 |
0.520478718355732 |
|
15029 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PROSER1 |
0.520478718355732 |
|
15030 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NHLRC3 |
0.520478718355732 |
|
15031 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNF217 |
0.520676124201046 |
|
15032 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SMIM2 |
0.520757751010621 |
|
15033 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SERP2 |
0.520757751010621 |
|
15034 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TSC22D1 |
0.520757751010621 |
|
15035 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238932.1 |
0.520757751010621 |
|
15036 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL751P |
0.520777052497311 |
|
15037 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EPHA4 |
0.520844242196824 |
|
15038 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP153 |
0.520953089645767 |
|
15039 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TAF2 |
0.520953089645767 |
|
15040 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CBLN2 |
0.521046831704017 |
|
15041 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR548AV |
0.521046831704017 |
|
15042 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NETO1 |
0.521046831704017 |
|
15043 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP460 |
0.521046831704017 |
|
15044 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL401P |
0.521046831704017 |
|
15045 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FBXO15 |
0.521046831704017 |
|
15046 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TIMM21 |
0.521046831704017 |
|
15047 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL551P |
0.521046831704017 |
|
15048 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CYB5A |
0.521046831704017 |
|
15049 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C18orf63 |
0.521046831704017 |
|
15050 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM69C |
0.521046831704017 |
|
15051 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DPP6 |
0.521065148932401 |
|
15052 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRRC3C |
0.521104828779945 |
|
15053 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GSDMA |
0.521104828779945 |
|
15054 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PSMD3 |
0.521104828779945 |
|
15055 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SERPINB11 |
0.521192020299215 |
|
15056 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
THRA |
0.521224829105693 |
|
15057 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NR1D1 |
0.521224829105693 |
|
15058 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ASAP2 |
0.521275869779007 |
|
15059 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ITGB1BP1 |
0.521275869779007 |
|
15060 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CPSF3 |
0.521275869779007 |
|
15061 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR378D1 |
0.521750950152167 |
|
15062 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C4orf50 |
0.521750950152167 |
|
15063 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
JAKMIP1 |
0.521750950152167 |
|
15064 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WFS1 |
0.521750950152167 |
|
15065 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HOOK3 |
0.521922938179641 |
|
15066 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPR139 |
0.521987829034772 |
|
15067 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AATK |
0.522168715377841 |
|
15068 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AZI1 |
0.522168715377841 |
|
15069 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ENTHD2 |
0.522168715377841 |
|
15070 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C17orf89 |
0.522168715377841 |
|
15071 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC38A10 |
0.522168715377841 |
|
15072 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00482 |
0.522168715377841 |
|
15073 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM105 |
0.522168715377841 |
|
15074 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4740 |
0.522168715377841 |
|
15075 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3186 |
0.522168715377841 |
|
15076 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VAX1 |
0.522454842899908 |
|
15077 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ERAP1 |
0.522550806413477 |
|
15078 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDH7 |
0.522637297954317 |
|
15079 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DEFB131 |
0.522861824135008 |
|
15080 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM90A26 |
0.522861824135008 |
|
15081 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HMX1 |
0.522861824135008 |
|
15082 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR548I2 |
0.522861824135008 |
|
15083 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP153 |
0.522861824135008 |
|
15084 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
USP17L10 |
0.522861824135008 |
|
15085 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
USP17L11 |
0.522861824135008 |
|
15086 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
USP17L12 |
0.522861824135008 |
|
15087 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
USP17L13 |
0.522861824135008 |
|
15088 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
USP17L15 |
0.522861824135008 |
|
15089 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
USP17L17 |
0.522861824135008 |
|
15090 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
USP17L18 |
0.522861824135008 |
|
15091 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
USP17L19 |
0.522861824135008 |
|
15092 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
USP17L20 |
0.522861824135008 |
|
15093 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
USP17L21 |
0.522861824135008 |
|
15094 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
USP17L22 |
0.522861824135008 |
|
15095 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
USP17L23 |
0.522861824135008 |
|
15096 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
USP17L24 |
0.522861824135008 |
|
15097 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
USP17L25 |
0.522861824135008 |
|
15098 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
USP17L26 |
0.522861824135008 |
|
15099 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
USP17L27 |
0.522861824135008 |
|
15100 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
USP17L28 |
0.522861824135008 |
|
15101 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
USP17L29 |
0.522861824135008 |
|
15102 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
USP17L30 |
0.522861824135008 |
|
15103 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
USP17L5 |
0.522861824135008 |
|
15104 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC2A9 |
0.522861824135008 |
|
15105 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DRD5 |
0.522861824135008 |
|
15106 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP154 |
0.522861824135008 |
|
15107 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WDR1 |
0.522861824135008 |
|
15108 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3138 |
0.522861824135008 |
|
15109 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LYPLAL1 |
0.523015907874816 |
|
15110 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BAI3 |
0.523142029796235 |
|
15111 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TBC1D21 |
0.523259834013454 |
|
15112 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LPHN3 |
0.523280924022724 |
|
15113 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BTC |
0.52335623562262 |
|
15114 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KLHL31 |
0.523479486512484 |
|
15115 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP192 |
0.523666172287058 |
|
15116 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR10V1 |
0.523666172287058 |
|
15117 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RIMS2 |
0.523811650838915 |
|
15118 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDC14B |
0.524882881731677 |
|
15119 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AAED1 |
0.524882881731677 |
|
15120 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF510 |
0.524882881731677 |
|
15121 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF782 |
0.524882881731677 |
|
15122 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HIATL2 |
0.524882881731677 |
|
15123 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NUTM2G |
0.524882881731677 |
|
15124 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CTSV |
0.524882881731677 |
|
15125 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPTOR |
0.52499066741741 |
|
15126 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GDAP1 |
0.525051849397857 |
|
15127 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KLHL32 |
0.525398459543891 |
|
15128 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MMS22L |
0.525398459543891 |
|
15129 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PATL1 |
0.525448493822039 |
|
15130 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL236P |
0.525469146203555 |
|
15131 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PGS1 |
0.525469146203555 |
|
15132 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA30|ENSG00000200063.1 |
0.525469146203555 |
|
15133 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL454P |
0.525469146203555 |
|
15134 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SKIL |
0.526234630416632 |
|
15135 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC7A14 |
0.526234630416632 |
|
15136 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR5B21 |
0.526270358646424 |
|
15137 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LPXN |
0.526270358646424 |
|
15138 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZFP91 |
0.526270358646424 |
|
15139 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CNTF |
0.526270358646424 |
|
15140 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GLYAT |
0.526270358646424 |
|
15141 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GLYATL1 |
0.526270358646424 |
|
15142 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP294 |
0.526361025677115 |
|
15143 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANO3 |
0.526484787484846 |
|
15144 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MUC15 |
0.526484787484846 |
|
15145 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZMYND15 |
0.526524096076908 |
|
15146 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NUPL2 |
0.526527876583522 |
|
15147 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPNMB |
0.526527876583522 |
|
15148 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MALSU1 |
0.526527876583522 |
|
15149 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IGF2BP3 |
0.526527876583522 |
|
15150 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD65|ENSG00000212264.1 |
0.526527876583522 |
|
15151 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MTUS2 |
0.526545684961436 |
|
15152 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CSF3 |
0.526872190862252 |
|
15153 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MED24 |
0.526872190862252 |
|
15154 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD124 |
0.526872190862252 |
|
15155 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CYP8B1 |
0.52693464614571 |
|
15156 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
B3GALNT1 |
0.527048193572258 |
|
15157 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DLL1 |
0.527348808228059 |
|
15158 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM120B |
0.527348808228059 |
|
15159 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4644 |
0.527348808228059 |
|
15160 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PSMB1 |
0.527348808228059 |
|
15161 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TBP |
0.527348808228059 |
|
15162 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PDCD2 |
0.527348808228059 |
|
15163 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
POLA1 |
0.52749748870243 |
|
15164 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARX |
0.52749748870243 |
|
15165 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL91P |
0.52749748870243 |
|
15166 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLAC1L |
0.527562553653071 |
|
15167 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MS4A3 |
0.527562553653071 |
|
15168 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MS4A2 |
0.527562553653071 |
|
15169 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MS4A6A |
0.527562553653071 |
|
15170 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MS4A4E |
0.527562553653071 |
|
15171 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MS4A5 |
0.527562553653071 |
|
15172 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MS4A1 |
0.527562553653071 |
|
15173 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MS4A12 |
0.527562553653071 |
|
15174 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MS4A13 |
0.527562553653071 |
|
15175 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARHGAP19 |
0.527743735608738 |
|
15176 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KRT16 |
0.528081668068998 |
|
15177 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CYSLTR2 |
0.528146175535672 |
|
15178 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TIMP2 |
0.528253435460054 |
|
15179 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DDC8 |
0.528253435460054 |
|
15180 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LGALS3BP |
0.528253435460054 |
|
15181 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CANT1 |
0.528253435460054 |
|
15182 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C1QTNF1 |
0.528253435460054 |
|
15183 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ENGASE |
0.528253435460054 |
|
15184 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RBFOX3 |
0.528253435460054 |
|
15185 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4447 |
0.528379481344627 |
|
15186 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000239034.1 |
0.528383717234416 |
|
15187 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TLR3 |
0.528383717234416 |
|
15188 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM149A |
0.528383717234416 |
|
15189 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA31|ENSG00000253013.1 |
0.528383717234416 |
|
15190 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CYP4V2 |
0.528383717234416 |
|
15191 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KLKB1 |
0.528383717234416 |
|
15192 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADAMTSL1 |
0.52841143570869 |
|
15193 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3152 |
0.52841143570869 |
|
15194 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP258 |
0.52841143570869 |
|
15195 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM154A |
0.52841143570869 |
|
15196 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RRAGA |
0.52841143570869 |
|
15197 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HAUS6 |
0.52841143570869 |
|
15198 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCARNA8 |
0.52841143570869 |
|
15199 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL158P |
0.52841143570869 |
|
15200 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLIN2 |
0.52841143570869 |
|
15201 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238348.1 |
0.52841143570869 |
|
15202 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC24A2 |
0.52841143570869 |
|
15203 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UBE2W |
0.528411723951274 |
|
15204 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TCEB1 |
0.528411723951274 |
|
15205 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM70 |
0.528411723951274 |
|
15206 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LY96 |
0.528411723951274 |
|
15207 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VDAC2 |
0.528698170911853 |
|
15208 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COMTD1 |
0.528698170911853 |
|
15209 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238687.1 |
0.528784273438282 |
|
15210 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GAN |
0.52881848292886 |
|
15211 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4720 |
0.52881848292886 |
|
15212 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLEKHA1 |
0.529200659097422 |
|
15213 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARMS2 |
0.529200659097422 |
|
15214 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HTRA1 |
0.529200659097422 |
|
15215 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DMBT1 |
0.529200659097422 |
|
15216 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GRB2 |
0.529516404641522 |
|
15217 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3678 |
0.529516404641522 |
|
15218 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PAPOLB |
0.529603237188534 |
|
15219 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MMD2 |
0.529603237188534 |
|
15220 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RBAK |
0.529603237188534 |
|
15221 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNF216P1 |
0.529603237188534 |
|
15222 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAP1 |
0.529978212185068 |
|
15223 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLUAP1 |
0.530008748770194 |
|
15224 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NLRC3 |
0.530008748770194 |
|
15225 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAAH2 |
0.530257478225645 |
|
15226 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZXDB |
0.530257478225645 |
|
15227 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GXYLT2 |
0.530627082608701 |
|
15228 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPP4R2 |
0.530627082608701 |
|
15229 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EBLN2 |
0.530627082608701 |
|
15230 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238416.1 |
0.530627082608701 |
|
15231 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00583 |
0.530696503129506 |
|
15232 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00514 |
0.530892769296327 |
|
15233 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAB40B |
0.530901538454097 |
|
15234 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4525 |
0.530901538454097 |
|
15235 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FN3KRP |
0.530901538454097 |
|
15236 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CASC7 |
0.530991470384442 |
|
15237 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CHRAC1 |
0.530991470384442 |
|
15238 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATP10A |
0.531064518284261 |
|
15239 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00864 |
0.531125884570673 |
|
15240 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL749P |
0.531134613849303 |
|
15241 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RGS10 |
0.531134613849303 |
|
15242 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TIAL1 |
0.531134613849303 |
|
15243 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BAG3 |
0.531134613849303 |
|
15244 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
INPP5F |
0.531134613849303 |
|
15245 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL846P |
0.531134613849303 |
|
15246 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MCMBP |
0.531134613849303 |
|
15247 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SEC23IP |
0.531134613849303 |
|
15248 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC172 |
0.531211428401628 |
|
15249 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CRTAC1 |
0.531301463458257 |
|
15250 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SERPINB5 |
0.531517631657297 |
|
15251 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SERPINB12 |
0.531517631657297 |
|
15252 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SERPINB13 |
0.531517631657297 |
|
15253 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SERPINB4 |
0.531517631657297 |
|
15254 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SERPINB3 |
0.531517631657297 |
|
15255 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP155 |
0.531848782626255 |
|
15256 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR1250 |
0.531874744639884 |
|
15257 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR338 |
0.531874744639884 |
|
15258 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR657 |
0.531874744639884 |
|
15259 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACTG1 |
0.531874744639884 |
|
15260 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OGG1 |
0.531915091276367 |
|
15261 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CAMK1 |
0.531915091276367 |
|
15262 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TADA3 |
0.531915091276367 |
|
15263 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARPC4 |
0.531915091276367 |
|
15264 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TTLL3 |
0.531915091276367 |
|
15265 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPUSD3 |
0.531915091276367 |
|
15266 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA70|ENSG00000251893.2 |
0.532135017909853 |
|
15267 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL734P |
0.532135017909853 |
|
15268 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PHLDA1 |
0.532135017909853 |
|
15269 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NAP1L1 |
0.532135017909853 |
|
15270 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP172 |
0.532135017909853 |
|
15271 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BBS10 |
0.532135017909853 |
|
15272 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RESP18 |
0.532164976320466 |
|
15273 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GUCY1B2 |
0.532169741431931 |
|
15274 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MEX3B |
0.532172524710601 |
|
15275 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EFTUD1 |
0.532172524710601 |
|
15276 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM154B |
0.532172524710601 |
|
15277 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CSPG4P8 |
0.532172524710601 |
|
15278 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GOLGA6L10|ENSG00000205281.6 |
0.532172524710601 |
|
15279 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GOLGA6L10|ENSG00000254374.2 |
0.532172524710601 |
|
15280 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GOLGA6L9|ENSG00000196648.6 |
0.532172524710601 |
|
15281 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GOLGA6L9|ENSG00000197978.8 |
0.532172524710601 |
|
15282 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL256P |
0.532172524710601 |
|
15283 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL410P |
0.532172524710601 |
|
15284 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL61P |
0.532172524710601 |
|
15285 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPS17 |
0.532172524710601 |
|
15286 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UBE2Q2P2 |
0.532172524710601 |
|
15287 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UBE2Q2P3 |
0.532172524710601 |
|
15288 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPS17L |
0.532172524710601 |
|
15289 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF317 |
0.53223084955429 |
|
15290 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PIN4 |
0.532321676049619 |
|
15291 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPS4X |
0.532321676049619 |
|
15292 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CITED1 |
0.532321676049619 |
|
15293 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HDAC8 |
0.532321676049619 |
|
15294 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HS6ST1 |
0.532469404990737 |
|
15295 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HKR1 |
0.532493644339295 |
|
15296 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NEURL3 |
0.533004639039849 |
|
15297 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARID5A |
0.533004639039849 |
|
15298 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KANSL3 |
0.533004639039849 |
|
15299 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FER1L5 |
0.533004639039849 |
|
15300 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LMAN2L |
0.533004639039849 |
|
15301 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OOSP1 |
0.533046191859361 |
|
15302 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SERPINB7 |
0.533197494922034 |
|
15303 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SERPINB2 |
0.533197494922034 |
|
15304 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SERPINB10 |
0.533197494922034 |
|
15305 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HMSD |
0.533197494922034 |
|
15306 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SERPINB8 |
0.533197494922034 |
|
15307 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00305 |
0.533197494922034 |
|
15308 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GALNT2 |
0.533315332543208 |
|
15309 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCTD14 |
0.533485320384399 |
|
15310 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
THRSP |
0.533485320384399 |
|
15311 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NDUFC2 |
0.533485320384399 |
|
15312 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ALG8 |
0.533485320384399 |
|
15313 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL351P |
0.533498953413555 |
|
15314 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SRPR |
0.533498953413555 |
|
15315 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FOXRED1 |
0.533498953413555 |
|
15316 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TIRAP |
0.533498953413555 |
|
15317 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238855.1 |
0.533498953413555 |
|
15318 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DCPS |
0.533498953413555 |
|
15319 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF501 |
0.53367288690654 |
|
15320 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIAA1143 |
0.53367288690654 |
|
15321 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNF213 |
0.533747201778318 |
|
15322 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ENDOV |
0.533747201778318 |
|
15323 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4730 |
0.533747201778318 |
|
15324 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NPTX1 |
0.533747201778318 |
|
15325 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC180 |
0.534125950557252 |
|
15326 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TDRD7 |
0.534125950557252 |
|
15327 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMOD1 |
0.534125950557252 |
|
15328 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00535 |
0.53420698169625 |
|
15329 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DPY19L4 |
0.53420698169625 |
|
15330 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
INTS8 |
0.53420698169625 |
|
15331 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCNE2 |
0.53420698169625 |
|
15332 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238791.1 |
0.53420698169625 |
|
15333 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TP53INP1 |
0.53420698169625 |
|
15334 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PMCHL1 |
0.534232688387154 |
|
15335 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL572P |
0.534232688387154 |
|
15336 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP228 |
0.53432718657693 |
|
15337 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000239098.1 |
0.53432718657693 |
|
15338 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NPY |
0.53432718657693 |
|
15339 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MPP6 |
0.53432718657693 |
|
15340 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DFNA5 |
0.53432718657693 |
|
15341 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CYCS |
0.53432718657693 |
|
15342 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C7orf31 |
0.53432718657693 |
|
15343 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NPVF |
0.53432718657693 |
|
15344 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U3|ENSG00000202233.1 |
0.53432718657693 |
|
15345 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IFNK |
0.534880414480726 |
|
15346 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C9orf72 |
0.534880414480726 |
|
15347 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CENPVP1 |
0.534940689134205 |
|
15348 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GSPT2 |
0.534940689134205 |
|
15349 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAGED1 |
0.534940689134205 |
|
15350 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00964 |
0.535194286874499 |
|
15351 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF572 |
0.535194286874499 |
|
15352 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SQLE |
0.535194286874499 |
|
15353 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TSKS |
0.535268607848055 |
|
15354 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PTOV1 |
0.535268607848055 |
|
15355 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4749 |
0.535268607848055 |
|
15356 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PNKP |
0.535268607848055 |
|
15357 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPRC5B |
0.535377427201906 |
|
15358 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GRHL1 |
0.535745809907431 |
|
15359 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KLF11 |
0.535745809907431 |
|
15360 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CYS1 |
0.535745809907431 |
|
15361 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA26|ENSG00000212558.1 |
0.535745809907431 |
|
15362 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CHAC2 |
0.536164044447718 |
|
15363 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ERLEC1 |
0.536164044447718 |
|
15364 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238756.1 |
0.536164044447718 |
|
15365 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3682 |
0.536164044447718 |
|
15366 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CNOT6 |
0.53620712517843 |
|
15367 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPIDR |
0.536496915517334 |
|
15368 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CEBPD |
0.536496915517334 |
|
15369 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UBE2V2 |
0.536496915517334 |
|
15370 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MPPED2 |
0.536824694992614 |
|
15371 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PDE1C |
0.536956943517599 |
|
15372 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DNAH17 |
0.537155098378109 |
|
15373 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CYTH1 |
0.537155098378109 |
|
15374 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
USP36 |
0.537155098378109 |
|
15375 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ERAP2 |
0.537254993268829 |
|
15376 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SHROOM4 |
0.537257615239428 |
|
15377 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AXIN2 |
0.537338274153664 |
|
15378 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238733.1 |
0.537361955023451 |
|
15379 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF28 |
0.537396541354079 |
|
15380 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF320 |
0.537396541354079 |
|
15381 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF321P |
0.537396541354079 |
|
15382 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF468 |
0.537396541354079 |
|
15383 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF600 |
0.537396541354079 |
|
15384 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF611 |
0.537396541354079 |
|
15385 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF702P |
0.537396541354079 |
|
15386 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF816 |
0.537396541354079 |
|
15387 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF888 |
0.537396541354079 |
|
15388 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF160 |
0.537396541354079 |
|
15389 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF347 |
0.537396541354079 |
|
15390 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF415 |
0.537396541354079 |
|
15391 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KREMEN2 |
0.537519151099822 |
|
15392 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PAQR4 |
0.537519151099822 |
|
15393 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PKMYT1 |
0.537519151099822 |
|
15394 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GCFC2 |
0.537565502408629 |
|
15395 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MRPL19 |
0.537565502408629 |
|
15396 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U3|ENSG00000221638.1 |
0.537565502408629 |
|
15397 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000239018.1 |
0.537565502408629 |
|
15398 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANO10 |
0.537795848299748 |
|
15399 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ABHD5 |
0.537795848299748 |
|
15400 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF330 |
0.537843830745023 |
|
15401 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238695.1 |
0.537843830745023 |
|
15402 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM193A |
0.537913234839891 |
|
15403 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TNIP2 |
0.537913234839891 |
|
15404 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HTT |
0.538348585864485 |
|
15405 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MSANTD1 |
0.538348585864485 |
|
15406 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP92 |
0.538496475651567 |
|
15407 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BEGAIN |
0.538496475651567 |
|
15408 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00523 |
0.538496475651567 |
|
15409 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DLK1 |
0.538496475651567 |
|
15410 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MEG3 |
0.538496475651567 |
|
15411 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR2392 |
0.538496475651567 |
|
15412 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR770 |
0.538496475651567 |
|
15413 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR493 |
0.538496475651567 |
|
15414 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR337 |
0.538496475651567 |
|
15415 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR431 |
0.538496475651567 |
|
15416 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR433 |
0.538496475651567 |
|
15417 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR665 |
0.538496475651567 |
|
15418 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RTL1 |
0.538496475651567 |
|
15419 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR127 |
0.538496475651567 |
|
15420 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR136 |
0.538496475651567 |
|
15421 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR432 |
0.538496475651567 |
|
15422 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MEG8 |
0.538496475651567 |
|
15423 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR370 |
0.538496475651567 |
|
15424 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD112|ENSG00000251769.1 |
0.538496475651567 |
|
15425 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD112|ENSG00000252873.1 |
0.538496475651567 |
|
15426 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD112|ENSG00000251949.1 |
0.538496475651567 |
|
15427 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD112|ENSG00000252144.1 |
0.538496475651567 |
|
15428 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD112|ENSG00000251918.1 |
0.538496475651567 |
|
15429 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD113|ENSG00000200150.1 |
0.538496475651567 |
|
15430 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD113|ENSG00000201036.1 |
0.538496475651567 |
|
15431 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD113|ENSG00000201500.1 |
0.538496475651567 |
|
15432 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD113|ENSG00000201710.1 |
0.538496475651567 |
|
15433 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD113|ENSG00000222095.1 |
0.538496475651567 |
|
15434 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD112|ENSG00000252009.1 |
0.538496475651567 |
|
15435 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD113|ENSG00000222185.1 |
0.538496475651567 |
|
15436 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR379 |
0.538496475651567 |
|
15437 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR411 |
0.538496475651567 |
|
15438 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR299 |
0.538496475651567 |
|
15439 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR380 |
0.538496475651567 |
|
15440 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR1197 |
0.538496475651567 |
|
15441 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR323A |
0.538496475651567 |
|
15442 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR758 |
0.538496475651567 |
|
15443 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR1193 |
0.538496475651567 |
|
15444 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR494 |
0.538496475651567 |
|
15445 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR495 |
0.538496475651567 |
|
15446 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR543 |
0.538496475651567 |
|
15447 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR300 |
0.538496475651567 |
|
15448 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR376A1 |
0.538496475651567 |
|
15449 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR376C |
0.538496475651567 |
|
15450 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR654 |
0.538496475651567 |
|
15451 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR381HG |
0.538496475651567 |
|
15452 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR381 |
0.538496475651567 |
|
15453 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR487B |
0.538496475651567 |
|
15454 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR539 |
0.538496475651567 |
|
15455 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR889 |
0.538496475651567 |
|
15456 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR544A |
0.538496475651567 |
|
15457 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR655 |
0.538496475651567 |
|
15458 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR487A |
0.538496475651567 |
|
15459 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR134 |
0.538496475651567 |
|
15460 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR382 |
0.538496475651567 |
|
15461 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR485 |
0.538496475651567 |
|
15462 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR323B |
0.538496475651567 |
|
15463 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR154 |
0.538496475651567 |
|
15464 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR377 |
0.538496475651567 |
|
15465 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR496 |
0.538496475651567 |
|
15466 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR369 |
0.538496475651567 |
|
15467 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR409 |
0.538496475651567 |
|
15468 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR410 |
0.538496475651567 |
|
15469 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR412 |
0.538496475651567 |
|
15470 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR541 |
0.538496475651567 |
|
15471 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR656 |
0.538496475651567 |
|
15472 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MEG9 |
0.538496475651567 |
|
15473 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U3|ENSG00000206761.1 |
0.538496475651567 |
|
15474 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00524 |
0.538496475651567 |
|
15475 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DIO3OS |
0.538496475651567 |
|
15476 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DIO3 |
0.538496475651567 |
|
15477 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TNFRSF11A |
0.539012831401265 |
|
15478 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP500 |
0.539051614625209 |
|
15479 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KRT38 |
0.539146225011699 |
|
15480 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KRT32 |
0.539146225011699 |
|
15481 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KRT35 |
0.539146225011699 |
|
15482 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KRT36 |
0.539146225011699 |
|
15483 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KRT13 |
0.539146225011699 |
|
15484 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KRT15 |
0.539146225011699 |
|
15485 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KRT19 |
0.539146225011699 |
|
15486 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00974 |
0.539146225011699 |
|
15487 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KRT9 |
0.539146225011699 |
|
15488 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KRT14 |
0.539146225011699 |
|
15489 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL599P |
0.539475533892173 |
|
15490 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ASB3 |
0.539558153918226 |
|
15491 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPR75 |
0.539558153918226 |
|
15492 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PSME4 |
0.539558153918226 |
|
15493 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SULT1A2 |
0.539937872471734 |
|
15494 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARMC1 |
0.539988102901836 |
|
15495 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC15A3 |
0.540117602016595 |
|
15496 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00445 |
0.540169477051279 |
|
15497 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRDM14 |
0.540227556674974 |
|
15498 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NCOA2 |
0.540227556674974 |
|
15499 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAM1 |
0.540227556674974 |
|
15500 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238450.1 |
0.540227556674974 |
|
15501 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LACTB2 |
0.540227556674974 |
|
15502 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL19P |
0.540227556674974 |
|
15503 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EYA1 |
0.540227556674974 |
|
15504 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KHDRBS2 |
0.540227909289397 |
|
15505 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SOCS3 |
0.540263784863491 |
|
15506 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IQUB |
0.540295722339478 |
|
15507 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NDUFA5 |
0.540295722339478 |
|
15508 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HAS2 |
0.540297772510421 |
|
15509 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR5681A |
0.540545862874882 |
|
15510 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PI15 |
0.540545862874882 |
|
15511 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CRISPLD1 |
0.540545862874882 |
|
15512 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CASC9 |
0.540545862874882 |
|
15513 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MFAP3 |
0.540559361685147 |
|
15514 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR4A47 |
0.541054292680537 |
|
15515 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR4C5 |
0.541054292680537 |
|
15516 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BMPER |
0.541270212934104 |
|
15517 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TSTD2 |
0.541274014328459 |
|
15518 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
APOL3 |
0.541339889985093 |
|
15519 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
APOL4 |
0.541339889985093 |
|
15520 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD45|ENSG00000200051.1 |
0.541611188937756 |
|
15521 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SRA1 |
0.541611188937756 |
|
15522 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EIF4EBP3 |
0.541611188937756 |
|
15523 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
APBB3 |
0.541611188937756 |
|
15524 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC35A4 |
0.541611188937756 |
|
15525 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA27|ENSG00000200235.1 |
0.541611188937756 |
|
15526 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CD14 |
0.541611188937756 |
|
15527 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NDUFA2 |
0.541611188937756 |
|
15528 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMCO6 |
0.541611188937756 |
|
15529 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COL6A2 |
0.541761359304377 |
|
15530 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FTCD |
0.541761359304377 |
|
15531 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPATC1L |
0.541761359304377 |
|
15532 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LSS |
0.541761359304377 |
|
15533 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR9Q1 |
0.541809231024434 |
|
15534 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR6Q1 |
0.541809231024434 |
|
15535 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR9I1 |
0.541809231024434 |
|
15536 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR9Q2 |
0.541809231024434 |
|
15537 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR1S2 |
0.541809231024434 |
|
15538 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR1S1 |
0.541809231024434 |
|
15539 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR10Q1 |
0.541809231024434 |
|
15540 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR10W1 |
0.541809231024434 |
|
15541 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR5B17 |
0.541809231024434 |
|
15542 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLDN11 |
0.541841045982825 |
|
15543 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNY5P3 |
0.541841045982825 |
|
15544 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPL22L1 |
0.541841045982825 |
|
15545 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EIF5A2 |
0.541841045982825 |
|
15546 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC2A2 |
0.541841045982825 |
|
15547 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TNIK |
0.541841045982825 |
|
15548 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATRN |
0.541851354172675 |
|
15549 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UBIAD1 |
0.542160779560881 |
|
15550 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PTCHD2 |
0.542160779560881 |
|
15551 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF114 |
0.542587618883221 |
|
15552 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CARD8 |
0.542587618883221 |
|
15553 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR608 |
0.542793245925063 |
|
15554 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MRPL43 |
0.542793245925063 |
|
15555 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SEMA4G |
0.542793245925063 |
|
15556 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C10orf2 |
0.542793245925063 |
|
15557 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LZTS2 |
0.542793245925063 |
|
15558 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PDZD7 |
0.542793245925063 |
|
15559 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SFXN3 |
0.542793245925063 |
|
15560 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KAZALD1 |
0.542793245925063 |
|
15561 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TLX1NB |
0.542793245925063 |
|
15562 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HUG1 |
0.542793245925063 |
|
15563 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TLX1 |
0.542793245925063 |
|
15564 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LBX1 |
0.542793245925063 |
|
15565 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD112|ENSG00000252844.1 |
0.542793245925063 |
|
15566 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CTNNA1 |
0.542861297694006 |
|
15567 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCNA4 |
0.542927960567813 |
|
15568 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCNG1 |
0.54294888601078 |
|
15569 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NUDCD2 |
0.54294888601078 |
|
15570 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HMMR |
0.54294888601078 |
|
15571 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAT2B |
0.54294888601078 |
|
15572 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STX3 |
0.543246111638399 |
|
15573 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF677 |
0.543390131265999 |
|
15574 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VN1R2 |
0.543390131265999 |
|
15575 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VN1R4 |
0.543390131265999 |
|
15576 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM90A27P |
0.543390131265999 |
|
15577 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BIRC8 |
0.543390131265999 |
|
15578 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM90A28P |
0.543390131265999 |
|
15579 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF845 |
0.543390131265999 |
|
15580 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF525 |
0.543390131265999 |
|
15581 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF765 |
0.543390131265999 |
|
15582 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TPM3P9 |
0.543390131265999 |
|
15583 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF761 |
0.543390131265999 |
|
15584 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF813 |
0.543390131265999 |
|
15585 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF331 |
0.543390131265999 |
|
15586 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
XKR9 |
0.543546437220775 |
|
15587 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMC2 |
0.543633998245189 |
|
15588 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EXOC4 |
0.543665932609172 |
|
15589 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GALNT10 |
0.54379478085902 |
|
15590 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR1294 |
0.54379478085902 |
|
15591 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL655P |
0.54379478085902 |
|
15592 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SAP30L |
0.54379478085902 |
|
15593 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HAND1 |
0.54379478085902 |
|
15594 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3141 |
0.54379478085902 |
|
15595 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR1303 |
0.54379478085902 |
|
15596 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL439P |
0.54379478085902 |
|
15597 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LARP1 |
0.54379478085902 |
|
15598 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR378H |
0.54379478085902 |
|
15599 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KAAG1 |
0.543839260409101 |
|
15600 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CNKSR3 |
0.543874292496549 |
|
15601 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACKR2 |
0.543904653764074 |
|
15602 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF662 |
0.543904653764074 |
|
15603 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GTDC2 |
0.543904653764074 |
|
15604 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C4orf21 |
0.544022521821458 |
|
15605 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LARP7 |
0.544022521821458 |
|
15606 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR302A |
0.544022521821458 |
|
15607 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR302B |
0.544022521821458 |
|
15608 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR302C |
0.544022521821458 |
|
15609 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR302D |
0.544022521821458 |
|
15610 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR367 |
0.544022521821458 |
|
15611 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HNF4G |
0.544208551583123 |
|
15612 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMC6 |
0.544285453599136 |
|
15613 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMC8 |
0.544285453599136 |
|
15614 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C17orf99 |
0.544285453599136 |
|
15615 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SYNGR2 |
0.544285453599136 |
|
15616 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TK1 |
0.544285453599136 |
|
15617 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AFMID |
0.544285453599136 |
|
15618 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BIRC5 |
0.544285453599136 |
|
15619 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM235 |
0.544285453599136 |
|
15620 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238546.1 |
0.54430873002982 |
|
15621 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PHLPP1 |
0.544428096712829 |
|
15622 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TBC1D2B |
0.544616650025965 |
|
15623 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR1827 |
0.544616650025965 |
|
15624 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SH2D7 |
0.544616650025965 |
|
15625 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA63|ENSG00000199633.1 |
0.544616650025965 |
|
15626 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATE1 |
0.544756029518066 |
|
15627 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C3orf58 |
0.545021825615494 |
|
15628 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP144 |
0.545021825615494 |
|
15629 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDRT15 |
0.545023018817478 |
|
15630 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDRT1 |
0.545023018817478 |
|
15631 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDRT4 |
0.545023018817478 |
|
15632 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDRT7 |
0.545023018817478 |
|
15633 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDRT8 |
0.545023018817478 |
|
15634 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HS3ST3B1 |
0.545023018817478 |
|
15635 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4731 |
0.545023018817478 |
|
15636 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PMP22 |
0.545023018817478 |
|
15637 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL792P |
0.545023018817478 |
|
15638 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA74|ENSG00000252129.1 |
0.545023018817478 |
|
15639 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TEKT3 |
0.545023018817478 |
|
15640 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRIM16 |
0.545023018817478 |
|
15641 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TVP23C |
0.545023018817478 |
|
15642 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238806.1 |
0.545023018817478 |
|
15643 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL705P |
0.545082029888698 |
|
15644 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TSC22D2 |
0.545222685341909 |
|
15645 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SERP1 |
0.545222685341909 |
|
15646 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EIF2A |
0.545222685341909 |
|
15647 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SELT |
0.545222685341909 |
|
15648 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM194A |
0.545222685341909 |
|
15649 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SIAH2 |
0.545222685341909 |
|
15650 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM188B2 |
0.545222685341909 |
|
15651 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLRN1 |
0.545222685341909 |
|
15652 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MRPL16 |
0.545337496735998 |
|
15653 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GIF |
0.545337496735998 |
|
15654 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TCN1 |
0.545337496735998 |
|
15655 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC171 |
0.546312682045889 |
|
15656 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C9orf92 |
0.546312682045889 |
|
15657 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KDSR |
0.546541932120241 |
|
15658 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VPS4B |
0.546541932120241 |
|
15659 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HIBADH |
0.546567351626103 |
|
15660 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NTM |
0.546584904027651 |
|
15661 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF83 |
0.546841525557036 |
|
15662 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4792 |
0.547006921198462 |
|
15663 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TEKT2 |
0.547103273512338 |
|
15664 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADPRHL2 |
0.547103273512338 |
|
15665 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COL8A2 |
0.547103273512338 |
|
15666 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAPPC3 |
0.547103273512338 |
|
15667 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C7orf60 |
0.547377153382072 |
|
15668 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HDHD2 |
0.547431273405151 |
|
15669 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IER3IP1 |
0.547431273405151 |
|
15670 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SKOR2 |
0.547431273405151 |
|
15671 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4527 |
0.547431273405151 |
|
15672 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SMAD2 |
0.547431273405151 |
|
15673 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD112|ENSG00000252932.1 |
0.547643526595126 |
|
15674 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZWINT |
0.547846934829724 |
|
15675 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EIF3CL |
0.547873426478741 |
|
15676 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NPIPB7 |
0.547873426478741 |
|
15677 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238703.1 |
0.547873426478741 |
|
15678 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BTN3A2 |
0.54828812347339 |
|
15679 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BTN2A2 |
0.54828812347339 |
|
15680 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BTN3A1 |
0.54828812347339 |
|
15681 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BTN2A1 |
0.54828812347339 |
|
15682 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BTN2A3P |
0.54828812347339 |
|
15683 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BTN3A3 |
0.54828812347339 |
|
15684 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BTN1A1 |
0.54828812347339 |
|
15685 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HCG11 |
0.54828812347339 |
|
15686 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HMGN4 |
0.54828812347339 |
|
15687 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNF165 |
0.548333203146924 |
|
15688 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3912 |
0.548358084571396 |
|
15689 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NPM1 |
0.548358084571396 |
|
15690 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FGF18 |
0.548358084571396 |
|
15691 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238568.1 |
0.54850358034059 |
|
15692 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GLCE |
0.548529413808442 |
|
15693 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DYNC1LI1 |
0.549051569216555 |
|
15694 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RRM2 |
0.549063351006951 |
|
15695 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C2orf48 |
0.549063351006951 |
|
15696 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA2|ENSG00000206647.1 |
0.549063351006951 |
|
15697 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR1M1 |
0.549753589018992 |
|
15698 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR7G2 |
0.549753589018992 |
|
15699 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR7G1 |
0.549753589018992 |
|
15700 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR7G3 |
0.549753589018992 |
|
15701 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAXDC2 |
0.549767666566255 |
|
15702 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CNOT8 |
0.549767666566255 |
|
15703 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GEMIN5 |
0.549767666566255 |
|
15704 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MRPL22 |
0.549767666566255 |
|
15705 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP199 |
0.549767666566255 |
|
15706 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ITPRIPL2 |
0.549803253816288 |
|
15707 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SYT17 |
0.549803253816288 |
|
15708 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLEC19A |
0.549803253816288 |
|
15709 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMC5 |
0.549803253816288 |
|
15710 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SHQ1 |
0.549862795516939 |
|
15711 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MTFR1 |
0.549942648570807 |
|
15712 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00603 |
0.55007704618956 |
|
15713 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BBOX1 |
0.55009701070087 |
|
15714 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCDH15 |
0.550181229066715 |
|
15715 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANKRD20A19P |
0.550192346916562 |
|
15716 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C1QTNF9B |
0.550192346916562 |
|
15717 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIPEP |
0.550192346916562 |
|
15718 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TNFRSF19 |
0.550192346916562 |
|
15719 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PAQR5 |
0.550241524013456 |
|
15720 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA77|ENSG00000221376.1 |
0.550241524013456 |
|
15721 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP398 |
0.550241524013456 |
|
15722 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIF23 |
0.550241524013456 |
|
15723 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPLP1 |
0.550241524013456 |
|
15724 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U3|ENSG00000207119.1 |
0.550241524013456 |
|
15725 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCARNA22 |
0.550470364673101 |
|
15726 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR943 |
0.550470364673101 |
|
15727 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NELFA |
0.550470364673101 |
|
15728 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C4orf48 |
0.550470364673101 |
|
15729 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NAT8L |
0.550470364673101 |
|
15730 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
POLN |
0.550470364673101 |
|
15731 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GLT8D1 |
0.550585315699754 |
|
15732 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPCS1 |
0.550585315699754 |
|
15733 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NEK4 |
0.550585315699754 |
|
15734 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ITIH1 |
0.550585315699754 |
|
15735 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ITIH3 |
0.550585315699754 |
|
15736 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ITIH4 |
0.550585315699754 |
|
15737 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MUSTN1 |
0.550585315699754 |
|
15738 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM110 |
0.550585315699754 |
|
15739 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SFMBT1 |
0.550585315699754 |
|
15740 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RFT1 |
0.550585315699754 |
|
15741 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GLI3 |
0.550911979821 |
|
15742 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPAPDC1A |
0.551529379597717 |
|
15743 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC14A2 |
0.551601340195344 |
|
15744 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC14A1 |
0.551601340195344 |
|
15745 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AQP12A |
0.551671655673892 |
|
15746 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AQP12B |
0.551671655673892 |
|
15747 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIF1A |
0.551671655673892 |
|
15748 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AGXT |
0.551671655673892 |
|
15749 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C2orf54 |
0.551671655673892 |
|
15750 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C3orf80 |
0.551958451841813 |
|
15751 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IFT80 |
0.551958451841813 |
|
15752 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SMC4 |
0.551958451841813 |
|
15753 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR15B |
0.551958451841813 |
|
15754 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRIM59 |
0.551958451841813 |
|
15755 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KPNA4 |
0.551958451841813 |
|
15756 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCARNA7 |
0.551958451841813 |
|
15757 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KRT8P12 |
0.551958451841813 |
|
15758 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00338 |
0.552260336835164 |
|
15759 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAPGEF2 |
0.552312628285729 |
|
15760 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U3|ENSG00000251979.1 |
0.552312628285729 |
|
15761 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MTMR8 |
0.552340683262073 |
|
15762 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ASAP1 |
0.552495089481295 |
|
15763 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADCY8 |
0.552495089481295 |
|
15764 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GALC |
0.552870525436233 |
|
15765 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPR65 |
0.552870525436233 |
|
15766 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SF3B1 |
0.552878237308223 |
|
15767 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA4|ENSG00000202434.1 |
0.552878237308223 |
|
15768 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COQ10B |
0.552878237308223 |
|
15769 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDC42EP4 |
0.553290543781886 |
|
15770 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
JMJD6 |
0.553396103654845 |
|
15771 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
METTL23 |
0.553396103654845 |
|
15772 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR636 |
0.553396103654845 |
|
15773 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SRSF2 |
0.553396103654845 |
|
15774 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TACR1 |
0.553723247528581 |
|
15775 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238521.1 |
0.553723247528581 |
|
15776 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AP2A1 |
0.553856652675065 |
|
15777 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FUZ |
0.553856652675065 |
|
15778 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MED25 |
0.553856652675065 |
|
15779 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL240P |
0.554107848701266 |
|
15780 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR606 |
0.554113762097087 |
|
15781 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FOCAD |
0.554134771962362 |
|
15782 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RFX5 |
0.55430646706374 |
|
15783 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIAA1598 |
0.554328070679488 |
|
15784 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR1269A |
0.554347931820931 |
|
15785 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CENPC |
0.554347931820931 |
|
15786 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STAP1 |
0.554347931820931 |
|
15787 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UBA6 |
0.554347931820931 |
|
15788 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IQCK |
0.554473559847348 |
|
15789 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CADPS |
0.554542524681678 |
|
15790 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL863P |
0.554542524681678 |
|
15791 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00698 |
0.554542524681678 |
|
15792 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EML1 |
0.554614782052688 |
|
15793 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR151B |
0.554614782052688 |
|
15794 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR342 |
0.554614782052688 |
|
15795 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF540 |
0.554660578376209 |
|
15796 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF571 |
0.554660578376209 |
|
15797 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00701 |
0.554673713604618 |
|
15798 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FASN |
0.554705017583656 |
|
15799 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC57 |
0.554705017583656 |
|
15800 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CSNK1D |
0.554705017583656 |
|
15801 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC16A3 |
0.554705017583656 |
|
15802 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238947.1 |
0.554705017583656 |
|
15803 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OGFOD3 |
0.554705017583656 |
|
15804 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HEXDC |
0.554705017583656 |
|
15805 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C17orf62 |
0.554705017583656 |
|
15806 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FRRS1L |
0.554875327003616 |
|
15807 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EPB41L4B |
0.554875327003616 |
|
15808 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PTPN3 |
0.554875327003616 |
|
15809 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3927 |
0.554875327003616 |
|
15810 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PALM2 |
0.554875327003616 |
|
15811 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MFSD2A |
0.555120969997632 |
|
15812 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC6A5 |
0.555283159793753 |
|
15813 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NELL1 |
0.555283159793753 |
|
15814 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP189 |
0.555291853666007 |
|
15815 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA31|ENSG00000252337.1 |
0.555291853666007 |
|
15816 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PJA2 |
0.555291853666007 |
|
15817 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAN2A1 |
0.555291853666007 |
|
15818 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP230 |
0.555291853666007 |
|
15819 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA51|ENSG00000207177.1 |
0.555291853666007 |
|
15820 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC25A46 |
0.555291853666007 |
|
15821 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TSLP |
0.555291853666007 |
|
15822 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WDR36 |
0.555291853666007 |
|
15823 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CAMK4 |
0.555291853666007 |
|
15824 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STARD4 |
0.555291853666007 |
|
15825 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NREP |
0.555291853666007 |
|
15826 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP57 |
0.555291853666007 |
|
15827 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA13 |
0.555291853666007 |
|
15828 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FLJ11235 |
0.555291853666007 |
|
15829 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
APC |
0.555291853666007 |
|
15830 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SRP19 |
0.555291853666007 |
|
15831 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
REEP5 |
0.555291853666007 |
|
15832 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZRSR1 |
0.555291853666007 |
|
15833 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP60 |
0.555344174198273 |
|
15834 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPR64 |
0.55546215537353 |
|
15835 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PHKA2 |
0.55546215537353 |
|
15836 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL48P |
0.55546215537353 |
|
15837 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZFYVE28 |
0.555839113134309 |
|
15838 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL589P |
0.555839113134309 |
|
15839 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GUCY1A3 |
0.555880336514282 |
|
15840 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GUCY1B3 |
0.555880336514282 |
|
15841 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ASIC5 |
0.555880336514282 |
|
15842 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TDO2 |
0.555880336514282 |
|
15843 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CTSO |
0.555880336514282 |
|
15844 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KAT6B |
0.556115911862077 |
|
15845 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP136 |
0.556291647375039 |
|
15846 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U6|ENSG00000272439.1 |
0.556435983502058 |
|
15847 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCNK |
0.556435983502058 |
|
15848 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC102B |
0.557120543294306 |
|
15849 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HOXB4 |
0.557937117677857 |
|
15850 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR10A |
0.557937117677857 |
|
15851 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HOXB5 |
0.557937117677857 |
|
15852 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCAPER |
0.557977197926646 |
|
15853 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZCCHC2 |
0.557996542682948 |
|
15854 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C10orf120 |
0.558166091587292 |
|
15855 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CUZD1 |
0.558166091587292 |
|
15856 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM24B |
0.558166091587292 |
|
15857 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM24A |
0.558166091587292 |
|
15858 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C10orf88 |
0.558166091587292 |
|
15859 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PSTK |
0.558166091587292 |
|
15860 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IKZF5 |
0.558166091587292 |
|
15861 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACADSB |
0.558166091587292 |
|
15862 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HMX2 |
0.558166091587292 |
|
15863 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HMX3 |
0.558166091587292 |
|
15864 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BUB3 |
0.558166091587292 |
|
15865 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPR26 |
0.558166091587292 |
|
15866 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CPXM2 |
0.558166091587292 |
|
15867 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CHST15 |
0.558166091587292 |
|
15868 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CXXC5 |
0.558317861971317 |
|
15869 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
POLR1E |
0.558351892687859 |
|
15870 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FBXO10 |
0.558351892687859 |
|
15871 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COX10 |
0.558452803492892 |
|
15872 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATP5A1 |
0.558906341404476 |
|
15873 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HAUS1 |
0.558906341404476 |
|
15874 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C18orf25 |
0.558906341404476 |
|
15875 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EFR3A |
0.559156900172237 |
|
15876 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OC90 |
0.559156900172237 |
|
15877 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HHLA1 |
0.559156900172237 |
|
15878 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CMTM7 |
0.559162273990699 |
|
15879 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CMTM6 |
0.559162273990699 |
|
15880 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KATNAL2 |
0.559325154067112 |
|
15881 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TCEB3B |
0.559325154067112 |
|
15882 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TCEB3CL2 |
0.559325154067112 |
|
15883 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TCEB3CL |
0.559325154067112 |
|
15884 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TCEB3C |
0.559325154067112 |
|
15885 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TAL2 |
0.559488229912269 |
|
15886 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NOC3L |
0.559862877132187 |
|
15887 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FBXL7 |
0.559963172226195 |
|
15888 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR887 |
0.559963172226195 |
|
15889 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP178 |
0.559963172226195 |
|
15890 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PDZRN3 |
0.560099455486467 |
|
15891 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PNLIP |
0.560124736035357 |
|
15892 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PNLIPRP1 |
0.560124736035357 |
|
15893 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PNLIPRP2 |
0.560124736035357 |
|
15894 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C10orf82 |
0.560124736035357 |
|
15895 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HSPA12A |
0.560124736035357 |
|
15896 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ENO4 |
0.560124736035357 |
|
15897 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COL3A1 |
0.560320586223311 |
|
15898 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR1245A |
0.560320586223311 |
|
15899 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COL5A2 |
0.560320586223311 |
|
15900 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3129 |
0.560320586223311 |
|
15901 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WDR75 |
0.560320586223311 |
|
15902 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FN3K |
0.560419968952415 |
|
15903 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF750 |
0.560419968952415 |
|
15904 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZCCHC7 |
0.560732467893909 |
|
15905 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GRHPR |
0.560732467893909 |
|
15906 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TAF1B |
0.560873207917391 |
|
15907 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4682 |
0.561380560129491 |
|
15908 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MINPP1 |
0.561552240167851 |
|
15909 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PAPSS2 |
0.561552240167851 |
|
15910 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATAD1 |
0.561552240167851 |
|
15911 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CFL1P1 |
0.561552240167851 |
|
15912 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL78P |
0.561552240167851 |
|
15913 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KLLN |
0.561552240167851 |
|
15914 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SVEP1 |
0.561634132435117 |
|
15915 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MTNR1A |
0.561849655671413 |
|
15916 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAT1 |
0.561849655671413 |
|
15917 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C16orf52 |
0.561894851841052 |
|
15918 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDR2 |
0.561894851841052 |
|
15919 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EEF2K |
0.561894851841052 |
|
15920 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IGSF6 |
0.561894851841052 |
|
15921 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
METTL9 |
0.561894851841052 |
|
15922 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NPIPB3 |
0.561894851841052 |
|
15923 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NPIPB4 |
0.561894851841052 |
|
15924 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NPIPB5 |
0.561894851841052 |
|
15925 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OTOA |
0.561894851841052 |
|
15926 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PDZD9 |
0.561894851841052 |
|
15927 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
POLR3E |
0.561894851841052 |
|
15928 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL245P |
0.561894851841052 |
|
15929 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RRN3P1 |
0.561894851841052 |
|
15930 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RRN3P3 |
0.561894851841052 |
|
15931 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCARNA6|ENSG00000252798.1 |
0.561894851841052 |
|
15932 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SDR42E2 |
0.561894851841052 |
|
15933 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SMG1P1 |
0.561894851841052 |
|
15934 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UQCRC2 |
0.561894851841052 |
|
15935 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VWA3A |
0.561894851841052 |
|
15936 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238712.1 |
0.561894851841052 |
|
15937 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238954.1 |
0.561894851841052 |
|
15938 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000239172.1 |
0.561894851841052 |
|
15939 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GSG1L |
0.561982206083999 |
|
15940 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NPIPB6 |
0.561982206083999 |
|
15941 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPIN4 |
0.562131096786581 |
|
15942 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4305 |
0.562189572081582 |
|
15943 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP187 |
0.562313906867894 |
|
15944 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IFRD1 |
0.562313906867894 |
|
15945 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LSMEM1 |
0.562313906867894 |
|
15946 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM168 |
0.562313906867894 |
|
15947 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPR85 |
0.562313906867894 |
|
15948 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TSRM |
0.562313906867894 |
|
15949 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FUT1 |
0.562348305432882 |
|
15950 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FGF21 |
0.562348305432882 |
|
15951 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL142P |
0.562404901932751 |
|
15952 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4475 |
0.562683069152939 |
|
15953 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4540 |
0.562683069152939 |
|
15954 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4476 |
0.562683069152939 |
|
15955 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
THBS2 |
0.563003169269837 |
|
15956 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4450 |
0.563112467150767 |
|
15957 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR548AH |
0.563112467150767 |
|
15958 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP103 |
0.563326903242472 |
|
15959 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP237 |
0.563438441970094 |
|
15960 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF277 |
0.563438441970094 |
|
15961 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SEPT7 |
0.563491610770749 |
|
15962 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PP13004 |
0.563491610770749 |
|
15963 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EEPD1 |
0.563491610770749 |
|
15964 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C2orf88 |
0.563686728426469 |
|
15965 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HIBCH |
0.563686728426469 |
|
15966 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
INPP1 |
0.563686728426469 |
|
15967 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MFSD6 |
0.563686728426469 |
|
15968 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP26 |
0.563867481258459 |
|
15969 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MYOF |
0.563872756875411 |
|
15970 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CEP55 |
0.563872756875411 |
|
15971 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP323 |
0.563872756875411 |
|
15972 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF597 |
0.563952331286642 |
|
15973 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NAA60 |
0.563952331286642 |
|
15974 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM127 |
0.564030321567669 |
|
15975 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CIAO1 |
0.564030321567669 |
|
15976 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNRNP200 |
0.564030321567669 |
|
15977 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ITPRIPL1 |
0.564030321567669 |
|
15978 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NCAPH |
0.564030321567669 |
|
15979 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TTC21A |
0.56500656222847 |
|
15980 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PGAM1 |
0.565142093659887 |
|
15981 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EXOSC1 |
0.565142093659887 |
|
15982 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL614P |
0.565343953910607 |
|
15983 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238462.1 |
0.565731316851197 |
|
15984 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
YWHAQ |
0.565731316851197 |
|
15985 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CPA6 |
0.565803665337726 |
|
15986 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HOXA1 |
0.565935483602873 |
|
15987 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HOTAIRM1 |
0.565935483602873 |
|
15988 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HOXA2 |
0.565935483602873 |
|
15989 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HOXA3 |
0.565935483602873 |
|
15990 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HOXA4 |
0.565935483602873 |
|
15991 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HOXA5 |
0.565935483602873 |
|
15992 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HOXA6 |
0.565935483602873 |
|
15993 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HOXA7 |
0.565935483602873 |
|
15994 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HOXA9 |
0.565935483602873 |
|
15995 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HOXA10 |
0.565935483602873 |
|
15996 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR196B |
0.565935483602873 |
|
15997 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HOXA11 |
0.565935483602873 |
|
15998 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HOXA13 |
0.565935483602873 |
|
15999 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HOTTIP |
0.565935483602873 |
|
16000 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EVX1 |
0.565935483602873 |
|
16001 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC40A1 |
0.566140373277871 |
|
16002 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
H3F3B |
0.566150176829301 |
|
16003 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4738 |
0.566150176829301 |
|
16004 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UNK |
0.566150176829301 |
|
16005 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UNC13D |
0.566150176829301 |
|
16006 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WBP2 |
0.566150176829301 |
|
16007 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRIM47 |
0.566150176829301 |
|
16008 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRIM65 |
0.566150176829301 |
|
16009 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MRPL38 |
0.566150176829301 |
|
16010 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FBF1 |
0.566150176829301 |
|
16011 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACOX1 |
0.566150176829301 |
|
16012 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM129B |
0.56622711711239 |
|
16013 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EDNRA |
0.56624980916732 |
|
16014 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM184C |
0.56624980916732 |
|
16015 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRMT10 |
0.56624980916732 |
|
16016 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP165 |
0.56624980916732 |
|
16017 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4799 |
0.56624980916732 |
|
16018 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL254P |
0.56624980916732 |
|
16019 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EVL |
0.566319100848193 |
|
16020 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DEGS2 |
0.566319100848193 |
|
16021 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
YY1 |
0.566319100848193 |
|
16022 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP180 |
0.566400203852725 |
|
16023 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA33|ENSG00000202283.1 |
0.566607011807925 |
|
16024 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00883 |
0.566630752683486 |
|
16025 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC54 |
0.566630752683486 |
|
16026 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAL2 |
0.566655625529093 |
|
16027 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00301 |
0.566796731388115 |
|
16028 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MS4A8 |
0.566796731388115 |
|
16029 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MS4A18 |
0.566796731388115 |
|
16030 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MS4A15 |
0.566796731388115 |
|
16031 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MS4A10 |
0.566796731388115 |
|
16032 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC86 |
0.566796731388115 |
|
16033 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PTGDR2 |
0.566796731388115 |
|
16034 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZP1 |
0.566796731388115 |
|
16035 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRPF19 |
0.566796731388115 |
|
16036 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM109 |
0.566796731388115 |
|
16037 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM132A |
0.566796731388115 |
|
16038 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GDE1 |
0.567022541481632 |
|
16039 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCP110 |
0.567022541481632 |
|
16040 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C16orf62 |
0.567022541481632 |
|
16041 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KNOP1 |
0.567022541481632 |
|
16042 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RP9 |
0.567101839890434 |
|
16043 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000252706.1 |
0.567101839890434 |
|
16044 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP229 |
0.567101839890434 |
|
16045 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR940 |
0.567373660286236 |
|
16046 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3677 |
0.567373660286236 |
|
16047 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ABCA3 |
0.567373660286236 |
|
16048 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4717 |
0.567373660286236 |
|
16049 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ABCA17P |
0.567373660286236 |
|
16050 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCNF |
0.567373660286236 |
|
16051 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CTDSPL |
0.567708091362016 |
|
16052 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
YARS2 |
0.567755716623626 |
|
16053 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TXLNB |
0.56811520254308 |
|
16054 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00511 |
0.568148211198727 |
|
16055 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC39A11 |
0.568148211198727 |
|
16056 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCARNA24|ENSG00000252274.1 |
0.568148211198727 |
|
16057 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC2A4 |
0.568149484473829 |
|
16058 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
YBX2 |
0.568149484473829 |
|
16059 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EIF5A |
0.568149484473829 |
|
16060 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPS2 |
0.568149484473829 |
|
16061 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NEURL4 |
0.568149484473829 |
|
16062 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACAP1 |
0.568149484473829 |
|
16063 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCTD11 |
0.568149484473829 |
|
16064 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM95 |
0.568149484473829 |
|
16065 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TNK1 |
0.568149484473829 |
|
16066 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLSCR3 |
0.568149484473829 |
|
16067 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM256 |
0.568149484473829 |
|
16068 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC85C |
0.568338991176395 |
|
16069 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HHIPL1 |
0.568338991176395 |
|
16070 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CYP46A1 |
0.568338991176395 |
|
16071 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IAH1 |
0.5686752805422 |
|
16072 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADAM17 |
0.5686752805422 |
|
16073 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP341 |
0.568765782033266 |
|
16074 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP259 |
0.568765782033266 |
|
16075 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RTN4RL2 |
0.568765782033266 |
|
16076 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC43A1 |
0.568765782033266 |
|
16077 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TIMM10 |
0.568765782033266 |
|
16078 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MED19 |
0.568765782033266 |
|
16079 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMX2 |
0.568765782033266 |
|
16080 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BTBD18 |
0.568765782033266 |
|
16081 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C11orf31 |
0.568765782033266 |
|
16082 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CTNND1 |
0.568765782033266 |
|
16083 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CIDECP |
0.568856189371638 |
|
16084 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FANCD2 |
0.568856189371638 |
|
16085 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP390 |
0.568868284503045 |
|
16086 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4715 |
0.568868284503045 |
|
16087 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NRIP1 |
0.569262682415461 |
|
16088 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CHMP6 |
0.56927282598589 |
|
16089 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC12A2 |
0.569432684748558 |
|
16090 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FBN2 |
0.569432684748558 |
|
16091 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RRM1 |
0.56947859053803 |
|
16092 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EFTUD1P1 |
0.569504865719422 |
|
16093 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FER |
0.569608939628331 |
|
16094 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DCP2 |
0.569608939628331 |
|
16095 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MCC |
0.569608939628331 |
|
16096 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRR16 |
0.569784158094405 |
|
16097 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATP5EP2 |
0.569836074275345 |
|
16098 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDX2 |
0.569836074275345 |
|
16099 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00543 |
0.569836074275345 |
|
16100 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PDX1 |
0.569836074275345 |
|
16101 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
URAD |
0.569836074275345 |
|
16102 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL272P |
0.569836074275345 |
|
16103 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FLT3 |
0.569836074275345 |
|
16104 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NAV3 |
0.569864183209891 |
|
16105 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ESRP1 |
0.569870243027816 |
|
16106 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANKRD20A8P |
0.570172657569388 |
|
16107 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TEKT4 |
0.570172657569388 |
|
16108 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARL14 |
0.570420411357969 |
|
16109 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA72|ENSG00000207084.1 |
0.570420411357969 |
|
16110 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPM1L |
0.570420411357969 |
|
16111 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UBE2E1 |
0.570541696900748 |
|
16112 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NKIRAS1 |
0.570541696900748 |
|
16113 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPL15 |
0.570541696900748 |
|
16114 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NR1D2 |
0.570541696900748 |
|
16115 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00691 |
0.570541696900748 |
|
16116 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
THRB |
0.570541696900748 |
|
16117 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PDHA1 |
0.570559389445421 |
|
16118 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAP3K15 |
0.570559389445421 |
|
16119 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FGD4 |
0.570587159956052 |
|
16120 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP182 |
0.570647690492118 |
|
16121 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADK |
0.570771193152791 |
|
16122 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC150 |
0.570802340208103 |
|
16123 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCARNA16|ENSG00000252923.1 |
0.570802340208103 |
|
16124 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NPFFR2 |
0.57084018623386 |
|
16125 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OAT |
0.570977055341042 |
|
16126 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LHPP |
0.570977055341042 |
|
16127 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM53B |
0.570977055341042 |
|
16128 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
METTL10 |
0.570977055341042 |
|
16129 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM175B |
0.570977055341042 |
|
16130 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA69|ENSG00000212206.1 |
0.571144586937337 |
|
16131 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ODF4 |
0.571144586937337 |
|
16132 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KRBA2 |
0.571144586937337 |
|
16133 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANK2 |
0.571241817137047 |
|
16134 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RBBP9 |
0.571442710740308 |
|
16135 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SEC23B |
0.571442710740308 |
|
16136 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00493 |
0.571442710740308 |
|
16137 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DTD1 |
0.571442710740308 |
|
16138 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL638P |
0.571442710740308 |
|
16139 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNU6ATAC34P |
0.571442710740308 |
|
16140 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIF4B |
0.571543968417892 |
|
16141 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LOXHD1 |
0.571602508204547 |
|
16142 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ST8SIA5 |
0.571602508204547 |
|
16143 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4764 |
0.571870692890851 |
|
16144 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACTB |
0.571991014186841 |
|
16145 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MLLT3 |
0.572068684685249 |
|
16146 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4473 |
0.572068684685249 |
|
16147 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR491 |
0.572068684685249 |
|
16148 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA30|ENSG00000202189.1 |
0.572068684685249 |
|
16149 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCTD21 |
0.572234720362897 |
|
16150 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
USP35 |
0.572234720362897 |
|
16151 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EVA1A |
0.572447986281277 |
|
16152 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU109|ENSG00000238410.1 |
0.572447986281277 |
|
16153 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STT3A |
0.572576839725888 |
|
16154 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CHEK1 |
0.572576839725888 |
|
16155 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACRV1 |
0.572576839725888 |
|
16156 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PATE1 |
0.572576839725888 |
|
16157 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PATE2 |
0.572576839725888 |
|
16158 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PATE3 |
0.572576839725888 |
|
16159 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PATE4 |
0.572576839725888 |
|
16160 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HYLS1 |
0.572576839725888 |
|
16161 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PUS3 |
0.572576839725888 |
|
16162 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DDX25 |
0.572576839725888 |
|
16163 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCAT1 |
0.573147977201531 |
|
16164 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDON |
0.573336908934738 |
|
16165 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ST3GAL4 |
0.573336908934738 |
|
16166 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIRREL3 |
0.573336908934738 |
|
16167 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL581P |
0.573357765092915 |
|
16168 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AWAT1 |
0.573357765092915 |
|
16169 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP507 |
0.573357765092915 |
|
16170 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
P2RY4 |
0.573357765092915 |
|
16171 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARR3 |
0.573357765092915 |
|
16172 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PDZD11 |
0.573357765092915 |
|
16173 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAB41 |
0.573357765092915 |
|
16174 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HMGB4 |
0.573446056222601 |
|
16175 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC115 |
0.573620061587864 |
|
16176 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC74B |
0.573620061587864 |
|
16177 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CYP4F43P |
0.573620061587864 |
|
16178 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IMP4 |
0.573620061587864 |
|
16179 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MZT2B |
0.573620061587864 |
|
16180 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
POTEF |
0.573620061587864 |
|
16181 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PTPN18 |
0.573620061587864 |
|
16182 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SMPD4 |
0.573620061587864 |
|
16183 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TUBA3E |
0.573620061587864 |
|
16184 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CFC1B |
0.573620061587864 |
|
16185 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CFC1 |
0.573620061587864 |
|
16186 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CYP4F30P |
0.573620061587864 |
|
16187 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
POTEI |
0.573620061587864 |
|
16188 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
POTEJ |
0.573620061587864 |
|
16189 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPR148 |
0.573620061587864 |
|
16190 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TFAP2D |
0.573665726376118 |
|
16191 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TFAP2B |
0.573665726376118 |
|
16192 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNX10 |
0.573881404615652 |
|
16193 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIAA0087 |
0.573881404615652 |
|
16194 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C7orf71 |
0.573881404615652 |
|
16195 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CHEK2P2 |
0.574204197968948 |
|
16196 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CT60 |
0.574204197968948 |
|
16197 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CYFIP1 |
0.574204197968948 |
|
16198 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DKFZP547L112 |
0.574204197968948 |
|
16199 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GOLGA6L1 |
0.574204197968948 |
|
16200 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GOLGA6L2 |
0.574204197968948 |
|
16201 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GOLGA6L6 |
0.574204197968948 |
|
16202 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GOLGA8DP |
0.574204197968948 |
|
16203 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GOLGA8EP |
0.574204197968948 |
|
16204 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GOLGA8I |
0.574204197968948 |
|
16205 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GOLGA8S |
0.574204197968948 |
|
16206 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HERC2P2 |
0.574204197968948 |
|
16207 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HERC2P3 |
0.574204197968948 |
|
16208 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR1268A |
0.574204197968948 |
|
16209 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NBEAP1 |
0.574204197968948 |
|
16210 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NIPA1 |
0.574204197968948 |
|
16211 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NIPA2 |
0.574204197968948 |
|
16212 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR4M2 |
0.574204197968948 |
|
16213 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR4N4 |
0.574204197968948 |
|
16214 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
POTEB2 |
0.574204197968948 |
|
16215 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
POTEB |
0.574204197968948 |
|
16216 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL106P |
0.574204197968948 |
|
16217 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL400P |
0.574204197968948 |
|
16218 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL495P |
0.574204197968948 |
|
16219 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL536P |
0.574204197968948 |
|
16220 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL545P |
0.574204197968948 |
|
16221 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL584P |
0.574204197968948 |
|
16222 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL759P |
0.574204197968948 |
|
16223 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TUBGCP5 |
0.574204197968948 |
|
16224 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WHAMMP3 |
0.574204197968948 |
|
16225 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238960.1 |
0.574204197968948 |
|
16226 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000239083.1 |
0.574204197968948 |
|
16227 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NFE2L3 |
0.574238620251719 |
|
16228 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HNRNPA2B1 |
0.574238620251719 |
|
16229 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CBX3 |
0.574238620251719 |
|
16230 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CASZ1 |
0.574265382477821 |
|
16231 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAP3K4 |
0.574276219938759 |
|
16232 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AGPAT4 |
0.574276219938759 |
|
16233 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AKAP2 |
0.574414753903317 |
|
16234 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DNTT |
0.574819814196479 |
|
16235 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OPALIN |
0.574819814196479 |
|
16236 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TLL2 |
0.574819814196479 |
|
16237 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RIMKLA |
0.574930276959632 |
|
16238 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CD6 |
0.575151575364513 |
|
16239 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CD5 |
0.575151575364513 |
|
16240 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VPS37C |
0.575151575364513 |
|
16241 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM232 |
0.575257948713641 |
|
16242 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR548F3 |
0.575257948713641 |
|
16243 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
P2RX3 |
0.575295191849507 |
|
16244 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRG3 |
0.575295191849507 |
|
16245 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRG2 |
0.575295191849507 |
|
16246 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC43A3 |
0.575295191849507 |
|
16247 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR588 |
0.575449660387748 |
|
16248 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MYH2 |
0.575683219172784 |
|
16249 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR5B3 |
0.575729263222555 |
|
16250 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR5B2 |
0.575729263222555 |
|
16251 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U1|ENSG00000271739.1 |
0.576104241823461 |
|
16252 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LIMS2 |
0.576136431170196 |
|
16253 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SFT2D3 |
0.576136431170196 |
|
16254 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WDR33 |
0.576136431170196 |
|
16255 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNY4P7 |
0.576136431170196 |
|
16256 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
POLR2D |
0.576136431170196 |
|
16257 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AMMECR1L |
0.576136431170196 |
|
16258 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SAP130 |
0.576136431170196 |
|
16259 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C10orf11 |
0.57627275491892 |
|
16260 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MYO16 |
0.576273337476052 |
|
16261 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AADACL2 |
0.576277839506631 |
|
16262 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AADAC |
0.576277839506631 |
|
16263 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CGN |
0.576600219528821 |
|
16264 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA44 |
0.576600219528821 |
|
16265 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TUFT1 |
0.576600219528821 |
|
16266 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR554 |
0.576600219528821 |
|
16267 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNX27 |
0.576600219528821 |
|
16268 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC25A2 |
0.576656268666592 |
|
16269 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TAF7 |
0.576656268666592 |
|
16270 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCDHGB8P |
0.576656268666592 |
|
16271 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CC2D2B |
0.576757890716336 |
|
16272 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCNJ |
0.576757890716336 |
|
16273 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3157 |
0.576757890716336 |
|
16274 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF518A |
0.576757890716336 |
|
16275 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM131 |
0.57689548512887 |
|
16276 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VWA3B |
0.57689548512887 |
|
16277 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CNGA3 |
0.57689548512887 |
|
16278 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CEP112 |
0.57702981977736 |
|
16279 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C16orf59 |
0.577097969102152 |
|
16280 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NTN3 |
0.577097969102152 |
|
16281 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TBC1D24 |
0.577097969102152 |
|
16282 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATP6C |
0.577097969102152 |
|
16283 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATP6V0C |
0.577097969102152 |
|
16284 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AMDHD2 |
0.577097969102152 |
|
16285 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CEMP1 |
0.577097969102152 |
|
16286 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3178 |
0.577097969102152 |
|
16287 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PDPK1 |
0.577097969102152 |
|
16288 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCTD5 |
0.577097969102152 |
|
16289 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PDPK2 |
0.577097969102152 |
|
16290 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRSS27 |
0.577097969102152 |
|
16291 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SRRM2 |
0.577097969102152 |
|
16292 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00423 |
0.577224178179248 |
|
16293 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KL |
0.577224178179248 |
|
16294 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HUNK |
0.577246790464415 |
|
16295 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GAB2 |
0.577570595895836 |
|
16296 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UBE2D2 |
0.577865402910616 |
|
16297 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SHROOM3 |
0.57817616353722 |
|
16298 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM114 |
0.57821073482609 |
|
16299 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
METTL22 |
0.57821073482609 |
|
16300 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC35D3 |
0.578655222812466 |
|
16301 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IL20RA |
0.578655222812466 |
|
16302 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IL22RA2 |
0.578655222812466 |
|
16303 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00320 |
0.578839072425869 |
|
16304 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ASPSCR1 |
0.578922642864595 |
|
16305 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STRA13 |
0.578922642864595 |
|
16306 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DCXR |
0.578922642864595 |
|
16307 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRRC45 |
0.578922642864595 |
|
16308 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAC3 |
0.578922642864595 |
|
16309 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RFNG |
0.578922642864595 |
|
16310 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPS1 |
0.578922642864595 |
|
16311 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DUS1L |
0.578922642864595 |
|
16312 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GAA |
0.579021137868123 |
|
16313 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EIF4A3 |
0.579021137868123 |
|
16314 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CARD14 |
0.579021137868123 |
|
16315 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SGSH |
0.579021137868123 |
|
16316 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC26A11 |
0.579021137868123 |
|
16317 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NDUFAF6 |
0.579095211338256 |
|
16318 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3150B |
0.579095211338256 |
|
16319 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLEKHF2 |
0.579095211338256 |
|
16320 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EXOC6B |
0.579271355021754 |
|
16321 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM186 |
0.579275553936162 |
|
16322 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PMM2 |
0.579275553936162 |
|
16323 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C16orf72 |
0.579275553936162 |
|
16324 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CARHSP1 |
0.579275553936162 |
|
16325 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
USP7 |
0.579275553936162 |
|
16326 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C2orf15 |
0.579680743101112 |
|
16327 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LYG1 |
0.579680743101112 |
|
16328 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LYG2 |
0.579680743101112 |
|
16329 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TXNDC9 |
0.579680743101112 |
|
16330 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EIF5B |
0.579680743101112 |
|
16331 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SERINC5 |
0.579961938722969 |
|
16332 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000239159.1 |
0.579961938722969 |
|
16333 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STK3 |
0.580161635358246 |
|
16334 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GRID1 |
0.580203873508851 |
|
16335 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR346 |
0.580203873508851 |
|
16336 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WAPAL |
0.580203873508851 |
|
16337 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SYBU |
0.580691937730813 |
|
16338 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL661P |
0.580777185186461 |
|
16339 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ALG13 |
0.580777185186461 |
|
16340 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP512 |
0.580777185186461 |
|
16341 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRPC5 |
0.580777185186461 |
|
16342 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRPC5OS |
0.580777185186461 |
|
16343 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLN3 |
0.580874339159189 |
|
16344 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
APOBR |
0.580874339159189 |
|
16345 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IL27 |
0.580874339159189 |
|
16346 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NUPR1 |
0.580874339159189 |
|
16347 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC101 |
0.580874339159189 |
|
16348 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP46 |
0.581419310114815 |
|
16349 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRBA |
0.581458979729805 |
|
16350 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GLS |
0.582012207357242 |
|
16351 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STAT1 |
0.582012207357242 |
|
16352 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STAT4 |
0.582012207357242 |
|
16353 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DST |
0.582079658635508 |
|
16354 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPATA13 |
0.582088021493484 |
|
16355 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL408P |
0.582155275824607 |
|
16356 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SGK1 |
0.582155275824607 |
|
16357 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238631.1 |
0.582155275824607 |
|
16358 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP218 |
0.582155275824607 |
|
16359 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL496P |
0.582349134136354 |
|
16360 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GCKR |
0.582940479014157 |
|
16361 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C2orf16 |
0.582940479014157 |
|
16362 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ABAT |
0.583000329481439 |
|
16363 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL743P |
0.583000329481439 |
|
16364 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TUSC7 |
0.583333197566779 |
|
16365 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FTLP10 |
0.583386958433191 |
|
16366 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
JAGN1 |
0.583518646130903 |
|
16367 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IL17RE |
0.583518646130903 |
|
16368 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IL17RC |
0.583518646130903 |
|
16369 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CRELD1 |
0.583518646130903 |
|
16370 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C5orf38 |
0.583563196707294 |
|
16371 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IRX2 |
0.583563196707294 |
|
16372 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIAA1244 |
0.583876812827828 |
|
16373 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AGTPBP1 |
0.583952688434515 |
|
16374 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NAA35 |
0.583952688434515 |
|
16375 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GOLM1 |
0.583952688434515 |
|
16376 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C9orf153 |
0.583952688434515 |
|
16377 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP264 |
0.583952688434515 |
|
16378 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ISCA1 |
0.583952688434515 |
|
16379 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZCCHC6 |
0.583952688434515 |
|
16380 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCND2 |
0.584008203565397 |
|
16381 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GUF1 |
0.584176492940721 |
|
16382 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GNPDA2 |
0.584176492940721 |
|
16383 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OXR1 |
0.584551549568261 |
|
16384 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ABRA |
0.584551549568261 |
|
16385 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANGPT1 |
0.584551549568261 |
|
16386 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00694 |
0.584558766373175 |
|
16387 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF445 |
0.584558766373175 |
|
16388 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR548AB |
0.584649864898323 |
|
16389 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GGA1 |
0.584959105576387 |
|
16390 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDC6 |
0.585012347442806 |
|
16391 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RARA |
0.585012347442806 |
|
16392 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GJD3 |
0.585012347442806 |
|
16393 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP441 |
0.585012347442806 |
|
16394 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GRAMD3 |
0.585017998796566 |
|
16395 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ALDH7A1 |
0.585017998796566 |
|
16396 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PHAX |
0.585017998796566 |
|
16397 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C5orf48 |
0.585017998796566 |
|
16398 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LMNB1 |
0.585017998796566 |
|
16399 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MARCH3 |
0.585017998796566 |
|
16400 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C5orf63 |
0.585017998796566 |
|
16401 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TSPAN12 |
0.585204306801949 |
|
16402 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DOK7 |
0.585213288687753 |
|
16403 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRPAP1 |
0.585213288687753 |
|
16404 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RGS12 |
0.585241491184947 |
|
16405 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HGFAC |
0.585241491184947 |
|
16406 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF860 |
0.585321444248456 |
|
16407 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLIT1 |
0.58543030060044 |
|
16408 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NLGN4X |
0.585658604249782 |
|
16409 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4770 |
0.585658604249782 |
|
16410 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNF4 |
0.585840829207917 |
|
16411 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PTPRG |
0.585885927546297 |
|
16412 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
7SK|ENSG00000249352.3 |
0.585897478310546 |
|
16413 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238595.1 |
0.586119902776805 |
|
16414 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC5A12 |
0.586126511931695 |
|
16415 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GC |
0.586154755654125 |
|
16416 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP163 |
0.586154755654125 |
|
16417 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRRC16A |
0.586274797639565 |
|
16418 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238322.1 |
0.586274797639565 |
|
16419 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HIST1H2AA |
0.586274797639565 |
|
16420 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HIST1H2BA |
0.586274797639565 |
|
16421 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCGN |
0.586274797639565 |
|
16422 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BCL2A1 |
0.586276938273567 |
|
16423 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZFAND6 |
0.586276938273567 |
|
16424 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD112|ENSG00000251881.1 |
0.586276938273567 |
|
16425 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAH |
0.586276938273567 |
|
16426 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COLEC10 |
0.586471735166197 |
|
16427 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BLNK |
0.586647249213764 |
|
16428 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RCHY1 |
0.586700502099468 |
|
16429 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
THAP6 |
0.586700502099468 |
|
16430 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C4orf26 |
0.586700502099468 |
|
16431 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDKL2 |
0.586700502099468 |
|
16432 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NAAA |
0.586700502099468 |
|
16433 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SDAD1 |
0.586700502099468 |
|
16434 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC25A51 |
0.587104280677511 |
|
16435 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SHB |
0.587104280677511 |
|
16436 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TNFAIP3 |
0.587261065078073 |
|
16437 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PERP |
0.587261065078073 |
|
16438 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00293 |
0.587661868796734 |
|
16439 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TCEB2 |
0.587680081731859 |
|
16440 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRSS33 |
0.587680081731859 |
|
16441 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRSS41 |
0.587680081731859 |
|
16442 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA3|ENSG00000221719.1 |
0.587680081731859 |
|
16443 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRSS21 |
0.587680081731859 |
|
16444 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZG16B |
0.587680081731859 |
|
16445 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRSS30P |
0.587680081731859 |
|
16446 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRSS22 |
0.587680081731859 |
|
16447 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM194B |
0.587699521777143 |
|
16448 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP179 |
0.587699521777143 |
|
16449 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NAB1 |
0.587699521777143 |
|
16450 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NRSN1 |
0.587731416982585 |
|
16451 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD46|ENSG00000251830.1 |
0.587731416982585 |
|
16452 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DCDC2 |
0.587731416982585 |
|
16453 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BMP3 |
0.587736837524722 |
|
16454 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRKG2 |
0.587736837524722 |
|
16455 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PAK3 |
0.587748938563252 |
|
16456 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CAPN6 |
0.587748938563252 |
|
16457 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DCX |
0.587748938563252 |
|
16458 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00890 |
0.587748938563252 |
|
16459 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C7orf25 |
0.587991455037234 |
|
16460 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HECW1 |
0.587991455037234 |
|
16461 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3943 |
0.587991455037234 |
|
16462 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MRPL32 |
0.587991455037234 |
|
16463 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PSMA2 |
0.587991455037234 |
|
16464 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GRIA3 |
0.587999769992952 |
|
16465 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DHX40 |
0.5880622376738 |
|
16466 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLTC |
0.5880622376738 |
|
16467 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PTRH2 |
0.5880622376738 |
|
16468 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VMP1 |
0.5880622376738 |
|
16469 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AGPAT5 |
0.588110474469904 |
|
16470 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4659A |
0.588110474469904 |
|
16471 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MFNG |
0.588310472193461 |
|
16472 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CARD10 |
0.588310472193461 |
|
16473 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDC42EP1 |
0.588310472193461 |
|
16474 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TOP2A |
0.588976230527702 |
|
16475 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IGFBP4 |
0.588976230527702 |
|
16476 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TNS4 |
0.588976230527702 |
|
16477 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCR7 |
0.588976230527702 |
|
16478 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HYI |
0.589012844993265 |
|
16479 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MXD4 |
0.58962405933537 |
|
16480 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4800 |
0.58962405933537 |
|
16481 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC9A9 |
0.589712339008471 |
|
16482 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NPPB |
0.589791988178614 |
|
16483 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DIAPH1 |
0.589943493971392 |
|
16484 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CREBBP |
0.590107094583942 |
|
16485 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TINAG |
0.59054232417305 |
|
16486 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00265 |
0.590555387752214 |
|
16487 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MPLKIP |
0.590555387752214 |
|
16488 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
INHBA |
0.590555387752214 |
|
16489 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AOX2P |
0.59064228540006 |
|
16490 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMPRSS11BNL |
0.590678782697846 |
|
16491 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMPRSS11B |
0.590678782697846 |
|
16492 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
YTHDC1 |
0.590678782697846 |
|
16493 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMPRSS11E |
0.590678782697846 |
|
16494 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UGT2A3 |
0.590678782697846 |
|
16495 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UGT2B10 |
0.590678782697846 |
|
16496 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UGT2B11 |
0.590678782697846 |
|
16497 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UGT2B15 |
0.590678782697846 |
|
16498 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UGT2B17 |
0.590678782697846 |
|
16499 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UGT2B28 |
0.590678782697846 |
|
16500 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UGT2B7 |
0.590678782697846 |
|
16501 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MSTN |
0.590681608067789 |
|
16502 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EDA |
0.590757454475137 |
|
16503 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U3|ENSG00000212434.1 |
0.590757454475137 |
|
16504 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPEF1 |
0.590981745893015 |
|
16505 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DPY19L2P1 |
0.591187683717061 |
|
16506 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAGEB10 |
0.591223488648295 |
|
16507 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CD2BP2 |
0.591403816378808 |
|
16508 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TBC1D10B |
0.591403816378808 |
|
16509 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MYLPF |
0.591403816378808 |
|
16510 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SEPT1 |
0.591403816378808 |
|
16511 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF48 |
0.591403816378808 |
|
16512 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF771 |
0.591403816378808 |
|
16513 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DCTPP1 |
0.591403816378808 |
|
16514 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA42|ENSG00000199787.1 |
0.591403816378808 |
|
16515 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OCA2 |
0.591636722198134 |
|
16516 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC26 |
0.591881399713855 |
|
16517 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3686 |
0.591881399713855 |
|
16518 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA12|ENSG00000212342.1 |
0.591881399713855 |
|
16519 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCNQ3 |
0.591881399713855 |
|
16520 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRRT3 |
0.591905254442895 |
|
16521 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EMC3 |
0.591905254442895 |
|
16522 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACKR6 |
0.5919522641796 |
|
16523 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PKP2 |
0.591980362880045 |
|
16524 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPATS2L |
0.592265621170227 |
|
16525 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCTD18 |
0.592265621170227 |
|
16526 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SGOL2 |
0.592265621170227 |
|
16527 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AOX1 |
0.592265621170227 |
|
16528 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL531P |
0.592266460992348 |
|
16529 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PREX2 |
0.592319499997093 |
|
16530 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP269 |
0.592319499997093 |
|
16531 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NPTXR |
0.592398805916985 |
|
16532 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CBX6 |
0.592398805916985 |
|
16533 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
7SK|ENSG00000232512.2 |
0.59249152060326 |
|
16534 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP489 |
0.59249152060326 |
|
16535 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00158 |
0.59249152060326 |
|
16536 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238314.1 |
0.59249152060326 |
|
16537 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR155HG |
0.59249152060326 |
|
16538 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00515 |
0.59249152060326 |
|
16539 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MRPL39 |
0.59249152060326 |
|
16540 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
JAM2 |
0.59249152060326 |
|
16541 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATP5J |
0.59249152060326 |
|
16542 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GABPA |
0.59249152060326 |
|
16543 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
APP |
0.59249152060326 |
|
16544 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KPNA3 |
0.592554438350091 |
|
16545 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TJP2 |
0.592642693610791 |
|
16546 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PIAS2 |
0.592732180096958 |
|
16547 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C7orf10 |
0.592937304767306 |
|
16548 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP238 |
0.593109091777187 |
|
16549 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3666 |
0.593109091777187 |
|
16550 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MDFIC |
0.593109091777187 |
|
16551 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MTRNR2L5 |
0.593144887245781 |
|
16552 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IK |
0.593440482497302 |
|
16553 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3655 |
0.593440482497302 |
|
16554 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WDR55 |
0.593440482497302 |
|
16555 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DND1 |
0.593440482497302 |
|
16556 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HARS |
0.593440482497302 |
|
16557 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HARS2 |
0.593440482497302 |
|
16558 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZMAT2 |
0.593440482497302 |
|
16559 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCDHA1 |
0.593440482497302 |
|
16560 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCDHA2 |
0.593440482497302 |
|
16561 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCDHA3 |
0.593440482497302 |
|
16562 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCDHA4 |
0.593440482497302 |
|
16563 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCDHA10 |
0.593440482497302 |
|
16564 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCDHA11 |
0.593440482497302 |
|
16565 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCDHA14 |
0.593440482497302 |
|
16566 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCDHA5 |
0.593440482497302 |
|
16567 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCDHA6 |
0.593440482497302 |
|
16568 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCDHA7 |
0.593440482497302 |
|
16569 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCDHA8 |
0.593440482497302 |
|
16570 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCDHA9 |
0.593440482497302 |
|
16571 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCDHA12 |
0.593440482497302 |
|
16572 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCDHA13 |
0.593440482497302 |
|
16573 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCDHAC1 |
0.593440482497302 |
|
16574 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCDHAC2 |
0.593440482497302 |
|
16575 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCDHB15 |
0.593440482497302 |
|
16576 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PXDN |
0.593456524152823 |
|
16577 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNTG2 |
0.593456524152823 |
|
16578 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TPO |
0.593456524152823 |
|
16579 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CRMP1 |
0.593512521256037 |
|
16580 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3167 |
0.593524782551688 |
|
16581 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UBE2E2 |
0.593557366741198 |
|
16582 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00476 |
0.593743649430232 |
|
16583 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DKFZP434H0512 |
0.593743649430232 |
|
16584 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ERCC6L2 |
0.593743649430232 |
|
16585 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP289 |
0.593743649430232 |
|
16586 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00092 |
0.593743649430232 |
|
16587 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HSD17B3 |
0.593743649430232 |
|
16588 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADRA1B |
0.593855302002901 |
|
16589 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TTC1 |
0.593855302002901 |
|
16590 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PWWP2A |
0.593855302002901 |
|
16591 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FABP6 |
0.593855302002901 |
|
16592 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCNJL |
0.593855302002901 |
|
16593 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL295P |
0.593855302002901 |
|
16594 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C1QTNF2 |
0.593855302002901 |
|
16595 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C5orf54 |
0.593855302002901 |
|
16596 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLU7 |
0.593855302002901 |
|
16597 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PTTG1 |
0.593855302002901 |
|
16598 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR146A |
0.593855302002901 |
|
16599 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3142 |
0.593855302002901 |
|
16600 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR23B |
0.594125108801267 |
|
16601 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR27B |
0.594125108801267 |
|
16602 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3074 |
0.594125108801267 |
|
16603 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
INSL4 |
0.594235495868545 |
|
16604 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
INSL6 |
0.594235495868545 |
|
16605 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF670 |
0.594289169757393 |
|
16606 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF695 |
0.594289169757393 |
|
16607 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TIFA |
0.594670990001724 |
|
16608 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ALPK1 |
0.594670990001724 |
|
16609 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NEUROG2 |
0.594670990001724 |
|
16610 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TIMD4 |
0.594689502034053 |
|
16611 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HAVCR1 |
0.594689502034053 |
|
16612 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HAVCR2 |
0.594689502034053 |
|
16613 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MID1IP1 |
0.59476557863516 |
|
16614 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LSM5 |
0.594926394989198 |
|
16615 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR550A2 |
0.594926394989198 |
|
16616 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LDLRAD3 |
0.595055961485884 |
|
16617 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ALDH8A1 |
0.595148058370003 |
|
16618 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HBS1L |
0.595148058370003 |
|
16619 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MYB |
0.595148058370003 |
|
16620 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR548A2 |
0.595148058370003 |
|
16621 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
G3BP2 |
0.595161857982733 |
|
16622 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
USO1 |
0.595161857982733 |
|
16623 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPEF2 |
0.595161857982733 |
|
16624 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HIVEP3 |
0.595656303800693 |
|
16625 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ART3 |
0.595708603773295 |
|
16626 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NUP54 |
0.595708603773295 |
|
16627 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCARB2 |
0.595708603773295 |
|
16628 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM47E |
0.595708603773295 |
|
16629 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNHG14 |
0.595714683151809 |
|
16630 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UBE3A |
0.595714683151809 |
|
16631 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SH3BP2 |
0.595771841484006 |
|
16632 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADD1 |
0.595771841484006 |
|
16633 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PSD2 |
0.59595670836348 |
|
16634 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00678 |
0.595984835097522 |
|
16635 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BDNF |
0.595984835097522 |
|
16636 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LCP1 |
0.596031728797643 |
|
16637 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL288P |
0.596031728797643 |
|
16638 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRRC63 |
0.596031728797643 |
|
16639 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238483.1 |
0.596031728797643 |
|
16640 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP5 |
0.596031728797643 |
|
16641 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00563 |
0.596031728797643 |
|
16642 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIAA0226L |
0.596031728797643 |
|
16643 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRCH1 |
0.596031728797643 |
|
16644 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ESD |
0.596031728797643 |
|
16645 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EMP2 |
0.596508684665534 |
|
16646 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TEKT5 |
0.596508684665534 |
|
16647 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ASNSD1 |
0.5966097518965 |
|
16648 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANKAR |
0.5966097518965 |
|
16649 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OSGEPL1 |
0.5966097518965 |
|
16650 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ORMDL1 |
0.5966097518965 |
|
16651 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PMS1 |
0.5966097518965 |
|
16652 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF830 |
0.5967543635828 |
|
16653 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LIG3 |
0.5967543635828 |
|
16654 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MON2 |
0.596876536952854 |
|
16655 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C12orf61 |
0.596876536952854 |
|
16656 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIRLET7I |
0.596876536952854 |
|
16657 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238475.1 |
0.596876536952854 |
|
16658 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCAF8 |
0.597225416307128 |
|
16659 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR1273C |
0.597225416307128 |
|
16660 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U8|ENSG00000238963.1 |
0.597225416307128 |
|
16661 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WDR65 |
0.597383625147967 |
|
16662 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM125 |
0.597383625147967 |
|
16663 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C1orf210 |
0.597383625147967 |
|
16664 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TIE1 |
0.597383625147967 |
|
16665 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MPL |
0.597383625147967 |
|
16666 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDC20 |
0.597383625147967 |
|
16667 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ELOVL1 |
0.597383625147967 |
|
16668 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MED8 |
0.597383625147967 |
|
16669 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SZT2 |
0.597383625147967 |
|
16670 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNRPG |
0.597384314339852 |
|
16671 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM136A |
0.597384314339852 |
|
16672 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TGFA |
0.597384314339852 |
|
16673 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR2278 |
0.597500668943306 |
|
16674 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAFF |
0.597505852505884 |
|
16675 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HIST1H2AB |
0.5975825432583 |
|
16676 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HIST1H3B |
0.5975825432583 |
|
16677 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HIST1H1C |
0.5975825432583 |
|
16678 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HIST1H2BB |
0.5975825432583 |
|
16679 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HIST1H3C |
0.5975825432583 |
|
16680 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HFE |
0.5975825432583 |
|
16681 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HIST1H4C |
0.5975825432583 |
|
16682 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HIST1H1T |
0.5975825432583 |
|
16683 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC25A38 |
0.598016483585298 |
|
16684 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPSA |
0.598016483585298 |
|
16685 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA62|ENSG00000202363.1 |
0.598016483585298 |
|
16686 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA6 |
0.598016483585298 |
|
16687 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BBS9 |
0.598227208379264 |
|
16688 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AVL9 |
0.598340298704544 |
|
16689 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA31|ENSG00000251999.1 |
0.598340298704544 |
|
16690 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KBTBD2 |
0.598340298704544 |
|
16691 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RP9P |
0.598340298704544 |
|
16692 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FKBP9 |
0.598340298704544 |
|
16693 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NT5C3A |
0.598340298704544 |
|
16694 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL505P |
0.598340298704544 |
|
16695 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZFAT |
0.598423080111378 |
|
16696 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR30B |
0.598423080111378 |
|
16697 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR30D |
0.598423080111378 |
|
16698 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NHSL2 |
0.599173596666255 |
|
16699 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RGAG4 |
0.599173596666255 |
|
16700 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL388P |
0.599173596666255 |
|
16701 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDX4 |
0.599173596666255 |
|
16702 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAP2K4P1 |
0.599173596666255 |
|
16703 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CHIC1 |
0.599173596666255 |
|
16704 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00977 |
0.599236503774671 |
|
16705 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARFGEF1 |
0.599422452738939 |
|
16706 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HIPK3 |
0.599425862599721 |
|
16707 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIAA1549L |
0.599425862599721 |
|
16708 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C11orf91 |
0.599425862599721 |
|
16709 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CD59 |
0.599425862599721 |
|
16710 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FBXO3 |
0.599425862599721 |
|
16711 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LMO2 |
0.599425862599721 |
|
16712 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CAPRIN1 |
0.599425862599721 |
|
16713 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF512 |
0.600005827250374 |
|
16714 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC121 |
0.600005827250374 |
|
16715 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPN1 |
0.600005827250374 |
|
16716 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA36|ENSG00000206731.1 |
0.600005827250374 |
|
16717 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SUPT7L |
0.600005827250374 |
|
16718 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC4A1AP |
0.600005827250374 |
|
16719 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MRPL33 |
0.600005827250374 |
|
16720 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RBKS |
0.600005827250374 |
|
16721 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZCCHC16 |
0.600032868725271 |
|
16722 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HOXB3 |
0.600266577514686 |
|
16723 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UGT2B4 |
0.600376292345638 |
|
16724 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UGT2A1 |
0.600376292345638 |
|
16725 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UGT2A2 |
0.600376292345638 |
|
16726 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SULT1B1 |
0.600376292345638 |
|
16727 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SULT1E1 |
0.600376292345638 |
|
16728 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CSN1S1 |
0.600376292345638 |
|
16729 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CSN2 |
0.600376292345638 |
|
16730 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STATH |
0.600376292345638 |
|
16731 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HTN3 |
0.600376292345638 |
|
16732 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HTN1 |
0.600376292345638 |
|
16733 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CSN1S2AP |
0.600376292345638 |
|
16734 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MYC |
0.600412435944595 |
|
16735 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FOSL2 |
0.600473322586746 |
|
16736 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NIPAL2 |
0.600697811523976 |
|
16737 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCNS2 |
0.600697811523976 |
|
16738 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP85 |
0.600697811523976 |
|
16739 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OSR2 |
0.600697811523976 |
|
16740 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR599 |
0.600697811523976 |
|
16741 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR875 |
0.600697811523976 |
|
16742 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL350P |
0.600697811523976 |
|
16743 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4263 |
0.600770577622566 |
|
16744 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF558 |
0.600838266566807 |
|
16745 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AREG |
0.600888806912078 |
|
16746 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HEXB |
0.601172150670722 |
|
16747 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4665 |
0.601259159495606 |
|
16748 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RANBP6 |
0.601259159495606 |
|
16749 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NOTUM |
0.601338985222734 |
|
16750 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MUSK |
0.601393837061404 |
|
16751 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SMTNL1 |
0.60144158733664 |
|
16752 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UBE2L6 |
0.60144158733664 |
|
16753 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SERPING1 |
0.60144158733664 |
|
16754 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR130A |
0.60144158733664 |
|
16755 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
YPEL4 |
0.60144158733664 |
|
16756 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLP1 |
0.60144158733664 |
|
16757 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZDHHC5 |
0.60144158733664 |
|
16758 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARPP21 |
0.601476228172679 |
|
16759 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPATA17 |
0.601547973705467 |
|
16760 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CNNM4 |
0.601683923835366 |
|
16761 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3127 |
0.601683923835366 |
|
16762 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CNNM3 |
0.601683923835366 |
|
16763 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL184P |
0.602152264686502 |
|
16764 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CAMK2D |
0.602152264686502 |
|
16765 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARSJ |
0.602152264686502 |
|
16766 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC28A |
0.602330724084619 |
|
16767 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ECT2L |
0.602330724084619 |
|
16768 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
REPS1 |
0.602330724084619 |
|
16769 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SRL |
0.602722167149917 |
|
16770 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CD7 |
0.603135039424257 |
|
16771 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SECTM1 |
0.603135039424257 |
|
16772 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TEX19 |
0.603135039424257 |
|
16773 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UTS2R |
0.603135039424257 |
|
16774 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LIN7B |
0.603170546975598 |
|
16775 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C19orf73 |
0.603170546975598 |
|
16776 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPFIA3 |
0.603170546975598 |
|
16777 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HRC |
0.603170546975598 |
|
16778 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRPM4 |
0.603170546975598 |
|
16779 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BMP15 |
0.603556728785558 |
|
16780 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RMI1 |
0.603715646775205 |
|
16781 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC28A3 |
0.603715646775205 |
|
16782 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NTRK2 |
0.603715646775205 |
|
16783 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C1orf21 |
0.603737302436508 |
|
16784 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FOXO6 |
0.603917799791814 |
|
16785 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP45 |
0.603917799791814 |
|
16786 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EDN2 |
0.603917799791814 |
|
16787 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GUCA2B |
0.603917799791814 |
|
16788 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GUCA2A |
0.603917799791814 |
|
16789 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FOXJ3 |
0.603917799791814 |
|
16790 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ST3GAL1 |
0.604055758072487 |
|
16791 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA40|ENSG00000212273.1 |
0.604055758072487 |
|
16792 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP84 |
0.604140100576456 |
|
16793 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP238 |
0.604140100576456 |
|
16794 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP322 |
0.604140100576456 |
|
16795 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PBOV1 |
0.604357571959473 |
|
16796 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MRS2 |
0.604459713835917 |
|
16797 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPLD1 |
0.604459713835917 |
|
16798 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ALDH5A1 |
0.604459713835917 |
|
16799 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIAA0319 |
0.604459713835917 |
|
16800 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TDP2 |
0.604459713835917 |
|
16801 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACOT13 |
0.604459713835917 |
|
16802 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C6orf62 |
0.604459713835917 |
|
16803 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GMNN |
0.604459713835917 |
|
16804 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM65B |
0.604459713835917 |
|
16805 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL334P |
0.604459713835917 |
|
16806 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CMAHP |
0.604459713835917 |
|
16807 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNY5P5 |
0.604459713835917 |
|
16808 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPR98 |
0.60493781352385 |
|
16809 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KHDRBS3 |
0.605078628169293 |
|
16810 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNTG1 |
0.605798691859565 |
|
16811 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAB4A |
0.605849843666857 |
|
16812 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPHAR |
0.605849843666857 |
|
16813 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCSAP |
0.605849843666857 |
|
16814 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF669 |
0.605864167412127 |
|
16815 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C1orf229 |
0.605864167412127 |
|
16816 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF124 |
0.605864167412127 |
|
16817 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3916 |
0.605864167412127 |
|
16818 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP82 |
0.605864167412127 |
|
16819 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CYP26B1 |
0.6059177136645 |
|
16820 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MED7 |
0.606003436718327 |
|
16821 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ITK |
0.606003436718327 |
|
16822 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM71B |
0.606003436718327 |
|
16823 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CYFIP2 |
0.606003436718327 |
|
16824 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FNDC9 |
0.606003436718327 |
|
16825 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP32 |
0.606087851529228 |
|
16826 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DPYS |
0.606095197769323 |
|
16827 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR548A3 |
0.606095197769323 |
|
16828 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRP12 |
0.606095197769323 |
|
16829 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP275 |
0.606146808233832 |
|
16830 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RSPO2 |
0.606146808233832 |
|
16831 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HIF3A |
0.606164510644018 |
|
16832 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPP5C |
0.606164510644018 |
|
16833 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZMIZ1 |
0.606201040604574 |
|
16834 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00330 |
0.60624932701776 |
|
16835 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NUFIP1 |
0.60624932701776 |
|
16836 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIAA1704 |
0.60624932701776 |
|
16837 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL49P |
0.60624932701776 |
|
16838 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP3 |
0.60624932701776 |
|
16839 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GTF2F2 |
0.60624932701776 |
|
16840 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
7SK|ENSG00000271818.1 |
0.60624932701776 |
|
16841 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCTD4 |
0.60624932701776 |
|
16842 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA31|ENSG00000253051.1 |
0.60624932701776 |
|
16843 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TPT1 |
0.60624932701776 |
|
16844 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA31|ENSG00000199477.1 |
0.60624932701776 |
|
16845 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC25A30 |
0.60624932701776 |
|
16846 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COG3 |
0.60624932701776 |
|
16847 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM194B |
0.60624932701776 |
|
16848 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP27 |
0.60624932701776 |
|
16849 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPERT |
0.60624932701776 |
|
16850 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SIAH3 |
0.60624932701776 |
|
16851 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZC3H13 |
0.60624932701776 |
|
16852 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CPB2 |
0.60624932701776 |
|
16853 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SMS |
0.606266959190515 |
|
16854 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ING3 |
0.606589270895199 |
|
16855 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP240 |
0.606589270895199 |
|
16856 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CPED1 |
0.606589270895199 |
|
16857 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP241 |
0.606589270895199 |
|
16858 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WNT16 |
0.606589270895199 |
|
16859 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM3C |
0.606589270895199 |
|
16860 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PELO |
0.606751852802244 |
|
16861 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPAT2 |
0.606893164394175 |
|
16862 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADRA2B |
0.606893164394175 |
|
16863 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ASTL |
0.606893164394175 |
|
16864 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DUSP2 |
0.606893164394175 |
|
16865 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STARD7 |
0.606893164394175 |
|
16866 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RRP15 |
0.606906627607682 |
|
16867 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TSGA10 |
0.60705037150097 |
|
16868 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP104 |
0.607076114759261 |
|
16869 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HEBP2 |
0.607107183238591 |
|
16870 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NHSL1 |
0.607107183238591 |
|
16871 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3145 |
0.607107183238591 |
|
16872 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
XIRP1 |
0.607131410769529 |
|
16873 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CX3CR1 |
0.607131410769529 |
|
16874 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCR8 |
0.607131410769529 |
|
16875 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MOBP |
0.607131410769529 |
|
16876 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLOD2 |
0.607159087245207 |
|
16877 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLSCR4 |
0.607159087245207 |
|
16878 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLSCR2 |
0.607159087245207 |
|
16879 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLSCR1 |
0.607159087245207 |
|
16880 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLSCR5 |
0.607159087245207 |
|
16881 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U3|ENSG00000251800.1 |
0.607159087245207 |
|
16882 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ST20 |
0.60756593377987 |
|
16883 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C15ORF37 |
0.60756593377987 |
|
16884 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C15orf37 |
0.60756593377987 |
|
16885 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238781.1 |
0.607608478974384 |
|
16886 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CTXN3 |
0.607877896437296 |
|
16887 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL430P |
0.608094720423558 |
|
16888 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CIB2 |
0.608690063964915 |
|
16889 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IDH3A |
0.608690063964915 |
|
16890 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL815P |
0.608752580162741 |
|
16891 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PFAS |
0.608871890572737 |
|
16892 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KRBOX1 |
0.608916926497802 |
|
16893 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM198A |
0.608916926497802 |
|
16894 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANKRD40 |
0.609002355496755 |
|
16895 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LUC7L3 |
0.609002355496755 |
|
16896 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00483 |
0.609002355496755 |
|
16897 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WFIKKN2 |
0.609002355496755 |
|
16898 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP276 |
0.609263880918141 |
|
16899 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACTA1 |
0.609263880918141 |
|
16900 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NUP133 |
0.609263880918141 |
|
16901 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC25A35 |
0.609288218858789 |
|
16902 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RANGRF |
0.609288218858789 |
|
16903 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CPB1 |
0.609345808030064 |
|
16904 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TXN2 |
0.609720107207409 |
|
16905 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FOXRED2 |
0.609720107207409 |
|
16906 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EIF3D |
0.609720107207409 |
|
16907 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CACNG2 |
0.609720107207409 |
|
16908 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DNAJA3 |
0.609733006025891 |
|
16909 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATP9B |
0.60986142693049 |
|
16910 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GABRB2 |
0.60992952846421 |
|
16911 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GABRA6 |
0.60992952846421 |
|
16912 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GABRA1 |
0.60992952846421 |
|
16913 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GABRG2 |
0.60992952846421 |
|
16914 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GLUD1 |
0.61004586491468 |
|
16915 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM35A |
0.61004586491468 |
|
16916 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00863 |
0.61004586491468 |
|
16917 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NUTM2A |
0.61004586491468 |
|
16918 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NUTM2D |
0.61004586491468 |
|
16919 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL733P |
0.61004586491468 |
|
16920 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RANBP17 |
0.610096958598553 |
|
16921 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GLYATL2 |
0.610107277536827 |
|
16922 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GLYATL1P2 |
0.610107277536827 |
|
16923 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MKL1 |
0.610180813182229 |
|
16924 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MCHR1 |
0.610180813182229 |
|
16925 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TFAP4 |
0.610193361868093 |
|
16926 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GLIS2 |
0.610193361868093 |
|
16927 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PAM16 |
0.610193361868093 |
|
16928 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CORO7 |
0.610193361868093 |
|
16929 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VASN |
0.610193361868093 |
|
16930 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DHDH |
0.610330420088862 |
|
16931 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BAX |
0.610330420088862 |
|
16932 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FTL |
0.610330420088862 |
|
16933 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GYS1 |
0.610330420088862 |
|
16934 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RUVBL2 |
0.610330420088862 |
|
16935 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LHB |
0.610330420088862 |
|
16936 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CGB2 |
0.610330420088862 |
|
16937 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CGB |
0.610330420088862 |
|
16938 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CGB1 |
0.610330420088862 |
|
16939 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CGB5 |
0.610330420088862 |
|
16940 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CGB7 |
0.610330420088862 |
|
16941 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CGB8 |
0.610330420088862 |
|
16942 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NTF4 |
0.610330420088862 |
|
16943 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCNA7 |
0.610330420088862 |
|
16944 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL708P |
0.610330420088862 |
|
16945 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNRNP70 |
0.610330420088862 |
|
16946 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LSAMP |
0.610337003553122 |
|
16947 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HAUS3 |
0.610448155455355 |
|
16948 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FLYWCH2 |
0.61051058478515 |
|
16949 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FLYWCH1 |
0.61051058478515 |
|
16950 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNY4P18 |
0.610521879461809 |
|
16951 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR2K2 |
0.610521879461809 |
|
16952 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIAA0368 |
0.610521879461809 |
|
16953 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP294 |
0.610521879461809 |
|
16954 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF483 |
0.610521879461809 |
|
16955 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PTGR1 |
0.610521879461809 |
|
16956 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRRC37A5P |
0.610521879461809 |
|
16957 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DNAJC25 |
0.610521879461809 |
|
16958 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GNG10 |
0.610521879461809 |
|
16959 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GCAT |
0.610541961429129 |
|
16960 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
H1F0 |
0.610541961429129 |
|
16961 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANKRD54 |
0.610541961429129 |
|
16962 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GALR3 |
0.610541961429129 |
|
16963 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR658 |
0.610541961429129 |
|
16964 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EIF3L |
0.610541961429129 |
|
16965 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR659 |
0.610541961429129 |
|
16966 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF503 |
0.610543802429188 |
|
16967 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR5B12 |
0.610634796145783 |
|
16968 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL799P |
0.611063632959077 |
|
16969 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ASB12 |
0.611063632959077 |
|
16970 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRRG4 |
0.611126287338446 |
|
16971 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPM1G |
0.611506472732096 |
|
16972 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NRBP1 |
0.611506472732096 |
|
16973 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IFT172 |
0.611506472732096 |
|
16974 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KRTCAP3 |
0.611506472732096 |
|
16975 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FNDC4 |
0.611506472732096 |
|
16976 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CHD2 |
0.611531043849046 |
|
16977 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3175 |
0.611531043849046 |
|
16978 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RGMA |
0.611531043849046 |
|
16979 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STXBP1 |
0.612088993163717 |
|
16980 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FOXP1 |
0.612278053304825 |
|
16981 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR1284 |
0.612278053304825 |
|
16982 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EIF4E3 |
0.612278053304825 |
|
16983 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
JPH1 |
0.612407907510441 |
|
16984 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IL15 |
0.612610434564837 |
|
16985 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARHGEF9 |
0.613132090398229 |
|
16986 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR1468 |
0.613132090398229 |
|
16987 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL716P |
0.613444231293369 |
|
16988 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRIM37 |
0.613444231293369 |
|
16989 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SKA2 |
0.613444231293369 |
|
16990 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRR11 |
0.613444231293369 |
|
16991 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SMG8 |
0.613444231293369 |
|
16992 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GDPD1 |
0.613444231293369 |
|
16993 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
YPEL2 |
0.613444231293369 |
|
16994 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4729 |
0.613444231293369 |
|
16995 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CADM2 |
0.613448438162504 |
|
16996 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCNK3 |
0.613492135539423 |
|
16997 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CENPA |
0.613492135539423 |
|
16998 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC35F6 |
0.613492135539423 |
|
16999 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DPYSL5 |
0.613492135539423 |
|
17000 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
THRAP3 |
0.613802158631619 |
|
17001 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SH3D21 |
0.613802158631619 |
|
17002 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U8|ENSG00000201809.1 |
0.613892282551522 |
|
17003 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CPO |
0.6140996737251 |
|
17004 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NAF1 |
0.614266749813932 |
|
17005 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NPY1R |
0.614266749813932 |
|
17006 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NPY5R |
0.614266749813932 |
|
17007 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GBE1 |
0.614496450480305 |
|
17008 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM159 |
0.614496561962227 |
|
17009 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZP2 |
0.614496561962227 |
|
17010 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANKS4B |
0.614496561962227 |
|
17011 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CRYM |
0.614496561962227 |
|
17012 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HIST1H4D |
0.614769049161414 |
|
17013 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LIPT1 |
0.615094478430624 |
|
17014 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MRPL30 |
0.615094478430624 |
|
17015 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MITD1 |
0.615094478430624 |
|
17016 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CACNA1E |
0.615152819396733 |
|
17017 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP70 |
0.615152819396733 |
|
17018 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP229 |
0.615152819396733 |
|
17019 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF648 |
0.615152819396733 |
|
17020 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GLUL |
0.615152819396733 |
|
17021 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TEDDM1 |
0.615152819396733 |
|
17022 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00272 |
0.615152819396733 |
|
17023 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNASEL |
0.615152819396733 |
|
17024 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RGS16 |
0.615152819396733 |
|
17025 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RGS8 |
0.615152819396733 |
|
17026 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRRG1 |
0.615190410831236 |
|
17027 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MUC8 |
0.615261097710583 |
|
17028 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FBRSL1 |
0.615261097710583 |
|
17029 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANHX |
0.615261097710583 |
|
17030 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANKLE2 |
0.615261097710583 |
|
17031 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CHFR |
0.615261097710583 |
|
17032 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GOLGA3 |
0.615261097710583 |
|
17033 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRCOL1 |
0.615261097710583 |
|
17034 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
P2RX2 |
0.615261097710583 |
|
17035 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PGAM5 |
0.615261097710583 |
|
17036 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
POLE |
0.615261097710583 |
|
17037 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PXMP2 |
0.615261097710583 |
|
17038 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP379 |
0.615261097710583 |
|
17039 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNU4ATAC12P |
0.615261097710583 |
|
17040 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF10 |
0.615261097710583 |
|
17041 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF140 |
0.615261097710583 |
|
17042 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF268 |
0.615261097710583 |
|
17043 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF26 |
0.615261097710583 |
|
17044 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF605 |
0.615261097710583 |
|
17045 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF84 |
0.615261097710583 |
|
17046 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF891 |
0.615261097710583 |
|
17047 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ASB15 |
0.615507344160939 |
|
17048 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCT6P3 |
0.615562232078333 |
|
17049 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
INTS4L1 |
0.615562232078333 |
|
17050 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
INTS4L2 |
0.615562232078333 |
|
17051 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA15|ENSG00000207062.1 |
0.615562232078333 |
|
17052 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA22|ENSG00000207344.1 |
0.615562232078333 |
|
17053 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA63|ENSG00000200130.1 |
0.615562232078333 |
|
17054 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA63|ENSG00000252102.1 |
0.615562232078333 |
|
17055 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF92 |
0.615562232078333 |
|
17056 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZSCAN1 |
0.615668725122208 |
|
17057 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF135 |
0.615668725122208 |
|
17058 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL526P |
0.615668725122208 |
|
17059 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZSCAN18 |
0.615668725122208 |
|
17060 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RYBP |
0.615785250313771 |
|
17061 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RFC3 |
0.615878573577502 |
|
17062 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA25|ENSG00000199196.1 |
0.615878573577502 |
|
17063 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAB21L1 |
0.615934888471067 |
|
17064 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DCLK1 |
0.615934888471067 |
|
17065 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARL2BPP3 |
0.615934888471067 |
|
17066 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RFXAP |
0.615934888471067 |
|
17067 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SMAD9 |
0.615934888471067 |
|
17068 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ALG5 |
0.615934888471067 |
|
17069 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EXOSC8 |
0.615934888471067 |
|
17070 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SUPT20H |
0.615934888471067 |
|
17071 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CSNK1A1L |
0.615934888471067 |
|
17072 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP1 |
0.615934888471067 |
|
17073 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
POSTN |
0.615934888471067 |
|
17074 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRPC4 |
0.615934888471067 |
|
17075 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF687 |
0.616011402911735 |
|
17076 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PI4KB |
0.616011402911735 |
|
17077 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL444P |
0.616011402911735 |
|
17078 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SSTR2 |
0.616238066129408 |
|
17079 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COG1 |
0.616238066129408 |
|
17080 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM104A |
0.616238066129408 |
|
17081 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C17orf80 |
0.616238066129408 |
|
17082 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CPSF4L |
0.616238066129408 |
|
17083 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MTRNR2L9 |
0.616241406932319 |
|
17084 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCT4 |
0.616372401763155 |
|
17085 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR454 |
0.616426985235033 |
|
17086 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR301A |
0.616426985235033 |
|
17087 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PDE7B |
0.616517299128898 |
|
17088 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COX5BP2 |
0.616517299128898 |
|
17089 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MTFR2 |
0.616517299128898 |
|
17090 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BCLAF1 |
0.616517299128898 |
|
17091 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00113 |
0.617126197062935 |
|
17092 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EFNA5 |
0.617225462090504 |
|
17093 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL782P |
0.617225462090504 |
|
17094 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP122 |
0.617225462090504 |
|
17095 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FBXL17 |
0.617225462090504 |
|
17096 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CXCL13 |
0.617319940029406 |
|
17097 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STAC |
0.617422862214108 |
|
17098 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP227 |
0.617422862214108 |
|
17099 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRANK1 |
0.617422862214108 |
|
17100 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNU6ATAC4P |
0.617422862214108 |
|
17101 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRRFIP2 |
0.617422862214108 |
|
17102 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GOLGA4 |
0.617422862214108 |
|
17103 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP129 |
0.617422862214108 |
|
17104 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C3orf35 |
0.617422862214108 |
|
17105 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM207A |
0.617597370681701 |
|
17106 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00163 |
0.617597370681701 |
|
17107 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00162 |
0.617597370681701 |
|
17108 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANKRD34B |
0.617768298031804 |
|
17109 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DHFR |
0.617768298031804 |
|
17110 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MTRNR2L2 |
0.617768298031804 |
|
17111 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MSH3 |
0.617768298031804 |
|
17112 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RASGRF2 |
0.617768298031804 |
|
17113 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CKMT2 |
0.617768298031804 |
|
17114 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZCCHC9 |
0.617768298031804 |
|
17115 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACOT12 |
0.617768298031804 |
|
17116 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SSBP2 |
0.617768298031804 |
|
17117 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL181P |
0.617789025551993 |
|
17118 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FANCD2OS |
0.617889183696998 |
|
17119 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANKRD23 |
0.61805372856682 |
|
17120 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANKRD39 |
0.61805372856682 |
|
17121 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SEMA4C |
0.61805372856682 |
|
17122 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLB1 |
0.618110176996516 |
|
17123 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP89 |
0.618110176996516 |
|
17124 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPP1CB |
0.618110176996516 |
|
17125 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM179A |
0.618110176996516 |
|
17126 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD53 |
0.618110176996516 |
|
17127 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD92 |
0.618110176996516 |
|
17128 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPDYA |
0.618110176996516 |
|
17129 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRMT61B |
0.618110176996516 |
|
17130 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WDR43 |
0.618110176996516 |
|
17131 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL177P |
0.618406570752462 |
|
17132 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AGO4 |
0.618625425640993 |
|
17133 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CNTRL |
0.619189254696151 |
|
17134 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAB14 |
0.619189254696151 |
|
17135 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4465 |
0.619255012594104 |
|
17136 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TPTE2 |
0.619437780280947 |
|
17137 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COL27A1 |
0.619512751286126 |
|
17138 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC158 |
0.619666643226667 |
|
17139 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM174B |
0.6197514727072 |
|
17140 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZFPM2 |
0.620180880108188 |
|
17141 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF792 |
0.620331860093546 |
|
17142 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GRAMD1A |
0.620331860093546 |
|
17143 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCN1B |
0.620331860093546 |
|
17144 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HPN |
0.620331860093546 |
|
17145 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FXYD3 |
0.620331860093546 |
|
17146 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LGI4 |
0.620331860093546 |
|
17147 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FXYD1 |
0.620331860093546 |
|
17148 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FXYD7 |
0.620331860093546 |
|
17149 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FXYD5 |
0.620331860093546 |
|
17150 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPIF |
0.620808184925302 |
|
17151 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZCCHC24 |
0.620808184925302 |
|
17152 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANXA11 |
0.620808184925302 |
|
17153 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EIF5AL1 |
0.620808184925302 |
|
17154 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00857 |
0.620808184925302 |
|
17155 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MBL1P |
0.620808184925302 |
|
17156 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NUTM2B |
0.620808184925302 |
|
17157 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NUTM2E |
0.620808184925302 |
|
17158 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLAC9 |
0.620808184925302 |
|
17159 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SFTPA1 |
0.620808184925302 |
|
17160 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SFTPA2 |
0.620808184925302 |
|
17161 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SFTPD |
0.620808184925302 |
|
17162 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM254 |
0.620808184925302 |
|
17163 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZC3H12A |
0.620891387672524 |
|
17164 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238871.1 |
0.620891387672524 |
|
17165 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MANEAL |
0.620891387672524 |
|
17166 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
YRDC |
0.620891387672524 |
|
17167 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C1orf122 |
0.620891387672524 |
|
17168 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP117 |
0.62097335092695 |
|
17169 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF608 |
0.620980835244179 |
|
17170 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PMCHL2 |
0.620987555436996 |
|
17171 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR610 |
0.621482801923545 |
|
17172 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAP7 |
0.621582852439877 |
|
17173 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
7SK|ENSG00000271765.1 |
0.621582852439877 |
|
17174 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAP3K5 |
0.621582852439877 |
|
17175 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP219 |
0.621582852439877 |
|
17176 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PEX7 |
0.621582852439877 |
|
17177 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA27|ENSG00000201807.1 |
0.621582852439877 |
|
17178 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TG |
0.621747785862082 |
|
17179 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLA |
0.621747785862082 |
|
17180 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM114A2 |
0.62186833718596 |
|
17181 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UBE3C |
0.621993466129225 |
|
17182 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IFNGR1 |
0.622000246951839 |
|
17183 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CAST |
0.622129891505204 |
|
17184 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP206 |
0.622260986585666 |
|
17185 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GSDMC |
0.622260986585666 |
|
17186 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM49B |
0.622260986585666 |
|
17187 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA25|ENSG00000200075.1 |
0.622260986585666 |
|
17188 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR5194 |
0.622260986585666 |
|
17189 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NPAP1 |
0.622320657882815 |
|
17190 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNRPN |
0.622320657882815 |
|
17191 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238615.1 |
0.622320657882815 |
|
17192 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNURF |
0.622320657882815 |
|
17193 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD64|ENSG00000270704.2 |
0.622320657882815 |
|
17194 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD108 |
0.622320657882815 |
|
17195 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD109A |
0.622320657882815 |
|
17196 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD115|ENSG00000212428.1 |
0.622320657882815 |
|
17197 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD109B |
0.622320657882815 |
|
17198 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADPRM |
0.622574111567505 |
|
17199 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM220 |
0.622574111567505 |
|
17200 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAGOH2 |
0.622574111567505 |
|
17201 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TNKS1BP1 |
0.623056336178033 |
|
17202 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SSRP1 |
0.623056336178033 |
|
17203 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238692.1 |
0.623056336178033 |
|
17204 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HMGCLL1 |
0.623199269989821 |
|
17205 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MED12L |
0.623406847473261 |
|
17206 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP145 |
0.623406847473261 |
|
17207 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPR171 |
0.623406847473261 |
|
17208 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
P2RY14 |
0.623406847473261 |
|
17209 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPR87 |
0.623406847473261 |
|
17210 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
P2RY13 |
0.623406847473261 |
|
17211 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
P2RY12 |
0.623406847473261 |
|
17212 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IGSF10 |
0.623406847473261 |
|
17213 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR5186 |
0.623406847473261 |
|
17214 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP288 |
0.623450023868849 |
|
17215 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TAS2R16 |
0.623725192001643 |
|
17216 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC13A1 |
0.623725192001643 |
|
17217 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TERF1 |
0.62408583247131 |
|
17218 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SBSPON |
0.62408583247131 |
|
17219 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PARP8 |
0.624176039971062 |
|
17220 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR345 |
0.624186582844291 |
|
17221 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL523P |
0.624186582844291 |
|
17222 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC25A47 |
0.624186582844291 |
|
17223 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WARS |
0.624186582844291 |
|
17224 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WDR25 |
0.624186582844291 |
|
17225 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AREGB |
0.624191335800504 |
|
17226 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PHF23 |
0.624269129338413 |
|
17227 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GABARAP |
0.624269129338413 |
|
17228 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CTDNEP1 |
0.624269129338413 |
|
17229 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ELP5 |
0.624269129338413 |
|
17230 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLDN7 |
0.624269129338413 |
|
17231 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRRN3 |
0.624508357311895 |
|
17232 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238922.1 |
0.624508357311895 |
|
17233 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP220 |
0.624791073046353 |
|
17234 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3668 |
0.624791073046353 |
|
17235 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COMMD1 |
0.625123564476075 |
|
17236 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FTMT |
0.625151611804652 |
|
17237 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNX2 |
0.625151611804652 |
|
17238 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000252295.1 |
0.625151611804652 |
|
17239 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000239103.1 |
0.625151611804652 |
|
17240 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MARCH11 |
0.625304884620295 |
|
17241 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAPRE3 |
0.625456305849275 |
|
17242 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM214 |
0.625456305849275 |
|
17243 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AGBL5 |
0.625456305849275 |
|
17244 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OST4 |
0.625456305849275 |
|
17245 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EMILIN1 |
0.625456305849275 |
|
17246 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KHK |
0.625456305849275 |
|
17247 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CGREF1 |
0.625456305849275 |
|
17248 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ABHD1 |
0.625456305849275 |
|
17249 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PREB |
0.625456305849275 |
|
17250 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C2orf53 |
0.625456305849275 |
|
17251 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TCF23 |
0.625456305849275 |
|
17252 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC5A6 |
0.625456305849275 |
|
17253 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATRAID |
0.625456305849275 |
|
17254 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CAD |
0.625456305849275 |
|
17255 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC30A3 |
0.625456305849275 |
|
17256 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DNAJC5G |
0.625456305849275 |
|
17257 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRIM54 |
0.625456305849275 |
|
17258 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MPV17 |
0.625456305849275 |
|
17259 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UCN |
0.625456305849275 |
|
17260 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GTF3C2 |
0.625456305849275 |
|
17261 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EIF2B4 |
0.625456305849275 |
|
17262 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNX17 |
0.625456305849275 |
|
17263 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF513 |
0.625456305849275 |
|
17264 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00635 |
0.625558761957228 |
|
17265 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM38B |
0.625588340079788 |
|
17266 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAT1A |
0.625773419310299 |
|
17267 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DYDC1 |
0.625773419310299 |
|
17268 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DYDC2 |
0.625773419310299 |
|
17269 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM213A |
0.625773419310299 |
|
17270 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C2orf71 |
0.625894818798923 |
|
17271 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLIP4 |
0.625894818798923 |
|
17272 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SELK |
0.626028590321157 |
|
17273 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDCA4 |
0.626037309449515 |
|
17274 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPR132 |
0.626037309449515 |
|
17275 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPP1R17 |
0.626143693575601 |
|
17276 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TNNI3K |
0.626318852655994 |
|
17277 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRIOBP |
0.626418042477723 |
|
17278 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SRP9 |
0.626610933335009 |
|
17279 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EPHX1 |
0.626610933335009 |
|
17280 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM63A |
0.626610933335009 |
|
17281 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LEFTY1 |
0.626610933335009 |
|
17282 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PYCR2 |
0.626610933335009 |
|
17283 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LEFTY2 |
0.626610933335009 |
|
17284 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SDE2 |
0.626610933335009 |
|
17285 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACBD3 |
0.626610933335009 |
|
17286 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000239094.1 |
0.626610933335009 |
|
17287 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PARP1 |
0.626610933335009 |
|
17288 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP165 |
0.626610933335009 |
|
17289 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C1orf95 |
0.626610933335009 |
|
17290 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ITPKB |
0.626610933335009 |
|
17291 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PSEN2 |
0.626610933335009 |
|
17292 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADCK3 |
0.626610933335009 |
|
17293 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDC42BPA |
0.626610933335009 |
|
17294 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UBE2G2 |
0.626619309702015 |
|
17295 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SUMO3 |
0.626619309702015 |
|
17296 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PTTG1IP |
0.626619309702015 |
|
17297 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ITGB2 |
0.626619309702015 |
|
17298 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C21orf67 |
0.626619309702015 |
|
17299 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NSMCE1 |
0.62670697357391 |
|
17300 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IL4R |
0.62670697357391 |
|
17301 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SMYD3 |
0.626766412879642 |
|
17302 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AHCTF1 |
0.626766412879642 |
|
17303 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CNST |
0.626766412879642 |
|
17304 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCCPDH |
0.626766412879642 |
|
17305 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA25|ENSG00000252011.1 |
0.626766412879642 |
|
17306 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD112|ENSG00000252495.1 |
0.626766412879642 |
|
17307 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TFB2M |
0.626766412879642 |
|
17308 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TM9SF3 |
0.627135270435283 |
|
17309 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PIK3AP1 |
0.627135270435283 |
|
17310 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP324 |
0.627135270435283 |
|
17311 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR607 |
0.627135270435283 |
|
17312 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LCOR |
0.627135270435283 |
|
17313 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C10orf12 |
0.627135270435283 |
|
17314 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BRE |
0.627271353512691 |
|
17315 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA25|ENSG00000201701.1 |
0.627416599027153 |
|
17316 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPD1L |
0.627416599027153 |
|
17317 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238646.1 |
0.627416599027153 |
|
17318 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4508 |
0.627694458730866 |
|
17319 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MKRN3 |
0.627694458730866 |
|
17320 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAGEL2 |
0.627694458730866 |
|
17321 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NDN |
0.627694458730866 |
|
17322 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PWRN1 |
0.627694458730866 |
|
17323 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PWRN2 |
0.627694458730866 |
|
17324 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL533P |
0.628071034906145 |
|
17325 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238569.1 |
0.628145884007209 |
|
17326 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARHGAP23P1 |
0.62833600924282 |
|
17327 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HERC2P4 |
0.62833600924282 |
|
17328 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HERC2P5 |
0.62833600924282 |
|
17329 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HERC2P8 |
0.62833600924282 |
|
17330 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00273 |
0.62833600924282 |
|
17331 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP406 |
0.62833600924282 |
|
17332 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP407 |
0.62833600924282 |
|
17333 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP408 |
0.62833600924282 |
|
17334 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP409 |
0.62833600924282 |
|
17335 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP410 |
0.62833600924282 |
|
17336 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP413 |
0.62833600924282 |
|
17337 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP415 |
0.62833600924282 |
|
17338 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP416 |
0.62833600924282 |
|
17339 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP417 |
0.62833600924282 |
|
17340 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP418 |
0.62833600924282 |
|
17341 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP419 |
0.62833600924282 |
|
17342 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP420 |
0.62833600924282 |
|
17343 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP421 |
0.62833600924282 |
|
17344 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP422 |
0.62833600924282 |
|
17345 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP423 |
0.62833600924282 |
|
17346 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC6A10P |
0.62833600924282 |
|
17347 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TP53TG3B |
0.62833600924282 |
|
17348 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TP53TG3C |
0.62833600924282 |
|
17349 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TP53TG3D |
0.62833600924282 |
|
17350 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TP53TG3 |
0.62833600924282 |
|
17351 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF267 |
0.62833600924282 |
|
17352 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL366P |
0.628357235836196 |
|
17353 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EBAG9 |
0.628486400297631 |
|
17354 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD112|ENSG00000252559.1 |
0.628486400297631 |
|
17355 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADAM19 |
0.62856704758732 |
|
17356 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NIPAL4 |
0.62856704758732 |
|
17357 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LSM11 |
0.62856704758732 |
|
17358 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLINT1 |
0.62856704758732 |
|
17359 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EBF1 |
0.62856704758732 |
|
17360 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNF145 |
0.62856704758732 |
|
17361 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA68|ENSG00000252458.1 |
0.62856704758732 |
|
17362 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UBLCP1 |
0.62856704758732 |
|
17363 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IL12B |
0.62856704758732 |
|
17364 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNU4ATAC2P |
0.62856704758732 |
|
17365 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ENC1 |
0.629102460077062 |
|
17366 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FEZF1 |
0.629196047553953 |
|
17367 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM163B |
0.629522028379173 |
|
17368 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DBH |
0.629522028379173 |
|
17369 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM71 |
0.629590917416439 |
|
17370 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PHF20L1 |
0.629590917416439 |
|
17371 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WISP1 |
0.629590917416439 |
|
17372 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NDRG1 |
0.629590917416439 |
|
17373 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZSCAN4 |
0.63005295886111 |
|
17374 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF551 |
0.63005295886111 |
|
17375 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF154 |
0.63005295886111 |
|
17376 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF671 |
0.63005295886111 |
|
17377 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF776 |
0.63005295886111 |
|
17378 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF586 |
0.63005295886111 |
|
17379 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF552 |
0.63005295886111 |
|
17380 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TOB1 |
0.630540516504745 |
|
17381 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF727 |
0.63054666018478 |
|
17382 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF679 |
0.63054666018478 |
|
17383 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF736 |
0.63054666018478 |
|
17384 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM47C |
0.630912250509389 |
|
17385 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR148A |
0.631018367162345 |
|
17386 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00317 |
0.631221111277754 |
|
17387 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VHL |
0.631880895768657 |
|
17388 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IRAK2 |
0.631880895768657 |
|
17389 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TATDN2 |
0.631880895768657 |
|
17390 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AMER3 |
0.632024943960818 |
|
17391 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCARNA4|ENSG00000252829.2 |
0.632024943960818 |
|
17392 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM168B |
0.632024943960818 |
|
17393 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLEKHB2 |
0.632024943960818 |
|
17394 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CYP4F31P |
0.632024943960818 |
|
17395 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4784 |
0.632024943960818 |
|
17396 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MZT2A |
0.632024943960818 |
|
17397 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
POTEE |
0.632024943960818 |
|
17398 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TUBA3D |
0.632024943960818 |
|
17399 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC74A |
0.632024943960818 |
|
17400 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DEFB110 |
0.632276398731716 |
|
17401 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238746.1 |
0.632301067556428 |
|
17402 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C9orf66 |
0.632655151441877 |
|
17403 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CBWD1 |
0.632655151441877 |
|
17404 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DOCK8 |
0.632655151441877 |
|
17405 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM138C |
0.632655151441877 |
|
17406 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FOXD4 |
0.632655151441877 |
|
17407 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KANK1 |
0.632655151441877 |
|
17408 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL412P |
0.632655151441877 |
|
17409 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SMIM15 |
0.633035006348971 |
|
17410 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARPC5 |
0.633148762045613 |
|
17411 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RGL1 |
0.633148762045613 |
|
17412 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
APOBEC4 |
0.633148762045613 |
|
17413 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR4S1 |
0.633455219096706 |
|
17414 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR4C3 |
0.633455219096706 |
|
17415 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF573 |
0.633459874160038 |
|
17416 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIER3 |
0.633763034208231 |
|
17417 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPATA16 |
0.63376548707244 |
|
17418 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIAA0556 |
0.633827965784783 |
|
17419 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACSL1 |
0.63386873744256 |
|
17420 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HELT |
0.63386873744256 |
|
17421 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIAA1430 |
0.63386873744256 |
|
17422 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRP2BP |
0.63386873744256 |
|
17423 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3945 |
0.63386873744256 |
|
17424 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4455 |
0.63386873744256 |
|
17425 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC25A4 |
0.63386873744256 |
|
17426 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNX25 |
0.63386873744256 |
|
17427 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANKRD37 |
0.63386873744256 |
|
17428 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UFSP2 |
0.63386873744256 |
|
17429 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C4orf47 |
0.63386873744256 |
|
17430 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC110 |
0.63386873744256 |
|
17431 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PDLIM3 |
0.63386873744256 |
|
17432 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SORBS2 |
0.63386873744256 |
|
17433 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SULF1 |
0.633975490546432 |
|
17434 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DMRT1 |
0.633995639655635 |
|
17435 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DMRT2 |
0.633995639655635 |
|
17436 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DMRT3 |
0.633995639655635 |
|
17437 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP279 |
0.633995639655635 |
|
17438 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MBTD1 |
0.634041835458731 |
|
17439 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZADH2 |
0.635140942371814 |
|
17440 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TSHZ1 |
0.635140942371814 |
|
17441 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SMIM21 |
0.635140942371814 |
|
17442 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRIM44 |
0.635292425389099 |
|
17443 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLDND2 |
0.635305617417029 |
|
17444 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NKG7 |
0.635305617417029 |
|
17445 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LIM2 |
0.635305617417029 |
|
17446 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GRIA1 |
0.635319729863532 |
|
17447 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC25A29 |
0.635348632510318 |
|
17448 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP336 |
0.63537568422625 |
|
17449 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP337 |
0.63537568422625 |
|
17450 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NFIB |
0.635642775439052 |
|
17451 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MOB3B |
0.635766546013145 |
|
17452 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLCL2 |
0.635898492450252 |
|
17453 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3714 |
0.635898492450252 |
|
17454 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL582P |
0.636515367607346 |
|
17455 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NPL |
0.636537265289123 |
|
17456 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RASA2 |
0.636619749801421 |
|
17457 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNF7 |
0.636619749801421 |
|
17458 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GRK7 |
0.636619749801421 |
|
17459 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATP1B3 |
0.636619749801421 |
|
17460 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TFDP2 |
0.636619749801421 |
|
17461 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GK5 |
0.636619749801421 |
|
17462 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP143 |
0.636619749801421 |
|
17463 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLS1 |
0.636619749801421 |
|
17464 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP25 |
0.636619749801421 |
|
17465 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRPC1 |
0.636619749801421 |
|
17466 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCOLCE2 |
0.636619749801421 |
|
17467 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PAQR9 |
0.636619749801421 |
|
17468 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U2SURP |
0.636619749801421 |
|
17469 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CHST2 |
0.636619749801421 |
|
17470 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PBX2P1 |
0.636619749801421 |
|
17471 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PHKA1 |
0.636759683859705 |
|
17472 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U3|ENSG00000202482.1 |
0.636759683859705 |
|
17473 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TBX20 |
0.637341301796903 |
|
17474 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP199 |
0.637358858397569 |
|
17475 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARHGEF4 |
0.637533411464377 |
|
17476 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP188 |
0.637573832913668 |
|
17477 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DDX60L |
0.637573832913668 |
|
17478 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA51|ENSG00000207171.1 |
0.637573832913668 |
|
17479 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PALLD |
0.637573832913668 |
|
17480 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CBR4 |
0.637573832913668 |
|
17481 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4522 |
0.637841166017744 |
|
17482 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC17A4 |
0.638003657075574 |
|
17483 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC17A1 |
0.638003657075574 |
|
17484 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC17A3 |
0.638003657075574 |
|
17485 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC17A2 |
0.638003657075574 |
|
17486 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRIM38 |
0.638003657075574 |
|
17487 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HIST1H1A |
0.638003657075574 |
|
17488 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HIST1H3A |
0.638003657075574 |
|
17489 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HIST1H4A |
0.638003657075574 |
|
17490 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HIST1H4B |
0.638003657075574 |
|
17491 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPATCH2 |
0.638042102555386 |
|
17492 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COLGALT2 |
0.638092182836541 |
|
17493 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TSEN15 |
0.638092182836541 |
|
17494 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL654P |
0.638092182836541 |
|
17495 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR513C |
0.638348315272945 |
|
17496 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR513B |
0.638348315272945 |
|
17497 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR513A1 |
0.638348315272945 |
|
17498 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR513A2 |
0.638348315272945 |
|
17499 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR506 |
0.638348315272945 |
|
17500 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR507 |
0.638348315272945 |
|
17501 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR508 |
0.638348315272945 |
|
17502 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR514B |
0.638348315272945 |
|
17503 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR510 |
0.638348315272945 |
|
17504 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR514A1 |
0.638348315272945 |
|
17505 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR514A2 |
0.638348315272945 |
|
17506 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR514A3 |
0.638348315272945 |
|
17507 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC46A3 |
0.638491790634671 |
|
17508 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HMG20A |
0.638507677256316 |
|
17509 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINGO1 |
0.638507677256316 |
|
17510 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PTBP3 |
0.638507878185131 |
|
17511 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL57P |
0.638507878185131 |
|
17512 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP295 |
0.638507878185131 |
|
17513 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000239188.1 |
0.63851489193465 |
|
17514 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPANXN3 |
0.63851489193465 |
|
17515 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HEY2 |
0.638545600002378 |
|
17516 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADI1 |
0.638706530884153 |
|
17517 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNASEH1 |
0.638706530884153 |
|
17518 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPS7 |
0.638706530884153 |
|
17519 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA73|ENSG00000252531.1 |
0.638706530884153 |
|
17520 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COLEC11 |
0.638706530884153 |
|
17521 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ALLC |
0.638706530884153 |
|
17522 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DCDC2C |
0.638706530884153 |
|
17523 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR5T3 |
0.638874974856629 |
|
17524 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C2orf27A |
0.638885182890203 |
|
17525 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C2orf27B |
0.638885182890203 |
|
17526 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL701P |
0.638885182890203 |
|
17527 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EPB41L4A |
0.6395429958221 |
|
17528 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DEFB112 |
0.639565626964545 |
|
17529 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NAALADL2 |
0.639671637525371 |
|
17530 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AOAH |
0.639824208705455 |
|
17531 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR1200 |
0.639824208705455 |
|
17532 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238772.1 |
0.639824208705455 |
|
17533 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MEAF6 |
0.639842111274601 |
|
17534 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR5581 |
0.639842111274601 |
|
17535 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNIP1 |
0.639842111274601 |
|
17536 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DNALI1 |
0.639842111274601 |
|
17537 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GNL2 |
0.639842111274601 |
|
17538 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RSPO1 |
0.639842111274601 |
|
17539 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C1orf109 |
0.639842111274601 |
|
17540 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDCA8 |
0.639842111274601 |
|
17541 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EPHA10 |
0.639842111274601 |
|
17542 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CHRNB1 |
0.639847089179101 |
|
17543 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZBTB4 |
0.639847089179101 |
|
17544 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC35G6 |
0.639847089179101 |
|
17545 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
POLR2A |
0.639847089179101 |
|
17546 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TNFSF12 |
0.639847089179101 |
|
17547 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SENP3 |
0.639847089179101 |
|
17548 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TNFSF13 |
0.639847089179101 |
|
17549 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA48|ENSG00000209582.1 |
0.639847089179101 |
|
17550 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SOHLH2 |
0.639959570525387 |
|
17551 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IFNA5 |
0.639983181889061 |
|
17552 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KLHL9 |
0.639983181889061 |
|
17553 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IFNA6 |
0.639983181889061 |
|
17554 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IFNA13 |
0.639983181889061 |
|
17555 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IFNA2 |
0.639983181889061 |
|
17556 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IFNA8 |
0.639983181889061 |
|
17557 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IFNA1 |
0.639983181889061 |
|
17558 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR31HG |
0.639983181889061 |
|
17559 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IFNE |
0.639983181889061 |
|
17560 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR31 |
0.639983181889061 |
|
17561 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD39|ENSG00000264379.1 |
0.639983181889061 |
|
17562 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DMRTA1 |
0.639983181889061 |
|
17563 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HSDL2 |
0.640177112989427 |
|
17564 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C9orf147 |
0.640177112989427 |
|
17565 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIAA1958 |
0.640177112989427 |
|
17566 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA48|ENSG00000212604.1 |
0.640517057839041 |
|
17567 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00929 |
0.640517057839041 |
|
17568 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GABRB3 |
0.640517057839041 |
|
17569 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3713 |
0.640559776324531 |
|
17570 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNUPN |
0.640566960812041 |
|
17571 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IMP3 |
0.640566960812041 |
|
17572 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNX33 |
0.640566960812041 |
|
17573 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CSPG4 |
0.640566960812041 |
|
17574 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ODF3L1 |
0.640566960812041 |
|
17575 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DNM1P35 |
0.640566960812041 |
|
17576 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RIOK2 |
0.640618919414375 |
|
17577 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LYPD1 |
0.641067814451148 |
|
17578 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NCKAP5 |
0.641067814451148 |
|
17579 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP154 |
0.641067814451148 |
|
17580 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP93 |
0.641067814451148 |
|
17581 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EXOC6 |
0.641104466150692 |
|
17582 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CYP26C1 |
0.641104466150692 |
|
17583 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CYP26A1 |
0.641104466150692 |
|
17584 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR548H3 |
0.641177438027007 |
|
17585 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLSTN1 |
0.641289633644278 |
|
17586 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CTNNBIP1 |
0.641289633644278 |
|
17587 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LZIC |
0.641289633644278 |
|
17588 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NMNAT1 |
0.641289633644278 |
|
17589 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP269 |
0.641289633644278 |
|
17590 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR5697 |
0.641289633644278 |
|
17591 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RBP7 |
0.641289633644278 |
|
17592 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UBE4B |
0.641289633644278 |
|
17593 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIF1B |
0.641289633644278 |
|
17594 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR1273D |
0.641289633644278 |
|
17595 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL731P |
0.641289633644278 |
|
17596 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL721P |
0.641289633644278 |
|
17597 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PGD |
0.641289633644278 |
|
17598 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
APITD1 |
0.641289633644278 |
|
17599 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CORT |
0.641289633644278 |
|
17600 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DFFA |
0.641289633644278 |
|
17601 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC169 |
0.641296631165549 |
|
17602 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPG20 |
0.641296631165549 |
|
17603 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPG20OS |
0.641296631165549 |
|
17604 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCNA1 |
0.641296631165549 |
|
17605 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SERTM1 |
0.641296631165549 |
|
17606 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPOCK3 |
0.641506224330475 |
|
17607 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL776P |
0.641506224330475 |
|
17608 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA51|ENSG00000200113.1 |
0.641640960054451 |
|
17609 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VPS13B |
0.641652334328571 |
|
17610 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COX6C |
0.641652334328571 |
|
17611 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RGS22 |
0.641652334328571 |
|
17612 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD77|ENSG00000212414.1 |
0.641652334328571 |
|
17613 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR1273A |
0.641652334328571 |
|
17614 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3659 |
0.64169620732223 |
|
17615 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NARS2 |
0.64170019373965 |
|
17616 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPR27 |
0.642105212981307 |
|
17617 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PROK2 |
0.642105212981307 |
|
17618 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL271P |
0.642105212981307 |
|
17619 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAML3 |
0.642239583273493 |
|
17620 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP253 |
0.642239583273493 |
|
17621 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD112|ENSG00000252790.1 |
0.642290585813458 |
|
17622 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EDEM3 |
0.642290585813458 |
|
17623 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STRADA |
0.642418279870851 |
|
17624 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC47 |
0.642418279870851 |
|
17625 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DDX42 |
0.642418279870851 |
|
17626 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U8|ENSG00000200026.1 |
0.642459109851697 |
|
17627 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00877 |
0.642614348940048 |
|
17628 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00870 |
0.642614348940048 |
|
17629 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C9orf152 |
0.64272294399962 |
|
17630 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TXNDC8 |
0.64272294399962 |
|
17631 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TXN |
0.64272294399962 |
|
17632 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZBTB5 |
0.64273659047041 |
|
17633 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL463P |
0.64273659047041 |
|
17634 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FIBIN |
0.642739911403618 |
|
17635 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TBC1D8B |
0.642806284851976 |
|
17636 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MORC4 |
0.642806284851976 |
|
17637 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLDN2 |
0.642806284851976 |
|
17638 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RIPPLY1 |
0.642806284851976 |
|
17639 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NUP62CL |
0.642806284851976 |
|
17640 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PIH1D3 |
0.642806284851976 |
|
17641 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RBM41 |
0.642806284851976 |
|
17642 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NUDCD1 |
0.643115254670188 |
|
17643 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ENY2 |
0.643115254670188 |
|
17644 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CXorf57 |
0.643308932012381 |
|
17645 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNF128 |
0.643308932012381 |
|
17646 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA70C |
0.643378348078179 |
|
17647 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP128 |
0.643378348078179 |
|
17648 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP125 |
0.643378348078179 |
|
17649 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TLR4 |
0.643378348078179 |
|
17650 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IGSF11 |
0.643826329386961 |
|
17651 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STARD8 |
0.643834460058978 |
|
17652 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OLIG3 |
0.643894344383448 |
|
17653 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD112|ENSG00000252476.1 |
0.643894344383448 |
|
17654 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00210 |
0.644020262260885 |
|
17655 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CADPS2 |
0.644464553728299 |
|
17656 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF502 |
0.644622313868175 |
|
17657 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIF15 |
0.644622313868175 |
|
17658 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR564 |
0.644622313868175 |
|
17659 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM42 |
0.644622313868175 |
|
17660 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TGM4 |
0.644622313868175 |
|
17661 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00314 |
0.644649526833501 |
|
17662 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIXL1 |
0.644774016898095 |
|
17663 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LIN9 |
0.644774016898095 |
|
17664 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238545.1 |
0.644774016898095 |
|
17665 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
H3F3A |
0.644877210298199 |
|
17666 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KNDC1 |
0.6449263757804 |
|
17667 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UTF1 |
0.6449263757804 |
|
17668 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VENTX |
0.6449263757804 |
|
17669 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR202 |
0.6449263757804 |
|
17670 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADAM8 |
0.6449263757804 |
|
17671 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TUBGCP2 |
0.6449263757804 |
|
17672 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF511 |
0.6449263757804 |
|
17673 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CALY |
0.6449263757804 |
|
17674 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRAP1 |
0.6449263757804 |
|
17675 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FUOM |
0.6449263757804 |
|
17676 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ECHS1 |
0.6449263757804 |
|
17677 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3944 |
0.6449263757804 |
|
17678 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PAOX |
0.6449263757804 |
|
17679 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MTG1 |
0.6449263757804 |
|
17680 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CYP2E1 |
0.6449263757804 |
|
17681 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FRG2B |
0.6449263757804 |
|
17682 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPRN |
0.6449263757804 |
|
17683 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SYCE1 |
0.6449263757804 |
|
17684 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR548AN |
0.645018750596134 |
|
17685 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RGS2 |
0.645648529279037 |
|
17686 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP126 |
0.645648529279037 |
|
17687 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UCHL5 |
0.645648529279037 |
|
17688 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DDX52 |
0.645667412356706 |
|
17689 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ITGA1 |
0.645760435834803 |
|
17690 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARL6IP1 |
0.645770876208202 |
|
17691 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238722.1 |
0.645909386986579 |
|
17692 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FGFR2 |
0.646487045493685 |
|
17693 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NSMCE4A |
0.646487045493685 |
|
17694 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TACC2 |
0.646487045493685 |
|
17695 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00327 |
0.646580765723911 |
|
17696 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00352 |
0.646580765723911 |
|
17697 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SUCNR1 |
0.646866344902896 |
|
17698 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA20|ENSG00000201660.1 |
0.647172145691186 |
|
17699 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PKNOX2 |
0.64718444458419 |
|
17700 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPR |
0.647440612806142 |
|
17701 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EMX1 |
0.647440612806142 |
|
17702 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SFXN5 |
0.647440612806142 |
|
17703 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAB11FIP5 |
0.647440612806142 |
|
17704 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NMUR2 |
0.647443834485905 |
|
17705 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NUDT10 |
0.64754393263654 |
|
17706 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CXorf67 |
0.64754393263654 |
|
17707 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NUDT11 |
0.64754393263654 |
|
17708 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TNC |
0.647599412938324 |
|
17709 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00474 |
0.647599412938324 |
|
17710 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PAPPA |
0.647599412938324 |
|
17711 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRIM32 |
0.647599412938324 |
|
17712 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPR123 |
0.647802857329991 |
|
17713 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SEC11C |
0.64785373133684 |
|
17714 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GRP |
0.64785373133684 |
|
17715 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAX |
0.64785373133684 |
|
17716 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CPLX4 |
0.64785373133684 |
|
17717 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LMAN1 |
0.64785373133684 |
|
17718 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF606 |
0.647941158415469 |
|
17719 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACYP2 |
0.648046849172745 |
|
17720 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C2orf73 |
0.648046849172745 |
|
17721 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TSPYL6 |
0.648046849172745 |
|
17722 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LCT |
0.648118944176348 |
|
17723 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MTF1 |
0.648203172352338 |
|
17724 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
INPP5B |
0.648203172352338 |
|
17725 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA63|ENSG00000252448.1 |
0.648203172352338 |
|
17726 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SF3A3 |
0.648203172352338 |
|
17727 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FHL3 |
0.648203172352338 |
|
17728 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UTP11L |
0.648203172352338 |
|
17729 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
POU3F1 |
0.648203172352338 |
|
17730 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CARTPT |
0.648481357044209 |
|
17731 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZDHHC16 |
0.648490245106399 |
|
17732 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MMS19 |
0.648490245106399 |
|
17733 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UBTD1 |
0.648490245106399 |
|
17734 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HOGA1 |
0.648490245106399 |
|
17735 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PI4K2A |
0.648490245106399 |
|
17736 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C10orf62 |
0.648490245106399 |
|
17737 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MORN4 |
0.648490245106399 |
|
17738 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AVPI1 |
0.648490245106399 |
|
17739 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MARVELD1 |
0.648490245106399 |
|
17740 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZFYVE27 |
0.648490245106399 |
|
17741 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SFRP5 |
0.648490245106399 |
|
17742 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00866 |
0.648490245106399 |
|
17743 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GOLGA7B |
0.648490245106399 |
|
17744 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NMRAL1 |
0.648635526368183 |
|
17745 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANKRD11 |
0.64864934604589 |
|
17746 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SOCS6 |
0.648685642212533 |
|
17747 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AFG3L1P |
0.648685871619668 |
|
17748 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C16orf3 |
0.648685871619668 |
|
17749 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDK10 |
0.648685871619668 |
|
17750 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CENPBD1 |
0.648685871619668 |
|
17751 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CHMP1A |
0.648685871619668 |
|
17752 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CPNE7 |
0.648685871619668 |
|
17753 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DBNDD1 |
0.648685871619668 |
|
17754 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DEF8 |
0.648685871619668 |
|
17755 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DPEP1 |
0.648685871619668 |
|
17756 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM157C |
0.648685871619668 |
|
17757 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FANCA |
0.648685871619668 |
|
17758 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GAS8 |
0.648685871619668 |
|
17759 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MC1R |
0.648685871619668 |
|
17760 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRDM7 |
0.648685871619668 |
|
17761 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPL13 |
0.648685871619668 |
|
17762 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD68 |
0.648685871619668 |
|
17763 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPATA2L |
0.648685871619668 |
|
17764 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPATA33 |
0.648685871619668 |
|
17765 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPG7 |
0.648685871619668 |
|
17766 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPIRE2 |
0.648685871619668 |
|
17767 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TCF25 |
0.648685871619668 |
|
17768 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TUBB3 |
0.648685871619668 |
|
17769 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TUBB8P7 |
0.648685871619668 |
|
17770 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
URAHP |
0.648685871619668 |
|
17771 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VPS9D1 |
0.648685871619668 |
|
17772 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF276 |
0.648685871619668 |
|
17773 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLHC1 |
0.648697756189696 |
|
17774 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPS27A |
0.648697756189696 |
|
17775 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MTIF2 |
0.648697756189696 |
|
17776 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRORSD1P |
0.648697756189696 |
|
17777 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC88A |
0.648697756189696 |
|
17778 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CSTF3 |
0.649039966018664 |
|
17779 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPT2 |
0.649140531175778 |
|
17780 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
METTL15 |
0.649142589530009 |
|
17781 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DENND4C |
0.649152016520585 |
|
17782 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPS6 |
0.649152016520585 |
|
17783 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACER2 |
0.649152016520585 |
|
17784 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TCAIM |
0.649282251929515 |
|
17785 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PDCD6IP |
0.649315404910977 |
|
17786 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA25|ENSG00000251744.1 |
0.64937874695286 |
|
17787 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL275P |
0.649636726016724 |
|
17788 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NME1 |
0.64975543863153 |
|
17789 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NME2 |
0.64975543863153 |
|
17790 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDK13 |
0.649767741991863 |
|
17791 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CNTN3 |
0.649783706818087 |
|
17792 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STX18 |
0.649884886316624 |
|
17793 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCNK9 |
0.64992419610336 |
|
17794 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C8orf17 |
0.64992419610336 |
|
17795 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MUC7 |
0.650077914613276 |
|
17796 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AMTN |
0.650077914613276 |
|
17797 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AMBN |
0.650077914613276 |
|
17798 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ENAM |
0.650077914613276 |
|
17799 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IGJ |
0.650077914613276 |
|
17800 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UTP3 |
0.650077914613276 |
|
17801 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
INPP5A |
0.650298355963118 |
|
17802 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MSX1 |
0.650433054281909 |
|
17803 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DHRS11 |
0.650473630624895 |
|
17804 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MRM1 |
0.650473630624895 |
|
17805 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00349 |
0.650608131301709 |
|
17806 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00387 |
0.650608131301709 |
|
17807 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00388 |
0.650608131301709 |
|
17808 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PHF2P2 |
0.650608131301709 |
|
17809 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00442 |
0.650608131301709 |
|
17810 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP24 |
0.650608131301709 |
|
17811 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TUBA3C |
0.650608131301709 |
|
17812 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00421 |
0.650608131301709 |
|
17813 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNF180 |
0.650627419364883 |
|
17814 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MFSD10 |
0.650691060689567 |
|
17815 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NOP14 |
0.650691060689567 |
|
17816 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BACH1 |
0.650941015682412 |
|
17817 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00189 |
0.650941015682412 |
|
17818 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TOM1L2 |
0.65100397428102 |
|
17819 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRRC48 |
0.65100397428102 |
|
17820 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATPAF2 |
0.65100397428102 |
|
17821 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GID4 |
0.65100397428102 |
|
17822 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DRG2 |
0.65100397428102 |
|
17823 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MYO15A |
0.65100397428102 |
|
17824 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238691.1 |
0.65100397428102 |
|
17825 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ALKBH5 |
0.65100397428102 |
|
17826 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LLGL1 |
0.65100397428102 |
|
17827 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FLII |
0.65100397428102 |
|
17828 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SMCR7 |
0.65100397428102 |
|
17829 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TOP3A |
0.65100397428102 |
|
17830 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TSPAN14 |
0.651051456168208 |
|
17831 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SH2D4B |
0.651051456168208 |
|
17832 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF781 |
0.65113051504888 |
|
17833 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF607 |
0.65113051504888 |
|
17834 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BRK1 |
0.65115253540807 |
|
17835 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238642.1 |
0.65115253540807 |
|
17836 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238345.1 |
0.65115253540807 |
|
17837 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MC4R |
0.651870038963124 |
|
17838 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC8 |
0.651878981059394 |
|
17839 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PNMAL1 |
0.651878981059394 |
|
17840 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PNMAL2 |
0.651878981059394 |
|
17841 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPP5D1 |
0.651878981059394 |
|
17842 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PEX14 |
0.651950497454072 |
|
17843 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GFI1B |
0.652004235924164 |
|
17844 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GTF3C5 |
0.652004235924164 |
|
17845 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CELP |
0.652004235924164 |
|
17846 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CEL |
0.652004235924164 |
|
17847 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SURF6 |
0.652004235924164 |
|
17848 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MED22 |
0.652004235924164 |
|
17849 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPL7A |
0.652004235924164 |
|
17850 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD24 |
0.652004235924164 |
|
17851 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD36A |
0.652004235924164 |
|
17852 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD36B |
0.652004235924164 |
|
17853 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD36C |
0.652004235924164 |
|
17854 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SURF1 |
0.652004235924164 |
|
17855 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SURF2 |
0.652004235924164 |
|
17856 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SURF4 |
0.652004235924164 |
|
17857 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C9orf96 |
0.652004235924164 |
|
17858 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADAMTS13 |
0.652004235924164 |
|
17859 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CACFD1 |
0.652004235924164 |
|
17860 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC2A6 |
0.652004235924164 |
|
17861 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM8C |
0.652004235924164 |
|
17862 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADAMTSL2 |
0.652004235924164 |
|
17863 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AMER1 |
0.652009911314476 |
|
17864 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CENPW |
0.652023327131631 |
|
17865 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C10orf85 |
0.652085535839397 |
|
17866 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RALGDS |
0.652361125565651 |
|
17867 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238657.1 |
0.652361125565651 |
|
17868 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GBGT1 |
0.652361125565651 |
|
17869 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OBP2B |
0.652361125565651 |
|
17870 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ABO |
0.652361125565651 |
|
17871 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL151P |
0.652484468994567 |
|
17872 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MTAP |
0.652484468994567 |
|
17873 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C9orf53 |
0.652484468994567 |
|
17874 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDKN2A |
0.652484468994567 |
|
17875 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDKN2B |
0.652484468994567 |
|
17876 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GNRHR |
0.653027403643 |
|
17877 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA62|ENSG00000202374.1 |
0.653027403643 |
|
17878 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMPRSS11D |
0.653027403643 |
|
17879 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMPRSS11A |
0.653027403643 |
|
17880 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NBAS |
0.653094436202402 |
|
17881 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC35G1 |
0.653186496843671 |
|
17882 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PIPSL |
0.653186496843671 |
|
17883 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLCE1 |
0.653186496843671 |
|
17884 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNY4P26 |
0.653186496843671 |
|
17885 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC39A10 |
0.653376380779079 |
|
17886 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DNAH7 |
0.653376380779079 |
|
17887 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ELAC2 |
0.653757032572313 |
|
17888 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SP2 |
0.653872093022779 |
|
17889 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PNPO |
0.653872093022779 |
|
17890 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRR15L |
0.653872093022779 |
|
17891 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BMP10 |
0.653954452094583 |
|
17892 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AHI1 |
0.654018554719916 |
|
17893 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00271 |
0.654018554719916 |
|
17894 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL795P |
0.65405117932435 |
|
17895 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GTSCR1 |
0.65405117932435 |
|
17896 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IFNW1 |
0.654129429010897 |
|
17897 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IFNA21 |
0.654129429010897 |
|
17898 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IFNA4 |
0.654129429010897 |
|
17899 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IFNA10 |
0.654129429010897 |
|
17900 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IFNA16 |
0.654129429010897 |
|
17901 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IFNA7 |
0.654129429010897 |
|
17902 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IFNA17 |
0.654129429010897 |
|
17903 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IFNA14 |
0.654129429010897 |
|
17904 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COPS5 |
0.654237048143855 |
|
17905 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CSPP1 |
0.654237048143855 |
|
17906 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP268 |
0.654237048143855 |
|
17907 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DHX9 |
0.654317049686068 |
|
17908 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LAMC1 |
0.654317049686068 |
|
17909 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CPEB1 |
0.654352014851309 |
|
17910 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AP3B2 |
0.654352014851309 |
|
17911 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000239136.1 |
0.654373362521429 |
|
17912 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SOX30 |
0.65468471503779 |
|
17913 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C5orf52 |
0.65468471503779 |
|
17914 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
THG1L |
0.65468471503779 |
|
17915 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LUZP2 |
0.654755833657066 |
|
17916 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UTP18 |
0.654821435826615 |
|
17917 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FBXO2 |
0.654846870542108 |
|
17918 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FBXO44 |
0.654846870542108 |
|
17919 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FBXO6 |
0.654846870542108 |
|
17920 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAD2L2 |
0.654846870542108 |
|
17921 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DRAXIN |
0.654846870542108 |
|
17922 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AGTRAP |
0.654846870542108 |
|
17923 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C1orf167 |
0.654846870542108 |
|
17924 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MTHFR |
0.654846870542108 |
|
17925 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLCN6 |
0.654846870542108 |
|
17926 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NPPA |
0.654846870542108 |
|
17927 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM18 |
0.655111216610545 |
|
17928 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C4orf40 |
0.655156946347826 |
|
17929 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ODAM |
0.655156946347826 |
|
17930 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FDCSP |
0.655156946347826 |
|
17931 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CSN3 |
0.655156946347826 |
|
17932 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CABS1 |
0.655156946347826 |
|
17933 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SMR3A |
0.655156946347826 |
|
17934 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SMR3B |
0.655156946347826 |
|
17935 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PROL1 |
0.655156946347826 |
|
17936 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STOM |
0.65566353116902 |
|
17937 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DAB2IP |
0.65566353116902 |
|
17938 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF616 |
0.655715655772563 |
|
17939 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238630.1 |
0.655715655772563 |
|
17940 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF836 |
0.655715655772563 |
|
17941 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPP2R1A |
0.655715655772563 |
|
17942 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF766 |
0.655715655772563 |
|
17943 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR643 |
0.655715655772563 |
|
17944 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF480 |
0.655715655772563 |
|
17945 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF610 |
0.655715655772563 |
|
17946 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STARD13 |
0.655824464222192 |
|
17947 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNX24 |
0.656072334226377 |
|
17948 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPIC |
0.656072334226377 |
|
17949 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL689P |
0.656072334226377 |
|
17950 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL711P |
0.656072334226377 |
|
17951 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRDM6 |
0.656072334226377 |
|
17952 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CEP120 |
0.656072334226377 |
|
17953 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CSNK1G3 |
0.656072334226377 |
|
17954 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADHFE1 |
0.656116157352471 |
|
17955 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RRS1 |
0.656116157352471 |
|
17956 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C8orf46 |
0.656116157352471 |
|
17957 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIF18A |
0.656480070993503 |
|
17958 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAPPC2P1 |
0.656506666630582 |
|
17959 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF547 |
0.656506666630582 |
|
17960 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U6|ENSG00000272393.1 |
0.65655337163083 |
|
17961 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FBXL18 |
0.656706613338801 |
|
17962 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238394.1 |
0.656706613338801 |
|
17963 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR589 |
0.656706613338801 |
|
17964 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DMGDH |
0.65691012855077 |
|
17965 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNY3P1 |
0.65691012855077 |
|
17966 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA18|ENSG00000206592.1 |
0.65691012855077 |
|
17967 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
JMY |
0.65691012855077 |
|
17968 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HOMER1 |
0.65691012855077 |
|
17969 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RCOR3 |
0.657182760335409 |
|
17970 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAF5 |
0.657182760335409 |
|
17971 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TNFRSF11B |
0.65744798723409 |
|
17972 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TCF4 |
0.657586954159606 |
|
17973 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4529 |
0.657586954159606 |
|
17974 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RASEF |
0.657640403736249 |
|
17975 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP242 |
0.657640403736249 |
|
17976 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FRMD3 |
0.657640403736249 |
|
17977 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238608.1 |
0.657640403736249 |
|
17978 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD112|ENSG00000252256.1 |
0.657640403736249 |
|
17979 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IDNK |
0.657640403736249 |
|
17980 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UBQLN1 |
0.657640403736249 |
|
17981 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GKAP1 |
0.657640403736249 |
|
17982 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C9orf64 |
0.657640403736249 |
|
17983 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HNRNPK |
0.657640403736249 |
|
17984 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FEZ1 |
0.657946919419297 |
|
17985 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EI24 |
0.657946919419297 |
|
17986 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM14E |
0.657975397394543 |
|
17987 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CSRNP1 |
0.658013853532939 |
|
17988 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C9orf84 |
0.658228524898252 |
|
17989 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HIST1H3D |
0.658228537913604 |
|
17990 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HIST1H2AD |
0.658228537913604 |
|
17991 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HIST1H2BF |
0.658228537913604 |
|
17992 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HIST1H4E |
0.658228537913604 |
|
17993 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HIST1H2BG |
0.658228537913604 |
|
17994 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HIST1H2AE |
0.658228537913604 |
|
17995 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HIST1H3E |
0.658228537913604 |
|
17996 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HIST1H1D |
0.658228537913604 |
|
17997 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HIST1H4F |
0.658228537913604 |
|
17998 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HIST1H4G |
0.658228537913604 |
|
17999 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HIST1H3F |
0.658228537913604 |
|
18000 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HIST1H2BH |
0.658228537913604 |
|
18001 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HIST1H2BI |
0.658228537913604 |
|
18002 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HIST1H3G |
0.658228537913604 |
|
18003 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HIST1H4H |
0.658228537913604 |
|
18004 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIAA1432 |
0.658419407188774 |
|
18005 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NUBP1 |
0.658456996974816 |
|
18006 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TVP23A |
0.658456996974816 |
|
18007 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP105 |
0.658595367407284 |
|
18008 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PNLIPRP3 |
0.658937505487918 |
|
18009 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATP11C |
0.658949199634726 |
|
18010 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CXorf66 |
0.658949199634726 |
|
18011 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR505 |
0.658949199634726 |
|
18012 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL727P |
0.658949199634726 |
|
18013 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNU6ATAC23P |
0.658949199634726 |
|
18014 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA18|ENSG00000252719.1 |
0.658949199634726 |
|
18015 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238485.1 |
0.658949199634726 |
|
18016 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
F11 |
0.65899559244963 |
|
18017 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4268 |
0.659459432687968 |
|
18018 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
XIRP2 |
0.659644527916788 |
|
18019 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR8J1 |
0.659880481490347 |
|
18020 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR8U1 |
0.659880481490347 |
|
18021 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR5R1 |
0.659880481490347 |
|
18022 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR5M9 |
0.659880481490347 |
|
18023 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR5M3 |
0.659880481490347 |
|
18024 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR5M8 |
0.659880481490347 |
|
18025 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR5M11 |
0.659880481490347 |
|
18026 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR5M10 |
0.659880481490347 |
|
18027 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DNAH9 |
0.660091412608257 |
|
18028 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MCF2 |
0.660310221847387 |
|
18029 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM84B |
0.660318562566268 |
|
18030 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR455 |
0.660938246194072 |
|
18031 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KLHL4 |
0.661561024655581 |
|
18032 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SYNPO2 |
0.661641330950692 |
|
18033 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CPEB3 |
0.661815686960741 |
|
18034 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA25|ENSG00000252993.1 |
0.661815686960741 |
|
18035 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MARCH5 |
0.661815686960741 |
|
18036 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HHEX |
0.661815686960741 |
|
18037 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IDE |
0.661815686960741 |
|
18038 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIF11 |
0.661815686960741 |
|
18039 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL644P |
0.661815686960741 |
|
18040 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF852 |
0.661953759850537 |
|
18041 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZKSCAN7 |
0.661953759850537 |
|
18042 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF660 |
0.661953759850537 |
|
18043 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF197 |
0.661953759850537 |
|
18044 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF35 |
0.661953759850537 |
|
18045 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IL21R |
0.662043153840335 |
|
18046 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GTF3C1 |
0.662043153840335 |
|
18047 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC6A16 |
0.662164693067667 |
|
18048 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4324 |
0.662164693067667 |
|
18049 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CD37 |
0.662164693067667 |
|
18050 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TEAD2 |
0.662164693067667 |
|
18051 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DKKL1 |
0.662164693067667 |
|
18052 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC155 |
0.662164693067667 |
|
18053 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PTH2 |
0.662164693067667 |
|
18054 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC17A7 |
0.662164693067667 |
|
18055 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PIH1D1 |
0.662164693067667 |
|
18056 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ALDH16A1 |
0.662164693067667 |
|
18057 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FLT3LG |
0.662164693067667 |
|
18058 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPL13A |
0.662164693067667 |
|
18059 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD32A |
0.662164693067667 |
|
18060 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD33|ENSG00000199631.1 |
0.662164693067667 |
|
18061 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD34 |
0.662164693067667 |
|
18062 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD35A |
0.662164693067667 |
|
18063 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPS11 |
0.662164693067667 |
|
18064 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD35B |
0.662164693067667 |
|
18065 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FCGRT |
0.662164693067667 |
|
18066 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR150 |
0.662164693067667 |
|
18067 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RCN3 |
0.662164693067667 |
|
18068 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ABRACL |
0.66232306631447 |
|
18069 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HECA |
0.66232306631447 |
|
18070 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CITED2 |
0.66232306631447 |
|
18071 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CD99L2 |
0.662403725170247 |
|
18072 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U3|ENSG00000253009.1 |
0.662403725170247 |
|
18073 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SGSM3 |
0.662710732768181 |
|
18074 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
F9 |
0.662759888201626 |
|
18075 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP40 |
0.662803607208152 |
|
18076 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC25A33 |
0.662803607208152 |
|
18077 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM201 |
0.662803607208152 |
|
18078 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C1orf200 |
0.662803607208152 |
|
18079 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PIK3CD |
0.662803607208152 |
|
18080 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NPSR1 |
0.662975067558751 |
|
18081 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACSM5 |
0.662980280206406 |
|
18082 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SDPR |
0.663133779375821 |
|
18083 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZFP30 |
0.663245939783948 |
|
18084 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SRD5A3 |
0.663251229243007 |
|
18085 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM165 |
0.663251229243007 |
|
18086 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACTR1B |
0.663972651296984 |
|
18087 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANKRD36B |
0.663972651296984 |
|
18088 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANKRD36 |
0.663972651296984 |
|
18089 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COX5B |
0.663972651296984 |
|
18090 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAHD2B |
0.663972651296984 |
|
18091 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL313P |
0.663972651296984 |
|
18092 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZAP70 |
0.663972651296984 |
|
18093 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CHCHD3 |
0.664124538072648 |
|
18094 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00856 |
0.664200741844812 |
|
18095 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
REV1 |
0.664209703514477 |
|
18096 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLASP1 |
0.665493125954124 |
|
18097 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR504 |
0.665686632130782 |
|
18098 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RHOU |
0.665796979487277 |
|
18099 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM171B |
0.665990460560893 |
|
18100 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZSWIM2 |
0.665990460560893 |
|
18101 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC79 |
0.66644806399032 |
|
18102 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CMTM8 |
0.666488544080729 |
|
18103 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EVC2 |
0.666525729180007 |
|
18104 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
XPO6 |
0.66652618775456 |
|
18105 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA25|ENSG00000200652.1 |
0.66652618775456 |
|
18106 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SBK1 |
0.66652618775456 |
|
18107 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF587B |
0.666556277260709 |
|
18108 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF814 |
0.666556277260709 |
|
18109 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF587 |
0.666556277260709 |
|
18110 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF417 |
0.666556277260709 |
|
18111 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF418 |
0.666556277260709 |
|
18112 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF256 |
0.666556277260709 |
|
18113 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C19orf18 |
0.666556277260709 |
|
18114 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLBP |
0.666560545054439 |
|
18115 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM129 |
0.666560545054439 |
|
18116 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TACC3 |
0.666560545054439 |
|
18117 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR5T1 |
0.666827066118683 |
|
18118 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR8H1 |
0.666827066118683 |
|
18119 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR8K3 |
0.666827066118683 |
|
18120 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR8K1 |
0.666827066118683 |
|
18121 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00457 |
0.666859748480593 |
|
18122 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C9orf123 |
0.666899296489135 |
|
18123 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MANEA |
0.667020227497584 |
|
18124 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP183 |
0.667023308692349 |
|
18125 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CNKSR2 |
0.667023308692349 |
|
18126 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KLHL34 |
0.667023308692349 |
|
18127 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SMPX |
0.667023308692349 |
|
18128 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NMD3 |
0.667135709732922 |
|
18129 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LPAR1 |
0.667136804387109 |
|
18130 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MBTPS2 |
0.667310982311361 |
|
18131 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
YY2 |
0.667310982311361 |
|
18132 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ORM1 |
0.667945092889011 |
|
18133 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ORM2 |
0.667945092889011 |
|
18134 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AKNA |
0.667945092889011 |
|
18135 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DFNB31 |
0.667945092889011 |
|
18136 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238530.1 |
0.667945092889011 |
|
18137 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATP6V1G1 |
0.667945092889011 |
|
18138 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C9orf91 |
0.667945092889011 |
|
18139 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TNFSF15 |
0.667945092889011 |
|
18140 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TNFSF8 |
0.667945092889011 |
|
18141 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM78 |
0.66824446878456 |
|
18142 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00299 |
0.668342998456807 |
|
18143 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ID2 |
0.668342998456807 |
|
18144 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIDINS220 |
0.668342998456807 |
|
18145 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MBOAT2 |
0.668342998456807 |
|
18146 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238888.1 |
0.668342998456807 |
|
18147 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COL21A1 |
0.668447628377553 |
|
18148 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IGFL1 |
0.668770985858071 |
|
18149 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD27|ENSG00000251699.1 |
0.669309115583469 |
|
18150 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EYS |
0.669356388325109 |
|
18151 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COL14A1 |
0.669706933673233 |
|
18152 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MKLN1 |
0.669716857462355 |
|
18153 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPANXN4 |
0.669730600473108 |
|
18154 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP81 |
0.669730600473108 |
|
18155 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP149 |
0.669730600473108 |
|
18156 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TNRC6B |
0.669801719549219 |
|
18157 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GP2 |
0.669864276407675 |
|
18158 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UMOD |
0.669864276407675 |
|
18159 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PDILT |
0.669864276407675 |
|
18160 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPAG9 |
0.669983790374254 |
|
18161 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238815.1 |
0.669983790374254 |
|
18162 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GAP43 |
0.670258628939488 |
|
18163 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CES4A |
0.670916650008958 |
|
18164 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL543P |
0.670916650008958 |
|
18165 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PJA1 |
0.670951839771408 |
|
18166 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00269 |
0.670951839771408 |
|
18167 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM155B |
0.670951839771408 |
|
18168 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00852 |
0.671014545270626 |
|
18169 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GHRLOS |
0.671014545270626 |
|
18170 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GHRL |
0.671014545270626 |
|
18171 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SEC13 |
0.671014545270626 |
|
18172 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR378B |
0.671014545270626 |
|
18173 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR885 |
0.671014545270626 |
|
18174 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PDE6C |
0.671200087857032 |
|
18175 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL132P |
0.671255057447825 |
|
18176 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA31|ENSG00000251802.1 |
0.671255057447825 |
|
18177 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DPY19L1 |
0.671255057447825 |
|
18178 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR548N |
0.671255057447825 |
|
18179 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL604P |
0.671871764957959 |
|
18180 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA36C |
0.671871764957959 |
|
18181 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANKRD26P1 |
0.672172989090609 |
|
18182 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GABRA5 |
0.672186693105866 |
|
18183 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BRF1 |
0.67224544918044 |
|
18184 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AKT1S1 |
0.67262297078299 |
|
18185 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATF5 |
0.67262297078299 |
|
18186 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IL4I1 |
0.67262297078299 |
|
18187 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4750 |
0.67262297078299 |
|
18188 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4751 |
0.67262297078299 |
|
18189 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NUP62 |
0.67262297078299 |
|
18190 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SIGLEC11 |
0.67262297078299 |
|
18191 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SIGLEC16 |
0.67262297078299 |
|
18192 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TBC1D17 |
0.67262297078299 |
|
18193 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U3|ENSG00000221125.1 |
0.67262297078299 |
|
18194 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VRK3 |
0.67262297078299 |
|
18195 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF473 |
0.67262297078299 |
|
18196 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAMLD1 |
0.672774807082474 |
|
18197 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MTM1 |
0.672774807082474 |
|
18198 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MTMR1 |
0.672774807082474 |
|
18199 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HMGB3 |
0.672774807082474 |
|
18200 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OPCML |
0.672788105664364 |
|
18201 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HOXB7 |
0.67282281283039 |
|
18202 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HOXB8 |
0.67282281283039 |
|
18203 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HOXB9 |
0.67282281283039 |
|
18204 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR196A1 |
0.67282281283039 |
|
18205 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NKIRAS2 |
0.672848431038846 |
|
18206 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF385C |
0.672848431038846 |
|
18207 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DHX58 |
0.672848431038846 |
|
18208 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KAT2A |
0.672848431038846 |
|
18209 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HSPB9 |
0.672848431038846 |
|
18210 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAB5C |
0.672848431038846 |
|
18211 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCNH4 |
0.672848431038846 |
|
18212 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HCRT |
0.672848431038846 |
|
18213 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GHDC |
0.672848431038846 |
|
18214 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STAT5B |
0.672848431038846 |
|
18215 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STAT5A |
0.672848431038846 |
|
18216 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STAT3 |
0.672848431038846 |
|
18217 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OACYLP |
0.67317455279047 |
|
18218 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA40|ENSG00000252138.1 |
0.673290920131622 |
|
18219 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
REEP2 |
0.67347006504718 |
|
18220 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EGR1 |
0.67347006504718 |
|
18221 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC66 |
0.673475949082071 |
|
18222 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM208A |
0.673475949082071 |
|
18223 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPATA12 |
0.673475949082071 |
|
18224 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IL17RD |
0.673475949082071 |
|
18225 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HESX1 |
0.673475949082071 |
|
18226 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ALDOA |
0.673545522541107 |
|
18227 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ASPHD1 |
0.673545522541107 |
|
18228 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BOLA2B |
0.673545522541107 |
|
18229 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BOLA2 |
0.673545522541107 |
|
18230 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C16orf54 |
0.673545522541107 |
|
18231 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C16orf92 |
0.673545522541107 |
|
18232 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDIPT |
0.673545522541107 |
|
18233 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CORO1A |
0.673545522541107 |
|
18234 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DOC2A |
0.673545522541107 |
|
18235 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM57B |
0.673545522541107 |
|
18236 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GDPD3 |
0.673545522541107 |
|
18237 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HIRIP3 |
0.673545522541107 |
|
18238 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
INO80E |
0.673545522541107 |
|
18239 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCTD13 |
0.673545522541107 |
|
18240 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIF22 |
0.673545522541107 |
|
18241 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAPK3 |
0.673545522541107 |
|
18242 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAZ |
0.673545522541107 |
|
18243 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MVP |
0.673545522541107 |
|
18244 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PAGR1 |
0.673545522541107 |
|
18245 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPP4C |
0.673545522541107 |
|
18246 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRRT2 |
0.673545522541107 |
|
18247 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
QPRT |
0.673545522541107 |
|
18248 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP127 |
0.673545522541107 |
|
18249 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SEZ6L2 |
0.673545522541107 |
|
18250 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLX1A |
0.673545522541107 |
|
18251 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLX1B |
0.673545522541107 |
|
18252 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPN |
0.673545522541107 |
|
18253 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SULT1A3 |
0.673545522541107 |
|
18254 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SULT1A4 |
0.673545522541107 |
|
18255 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TAOK2 |
0.673545522541107 |
|
18256 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TBX6 |
0.673545522541107 |
|
18257 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM219 |
0.673545522541107 |
|
18258 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
YPEL3 |
0.673545522541107 |
|
18259 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZG16 |
0.673545522541107 |
|
18260 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238639.1 |
0.673545522541107 |
|
18261 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000239114.1 |
0.673545522541107 |
|
18262 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000239193.1 |
0.673545522541107 |
|
18263 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZFHX4 |
0.673940256845043 |
|
18264 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PEX2 |
0.673940256845043 |
|
18265 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NAE1 |
0.673966150400572 |
|
18266 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WDR11 |
0.674199594411491 |
|
18267 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP167 |
0.674199594411491 |
|
18268 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPTSSB |
0.674476723084071 |
|
18269 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OTOL1 |
0.674476723084071 |
|
18270 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNF144A |
0.674920462155331 |
|
18271 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP112 |
0.674949681332688 |
|
18272 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNU6ATAC37P |
0.674949681332688 |
|
18273 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CASP6 |
0.67569983360463 |
|
18274 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLA2G12A |
0.67569983360463 |
|
18275 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CFI |
0.67569983360463 |
|
18276 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GAR1 |
0.67569983360463 |
|
18277 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RRH |
0.67569983360463 |
|
18278 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRIT3 |
0.67569983360463 |
|
18279 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EGF |
0.67569983360463 |
|
18280 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ELOVL6 |
0.67569983360463 |
|
18281 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NDUFAF2 |
0.675721900610394 |
|
18282 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR378E |
0.676065745681496 |
|
18283 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FOXI1 |
0.676065745681496 |
|
18284 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C5orf58 |
0.676065745681496 |
|
18285 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LCP2 |
0.676065745681496 |
|
18286 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCNMB1 |
0.676065745681496 |
|
18287 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ELOVL7 |
0.676097188966634 |
|
18288 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PACS2 |
0.676537523997262 |
|
18289 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BCHE |
0.676650946385945 |
|
18290 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PABPC4 |
0.676793364737271 |
|
18291 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA55 |
0.676793364737271 |
|
18292 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HEYL |
0.676793364737271 |
|
18293 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HPCAL4 |
0.676793364737271 |
|
18294 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NT5C1A |
0.676793364737271 |
|
18295 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPIE |
0.676793364737271 |
|
18296 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BMP8B |
0.676793364737271 |
|
18297 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OXCT2 |
0.676793364737271 |
|
18298 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRIT1 |
0.676793364737271 |
|
18299 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MYCL |
0.676793364737271 |
|
18300 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDK5RAP3 |
0.676850909318985 |
|
18301 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP113 |
0.677141315793965 |
|
18302 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CYTL1 |
0.677141315793965 |
|
18303 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP275 |
0.677141315793965 |
|
18304 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C4orf6 |
0.677141315793965 |
|
18305 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GFRAL |
0.677217238440954 |
|
18306 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM83B |
0.677748439450631 |
|
18307 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANKRD30BL |
0.677761284736804 |
|
18308 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPR39 |
0.677761284736804 |
|
18309 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR663B |
0.677761284736804 |
|
18310 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP103 |
0.677761284736804 |
|
18311 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FANCC |
0.677969475939412 |
|
18312 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SRFBP1 |
0.678102033960512 |
|
18313 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LOX |
0.678102033960512 |
|
18314 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF474 |
0.678102033960512 |
|
18315 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNCAIP |
0.678102033960512 |
|
18316 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCHIP1 |
0.678358542926256 |
|
18317 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IL12A |
0.678358542926256 |
|
18318 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238905.1 |
0.678372249449238 |
|
18319 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FFAR4 |
0.678389580640247 |
|
18320 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RBP4 |
0.678389580640247 |
|
18321 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SIGLECL1 |
0.678614603751255 |
|
18322 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IGLON5 |
0.678614603751255 |
|
18323 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VSIG10L |
0.678614603751255 |
|
18324 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ETFB |
0.678614603751255 |
|
18325 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP42 |
0.678687262118335 |
|
18326 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RBFOX1 |
0.67896434279589 |
|
18327 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARHGEF3 |
0.678985793455774 |
|
18328 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ERMP1 |
0.679211367711331 |
|
18329 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DEPDC1B |
0.679218806275603 |
|
18330 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AGBL1 |
0.679364872488189 |
|
18331 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CSNK1A1 |
0.679473949228942 |
|
18332 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARHGEF37 |
0.679473949228942 |
|
18333 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U3|ENSG00000221043.1 |
0.679473949228942 |
|
18334 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL868P |
0.679473949228942 |
|
18335 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR378A |
0.679473949228942 |
|
18336 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPARGC1B |
0.679473949228942 |
|
18337 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNF133 |
0.679857671992376 |
|
18338 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNF148 |
0.679857671992376 |
|
18339 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ST6GALNAC3 |
0.679982281872201 |
|
18340 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL216P |
0.680249840290578 |
|
18341 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP125 |
0.680249840290578 |
|
18342 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RARB |
0.680249840290578 |
|
18343 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP126 |
0.680249840290578 |
|
18344 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD5|ENSG00000272166.1 |
0.680249840290578 |
|
18345 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TOP2B |
0.680249840290578 |
|
18346 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4442 |
0.680249840290578 |
|
18347 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NGLY1 |
0.680249840290578 |
|
18348 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OXSM |
0.680249840290578 |
|
18349 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00692 |
0.680249840290578 |
|
18350 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRRC3B |
0.680249840290578 |
|
18351 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3122 |
0.680266287580002 |
|
18352 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF618 |
0.680436084749601 |
|
18353 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AMBP |
0.680436084749601 |
|
18354 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF527 |
0.680816521116101 |
|
18355 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF569 |
0.680816521116101 |
|
18356 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF570 |
0.680816521116101 |
|
18357 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF793 |
0.680816521116101 |
|
18358 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GRM7 |
0.680985685050164 |
|
18359 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SARDH |
0.681544264023885 |
|
18360 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TNS1 |
0.681957010453129 |
|
18361 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RUFY4 |
0.681957010453129 |
|
18362 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CXCR2P1 |
0.681957010453129 |
|
18363 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CXCR2 |
0.681957010453129 |
|
18364 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CXCR1 |
0.681957010453129 |
|
18365 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RLN2 |
0.681999614147767 |
|
18366 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RLN1 |
0.681999614147767 |
|
18367 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLGRKT |
0.681999614147767 |
|
18368 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CD274 |
0.681999614147767 |
|
18369 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PDCD1LG2 |
0.681999614147767 |
|
18370 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANKRD36C |
0.682050647231634 |
|
18371 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAHD2CP |
0.682050647231634 |
|
18372 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL210P |
0.682050647231634 |
|
18373 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FRY |
0.682101801735537 |
|
18374 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FPR1 |
0.682423132618078 |
|
18375 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FPR2 |
0.682423132618078 |
|
18376 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FPR3 |
0.682423132618078 |
|
18377 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HCCAT3 |
0.682423132618078 |
|
18378 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF350 |
0.682423132618078 |
|
18379 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF432 |
0.682423132618078 |
|
18380 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF577 |
0.682423132618078 |
|
18381 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF613 |
0.682423132618078 |
|
18382 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF614 |
0.682423132618078 |
|
18383 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF615 |
0.682423132618078 |
|
18384 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF649 |
0.682423132618078 |
|
18385 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF841 |
0.682423132618078 |
|
18386 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF528 |
0.682423132618078 |
|
18387 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF534 |
0.682423132618078 |
|
18388 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF578 |
0.682423132618078 |
|
18389 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF880 |
0.682423132618078 |
|
18390 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF808 |
0.682423132618078 |
|
18391 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF701 |
0.682423132618078 |
|
18392 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF137P |
0.682423132618078 |
|
18393 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PTRF |
0.682556863316797 |
|
18394 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAPPC10 |
0.68277556087938 |
|
18395 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRRTM2 |
0.682901992779084 |
|
18396 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP194 |
0.682901992779084 |
|
18397 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FGF13 |
0.683006054505326 |
|
18398 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OPN4 |
0.683204535348033 |
|
18399 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LDB3 |
0.683204535348033 |
|
18400 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U3|ENSG00000252189.1 |
0.683204535348033 |
|
18401 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TCERG1L |
0.683473860152696 |
|
18402 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CBFB |
0.683505862259423 |
|
18403 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C16orf70 |
0.683505862259423 |
|
18404 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
B3GNT9 |
0.683505862259423 |
|
18405 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FBXL8 |
0.683505862259423 |
|
18406 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRADD |
0.683505862259423 |
|
18407 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HSF4 |
0.683505862259423 |
|
18408 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NOL3 |
0.683505862259423 |
|
18409 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIAA0895L |
0.683505862259423 |
|
18410 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EXOC3L1 |
0.683505862259423 |
|
18411 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
E2F4 |
0.683505862259423 |
|
18412 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ELMO3 |
0.683505862259423 |
|
18413 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR328 |
0.683505862259423 |
|
18414 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRRC29 |
0.683505862259423 |
|
18415 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM208 |
0.683505862259423 |
|
18416 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA74|ENSG00000252305.1 |
0.683959066559718 |
|
18417 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DNM1L |
0.683994969501977 |
|
18418 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPL26 |
0.684013634680206 |
|
18419 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNF222 |
0.684013634680206 |
|
18420 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FSIP2 |
0.684026839469563 |
|
18421 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U8|ENSG00000212581.1 |
0.684026839469563 |
|
18422 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNU6ATAC12P |
0.684058121611443 |
|
18423 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL99P |
0.684121142673151 |
|
18424 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINGO2 |
0.684396239004023 |
|
18425 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MBP |
0.684769789790655 |
|
18426 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GALR1 |
0.684769789790655 |
|
18427 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HCRTR2 |
0.684966690635482 |
|
18428 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PART1 |
0.685245294182254 |
|
18429 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CBX1 |
0.68537178580618 |
|
18430 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNX11 |
0.68537178580618 |
|
18431 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR1203 |
0.68537178580618 |
|
18432 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4313 |
0.685373837025472 |
|
18433 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL319P |
0.685373837025472 |
|
18434 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD112|ENSG00000252372.1 |
0.685373837025472 |
|
18435 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UBE2Q2 |
0.685373837025472 |
|
18436 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL510P |
0.685373837025472 |
|
18437 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FBXO22 |
0.685373837025472 |
|
18438 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NRG4 |
0.685373837025472 |
|
18439 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4668 |
0.685522157182952 |
|
18440 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COPZ2 |
0.685619444086745 |
|
18441 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR152 |
0.685619444086745 |
|
18442 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NFE2L1 |
0.685619444086745 |
|
18443 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM225A |
0.685912589409978 |
|
18444 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM225B |
0.685912589409978 |
|
18445 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZFP37 |
0.685912589409978 |
|
18446 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF883 |
0.685912589409978 |
|
18447 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC31A2 |
0.685912589409978 |
|
18448 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FKBP15 |
0.685912589409978 |
|
18449 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC31A1 |
0.685912589409978 |
|
18450 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDC26 |
0.685912589409978 |
|
18451 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRPF4 |
0.685912589409978 |
|
18452 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNF183 |
0.685912589409978 |
|
18453 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPL |
0.686000740551876 |
|
18454 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238313.1 |
0.686366480663345 |
|
18455 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR147A |
0.686368757896583 |
|
18456 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ABCB10 |
0.686416468134813 |
|
18457 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP78 |
0.686416468134813 |
|
18458 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TAF5L |
0.686416468134813 |
|
18459 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
URB2 |
0.686416468134813 |
|
18460 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NOSIP |
0.686673977668812 |
|
18461 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRRG2 |
0.686673977668812 |
|
18462 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRR12 |
0.686673977668812 |
|
18463 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PTPRZ1 |
0.687000563500997 |
|
18464 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GK |
0.687082174633486 |
|
18465 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SMARCA2 |
0.68720940170463 |
|
18466 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CRYAA |
0.687224145703984 |
|
18467 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00319 |
0.687224145703984 |
|
18468 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00322 |
0.687224145703984 |
|
18469 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SIK1 |
0.687224145703984 |
|
18470 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF638 |
0.687445876877951 |
|
18471 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DYSF |
0.687445876877951 |
|
18472 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FMR1 |
0.687545363511385 |
|
18473 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FMR1NB |
0.687545363511385 |
|
18474 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR582 |
0.687649194384474 |
|
18475 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCDH1 |
0.687738021297869 |
|
18476 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA31|ENSG00000252238.1 |
0.68777971277768 |
|
18477 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SEC14L5 |
0.687792786347257 |
|
18478 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NAGPA |
0.687792786347257 |
|
18479 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ALG1 |
0.687792786347257 |
|
18480 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C16orf89 |
0.687792786347257 |
|
18481 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM86A |
0.687792786347257 |
|
18482 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C5 |
0.687820677468682 |
|
18483 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACSM3 |
0.687831647983928 |
|
18484 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
THUMPD1 |
0.687831647983928 |
|
18485 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ERI2 |
0.687831647983928 |
|
18486 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCGEM1 |
0.688020676455024 |
|
18487 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WDR31 |
0.688225675383404 |
|
18488 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BSPRY |
0.688225675383404 |
|
18489 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HDHD3 |
0.688225675383404 |
|
18490 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ALAD |
0.688225675383404 |
|
18491 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C9orf43 |
0.688225675383404 |
|
18492 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
POLE3 |
0.688225675383404 |
|
18493 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RGS3 |
0.688225675383404 |
|
18494 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NLGN2 |
0.688360629922714 |
|
18495 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPEM1 |
0.688360629922714 |
|
18496 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C17orf74 |
0.688360629922714 |
|
18497 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FGF11 |
0.688360629922714 |
|
18498 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM102 |
0.688360629922714 |
|
18499 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4454 |
0.688408931379916 |
|
18500 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GABRP |
0.688408931379916 |
|
18501 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL623P |
0.688408931379916 |
|
18502 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000252387.1 |
0.688408931379916 |
|
18503 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AGO2 |
0.688469213416258 |
|
18504 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DENND3 |
0.688469213416258 |
|
18505 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR151A |
0.688469213416258 |
|
18506 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PTK2 |
0.688469213416258 |
|
18507 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP278 |
0.688469213416258 |
|
18508 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IFNB1 |
0.688534989920754 |
|
18509 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CA7 |
0.688675760401683 |
|
18510 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL150P |
0.688780359144578 |
|
18511 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ESR1 |
0.689002763445044 |
|
18512 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PDP2 |
0.689312770761124 |
|
18513 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDH16 |
0.689312770761124 |
|
18514 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RRAD |
0.689312770761124 |
|
18515 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM96B |
0.689312770761124 |
|
18516 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CES2 |
0.689312770761124 |
|
18517 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CES3 |
0.689312770761124 |
|
18518 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TAB3 |
0.689488044621925 |
|
18519 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FTHL17 |
0.689488044621925 |
|
18520 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GFRA3 |
0.689878199768792 |
|
18521 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL682P |
0.689878199768792 |
|
18522 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDC25C |
0.689878199768792 |
|
18523 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM53C |
0.689878199768792 |
|
18524 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KDM3B |
0.689878199768792 |
|
18525 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SUSD1 |
0.690019388835623 |
|
18526 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MFSD1 |
0.690058829316121 |
|
18527 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IQCJ |
0.690058829316121 |
|
18528 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3919 |
0.690058829316121 |
|
18529 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
XKR5 |
0.690075389984828 |
|
18530 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DEFB1 |
0.690075389984828 |
|
18531 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DEFA6 |
0.690075389984828 |
|
18532 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DEFA4 |
0.690075389984828 |
|
18533 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FBXW2 |
0.690099473021244 |
|
18534 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PSMD5 |
0.690099473021244 |
|
18535 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PHF19 |
0.690099473021244 |
|
18536 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAF1 |
0.690099473021244 |
|
18537 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF329 |
0.690180747017066 |
|
18538 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IRX1 |
0.690291977779826 |
|
18539 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UGCG |
0.690363730157437 |
|
18540 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
INIP |
0.690363730157437 |
|
18541 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNX30 |
0.690363730157437 |
|
18542 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC46A2 |
0.690363730157437 |
|
18543 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00487 |
0.690366183902567 |
|
18544 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000252525.1 |
0.690858901489688 |
|
18545 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACKR3 |
0.691112099842699 |
|
18546 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COPS8 |
0.691112099842699 |
|
18547 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARL15 |
0.691143389528064 |
|
18548 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RFX3 |
0.691461079024487 |
|
18549 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIAA2026 |
0.691526872472771 |
|
18550 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MLANA |
0.691526872472771 |
|
18551 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238654.1 |
0.691526872472771 |
|
18552 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DNAJC24 |
0.691540130263164 |
|
18553 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IMMP1L |
0.691540130263164 |
|
18554 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RWDD2B |
0.691692088064791 |
|
18555 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
USP16 |
0.691692088064791 |
|
18556 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCT8 |
0.691692088064791 |
|
18557 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAP3K7CL |
0.691692088064791 |
|
18558 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U3|ENSG00000212479.1 |
0.691692088064791 |
|
18559 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000239171.1 |
0.691692088064791 |
|
18560 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GRIK1 |
0.691692088064791 |
|
18561 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MTA1 |
0.691979965186107 |
|
18562 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CRIP2 |
0.691979965186107 |
|
18563 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C14orf80 |
0.691979965186107 |
|
18564 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CRIP1 |
0.691979965186107 |
|
18565 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADAM6 |
0.691979965186107 |
|
18566 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IGHA1 |
0.691979965186107 |
|
18567 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IGHA2 |
0.691979965186107 |
|
18568 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IGHD |
0.691979965186107 |
|
18569 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IGHE |
0.691979965186107 |
|
18570 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IGHG1 |
0.691979965186107 |
|
18571 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IGHG2 |
0.691979965186107 |
|
18572 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IGHG3 |
0.691979965186107 |
|
18573 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IGHG4 |
0.691979965186107 |
|
18574 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IGHJ1 |
0.691979965186107 |
|
18575 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IGHJ2 |
0.691979965186107 |
|
18576 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IGHJ3 |
0.691979965186107 |
|
18577 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IGHJ4 |
0.691979965186107 |
|
18578 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IGHJ5 |
0.691979965186107 |
|
18579 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IGHJ6 |
0.691979965186107 |
|
18580 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IGHM |
0.691979965186107 |
|
18581 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIAA0125 |
0.691979965186107 |
|
18582 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00221 |
0.691979965186107 |
|
18583 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00226 |
0.691979965186107 |
|
18584 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP389 |
0.691979965186107 |
|
18585 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM121 |
0.691979965186107 |
|
18586 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CNDP2 |
0.692146311908607 |
|
18587 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CNDP1 |
0.692146311908607 |
|
18588 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00909 |
0.692146311908607 |
|
18589 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00955 |
0.692179749495196 |
|
18590 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF407 |
0.692290548235468 |
|
18591 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA31|ENSG00000251828.1 |
0.692736272437327 |
|
18592 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPZ1 |
0.692736272437327 |
|
18593 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZFYVE16 |
0.692736272437327 |
|
18594 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM151B |
0.692736272437327 |
|
18595 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP225 |
0.692749189575615 |
|
18596 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ETF1 |
0.692831686658819 |
|
18597 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HSPA9 |
0.692831686658819 |
|
18598 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD63|ENSG00000222937.1 |
0.692831686658819 |
|
18599 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD63|ENSG00000206989.1 |
0.692831686658819 |
|
18600 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238745.1 |
0.692831686658819 |
|
18601 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF773 |
0.692908632069526 |
|
18602 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF549 |
0.692908632069526 |
|
18603 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF550 |
0.692908632069526 |
|
18604 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MYH8 |
0.692982243256713 |
|
18605 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MYH4 |
0.692982243256713 |
|
18606 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MYH1 |
0.692982243256713 |
|
18607 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00904 |
0.693073104886138 |
|
18608 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF30 |
0.693073104886138 |
|
18609 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL601P |
0.693073994402968 |
|
18610 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPP1R3A |
0.693116794653738 |
|
18611 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DROSHA |
0.69314217041129 |
|
18612 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADRA2C |
0.693356770569916 |
|
18613 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM86EP |
0.693356770569916 |
|
18614 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OTOP1 |
0.693356770569916 |
|
18615 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM128 |
0.693356770569916 |
|
18616 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LYAR |
0.693356770569916 |
|
18617 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZBTB49 |
0.693356770569916 |
|
18618 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP158 |
0.693744073524547 |
|
18619 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COL1A1 |
0.693847479906516 |
|
18620 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U3|ENSG00000199927.1 |
0.693925421256353 |
|
18621 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC27A6 |
0.693956517672424 |
|
18622 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STMN2 |
0.694001184495854 |
|
18623 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HEY1 |
0.694001184495854 |
|
18624 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MRPS28 |
0.694001184495854 |
|
18625 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HMOX2 |
0.69417820194049 |
|
18626 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDIP1 |
0.69417820194049 |
|
18627 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C16orf96 |
0.69417820194049 |
|
18628 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UBALD1 |
0.69417820194049 |
|
18629 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MGRN1 |
0.69417820194049 |
|
18630 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL850P |
0.69417820194049 |
|
18631 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NUDT16L1 |
0.69417820194049 |
|
18632 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANKS3 |
0.69417820194049 |
|
18633 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C16orf71 |
0.69417820194049 |
|
18634 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF500 |
0.69417820194049 |
|
18635 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SEPT12 |
0.69417820194049 |
|
18636 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SMIM22 |
0.69417820194049 |
|
18637 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ROGDI |
0.69417820194049 |
|
18638 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SMCR2 |
0.694459390567992 |
|
18639 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAI1 |
0.694459390567992 |
|
18640 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SMCR5 |
0.694459390567992 |
|
18641 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR33B |
0.694459390567992 |
|
18642 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SREBF1 |
0.694459390567992 |
|
18643 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GNL3L |
0.694613592616633 |
|
18644 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP461 |
0.694883764121011 |
|
18645 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NSG1 |
0.695265522803056 |
|
18646 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MEGF10 |
0.695300958755322 |
|
18647 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRRC1 |
0.695300958755322 |
|
18648 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UBN1 |
0.695698832504434 |
|
18649 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCNH1 |
0.695738194200203 |
|
18650 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00467 |
0.695738194200203 |
|
18651 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RD3 |
0.695738194200203 |
|
18652 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC30A1 |
0.695738194200203 |
|
18653 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEFF2 |
0.695939766196914 |
|
18654 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LAMC2 |
0.696665556493213 |
|
18655 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NMNAT2 |
0.696665556493213 |
|
18656 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FSTL5 |
0.69676407788263 |
|
18657 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STT3B |
0.696911452083125 |
|
18658 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TIAM2 |
0.697004913884387 |
|
18659 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DCDC1 |
0.69721259349326 |
|
18660 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
QKI |
0.69737612894273 |
|
18661 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VWCE |
0.697705441400788 |
|
18662 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00297 |
0.697838212082861 |
|
18663 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL609P |
0.698201078502817 |
|
18664 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GLYR1 |
0.698322007913271 |
|
18665 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SOX3 |
0.698540391949754 |
|
18666 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00632 |
0.698540391949754 |
|
18667 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDR1 |
0.698540391949754 |
|
18668 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR320D2 |
0.698540391949754 |
|
18669 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPANXB1 |
0.698540391949754 |
|
18670 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPANXB2 |
0.698540391949754 |
|
18671 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCNV1 |
0.698649475471408 |
|
18672 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM132E |
0.698655073405833 |
|
18673 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CMPK2 |
0.698745403735452 |
|
18674 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RSAD2 |
0.698745403735452 |
|
18675 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL112P |
0.69876183257261 |
|
18676 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U8|ENSG00000199713.1 |
0.69876183257261 |
|
18677 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF532 |
0.69876183257261 |
|
18678 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MATR3 |
0.698954785247622 |
|
18679 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA74|ENSG00000252213.1 |
0.698954785247622 |
|
18680 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA74A |
0.698954785247622 |
|
18681 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP195 |
0.698954785247622 |
|
18682 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP64 |
0.698954785247622 |
|
18683 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
POLK |
0.699152020064735 |
|
18684 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANKDD1B |
0.699152020064735 |
|
18685 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
POC5 |
0.699152020064735 |
|
18686 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RGSL1 |
0.699172258203896 |
|
18687 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CYP11A1 |
0.699212844904033 |
|
18688 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HDAC3 |
0.700040405120115 |
|
18689 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RELL2 |
0.700040405120115 |
|
18690 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FCHSD1 |
0.700040405120115 |
|
18691 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARAP3 |
0.700040405120115 |
|
18692 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DBC1 |
0.70034349630043 |
|
18693 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TNRC6A |
0.700343518295604 |
|
18694 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC5A11 |
0.700343518295604 |
|
18695 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARHGAP17 |
0.700343518295604 |
|
18696 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LCMT1 |
0.700343518295604 |
|
18697 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL557P |
0.700343518295604 |
|
18698 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AQP8 |
0.700343518295604 |
|
18699 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZKSCAN2 |
0.700343518295604 |
|
18700 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NAGK |
0.700388328368843 |
|
18701 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MCEE |
0.700388328368843 |
|
18702 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MPHOSPH10 |
0.700388328368843 |
|
18703 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PAIP2B |
0.700388328368843 |
|
18704 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ELP4 |
0.700404441474669 |
|
18705 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP516 |
0.70041269007694 |
|
18706 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ITGA2 |
0.700597130538954 |
|
18707 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EP400 |
0.700806510856652 |
|
18708 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EP400NL |
0.700806510856652 |
|
18709 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DDX51 |
0.700806510856652 |
|
18710 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GALNT9 |
0.700806510856652 |
|
18711 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NOC4L |
0.700806510856652 |
|
18712 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF274 |
0.700959409125197 |
|
18713 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF544 |
0.700959409125197 |
|
18714 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF8 |
0.700959409125197 |
|
18715 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZSCAN22 |
0.700959409125197 |
|
18716 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
A1BG |
0.700959409125197 |
|
18717 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C2orf42 |
0.701091685992568 |
|
18718 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TIA1 |
0.701091685992568 |
|
18719 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CXCL9 |
0.70121815182108 |
|
18720 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CXCL10 |
0.70121815182108 |
|
18721 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CXCL11 |
0.70121815182108 |
|
18722 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF497 |
0.701454623010737 |
|
18723 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP473 |
0.701454623010737 |
|
18724 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CHMP2A |
0.701454623010737 |
|
18725 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4754 |
0.701454623010737 |
|
18726 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MZF1 |
0.701454623010737 |
|
18727 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL525P |
0.701454623010737 |
|
18728 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL693P |
0.701454623010737 |
|
18729 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPL23AP79 |
0.701454623010737 |
|
18730 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPS5 |
0.701454623010737 |
|
18731 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC27A5 |
0.701454623010737 |
|
18732 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRIM28 |
0.701454623010737 |
|
18733 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UBE2M |
0.701454623010737 |
|
18734 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZBTB45 |
0.701454623010737 |
|
18735 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF132 |
0.701454623010737 |
|
18736 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF324B |
0.701454623010737 |
|
18737 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF324 |
0.701454623010737 |
|
18738 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF446 |
0.701454623010737 |
|
18739 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF584 |
0.701454623010737 |
|
18740 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF837 |
0.701454623010737 |
|
18741 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AASS |
0.701561649748831 |
|
18742 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ROBO1 |
0.701865045012806 |
|
18743 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL699P |
0.701877678899193 |
|
18744 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCARNA15|ENSG00000252690.2 |
0.701991515675803 |
|
18745 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FSD2 |
0.701991515675803 |
|
18746 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WHAMM |
0.701991515675803 |
|
18747 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAIP |
0.702061652962402 |
|
18748 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CAMKV |
0.702061652962402 |
|
18749 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL217P |
0.702061652962402 |
|
18750 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00350 |
0.702112656094626 |
|
18751 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MPHOSPH8 |
0.702112656094626 |
|
18752 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PSPC1 |
0.702112656094626 |
|
18753 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL166P |
0.702112656094626 |
|
18754 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZMYM5 |
0.702112656094626 |
|
18755 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238665.1 |
0.702112656094626 |
|
18756 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FNDC3A |
0.702212083093418 |
|
18757 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNY3P2 |
0.702212083093418 |
|
18758 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MLNR |
0.702212083093418 |
|
18759 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDADC1 |
0.702212083093418 |
|
18760 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CAB39L |
0.702212083093418 |
|
18761 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SETDB2 |
0.702212083093418 |
|
18762 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PHF11 |
0.702212083093418 |
|
18763 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RCBTB1 |
0.702212083093418 |
|
18764 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP280 |
0.70286981254817 |
|
18765 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00032 |
0.70286981254817 |
|
18766 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EQTN |
0.70286981254817 |
|
18767 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AAK1 |
0.703014284443794 |
|
18768 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RASL10B |
0.703093006796922 |
|
18769 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MMP28 |
0.703093006796922 |
|
18770 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TAF15 |
0.703093006796922 |
|
18771 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C17orf66 |
0.703093006796922 |
|
18772 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCL5 |
0.703093006796922 |
|
18773 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP274 |
0.703093006796922 |
|
18774 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR548F2 |
0.703195811494881 |
|
18775 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCYOX1 |
0.703643671080301 |
|
18776 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADD2 |
0.703643671080301 |
|
18777 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FIGLA |
0.703643671080301 |
|
18778 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLEC4F |
0.703643671080301 |
|
18779 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CD207 |
0.703643671080301 |
|
18780 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VAX2 |
0.703643671080301 |
|
18781 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATP6V1B1 |
0.703643671080301 |
|
18782 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000239064.1 |
0.703643671080301 |
|
18783 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL160P |
0.703643671080301 |
|
18784 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANKRD53 |
0.703643671080301 |
|
18785 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TEX261 |
0.703643671080301 |
|
18786 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BOLA3 |
0.703643671080301 |
|
18787 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MGC10955 |
0.703643671080301 |
|
18788 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MOB1A |
0.703643671080301 |
|
18789 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MTHFD2 |
0.703643671080301 |
|
18790 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC4A5 |
0.703643671080301 |
|
18791 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DCTN1 |
0.703643671080301 |
|
18792 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C2orf81 |
0.703643671080301 |
|
18793 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WDR54 |
0.703643671080301 |
|
18794 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RTKN |
0.703643671080301 |
|
18795 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
INO80B |
0.703643671080301 |
|
18796 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WBP1 |
0.703643671080301 |
|
18797 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MOGS |
0.703643671080301 |
|
18798 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC142 |
0.703643671080301 |
|
18799 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MRPL53 |
0.703643671080301 |
|
18800 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TTC31 |
0.703643671080301 |
|
18801 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LBX2 |
0.703643671080301 |
|
18802 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCGF1 |
0.703643671080301 |
|
18803 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TLX2 |
0.703643671080301 |
|
18804 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DQX1 |
0.703643671080301 |
|
18805 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AUP1 |
0.703643671080301 |
|
18806 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HTRA2 |
0.703643671080301 |
|
18807 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LOXL3 |
0.703643671080301 |
|
18808 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DOK1 |
0.703643671080301 |
|
18809 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
M1AP |
0.703643671080301 |
|
18810 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SEMA4F |
0.703643671080301 |
|
18811 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HK2 |
0.703643671080301 |
|
18812 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00159 |
0.704158141982342 |
|
18813 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA31|ENSG00000252888.1 |
0.704531554633773 |
|
18814 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LMX1B |
0.704556289332901 |
|
18815 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OPHN1 |
0.704568990343493 |
|
18816 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
YIPF6 |
0.704568990343493 |
|
18817 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATXN3L |
0.704699424964103 |
|
18818 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EGFL6 |
0.704699424964103 |
|
18819 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP20 |
0.704699424964103 |
|
18820 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TCEANC |
0.704699424964103 |
|
18821 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAB9A |
0.704699424964103 |
|
18822 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAPPC2 |
0.704699424964103 |
|
18823 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BFAR |
0.704786242883124 |
|
18824 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCNIP1 |
0.704959421324225 |
|
18825 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
INPP4A |
0.705134681576946 |
|
18826 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COA5 |
0.705134681576946 |
|
18827 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UNC50 |
0.705134681576946 |
|
18828 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MGAT4A |
0.705134681576946 |
|
18829 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIAA1211L |
0.705134681576946 |
|
18830 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UNC80 |
0.705209401746613 |
|
18831 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MCPH1 |
0.705228883594989 |
|
18832 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANGPT2 |
0.705228883594989 |
|
18833 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DMRTC1B |
0.705372860499952 |
|
18834 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM226A |
0.705372860499952 |
|
18835 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DMRTC1 |
0.705372860499952 |
|
18836 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00684 |
0.705372860499952 |
|
18837 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PABPC1L2B |
0.705372860499952 |
|
18838 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PABPC1L2A |
0.705372860499952 |
|
18839 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NAP1L6 |
0.705372860499952 |
|
18840 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NAP1L2 |
0.705372860499952 |
|
18841 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OBSCN |
0.705458079329136 |
|
18842 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BTNL10 |
0.705458079329136 |
|
18843 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HIST3H2A |
0.705458079329136 |
|
18844 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HIST3H2BB |
0.705458079329136 |
|
18845 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HIST3H3 |
0.705458079329136 |
|
18846 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4666A |
0.705458079329136 |
|
18847 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5S10 |
0.705458079329136 |
|
18848 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5S11 |
0.705458079329136 |
|
18849 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5S12 |
0.705458079329136 |
|
18850 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5S13 |
0.705458079329136 |
|
18851 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5S14 |
0.705458079329136 |
|
18852 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5S15 |
0.705458079329136 |
|
18853 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5S16 |
0.705458079329136 |
|
18854 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5S17 |
0.705458079329136 |
|
18855 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5S1 |
0.705458079329136 |
|
18856 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5S2 |
0.705458079329136 |
|
18857 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5S3 |
0.705458079329136 |
|
18858 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5S4 |
0.705458079329136 |
|
18859 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5S5 |
0.705458079329136 |
|
18860 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5S6 |
0.705458079329136 |
|
18861 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5S7 |
0.705458079329136 |
|
18862 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5S8 |
0.705458079329136 |
|
18863 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5S9 |
0.705458079329136 |
|
18864 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP18 |
0.705458079329136 |
|
18865 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP19 |
0.705458079329136 |
|
18866 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNF187 |
0.705458079329136 |
|
18867 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA51|ENSG00000206878.1 |
0.705458079329136 |
|
18868 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRIM11 |
0.705458079329136 |
|
18869 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRIM17 |
0.705458079329136 |
|
18870 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SEC24D |
0.705461680946899 |
|
18871 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GNL3 |
0.705589153179011 |
|
18872 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD19B|ENSG00000238862.1 |
0.705589153179011 |
|
18873 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD19B|ENSG00000252787.1 |
0.705589153179011 |
|
18874 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD19|ENSG00000212493.1 |
0.705589153179011 |
|
18875 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD19|ENSG00000222345.1 |
0.705589153179011 |
|
18876 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD69 |
0.705589153179011 |
|
18877 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MST1R |
0.705863323863662 |
|
18878 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MON1A |
0.705863323863662 |
|
18879 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CSPG4P5 |
0.706149205823396 |
|
18880 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GOLGA6L4 |
0.706149205823396 |
|
18881 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GOLGA6L5 |
0.706149205823396 |
|
18882 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL331P |
0.706149205823396 |
|
18883 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL417P |
0.706149205823396 |
|
18884 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UBE2Q2P1 |
0.706149205823396 |
|
18885 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CBR1 |
0.706260840268245 |
|
18886 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TM4SF2 |
0.706453368110356 |
|
18887 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIAA0141 |
0.707108006766338 |
|
18888 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCDH12 |
0.707108006766338 |
|
18889 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNF14 |
0.707108006766338 |
|
18890 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GNPDA1 |
0.707108006766338 |
|
18891 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DEC1 |
0.707882302314 |
|
18892 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LGALS2 |
0.707924192580015 |
|
18893 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
POC1A |
0.708352467634043 |
|
18894 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DNAH1 |
0.708352467634043 |
|
18895 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BAP1 |
0.708352467634043 |
|
18896 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PHF7 |
0.708352467634043 |
|
18897 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SEMA3G |
0.708352467634043 |
|
18898 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TNNC1 |
0.708352467634043 |
|
18899 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NISCH |
0.708352467634043 |
|
18900 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STAB1 |
0.708352467634043 |
|
18901 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NT5DC2 |
0.708352467634043 |
|
18902 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SMIM4 |
0.708352467634043 |
|
18903 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PBRM1 |
0.708352467634043 |
|
18904 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNU6ATAC16P |
0.708352467634043 |
|
18905 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00930 |
0.708422399666786 |
|
18906 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MCMDC2 |
0.708494003211715 |
|
18907 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNHG6 |
0.708494003211715 |
|
18908 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD87 |
0.708494003211715 |
|
18909 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TCF24 |
0.708494003211715 |
|
18910 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPP1R42 |
0.708494003211715 |
|
18911 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KLK1 |
0.708561897774433 |
|
18912 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KLK15 |
0.708561897774433 |
|
18913 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KLK2 |
0.708561897774433 |
|
18914 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KLK3 |
0.708561897774433 |
|
18915 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KLK4 |
0.708561897774433 |
|
18916 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KLKP1 |
0.708561897774433 |
|
18917 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC1A1 |
0.708569811413227 |
|
18918 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPATA6L |
0.708569811413227 |
|
18919 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPAPDC2 |
0.708569811413227 |
|
18920 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDC37L1 |
0.708569811413227 |
|
18921 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AK3 |
0.708569811413227 |
|
18922 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RCL1 |
0.708569811413227 |
|
18923 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WNK3 |
0.708733543860661 |
|
18924 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FGD1 |
0.708733543860661 |
|
18925 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TSR2 |
0.708733543860661 |
|
18926 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAGED2 |
0.708733543860661 |
|
18927 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA11|ENSG00000221716.1 |
0.708733543860661 |
|
18928 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRO |
0.708733543860661 |
|
18929 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA11|ENSG00000221750.1 |
0.708733543860661 |
|
18930 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PFKFB1 |
0.708733543860661 |
|
18931 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ALAS2 |
0.708733543860661 |
|
18932 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
APEX2 |
0.708733543860661 |
|
18933 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PAGE2B |
0.708733543860661 |
|
18934 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PAGE2 |
0.708733543860661 |
|
18935 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM104B |
0.708733543860661 |
|
18936 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MTRNR2L10 |
0.708733543860661 |
|
18937 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PAGE5 |
0.708733543860661 |
|
18938 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WDR4 |
0.708843014080234 |
|
18939 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NDUFV3 |
0.708843014080234 |
|
18940 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GRIN2A |
0.708926636411556 |
|
18941 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
XRN1 |
0.709441429061175 |
|
18942 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATR |
0.709441429061175 |
|
18943 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00927 |
0.709881746529728 |
|
18944 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARNT2 |
0.709881746529728 |
|
18945 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U8|ENSG00000202269.1 |
0.709964774209379 |
|
18946 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STEAP4 |
0.710363475267853 |
|
18947 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EPM2AIP1 |
0.710386037066561 |
|
18948 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MLH1 |
0.710386037066561 |
|
18949 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238929.1 |
0.710386037066561 |
|
18950 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MARS |
0.710619493317901 |
|
18951 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL312P |
0.710619493317901 |
|
18952 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DDIT3 |
0.710619493317901 |
|
18953 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MBD6 |
0.710619493317901 |
|
18954 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR616 |
0.710619493317901 |
|
18955 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DCTN2 |
0.710619493317901 |
|
18956 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIF5A |
0.710619493317901 |
|
18957 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PIP4K2C |
0.710619493317901 |
|
18958 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CTDSP1 |
0.710741632533796 |
|
18959 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR26B |
0.710741632533796 |
|
18960 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VIL1 |
0.710741632533796 |
|
18961 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
USP37 |
0.710741632533796 |
|
18962 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP38 |
0.710741632533796 |
|
18963 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RQCD1 |
0.710741632533796 |
|
18964 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLCD4 |
0.710741632533796 |
|
18965 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U3|ENSG00000252805.1 |
0.710741632533796 |
|
18966 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF142 |
0.710741632533796 |
|
18967 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BCS1L |
0.710741632533796 |
|
18968 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNF25 |
0.710741632533796 |
|
18969 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STK36 |
0.710741632533796 |
|
18970 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TTLL4 |
0.710741632533796 |
|
18971 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CYP27A1 |
0.710741632533796 |
|
18972 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRKAG3 |
0.710741632533796 |
|
18973 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WNT6 |
0.710741632533796 |
|
18974 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WNT10A |
0.710741632533796 |
|
18975 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDK5R2 |
0.710741632533796 |
|
18976 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00608 |
0.710741632533796 |
|
18977 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CRYBA2 |
0.710741632533796 |
|
18978 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FEV |
0.710741632533796 |
|
18979 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC108 |
0.710741632533796 |
|
18980 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR375 |
0.710741632533796 |
|
18981 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IHH |
0.710741632533796 |
|
18982 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3131 |
0.710741632533796 |
|
18983 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL764P |
0.710741632533796 |
|
18984 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SALL3 |
0.711552180613524 |
|
18985 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP377 |
0.711557653031977 |
|
18986 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NRF1 |
0.711612845598857 |
|
18987 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP244 |
0.711612845598857 |
|
18988 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DYTN |
0.711735860955848 |
|
18989 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MDH1B |
0.711735860955848 |
|
18990 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FASTKD2 |
0.711735860955848 |
|
18991 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KLF7 |
0.711735860955848 |
|
18992 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR2355 |
0.711735860955848 |
|
18993 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CREB1 |
0.711735860955848 |
|
18994 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
METTL21A |
0.711735860955848 |
|
18995 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00313 |
0.71252504904737 |
|
18996 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PDE5A |
0.712942609049322 |
|
18997 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA11|ENSG00000221245.1 |
0.712942609049322 |
|
18998 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U8|ENSG00000212249.2 |
0.713117008073791 |
|
18999 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC30A5 |
0.713117008073791 |
|
19000 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL103P |
0.713117008073791 |
|
19001 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA50|ENSG00000220986.1 |
0.713117008073791 |
|
19002 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCNB1 |
0.713117008073791 |
|
19003 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238334.1 |
0.713117008073791 |
|
19004 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LAPTM4B |
0.713127409145425 |
|
19005 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MATN2 |
0.713127409145425 |
|
19006 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPL30 |
0.713127409145425 |
|
19007 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA72|ENSG00000207067.1 |
0.713127409145425 |
|
19008 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C8orf47 |
0.713127409145425 |
|
19009 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HRSP12 |
0.713127409145425 |
|
19010 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
POP1 |
0.713127409145425 |
|
19011 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP277 |
0.713139545366384 |
|
19012 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP298 |
0.713523706309749 |
|
19013 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ITIH6 |
0.713726567973387 |
|
19014 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000239135.1 |
0.713805615724943 |
|
19015 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SP5 |
0.714085664671044 |
|
19016 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CSTB |
0.714145523402792 |
|
19017 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RRP1 |
0.714145523402792 |
|
19018 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AGPAT3 |
0.714145523402792 |
|
19019 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MTX3 |
0.714281566431015 |
|
19020 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCTD15 |
0.71432047374078 |
|
19021 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WDR7 |
0.714828269082115 |
|
19022 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TUSC1 |
0.714857646879477 |
|
19023 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CAAP1 |
0.714857646879477 |
|
19024 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL100P |
0.714857646879477 |
|
19025 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLAA |
0.714857646879477 |
|
19026 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IFT74 |
0.714857646879477 |
|
19027 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRRC19 |
0.714857646879477 |
|
19028 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADORA2B |
0.715764997333653 |
|
19029 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZSWIM7 |
0.715764997333653 |
|
19030 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TTC19 |
0.715764997333653 |
|
19031 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FSIP1 |
0.71587765295313 |
|
19032 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00908 |
0.715924135575396 |
|
19033 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP121 |
0.715932950390848 |
|
19034 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP279 |
0.715932950390848 |
|
19035 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MYBL1 |
0.716035283424722 |
|
19036 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VCPIP1 |
0.716035283424722 |
|
19037 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C8orf44 |
0.716035283424722 |
|
19038 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SGK3 |
0.716035283424722 |
|
19039 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HSF2BP |
0.716131930501531 |
|
19040 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP118 |
0.71657580309632 |
|
19041 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PWP2 |
0.716656895329674 |
|
19042 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C21orf33 |
0.716656895329674 |
|
19043 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP217 |
0.716935473044496 |
|
19044 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RCN2 |
0.716935473044496 |
|
19045 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL278P |
0.716935473044496 |
|
19046 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL214P |
0.716935473044496 |
|
19047 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZAR1L |
0.717228874017642 |
|
19048 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SMARCAL1 |
0.717236587342396 |
|
19049 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL153P |
0.717339270593085 |
|
19050 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PTCD2 |
0.717339270593085 |
|
19051 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DPP4 |
0.717383576548374 |
|
19052 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GCG |
0.717383576548374 |
|
19053 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAP |
0.717383576548374 |
|
19054 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IFIH1 |
0.717383576548374 |
|
19055 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GCA |
0.717383576548374 |
|
19056 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
JAK2 |
0.717406781153688 |
|
19057 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ABCC1 |
0.717639601025613 |
|
19058 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ABCC6P1 |
0.717639601025613 |
|
19059 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ABCC6 |
0.717639601025613 |
|
19060 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C16orf45 |
0.717639601025613 |
|
19061 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FOPNL |
0.717639601025613 |
|
19062 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIAA0430 |
0.717639601025613 |
|
19063 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR484 |
0.717639601025613 |
|
19064 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MPV17L |
0.717639601025613 |
|
19065 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MYH11 |
0.717639601025613 |
|
19066 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NDE1 |
0.717639601025613 |
|
19067 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NOMO1 |
0.717639601025613 |
|
19068 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NOMO2 |
0.717639601025613 |
|
19069 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NOMO3 |
0.717639601025613 |
|
19070 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NPIPA1 |
0.717639601025613 |
|
19071 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NPIPA2 |
0.717639601025613 |
|
19072 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NPIPA3 |
0.717639601025613 |
|
19073 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NPIPA5 |
0.717639601025613 |
|
19074 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NPIPA7 |
0.717639601025613 |
|
19075 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NPIPA8 |
0.717639601025613 |
|
19076 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NPIPP1 |
0.717639601025613 |
|
19077 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NTAN1 |
0.717639601025613 |
|
19078 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PDXDC1 |
0.717639601025613 |
|
19079 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PKD1P5 |
0.717639601025613 |
|
19080 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PKD1P6 |
0.717639601025613 |
|
19081 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLA2G10 |
0.717639601025613 |
|
19082 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL90P |
0.717639601025613 |
|
19083 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPS15A |
0.717639601025613 |
|
19084 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RRN3 |
0.717639601025613 |
|
19085 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
XYLT1 |
0.717639601025613 |
|
19086 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF416 |
0.717810342574091 |
|
19087 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZIK1 |
0.717810342574091 |
|
19088 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF530 |
0.717810342574091 |
|
19089 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF134 |
0.717810342574091 |
|
19090 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF211 |
0.717810342574091 |
|
19091 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TSPAN33 |
0.718059745680225 |
|
19092 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SMO |
0.718059745680225 |
|
19093 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CXCR4 |
0.718110349300379 |
|
19094 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4666B |
0.718136320487368 |
|
19095 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAGEB2 |
0.718136320487368 |
|
19096 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAGEB3 |
0.718136320487368 |
|
19097 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAGEB4 |
0.718136320487368 |
|
19098 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAGEB1 |
0.718136320487368 |
|
19099 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NR0B1 |
0.718136320487368 |
|
19100 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATP2B2 |
0.718263359059673 |
|
19101 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDC73 |
0.718316505465759 |
|
19102 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR1278 |
0.718316505465759 |
|
19103 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
B3GALT2 |
0.718316505465759 |
|
19104 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RRP1B |
0.718532875875652 |
|
19105 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PDXK |
0.718532875875652 |
|
19106 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATP6V0A1 |
0.718554946459055 |
|
19107 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ERBB4 |
0.718666309180767 |
|
19108 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACSM2A |
0.718729986218658 |
|
19109 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACSM2B |
0.718729986218658 |
|
19110 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACSM1 |
0.718729986218658 |
|
19111 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DCUN1D3 |
0.718729986218658 |
|
19112 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LYRM1 |
0.718729986218658 |
|
19113 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DNAH3 |
0.718729986218658 |
|
19114 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP127 |
0.718827212894987 |
|
19115 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ELAVL2 |
0.719190638980102 |
|
19116 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZBTB43 |
0.719283613561173 |
|
19117 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZBTB34 |
0.719283613561173 |
|
19118 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SH3RF1 |
0.719302639505693 |
|
19119 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA25|ENSG00000199392.1 |
0.719799407458274 |
|
19120 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRRC4B |
0.720086024614605 |
|
19121 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MYT1L |
0.720223459299653 |
|
19122 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADAMTS1 |
0.720289337528558 |
|
19123 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADAMTS5 |
0.720289337528558 |
|
19124 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4759 |
0.720289337528558 |
|
19125 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIF12 |
0.720362856546632 |
|
19126 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OLA1 |
0.720705737019236 |
|
19127 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MACF1 |
0.720820933766158 |
|
19128 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP212 |
0.721010042747699 |
|
19129 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CBY1 |
0.721159824845756 |
|
19130 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TOMM22 |
0.721159824845756 |
|
19131 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
JOSD1 |
0.721159824845756 |
|
19132 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GTPBP1 |
0.721159824845756 |
|
19133 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SUN2 |
0.721159824845756 |
|
19134 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DNAL4 |
0.721159824845756 |
|
19135 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM196B |
0.721459952232779 |
|
19136 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SFSWAP |
0.72160396610291 |
|
19137 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP378 |
0.72160396610291 |
|
19138 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MMP17 |
0.72160396610291 |
|
19139 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ULK1 |
0.72160396610291 |
|
19140 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PUS1 |
0.72160396610291 |
|
19141 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA49 |
0.72160396610291 |
|
19142 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCR2 |
0.721625929745852 |
|
19143 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCR5 |
0.721625929745852 |
|
19144 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACKR5 |
0.721625929745852 |
|
19145 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LTF |
0.721625929745852 |
|
19146 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RTP3 |
0.721625929745852 |
|
19147 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRRC2 |
0.721625929745852 |
|
19148 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LUZPP1 |
0.721625929745852 |
|
19149 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPINT2 |
0.721673940263363 |
|
19150 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPP1R14A |
0.721673940263363 |
|
19151 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C19orf33 |
0.721673940263363 |
|
19152 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
YIF1B |
0.721673940263363 |
|
19153 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCNK6 |
0.721673940263363 |
|
19154 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CATSPERG |
0.721673940263363 |
|
19155 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238838.1 |
0.721673940263363 |
|
19156 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GRK4 |
0.721746170662985 |
|
19157 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR5692B |
0.721978049497803 |
|
19158 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PKNOX1 |
0.721978049497803 |
|
19159 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CBS |
0.721978049497803 |
|
19160 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U2AF1 |
0.721978049497803 |
|
19161 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MYO3B |
0.722259700529987 |
|
19162 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ASTN2 |
0.722316033702944 |
|
19163 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CENPK |
0.722588628223767 |
|
19164 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPWD1 |
0.722588628223767 |
|
19165 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MED9 |
0.722725947745013 |
|
19166 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RASD1 |
0.722725947745013 |
|
19167 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PEMT |
0.722725947745013 |
|
19168 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SIPA1L3 |
0.722744645592995 |
|
19169 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DOCK2 |
0.722962261599768 |
|
19170 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SOX11 |
0.723137691102469 |
|
19171 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FLJ30594 |
0.723137691102469 |
|
19172 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM178B |
0.723275910227917 |
|
19173 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP101 |
0.723275910227917 |
|
19174 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238760.1 |
0.723275910227917 |
|
19175 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CBR3 |
0.723825887325074 |
|
19176 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DOPEY2 |
0.723825887325074 |
|
19177 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL73P |
0.723825887325074 |
|
19178 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAF4 |
0.723914543974479 |
|
19179 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM222B |
0.723914543974479 |
|
19180 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MBD3L1 |
0.723990500976082 |
|
19181 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCNYL1 |
0.724055868717756 |
|
19182 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4775 |
0.724055868717756 |
|
19183 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FZD5 |
0.724055868717756 |
|
19184 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAP2 |
0.724055868717756 |
|
19185 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ABHD17C |
0.724151384035313 |
|
19186 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CARM1P1 |
0.724233331049435 |
|
19187 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA73|ENSG00000201816.1 |
0.72435395267448 |
|
19188 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TXNL1 |
0.72435395267448 |
|
19189 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAPPC12 |
0.724497016084647 |
|
19190 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OBSL1 |
0.724628222746582 |
|
19191 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
INHA |
0.724628222746582 |
|
19192 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP213 |
0.724628222746582 |
|
19193 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STK11IP |
0.724628222746582 |
|
19194 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HTR1A |
0.724630882899878 |
|
19195 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ALMS1 |
0.72474335515618 |
|
19196 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PDCD5 |
0.724851474622281 |
|
19197 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANKRD27 |
0.724851474622281 |
|
19198 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA68|ENSG00000201388.1 |
0.724851474622281 |
|
19199 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL789P |
0.724851474622281 |
|
19200 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RGS9BP |
0.724851474622281 |
|
19201 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NUDT19 |
0.724851474622281 |
|
19202 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TDRD12 |
0.724851474622281 |
|
19203 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM189A2 |
0.725241001489195 |
|
19204 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIAA2013 |
0.725591921963143 |
|
19205 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLOD1 |
0.725591921963143 |
|
19206 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MFN2 |
0.725591921963143 |
|
19207 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIIP |
0.725591921963143 |
|
19208 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL649P |
0.725591921963143 |
|
19209 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TNFRSF1B |
0.725591921963143 |
|
19210 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4632 |
0.725591921963143 |
|
19211 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA70|ENSG00000252969.1 |
0.725591921963143 |
|
19212 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VPS13D |
0.725591921963143 |
|
19213 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA59A |
0.725591921963143 |
|
19214 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DHRS3 |
0.725591921963143 |
|
19215 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNU6ATAC18P |
0.725591921963143 |
|
19216 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AADACL3 |
0.725591921963143 |
|
19217 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238771.1 |
0.725591921963143 |
|
19218 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C1orf158 |
0.725591921963143 |
|
19219 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HNRNPCL1 |
0.725591921963143 |
|
19220 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRAMEF10 |
0.725591921963143 |
|
19221 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRAMEF11 |
0.725591921963143 |
|
19222 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRAMEF12 |
0.725591921963143 |
|
19223 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRAMEF13 |
0.725591921963143 |
|
19224 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRAMEF14 |
0.725591921963143 |
|
19225 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRAMEF15 |
0.725591921963143 |
|
19226 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRAMEF16 |
0.725591921963143 |
|
19227 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRAMEF17 |
0.725591921963143 |
|
19228 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRAMEF18 |
0.725591921963143 |
|
19229 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRAMEF19 |
0.725591921963143 |
|
19230 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRAMEF1 |
0.725591921963143 |
|
19231 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRAMEF21 |
0.725591921963143 |
|
19232 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRAMEF22 |
0.725591921963143 |
|
19233 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRAMEF2 |
0.725591921963143 |
|
19234 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRAMEF3 |
0.725591921963143 |
|
19235 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRAMEF4 |
0.725591921963143 |
|
19236 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRAMEF5 |
0.725591921963143 |
|
19237 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRAMEF6 |
0.725591921963143 |
|
19238 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRAMEF7 |
0.725591921963143 |
|
19239 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRAMEF8 |
0.725591921963143 |
|
19240 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRAMEF9 |
0.725591921963143 |
|
19241 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAP7D1 |
0.726020674075144 |
|
19242 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL131P |
0.726020674075144 |
|
19243 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EVA1B |
0.726020674075144 |
|
19244 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STK40 |
0.726020674075144 |
|
19245 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LSM10 |
0.726020674075144 |
|
19246 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HAS1 |
0.726024288571623 |
|
19247 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U3|ENSG00000212539.1 |
0.726063403304696 |
|
19248 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BOD1L2 |
0.726063403304696 |
|
19249 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ST8SIA3 |
0.726063403304696 |
|
19250 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ONECUT2 |
0.726063403304696 |
|
19251 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FECH |
0.726063403304696 |
|
19252 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR122 |
0.726063403304696 |
|
19253 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ALPK2 |
0.726063403304696 |
|
19254 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD28|ENSG00000252284.1 |
0.726063403304696 |
|
19255 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MALT1 |
0.726063403304696 |
|
19256 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA8|ENSG00000207100.1 |
0.726138748273273 |
|
19257 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA40|ENSG00000253065.1 |
0.726325909492162 |
|
19258 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RARS |
0.726325909492162 |
|
19259 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FBLL1 |
0.726325909492162 |
|
19260 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PANK3 |
0.726325909492162 |
|
19261 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR103A1 |
0.726325909492162 |
|
19262 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLIT3 |
0.726325909492162 |
|
19263 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RFFL |
0.726889331445603 |
|
19264 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238858.1 |
0.726889331445603 |
|
19265 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
Vault|ENSG00000252328.1 |
0.726889331445603 |
|
19266 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM184B |
0.726931660812853 |
|
19267 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL704P |
0.726931660812853 |
|
19268 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CSNK1E |
0.726931660812853 |
|
19269 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EIF3E |
0.727127327498084 |
|
19270 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EMC2 |
0.727127327498084 |
|
19271 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP94 |
0.727162386528752 |
|
19272 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CHDH |
0.727422819089261 |
|
19273 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IL17RB |
0.727422819089261 |
|
19274 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACTR8 |
0.727422819089261 |
|
19275 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LAIR2 |
0.727435049393226 |
|
19276 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIR3DX1 |
0.727435049393226 |
|
19277 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LILRA2 |
0.727435049393226 |
|
19278 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LILRB1 |
0.727435049393226 |
|
19279 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LILRA1 |
0.727435049393226 |
|
19280 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LILRB4 |
0.727435049393226 |
|
19281 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FCAR |
0.727435049393226 |
|
19282 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIR2DL1 |
0.727435049393226 |
|
19283 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIR2DL3 |
0.727435049393226 |
|
19284 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIR2DL4 |
0.727435049393226 |
|
19285 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIR2DS4 |
0.727435049393226 |
|
19286 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIR3DL1 |
0.727435049393226 |
|
19287 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIR3DL2 |
0.727435049393226 |
|
19288 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIR3DL3 |
0.727435049393226 |
|
19289 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SH3GL3 |
0.727469757046737 |
|
19290 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LANCL3 |
0.727478728925079 |
|
19291 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
XK |
0.727478728925079 |
|
19292 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CYBB |
0.727478728925079 |
|
19293 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GFPT1 |
0.727735678496377 |
|
19294 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NFU1 |
0.727735678496377 |
|
19295 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238717.1 |
0.727850471378322 |
|
19296 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TTC14 |
0.727892223541397 |
|
19297 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL229P |
0.727892223541397 |
|
19298 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM201A |
0.728267714230895 |
|
19299 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA68|ENSG00000201407.1 |
0.728326157738514 |
|
19300 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZFX |
0.728326157738514 |
|
19301 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PDK3 |
0.728326157738514 |
|
19302 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C17orf112 |
0.728539463560504 |
|
19303 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BEND6 |
0.728693329299935 |
|
19304 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIAA1586 |
0.728693329299935 |
|
19305 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF451 |
0.728693329299935 |
|
19306 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BAG2 |
0.728693329299935 |
|
19307 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAB23 |
0.728693329299935 |
|
19308 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PAGE3 |
0.728845506347732 |
|
19309 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PAIP2 |
0.728903998635316 |
|
19310 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SSX7 |
0.729542069026193 |
|
19311 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP504 |
0.729542069026193 |
|
19312 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SSX2 |
0.729542069026193 |
|
19313 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SSX2B |
0.729542069026193 |
|
19314 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPANXN5 |
0.729542069026193 |
|
19315 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
XAGE5 |
0.729542069026193 |
|
19316 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM156A |
0.729542069026193 |
|
19317 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM156B |
0.729542069026193 |
|
19318 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
XAGE3 |
0.729542069026193 |
|
19319 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPR173 |
0.729542069026193 |
|
19320 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TSPYL2 |
0.729542069026193 |
|
19321 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KDM5C |
0.729542069026193 |
|
19322 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TSSC1 |
0.729605902444049 |
|
19323 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZC3H4 |
0.729781720605642 |
|
19324 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DIRC3 |
0.729798345056436 |
|
19325 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
QSER1 |
0.72991681829099 |
|
19326 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DEPDC7 |
0.72991681829099 |
|
19327 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TCP11L1 |
0.72991681829099 |
|
19328 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR5AK2 |
0.729967352808524 |
|
19329 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ICOSLG |
0.729999900849863 |
|
19330 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DNMT3L |
0.729999900849863 |
|
19331 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AIRE |
0.729999900849863 |
|
19332 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PFKL |
0.729999900849863 |
|
19333 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C21orf2 |
0.729999900849863 |
|
19334 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRPM2 |
0.729999900849863 |
|
19335 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3938 |
0.730081856289178 |
|
19336 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP45 |
0.730081856289178 |
|
19337 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP133 |
0.730081856289178 |
|
19338 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GOLGA1 |
0.730192578970674 |
|
19339 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RHPN2 |
0.730480655647653 |
|
19340 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR551B |
0.730640321232436 |
|
19341 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC6A4 |
0.731204179743436 |
|
19342 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COLEC12 |
0.731264381882543 |
|
19343 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C18orf56 |
0.731264381882543 |
|
19344 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CETN1 |
0.731264381882543 |
|
19345 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLUL1 |
0.731264381882543 |
|
19346 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ENOSF1 |
0.731264381882543 |
|
19347 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP146 |
0.731264381882543 |
|
19348 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TYMS |
0.731264381882543 |
|
19349 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
YES1 |
0.731264381882543 |
|
19350 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADAM12 |
0.731314096891543 |
|
19351 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP328 |
0.731314096891543 |
|
19352 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CALM3 |
0.731526134435756 |
|
19353 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PTGIR |
0.731526134435756 |
|
19354 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GNG8 |
0.731526134435756 |
|
19355 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DACT3 |
0.731526134435756 |
|
19356 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRKD2 |
0.731526134435756 |
|
19357 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL364P |
0.731526134435756 |
|
19358 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR320E |
0.731526134435756 |
|
19359 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STRN4 |
0.731526134435756 |
|
19360 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FKRP |
0.731526134435756 |
|
19361 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC1A5 |
0.731526134435756 |
|
19362 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
USP12 |
0.731695552569663 |
|
19363 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPL21 |
0.731695552569663 |
|
19364 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD102 |
0.731695552569663 |
|
19365 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA27|ENSG00000207051.1 |
0.731695552569663 |
|
19366 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RASL11A |
0.731695552569663 |
|
19367 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNY1P1 |
0.731695552569663 |
|
19368 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GTF3A |
0.731695552569663 |
|
19369 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MTIF3 |
0.731695552569663 |
|
19370 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LNX2 |
0.731695552569663 |
|
19371 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
POLR1D |
0.731695552569663 |
|
19372 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GSX1 |
0.731695552569663 |
|
19373 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MYH3 |
0.731729474067085 |
|
19374 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCO1 |
0.731729474067085 |
|
19375 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00675 |
0.731729474067085 |
|
19376 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PIRT |
0.731729474067085 |
|
19377 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MRGPRX2 |
0.731914672498087 |
|
19378 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COBLL1 |
0.732017981351408 |
|
19379 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA70F |
0.732017981351408 |
|
19380 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP110 |
0.732017981351408 |
|
19381 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP111 |
0.732017981351408 |
|
19382 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC38A11 |
0.732017981351408 |
|
19383 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRRC55 |
0.732175709477102 |
|
19384 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
APLNR |
0.732175709477102 |
|
19385 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP106 |
0.732523551581942 |
|
19386 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NMBR |
0.732523551581942 |
|
19387 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GJE1 |
0.732523551581942 |
|
19388 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VTA1 |
0.732523551581942 |
|
19389 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EFNB1 |
0.73283333673923 |
|
19390 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U3|ENSG00000212610.1 |
0.732878372629471 |
|
19391 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000239044.1 |
0.732989324469287 |
|
19392 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CPA5 |
0.732989324469287 |
|
19393 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CPA1 |
0.732989324469287 |
|
19394 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CEP41 |
0.732989324469287 |
|
19395 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MEST |
0.732989324469287 |
|
19396 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR335 |
0.732989324469287 |
|
19397 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COPG2 |
0.732989324469287 |
|
19398 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP246 |
0.732989324469287 |
|
19399 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
METTL14 |
0.733015751740343 |
|
19400 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BARHL1 |
0.733251658518955 |
|
19401 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DDX31 |
0.733251658518955 |
|
19402 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GTF3C4 |
0.733251658518955 |
|
19403 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C9orf9 |
0.733251658518955 |
|
19404 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TSC1 |
0.733251658518955 |
|
19405 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR548AW |
0.733251658518955 |
|
19406 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD60|ENSG00000199321.1 |
0.733258337919657 |
|
19407 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDH19 |
0.733724891089277 |
|
19408 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR5011 |
0.733724891089277 |
|
19409 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMX3 |
0.733724891089277 |
|
19410 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAPKAP1 |
0.733744021985559 |
|
19411 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL30P |
0.733744021985559 |
|
19412 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATP2C1 |
0.733819732498165 |
|
19413 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TSPYL5 |
0.734104916530653 |
|
19414 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U3|ENSG00000207215.1 |
0.734104916530653 |
|
19415 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MTDH |
0.734104916530653 |
|
19416 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KRT17 |
0.734174583131012 |
|
19417 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KRT42P |
0.734174583131012 |
|
19418 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EIF1 |
0.734174583131012 |
|
19419 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GAST |
0.734174583131012 |
|
19420 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HAP1 |
0.734174583131012 |
|
19421 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP442 |
0.734174583131012 |
|
19422 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNY4P22 |
0.73419634623347 |
|
19423 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SIL1 |
0.734338506528963 |
|
19424 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SMC1A |
0.734842395801889 |
|
19425 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RIBC1 |
0.734842395801889 |
|
19426 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HSD17B10 |
0.734842395801889 |
|
19427 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SACM1L |
0.735167594121542 |
|
19428 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL145P |
0.735167594121542 |
|
19429 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC6A20 |
0.735167594121542 |
|
19430 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LZTFL1 |
0.735167594121542 |
|
19431 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPP2R2D |
0.735182533276024 |
|
19432 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BNIP3 |
0.735182533276024 |
|
19433 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA31|ENSG00000252291.1 |
0.735642069206528 |
|
19434 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF175 |
0.735731332867964 |
|
19435 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SIGLEC5 |
0.735731332867964 |
|
19436 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SIGLEC14 |
0.735731332867964 |
|
19437 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238486.1 |
0.735731332867964 |
|
19438 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00085 |
0.735731332867964 |
|
19439 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR125A |
0.735731332867964 |
|
19440 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR99B |
0.735731332867964 |
|
19441 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIRLET7E |
0.735731332867964 |
|
19442 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR585 |
0.735878465995434 |
|
19443 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPDL1 |
0.735878465995434 |
|
19444 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C16orf82 |
0.735921474139063 |
|
19445 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KDM8 |
0.735921474139063 |
|
19446 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIAA0020 |
0.735928152885744 |
|
19447 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARHGAP25 |
0.735933936275948 |
|
19448 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GABRG3 |
0.735947735323435 |
|
19449 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL822P |
0.736211704583736 |
|
19450 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EFHB |
0.73628393750646 |
|
19451 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAB5A |
0.73628393750646 |
|
19452 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PP2D1 |
0.736296092769736 |
|
19453 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KAT2B |
0.736296092769736 |
|
19454 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3135A |
0.736296092769736 |
|
19455 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SGOL1 |
0.736296092769736 |
|
19456 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RUFY3 |
0.736570897023869 |
|
19457 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238318.1 |
0.736570897023869 |
|
19458 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GRSF1 |
0.736570897023869 |
|
19459 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP98 |
0.736624943517116 |
|
19460 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CYP1A1 |
0.73700225503841 |
|
19461 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CYP1A2 |
0.73700225503841 |
|
19462 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CSK |
0.73700225503841 |
|
19463 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4513 |
0.73700225503841 |
|
19464 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LMAN1L |
0.73700225503841 |
|
19465 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CPLX3 |
0.73700225503841 |
|
19466 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PAX8 |
0.737109537857142 |
|
19467 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR1913 |
0.737163793419138 |
|
19468 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BMP8A |
0.73734800765209 |
|
19469 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARL11 |
0.737521233506711 |
|
19470 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EBPL |
0.737521233506711 |
|
19471 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IGFBPL1 |
0.737707750571892 |
|
19472 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF680 |
0.737713478023891 |
|
19473 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF107 |
0.737713478023891 |
|
19474 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF138 |
0.737713478023891 |
|
19475 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VAV2 |
0.737799265998128 |
|
19476 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00094 |
0.737799265998128 |
|
19477 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BRD3 |
0.737799265998128 |
|
19478 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SHOX2 |
0.738124105420349 |
|
19479 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RSRC1 |
0.738124105420349 |
|
19480 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR5M1 |
0.738402160583279 |
|
19481 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR5AP2 |
0.738402160583279 |
|
19482 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR5AR1 |
0.738402160583279 |
|
19483 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR9G1 |
0.738402160583279 |
|
19484 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoZ6|ENSG00000264452.1 |
0.738503891770939 |
|
19485 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoZ6|ENSG00000266692.1 |
0.738503891770939 |
|
19486 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OPRM1 |
0.739377819550293 |
|
19487 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
USH2A |
0.73950618174038 |
|
19488 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00308 |
0.739701034876602 |
|
19489 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SH3TC2 |
0.739750049281726 |
|
19490 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR584 |
0.739750049281726 |
|
19491 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NCDN |
0.739888123835884 |
|
19492 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TFAP2E |
0.739888123835884 |
|
19493 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PSMB2 |
0.739888123835884 |
|
19494 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL281P |
0.739888123835884 |
|
19495 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C1orf216 |
0.739888123835884 |
|
19496 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLSPN |
0.739888123835884 |
|
19497 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CXorf64 |
0.740147055276831 |
|
19498 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238708.1 |
0.740219783489761 |
|
19499 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRIM2 |
0.740287997356505 |
|
19500 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BMP5 |
0.740441697388512 |
|
19501 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HOXB13 |
0.740687085133642 |
|
19502 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3185 |
0.740687085133642 |
|
19503 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRAC |
0.740687085133642 |
|
19504 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TTLL6 |
0.740687085133642 |
|
19505 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL125P |
0.740687085133642 |
|
19506 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SIGLEC10 |
0.74115575426694 |
|
19507 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SIGLEC8 |
0.74115575426694 |
|
19508 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CEACAM18 |
0.74115575426694 |
|
19509 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SIGLEC12 |
0.74115575426694 |
|
19510 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SIGLEC6 |
0.74115575426694 |
|
19511 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NEK7 |
0.741204251486815 |
|
19512 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRR18 |
0.741218066190765 |
|
19513 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SFT2D1 |
0.741218066190765 |
|
19514 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MPC1 |
0.741218066190765 |
|
19515 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LAIR1 |
0.741908826808175 |
|
19516 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TTYH1 |
0.741908826808175 |
|
19517 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00601 |
0.742085512238283 |
|
19518 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATP8B1 |
0.742528465421557 |
|
19519 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PAX6 |
0.742675245527341 |
|
19520 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00052 |
0.742704487896997 |
|
19521 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NTRK3 |
0.742704487896997 |
|
19522 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UBXN4 |
0.742715770655601 |
|
19523 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C1orf143 |
0.742731586866853 |
|
19524 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NEDD4L |
0.742902580071529 |
|
19525 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL329P |
0.742943966948882 |
|
19526 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RDM1 |
0.743044281613275 |
|
19527 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LYZL6 |
0.743044281613275 |
|
19528 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCL16 |
0.743044281613275 |
|
19529 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCL14 |
0.743044281613275 |
|
19530 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCL15 |
0.743044281613275 |
|
19531 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCL23 |
0.743044281613275 |
|
19532 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCL18 |
0.743044281613275 |
|
19533 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCL3L1 |
0.743044281613275 |
|
19534 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCL3L3 |
0.743044281613275 |
|
19535 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCL3 |
0.743044281613275 |
|
19536 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCL4L1 |
0.743044281613275 |
|
19537 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCL4L2 |
0.743044281613275 |
|
19538 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCL4 |
0.743044281613275 |
|
19539 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GGNBP2 |
0.743044281613275 |
|
19540 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MYO19 |
0.743044281613275 |
|
19541 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PIGW |
0.743044281613275 |
|
19542 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL301P |
0.743044281613275 |
|
19543 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP439 |
0.743044281613275 |
|
19544 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TBC1D3B |
0.743044281613275 |
|
19545 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TBC1D3C |
0.743044281613275 |
|
19546 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TBC1D3G |
0.743044281613275 |
|
19547 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TBC1D3H |
0.743044281613275 |
|
19548 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNHIT3 |
0.743044281613275 |
|
19549 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NARS |
0.743088144141187 |
|
19550 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIF20A |
0.743410062913135 |
|
19551 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDC23 |
0.743410062913135 |
|
19552 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00606 |
0.743712827769334 |
|
19553 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC6A11 |
0.743712827769334 |
|
19554 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MUC16 |
0.743873452971387 |
|
19555 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OFD1 |
0.744014236984762 |
|
19556 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TGFBR2 |
0.744073840453731 |
|
19557 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CXorf49 |
0.744206878808945 |
|
19558 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CXorf49B |
0.744206878808945 |
|
19559 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MICALL1 |
0.744252851988577 |
|
19560 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C22orf23 |
0.744252851988577 |
|
19561 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
POLR2F |
0.744252851988577 |
|
19562 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SOX10 |
0.744252851988577 |
|
19563 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4534 |
0.744252851988577 |
|
19564 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FIGN |
0.744527517377264 |
|
19565 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4643 |
0.744753476052938 |
|
19566 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL415P |
0.744753476052938 |
|
19567 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MRPL13 |
0.745013836007316 |
|
19568 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MTBP |
0.745013836007316 |
|
19569 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNTB1 |
0.745013836007316 |
|
19570 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MTERFD1 |
0.745156990127083 |
|
19571 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PTDSS1 |
0.745156990127083 |
|
19572 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UQCRB |
0.745156990127083 |
|
19573 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SDC2 |
0.745156990127083 |
|
19574 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CPQ |
0.745156990127083 |
|
19575 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000239058.1 |
0.74527029216095 |
|
19576 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA40|ENSG00000252693.1 |
0.74527029216095 |
|
19577 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SH2D1A |
0.74527029216095 |
|
19578 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TENM1 |
0.74527029216095 |
|
19579 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SHISA6 |
0.745272373347045 |
|
19580 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SDK1 |
0.745331417896707 |
|
19581 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C10orf90 |
0.745409821030216 |
|
19582 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00933 |
0.745501028777103 |
|
19583 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZSCAN2 |
0.745501028777103 |
|
19584 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCAND2P |
0.745501028777103 |
|
19585 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WDR73 |
0.745501028777103 |
|
19586 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NMB |
0.745501028777103 |
|
19587 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SEC11A |
0.745501028777103 |
|
19588 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF592 |
0.745501028777103 |
|
19589 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ALPK3 |
0.745501028777103 |
|
19590 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA25|ENSG00000200991.1 |
0.745501028777103 |
|
19591 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC28A1 |
0.745501028777103 |
|
19592 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PDE8A |
0.745501028777103 |
|
19593 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PDS5B |
0.745584247586468 |
|
19594 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCR9 |
0.745600024853624 |
|
19595 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FYCO1 |
0.745600024853624 |
|
19596 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CXCR6 |
0.745600024853624 |
|
19597 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
XCR1 |
0.745600024853624 |
|
19598 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCR3 |
0.745600024853624 |
|
19599 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCR1 |
0.745600024853624 |
|
19600 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TNP1 |
0.745810228572924 |
|
19601 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP43 |
0.745810228572924 |
|
19602 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MLLT4 |
0.745884956132443 |
|
19603 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DACT2 |
0.745884956132443 |
|
19604 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FRMD1 |
0.745884956132443 |
|
19605 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIF25 |
0.745884956132443 |
|
19606 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SMOC2 |
0.745884956132443 |
|
19607 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HOXB2 |
0.746011130630049 |
|
19608 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZC4H2 |
0.746122291631972 |
|
19609 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TTC40 |
0.74614910549094 |
|
19610 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STK32B |
0.746181324708678 |
|
19611 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL518P |
0.746264108015932 |
|
19612 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TSIX |
0.746737649555921 |
|
19613 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
XIST |
0.746737649555921 |
|
19614 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
JPX |
0.746737649555921 |
|
19615 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FTX |
0.746737649555921 |
|
19616 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
B3GNT2 |
0.746893392755689 |
|
19617 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR5192 |
0.746893392755689 |
|
19618 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL51P |
0.746893392755689 |
|
19619 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238809.1 |
0.746893392755689 |
|
19620 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL18P |
0.746893392755689 |
|
19621 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPIA |
0.747054954240912 |
|
19622 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANKRD36BP2 |
0.747054954240912 |
|
19623 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4436A |
0.747054954240912 |
|
19624 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SHCBP1L |
0.747159532662189 |
|
19625 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP71 |
0.747159532662189 |
|
19626 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WWC1 |
0.747345163285442 |
|
19627 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MCCC2 |
0.747346967833827 |
|
19628 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAP1B |
0.747346967833827 |
|
19629 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4803 |
0.747346967833827 |
|
19630 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MRPS27 |
0.747346967833827 |
|
19631 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRSS38 |
0.747510259711514 |
|
19632 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WNT9A |
0.747510259711514 |
|
19633 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR5008 |
0.747510259711514 |
|
19634 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WNT3A |
0.747510259711514 |
|
19635 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARF1 |
0.747510259711514 |
|
19636 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3620 |
0.747510259711514 |
|
19637 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C1orf35 |
0.747510259711514 |
|
19638 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MRPL55 |
0.747510259711514 |
|
19639 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GJC2 |
0.747510259711514 |
|
19640 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GUK1 |
0.747510259711514 |
|
19641 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C1orf148 |
0.747510259711514 |
|
19642 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IBA57 |
0.747510259711514 |
|
19643 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00861 |
0.747538626330954 |
|
19644 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EDA2R |
0.74764187379214 |
|
19645 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC71 |
0.747694627229644 |
|
19646 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KLHDC8B |
0.747694627229644 |
|
19647 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C3orf84 |
0.747694627229644 |
|
19648 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC36 |
0.747694627229644 |
|
19649 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C3orf62 |
0.747694627229644 |
|
19650 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4271 |
0.747694627229644 |
|
19651 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
USP4 |
0.747694627229644 |
|
19652 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPX1 |
0.747694627229644 |
|
19653 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RHOA |
0.747694627229644 |
|
19654 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CYSLTR1 |
0.747728147699689 |
|
19655 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANXA4 |
0.748290671652612 |
|
19656 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GMCL1 |
0.748290671652612 |
|
19657 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNRNP27 |
0.748290671652612 |
|
19658 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MXD1 |
0.748290671652612 |
|
19659 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238465.1 |
0.748290671652612 |
|
19660 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000239072.1 |
0.748290671652612 |
|
19661 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ASPRV1 |
0.748290671652612 |
|
19662 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DPY19L3 |
0.74841298359501 |
|
19663 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MBNL1 |
0.748755236515737 |
|
19664 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WT1 |
0.748807202376646 |
|
19665 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIF24 |
0.748821178605975 |
|
19666 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NUDT2 |
0.748821178605975 |
|
19667 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIAA1161 |
0.748821178605975 |
|
19668 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C9orf24 |
0.748821178605975 |
|
19669 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM219A |
0.748821178605975 |
|
19670 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP435 |
0.748823978306586 |
|
19671 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PDE9A |
0.748932248301443 |
|
19672 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ASGR1 |
0.749158260119191 |
|
19673 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DLG4 |
0.749158260119191 |
|
19674 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACADVL |
0.749158260119191 |
|
19675 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DVL2 |
0.749158260119191 |
|
19676 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR324 |
0.749158260119191 |
|
19677 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KRT18P55 |
0.749181420733592 |
|
19678 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM97 |
0.749181420733592 |
|
19679 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IFT20 |
0.749181420733592 |
|
19680 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TNFAIP1 |
0.749181420733592 |
|
19681 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
POLDIP2 |
0.749181420733592 |
|
19682 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM199 |
0.749181420733592 |
|
19683 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4723 |
0.749181420733592 |
|
19684 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SARM1 |
0.749181420733592 |
|
19685 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SEBOX |
0.749181420733592 |
|
19686 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VTN |
0.749181420733592 |
|
19687 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC46A1 |
0.749181420733592 |
|
19688 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DIRC1 |
0.749378116893399 |
|
19689 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DAW1 |
0.749575097982133 |
|
19690 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA25|ENSG00000272237.1 |
0.749575097982133 |
|
19691 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPHKAP |
0.749575097982133 |
|
19692 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EXOSC7 |
0.749730335818945 |
|
19693 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLEC3B |
0.749730335818945 |
|
19694 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDCP1 |
0.749730335818945 |
|
19695 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR182 |
0.750017786578053 |
|
19696 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR183 |
0.750017786578053 |
|
19697 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR96 |
0.750017786578053 |
|
19698 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP403 |
0.750161881699244 |
|
19699 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
METTL8 |
0.750206208525885 |
|
19700 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00680 |
0.750346665145825 |
|
19701 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR548U |
0.750346665145825 |
|
19702 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL503P |
0.750358523628497 |
|
19703 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA62|ENSG00000201542.1 |
0.750358523628497 |
|
19704 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNY5P1 |
0.750358523628497 |
|
19705 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIAA0319L |
0.750358523628497 |
|
19706 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AADACL4 |
0.750760415203743 |
|
19707 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP472 |
0.750839360518749 |
|
19708 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF507 |
0.750839360518749 |
|
19709 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DOCK1 |
0.751046607243345 |
|
19710 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STARD5 |
0.751207891026077 |
|
19711 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMC3 |
0.751207891026077 |
|
19712 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TOPAZ1 |
0.751315465658339 |
|
19713 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CTU1 |
0.751432329913057 |
|
19714 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SIGLEC7 |
0.751432329913057 |
|
19715 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SIGLEC9 |
0.751432329913057 |
|
19716 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SIGLEC17P |
0.751432329913057 |
|
19717 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SIGLEC22P |
0.751432329913057 |
|
19718 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CD33 |
0.751432329913057 |
|
19719 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
N6AMT1 |
0.75167104768862 |
|
19720 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LTN1 |
0.75167104768862 |
|
19721 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EPG5 |
0.751681846952098 |
|
19722 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP26 |
0.751681846952098 |
|
19723 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IZUMO2 |
0.751713728804944 |
|
19724 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HEPH |
0.752068000601895 |
|
19725 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FRMD5 |
0.75231979875016 |
|
19726 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00683 |
0.75233404595273 |
|
19727 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCN3A |
0.75248370676527 |
|
19728 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL455P |
0.75248370676527 |
|
19729 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCN2A |
0.75248370676527 |
|
19730 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GALNT3 |
0.75248370676527 |
|
19731 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TTC21B |
0.75248370676527 |
|
19732 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCN1A |
0.75248370676527 |
|
19733 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP152 |
0.75248370676527 |
|
19734 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCN9A |
0.75248370676527 |
|
19735 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238662.1 |
0.75248370676527 |
|
19736 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCN7A |
0.75248370676527 |
|
19737 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SUPT6H |
0.752576347211879 |
|
19738 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PROCA1 |
0.752576347211879 |
|
19739 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAB34 |
0.752576347211879 |
|
19740 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPL23A |
0.752576347211879 |
|
19741 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD42B |
0.752576347211879 |
|
19742 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD42A |
0.752576347211879 |
|
19743 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD4A |
0.752576347211879 |
|
19744 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD4B |
0.752576347211879 |
|
19745 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TLCD1 |
0.752576347211879 |
|
19746 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NEK8 |
0.752576347211879 |
|
19747 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRRC3 |
0.75278431809124 |
|
19748 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRRC3DN |
0.75278431809124 |
|
19749 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HERPUD2 |
0.752805436689732 |
|
19750 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SMG7 |
0.752974520681042 |
|
19751 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NCF2 |
0.752974520681042 |
|
19752 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IPCEF1 |
0.753206554905894 |
|
19753 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TGFB2 |
0.753230811096339 |
|
19754 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZC3H12B |
0.753350313380076 |
|
19755 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LAS1L |
0.753350313380076 |
|
19756 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MSN |
0.753350313380076 |
|
19757 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR223 |
0.753350313380076 |
|
19758 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VSIG4 |
0.753350313380076 |
|
19759 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP321 |
0.753719015753581 |
|
19760 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EDEM1 |
0.753840572750517 |
|
19761 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4790 |
0.753840572750517 |
|
19762 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL553P |
0.753840572750517 |
|
19763 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DTL |
0.753875113448435 |
|
19764 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL592P |
0.753955628755951 |
|
19765 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U3|ENSG00000200492.1 |
0.754043968748671 |
|
19766 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BIN1 |
0.754054642176379 |
|
19767 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CYP27C1 |
0.754054642176379 |
|
19768 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ERCC3 |
0.754054642176379 |
|
19769 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAP3K2 |
0.754054642176379 |
|
19770 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4783 |
0.754054642176379 |
|
19771 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PROC |
0.754054642176379 |
|
19772 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IWS1 |
0.754054642176379 |
|
19773 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ERI1 |
0.754306163510083 |
|
19774 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPP1R3B |
0.754306163510083 |
|
19775 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U3|ENSG00000252543.1 |
0.754306163510083 |
|
19776 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GAS2L2 |
0.754361489474801 |
|
19777 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C17orf50 |
0.754361489474801 |
|
19778 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FRA10AC1 |
0.75552844574642 |
|
19779 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LGI1 |
0.75552844574642 |
|
19780 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC23A1 |
0.755576854925965 |
|
19781 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MZB1 |
0.755576854925965 |
|
19782 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PROB1 |
0.755576854925965 |
|
19783 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPATA24 |
0.755576854925965 |
|
19784 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DNAJC18 |
0.755576854925965 |
|
19785 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ECSCR |
0.755576854925965 |
|
19786 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM173 |
0.755576854925965 |
|
19787 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR5688 |
0.755587530938965 |
|
19788 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLA2G4A |
0.755649321221606 |
|
19789 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ERCC8 |
0.755705994214651 |
|
19790 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LEKR1 |
0.755874959185408 |
|
19791 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF385D |
0.756351341539147 |
|
19792 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HMGB1P5 |
0.756351341539147 |
|
19793 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP121 |
0.756480911687247 |
|
19794 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCL20 |
0.756480911687247 |
|
19795 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD78|ENSG00000212378.1 |
0.756501839917841 |
|
19796 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NOTO |
0.756501839917841 |
|
19797 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SMYD5 |
0.756501839917841 |
|
19798 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCT7 |
0.756501839917841 |
|
19799 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRADC1 |
0.756501839917841 |
|
19800 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FBXO41 |
0.756501839917841 |
|
19801 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EGR4 |
0.756501839917841 |
|
19802 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP72 |
0.756654036119668 |
|
19803 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNF2 |
0.756654036119668 |
|
19804 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRMT1L |
0.756654036119668 |
|
19805 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SWT1 |
0.756654036119668 |
|
19806 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SH3BP1 |
0.756667202315126 |
|
19807 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PDXP |
0.756667202315126 |
|
19808 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL385P |
0.756667202315126 |
|
19809 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LGALS1 |
0.756667202315126 |
|
19810 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NOL12 |
0.756667202315126 |
|
19811 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP120 |
0.756747198148409 |
|
19812 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U3|ENSG00000200538.1 |
0.756749423678537 |
|
19813 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU109|ENSG00000238754.1 |
0.756771554001138 |
|
19814 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TROVE2 |
0.756771554001138 |
|
19815 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GLRX2 |
0.756771554001138 |
|
19816 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACP1 |
0.756916885331766 |
|
19817 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM110C |
0.756916885331766 |
|
19818 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM150B |
0.756916885331766 |
|
19819 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SH3YL1 |
0.756916885331766 |
|
19820 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BBX |
0.756919259244464 |
|
19821 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SYT3 |
0.757062061875954 |
|
19822 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C19orf81 |
0.757062061875954 |
|
19823 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SHANK1 |
0.757062061875954 |
|
19824 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLEC11A |
0.757062061875954 |
|
19825 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPR32 |
0.757062061875954 |
|
19826 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACPT |
0.757062061875954 |
|
19827 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C19orf48 |
0.757062061875954 |
|
19828 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD88A |
0.757062061875954 |
|
19829 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD88B |
0.757062061875954 |
|
19830 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD88C |
0.757062061875954 |
|
19831 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IL16 |
0.757137021141142 |
|
19832 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
JAG2 |
0.757320819214309 |
|
19833 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NUDT14 |
0.757320819214309 |
|
19834 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BTBD6 |
0.757320819214309 |
|
19835 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NEK10 |
0.757322150782627 |
|
19836 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC4A7 |
0.757322150782627 |
|
19837 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL859P |
0.757322150782627 |
|
19838 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP145 |
0.75742440450769 |
|
19839 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ABLIM3 |
0.75742440450769 |
|
19840 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AFAP1L1 |
0.75742440450769 |
|
19841 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GRPEL2 |
0.75742440450769 |
|
19842 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCYOX1L |
0.75742440450769 |
|
19843 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TBC1D5 |
0.758322520855325 |
|
19844 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANO5 |
0.75859615209393 |
|
19845 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C10orf91 |
0.75865939813624 |
|
19846 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GKN2 |
0.758708471776805 |
|
19847 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GKN1 |
0.758708471776805 |
|
19848 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANTXR1 |
0.758708471776805 |
|
19849 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3126 |
0.758708471776805 |
|
19850 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP96 |
0.758708471776805 |
|
19851 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LTV1 |
0.758746809357205 |
|
19852 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZC2HC1B |
0.758746809357205 |
|
19853 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STX11 |
0.758746809357205 |
|
19854 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UTRN |
0.758746809357205 |
|
19855 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EPM2A |
0.758746809357205 |
|
19856 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FBXO30 |
0.758746809357205 |
|
19857 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SHPRH |
0.758746809357205 |
|
19858 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4432 |
0.758812829854094 |
|
19859 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FHIT |
0.759020973277004 |
|
19860 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NPCDR1 |
0.759020973277004 |
|
19861 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U3|ENSG00000212211.1 |
0.759020973277004 |
|
19862 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SETD4 |
0.75912448196135 |
|
19863 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM122A |
0.759267490420348 |
|
19864 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CASC4 |
0.759377440064571 |
|
19865 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TGFBI |
0.759468717152011 |
|
19866 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SMAD5 |
0.759468717152011 |
|
19867 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRPC7 |
0.759468717152011 |
|
19868 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GGTA1P |
0.759605440927647 |
|
19869 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL187P |
0.759605440927647 |
|
19870 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ALS2 |
0.760283836000216 |
|
19871 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDK15 |
0.760283836000216 |
|
19872 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TEX22 |
0.760652966516096 |
|
19873 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNX29P2 |
0.760759415576313 |
|
19874 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4660 |
0.760780629170448 |
|
19875 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANKZF1 |
0.760802431826658 |
|
19876 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GLB1L |
0.760802431826658 |
|
19877 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STK16 |
0.760802431826658 |
|
19878 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TUBA4A |
0.760802431826658 |
|
19879 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TUBA4B |
0.760802431826658 |
|
19880 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DNAJB2 |
0.760802431826658 |
|
19881 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PTCH1 |
0.760934674556181 |
|
19882 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EIF2AK3 |
0.760938466515075 |
|
19883 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STRIP2 |
0.761377027917737 |
|
19884 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SMKR1 |
0.761377027917737 |
|
19885 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TBC1D26 |
0.761480523542117 |
|
19886 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF286A |
0.761480523542117 |
|
19887 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP436 |
0.761480523542117 |
|
19888 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00152 |
0.761601525709899 |
|
19889 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLGLB1 |
0.761601525709899 |
|
19890 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLGLB2 |
0.761601525709899 |
|
19891 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RGPD1 |
0.761601525709899 |
|
19892 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RGPD2 |
0.761601525709899 |
|
19893 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238979.1 |
0.761601525709899 |
|
19894 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KRCC1 |
0.761601525709899 |
|
19895 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SMYD1 |
0.761601525709899 |
|
19896 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4780 |
0.761601525709899 |
|
19897 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FABP1 |
0.761601525709899 |
|
19898 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
THNSL2 |
0.761601525709899 |
|
19899 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNY4P15 |
0.761601525709899 |
|
19900 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000239049.1 |
0.761601525709899 |
|
19901 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FOXI3 |
0.761601525709899 |
|
19902 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TEX37 |
0.761601525709899 |
|
19903 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLITRK4 |
0.761936672329372 |
|
19904 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIAA0226 |
0.76204753029898 |
|
19905 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR922 |
0.76204753029898 |
|
19906 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FYTTD1 |
0.76204753029898 |
|
19907 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRCH3 |
0.76204753029898 |
|
19908 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANKRD18DP |
0.76204753029898 |
|
19909 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM157A |
0.76204753029898 |
|
19910 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IQCG |
0.76204753029898 |
|
19911 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LMLN |
0.76204753029898 |
|
19912 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPL35A |
0.76204753029898 |
|
19913 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PWWP2B |
0.762167235394398 |
|
19914 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00161 |
0.762418404390891 |
|
19915 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NHEJ1 |
0.762881171749457 |
|
19916 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL663P |
0.762889426351023 |
|
19917 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNY1P4 |
0.762903381111876 |
|
19918 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ALDH1B1 |
0.763178148504236 |
|
19919 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA18|ENSG00000252249.1 |
0.763341942878966 |
|
19920 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PEAK1 |
0.763457850388113 |
|
19921 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP502 |
0.763682277331943 |
|
19922 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DDX3X |
0.763682277331943 |
|
19923 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL15P |
0.763682277331943 |
|
19924 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GOSR2 |
0.764414603262963 |
|
19925 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRRC37A17P |
0.764414603262963 |
|
19926 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL270P |
0.764414603262963 |
|
19927 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LHX1 |
0.764580004200602 |
|
19928 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AATF |
0.764580004200602 |
|
19929 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR2909 |
0.764580004200602 |
|
19930 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACACA |
0.764580004200602 |
|
19931 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HMGB1P24 |
0.764580004200602 |
|
19932 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C18orf32 |
0.764584446521911 |
|
19933 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR1539 |
0.764584446521911 |
|
19934 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPL17 |
0.764584446521911 |
|
19935 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD58C |
0.764584446521911 |
|
19936 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD58A |
0.764584446521911 |
|
19937 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD58B |
0.764584446521911 |
|
19938 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LIPG |
0.764584446521911 |
|
19939 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACAA2 |
0.764584446521911 |
|
19940 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCARNA17|ENSG00000251992.1 |
0.764584446521911 |
|
19941 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCARNA17|ENSG00000267322.1 |
0.764584446521911 |
|
19942 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCARNA18|ENSG00000252139.1 |
0.764584446521911 |
|
19943 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MYO5B |
0.764584446521911 |
|
19944 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP457 |
0.764584446521911 |
|
19945 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL310P |
0.764584446521911 |
|
19946 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC11 |
0.764584446521911 |
|
19947 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MBD1 |
0.764584446521911 |
|
19948 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CXXC1 |
0.764584446521911 |
|
19949 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP458 |
0.764584446521911 |
|
19950 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SKA1 |
0.764584446521911 |
|
19951 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAPK4 |
0.764584446521911 |
|
19952 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MRO |
0.764584446521911 |
|
19953 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ME2 |
0.764584446521911 |
|
19954 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ELAC1 |
0.764584446521911 |
|
19955 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SMAD4 |
0.764584446521911 |
|
19956 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL695P |
0.764584446521911 |
|
19957 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MEX3C |
0.764584446521911 |
|
19958 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238885.1 |
0.764584446521911 |
|
19959 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR29A |
0.765152195691607 |
|
19960 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR29B1 |
0.765152195691607 |
|
19961 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF273 |
0.765420169358297 |
|
19962 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF117 |
0.765420169358297 |
|
19963 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GLRA2 |
0.765673083550271 |
|
19964 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FANCB |
0.765673083550271 |
|
19965 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MOSPD2 |
0.765673083550271 |
|
19966 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACE2 |
0.765673083550271 |
|
19967 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ASB11 |
0.765673083550271 |
|
19968 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ASB9 |
0.765673083550271 |
|
19969 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BMX |
0.765673083550271 |
|
19970 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FIGF |
0.765673083550271 |
|
19971 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PIGA |
0.765673083550271 |
|
19972 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PIR |
0.765673083550271 |
|
19973 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPGR |
0.765778678403402 |
|
19974 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA31|ENSG00000252050.1 |
0.765778678403402 |
|
19975 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OTC |
0.765778678403402 |
|
19976 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TSPAN7 |
0.765778678403402 |
|
19977 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SMCR8 |
0.765790368231974 |
|
19978 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL308P |
0.766125035581923 |
|
19979 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DARS |
0.766249263282067 |
|
19980 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ERICH2 |
0.766360105418834 |
|
19981 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GAD1 |
0.766360105418834 |
|
19982 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GORASP2 |
0.766360105418834 |
|
19983 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TLK1 |
0.766360105418834 |
|
19984 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238567.1 |
0.766360105418834 |
|
19985 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ALMS1P |
0.766397405406576 |
|
19986 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NAT8 |
0.766397405406576 |
|
19987 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TPRKB |
0.766397405406576 |
|
19988 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DUSP11 |
0.766397405406576 |
|
19989 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C2orf78 |
0.766397405406576 |
|
19990 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STAMBP |
0.766397405406576 |
|
19991 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACTG2 |
0.766397405406576 |
|
19992 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP251 |
0.766493438882311 |
|
19993 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
USP34 |
0.766552353083928 |
|
19994 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
XAGE1C |
0.766581839458644 |
|
19995 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
XAGE1D |
0.766581839458644 |
|
19996 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
XAGE1E |
0.766581839458644 |
|
19997 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TCERG1 |
0.766589409419288 |
|
19998 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPR151 |
0.766589409419288 |
|
19999 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KNG1 |
0.766592356242819 |
|
20000 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EIF4A2 |
0.766592356242819 |
|
20001 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD2|ENSG00000238942.1 |
0.766592356242819 |
|
20002 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RFC4 |
0.766592356242819 |
|
20003 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA4|ENSG00000263776.1 |
0.766592356242819 |
|
20004 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA63|ENSG00000200320.1 |
0.766592356242819 |
|
20005 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA63|ENSG00000200418.1 |
0.766592356242819 |
|
20006 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA81|ENSG00000221420.2 |
0.766592356242819 |
|
20007 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADIPOQ |
0.766592356242819 |
|
20008 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ST6GAL1 |
0.766592356242819 |
|
20009 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPL39L |
0.766592356242819 |
|
20010 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RTP1 |
0.766592356242819 |
|
20011 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MASP1 |
0.766592356242819 |
|
20012 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RTP4 |
0.766592356242819 |
|
20013 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000239093.1 |
0.766592356242819 |
|
20014 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SST |
0.766592356242819 |
|
20015 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RTP2 |
0.766592356242819 |
|
20016 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BCL6 |
0.766592356242819 |
|
20017 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
JAKMIP3 |
0.766808420267244 |
|
20018 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DPYSL4 |
0.766808420267244 |
|
20019 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STK32C |
0.766808420267244 |
|
20020 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRRC27 |
0.766808420267244 |
|
20021 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZDHHC3 |
0.767058205686952 |
|
20022 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PICK1 |
0.76713915679351 |
|
20023 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC16A8 |
0.76713915679351 |
|
20024 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BAIAP2L2 |
0.76713915679351 |
|
20025 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLA2G6 |
0.76713915679351 |
|
20026 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNX29 |
0.767154720967523 |
|
20027 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PODXL |
0.767204985553812 |
|
20028 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACPP |
0.767283256222147 |
|
20029 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF367 |
0.767457644381588 |
|
20030 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HABP4 |
0.767457644381588 |
|
20031 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TFF2 |
0.767652842834394 |
|
20032 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TFF1 |
0.767652842834394 |
|
20033 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMPRSS3 |
0.767652842834394 |
|
20034 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UBASH3A |
0.767652842834394 |
|
20035 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RSPH1 |
0.767652842834394 |
|
20036 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC37A1 |
0.767652842834394 |
|
20037 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U3|ENSG00000221455.1 |
0.767848096923896 |
|
20038 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EPHA7 |
0.767848096923896 |
|
20039 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADAMTS9 |
0.76793006520548 |
|
20040 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC35D2 |
0.76798965508678 |
|
20041 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LIMD1 |
0.76810213756318 |
|
20042 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NCOA7 |
0.768114874923567 |
|
20043 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM129A |
0.768121076009132 |
|
20044 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IVNS1ABP |
0.768121076009132 |
|
20045 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HMCN1 |
0.768121076009132 |
|
20046 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRG4 |
0.768121076009132 |
|
20047 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TPR |
0.768121076009132 |
|
20048 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C1orf27 |
0.768121076009132 |
|
20049 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OCLM |
0.768121076009132 |
|
20050 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PDC |
0.768121076009132 |
|
20051 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PTGS2 |
0.768121076009132 |
|
20052 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP404 |
0.768180855736018 |
|
20053 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GRB14 |
0.768513612126453 |
|
20054 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM158 |
0.768751952105634 |
|
20055 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U3|ENSG00000202268.1 |
0.768751952105634 |
|
20056 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LARS2 |
0.768751952105634 |
|
20057 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR98 |
0.768784967230628 |
|
20058 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIRLET7F2 |
0.768784967230628 |
|
20059 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NEK2 |
0.768908887989121 |
|
20060 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LPGAT1 |
0.768908887989121 |
|
20061 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL344P |
0.768908887989121 |
|
20062 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC68 |
0.76939137394871 |
|
20063 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP459 |
0.76939137394871 |
|
20064 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U8|ENSG00000201398.1 |
0.769409210660944 |
|
20065 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARHGEF26 |
0.769409210660944 |
|
20066 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DHX36 |
0.769409210660944 |
|
20067 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000271922.1 |
0.769409210660944 |
|
20068 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPR149 |
0.769409210660944 |
|
20069 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PDPN |
0.76952438409989 |
|
20070 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP41 |
0.76952438409989 |
|
20071 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCARNA11|ENSG00000253085.1 |
0.76952438409989 |
|
20072 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRDM2 |
0.76952438409989 |
|
20073 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PSTPIP2 |
0.769603639629956 |
|
20074 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NDFIP1 |
0.7696621473444 |
|
20075 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
P2RY1 |
0.769672478323057 |
|
20076 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAP2B |
0.769672478323057 |
|
20077 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL300P |
0.769672478323057 |
|
20078 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C3orf79 |
0.769672478323057 |
|
20079 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IQSEC2 |
0.769718540172872 |
|
20080 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CD55 |
0.769814088859343 |
|
20081 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR9G4 |
0.769868189888175 |
|
20082 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR5G5P |
0.769868189888175 |
|
20083 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ABCA11P |
0.770069008525925 |
|
20084 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATP5I |
0.770069008525925 |
|
20085 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CPLX1 |
0.770069008525925 |
|
20086 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DGKQ |
0.770069008525925 |
|
20087 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FGFRL1 |
0.770069008525925 |
|
20088 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GAK |
0.770069008525925 |
|
20089 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IDUA |
0.770069008525925 |
|
20090 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MFSD7 |
0.770069008525925 |
|
20091 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR571 |
0.770069008525925 |
|
20092 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MYL5 |
0.770069008525925 |
|
20093 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCGF3 |
0.770069008525925 |
|
20094 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PDE6B |
0.770069008525925 |
|
20095 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PIGG |
0.770069008525925 |
|
20096 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL358P |
0.770069008525925 |
|
20097 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNF212 |
0.770069008525925 |
|
20098 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC26A1 |
0.770069008525925 |
|
20099 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM175 |
0.770069008525925 |
|
20100 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF141 |
0.770069008525925 |
|
20101 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF595 |
0.770069008525925 |
|
20102 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF718 |
0.770069008525925 |
|
20103 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF721 |
0.770069008525925 |
|
20104 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF732 |
0.770069008525925 |
|
20105 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF876P |
0.770069008525925 |
|
20106 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMED11P |
0.770069008525925 |
|
20107 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA48|ENSG00000212458.1 |
0.770069008525925 |
|
20108 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACA64|ENSG00000238685.1 |
0.770310172379863 |
|
20109 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM161A |
0.77036850617869 |
|
20110 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAF3IP1 |
0.77039134075856 |
|
20111 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ASB1 |
0.77039134075856 |
|
20112 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IZUMO3 |
0.770413087402835 |
|
20113 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RMRPP5 |
0.770413087402835 |
|
20114 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MOB1B |
0.770793022763721 |
|
20115 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DCK |
0.770793022763721 |
|
20116 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000252609.1 |
0.770918751697475 |
|
20117 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ST8SIA2 |
0.771176272992885 |
|
20118 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU109|ENSG00000239197.1 |
0.771176272992885 |
|
20119 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C15orf32 |
0.771176272992885 |
|
20120 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CIITA |
0.771248809627642 |
|
20121 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DEXI |
0.771248809627642 |
|
20122 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLEC16A |
0.771248809627642 |
|
20123 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PHF8 |
0.771440346590194 |
|
20124 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U3|ENSG00000252175.1 |
0.771440346590194 |
|
20125 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM120C |
0.771440346590194 |
|
20126 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPIHBP1 |
0.771638577900511 |
|
20127 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAD51D |
0.7716634030477 |
|
20128 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FNDC8 |
0.7716634030477 |
|
20129 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NLE1 |
0.7716634030477 |
|
20130 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UNC45B |
0.7716634030477 |
|
20131 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC35G3 |
0.7716634030477 |
|
20132 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLFN5 |
0.7716634030477 |
|
20133 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLFN11 |
0.7716634030477 |
|
20134 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLFN12 |
0.7716634030477 |
|
20135 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLFN13 |
0.7716634030477 |
|
20136 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLFN12L |
0.7716634030477 |
|
20137 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLFN14 |
0.7716634030477 |
|
20138 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AP2B1 |
0.7716634030477 |
|
20139 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PEX12 |
0.7716634030477 |
|
20140 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD7 |
0.7716634030477 |
|
20141 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
B3GALT1 |
0.771811875939225 |
|
20142 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LPP |
0.771828855460818 |
|
20143 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WDR87 |
0.77272860248386 |
|
20144 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ABCG1 |
0.772908514984295 |
|
20145 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP492 |
0.772908514984295 |
|
20146 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TFF3 |
0.772908514984295 |
|
20147 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCNC3 |
0.77294010061141 |
|
20148 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NAPSB |
0.77294010061141 |
|
20149 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NR1H2 |
0.77294010061141 |
|
20150 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NAPSA |
0.77294010061141 |
|
20151 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
POLD1 |
0.77294010061141 |
|
20152 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL324P |
0.77294010061141 |
|
20153 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPIB |
0.77294010061141 |
|
20154 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MYBPC2 |
0.77294010061141 |
|
20155 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DPF1 |
0.773027731900933 |
|
20156 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RRAGD |
0.773056520192358 |
|
20157 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GJA10 |
0.773056520192358 |
|
20158 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP110 |
0.773056520192358 |
|
20159 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIAA1210 |
0.773207590995574 |
|
20160 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC13A2 |
0.773278737503356 |
|
20161 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FOXN1 |
0.773278737503356 |
|
20162 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UNC119 |
0.773278737503356 |
|
20163 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PIGS |
0.773278737503356 |
|
20164 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ALDOC |
0.773278737503356 |
|
20165 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPAG5 |
0.773278737503356 |
|
20166 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIAA0100 |
0.773278737503356 |
|
20167 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SGK494 |
0.773278737503356 |
|
20168 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COL22A1 |
0.773384176435347 |
|
20169 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FBXL20 |
0.773438972016853 |
|
20170 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DSEL |
0.773547785738643 |
|
20171 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL399P |
0.773695380689541 |
|
20172 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZDHHC14 |
0.77369953147046 |
|
20173 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MOCS2 |
0.773835316900561 |
|
20174 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP46 |
0.773862683843749 |
|
20175 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MOGAT1 |
0.773974792574837 |
|
20176 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACSL3 |
0.773974792574837 |
|
20177 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCNE4 |
0.773974792574837 |
|
20178 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KLK10 |
0.774228265027544 |
|
20179 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRAMEF20 |
0.774346473088059 |
|
20180 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRRC38 |
0.774346473088059 |
|
20181 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPP1R14C |
0.774364672241485 |
|
20182 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CYLC1 |
0.774619067702772 |
|
20183 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPS6KA6 |
0.774619067702772 |
|
20184 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR548I4 |
0.774619067702772 |
|
20185 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CHM |
0.774619067702772 |
|
20186 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CPA4 |
0.774976378587037 |
|
20187 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238336.1 |
0.774976378587037 |
|
20188 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TSGA13 |
0.774976378587037 |
|
20189 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KLF14 |
0.774976378587037 |
|
20190 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BDP1 |
0.775063034927892 |
|
20191 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR4C13 |
0.775125801727304 |
|
20192 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C3orf33 |
0.775323507442789 |
|
20193 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC33A1 |
0.775323507442789 |
|
20194 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GMPS |
0.775323507442789 |
|
20195 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SSR3 |
0.775323507442789 |
|
20196 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TIPARP |
0.775323507442789 |
|
20197 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00886 |
0.775323507442789 |
|
20198 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BZW1 |
0.775467775877635 |
|
20199 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP115 |
0.775467775877635 |
|
20200 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLK1 |
0.775467775877635 |
|
20201 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00595 |
0.775486571260862 |
|
20202 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA71|ENSG00000201393.1 |
0.775486571260862 |
|
20203 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DYNLT3 |
0.775514183757813 |
|
20204 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DCAF12L2 |
0.77561732041593 |
|
20205 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DCAF12L1 |
0.77561732041593 |
|
20206 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LENG8 |
0.776005457944467 |
|
20207 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDC42EP5 |
0.776005457944467 |
|
20208 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LENG9 |
0.776005457944467 |
|
20209 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCDP1 |
0.776145296928045 |
|
20210 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GSPT1 |
0.776294089966471 |
|
20211 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP177 |
0.776490771827514 |
|
20212 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00880 |
0.776490771827514 |
|
20213 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00881 |
0.776490771827514 |
|
20214 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCNL1 |
0.776490771827514 |
|
20215 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP146 |
0.776490771827514 |
|
20216 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VEPH1 |
0.776490771827514 |
|
20217 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PTX3 |
0.776490771827514 |
|
20218 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C3orf55 |
0.776490771827514 |
|
20219 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MLF1 |
0.776490771827514 |
|
20220 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GFM1 |
0.776490771827514 |
|
20221 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LXN |
0.776490771827514 |
|
20222 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RARRES1 |
0.776490771827514 |
|
20223 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SOD1 |
0.776573827757974 |
|
20224 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCAF4 |
0.776573827757974 |
|
20225 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA81|ENSG00000238390.1 |
0.776573827757974 |
|
20226 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MME |
0.776585342777023 |
|
20227 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCNAB1 |
0.776771132939014 |
|
20228 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CALCRL |
0.777156101300025 |
|
20229 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TFPI |
0.777156101300025 |
|
20230 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP114 |
0.777156101300025 |
|
20231 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GULP1 |
0.777156101300025 |
|
20232 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR561 |
0.777156101300025 |
|
20233 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP42 |
0.777477279784626 |
|
20234 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C1orf94 |
0.777477279784626 |
|
20235 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UMODL1 |
0.777498273597846 |
|
20236 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SMYD2 |
0.777650333530333 |
|
20237 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF181 |
0.777856586705358 |
|
20238 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF599 |
0.777856586705358 |
|
20239 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EIF2D |
0.778079102169121 |
|
20240 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AP2S1 |
0.778396388832797 |
|
20241 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COL7A1 |
0.778500997413082 |
|
20242 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR711 |
0.778500997413082 |
|
20243 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UQCRC1 |
0.778500997413082 |
|
20244 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM196A |
0.77857116001492 |
|
20245 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIAA1715 |
0.77880663450623 |
|
20246 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EVX2 |
0.77880663450623 |
|
20247 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HOXD13 |
0.77880663450623 |
|
20248 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HOXD12 |
0.77880663450623 |
|
20249 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HOXD10 |
0.77880663450623 |
|
20250 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HOXD11 |
0.77880663450623 |
|
20251 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR548AE1 |
0.779137257149299 |
|
20252 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GARNL3 |
0.779288250684033 |
|
20253 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC2A8 |
0.779288250684033 |
|
20254 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UBE2F |
0.779316714649494 |
|
20255 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCLY |
0.779316714649494 |
|
20256 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ESPNL |
0.779316714649494 |
|
20257 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KLHL30 |
0.779316714649494 |
|
20258 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM132B |
0.779316714649494 |
|
20259 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CPPED1 |
0.779339210808669 |
|
20260 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4718 |
0.779339210808669 |
|
20261 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA27|ENSG00000199474.1 |
0.779339210808669 |
|
20262 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCNV2 |
0.779417228142844 |
|
20263 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
POU3F4 |
0.7795714091329 |
|
20264 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PDE4D |
0.779622596581768 |
|
20265 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HIVEP2 |
0.779623197834696 |
|
20266 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPC1 |
0.780157354567793 |
|
20267 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR149 |
0.780157354567793 |
|
20268 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANKMY1 |
0.780157354567793 |
|
20269 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DUSP28 |
0.780157354567793 |
|
20270 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNPEPL1 |
0.780157354567793 |
|
20271 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CAPN10 |
0.780157354567793 |
|
20272 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPR35 |
0.780157354567793 |
|
20273 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U7|ENSG00000271841.1 |
0.780254459326407 |
|
20274 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM135B |
0.780289995481389 |
|
20275 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FKSG52 |
0.780308544640652 |
|
20276 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPC4 |
0.780344936522705 |
|
20277 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPC3 |
0.780599356395775 |
|
20278 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR106A |
0.780599356395775 |
|
20279 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR18B |
0.780599356395775 |
|
20280 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR19B2 |
0.780599356395775 |
|
20281 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR20B |
0.780599356395775 |
|
20282 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR363 |
0.780599356395775 |
|
20283 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR92A2 |
0.780599356395775 |
|
20284 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC17A6 |
0.780650462796707 |
|
20285 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BBS5 |
0.78083288240377 |
|
20286 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KLHL41 |
0.78083288240377 |
|
20287 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FASTKD1 |
0.78083288240377 |
|
20288 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCNH8 |
0.78092383752974 |
|
20289 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IGFBP2 |
0.781155547371437 |
|
20290 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IGFBP5 |
0.781155547371437 |
|
20291 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP120 |
0.781155547371437 |
|
20292 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KLHDC10 |
0.781913493908781 |
|
20293 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM209 |
0.781913493908781 |
|
20294 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SSMEM1 |
0.781913493908781 |
|
20295 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DGUOK |
0.782051653542762 |
|
20296 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP97 |
0.782051653542762 |
|
20297 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TET3 |
0.782051653542762 |
|
20298 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLAGL1 |
0.782298754920834 |
|
20299 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SF3B5 |
0.782298754920834 |
|
20300 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EIF3M |
0.782347873865683 |
|
20301 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GADL1 |
0.782636097623569 |
|
20302 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR549 |
0.782988891376624 |
|
20303 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BHLHE40 |
0.783007324546211 |
|
20304 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPR126 |
0.783055012339165 |
|
20305 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AIG1 |
0.783055012339165 |
|
20306 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCAI |
0.783122226320129 |
|
20307 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPP6C |
0.783122226320129 |
|
20308 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RABEPK |
0.783122226320129 |
|
20309 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HSPA5 |
0.783122226320129 |
|
20310 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GAPVD1 |
0.783122226320129 |
|
20311 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BNC1 |
0.783205305653258 |
|
20312 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FKBP1C |
0.783357263155377 |
|
20313 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LGSN |
0.783357263155377 |
|
20314 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PTP4A1 |
0.783357263155377 |
|
20315 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NBEA |
0.783438211176981 |
|
20316 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIAA1199 |
0.783485329896442 |
|
20317 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FOXD4L1 |
0.783501939568258 |
|
20318 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CBWD2 |
0.783522186672924 |
|
20319 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KLK5 |
0.78382370067562 |
|
20320 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KLK6 |
0.78382370067562 |
|
20321 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CXorf21 |
0.784248904663984 |
|
20322 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPIG |
0.784306146274801 |
|
20323 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC173 |
0.784306146274801 |
|
20324 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KLHL23 |
0.784306146274801 |
|
20325 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PHOSPHO2 |
0.784306146274801 |
|
20326 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA51|ENSG00000206961.1 |
0.784306146274801 |
|
20327 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SSB |
0.784306146274801 |
|
20328 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
METTL5 |
0.784306146274801 |
|
20329 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U3|ENSG00000252981.1 |
0.784306146274801 |
|
20330 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UBR3 |
0.784306146274801 |
|
20331 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
THEG5 |
0.784467767121707 |
|
20332 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP471 |
0.784467767121707 |
|
20333 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00925 |
0.784473113368609 |
|
20334 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AUTS2 |
0.784563079792356 |
|
20335 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP391 |
0.784593036269293 |
|
20336 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACSL6 |
0.784639538616237 |
|
20337 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPON2 |
0.784813583030758 |
|
20338 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CTBP1 |
0.784813583030758 |
|
20339 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PSMD6 |
0.784853359585811 |
|
20340 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U3|ENSG00000200222.1 |
0.784853359585811 |
|
20341 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRICKLE2 |
0.784853359585811 |
|
20342 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GSN |
0.785434141812476 |
|
20343 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TCOF1 |
0.785463563924044 |
|
20344 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL45P |
0.785484331806147 |
|
20345 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4724 |
0.785484331806147 |
|
20346 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR193A |
0.785484331806147 |
|
20347 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNU6ATAC7P |
0.785484331806147 |
|
20348 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR365B |
0.785484331806147 |
|
20349 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4725 |
0.785484331806147 |
|
20350 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL79P |
0.785678863742178 |
|
20351 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR632 |
0.785781552993095 |
|
20352 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZPLD1 |
0.785901894314803 |
|
20353 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C3orf14 |
0.785971866738608 |
|
20354 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FEZF2 |
0.785971866738608 |
|
20355 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
R3HDM1 |
0.786200578932224 |
|
20356 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MCM6 |
0.786200578932224 |
|
20357 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CT64 |
0.786835351776661 |
|
20358 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238398.1 |
0.786835351776661 |
|
20359 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR1263 |
0.786835351776661 |
|
20360 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR720 |
0.786835351776661 |
|
20361 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BRD8 |
0.787002180126619 |
|
20362 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoZ178 |
0.787099281748621 |
|
20363 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UCN2 |
0.787198845538029 |
|
20364 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00971 |
0.78738755718483 |
|
20365 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CSRNP3 |
0.78748999312085 |
|
20366 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IQCA1 |
0.787733694931569 |
|
20367 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000252088.1 |
0.787766327977447 |
|
20368 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HDX |
0.787782809051 |
|
20369 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
APOOL |
0.787782809051 |
|
20370 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
POF1B |
0.787782809051 |
|
20371 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SATL1 |
0.787782809051 |
|
20372 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UBE2DNL |
0.787782809051 |
|
20373 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF711 |
0.787782809051 |
|
20374 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR361 |
0.787782809051 |
|
20375 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NDST1 |
0.788082419977917 |
|
20376 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000239191.1 |
0.788082419977917 |
|
20377 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DYM |
0.788339099931701 |
|
20378 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCDHB1 |
0.788345450273346 |
|
20379 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCDHB2 |
0.788345450273346 |
|
20380 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCDHB3 |
0.788345450273346 |
|
20381 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCDHB17 |
0.788345450273346 |
|
20382 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCDHB4 |
0.788345450273346 |
|
20383 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCDHB5 |
0.788345450273346 |
|
20384 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCDHB6 |
0.788345450273346 |
|
20385 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCDHB7 |
0.788345450273346 |
|
20386 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCDHB16 |
0.788345450273346 |
|
20387 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCDHB8 |
0.788345450273346 |
|
20388 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCDHB10 |
0.788345450273346 |
|
20389 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCDHB11 |
0.788345450273346 |
|
20390 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCDHB12 |
0.788345450273346 |
|
20391 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCDHB13 |
0.788345450273346 |
|
20392 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCDHB14 |
0.788345450273346 |
|
20393 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCDHB18 |
0.788345450273346 |
|
20394 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SATB1 |
0.788765699471301 |
|
20395 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCNH7 |
0.788766341594836 |
|
20396 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC7A9 |
0.788814605543845 |
|
20397 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP22 |
0.788814605543845 |
|
20398 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CEP89 |
0.788814605543845 |
|
20399 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C19orf40 |
0.788814605543845 |
|
20400 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STK39 |
0.788930668410262 |
|
20401 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NOSTRIN |
0.788930668410262 |
|
20402 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPC25 |
0.788930668410262 |
|
20403 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
G6PC2 |
0.788930668410262 |
|
20404 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ABCB11 |
0.788930668410262 |
|
20405 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRP2 |
0.788930668410262 |
|
20406 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL470P |
0.788976699673979 |
|
20407 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCBP1 |
0.788976699673979 |
|
20408 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00284 |
0.789057947244026 |
|
20409 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CD74 |
0.789644476091296 |
|
20410 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPS14 |
0.789644476091296 |
|
20411 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CWC27 |
0.789738413502113 |
|
20412 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADAMTS6 |
0.789738413502113 |
|
20413 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA4|ENSG00000202183.1 |
0.789928846802538 |
|
20414 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCNJ4 |
0.790061458524559 |
|
20415 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KDELR3 |
0.790061458524559 |
|
20416 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DDX17 |
0.790061458524559 |
|
20417 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DMC1 |
0.790061458524559 |
|
20418 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM227A |
0.790061458524559 |
|
20419 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OSCP1 |
0.790100757884543 |
|
20420 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA63|ENSG00000201448.1 |
0.790100757884543 |
|
20421 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MRPS15 |
0.790100757884543 |
|
20422 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CSF3R |
0.790100757884543 |
|
20423 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IGKC |
0.790101943342022 |
|
20424 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IGKJ1 |
0.790101943342022 |
|
20425 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IGKJ2 |
0.790101943342022 |
|
20426 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IGKJ3 |
0.790101943342022 |
|
20427 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IGKJ4 |
0.790101943342022 |
|
20428 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IGKJ5 |
0.790101943342022 |
|
20429 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP100 |
0.790101943342022 |
|
20430 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC9B1P2 |
0.790101943342022 |
|
20431 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP267 |
0.790210095140849 |
|
20432 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF236 |
0.790396770475306 |
|
20433 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CAHM |
0.790552801060018 |
|
20434 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPARC |
0.790664051126547 |
|
20435 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP232 |
0.790664051126547 |
|
20436 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
G3BP1 |
0.790664051126547 |
|
20437 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GLRA1 |
0.790664051126547 |
|
20438 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP198 |
0.790664051126547 |
|
20439 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR297 |
0.79069368684631 |
|
20440 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARL8B |
0.790863307013919 |
|
20441 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NTMT1 |
0.79092973294043 |
|
20442 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAMP1 |
0.791200483067548 |
|
20443 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD39|ENSG00000263723.1 |
0.791200483067548 |
|
20444 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC73 |
0.791201886525648 |
|
20445 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RBM44 |
0.791380655079987 |
|
20446 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP116 |
0.791513206782203 |
|
20447 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NME6 |
0.791546489874202 |
|
20448 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR2115 |
0.791546489874202 |
|
20449 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPINK8 |
0.791546489874202 |
|
20450 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FBXW12 |
0.791546489874202 |
|
20451 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL321P |
0.791546489874202 |
|
20452 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLXNB1 |
0.791546489874202 |
|
20453 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC51 |
0.791546489874202 |
|
20454 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMA7 |
0.791546489874202 |
|
20455 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATRIP |
0.791546489874202 |
|
20456 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SHISA5 |
0.791546489874202 |
|
20457 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TREX1 |
0.791546489874202 |
|
20458 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMPRSS11F |
0.791677144689246 |
|
20459 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMPRSS11GP |
0.791677144689246 |
|
20460 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COL4A6 |
0.791731844728465 |
|
20461 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COL4A5 |
0.791731844728465 |
|
20462 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RGS7BP |
0.791754791670193 |
|
20463 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL169P |
0.791754791670193 |
|
20464 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM159B |
0.791754791670193 |
|
20465 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PGA3 |
0.791756915042047 |
|
20466 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PGA4 |
0.791756915042047 |
|
20467 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PGA5 |
0.791756915042047 |
|
20468 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LITAF |
0.791861332811809 |
|
20469 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNN |
0.791861332811809 |
|
20470 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TXNDC11 |
0.791861332811809 |
|
20471 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZC3H7A |
0.791861332811809 |
|
20472 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SULT1A1 |
0.791991524967785 |
|
20473 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATP2A1 |
0.791991524967785 |
|
20474 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATXN2L |
0.791991524967785 |
|
20475 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CD19 |
0.791991524967785 |
|
20476 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EIF3C |
0.791991524967785 |
|
20477 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LAT |
0.791991524967785 |
|
20478 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4517 |
0.791991524967785 |
|
20479 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4721 |
0.791991524967785 |
|
20480 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NFATC2IP |
0.791991524967785 |
|
20481 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NPIPB8 |
0.791991524967785 |
|
20482 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NPIPB9 |
0.791991524967785 |
|
20483 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RABEP2 |
0.791991524967785 |
|
20484 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RRN3P2 |
0.791991524967785 |
|
20485 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SH2B1 |
0.791991524967785 |
|
20486 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA43|ENSG00000252461.1 |
0.791991524967785 |
|
20487 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPNS1 |
0.791991524967785 |
|
20488 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TUFM |
0.791991524967785 |
|
20489 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238352.1 |
0.791991524967785 |
|
20490 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238684.1 |
0.791991524967785 |
|
20491 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238699.1 |
0.791991524967785 |
|
20492 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PFKFB4 |
0.792169145117421 |
|
20493 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EOMES |
0.792234072401825 |
|
20494 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL204P |
0.792383325492294 |
|
20495 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IL1RL2 |
0.792591550831216 |
|
20496 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IL18R1 |
0.792591550831216 |
|
20497 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IL1RL1 |
0.792591550831216 |
|
20498 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IL18RAP |
0.792591550831216 |
|
20499 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4772 |
0.792591550831216 |
|
20500 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC9A4 |
0.792591550831216 |
|
20501 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC9A2 |
0.792591550831216 |
|
20502 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CA10 |
0.79281215517818 |
|
20503 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BSN |
0.792935685264033 |
|
20504 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
APEH |
0.792935685264033 |
|
20505 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MST1 |
0.792935685264033 |
|
20506 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNF123 |
0.792935685264033 |
|
20507 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AMIGO3 |
0.792935685264033 |
|
20508 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GMPPB |
0.792935685264033 |
|
20509 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IP6K1 |
0.792935685264033 |
|
20510 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDHR4 |
0.792935685264033 |
|
20511 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM212A |
0.792935685264033 |
|
20512 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR5193 |
0.792935685264033 |
|
20513 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UBA7 |
0.792935685264033 |
|
20514 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAP3K1 |
0.793342387078896 |
|
20515 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SETD9 |
0.793342387078896 |
|
20516 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPBP1 |
0.793342387078896 |
|
20517 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACTBL2 |
0.793342387078896 |
|
20518 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAXC |
0.793438983509678 |
|
20519 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COQ3 |
0.793438983509678 |
|
20520 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PNISR |
0.793438983509678 |
|
20521 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
USP45 |
0.793438983509678 |
|
20522 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TSTD3 |
0.793438983509678 |
|
20523 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCNC |
0.793438983509678 |
|
20524 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRDM13 |
0.793438983509678 |
|
20525 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MCHR2 |
0.793438983509678 |
|
20526 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TAF1 |
0.793483556292429 |
|
20527 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
INGX |
0.793483556292429 |
|
20528 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OGT |
0.793483556292429 |
|
20529 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACRC |
0.793483556292429 |
|
20530 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CXCR3 |
0.793483556292429 |
|
20531 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ERAL1 |
0.793637647009681 |
|
20532 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4732 |
0.793637647009681 |
|
20533 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FLOT2 |
0.793637647009681 |
|
20534 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DHRS13 |
0.793637647009681 |
|
20535 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PHF12 |
0.793637647009681 |
|
20536 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP73 |
0.793912387094453 |
|
20537 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADAMTS16 |
0.793912387094453 |
|
20538 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIAA0947 |
0.793912387094453 |
|
20539 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRPS1 |
0.794549980956119 |
|
20540 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SYT2 |
0.794771172595376 |
|
20541 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KDM5B |
0.794771172595376 |
|
20542 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCAT6 |
0.794771172595376 |
|
20543 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RABIF |
0.794771172595376 |
|
20544 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KLHL12 |
0.794771172595376 |
|
20545 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADIPOR1 |
0.794771172595376 |
|
20546 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TCTA |
0.794951777978984 |
|
20547 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AMT |
0.794951777978984 |
|
20548 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NICN1 |
0.794951777978984 |
|
20549 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP130 |
0.794951777978984 |
|
20550 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PTGES |
0.7950411520447 |
|
20551 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TTLL11 |
0.795213606765464 |
|
20552 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4478 |
0.795213606765464 |
|
20553 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NDUFA8 |
0.795213606765464 |
|
20554 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MORN5 |
0.795213606765464 |
|
20555 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LHX6 |
0.795213606765464 |
|
20556 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RBM18 |
0.795213606765464 |
|
20557 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MRRF |
0.795213606765464 |
|
20558 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL227P |
0.795213606765464 |
|
20559 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CTIF |
0.79573986185566 |
|
20560 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4743 |
0.79573986185566 |
|
20561 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4744 |
0.79573986185566 |
|
20562 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IL17B |
0.795917349591195 |
|
20563 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR143HG |
0.795917349591195 |
|
20564 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR143 |
0.795917349591195 |
|
20565 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR145 |
0.795917349591195 |
|
20566 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CXorf27 |
0.795982091640754 |
|
20567 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR548AJ2 |
0.795982091640754 |
|
20568 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SRPX |
0.795982091640754 |
|
20569 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SYTL5 |
0.795982091640754 |
|
20570 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PKIA |
0.796027224693835 |
|
20571 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZC2HC1A |
0.796027224693835 |
|
20572 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IL7 |
0.796027224693835 |
|
20573 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C6orf118 |
0.79627171091 |
|
20574 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PDE10A |
0.79627171091 |
|
20575 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP226 |
0.79627171091 |
|
20576 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SDIM1 |
0.79627171091 |
|
20577 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00473 |
0.79627171091 |
|
20578 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ASB6 |
0.796611949105757 |
|
20579 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRRX2 |
0.796611949105757 |
|
20580 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PDCL3 |
0.79672081453553 |
|
20581 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238328.1 |
0.79672081453553 |
|
20582 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL360P |
0.79672081453553 |
|
20583 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4440 |
0.79677584007115 |
|
20584 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4441 |
0.79677584007115 |
|
20585 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TWIST2 |
0.79677584007115 |
|
20586 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GEMIN8 |
0.797354012481525 |
|
20587 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KBTBD8 |
0.797416055445294 |
|
20588 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCYT1B |
0.797541234055146 |
|
20589 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR4C12 |
0.797662593953171 |
|
20590 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PMP2 |
0.797793510361122 |
|
20591 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FABP9 |
0.797793510361122 |
|
20592 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FABP4 |
0.797793510361122 |
|
20593 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FABP12 |
0.797793510361122 |
|
20594 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IMPA1P |
0.797793510361122 |
|
20595 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IMPA1 |
0.797793510361122 |
|
20596 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC10A5 |
0.797793510361122 |
|
20597 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZFAND1 |
0.797793510361122 |
|
20598 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CHMP4C |
0.797793510361122 |
|
20599 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNX16 |
0.797793510361122 |
|
20600 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SEMA7A |
0.797904900744468 |
|
20601 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EXD1 |
0.797934565578634 |
|
20602 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL497P |
0.797934565578634 |
|
20603 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CHP1 |
0.797934565578634 |
|
20604 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TCP10L2 |
0.797963972647801 |
|
20605 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C6orf123 |
0.797963972647801 |
|
20606 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPR31 |
0.797963972647801 |
|
20607 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TCP10 |
0.797963972647801 |
|
20608 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TTLL2 |
0.797963972647801 |
|
20609 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UNC93A |
0.797963972647801 |
|
20610 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TSPEAR |
0.79806241678168 |
|
20611 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DUX4L2 |
0.798259881157867 |
|
20612 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DUX4L3 |
0.798259881157867 |
|
20613 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DUX4L4 |
0.798259881157867 |
|
20614 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DUX4L5 |
0.798259881157867 |
|
20615 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DUX4L6 |
0.798259881157867 |
|
20616 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DUX4L7 |
0.798259881157867 |
|
20617 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DUX4 |
0.798259881157867 |
|
20618 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FRG1 |
0.798259881157867 |
|
20619 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FRG2 |
0.798259881157867 |
|
20620 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HSP90AA4P |
0.798259881157867 |
|
20621 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP174 |
0.798259881157867 |
|
20622 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP175 |
0.798259881157867 |
|
20623 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRIML1 |
0.798259881157867 |
|
20624 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRIML2 |
0.798259881157867 |
|
20625 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZFP42 |
0.798259881157867 |
|
20626 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PHF3 |
0.798261178732274 |
|
20627 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM92 |
0.798283713067433 |
|
20628 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
XYLT2 |
0.798283713067433 |
|
20629 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MRPL27 |
0.798283713067433 |
|
20630 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EME1 |
0.798283713067433 |
|
20631 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRRC59 |
0.798283713067433 |
|
20632 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACSF2 |
0.798283713067433 |
|
20633 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CHAD |
0.798283713067433 |
|
20634 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RSAD1 |
0.798283713067433 |
|
20635 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MYL4 |
0.798448423455435 |
|
20636 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATP10B |
0.798494475881878 |
|
20637 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MCTP2 |
0.798594861111361 |
|
20638 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARHGAP44 |
0.79860617091221 |
|
20639 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL550P |
0.79860617091221 |
|
20640 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLSTN2 |
0.799985371732767 |
|
20641 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRIM42 |
0.799985371732767 |
|
20642 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC25A36 |
0.799985371732767 |
|
20643 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PTPRN |
0.80004657089266 |
|
20644 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DNPEP |
0.80004657089266 |
|
20645 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DES |
0.80004657089266 |
|
20646 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPEG |
0.80004657089266 |
|
20647 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GMPPA |
0.80004657089266 |
|
20648 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ASIC4 |
0.80004657089266 |
|
20649 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CHPF |
0.80004657089266 |
|
20650 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM198 |
0.80004657089266 |
|
20651 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3132 |
0.80004657089266 |
|
20652 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC4A3 |
0.80004657089266 |
|
20653 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DUSP9 |
0.800789902120128 |
|
20654 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL687P |
0.800789902120128 |
|
20655 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PNCK |
0.800789902120128 |
|
20656 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PDK1 |
0.800824476291518 |
|
20657 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPRY4 |
0.801154298699134 |
|
20658 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FGF1 |
0.801154298699134 |
|
20659 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR5197 |
0.801154298699134 |
|
20660 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HMHB1 |
0.801154298699134 |
|
20661 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL87P |
0.801154298699134 |
|
20662 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
YIPF5 |
0.801154298699134 |
|
20663 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCTD16 |
0.801154298699134 |
|
20664 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP246 |
0.801154298699134 |
|
20665 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CEBPG |
0.801261292972933 |
|
20666 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PEPD |
0.801261292972933 |
|
20667 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPE |
0.801433300053944 |
|
20668 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KANSL1L |
0.801433300053944 |
|
20669 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP245 |
0.801453459418164 |
|
20670 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPL37A |
0.801494830699132 |
|
20671 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PAX3 |
0.801763616877602 |
|
20672 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC140 |
0.801763616877602 |
|
20673 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPP2R2B |
0.801917739133445 |
|
20674 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACTRT1 |
0.802081067726991 |
|
20675 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PTGS1 |
0.802430669407464 |
|
20676 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR1J1 |
0.802430669407464 |
|
20677 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR1J2 |
0.802430669407464 |
|
20678 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR1J4 |
0.802430669407464 |
|
20679 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR1N1 |
0.802430669407464 |
|
20680 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR1N2 |
0.802430669407464 |
|
20681 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR1L8 |
0.802430669407464 |
|
20682 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR1Q1 |
0.802430669407464 |
|
20683 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR1B1 |
0.802430669407464 |
|
20684 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR1L1 |
0.802430669407464 |
|
20685 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR1L3 |
0.802430669407464 |
|
20686 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FLJ20373 |
0.802450387024597 |
|
20687 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IL1R2 |
0.802450387024597 |
|
20688 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IL1R1 |
0.802450387024597 |
|
20689 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GHITM |
0.802538215247786 |
|
20690 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRIT2 |
0.802538215247786 |
|
20691 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRIT1 |
0.802538215247786 |
|
20692 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RGR |
0.802538215247786 |
|
20693 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00858 |
0.802538215247786 |
|
20694 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCSER2 |
0.802538215247786 |
|
20695 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPACA1 |
0.802587928679602 |
|
20696 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CNR1 |
0.802587928679602 |
|
20697 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNGTT |
0.802587928679602 |
|
20698 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA73|ENSG00000222145.1 |
0.802587928679602 |
|
20699 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PNRC1 |
0.802587928679602 |
|
20700 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL336P |
0.802587928679602 |
|
20701 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SRSF12 |
0.802587928679602 |
|
20702 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PM20D2 |
0.802587928679602 |
|
20703 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GABRR1 |
0.802587928679602 |
|
20704 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GABRR2 |
0.802587928679602 |
|
20705 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UBE2J1 |
0.802587928679602 |
|
20706 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000239126.1 |
0.802638458414104 |
|
20707 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KRT26 |
0.802676950985268 |
|
20708 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KRT27 |
0.802676950985268 |
|
20709 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KRT28 |
0.802676950985268 |
|
20710 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KRT10 |
0.802676950985268 |
|
20711 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM99 |
0.802676950985268 |
|
20712 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KRT12 |
0.802676950985268 |
|
20713 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KRT20 |
0.802676950985268 |
|
20714 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAB2A |
0.802755838892495 |
|
20715 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF804A |
0.802789629786672 |
|
20716 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPSB4 |
0.802885317602063 |
|
20717 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACPL2 |
0.802885317602063 |
|
20718 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZBTB38 |
0.802885317602063 |
|
20719 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TOP1MT |
0.802895510026696 |
|
20720 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RHPN1 |
0.802895510026696 |
|
20721 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAFA |
0.802895510026696 |
|
20722 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZC3H3 |
0.802895510026696 |
|
20723 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
7SK|ENSG00000254144.2 |
0.802895510026696 |
|
20724 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GSDMD |
0.802895510026696 |
|
20725 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MROH6 |
0.802895510026696 |
|
20726 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EEF1D |
0.802895510026696 |
|
20727 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NAPRT1 |
0.802895510026696 |
|
20728 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
THBS4 |
0.802924272829783 |
|
20729 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF302 |
0.802968331580272 |
|
20730 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238852.1 |
0.80341020249402 |
|
20731 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NCOR1 |
0.803622285732022 |
|
20732 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL442P |
0.803622285732022 |
|
20733 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PIGL |
0.803622285732022 |
|
20734 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR1288 |
0.803622285732022 |
|
20735 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CENPV |
0.803622285732022 |
|
20736 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UBB |
0.803622285732022 |
|
20737 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRPV2 |
0.803622285732022 |
|
20738 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM211A |
0.803622285732022 |
|
20739 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF287 |
0.803622285732022 |
|
20740 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF624 |
0.803622285732022 |
|
20741 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC144A |
0.803622285732022 |
|
20742 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL620P |
0.803622285732022 |
|
20743 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KRT16P2 |
0.803622285732022 |
|
20744 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KRT17P1 |
0.803622285732022 |
|
20745 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
USP32P1 |
0.803622285732022 |
|
20746 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TBC1D27 |
0.803622285732022 |
|
20747 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TNFRSF13B |
0.803622285732022 |
|
20748 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BACH2 |
0.804269679361197 |
|
20749 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4464 |
0.804269679361197 |
|
20750 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAP3K7 |
0.804269679361197 |
|
20751 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SREK1IP1 |
0.804277589061486 |
|
20752 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRIM23 |
0.804277589061486 |
|
20753 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAPPC13 |
0.804277589061486 |
|
20754 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SGTB |
0.804277589061486 |
|
20755 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD46|ENSG00000201009.1 |
0.804503903814513 |
|
20756 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
THOC2 |
0.804659958653181 |
|
20757 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL29P |
0.804659958653181 |
|
20758 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238626.1 |
0.804659958653181 |
|
20759 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC45A4 |
0.804746868896389 |
|
20760 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPR20 |
0.804746868896389 |
|
20761 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00051 |
0.804746868896389 |
|
20762 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MROH5 |
0.804746868896389 |
|
20763 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PTP4A3 |
0.804746868896389 |
|
20764 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD5|ENSG00000238854.1 |
0.804746868896389 |
|
20765 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TSNARE1 |
0.804746868896389 |
|
20766 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MYO7B |
0.805433463575414 |
|
20767 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPR17 |
0.805433463575414 |
|
20768 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NPAS2 |
0.805587469288157 |
|
20769 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPL31 |
0.805587469288157 |
|
20770 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL548P |
0.805587469288157 |
|
20771 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SVIP |
0.805607847881901 |
|
20772 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4791 |
0.80571857938708 |
|
20773 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF79 |
0.805728066796998 |
|
20774 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPL12 |
0.805728066796998 |
|
20775 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA65 |
0.805728066796998 |
|
20776 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MFSD9 |
0.805838234136625 |
|
20777 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GAS2 |
0.80602703659743 |
|
20778 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KLK11 |
0.806236085397865 |
|
20779 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KLK12 |
0.806236085397865 |
|
20780 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KLK13 |
0.806236085397865 |
|
20781 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KLK14 |
0.806236085397865 |
|
20782 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAP4K4 |
0.806417489454474 |
|
20783 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
INTS7 |
0.806598874672525 |
|
20784 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA26|ENSG00000212187.1 |
0.806598874672525 |
|
20785 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SGPP2 |
0.806758581048486 |
|
20786 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIS18A |
0.806982026806371 |
|
20787 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MRAP |
0.806982026806371 |
|
20788 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
URB1 |
0.806982026806371 |
|
20789 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL109P |
0.806982026806371 |
|
20790 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA80 |
0.806982026806371 |
|
20791 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C21orf119 |
0.806982026806371 |
|
20792 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARHGAP26 |
0.807137399474115 |
|
20793 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NR3C1 |
0.807137399474115 |
|
20794 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACADL |
0.807364769382762 |
|
20795 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
USP51 |
0.807458606410692 |
|
20796 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NPAS1 |
0.807719108274569 |
|
20797 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM160 |
0.807719108274569 |
|
20798 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADCYAP1 |
0.807932843041271 |
|
20799 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
T |
0.808149810218771 |
|
20800 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD45|ENSG00000231297.2 |
0.808173372685502 |
|
20801 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4269 |
0.808650514528776 |
|
20802 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR2467 |
0.808650514528776 |
|
20803 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF280C |
0.808821067642832 |
|
20804 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC25A14 |
0.808821067642832 |
|
20805 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPR119 |
0.808821067642832 |
|
20806 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RBMX2 |
0.808821067642832 |
|
20807 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM45B |
0.808821067642832 |
|
20808 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP157 |
0.808952334653618 |
|
20809 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DIMT1 |
0.808952334653618 |
|
20810 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WDR38 |
0.809030125745872 |
|
20811 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPL35 |
0.809030125745872 |
|
20812 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARPC5L |
0.809030125745872 |
|
20813 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FARSB |
0.809383292222644 |
|
20814 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CD180 |
0.809583633080216 |
|
20815 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MPP4 |
0.809666689854323 |
|
20816 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ABHD15 |
0.809988122483181 |
|
20817 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GIT1 |
0.809988122483181 |
|
20818 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TP53I13 |
0.809988122483181 |
|
20819 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANKRD13B |
0.809988122483181 |
|
20820 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CORO6 |
0.809988122483181 |
|
20821 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA70|ENSG00000252657.1 |
0.809988122483181 |
|
20822 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRH |
0.810010281722984 |
|
20823 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
XPO4 |
0.810066149999192 |
|
20824 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPR160 |
0.810089512170357 |
|
20825 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PHC3 |
0.810089512170357 |
|
20826 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRKCI |
0.810089512170357 |
|
20827 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLD1 |
0.810089512170357 |
|
20828 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PP13439 |
0.810089512170357 |
|
20829 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM212 |
0.810089512170357 |
|
20830 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238359.1 |
0.810089512170357 |
|
20831 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FNDC3B |
0.810089512170357 |
|
20832 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL141P |
0.810089512170357 |
|
20833 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GHSR |
0.810089512170357 |
|
20834 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TNFSF10 |
0.810089512170357 |
|
20835 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ECT2 |
0.810089512170357 |
|
20836 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DLG5 |
0.810122094911867 |
|
20837 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
POLR3A |
0.810122094911867 |
|
20838 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPS24 |
0.810122094911867 |
|
20839 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SWI5 |
0.810135797428458 |
|
20840 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ENOX2 |
0.81034109548014 |
|
20841 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARHGAP36 |
0.81034109548014 |
|
20842 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL191P |
0.81034109548014 |
|
20843 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MBNL3 |
0.81034109548014 |
|
20844 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HS6ST2 |
0.81034109548014 |
|
20845 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
USP26 |
0.81034109548014 |
|
20846 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GNAT1 |
0.810665768668003 |
|
20847 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC38A3 |
0.810665768668003 |
|
20848 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C17orf78 |
0.810763518253852 |
|
20849 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TADA2A |
0.810763518253852 |
|
20850 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DUSP14 |
0.810763518253852 |
|
20851 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SYNRG |
0.810763518253852 |
|
20852 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NLK |
0.811073259717496 |
|
20853 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PYY2 |
0.811073259717496 |
|
20854 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPY2 |
0.811073259717496 |
|
20855 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR378C |
0.811274635331863 |
|
20856 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SP9 |
0.811533353839206 |
|
20857 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CIR1 |
0.811533353839206 |
|
20858 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCRN3 |
0.811533353839206 |
|
20859 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPR155 |
0.811533353839206 |
|
20860 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CHRNA1 |
0.811533353839206 |
|
20861 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TFDP3 |
0.811712062772338 |
|
20862 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IKBKE |
0.811853504560936 |
|
20863 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C1orf147 |
0.811853504560936 |
|
20864 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RASSF5 |
0.811853504560936 |
|
20865 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LGR6 |
0.811897091802827 |
|
20866 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238571.1 |
0.811897091802827 |
|
20867 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000239046.1 |
0.811897091802827 |
|
20868 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UBE2T |
0.811897091802827 |
|
20869 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPP1R12B |
0.811897091802827 |
|
20870 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U6|ENSG00000272262.1 |
0.811897091802827 |
|
20871 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA70|ENSG00000253042.1 |
0.811897091802827 |
|
20872 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00887 |
0.812113389304507 |
|
20873 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CPN2 |
0.812113389304507 |
|
20874 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRRC15 |
0.812113389304507 |
|
20875 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANKRD6 |
0.812168295384555 |
|
20876 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL11P |
0.812168295384555 |
|
20877 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LYRM2 |
0.812168295384555 |
|
20878 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MDN1 |
0.812168295384555 |
|
20879 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CASP8AP2 |
0.812168295384555 |
|
20880 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238747.1 |
0.812168295384555 |
|
20881 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IGSF1 |
0.81239614424801 |
|
20882 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR13H1 |
0.81239614424801 |
|
20883 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP514 |
0.81239614424801 |
|
20884 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MST4 |
0.81239614424801 |
|
20885 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FRMD7 |
0.81239614424801 |
|
20886 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAP2C |
0.81239614424801 |
|
20887 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP513 |
0.812462139316937 |
|
20888 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SMARCA1 |
0.812462139316937 |
|
20889 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OCRL |
0.812462139316937 |
|
20890 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
APLN |
0.812462139316937 |
|
20891 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
XPNPEP2 |
0.812462139316937 |
|
20892 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SASH3 |
0.812462139316937 |
|
20893 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZDHHC9 |
0.812462139316937 |
|
20894 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UTP14A |
0.812462139316937 |
|
20895 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BCORL1 |
0.812462139316937 |
|
20896 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ELF4 |
0.812462139316937 |
|
20897 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AIFM1 |
0.812462139316937 |
|
20898 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAB33A |
0.812462139316937 |
|
20899 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ETV5 |
0.812811920368957 |
|
20900 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DGKG |
0.812811920368957 |
|
20901 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WIPF2 |
0.813157517710865 |
|
20902 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNY4P8 |
0.813157517710865 |
|
20903 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ISOC1 |
0.813183820612914 |
|
20904 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4633 |
0.813183820612914 |
|
20905 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4460 |
0.813183820612914 |
|
20906 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADAMTS19 |
0.813183820612914 |
|
20907 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIAA1024L |
0.813183820612914 |
|
20908 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CHSY3 |
0.813183820612914 |
|
20909 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CSMD3 |
0.813257255147236 |
|
20910 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SIM2 |
0.813329734536584 |
|
20911 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HLCS |
0.813329734536584 |
|
20912 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP491 |
0.813329734536584 |
|
20913 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RIPPLY3 |
0.813329734536584 |
|
20914 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PIGP |
0.813329734536584 |
|
20915 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TTC3 |
0.813329734536584 |
|
20916 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DSCR9 |
0.813329734536584 |
|
20917 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL678P |
0.813329734536584 |
|
20918 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DSCR3 |
0.813329734536584 |
|
20919 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRSS12 |
0.813507494991793 |
|
20920 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CKS1B|ENSG00000268942.1 |
0.813512573106805 |
|
20921 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRRC70 |
0.813512573106805 |
|
20922 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TPD52 |
0.813570215420847 |
|
20923 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL41P |
0.813570215420847 |
|
20924 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR5708 |
0.813570215420847 |
|
20925 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA20|ENSG00000206649.1 |
0.813570215420847 |
|
20926 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZBTB10 |
0.813570215420847 |
|
20927 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3134 |
0.813570674735182 |
|
20928 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL4P |
0.813570674735182 |
|
20929 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ESRRG |
0.813620218494804 |
|
20930 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL872P |
0.813754759808867 |
|
20931 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPP2R5A |
0.813805320568784 |
|
20932 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA16B |
0.813805320568784 |
|
20933 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM206 |
0.813805320568784 |
|
20934 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NENF |
0.813805320568784 |
|
20935 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATF3 |
0.813805320568784 |
|
20936 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL512P |
0.813805320568784 |
|
20937 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM71A |
0.813805320568784 |
|
20938 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BATF3 |
0.813805320568784 |
|
20939 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NSL1 |
0.813805320568784 |
|
20940 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLK2 |
0.813845049409575 |
|
20941 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GAPT |
0.813845049409575 |
|
20942 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR548AE2 |
0.813845049409575 |
|
20943 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZBTB7C |
0.814072991999675 |
|
20944 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP456 |
0.814072991999675 |
|
20945 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC166 |
0.814521416250533 |
|
20946 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM83H |
0.814521416250533 |
|
20947 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAPK15 |
0.814521416250533 |
|
20948 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4664 |
0.814521416250533 |
|
20949 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF707 |
0.814521416250533 |
|
20950 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCRIB |
0.814521416250533 |
|
20951 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR937 |
0.814521416250533 |
|
20952 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PUF60 |
0.814521416250533 |
|
20953 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NRBP2 |
0.814521416250533 |
|
20954 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EPPK1 |
0.814521416250533 |
|
20955 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLEC |
0.814521416250533 |
|
20956 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR661 |
0.814521416250533 |
|
20957 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PARP10 |
0.814521416250533 |
|
20958 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GRINA |
0.814521416250533 |
|
20959 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPATC1 |
0.814521416250533 |
|
20960 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OPLAH |
0.814521416250533 |
|
20961 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EXOSC4 |
0.814521416250533 |
|
20962 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPAA1 |
0.814521416250533 |
|
20963 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CYC1 |
0.814521416250533 |
|
20964 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SHARPIN |
0.814521416250533 |
|
20965 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIAA1875 |
0.814521416250533 |
|
20966 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAF1 |
0.814521416250533 |
|
20967 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPM6B |
0.814549012198546 |
|
20968 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC160 |
0.814763321594125 |
|
20969 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PHF6 |
0.814763321594125 |
|
20970 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HPRT1 |
0.814763321594125 |
|
20971 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR450A1 |
0.814763321594125 |
|
20972 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR450A2 |
0.814763321594125 |
|
20973 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR450B |
0.814763321594125 |
|
20974 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR503HG |
0.814763321594125 |
|
20975 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR542 |
0.814763321594125 |
|
20976 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR503 |
0.814763321594125 |
|
20977 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00629 |
0.814763321594125 |
|
20978 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLAC1 |
0.814763321594125 |
|
20979 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C4orf3 |
0.815210211462535 |
|
20980 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FABP2 |
0.815210211462535 |
|
20981 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HOXB1 |
0.816005446560022 |
|
20982 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR2113 |
0.816031363029529 |
|
20983 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BRCA1 |
0.816261689697487 |
|
20984 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GLIS3 |
0.816384671147491 |
|
20985 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
USP9X |
0.816420449202664 |
|
20986 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL405P |
0.816567251527867 |
|
20987 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC103 |
0.816567251527867 |
|
20988 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM187A |
0.816567251527867 |
|
20989 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GFAP |
0.816567251527867 |
|
20990 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM17 |
0.816716143793408 |
|
20991 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OTX1 |
0.816716143793408 |
|
20992 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DBIL5P2 |
0.816716143793408 |
|
20993 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KALRN |
0.816818875711759 |
|
20994 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCNMA1 |
0.817011304624177 |
|
20995 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TBX21 |
0.817176258007291 |
|
20996 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OSBPL7 |
0.817176258007291 |
|
20997 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MRPL10 |
0.817176258007291 |
|
20998 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRRC46 |
0.817176258007291 |
|
20999 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCRN2 |
0.817176258007291 |
|
21000 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SP6 |
0.817176258007291 |
|
21001 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MYOT |
0.817270615764609 |
|
21002 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PKD2L2 |
0.817270615764609 |
|
21003 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM13B |
0.817270615764609 |
|
21004 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TSTA3 |
0.817292496167791 |
|
21005 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF623 |
0.817292496167791 |
|
21006 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LY6E |
0.817298379207775 |
|
21007 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C8orf31 |
0.817298379207775 |
|
21008 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LY6H |
0.817298379207775 |
|
21009 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZFP41 |
0.817298379207775 |
|
21010 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GLI4 |
0.817298379207775 |
|
21011 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF696 |
0.817298379207775 |
|
21012 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TIGD5 |
0.817298379207775 |
|
21013 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PYCRL |
0.817298379207775 |
|
21014 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL867P |
0.817324530950306 |
|
21015 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MBD2 |
0.817391764195595 |
|
21016 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA37 |
0.817391764195595 |
|
21017 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
POLI |
0.817391764195595 |
|
21018 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STARD6 |
0.817391764195595 |
|
21019 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C18orf54 |
0.817391764195595 |
|
21020 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRIB1 |
0.817491558381608 |
|
21021 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL590P |
0.817491558381608 |
|
21022 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CPXCR1 |
0.817855307524799 |
|
21023 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAGEC2 |
0.81788478274255 |
|
21024 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADAT2 |
0.818495995699342 |
|
21025 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PEX3 |
0.818495995699342 |
|
21026 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP221 |
0.818495995699342 |
|
21027 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FUCA2 |
0.818495995699342 |
|
21028 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PHACTR2 |
0.818495995699342 |
|
21029 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP222 |
0.818495995699342 |
|
21030 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BTRC |
0.818500735639473 |
|
21031 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000239091.1 |
0.818500735639473 |
|
21032 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
USP53 |
0.818674826578884 |
|
21033 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPACA3 |
0.819051380292364 |
|
21034 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EHBP1 |
0.819074957930141 |
|
21035 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLG |
0.819619305102924 |
|
21036 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CMC1 |
0.819779655311048 |
|
21037 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AZI2 |
0.819779655311048 |
|
21038 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZCWPW2 |
0.819779655311048 |
|
21039 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNU6ATAC10P |
0.820038344838398 |
|
21040 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP191 |
0.820038344838398 |
|
21041 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HINT1 |
0.820038344838398 |
|
21042 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LYRM7 |
0.820038344838398 |
|
21043 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FBXO38 |
0.820068924089432 |
|
21044 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SGCA |
0.82011384233372 |
|
21045 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HILS1 |
0.82011384233372 |
|
21046 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TATDN3 |
0.820382267857774 |
|
21047 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C1orf227 |
0.820382267857774 |
|
21048 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FLVCR1 |
0.820382267857774 |
|
21049 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VASH2 |
0.820382267857774 |
|
21050 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANGEL2 |
0.820382267857774 |
|
21051 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPS6KC1 |
0.820382267857774 |
|
21052 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PROX1 |
0.820382267857774 |
|
21053 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C9orf57 |
0.820674488746213 |
|
21054 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GDA |
0.820674488746213 |
|
21055 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CPA2 |
0.82067910503921 |
|
21056 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HIGD1B |
0.820834454096459 |
|
21057 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EFTUD2 |
0.820834454096459 |
|
21058 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GSK3B |
0.821058119479585 |
|
21059 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAGEH1 |
0.821102071139376 |
|
21060 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FOXR2 |
0.821102071139376 |
|
21061 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RRAGB |
0.821102071139376 |
|
21062 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRIO |
0.822321661591312 |
|
21063 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CXorf23 |
0.822353002531069 |
|
21064 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAP7D2 |
0.822353002531069 |
|
21065 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR23C |
0.822353002531069 |
|
21066 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EIF1AX |
0.822353002531069 |
|
21067 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPS6KA3 |
0.822353002531069 |
|
21068 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCARNA20|ENSG00000251818.1 |
0.822593172937319 |
|
21069 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA70|ENSG00000202389.1 |
0.822593172937319 |
|
21070 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
Vault|ENSG00000252283.1 |
0.822593172937319 |
|
21071 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR1L6 |
0.822648638145137 |
|
21072 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP43 |
0.822691052206749 |
|
21073 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARID3B |
0.822977403938162 |
|
21074 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLK3 |
0.822977403938162 |
|
21075 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EDC3 |
0.822977403938162 |
|
21076 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ULK3 |
0.822977403938162 |
|
21077 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCAMP2 |
0.822977403938162 |
|
21078 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MPI |
0.822977403938162 |
|
21079 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM219B |
0.822977403938162 |
|
21080 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COX5A |
0.822977403938162 |
|
21081 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPP25 |
0.822977403938162 |
|
21082 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCAMP5 |
0.822977403938162 |
|
21083 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPCDC |
0.822977403938162 |
|
21084 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCARNA20|ENSG00000252722.1 |
0.822977403938162 |
|
21085 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C15orf39 |
0.822977403938162 |
|
21086 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DNM1P34 |
0.822977403938162 |
|
21087 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GOLGA6C |
0.822977403938162 |
|
21088 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GOLGA6D |
0.822977403938162 |
|
21089 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL327P |
0.822977403938162 |
|
21090 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL489P |
0.822977403938162 |
|
21091 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANP32BP1 |
0.822977403938162 |
|
21092 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COMMD4 |
0.822977403938162 |
|
21093 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NEIL1 |
0.822977403938162 |
|
21094 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAN2C1 |
0.822977403938162 |
|
21095 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR631 |
0.822977403938162 |
|
21096 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SIN3A |
0.822977403938162 |
|
21097 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PTPN9 |
0.822977403938162 |
|
21098 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238341.1 |
0.823280724020289 |
|
21099 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MKI67IP |
0.823280724020289 |
|
21100 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TSN |
0.823280724020289 |
|
21101 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP102 |
0.823280724020289 |
|
21102 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CNTNAP5 |
0.823280724020289 |
|
21103 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP102 |
0.823280724020289 |
|
21104 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GYPC |
0.823280724020289 |
|
21105 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATP6V1G3 |
0.82331690407026 |
|
21106 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC6A8 |
0.823328869957024 |
|
21107 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BCAP31 |
0.823328869957024 |
|
21108 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ABCD1 |
0.823328869957024 |
|
21109 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLXNB3 |
0.823328869957024 |
|
21110 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IDH3G |
0.823328869957024 |
|
21111 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SRPK3 |
0.823328869957024 |
|
21112 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SSR4 |
0.823328869957024 |
|
21113 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PDZD4 |
0.823328869957024 |
|
21114 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD36|ENSG00000251846.1 |
0.823328869957024 |
|
21115 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LCA10 |
0.823328869957024 |
|
21116 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM122B |
0.82342874503936 |
|
21117 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM122C |
0.82342874503936 |
|
21118 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MOSPD1 |
0.82342874503936 |
|
21119 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SMIM10 |
0.82342874503936 |
|
21120 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM127C |
0.82342874503936 |
|
21121 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM127A |
0.82342874503936 |
|
21122 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM127B |
0.82342874503936 |
|
21123 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00087 |
0.82342874503936 |
|
21124 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00633 |
0.82342874503936 |
|
21125 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CT45A1 |
0.82342874503936 |
|
21126 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CT45A2 |
0.82342874503936 |
|
21127 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CT45A3 |
0.82342874503936 |
|
21128 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CT45A4 |
0.82342874503936 |
|
21129 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CT45A5 |
0.82342874503936 |
|
21130 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CT45A6 |
0.82342874503936 |
|
21131 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CXorf48 |
0.82342874503936 |
|
21132 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DDX26B |
0.82342874503936 |
|
21133 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00086 |
0.82342874503936 |
|
21134 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP515 |
0.82342874503936 |
|
21135 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SAGE1 |
0.82342874503936 |
|
21136 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF449 |
0.82342874503936 |
|
21137 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF75D |
0.82342874503936 |
|
21138 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL107P |
0.823786917241312 |
|
21139 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF704 |
0.823786917241312 |
|
21140 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PAG1 |
0.823786917241312 |
|
21141 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STAG2 |
0.823897906208597 |
|
21142 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZMYM2 |
0.823928817180463 |
|
21143 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GJA3 |
0.823928817180463 |
|
21144 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00556 |
0.823928817180463 |
|
21145 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GJB2 |
0.823928817180463 |
|
21146 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC23A3 |
0.824112416745996 |
|
21147 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CHN1 |
0.82427719203336 |
|
21148 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MYO1B |
0.82453659953377 |
|
21149 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DLX4 |
0.824696636894919 |
|
21150 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DLX3 |
0.824696636894919 |
|
21151 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LSM14A |
0.824933281840622 |
|
21152 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CNRIP1 |
0.824989780430728 |
|
21153 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLEK |
0.824989780430728 |
|
21154 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
APLF |
0.824989780430728 |
|
21155 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FBXO48 |
0.824989780430728 |
|
21156 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PROKR1 |
0.824989780430728 |
|
21157 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RRAGC |
0.825527465408819 |
|
21158 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MYCBP |
0.825527465408819 |
|
21159 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GJA9 |
0.825527465408819 |
|
21160 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RHBDL2 |
0.825527465408819 |
|
21161 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AKIRIN1 |
0.825527465408819 |
|
21162 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NDUFS5 |
0.825527465408819 |
|
21163 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP44 |
0.825527465408819 |
|
21164 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COL6A3 |
0.825776789190553 |
|
21165 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SMAD7 |
0.825871393044967 |
|
21166 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ALG1L13P |
0.826459909688998 |
|
21167 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DEFA1B |
0.826459909688998 |
|
21168 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DEFA1 |
0.826459909688998 |
|
21169 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DEFA3 |
0.826459909688998 |
|
21170 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DEFA5 |
0.826459909688998 |
|
21171 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DEFB103A |
0.826459909688998 |
|
21172 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DEFB103B |
0.826459909688998 |
|
21173 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DEFB104A |
0.826459909688998 |
|
21174 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DEFB104B |
0.826459909688998 |
|
21175 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DEFB105A |
0.826459909688998 |
|
21176 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DEFB105B |
0.826459909688998 |
|
21177 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DEFB106A |
0.826459909688998 |
|
21178 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DEFB106B |
0.826459909688998 |
|
21179 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DEFB107A |
0.826459909688998 |
|
21180 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DEFB107B |
0.826459909688998 |
|
21181 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DEFB4A |
0.826459909688998 |
|
21182 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DEFB4B |
0.826459909688998 |
|
21183 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM66B |
0.826459909688998 |
|
21184 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM66E |
0.826459909688998 |
|
21185 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM85B |
0.826459909688998 |
|
21186 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM86B3P |
0.826459909688998 |
|
21187 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM90A24P |
0.826459909688998 |
|
21188 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRLE1 |
0.826459909688998 |
|
21189 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR548I3 |
0.826459909688998 |
|
21190 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SGK223 |
0.826459909688998 |
|
21191 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPAG11A |
0.826459909688998 |
|
21192 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPAG11B |
0.826459909688998 |
|
21193 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF705B |
0.826459909688998 |
|
21194 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF705G |
0.826459909688998 |
|
21195 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HNRNPA1P30 |
0.827071173102497 |
|
21196 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LATS2 |
0.827071173102497 |
|
21197 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238893.1 |
0.827071173102497 |
|
21198 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL80P |
0.827071173102497 |
|
21199 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD27|ENSG00000252128.1 |
0.827071173102497 |
|
21200 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP285 |
0.827227819123335 |
|
21201 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C21orf90 |
0.827306796699227 |
|
21202 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238969.1 |
0.827310895666298 |
|
21203 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BCL11A |
0.827360811848644 |
|
21204 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FARP2 |
0.827386621011593 |
|
21205 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3133 |
0.827386621011593 |
|
21206 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STK25 |
0.827386621011593 |
|
21207 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATG4B |
0.827386621011593 |
|
21208 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BOK |
0.827386621011593 |
|
21209 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CXXC11 |
0.827386621011593 |
|
21210 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
D2HGDH |
0.827386621011593 |
|
21211 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DTYMK |
0.827386621011593 |
|
21212 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GAL3ST2 |
0.827386621011593 |
|
21213 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ING5 |
0.827386621011593 |
|
21214 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NEU4 |
0.827386621011593 |
|
21215 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PDCD1 |
0.827386621011593 |
|
21216 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP122 |
0.827386621011593 |
|
21217 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
THAP4 |
0.827386621011593 |
|
21218 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RBP2 |
0.827419540416839 |
|
21219 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RBP1 |
0.827419540416839 |
|
21220 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM237 |
0.827573081567504 |
|
21221 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZFYVE20 |
0.827984732080894 |
|
21222 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SKAP1 |
0.828029900893121 |
|
21223 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ERCC4 |
0.828089976008084 |
|
21224 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MKL2 |
0.828089976008084 |
|
21225 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR193B |
0.828089976008084 |
|
21226 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR365A |
0.828089976008084 |
|
21227 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4786 |
0.828178908814635 |
|
21228 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DYNAP |
0.828295693617742 |
|
21229 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00693 |
0.828349487466708 |
|
21230 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LDOC1 |
0.82876332174688 |
|
21231 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PTH2R |
0.828959559807272 |
|
21232 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP117 |
0.828959559807272 |
|
21233 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OSBPL3 |
0.829069405732306 |
|
21234 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATP11B |
0.829479918295274 |
|
21235 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CHST8 |
0.829488895871654 |
|
21236 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PDIA5 |
0.829694791146034 |
|
21237 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KRT222 |
0.829749592128823 |
|
21238 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SMARCE1 |
0.829749592128823 |
|
21239 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KRT24 |
0.829749592128823 |
|
21240 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KRT223P |
0.829749592128823 |
|
21241 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KRT25 |
0.829749592128823 |
|
21242 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM71E1 |
0.829834452633811 |
|
21243 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EMC10 |
0.829834452633811 |
|
21244 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
JOSD2 |
0.829834452633811 |
|
21245 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ASPDH |
0.829834452633811 |
|
21246 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PITX2 |
0.829980512686412 |
|
21247 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DNAH5 |
0.83020213246192 |
|
21248 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR1269B |
0.830466914977325 |
|
21249 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADSL |
0.83061859221927 |
|
21250 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TEX264 |
0.830663507802841 |
|
21251 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP132 |
0.830663507802841 |
|
21252 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GRM2 |
0.830663507802841 |
|
21253 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IQCF6 |
0.830663507802841 |
|
21254 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IQCF3 |
0.830663507802841 |
|
21255 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IQCF2 |
0.830663507802841 |
|
21256 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL504P |
0.830663507802841 |
|
21257 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IQCF5 |
0.830663507802841 |
|
21258 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IQCF1 |
0.830663507802841 |
|
21259 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RRP9 |
0.830663507802841 |
|
21260 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PARP3 |
0.830663507802841 |
|
21261 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPR62 |
0.830663507802841 |
|
21262 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCBP4 |
0.830663507802841 |
|
21263 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ABHD14B |
0.830663507802841 |
|
21264 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ABHD14A |
0.830663507802841 |
|
21265 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACY1 |
0.830663507802841 |
|
21266 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPL29 |
0.830663507802841 |
|
21267 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DUSP7 |
0.830663507802841 |
|
21268 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00696 |
0.830663507802841 |
|
21269 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PTGES2 |
0.830788612428675 |
|
21270 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LCN2 |
0.830788612428675 |
|
21271 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C9orf16 |
0.830788612428675 |
|
21272 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CIZ1 |
0.830788612428675 |
|
21273 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DNM1 |
0.830788612428675 |
|
21274 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR199B |
0.830788612428675 |
|
21275 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3154 |
0.830788612428675 |
|
21276 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GOLGA2 |
0.830788612428675 |
|
21277 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ILKAP |
0.830818719601636 |
|
21278 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HES6 |
0.830818719601636 |
|
21279 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PER2 |
0.830818719601636 |
|
21280 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP77 |
0.830895088023603 |
|
21281 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF678 |
0.830895088023603 |
|
21282 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
JMJD4 |
0.830895088023603 |
|
21283 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TM6SF1 |
0.830897791978191 |
|
21284 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HDGFRP3 |
0.830897791978191 |
|
21285 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00111 |
0.830977608876954 |
|
21286 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00479 |
0.830977608876954 |
|
21287 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00112 |
0.830977608876954 |
|
21288 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RIPK4 |
0.830977608876954 |
|
21289 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRDM15 |
0.830977608876954 |
|
21290 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA3|ENSG00000251778.1 |
0.830977608876954 |
|
21291 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C2CD2 |
0.830977608876954 |
|
21292 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PSTPIP1 |
0.831038008274714 |
|
21293 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TSPAN3 |
0.831038008274714 |
|
21294 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C1orf145 |
0.831060029029299 |
|
21295 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MRPL46 |
0.831245435164497 |
|
21296 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MRPS11 |
0.831245435164497 |
|
21297 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DET1 |
0.831245435164497 |
|
21298 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR1179 |
0.831245435164497 |
|
21299 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AEN |
0.831245435164497 |
|
21300 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ISG20 |
0.831245435164497 |
|
21301 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACAN |
0.831245435164497 |
|
21302 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HAPLN3 |
0.831245435164497 |
|
21303 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MFGE8 |
0.831245435164497 |
|
21304 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KLK7 |
0.831832955483479 |
|
21305 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KLK8 |
0.831832955483479 |
|
21306 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KLK9 |
0.831832955483479 |
|
21307 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EPN3 |
0.832232556020824 |
|
21308 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPATA20 |
0.832232556020824 |
|
21309 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BDH1 |
0.832490228254103 |
|
21310 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM102A |
0.832847366817062 |
|
21311 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AGO3 |
0.832890898582383 |
|
21312 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CNBD1 |
0.833037763152738 |
|
21313 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZBBX |
0.833082064335071 |
|
21314 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SERPINI2 |
0.833082064335071 |
|
21315 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WDR49 |
0.833082064335071 |
|
21316 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PDCD10 |
0.833082064335071 |
|
21317 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SERPINI1 |
0.833082064335071 |
|
21318 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GOLIM4 |
0.833082064335071 |
|
21319 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR569 |
0.833207149855475 |
|
21320 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DHRS9 |
0.833453406342463 |
|
21321 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DHX8 |
0.833556515510267 |
|
21322 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ETV4 |
0.833556515510267 |
|
21323 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MEOX1 |
0.833556515510267 |
|
21324 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00924 |
0.833671182672124 |
|
21325 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZSWIM6 |
0.833813186294318 |
|
21326 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C5orf64 |
0.833813186294318 |
|
21327 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EGOT |
0.833933134054024 |
|
21328 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MITF |
0.833958572233992 |
|
21329 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
G0S2 |
0.834059779219193 |
|
21330 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HSD11B1 |
0.834059779219193 |
|
21331 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAF3IP3 |
0.834059779219193 |
|
21332 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C1orf74 |
0.834059779219193 |
|
21333 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IRF6 |
0.834059779219193 |
|
21334 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DIEXF |
0.834059779219193 |
|
21335 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIF2A |
0.834215845717508 |
|
21336 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IPO11 |
0.834215845717508 |
|
21337 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PTPRE |
0.834496383164958 |
|
21338 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MKI67 |
0.834496383164958 |
|
21339 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CACNA2D3 |
0.834644689311917 |
|
21340 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAGEC1 |
0.834728320797308 |
|
21341 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAGEC3 |
0.834728320797308 |
|
21342 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPANXA1 |
0.834728320797308 |
|
21343 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPANXA2 |
0.834728320797308 |
|
21344 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPANXC |
0.834728320797308 |
|
21345 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPANXD |
0.834728320797308 |
|
21346 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NDEL1 |
0.835475024067802 |
|
21347 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MYH10 |
0.835475024067802 |
|
21348 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL129P |
0.835475024067802 |
|
21349 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
INTU |
0.835572029435405 |
|
21350 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC25A31 |
0.835572029435405 |
|
21351 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HSPA4L |
0.835572029435405 |
|
21352 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLK4 |
0.835572029435405 |
|
21353 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MFSD8 |
0.835572029435405 |
|
21354 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C4orf29 |
0.835572029435405 |
|
21355 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LARP1B |
0.835572029435405 |
|
21356 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PGRMC2 |
0.835572029435405 |
|
21357 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238802.1 |
0.835572029435405 |
|
21358 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PHF17 |
0.835572029435405 |
|
21359 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCLT1 |
0.835572029435405 |
|
21360 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C4orf33 |
0.835572029435405 |
|
21361 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DAG1 |
0.835722584170795 |
|
21362 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDC42SE2 |
0.835914683971035 |
|
21363 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAPGEF6 |
0.835914683971035 |
|
21364 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FNIP1 |
0.835914683971035 |
|
21365 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DACH2 |
0.835947919053346 |
|
21366 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SI |
0.836439361853409 |
|
21367 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLITRK3 |
0.836439361853409 |
|
21368 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNAP47 |
0.83655042115071 |
|
21369 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM242 |
0.836760897356102 |
|
21370 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WDR44 |
0.836784562655621 |
|
21371 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR1277 |
0.836784562655621 |
|
21372 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DOCK11 |
0.836784562655621 |
|
21373 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IL13RA1 |
0.836784562655621 |
|
21374 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA35|ENSG00000239182.1 |
0.836784562655621 |
|
21375 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZCCHC12 |
0.836784562655621 |
|
21376 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LONRF3 |
0.836784562655621 |
|
21377 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PGRMC1 |
0.836784562655621 |
|
21378 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL118P |
0.836784562655621 |
|
21379 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC25A43 |
0.836784562655621 |
|
21380 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC25A5 |
0.836784562655621 |
|
21381 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CXorf56 |
0.836784562655621 |
|
21382 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NDUFA1 |
0.836784562655621 |
|
21383 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNF113A |
0.836784562655621 |
|
21384 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AKAP14 |
0.836784562655621 |
|
21385 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NKAP |
0.836784562655621 |
|
21386 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RHOXF2B |
0.836784562655621 |
|
21387 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RHOXF1 |
0.836784562655621 |
|
21388 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NKAPP1 |
0.836784562655621 |
|
21389 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RHOXF2 |
0.836784562655621 |
|
21390 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZBTB33 |
0.836784562655621 |
|
21391 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM255A |
0.836784562655621 |
|
21392 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATP1B4 |
0.836784562655621 |
|
21393 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MESDC2 |
0.836887551276421 |
|
21394 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4514 |
0.836887551276421 |
|
21395 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MESDC1 |
0.836887551276421 |
|
21396 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C15orf26 |
0.836887551276421 |
|
21397 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CRYGS |
0.837200555920127 |
|
21398 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TBCCD1 |
0.837200555920127 |
|
21399 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DNAJB11 |
0.837200555920127 |
|
21400 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AHSG |
0.837200555920127 |
|
21401 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FETUB |
0.837200555920127 |
|
21402 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HRG |
0.837200555920127 |
|
21403 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SH2D3C |
0.837253353566105 |
|
21404 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDK9 |
0.837253353566105 |
|
21405 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3960 |
0.837253353566105 |
|
21406 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FPGS |
0.837253353566105 |
|
21407 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ENG |
0.837253353566105 |
|
21408 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP296 |
0.837253353566105 |
|
21409 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AK1 |
0.837253353566105 |
|
21410 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4672 |
0.837253353566105 |
|
21411 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ST6GALNAC6 |
0.837253353566105 |
|
21412 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ST6GALNAC4 |
0.837253353566105 |
|
21413 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PIP5KL1 |
0.837253353566105 |
|
21414 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DPM2 |
0.837253353566105 |
|
21415 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC4A4 |
0.837582153992726 |
|
21416 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4774 |
0.837741814809539 |
|
21417 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SSH2 |
0.837885432981142 |
|
21418 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000239129.1 |
0.837885432981142 |
|
21419 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR5089 |
0.837973428206686 |
|
21420 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPRML |
0.837973428206686 |
|
21421 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NAIF1 |
0.838415634127956 |
|
21422 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC25A25 |
0.838415634127956 |
|
21423 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TFB1M |
0.838523404753927 |
|
21424 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NOX3 |
0.838523404753927 |
|
21425 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
THUMPD3 |
0.838579075204833 |
|
21426 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DDX18 |
0.838747873969879 |
|
21427 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NPS |
0.838987833467206 |
|
21428 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPP1R12C |
0.839012059638228 |
|
21429 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AHCYL2 |
0.839933768480807 |
|
21430 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATXN7 |
0.840167823215113 |
|
21431 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARHGAP35 |
0.840229537830623 |
|
21432 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000252071.1 |
0.840229537830623 |
|
21433 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MYLK |
0.840300594456189 |
|
21434 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MYCBPAP |
0.840432780653581 |
|
21435 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ERC2 |
0.840732904712884 |
|
21436 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLEKHM3 |
0.841020163261079 |
|
21437 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANKRD18A |
0.841022582150903 |
|
21438 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNX18P3 |
0.841022582150903 |
|
21439 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIAA1841 |
0.841331521757775 |
|
21440 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C2orf74 |
0.841331521757775 |
|
21441 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AHSA2 |
0.841331521757775 |
|
21442 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA70B |
0.841331521757775 |
|
21443 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
XPO1 |
0.841331521757775 |
|
21444 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIF2B |
0.841511000705718 |
|
21445 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VN1R1 |
0.841538189874989 |
|
21446 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF419 |
0.841538189874989 |
|
21447 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF772 |
0.841538189874989 |
|
21448 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HUWE1 |
0.841644150801071 |
|
21449 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP505 |
0.841644150801071 |
|
21450 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZC3HC1 |
0.841686772898737 |
|
21451 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR874 |
0.84178115139506 |
|
21452 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HNRNPA0 |
0.84178115139506 |
|
21453 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NPY6R |
0.84178115139506 |
|
21454 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRHR |
0.841833173496936 |
|
21455 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL712P |
0.842233597790136 |
|
21456 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AGTR2 |
0.842233597790136 |
|
21457 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM72A |
0.842312256185611 |
|
21458 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRIM16L |
0.842694455991123 |
|
21459 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FBXW10 |
0.842694455991123 |
|
21460 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TVP23B |
0.842694455991123 |
|
21461 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SETD5 |
0.842768517616991 |
|
21462 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RBMS3 |
0.842777105621466 |
|
21463 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP338 |
0.842878973576361 |
|
21464 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC179 |
0.842878973576361 |
|
21465 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR581 |
0.843162085251917 |
|
21466 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL801P |
0.843162085251917 |
|
21467 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4459 |
0.843162085251917 |
|
21468 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DCAF17 |
0.84359574881385 |
|
21469 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CYBRD1 |
0.84359574881385 |
|
21470 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UBE2A |
0.84378262280267 |
|
21471 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NKRF |
0.84378262280267 |
|
21472 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SEPT6 |
0.84378262280267 |
|
21473 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR766 |
0.84378262280267 |
|
21474 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SOWAHD |
0.84378262280267 |
|
21475 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UPF3B |
0.84378262280267 |
|
21476 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CD86 |
0.843868090409696 |
|
21477 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CASR |
0.843868090409696 |
|
21478 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD112|ENSG00000252170.1 |
0.843868090409696 |
|
21479 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CSTA |
0.843868090409696 |
|
21480 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC58 |
0.843868090409696 |
|
21481 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM162A |
0.843868090409696 |
|
21482 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WDR5B |
0.843868090409696 |
|
21483 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAB27B |
0.844071710511962 |
|
21484 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TSHZ3 |
0.844082466342398 |
|
21485 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM169 |
0.844141287944156 |
|
21486 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
XRCC5 |
0.844141287944156 |
|
21487 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FST |
0.844311331434581 |
|
21488 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NDUFS4 |
0.844311331434581 |
|
21489 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FANCF |
0.844342522027417 |
|
21490 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP99 |
0.844999633691247 |
|
21491 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL201P |
0.844999633691247 |
|
21492 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C21orf49 |
0.845016878754048 |
|
21493 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC25A20 |
0.845037543633037 |
|
21494 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARIH2OS |
0.845037543633037 |
|
21495 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARIH2 |
0.845037543633037 |
|
21496 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
P4HTM |
0.845037543633037 |
|
21497 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WDR6 |
0.845037543633037 |
|
21498 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DALRD3 |
0.845037543633037 |
|
21499 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR191 |
0.845037543633037 |
|
21500 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR425 |
0.845037543633037 |
|
21501 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NDUFAF3 |
0.845037543633037 |
|
21502 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IMPDH2 |
0.845037543633037 |
|
21503 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
QRICH1 |
0.845037543633037 |
|
21504 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL182P |
0.845037543633037 |
|
21505 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
QARS |
0.845037543633037 |
|
21506 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
USP19 |
0.845037543633037 |
|
21507 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LAMB2 |
0.845037543633037 |
|
21508 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPATCH1 |
0.845500724212852 |
|
21509 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WDR88 |
0.845500724212852 |
|
21510 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRP3 |
0.845500724212852 |
|
21511 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC7A10 |
0.845500724212852 |
|
21512 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CEBPA |
0.845500724212852 |
|
21513 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP134 |
0.845538551964516 |
|
21514 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNTN |
0.845538551964516 |
|
21515 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C3orf49 |
0.845538551964516 |
|
21516 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
THOC7 |
0.845538551964516 |
|
21517 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U3|ENSG00000199727.1 |
0.845629064075484 |
|
21518 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA72|ENSG00000207249.1 |
0.845629064075484 |
|
21519 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
POU3F3 |
0.845629064075484 |
|
21520 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MRPS9 |
0.845629064075484 |
|
21521 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAD51C |
0.846172226686415 |
|
21522 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPM1E |
0.846172226686415 |
|
21523 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCGB2B2 |
0.846400502071178 |
|
21524 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U3|ENSG00000201674.1 |
0.846526339176243 |
|
21525 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL93P |
0.846526339176243 |
|
21526 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD30 |
0.846526339176243 |
|
21527 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HTR2C |
0.846526339176243 |
|
21528 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA35|ENSG00000208839.1 |
0.846526339176243 |
|
21529 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR764 |
0.846526339176243 |
|
21530 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR1912 |
0.846526339176243 |
|
21531 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR1298 |
0.846526339176243 |
|
21532 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR1911 |
0.846526339176243 |
|
21533 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR448 |
0.846526339176243 |
|
21534 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IL13RA2 |
0.846526339176243 |
|
21535 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRCH2 |
0.846526339176243 |
|
21536 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LUZP4 |
0.846526339176243 |
|
21537 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RBMXL3 |
0.846526339176243 |
|
21538 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA35|ENSG00000271907.1 |
0.846526339176243 |
|
21539 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ITGB3 |
0.846779686230189 |
|
21540 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EIF2B5 |
0.846975791757966 |
|
21541 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PABPC5 |
0.847036645212898 |
|
21542 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCDH11X |
0.847036645212898 |
|
21543 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C21orf128 |
0.847109948614587 |
|
21544 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SH3RF2 |
0.847152100531215 |
|
21545 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLAC8L1 |
0.847152100531215 |
|
21546 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LARS |
0.847152100531215 |
|
21547 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PTAR1 |
0.847207981012912 |
|
21548 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC38A9 |
0.847226988725879 |
|
21549 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DDX4 |
0.847226988725879 |
|
21550 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP183 |
0.847226988725879 |
|
21551 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR552 |
0.847339887722491 |
|
21552 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCKAR |
0.847850319670239 |
|
21553 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IL1RAPL1 |
0.847905532115107 |
|
21554 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SETX |
0.848289229709201 |
|
21555 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LAMP2 |
0.848808887788861 |
|
21556 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CUL4B |
0.848808887788861 |
|
21557 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000272179.1 |
0.848808887788861 |
|
21558 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MCTS1 |
0.848808887788861 |
|
21559 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C1GALT1C1 |
0.848808887788861 |
|
21560 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CT47A10 |
0.848808887788861 |
|
21561 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CT47A11 |
0.848808887788861 |
|
21562 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CT47A12 |
0.848808887788861 |
|
21563 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CT47A1 |
0.848808887788861 |
|
21564 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CT47A2 |
0.848808887788861 |
|
21565 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CT47A3 |
0.848808887788861 |
|
21566 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CT47A4 |
0.848808887788861 |
|
21567 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CT47A5 |
0.848808887788861 |
|
21568 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CT47A6 |
0.848808887788861 |
|
21569 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CT47A7 |
0.848808887788861 |
|
21570 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CT47A8 |
0.848808887788861 |
|
21571 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CT47A9 |
0.848808887788861 |
|
21572 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CT47B1 |
0.848808887788861 |
|
21573 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GLUD2 |
0.848808887788861 |
|
21574 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRKCD |
0.849179483796854 |
|
21575 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TKT |
0.849179483796854 |
|
21576 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238565.1 |
0.849179483796854 |
|
21577 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DCP1A |
0.849179483796854 |
|
21578 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL821P |
0.849179483796854 |
|
21579 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD38|ENSG00000207109.1 |
0.849179483796854 |
|
21580 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA26|ENSG00000212608.1 |
0.849179483796854 |
|
21581 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NYX |
0.849276177244069 |
|
21582 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CASK |
0.849276177244069 |
|
21583 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL406P |
0.849276177244069 |
|
21584 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL144P |
0.849276177244069 |
|
21585 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPR34 |
0.849276177244069 |
|
21586 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPR82 |
0.849276177244069 |
|
21587 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238656.1 |
0.849331456573319 |
|
21588 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR2053 |
0.849331456573319 |
|
21589 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
L1CAM |
0.849356685483355 |
|
21590 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AVPR2 |
0.849356685483355 |
|
21591 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARHGAP4 |
0.849356685483355 |
|
21592 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NAA10 |
0.849356685483355 |
|
21593 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HCFC1 |
0.849356685483355 |
|
21594 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RENBP |
0.849356685483355 |
|
21595 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM187 |
0.849356685483355 |
|
21596 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IRAK1 |
0.849356685483355 |
|
21597 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MECP2 |
0.849356685483355 |
|
21598 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR718 |
0.849356685483355 |
|
21599 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OPN1LW |
0.849356685483355 |
|
21600 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OPN1MW2 |
0.849356685483355 |
|
21601 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OPN1MW |
0.849356685483355 |
|
21602 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TEX28P1 |
0.849356685483355 |
|
21603 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TEX28P2 |
0.849356685483355 |
|
21604 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TEX28 |
0.849356685483355 |
|
21605 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TKTL1 |
0.849356685483355 |
|
21606 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EMD |
0.849356685483355 |
|
21607 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FLNA |
0.849356685483355 |
|
21608 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPL10 |
0.849356685483355 |
|
21609 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA70|ENSG00000207165.1 |
0.849356685483355 |
|
21610 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DNASE1L1 |
0.849356685483355 |
|
21611 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TAZ |
0.849356685483355 |
|
21612 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATP6AP1 |
0.849356685483355 |
|
21613 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM50A |
0.849356685483355 |
|
21614 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GDI1 |
0.849356685483355 |
|
21615 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLXNA3 |
0.849356685483355 |
|
21616 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LAGE3 |
0.849356685483355 |
|
21617 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UBL4A |
0.849356685483355 |
|
21618 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC10A3 |
0.849356685483355 |
|
21619 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL697P |
0.849356685483355 |
|
21620 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL742P |
0.849356685483355 |
|
21621 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM3A |
0.849356685483355 |
|
21622 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DPP10 |
0.849403775814905 |
|
21623 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM177 |
0.849946781314389 |
|
21624 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PTPN4 |
0.849946781314389 |
|
21625 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C21orf62 |
0.849972556158326 |
|
21626 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA70|ENSG00000207098.1 |
0.849972556158326 |
|
21627 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OLIG2 |
0.849972556158326 |
|
21628 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NBR1 |
0.850125093640528 |
|
21629 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARL4D |
0.850125093640528 |
|
21630 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00854 |
0.850125093640528 |
|
21631 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00910 |
0.850125093640528 |
|
21632 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM106A |
0.850125093640528 |
|
21633 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR2117 |
0.850125093640528 |
|
21634 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CNPPD1 |
0.850289245235715 |
|
21635 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM134A |
0.850289245235715 |
|
21636 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZFAND2B |
0.850289245235715 |
|
21637 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ABCB6 |
0.850289245235715 |
|
21638 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATG9A |
0.850289245235715 |
|
21639 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238851.1 |
0.850642581408537 |
|
21640 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP56 |
0.850983330225702 |
|
21641 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HOXD9 |
0.851416079621085 |
|
21642 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HOXD8 |
0.851416079621085 |
|
21643 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HOXD4 |
0.851416079621085 |
|
21644 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR10B |
0.851416079621085 |
|
21645 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MTX2 |
0.851416079621085 |
|
21646 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNU6ATAC14P |
0.851416079621085 |
|
21647 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4669 |
0.851521289938795 |
|
21648 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COL5A1 |
0.851521289938795 |
|
21649 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3689A |
0.851521289938795 |
|
21650 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3689B |
0.851521289938795 |
|
21651 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3689C |
0.851521289938795 |
|
21652 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3689D1 |
0.851521289938795 |
|
21653 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3689D2 |
0.851521289938795 |
|
21654 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3689E |
0.851521289938795 |
|
21655 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3689F |
0.851521289938795 |
|
21656 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FCN2 |
0.851521289938795 |
|
21657 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FCN1 |
0.851521289938795 |
|
21658 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OLFM1 |
0.851521289938795 |
|
21659 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PSMD2 |
0.851528297794475 |
|
21660 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD45|ENSG00000200422.1 |
0.851861537149553 |
|
21661 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RABGAP1 |
0.852025383983813 |
|
21662 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NABP1 |
0.852091038957503 |
|
21663 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM252 |
0.852143082822021 |
|
21664 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SV2C |
0.8523506626279 |
|
21665 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP186 |
0.8523506626279 |
|
21666 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IQGAP2 |
0.8523506626279 |
|
21667 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
F2RL2 |
0.8523506626279 |
|
21668 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR3A4P |
0.852487858151048 |
|
21669 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL807P |
0.853346275044198 |
|
21670 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EFEMP1 |
0.853577395526087 |
|
21671 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP208 |
0.853577395526087 |
|
21672 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR216A |
0.853577395526087 |
|
21673 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR217 |
0.853577395526087 |
|
21674 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR216B |
0.853577395526087 |
|
21675 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ASTE1 |
0.853744182338564 |
|
21676 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C9orf50 |
0.853782694524965 |
|
21677 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TGIF2LX |
0.853793234315883 |
|
21678 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COQ4 |
0.85389272041494 |
|
21679 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC27A4 |
0.85389272041494 |
|
21680 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
URM1 |
0.85389272041494 |
|
21681 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CERCAM |
0.85389272041494 |
|
21682 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EFCAB5 |
0.854118556310346 |
|
21683 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNY4P13 |
0.854118556310346 |
|
21684 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3184 |
0.854118556310346 |
|
21685 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR423 |
0.854118556310346 |
|
21686 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NSRP1 |
0.854118556310346 |
|
21687 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CRYL1 |
0.854263875633859 |
|
21688 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GJB6 |
0.854263875633859 |
|
21689 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4499 |
0.854263875633859 |
|
21690 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MLPH |
0.85427731031212 |
|
21691 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRLH |
0.85427731031212 |
|
21692 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VLDLR |
0.854374805711901 |
|
21693 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LOXL1 |
0.854405089574348 |
|
21694 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MREG |
0.854421462710914 |
|
21695 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PECR |
0.854421462710914 |
|
21696 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FOXI2 |
0.85445216125631 |
|
21697 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLRN3 |
0.85445216125631 |
|
21698 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC14 |
0.854605635796904 |
|
21699 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PIK3R4 |
0.854997089054183 |
|
21700 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC10A7 |
0.855255549476163 |
|
21701 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EBF3 |
0.855270408636874 |
|
21702 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00959 |
0.855270408636874 |
|
21703 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GLRX3 |
0.855270408636874 |
|
21704 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
YOD1 |
0.855345891139414 |
|
21705 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PFKFB2 |
0.855345891139414 |
|
21706 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C4BPB |
0.855345891139414 |
|
21707 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C4BPA |
0.855345891139414 |
|
21708 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TICRR |
0.855382194494328 |
|
21709 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SEC24A |
0.855491177434066 |
|
21710 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CAMLG |
0.855491177434066 |
|
21711 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DDX46 |
0.855491177434066 |
|
21712 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C5orf24 |
0.855491177434066 |
|
21713 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TXNDC15 |
0.855491177434066 |
|
21714 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR374B |
0.855734108597615 |
|
21715 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR421 |
0.855734108597615 |
|
21716 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL648P |
0.855734108597615 |
|
21717 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR374A |
0.855734108597615 |
|
21718 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR545 |
0.855734108597615 |
|
21719 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZCCHC13 |
0.855734108597615 |
|
21720 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RLIM |
0.855734108597615 |
|
21721 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIAA2022 |
0.855734108597615 |
|
21722 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF710 |
0.856039799371367 |
|
21723 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3174 |
0.856039799371367 |
|
21724 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARSB |
0.856065659428783 |
|
21725 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BHMT2 |
0.856065659428783 |
|
21726 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BHMT |
0.856065659428783 |
|
21727 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TNIP1 |
0.856386292155332 |
|
21728 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANXA6 |
0.856386292155332 |
|
21729 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC69 |
0.856386292155332 |
|
21730 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GM2A |
0.856386292155332 |
|
21731 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC36A3 |
0.856386292155332 |
|
21732 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC36A2 |
0.856386292155332 |
|
21733 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC36A1 |
0.856386292155332 |
|
21734 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP197 |
0.856386292155332 |
|
21735 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAT2 |
0.856386292155332 |
|
21736 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SETD2 |
0.856399158224098 |
|
21737 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DYRK3 |
0.856493586576121 |
|
21738 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD112|ENSG00000252853.1 |
0.856493586576121 |
|
21739 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF18 |
0.856673215966495 |
|
21740 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPL21P122 |
0.856673215966495 |
|
21741 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAP2K4 |
0.856673215966495 |
|
21742 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR744 |
0.856673215966495 |
|
21743 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RC3H2 |
0.857210894372976 |
|
21744 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDC27 |
0.857314907597538 |
|
21745 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UBE2H |
0.85764220978516 |
|
21746 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NMNAT3 |
0.857784771363174 |
|
21747 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP124 |
0.857784771363174 |
|
21748 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL724P |
0.857784771363174 |
|
21749 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RBM22 |
0.857789326023911 |
|
21750 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DCTN4 |
0.857789326023911 |
|
21751 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SMIM3 |
0.857789326023911 |
|
21752 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IRGM |
0.857789326023911 |
|
21753 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF300 |
0.857789326023911 |
|
21754 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF300P1 |
0.857789326023911 |
|
21755 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPX3 |
0.857789326023911 |
|
21756 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNU4ATAC |
0.857996732864063 |
|
21757 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ABCC3 |
0.858731887551741 |
|
21758 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238306.1 |
0.858752029042798 |
|
21759 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DSCR4 |
0.858857869259625 |
|
21760 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANKRD50 |
0.859228788637205 |
|
21761 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAT4 |
0.859228788637205 |
|
21762 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PKP1 |
0.859253945283905 |
|
21763 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RMI2 |
0.859609762408232 |
|
21764 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SOCS1 |
0.859609762408232 |
|
21765 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TNP2 |
0.859609762408232 |
|
21766 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRM3 |
0.859609762408232 |
|
21767 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA48|ENSG00000212228.1 |
0.859609762408232 |
|
21768 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRM2 |
0.859609762408232 |
|
21769 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRM1 |
0.859609762408232 |
|
21770 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238409.1 |
0.859609762408232 |
|
21771 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR548H2 |
0.859609762408232 |
|
21772 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CACNA1D |
0.859674141731706 |
|
21773 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ITGA6 |
0.859819116559084 |
|
21774 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIAA0355 |
0.859923889631135 |
|
21775 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP193 |
0.860377104108371 |
|
21776 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPOCK1 |
0.860377104108371 |
|
21777 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM138B |
0.860570687824178 |
|
21778 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RABL2A |
0.860570687824178 |
|
21779 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPL23AP7 |
0.860570687824178 |
|
21780 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WASH2P |
0.860570687824178 |
|
21781 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC35F5 |
0.860570687824178 |
|
21782 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4782 |
0.860570687824178 |
|
21783 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MMGT1 |
0.860792380061963 |
|
21784 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC85A |
0.861080477229088 |
|
21785 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP93 |
0.861080477229088 |
|
21786 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WDPCP |
0.861413944698178 |
|
21787 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA64|ENSG00000252441.1 |
0.861597523457157 |
|
21788 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IL3 |
0.861623147632462 |
|
21789 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CSF2 |
0.861623147632462 |
|
21790 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoZ6|ENSG00000253067.1 |
0.861623147632462 |
|
21791 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
P4HA2 |
0.861623147632462 |
|
21792 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PDLIM4 |
0.861623147632462 |
|
21793 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC22A4 |
0.861623147632462 |
|
21794 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3936 |
0.861623147632462 |
|
21795 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC22A5 |
0.861623147632462 |
|
21796 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRELID2 |
0.861928864408672 |
|
21797 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GRXCR2 |
0.861928864408672 |
|
21798 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RBM27 |
0.861928864408672 |
|
21799 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
POU4F3 |
0.861928864408672 |
|
21800 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CAMK2A |
0.861983944877903 |
|
21801 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARSI |
0.861983944877903 |
|
21802 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL283P |
0.862318575394936 |
|
21803 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD90 |
0.862338109836382 |
|
21804 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAD50 |
0.862391361473307 |
|
21805 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RALGPS1 |
0.862491081516202 |
|
21806 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANGPTL2 |
0.862491081516202 |
|
21807 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL790P |
0.862511974404861 |
|
21808 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC16A2 |
0.862511974404861 |
|
21809 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL641P |
0.862511974404861 |
|
21810 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPAG16 |
0.862760020325172 |
|
21811 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AFF2 |
0.86287260758095 |
|
21812 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IDS |
0.86287260758095 |
|
21813 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00893 |
0.86287260758095 |
|
21814 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CXorf40A |
0.86287260758095 |
|
21815 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CXorf40B |
0.86287260758095 |
|
21816 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HSFX1 |
0.86287260758095 |
|
21817 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HSFX2 |
0.86287260758095 |
|
21818 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00894 |
0.86287260758095 |
|
21819 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAGEA11 |
0.86287260758095 |
|
21820 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAGEA8 |
0.86287260758095 |
|
21821 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAGEA9B |
0.86287260758095 |
|
21822 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAGEA9 |
0.86287260758095 |
|
21823 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM185A |
0.86287260758095 |
|
21824 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR2114 |
0.86287260758095 |
|
21825 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4330 |
0.86287260758095 |
|
21826 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPR50 |
0.86287260758095 |
|
21827 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VMA21 |
0.86287260758095 |
|
21828 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PASD1 |
0.86287260758095 |
|
21829 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLS3 |
0.862881632721133 |
|
21830 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PDK2 |
0.863137216527238 |
|
21831 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SAMD14 |
0.863137216527238 |
|
21832 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPP1R9B |
0.863137216527238 |
|
21833 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR5C1 |
0.863229388041094 |
|
21834 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR1K1 |
0.863229388041094 |
|
21835 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PDCL |
0.863229388041094 |
|
21836 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FBXO25 |
0.863317940584369 |
|
21837 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR4F21 |
0.863317940584369 |
|
21838 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPL23AP53 |
0.863317940584369 |
|
21839 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TDRP |
0.863317940584369 |
|
21840 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF596 |
0.863317940584369 |
|
21841 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WDR5 |
0.863388644150537 |
|
21842 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNU6ATAC |
0.863388644150537 |
|
21843 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RXRA |
0.863388644150537 |
|
21844 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNX9 |
0.863515060355797 |
|
21845 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SYNJ2 |
0.863515060355797 |
|
21846 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PARN |
0.86378738805347 |
|
21847 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL274P |
0.86378738805347 |
|
21848 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MYH14 |
0.863853159005042 |
|
21849 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLDN20 |
0.863901733691726 |
|
21850 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MYOZ2 |
0.864031323511105 |
|
21851 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CAND2 |
0.864045435294797 |
|
21852 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPL32 |
0.864045435294797 |
|
21853 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA7A |
0.864045435294797 |
|
21854 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IQSEC1 |
0.864045435294797 |
|
21855 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NUP210 |
0.864045435294797 |
|
21856 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HDAC11 |
0.864045435294797 |
|
21857 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARHGAP32 |
0.864286211225543 |
|
21858 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BARX2 |
0.864286211225543 |
|
21859 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000272310.1 |
0.864747977048384 |
|
21860 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL522P |
0.864747977048384 |
|
21861 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BCAR4 |
0.864747977048384 |
|
21862 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RSL1D1 |
0.864747977048384 |
|
21863 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TNFRSF17 |
0.864747977048384 |
|
21864 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IKZF2 |
0.865424182099735 |
|
21865 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACA64|ENSG00000252016.1 |
0.865574736085655 |
|
21866 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR5094 |
0.865645764243066 |
|
21867 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR5009 |
0.865645764243066 |
|
21868 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C15orf38 |
0.865645764243066 |
|
21869 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KLHL3 |
0.865812817685231 |
|
21870 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD63|ENSG00000251987.1 |
0.866146074264053 |
|
21871 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL791P |
0.866159994430173 |
|
21872 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM89 |
0.866364775602206 |
|
21873 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC26A6 |
0.866364775602206 |
|
21874 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CELSR3 |
0.866364775602206 |
|
21875 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4793 |
0.866364775602206 |
|
21876 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NCKIPSD |
0.866364775602206 |
|
21877 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IP6K2 |
0.866364775602206 |
|
21878 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL95P |
0.866446464647572 |
|
21879 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL813P |
0.866446464647572 |
|
21880 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SP3 |
0.866678570419911 |
|
21881 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WIPF1 |
0.866678570419911 |
|
21882 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VEZF1 |
0.867017474426676 |
|
21883 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SRSF1 |
0.867017474426676 |
|
21884 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EN1 |
0.86714491195602 |
|
21885 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MARCO |
0.86714491195602 |
|
21886 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ASCC3 |
0.867160602368641 |
|
21887 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238999.1 |
0.867160602368641 |
|
21888 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
POU3F2 |
0.867320598363103 |
|
21889 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FBXL4 |
0.867320598363103 |
|
21890 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR548AI |
0.867320598363103 |
|
21891 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SIM1 |
0.867320598363103 |
|
21892 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MESP1 |
0.867511485080141 |
|
21893 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANPEP |
0.867511485080141 |
|
21894 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AP3S2 |
0.867511485080141 |
|
21895 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLXNA2 |
0.867534702757092 |
|
21896 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PDGFRB |
0.867561217524084 |
|
21897 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM182 |
0.867708116032118 |
|
21898 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM19A1 |
0.867716449046323 |
|
21899 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF516 |
0.867763771759314 |
|
21900 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NACC2 |
0.867783170730044 |
|
21901 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C9orf69 |
0.867783170730044 |
|
21902 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ESM1 |
0.867883030450422 |
|
21903 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GZMK |
0.867883030450422 |
|
21904 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GZMA |
0.867883030450422 |
|
21905 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDC20B |
0.867883030450422 |
|
21906 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPX8 |
0.867883030450422 |
|
21907 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR449A |
0.867883030450422 |
|
21908 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR449B |
0.867883030450422 |
|
21909 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR449C |
0.867883030450422 |
|
21910 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MCIDAS |
0.867883030450422 |
|
21911 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCNO |
0.867883030450422 |
|
21912 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DHX29 |
0.867883030450422 |
|
21913 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SKIV2L2 |
0.867883030450422 |
|
21914 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPAP2A |
0.867883030450422 |
|
21915 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR5687 |
0.867883030450422 |
|
21916 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SOWAHB |
0.868305954912352 |
|
21917 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DGKD |
0.868556029943923 |
|
21918 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NSMCE2 |
0.868625931773786 |
|
21919 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238368.1 |
0.868640356053064 |
|
21920 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EPB41L5 |
0.868640356053064 |
|
21921 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM185B |
0.868640356053064 |
|
21922 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RALB |
0.868640356053064 |
|
21923 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
INHBB |
0.868640356053064 |
|
21924 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FLJ14816 |
0.868640356053064 |
|
21925 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GLI2 |
0.868640356053064 |
|
21926 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TFCP2L1 |
0.868640356053064 |
|
21927 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00945 |
0.868658555722945 |
|
21928 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OLIG1 |
0.868658555722945 |
|
21929 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TEK |
0.868673108538635 |
|
21930 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA43|ENSG00000199815.1 |
0.868783355242808 |
|
21931 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NF1 |
0.869016896607924 |
|
21932 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TDGF1 |
0.869017253575618 |
|
21933 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD77|ENSG00000251967.1 |
0.869017253575618 |
|
21934 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ALS2CL |
0.869017253575618 |
|
21935 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMIE |
0.869017253575618 |
|
21936 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRSS50 |
0.869017253575618 |
|
21937 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRSS46 |
0.869017253575618 |
|
21938 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRSS42 |
0.869017253575618 |
|
21939 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRSS44 |
0.869017253575618 |
|
21940 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRSS45 |
0.869017253575618 |
|
21941 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MYL3 |
0.869017253575618 |
|
21942 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PTH1R |
0.869017253575618 |
|
21943 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC12 |
0.869017253575618 |
|
21944 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NBEAL2 |
0.869017253575618 |
|
21945 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SETMAR |
0.869674182220013 |
|
21946 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
JUP |
0.869713393493803 |
|
21947 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SULT1C3 |
0.870707842169891 |
|
21948 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRUB2 |
0.870734483630307 |
|
21949 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C1QL2 |
0.870757304404563 |
|
21950 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL468P |
0.870757304404563 |
|
21951 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STEAP3 |
0.870757304404563 |
|
21952 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
APBA1 |
0.870903083268939 |
|
21953 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U3|ENSG00000212321.1 |
0.87134514892631 |
|
21954 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4297 |
0.871375848512329 |
|
21955 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PDHB |
0.871428422497599 |
|
21956 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCTD6 |
0.871428422497599 |
|
21957 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACOX2 |
0.871428422497599 |
|
21958 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM107A |
0.871428422497599 |
|
21959 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM3D |
0.871428422497599 |
|
21960 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C3orf67 |
0.871428422497599 |
|
21961 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
USP38 |
0.871467942345941 |
|
21962 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRRG3 |
0.871498415564466 |
|
21963 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FATE1 |
0.871498415564466 |
|
21964 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CNGA2 |
0.871498415564466 |
|
21965 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAGEA4 |
0.871498415564466 |
|
21966 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GABRE |
0.871498415564466 |
|
21967 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR224 |
0.871498415564466 |
|
21968 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR452 |
0.871498415564466 |
|
21969 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAGEA10 |
0.871498415564466 |
|
21970 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GABRA3 |
0.871498415564466 |
|
21971 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR767 |
0.871498415564466 |
|
21972 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GABRQ |
0.871498415564466 |
|
21973 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CETN2 |
0.871498415564466 |
|
21974 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CSAG1 |
0.871498415564466 |
|
21975 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CSAG2 |
0.871498415564466 |
|
21976 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CSAG3 |
0.871498415564466 |
|
21977 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CSAG4 |
0.871498415564466 |
|
21978 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAGEA12 |
0.871498415564466 |
|
21979 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAGEA1 |
0.871498415564466 |
|
21980 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAGEA2B |
0.871498415564466 |
|
21981 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAGEA2 |
0.871498415564466 |
|
21982 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAGEA3 |
0.871498415564466 |
|
21983 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAGEA6 |
0.871498415564466 |
|
21984 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NSDHL |
0.871498415564466 |
|
21985 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PNMA3 |
0.871498415564466 |
|
21986 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PNMA5 |
0.871498415564466 |
|
21987 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PNMA6A |
0.871498415564466 |
|
21988 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PNMA6B |
0.871498415564466 |
|
21989 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PNMA6C |
0.871498415564466 |
|
21990 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PNMA6D |
0.871498415564466 |
|
21991 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL190P |
0.871498415564466 |
|
21992 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL667P |
0.871498415564466 |
|
21993 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZFP92 |
0.871498415564466 |
|
21994 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF185 |
0.871498415564466 |
|
21995 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF275 |
0.871498415564466 |
|
21996 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000239037.1 |
0.871498415564466 |
|
21997 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HAUS7 |
0.871498415564466 |
|
21998 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TREX2 |
0.871498415564466 |
|
21999 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BGN |
0.871498415564466 |
|
22000 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATP2B3 |
0.871498415564466 |
|
22001 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM58A |
0.871498415564466 |
|
22002 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ALS2CR11 |
0.871617612434619 |
|
22003 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RTN4RL1 |
0.871754911414902 |
|
22004 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZBTB21 |
0.872032314225136 |
|
22005 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FIZ1 |
0.872125868100812 |
|
22006 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF524 |
0.872125868100812 |
|
22007 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF865 |
0.872125868100812 |
|
22008 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF784 |
0.872125868100812 |
|
22009 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF580 |
0.872125868100812 |
|
22010 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF581 |
0.872125868100812 |
|
22011 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC106 |
0.872125868100812 |
|
22012 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U2AF2 |
0.872125868100812 |
|
22013 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EPN1 |
0.872125868100812 |
|
22014 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NLRP9 |
0.872125868100812 |
|
22015 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP109 |
0.872125868100812 |
|
22016 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RFPL4AL1 |
0.872125868100812 |
|
22017 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RFPL4A |
0.872125868100812 |
|
22018 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NLRP11 |
0.872125868100812 |
|
22019 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NLRP4 |
0.872125868100812 |
|
22020 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NLRP13 |
0.872125868100812 |
|
22021 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NLRP8 |
0.872125868100812 |
|
22022 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CR2 |
0.872186796424147 |
|
22023 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CR1 |
0.872186796424147 |
|
22024 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CR1L |
0.872186796424147 |
|
22025 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CD46 |
0.872186796424147 |
|
22026 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR29B2 |
0.872186796424147 |
|
22027 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR29C |
0.872186796424147 |
|
22028 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C1orf132 |
0.872186796424147 |
|
22029 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00536 |
0.872262787152762 |
|
22030 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP276 |
0.872262787152762 |
|
22031 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BAI1 |
0.872498654037166 |
|
22032 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARC |
0.872498654037166 |
|
22033 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
JRK |
0.872498654037166 |
|
22034 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PSCA |
0.872498654037166 |
|
22035 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LY6K |
0.872498654037166 |
|
22036 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
THEM6 |
0.872498654037166 |
|
22037 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLURP1 |
0.872498654037166 |
|
22038 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LYPD2 |
0.872498654037166 |
|
22039 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LY6D |
0.872498654037166 |
|
22040 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LYNX1 |
0.872498654037166 |
|
22041 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GML |
0.872498654037166 |
|
22042 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CYP11B1 |
0.872498654037166 |
|
22043 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CYP11B2 |
0.872498654037166 |
|
22044 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ELMO1 |
0.872589405730486 |
|
22045 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TENM2 |
0.87268237520728 |
|
22046 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CPS1 |
0.872764720557152 |
|
22047 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA76|ENSG00000252904.1 |
0.872804087710716 |
|
22048 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IRS4 |
0.872868210068486 |
|
22049 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DYRK1A |
0.873210801459059 |
|
22050 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DPH1 |
0.873461119083814 |
|
22051 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OVCA2 |
0.873461119083814 |
|
22052 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HIC1 |
0.873461119083814 |
|
22053 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR132 |
0.873461119083814 |
|
22054 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR212 |
0.873461119083814 |
|
22055 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL624P |
0.873461119083814 |
|
22056 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PDE6A |
0.873481557298951 |
|
22057 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC26A2 |
0.873481557298951 |
|
22058 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TIGD6 |
0.873481557298951 |
|
22059 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HMGXB3 |
0.873481557298951 |
|
22060 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238369.1 |
0.873481557298951 |
|
22061 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CSF1R |
0.873481557298951 |
|
22062 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDX1 |
0.873481557298951 |
|
22063 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC6A7 |
0.873481557298951 |
|
22064 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRIM25 |
0.873548426254908 |
|
22065 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3614 |
0.873548426254908 |
|
22066 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COIL |
0.873548426254908 |
|
22067 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCPEP1 |
0.873548426254908 |
|
22068 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNF126P1 |
0.873548426254908 |
|
22069 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AKAP1 |
0.873548426254908 |
|
22070 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MSI2 |
0.873548426254908 |
|
22071 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C10orf99 |
0.873697971073055 |
|
22072 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDHR1 |
0.873697971073055 |
|
22073 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF366 |
0.874116811357467 |
|
22074 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3139 |
0.874369771537945 |
|
22075 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PDGFC |
0.874379471766646 |
|
22076 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNX19 |
0.874509130275381 |
|
22077 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL167P |
0.874509130275381 |
|
22078 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TLE4 |
0.87467198356362 |
|
22079 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NBR2 |
0.874724973556817 |
|
22080 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MARCH4 |
0.874955584173482 |
|
22081 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SYNPO |
0.875091136043683 |
|
22082 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MYOZ3 |
0.875091136043683 |
|
22083 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NOG |
0.875173122081879 |
|
22084 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NPIPB11 |
0.875254542865399 |
|
22085 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC25A12 |
0.875363688016952 |
|
22086 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HAT1 |
0.875363688016952 |
|
22087 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
METAP1D |
0.875363688016952 |
|
22088 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
APOD |
0.875588540178497 |
|
22089 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00969 |
0.875588540178497 |
|
22090 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR570 |
0.875588540178497 |
|
22091 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MUC20 |
0.875588540178497 |
|
22092 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MUC4 |
0.875588540178497 |
|
22093 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPP1R2 |
0.875588540178497 |
|
22094 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL773P |
0.875588540178497 |
|
22095 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNU6ATAC24P |
0.875588540178497 |
|
22096 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SDHAP1 |
0.875588540178497 |
|
22097 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TNK2 |
0.875588540178497 |
|
22098 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TFRC |
0.875588540178497 |
|
22099 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00885 |
0.875588540178497 |
|
22100 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZDHHC19 |
0.875588540178497 |
|
22101 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC51A |
0.875588540178497 |
|
22102 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCYT1A |
0.875588540178497 |
|
22103 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TCTEX1D2 |
0.875588540178497 |
|
22104 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TM4SF19 |
0.875588540178497 |
|
22105 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UBXN7 |
0.875588540178497 |
|
22106 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL434P |
0.875588540178497 |
|
22107 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL738P |
0.875588540178497 |
|
22108 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNF168 |
0.875588540178497 |
|
22109 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SMCO1 |
0.875588540178497 |
|
22110 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WDR53 |
0.875588540178497 |
|
22111 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FBXO45 |
0.875588540178497 |
|
22112 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CASP8 |
0.875657998081521 |
|
22113 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ALS2CR12 |
0.875657998081521 |
|
22114 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MSRA |
0.875842163404655 |
|
22115 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRSS51 |
0.875842163404655 |
|
22116 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRSS55 |
0.875842163404655 |
|
22117 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SULT1C2 |
0.875887270260284 |
|
22118 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SULT1C2P1 |
0.875887270260284 |
|
22119 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SULT1C4 |
0.875887270260284 |
|
22120 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C3orf30 |
0.876354965187321 |
|
22121 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UPK1B |
0.876354965187321 |
|
22122 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
B4GALT4 |
0.876354965187321 |
|
22123 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARHGAP31 |
0.876354965187321 |
|
22124 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM39A |
0.876354965187321 |
|
22125 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
POGLUT1 |
0.876354965187321 |
|
22126 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TIMMDC1 |
0.876354965187321 |
|
22127 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CD80 |
0.876354965187321 |
|
22128 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADPRH |
0.876354965187321 |
|
22129 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLA1A |
0.876354965187321 |
|
22130 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
POPDC2 |
0.876354965187321 |
|
22131 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COX17 |
0.876354965187321 |
|
22132 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAATS1 |
0.876354965187321 |
|
22133 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NR1I2 |
0.876354965187321 |
|
22134 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCARB1 |
0.876622367770376 |
|
22135 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GNAQ |
0.876894739945294 |
|
22136 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HDAC4 |
0.876911862262222 |
|
22137 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM134C |
0.876934401328237 |
|
22138 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TUBG1 |
0.876934401328237 |
|
22139 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TUBG2 |
0.876934401328237 |
|
22140 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCR10 |
0.876934401328237 |
|
22141 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CNTNAP1 |
0.876934401328237 |
|
22142 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLEKHH3 |
0.876934401328237 |
|
22143 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EZH1 |
0.876934401328237 |
|
22144 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAMP2 |
0.876934401328237 |
|
22145 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VPS25 |
0.876934401328237 |
|
22146 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WNK4 |
0.876934401328237 |
|
22147 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CNTD1 |
0.876934401328237 |
|
22148 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COA3 |
0.876934401328237 |
|
22149 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BECN1 |
0.876934401328237 |
|
22150 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PSME3 |
0.876934401328237 |
|
22151 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AOC2 |
0.876934401328237 |
|
22152 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AOC3 |
0.876934401328237 |
|
22153 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AOC4P |
0.876934401328237 |
|
22154 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00671 |
0.876934401328237 |
|
22155 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
G6PC |
0.876934401328237 |
|
22156 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNY4P2 |
0.876934401328237 |
|
22157 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA40|ENSG00000212149.1 |
0.876934401328237 |
|
22158 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AARSD1 |
0.876934401328237 |
|
22159 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PTGES3L |
0.876934401328237 |
|
22160 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RUNDC1 |
0.876934401328237 |
|
22161 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPL27 |
0.876934401328237 |
|
22162 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IFI35 |
0.876934401328237 |
|
22163 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VAT1 |
0.876934401328237 |
|
22164 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RND2 |
0.876934401328237 |
|
22165 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANKFN1 |
0.876955548618732 |
|
22166 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C17orf67 |
0.876955548618732 |
|
22167 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DGKE |
0.876955548618732 |
|
22168 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C9orf62 |
0.876986889155697 |
|
22169 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPP1R26 |
0.876986889155697 |
|
22170 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C9orf116 |
0.876986889155697 |
|
22171 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MRPS2 |
0.876986889155697 |
|
22172 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LCN1 |
0.876986889155697 |
|
22173 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OBP2A |
0.876986889155697 |
|
22174 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PAEP |
0.876986889155697 |
|
22175 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL437P |
0.877136311446856 |
|
22176 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL449P |
0.877136311446856 |
|
22177 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MTMR4 |
0.877136311446856 |
|
22178 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SEPT4 |
0.877136311446856 |
|
22179 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C17orf47 |
0.877136311446856 |
|
22180 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TEX14 |
0.877136311446856 |
|
22181 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U3|ENSG00000212195.1 |
0.877136311446856 |
|
22182 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CACNA1G |
0.877210094159004 |
|
22183 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CARD9 |
0.877504067037522 |
|
22184 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DKFZP434A062 |
0.877504067037522 |
|
22185 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DNLZ |
0.877504067037522 |
|
22186 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPSM1 |
0.877504067037522 |
|
22187 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LHX3 |
0.877504067037522 |
|
22188 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
QSOX2 |
0.877504067037522 |
|
22189 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRTM1 |
0.877523170896455 |
|
22190 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00470 |
0.877615150499902 |
|
22191 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP72 |
0.877615150499902 |
|
22192 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
REN |
0.877695856631787 |
|
22193 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KISS1 |
0.877695856631787 |
|
22194 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GOLT1A |
0.877695856631787 |
|
22195 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLEKHA6 |
0.877695856631787 |
|
22196 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPP1R15B |
0.877695856631787 |
|
22197 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PIK3C2B |
0.877695856631787 |
|
22198 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MDM4 |
0.877695856631787 |
|
22199 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BLMH |
0.877697919104154 |
|
22200 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD63|ENSG00000252112.1 |
0.877697919104154 |
|
22201 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMIGD1 |
0.877697919104154 |
|
22202 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000239128.1 |
0.877944227070915 |
|
22203 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DCC |
0.878074924542465 |
|
22204 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL147P |
0.878190956242551 |
|
22205 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SYN2 |
0.878190956242551 |
|
22206 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TIMP4 |
0.878190956242551 |
|
22207 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPARG |
0.878190956242551 |
|
22208 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TSEN2 |
0.878190956242551 |
|
22209 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP123 |
0.878190956242551 |
|
22210 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C3orf83 |
0.878190956242551 |
|
22211 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MKRN2 |
0.878190956242551 |
|
22212 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAF1 |
0.878190956242551 |
|
22213 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACAP2 |
0.878262143176261 |
|
22214 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FBXO5 |
0.878382912353594 |
|
22215 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MTRF1L |
0.878382912353594 |
|
22216 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RP1L1 |
0.878420651202031 |
|
22217 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4286 |
0.878420651202031 |
|
22218 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C8orf74 |
0.878420651202031 |
|
22219 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP252 |
0.878420651202031 |
|
22220 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SOX7 |
0.878420651202031 |
|
22221 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PINX1 |
0.878420651202031 |
|
22222 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD112|ENSG00000252565.1 |
0.878420651202031 |
|
22223 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
XKR6 |
0.878420651202031 |
|
22224 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR598 |
0.878420651202031 |
|
22225 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00529 |
0.878420651202031 |
|
22226 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MTMR9 |
0.878420651202031 |
|
22227 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC35G5 |
0.878420651202031 |
|
22228 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TDH |
0.878420651202031 |
|
22229 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C8orf12 |
0.878420651202031 |
|
22230 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL293P |
0.878420651202031 |
|
22231 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM167A |
0.878420651202031 |
|
22232 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BLK |
0.878420651202031 |
|
22233 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00208 |
0.878420651202031 |
|
22234 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNF149 |
0.878978729171428 |
|
22235 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD89 |
0.878978729171428 |
|
22236 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR5696 |
0.878978729171428 |
|
22237 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CREG2 |
0.878978729171428 |
|
22238 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RFX8 |
0.878978729171428 |
|
22239 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ABR |
0.879111423909417 |
|
22240 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C17orf97 |
0.879111423909417 |
|
22241 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DBIL5P |
0.879111423909417 |
|
22242 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DOC2B |
0.879111423909417 |
|
22243 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM101B |
0.879111423909417 |
|
22244 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM57A |
0.879111423909417 |
|
22245 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GEMIN4 |
0.879111423909417 |
|
22246 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GLOD4 |
0.879111423909417 |
|
22247 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3183 |
0.879111423909417 |
|
22248 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NXN |
0.879111423909417 |
|
22249 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNMTL1 |
0.879111423909417 |
|
22250 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPH3AL |
0.879111423909417 |
|
22251 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TIMM22 |
0.879111423909417 |
|
22252 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VPS53 |
0.879111423909417 |
|
22253 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BHLHA9 |
0.879111423909417 |
|
22254 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TUSC5 |
0.879111423909417 |
|
22255 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CD34 |
0.879313099291603 |
|
22256 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KSR1 |
0.879382887734221 |
|
22257 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LGALS9 |
0.879382887734221 |
|
22258 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL576P |
0.879382887734221 |
|
22259 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NOS2 |
0.879382887734221 |
|
22260 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MTHFD1L |
0.879466145060734 |
|
22261 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIF9 |
0.879480151821428 |
|
22262 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARID1B |
0.879607967048316 |
|
22263 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SRGAP3 |
0.879738442192229 |
|
22264 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP59 |
0.879910291713723 |
|
22265 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000251938.1 |
0.879971947860992 |
|
22266 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MORC3 |
0.880187968360219 |
|
22267 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CHAF1B |
0.880187968360219 |
|
22268 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLDN14 |
0.880187968360219 |
|
22269 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL33P |
0.880243244079448 |
|
22270 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PAFAH1B1 |
0.880243244079448 |
|
22271 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000239024.1 |
0.880243244079448 |
|
22272 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL608P |
0.880243244079448 |
|
22273 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLUH |
0.880243244079448 |
|
22274 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR1253 |
0.880243244079448 |
|
22275 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL605P |
0.880243244079448 |
|
22276 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAP1GAP2 |
0.880243244079448 |
|
22277 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C9orf171 |
0.880283504089963 |
|
22278 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HTR5BP |
0.880295679173987 |
|
22279 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC93 |
0.880295679173987 |
|
22280 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL111P |
0.880295679173987 |
|
22281 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
INSIG2 |
0.880295679173987 |
|
22282 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNF38 |
0.880296840385923 |
|
22283 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EEFSEC |
0.880370295532711 |
|
22284 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL284P |
0.880386300433432 |
|
22285 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WTIP |
0.880473135239028 |
|
22286 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCGB1B2P |
0.880473135239028 |
|
22287 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SYNPR |
0.880699756461955 |
|
22288 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GRIK2 |
0.880765212277557 |
|
22289 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TAF9B |
0.880927310655667 |
|
22290 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP196 |
0.880933278763077 |
|
22291 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP14 |
0.881341507620679 |
|
22292 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TOM1L1 |
0.881341507620679 |
|
22293 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COX11 |
0.881341507620679 |
|
22294 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WNT8A |
0.881611878799568 |
|
22295 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NME5 |
0.881611878799568 |
|
22296 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238605.1 |
0.881611878799568 |
|
22297 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLCD3 |
0.881721412891485 |
|
22298 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACBD4 |
0.881721412891485 |
|
22299 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ALG1L2 |
0.881799113226781 |
|
22300 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM86HP |
0.881799113226781 |
|
22301 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
USP40 |
0.881920977730318 |
|
22302 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NEK6 |
0.881922426747365 |
|
22303 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PSMB7 |
0.881922426747365 |
|
22304 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MDH1 |
0.882024588868829 |
|
22305 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPS4XP5 |
0.882024588868829 |
|
22306 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CSPG4P12 |
0.882181232433849 |
|
22307 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL428P |
0.882181232433849 |
|
22308 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD74|ENSG00000200206.1 |
0.882181232433849 |
|
22309 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PSMG1 |
0.88224125523228 |
|
22310 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TTC29 |
0.882248816474361 |
|
22311 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLXNA4 |
0.882271266041083 |
|
22312 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP185 |
0.882276639547948 |
|
22313 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNU6ATAC2P |
0.882276639547948 |
|
22314 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC9A6 |
0.882281207722988 |
|
22315 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000239080.1 |
0.882281207722988 |
|
22316 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FHL1 |
0.882281207722988 |
|
22317 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAP7D3 |
0.882281207722988 |
|
22318 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U3|ENSG00000212551.1 |
0.882493972509438 |
|
22319 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPIL3 |
0.882538145809557 |
|
22320 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NIF3L1 |
0.882538145809557 |
|
22321 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ORC2 |
0.882538145809557 |
|
22322 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL694P |
0.882538145809557 |
|
22323 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
XIAP |
0.882570335316536 |
|
22324 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SH3BP4 |
0.883171540276332 |
|
22325 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL102P |
0.883301633949805 |
|
22326 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPL23 |
0.883301633949805 |
|
22327 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA21|ENSG00000199293.1 |
0.883301633949805 |
|
22328 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPP6R1 |
0.883441604716178 |
|
22329 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HSPBP1 |
0.883441604716178 |
|
22330 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BRSK1 |
0.883441604716178 |
|
22331 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR1L4 |
0.883497570071494 |
|
22332 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR5692A2 |
0.883767297148176 |
|
22333 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LONRF1 |
0.883767297148176 |
|
22334 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DLC1 |
0.883767297148176 |
|
22335 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TAOK1 |
0.884122068292603 |
|
22336 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GLT6D1 |
0.884166700246023 |
|
22337 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LCN9 |
0.884166700246023 |
|
22338 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SOHLH1 |
0.884166700246023 |
|
22339 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FGD5 |
0.884441338526341 |
|
22340 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPR45 |
0.884531133081165 |
|
22341 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NLN |
0.884630008175019 |
|
22342 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR548G |
0.884701003179722 |
|
22343 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM27 |
0.885032497418947 |
|
22344 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CA5BP1 |
0.885032497418947 |
|
22345 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CA5B |
0.885032497418947 |
|
22346 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA7|ENSG00000200620.1 |
0.885032497418947 |
|
22347 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZRSR2 |
0.885032497418947 |
|
22348 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AP1S2 |
0.885032497418947 |
|
22349 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GRPR |
0.885032497418947 |
|
22350 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAGEB17 |
0.885032497418947 |
|
22351 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SHMT1 |
0.885370300549245 |
|
22352 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MGC4771 |
0.885452850977055 |
|
22353 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PTMA |
0.885452850977055 |
|
22354 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CHL1 |
0.885619789084222 |
|
22355 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CNTN4 |
0.885619789084222 |
|
22356 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CNTN6 |
0.885619789084222 |
|
22357 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP144 |
0.885619789084222 |
|
22358 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL120P |
0.885619789084222 |
|
22359 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IL5RA |
0.885619789084222 |
|
22360 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA43|ENSG00000253049.1 |
0.885619789084222 |
|
22361 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRNT1 |
0.885619789084222 |
|
22362 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CRBN |
0.885619789084222 |
|
22363 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NRROS |
0.885688317624994 |
|
22364 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PIGX |
0.885688317624994 |
|
22365 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CEP19 |
0.885688317624994 |
|
22366 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DLG1 |
0.885688317624994 |
|
22367 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MFI2 |
0.885688317624994 |
|
22368 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NCBP2 |
0.885688317624994 |
|
22369 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PAK2 |
0.885688317624994 |
|
22370 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PIGZ |
0.885688317624994 |
|
22371 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SENP5 |
0.885688317624994 |
|
22372 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U4|ENSG00000272359.1 |
0.885688317624994 |
|
22373 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4797 |
0.885688317624994 |
|
22374 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238491.1 |
0.885688317624994 |
|
22375 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPINK14 |
0.885827708460348 |
|
22376 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLDN23 |
0.886202113629265 |
|
22377 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CSMD1 |
0.88633403392164 |
|
22378 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC174 |
0.886353477532717 |
|
22379 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C3orf20 |
0.886353477532717 |
|
22380 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZBTB11 |
0.886423001946891 |
|
22381 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPL24 |
0.886423001946891 |
|
22382 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CEP97 |
0.886423001946891 |
|
22383 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NXPE3 |
0.886423001946891 |
|
22384 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
METTL6 |
0.88666623192434 |
|
22385 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GRIK3 |
0.886671943312696 |
|
22386 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNX18 |
0.88683481458728 |
|
22387 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00114 |
0.886963003543921 |
|
22388 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ETS2 |
0.886963003543921 |
|
22389 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA62|ENSG00000272015.1 |
0.886963003543921 |
|
22390 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPP14 |
0.887012773134548 |
|
22391 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PXK |
0.887012773134548 |
|
22392 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PARK2 |
0.887067355760406 |
|
22393 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MRPL3 |
0.887126343695515 |
|
22394 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CPNE4 |
0.887126343695515 |
|
22395 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IL20RB |
0.887133408397215 |
|
22396 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CA3 |
0.887297387973318 |
|
22397 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CA2 |
0.887297387973318 |
|
22398 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
REXO1L10P|ENSG00000255940.1 |
0.887297387973318 |
|
22399 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
REXO1L10P|ENSG00000270416.1 |
0.887297387973318 |
|
22400 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
REXO1L11P |
0.887297387973318 |
|
22401 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
REXO1L1 |
0.887297387973318 |
|
22402 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARGFX |
0.887738431227929 |
|
22403 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FBXO40 |
0.887738431227929 |
|
22404 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HCLS1 |
0.887738431227929 |
|
22405 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL172P |
0.887738431227929 |
|
22406 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238670.1 |
0.887738431227929 |
|
22407 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GNA14 |
0.888208065887977 |
|
22408 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL766P |
0.888379781164465 |
|
22409 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00424 |
0.888379781164465 |
|
22410 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HACL1 |
0.888496196044046 |
|
22411 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TGFBRAP1 |
0.888755670728913 |
|
22412 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C2orf49 |
0.888755670728913 |
|
22413 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DSCAM |
0.889029745411722 |
|
22414 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KPNA1 |
0.889194272730694 |
|
22415 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PARP9 |
0.889194272730694 |
|
22416 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DTX3L |
0.889194272730694 |
|
22417 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PARP15 |
0.889194272730694 |
|
22418 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PARP14 |
0.889194272730694 |
|
22419 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HSPBAP1 |
0.889194272730694 |
|
22420 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238480.1 |
0.889194272730694 |
|
22421 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KBTBD12 |
0.889258397632796 |
|
22422 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP139 |
0.889258397632796 |
|
22423 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ABHD17B |
0.889364838928541 |
|
22424 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C9orf85 |
0.889364838928541 |
|
22425 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00892 |
0.889444370894524 |
|
22426 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CD40LG |
0.889444370894524 |
|
22427 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARHGEF6 |
0.889444370894524 |
|
22428 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C17orf96 |
0.889587197289642 |
|
22429 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4734 |
0.889587197289642 |
|
22430 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MLLT6 |
0.889587197289642 |
|
22431 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CISD3 |
0.889587197289642 |
|
22432 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4726 |
0.889587197289642 |
|
22433 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP440 |
0.889587197289642 |
|
22434 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCGF2 |
0.889587197289642 |
|
22435 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PSMB3 |
0.889587197289642 |
|
22436 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PIP4K2B |
0.889587197289642 |
|
22437 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CWC25 |
0.889587197289642 |
|
22438 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4727 |
0.889587197289642 |
|
22439 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C17orf98 |
0.889587197289642 |
|
22440 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA21|ENSG00000252699.1 |
0.889587197289642 |
|
22441 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TTF1 |
0.88962108327185 |
|
22442 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EPHB1 |
0.889696662031984 |
|
22443 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KY |
0.889696662031984 |
|
22444 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP141 |
0.889696662031984 |
|
22445 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EAF1 |
0.889931777580647 |
|
22446 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COLQ |
0.889931777580647 |
|
22447 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4270 |
0.889931777580647 |
|
22448 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL110P |
0.889931777580647 |
|
22449 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4255 |
0.890004465544489 |
|
22450 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3911 |
0.890084558497504 |
|
22451 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PTRH1 |
0.890084558497504 |
|
22452 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF471 |
0.890153315246477 |
|
22453 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCNT1 |
0.890206985279706 |
|
22454 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR548AT |
0.890400874225195 |
|
22455 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238891.1 |
0.890516494791729 |
|
22456 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPR21 |
0.890711027116673 |
|
22457 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZFAND5 |
0.890933433191812 |
|
22458 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CPD |
0.891432943569845 |
|
22459 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CTSB |
0.891959158042097 |
|
22460 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DEFB130|ENSG00000232948.1 |
0.891959158042097 |
|
22461 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DEFB130|ENSG00000233050.1 |
0.891959158042097 |
|
22462 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DEFB134 |
0.891959158042097 |
|
22463 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DEFB135 |
0.891959158042097 |
|
22464 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DEFB136 |
0.891959158042097 |
|
22465 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM66A |
0.891959158042097 |
|
22466 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM66D |
0.891959158042097 |
|
22467 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM86B1 |
0.891959158042097 |
|
22468 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM86B2 |
0.891959158042097 |
|
22469 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FDFT1 |
0.891959158042097 |
|
22470 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP253 |
0.891959158042097 |
|
22471 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP254 |
0.891959158042097 |
|
22472 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
USP17L2 |
0.891959158042097 |
|
22473 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF705D |
0.891959158042097 |
|
22474 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM126B |
0.892034624396884 |
|
22475 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NDUFB3 |
0.892034624396884 |
|
22476 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MYL1 |
0.892409143578345 |
|
22477 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LANCL1 |
0.892409143578345 |
|
22478 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NR2C2 |
0.892414061693224 |
|
22479 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MRPS25 |
0.892414061693224 |
|
22480 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IRF1 |
0.892581979490299 |
|
22481 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM74 |
0.892710912275295 |
|
22482 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCNJ6 |
0.892875250531963 |
|
22483 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CRYGB |
0.893005606074337 |
|
22484 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CRYGA |
0.893005606074337 |
|
22485 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C2orf80 |
0.893005606074337 |
|
22486 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TNKS |
0.893094146482666 |
|
22487 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR597 |
0.893094146482666 |
|
22488 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000239065.1 |
0.893094146482666 |
|
22489 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00599 |
0.893094146482666 |
|
22490 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238496.1 |
0.893094146482666 |
|
22491 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
YWHAE |
0.89315565271991 |
|
22492 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD78|ENSG00000212168.1 |
0.893283882274965 |
|
22493 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FUBP3 |
0.89334976225018 |
|
22494 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRDM12 |
0.89334976225018 |
|
22495 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EXOSC2 |
0.89334976225018 |
|
22496 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR5704 |
0.89351440766461 |
|
22497 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238701.1 |
0.89351440766461 |
|
22498 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD111|ENSG00000252230.1 |
0.893637822147079 |
|
22499 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RUNX1 |
0.893685768740997 |
|
22500 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GOLGB1 |
0.893758744258426 |
|
22501 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MYCT1 |
0.893823265127578 |
|
22502 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VIP |
0.893823265127578 |
|
22503 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPI |
0.893969130667164 |
|
22504 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PDCD2L |
0.893969130667164 |
|
22505 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL154P |
0.893969130667164 |
|
22506 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UBA2 |
0.893969130667164 |
|
22507 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SDF2 |
0.894280183793214 |
|
22508 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLGLA |
0.894476859761593 |
|
22509 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RGPD3 |
0.894476859761593 |
|
22510 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CD8BP |
0.894476859761593 |
|
22511 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ST6GAL2 |
0.894476859761593 |
|
22512 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3672 |
0.894516037365039 |
|
22513 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00681 |
0.894781777951857 |
|
22514 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIAA1456 |
0.894781777951857 |
|
22515 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CAMSAP1 |
0.894871916842599 |
|
22516 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UBAC1 |
0.894871916842599 |
|
22517 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ITPR1 |
0.896911690553999 |
|
22518 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMF1 |
0.897030129977999 |
|
22519 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3136 |
0.897030129977999 |
|
22520 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UBA3 |
0.897030129977999 |
|
22521 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARL6IP5 |
0.897030129977999 |
|
22522 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LMOD3 |
0.897030129977999 |
|
22523 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UBE2E3 |
0.897193758274425 |
|
22524 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4437 |
0.897193758274425 |
|
22525 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WNT5A |
0.897410848299241 |
|
22526 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238981.1 |
0.89744591494167 |
|
22527 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR600HG |
0.897709983942419 |
|
22528 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STRBP |
0.897709983942419 |
|
22529 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CRB2 |
0.897709983942419 |
|
22530 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DENND1A |
0.897709983942419 |
|
22531 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DNAH12 |
0.897865406796764 |
|
22532 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PDE12 |
0.897865406796764 |
|
22533 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARF4 |
0.897865406796764 |
|
22534 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNU6ATAC26P |
0.897865406796764 |
|
22535 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DENND6A |
0.897865406796764 |
|
22536 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MECOM |
0.897925017572152 |
|
22537 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADAMTS7 |
0.897925699912049 |
|
22538 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MORF4L1 |
0.897925699912049 |
|
22539 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
H2AFY |
0.897937832145888 |
|
22540 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C5orf20 |
0.897937832145888 |
|
22541 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TIFAB |
0.897937832145888 |
|
22542 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NEUROG1 |
0.897937832145888 |
|
22543 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CXCL14 |
0.897937832145888 |
|
22544 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UBE2Z |
0.89808708177268 |
|
22545 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UNC45A |
0.898195689391118 |
|
22546 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RCCD1 |
0.898195689391118 |
|
22547 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRC1 |
0.898195689391118 |
|
22548 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VPS33B |
0.898195689391118 |
|
22549 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ESRRAP2 |
0.898261782140386 |
|
22550 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIPEPP3 |
0.898261782140386 |
|
22551 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP25 |
0.898261782140386 |
|
22552 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZDHHC20 |
0.898261782140386 |
|
22553 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC35G2 |
0.898291855876499 |
|
22554 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NCK1 |
0.898291855876499 |
|
22555 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00607 |
0.898340643560145 |
|
22556 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPP3R1 |
0.898360508254399 |
|
22557 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCT6B |
0.898453321161618 |
|
22558 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL418P |
0.898589532958473 |
|
22559 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ILDR1 |
0.898660205197335 |
|
22560 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPS6KA2 |
0.898837141493232 |
|
22561 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNASET2 |
0.898837141493232 |
|
22562 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FGFR1OP |
0.898837141493232 |
|
22563 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3939 |
0.898837141493232 |
|
22564 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCR6 |
0.898837141493232 |
|
22565 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNED1 |
0.898921440552878 |
|
22566 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MTERFD2 |
0.898921440552878 |
|
22567 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PASK |
0.898921440552878 |
|
22568 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPP1R7 |
0.898921440552878 |
|
22569 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANO7 |
0.898921440552878 |
|
22570 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HDLBP |
0.898921440552878 |
|
22571 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SEPT2 |
0.898921440552878 |
|
22572 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EFCAB13 |
0.898928516007743 |
|
22573 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MRPL45P2 |
0.898928516007743 |
|
22574 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NPEPPS |
0.898928516007743 |
|
22575 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KPNB1 |
0.898928516007743 |
|
22576 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TBKBP1 |
0.898928516007743 |
|
22577 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AKAP12 |
0.898993000372098 |
|
22578 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNY4P20 |
0.898993000372098 |
|
22579 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP268 |
0.898993000372098 |
|
22580 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238939.1 |
0.898993000372098 |
|
22581 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZBTB2 |
0.898993000372098 |
|
22582 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RMND1 |
0.898993000372098 |
|
22583 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C6orf211 |
0.898993000372098 |
|
22584 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC170 |
0.898993000372098 |
|
22585 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PAPOLG |
0.899472130819225 |
|
22586 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL632P |
0.899472130819225 |
|
22587 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
REL |
0.899472130819225 |
|
22588 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PUS10 |
0.899472130819225 |
|
22589 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP95 |
0.899472130819225 |
|
22590 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PEX13 |
0.899472130819225 |
|
22591 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATF2 |
0.899478242302295 |
|
22592 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR933 |
0.899478242302295 |
|
22593 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATP5G3 |
0.899478242302295 |
|
22594 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PIPOX |
0.899916881031608 |
|
22595 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLXND1 |
0.899938015169756 |
|
22596 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL752P |
0.899938015169756 |
|
22597 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMCC1 |
0.899938015169756 |
|
22598 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C5orf56 |
0.90032144124896 |
|
22599 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NDUFA10 |
0.900576767427237 |
|
22600 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR6B2 |
0.900576767427237 |
|
22601 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRR21 |
0.900576767427237 |
|
22602 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR6B3 |
0.900576767427237 |
|
22603 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MYEOV2 |
0.900576767427237 |
|
22604 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OTOS |
0.900576767427237 |
|
22605 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR1202 |
0.900865557664568 |
|
22606 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SRCIN1 |
0.900888103438265 |
|
22607 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NFKBIZ |
0.900920889683811 |
|
22608 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DYNC1I2 |
0.900921245704122 |
|
22609 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DLX1 |
0.900921245704122 |
|
22610 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DLX2 |
0.900921245704122 |
|
22611 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238572.1 |
0.900921245704122 |
|
22612 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000239041.1 |
0.900921245704122 |
|
22613 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAPGEF4 |
0.900921245704122 |
|
22614 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ESRG |
0.90124014895984 |
|
22615 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DHX30 |
0.90130581805086 |
|
22616 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAP4 |
0.90130581805086 |
|
22617 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL664P |
0.90130581805086 |
|
22618 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIF7 |
0.901494251241638 |
|
22619 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLIN1 |
0.901494251241638 |
|
22620 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PEX11A |
0.901494251241638 |
|
22621 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WDR93 |
0.901494251241638 |
|
22622 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP109 |
0.902011749571673 |
|
22623 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM19A4 |
0.902090474957105 |
|
22624 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP135 |
0.902090474957105 |
|
22625 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EOGT |
0.902090474957105 |
|
22626 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FRMD4B |
0.902090474957105 |
|
22627 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00323 |
0.902289945749148 |
|
22628 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BACE2 |
0.902289945749148 |
|
22629 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3197 |
0.902289945749148 |
|
22630 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MX1 |
0.902289945749148 |
|
22631 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
POLQ |
0.902312455430141 |
|
22632 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL363P |
0.90240605954728 |
|
22633 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FURIN |
0.90240605954728 |
|
22634 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FES |
0.90240605954728 |
|
22635 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAN2A2 |
0.90240605954728 |
|
22636 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HDDC3 |
0.90240605954728 |
|
22637 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL361P |
0.902590961339904 |
|
22638 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WNT9B |
0.902661728739193 |
|
22639 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC1A4 |
0.902723701594641 |
|
22640 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CEP68 |
0.902723701594641 |
|
22641 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAB1A |
0.902723701594641 |
|
22642 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA74|ENSG00000272025.1 |
0.902723701594641 |
|
22643 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACTR2 |
0.902723701594641 |
|
22644 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAB32 |
0.902738305988871 |
|
22645 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADGB |
0.902738305988871 |
|
22646 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL178P |
0.902761949310049 |
|
22647 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF548 |
0.902771379072531 |
|
22648 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF17 |
0.902771379072531 |
|
22649 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF749 |
0.902771379072531 |
|
22650 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZBTB6 |
0.902806948720076 |
|
22651 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZBTB26 |
0.902806948720076 |
|
22652 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LHX2 |
0.902806948720076 |
|
22653 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ETAA1 |
0.902814298913277 |
|
22654 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KLHL13 |
0.902918554933179 |
|
22655 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SUMF1 |
0.90297891570089 |
|
22656 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR1226 |
0.903145454741946 |
|
22657 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4438 |
0.903435225631881 |
|
22658 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C2orf76 |
0.90367622788373 |
|
22659 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DBI |
0.90367622788373 |
|
22660 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VWC2L |
0.903843293889323 |
|
22661 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BARD1 |
0.903843293889323 |
|
22662 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA70|ENSG00000207274.1 |
0.903843293889323 |
|
22663 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ABCA12 |
0.903843293889323 |
|
22664 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238663.1 |
0.903843293889323 |
|
22665 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATIC |
0.903843293889323 |
|
22666 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FN1 |
0.903843293889323 |
|
22667 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PGM5 |
0.903958385634256 |
|
22668 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C1D |
0.90396684805927 |
|
22669 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WDR92 |
0.90396684805927 |
|
22670 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PNO1 |
0.90396684805927 |
|
22671 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ROPN1 |
0.904194271387236 |
|
22672 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PDE6D |
0.904221770016599 |
|
22673 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COPS7B |
0.904221770016599 |
|
22674 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PIK3CB |
0.904342408047836 |
|
22675 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C3orf72 |
0.904342408047836 |
|
22676 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FOXL2 |
0.904342408047836 |
|
22677 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MRPS22 |
0.904342408047836 |
|
22678 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRR23A |
0.904342408047836 |
|
22679 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRR23B |
0.904342408047836 |
|
22680 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRR23C |
0.904342408047836 |
|
22681 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BPESC1 |
0.904342408047836 |
|
22682 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COPB2 |
0.904342408047836 |
|
22683 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IL6ST |
0.904387510276562 |
|
22684 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238326.1 |
0.904387510276562 |
|
22685 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANKRD55 |
0.904387510276562 |
|
22686 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP184 |
0.904387510276562 |
|
22687 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
E2F5 |
0.904408155978288 |
|
22688 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C8orf59 |
0.904408155978288 |
|
22689 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CA13 |
0.904408155978288 |
|
22690 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CA1 |
0.904408155978288 |
|
22691 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FSTL1 |
0.904583911454951 |
|
22692 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NDUFB4 |
0.904583911454951 |
|
22693 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HGD |
0.904583911454951 |
|
22694 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RABL3 |
0.904583911454951 |
|
22695 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GTF2E1 |
0.904583911454951 |
|
22696 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL762P |
0.904614847911377 |
|
22697 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL397P |
0.904614847911377 |
|
22698 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPR156 |
0.904614847911377 |
|
22699 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRRC58 |
0.904614847911377 |
|
22700 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM132B |
0.904617345353295 |
|
22701 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAPKAPK2 |
0.90469044851274 |
|
22702 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IL19 |
0.90469044851274 |
|
22703 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IL20 |
0.90469044851274 |
|
22704 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IL24 |
0.90469044851274 |
|
22705 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAIM3 |
0.90469044851274 |
|
22706 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PIGR |
0.90469044851274 |
|
22707 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FCAMR |
0.90469044851274 |
|
22708 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IQCB1 |
0.905113518177038 |
|
22709 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EAF2 |
0.905113518177038 |
|
22710 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC15A2 |
0.905113518177038 |
|
22711 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MFHAS1 |
0.905275640096014 |
|
22712 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA70|ENSG00000207244.1 |
0.905275640096014 |
|
22713 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LAX1 |
0.90536749814379 |
|
22714 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZBED6 |
0.90536749814379 |
|
22715 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZC3H11A |
0.90536749814379 |
|
22716 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ALAS1 |
0.905441018332556 |
|
22717 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TLR9 |
0.905441018332556 |
|
22718 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TWF2 |
0.905441018332556 |
|
22719 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPM1M |
0.905441018332556 |
|
22720 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WDR82 |
0.905441018332556 |
|
22721 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIRLET7G |
0.905441018332556 |
|
22722 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GLYCTK |
0.905441018332556 |
|
22723 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR135A1 |
0.905441018332556 |
|
22724 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZIC3 |
0.905483070189734 |
|
22725 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL325P |
0.905483070189734 |
|
22726 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPA4 |
0.905634037015602 |
|
22727 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GACAT1 |
0.905837709317554 |
|
22728 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RGPD4 |
0.905837709317554 |
|
22729 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HLF |
0.905951679030091 |
|
22730 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIF14 |
0.906148273832039 |
|
22731 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DDX59 |
0.906148273832039 |
|
22732 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CAMSAP2 |
0.906148273832039 |
|
22733 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPR25 |
0.906148273832039 |
|
22734 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRKRA |
0.90631573856788 |
|
22735 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DFNB59 |
0.90631573856788 |
|
22736 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FKBP7 |
0.90631573856788 |
|
22737 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLEKHA3 |
0.90631573856788 |
|
22738 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRRN1 |
0.906610363118177 |
|
22739 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AGFG1 |
0.906613471279337 |
|
22740 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR5703 |
0.906613471279337 |
|
22741 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C2orf83 |
0.906613471279337 |
|
22742 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC19A3 |
0.906613471279337 |
|
22743 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238582.1 |
0.906660136463542 |
|
22744 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CRYGEP |
0.906660136463542 |
|
22745 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CRYGD |
0.906660136463542 |
|
22746 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CRYGC |
0.906660136463542 |
|
22747 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IDH1 |
0.906660136463542 |
|
22748 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PIKFYVE |
0.906660136463542 |
|
22749 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAIM |
0.906702556994667 |
|
22750 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VRK2 |
0.906706867044127 |
|
22751 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C9orf117 |
0.906797986984036 |
|
22752 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TTC16 |
0.906797986984036 |
|
22753 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TOR2A |
0.906797986984036 |
|
22754 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNF43 |
0.906902628589818 |
|
22755 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CUL3 |
0.907133751406919 |
|
22756 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00620 |
0.907261740654581 |
|
22757 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAB17 |
0.907306448088358 |
|
22758 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRRFIP1 |
0.907306448088358 |
|
22759 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DSCR8 |
0.907355731553918 |
|
22760 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCNJ15 |
0.907355731553918 |
|
22761 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238581.1 |
0.907355731553918 |
|
22762 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DSCR10 |
0.907355731553918 |
|
22763 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ERG |
0.907355731553918 |
|
22764 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL775P |
0.907612652896 |
|
22765 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIAA0754 |
0.907723887011451 |
|
22766 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM3B |
0.907832121137158 |
|
22767 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MX2 |
0.907832121137158 |
|
22768 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LHFPL2 |
0.908044033110134 |
|
22769 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SMARCC1 |
0.908055807583041 |
|
22770 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC104 |
0.908057069120375 |
|
22771 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SMEK2 |
0.908057069120375 |
|
22772 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA12|ENSG00000212175.1 |
0.908057069120375 |
|
22773 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PNPT1 |
0.908057069120375 |
|
22774 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RHCG |
0.908137319076664 |
|
22775 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00928 |
0.908137319076664 |
|
22776 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NCR1 |
0.908188478651977 |
|
22777 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NLRP7 |
0.908188478651977 |
|
22778 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NLRP2 |
0.908188478651977 |
|
22779 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GP6 |
0.908188478651977 |
|
22780 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RDH13 |
0.908188478651977 |
|
22781 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EPS8L1 |
0.908188478651977 |
|
22782 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KBTBD11 |
0.908463707842968 |
|
22783 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MYOM2 |
0.908463707842968 |
|
22784 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM37 |
0.908750653147254 |
|
22785 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCTR |
0.908750653147254 |
|
22786 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR5010 |
0.908932616930782 |
|
22787 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NAGLU |
0.908932616930782 |
|
22788 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HSD17B1 |
0.908932616930782 |
|
22789 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COASY |
0.908932616930782 |
|
22790 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MLX |
0.908932616930782 |
|
22791 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PSMC3IP |
0.908932616930782 |
|
22792 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ITGA4 |
0.908973950085632 |
|
22793 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CERKL |
0.908973950085632 |
|
22794 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NEUROD1 |
0.908973950085632 |
|
22795 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNU6ATAC19P |
0.908973950085632 |
|
22796 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SSFA2 |
0.908973950085632 |
|
22797 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CAMP |
0.909069383623306 |
|
22798 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL870P |
0.909465768981987 |
|
22799 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CSPG5 |
0.909465768981987 |
|
22800 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ITGA3 |
0.909654951337184 |
|
22801 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FBLN2 |
0.909708977279298 |
|
22802 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZSCAN5C |
0.909716054861032 |
|
22803 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZSCAN5D |
0.909716054861032 |
|
22804 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00670 |
0.909745516805079 |
|
22805 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MYOCD |
0.909745516805079 |
|
22806 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCDH18 |
0.909868198577714 |
|
22807 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00616 |
0.909868198577714 |
|
22808 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC7A11 |
0.909868198577714 |
|
22809 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00498 |
0.909868198577714 |
|
22810 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00499 |
0.909868198577714 |
|
22811 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C3orf37 |
0.910295574676423 |
|
22812 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
H1FX |
0.910295574676423 |
|
22813 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPL32P3 |
0.910295574676423 |
|
22814 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA7B |
0.910295574676423 |
|
22815 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RHO |
0.910295574676423 |
|
22816 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
H1FOO |
0.910295574676423 |
|
22817 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCNE1 |
0.910344832226795 |
|
22818 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCNE2 |
0.910344832226795 |
|
22819 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RCAN1 |
0.910344832226795 |
|
22820 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SMIM11 |
0.910344832226795 |
|
22821 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA11|ENSG00000221398.1 |
0.910344832226795 |
|
22822 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLIC6 |
0.910344832226795 |
|
22823 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00160 |
0.910344832226795 |
|
22824 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HOXD3 |
0.910423465917157 |
|
22825 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HOXD1 |
0.910423465917157 |
|
22826 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MNT |
0.910701429149771 |
|
22827 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPINK13 |
0.910785230028776 |
|
22828 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPINK7 |
0.910785230028776 |
|
22829 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPINK9 |
0.910785230028776 |
|
22830 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HTR4 |
0.910785230028776 |
|
22831 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LPO |
0.910977624085568 |
|
22832 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MPO |
0.910977624085568 |
|
22833 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BZRAP1 |
0.910977624085568 |
|
22834 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR142 |
0.910977624085568 |
|
22835 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4736 |
0.910977624085568 |
|
22836 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SUPT4H1 |
0.910977624085568 |
|
22837 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAB3C |
0.911344238726868 |
|
22838 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PTPN23 |
0.911361329994167 |
|
22839 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCAP |
0.911361329994167 |
|
22840 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238350.1 |
0.911361329994167 |
|
22841 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ELP6 |
0.911361329994167 |
|
22842 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MPRIP |
0.911561697451051 |
|
22843 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLD6 |
0.911561697451051 |
|
22844 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FLCN |
0.911561697451051 |
|
22845 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COPS3 |
0.911561697451051 |
|
22846 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NT5M |
0.911561697451051 |
|
22847 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HINT3 |
0.911603988671738 |
|
22848 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP216 |
0.911603988671738 |
|
22849 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRMT11 |
0.911603988671738 |
|
22850 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM100 |
0.911704910432052 |
|
22851 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCTP |
0.911704910432052 |
|
22852 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF589 |
0.911756807765492 |
|
22853 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RGS17 |
0.911853266534982 |
|
22854 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP224 |
0.911853266534982 |
|
22855 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP222 |
0.911870491851922 |
|
22856 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FGF12 |
0.911870491851922 |
|
22857 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238902.1 |
0.911870491851922 |
|
22858 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MB21D2 |
0.911870491851922 |
|
22859 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HRASLS |
0.911870491851922 |
|
22860 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATP13A5 |
0.911870491851922 |
|
22861 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATP13A4 |
0.911870491851922 |
|
22862 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OPA1 |
0.911870491851922 |
|
22863 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TCP1 |
0.912073193115202 |
|
22864 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA29 |
0.912073193115202 |
|
22865 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MRPL18 |
0.912073193115202 |
|
22866 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PNLDC1 |
0.912073193115202 |
|
22867 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAS1 |
0.912073193115202 |
|
22868 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IGF2R |
0.912073193115202 |
|
22869 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AIRN |
0.912073193115202 |
|
22870 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC22A1 |
0.912073193115202 |
|
22871 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC22A2 |
0.912073193115202 |
|
22872 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC22A3 |
0.912073193115202 |
|
22873 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LPAL2 |
0.912073193115202 |
|
22874 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LPA |
0.912073193115202 |
|
22875 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PTPRC |
0.9121225255008 |
|
22876 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR181A1HG |
0.9121225255008 |
|
22877 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR181A1 |
0.9121225255008 |
|
22878 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR181B1 |
0.9121225255008 |
|
22879 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD112|ENSG00000252298.1 |
0.912244306269207 |
|
22880 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR563 |
0.912285167595281 |
|
22881 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SEC61A1 |
0.912511031602314 |
|
22882 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RUVBL1 |
0.912511031602314 |
|
22883 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COL6A6 |
0.912668528929346 |
|
22884 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NUDT16P |
0.912668528929346 |
|
22885 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NUDT16 |
0.912668528929346 |
|
22886 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA58|ENSG00000249020.1 |
0.912668528929346 |
|
22887 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000239140.1 |
0.912812010744462 |
|
22888 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM40 |
0.912812010744462 |
|
22889 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00862 |
0.912830958078032 |
|
22890 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF281 |
0.912830958078032 |
|
22891 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATP6V0D2 |
0.913144163090529 |
|
22892 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PSKH2 |
0.913144163090529 |
|
22893 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC7A13 |
0.913144163090529 |
|
22894 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WWP1 |
0.913144163090529 |
|
22895 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C1orf106 |
0.913218192403433 |
|
22896 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIF21B |
0.913218192403433 |
|
22897 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CACNA1S |
0.913218192403433 |
|
22898 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ASCL5 |
0.913218192403433 |
|
22899 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM9 |
0.913218192403433 |
|
22900 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IGFN1 |
0.913218192403433 |
|
22901 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNF135 |
0.913312520655669 |
|
22902 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4733 |
0.913312520655669 |
|
22903 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HNF1B |
0.913516606235641 |
|
22904 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM205CP |
0.913838642675823 |
|
22905 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC26A9 |
0.913907417176435 |
|
22906 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SAP18 |
0.913998206004416 |
|
22907 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SKA3 |
0.913998206004416 |
|
22908 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MRP63 |
0.913998206004416 |
|
22909 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CNBP |
0.914063025887956 |
|
22910 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLN8 |
0.914335654595701 |
|
22911 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR596 |
0.914335654595701 |
|
22912 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARHGEF10 |
0.914335654595701 |
|
22913 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UBE2NL |
0.914374597046247 |
|
22914 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RBM5 |
0.914458762094137 |
|
22915 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MICU2 |
0.914467277706053 |
|
22916 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238878.1 |
0.914467277706053 |
|
22917 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FGF9 |
0.914467277706053 |
|
22918 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
POU4F2 |
0.914614226224331 |
|
22919 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SEZ6 |
0.914682691778148 |
|
22920 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PGK1 |
0.914687895319169 |
|
22921 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GJB5 |
0.914813267997729 |
|
22922 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GJB4 |
0.914813267997729 |
|
22923 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GJB3 |
0.914813267997729 |
|
22924 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GJA4 |
0.914813267997729 |
|
22925 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RCN1 |
0.915166987435342 |
|
22926 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ALDH1A1 |
0.915306734761024 |
|
22927 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANXA1 |
0.915306734761024 |
|
22928 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZCCHC10 |
0.915517025872087 |
|
22929 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HSPA4 |
0.915517025872087 |
|
22930 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AKAP13 |
0.915755927901133 |
|
22931 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KLHL25 |
0.915755927901133 |
|
22932 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR1276 |
0.915755927901133 |
|
22933 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR548AP |
0.915755927901133 |
|
22934 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP400 |
0.915755927901133 |
|
22935 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FXN |
0.915921699281251 |
|
22936 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
INPP4B |
0.915937053260926 |
|
22937 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238520.1 |
0.91615760552095 |
|
22938 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238690.1 |
0.916472974442751 |
|
22939 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C11orf44 |
0.916539403875784 |
|
22940 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL173P |
0.916595747403995 |
|
22941 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM181 |
0.916595747403995 |
|
22942 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DYNLT1 |
0.916595747403995 |
|
22943 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SYTL3 |
0.916595747403995 |
|
22944 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPR144 |
0.916709119885824 |
|
22945 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC6A14 |
0.916935798483631 |
|
22946 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CXorf61 |
0.916935798483631 |
|
22947 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CRK |
0.916965546702943 |
|
22948 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TULP4 |
0.917003345565059 |
|
22949 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VGLL4 |
0.917006848668869 |
|
22950 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TAMM41 |
0.917006848668869 |
|
22951 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SERAC1 |
0.917163767337876 |
|
22952 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GTF2H5 |
0.917163767337876 |
|
22953 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA72|ENSG00000206901.1 |
0.917208951607264 |
|
22954 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DDB1 |
0.917462918383828 |
|
22955 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DAK |
0.917462918383828 |
|
22956 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CYB561A3 |
0.917462918383828 |
|
22957 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM138 |
0.917462918383828 |
|
22958 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00939 |
0.917500803880755 |
|
22959 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LHFPL1 |
0.917977777502285 |
|
22960 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BTD |
0.91869941110134 |
|
22961 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FGD5P1 |
0.91874225428324 |
|
22962 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TPRXL |
0.91874225428324 |
|
22963 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CHCHD4 |
0.91874225428324 |
|
22964 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM43 |
0.91874225428324 |
|
22965 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
XPC |
0.91874225428324 |
|
22966 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LSM3 |
0.91874225428324 |
|
22967 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TNNT1 |
0.91886623516808 |
|
22968 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DNAAF3 |
0.91886623516808 |
|
22969 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TNNI3 |
0.91886623516808 |
|
22970 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000239137.1 |
0.91886623516808 |
|
22971 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SYT5 |
0.91886623516808 |
|
22972 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PTPRH |
0.91886623516808 |
|
22973 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM86B |
0.91886623516808 |
|
22974 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRKAR2A |
0.918949864679403 |
|
22975 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPRED2 |
0.919193152350733 |
|
22976 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAP9 |
0.919238790430246 |
|
22977 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPL39 |
0.919419863179138 |
|
22978 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA69|ENSG00000206622.1 |
0.919419863179138 |
|
22979 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C1orf116 |
0.919441147842792 |
|
22980 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238401.1 |
0.919441147842792 |
|
22981 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WSB1 |
0.919481833990086 |
|
22982 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ELF3 |
0.919483412173179 |
|
22983 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GLRB |
0.919728581824269 |
|
22984 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GRIA2 |
0.919728581824269 |
|
22985 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAST4 |
0.920034724190421 |
|
22986 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACMSD |
0.920235517972422 |
|
22987 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR5590 |
0.920235517972422 |
|
22988 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCNT2 |
0.920235517972422 |
|
22989 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UST |
0.920304056886346 |
|
22990 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP31 |
0.920417901205169 |
|
22991 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3937 |
0.920468831269881 |
|
22992 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL732P |
0.920468831269881 |
|
22993 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR1587 |
0.920468831269881 |
|
22994 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BCOR |
0.920468831269881 |
|
22995 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238920.1 |
0.920468831269881 |
|
22996 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATP6AP2 |
0.920468831269881 |
|
22997 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CXorf38 |
0.920468831269881 |
|
22998 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MED14 |
0.920468831269881 |
|
22999 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADRB2 |
0.92065169799494 |
|
23000 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00901 |
0.920762257909122 |
|
23001 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC6A6 |
0.921419156041444 |
|
23002 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SEMA3F |
0.921593732283486 |
|
23003 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR566 |
0.921593732283486 |
|
23004 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MLTK |
0.921601031437777 |
|
23005 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDCA7 |
0.921601031437777 |
|
23006 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP159 |
0.921622258046192 |
|
23007 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GRM1 |
0.921668342248919 |
|
23008 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRPM8 |
0.921804494016376 |
|
23009 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPP2 |
0.921804494016376 |
|
23010 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARL4C |
0.921804494016376 |
|
23011 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CACNA2D2 |
0.921836986691814 |
|
23012 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR1305 |
0.921846640591253 |
|
23013 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NR5A2 |
0.922109739440394 |
|
23014 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CEP78 |
0.922166511600903 |
|
23015 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PSAT1 |
0.922166511600903 |
|
23016 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLEKHG1 |
0.922328560988282 |
|
23017 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RHOT1 |
0.922588489841519 |
|
23018 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RHBDL3 |
0.922588489841519 |
|
23019 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C17orf75 |
0.922588489841519 |
|
23020 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF207 |
0.922588489841519 |
|
23021 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PSMD11 |
0.922588489841519 |
|
23022 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDK5R1 |
0.922588489841519 |
|
23023 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MYO1D |
0.922588489841519 |
|
23024 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM98 |
0.922588489841519 |
|
23025 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FLI1 |
0.922605367500733 |
|
23026 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UBE2S |
0.922629088068474 |
|
23027 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SHISA7 |
0.922629088068474 |
|
23028 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ISOC2 |
0.922629088068474 |
|
23029 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF628 |
0.922629088068474 |
|
23030 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NAT14 |
0.922629088068474 |
|
23031 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SSC5D |
0.922629088068474 |
|
23032 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SBK2 |
0.922629088068474 |
|
23033 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SGK110 |
0.922629088068474 |
|
23034 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF579 |
0.922629088068474 |
|
23035 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM150B |
0.922707070592894 |
|
23036 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COX6B2 |
0.922707070592894 |
|
23037 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SUV420H2 |
0.922707070592894 |
|
23038 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM71E2 |
0.922707070592894 |
|
23039 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IL11 |
0.922707070592894 |
|
23040 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM190 |
0.922707070592894 |
|
23041 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM238 |
0.922707070592894 |
|
23042 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPL28 |
0.922707070592894 |
|
23043 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MGST2 |
0.923438198523266 |
|
23044 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CEP170P1 |
0.923441322562734 |
|
23045 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF667 |
0.923534303693247 |
|
23046 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZFP28 |
0.923534303693247 |
|
23047 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF470 |
0.923534303693247 |
|
23048 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF71 |
0.923534303693247 |
|
23049 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4433 |
0.923575793306345 |
|
23050 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMC1 |
0.923591902718223 |
|
23051 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238402.1 |
0.923591902718223 |
|
23052 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3692 |
0.923626461776608 |
|
23053 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIF18B |
0.924068693808199 |
|
23054 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA32|ENSG00000207503.1 |
0.924112261326046 |
|
23055 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000252771.1 |
0.924112261326046 |
|
23056 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NEK11 |
0.924229564507632 |
|
23057 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR5002 |
0.924313547660593 |
|
23058 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C3orf56 |
0.924491311257626 |
|
23059 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TPRA1 |
0.924491311257626 |
|
23060 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MCM2 |
0.924491311257626 |
|
23061 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PODXL2 |
0.924491311257626 |
|
23062 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ABTB1 |
0.924491311257626 |
|
23063 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MGLL |
0.924491311257626 |
|
23064 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CASP10 |
0.924768188465024 |
|
23065 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPL39P5 |
0.924993307346214 |
|
23066 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AMOTL2 |
0.924993307346214 |
|
23067 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4788 |
0.924993307346214 |
|
23068 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANAPC13 |
0.924993307346214 |
|
23069 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CEP63 |
0.924993307346214 |
|
23070 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TP63 |
0.92511673618816 |
|
23071 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LYRM9 |
0.925124019897604 |
|
23072 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR802 |
0.925186340580462 |
|
23073 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCNJ1 |
0.925205839563641 |
|
23074 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCNJ5 |
0.925205839563641 |
|
23075 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C11orf45 |
0.925205839563641 |
|
23076 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TP53AIP1 |
0.925205839563641 |
|
23077 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HES1 |
0.92534317041075 |
|
23078 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL215P |
0.92534317041075 |
|
23079 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GP5 |
0.92534317041075 |
|
23080 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATP13A3 |
0.92534317041075 |
|
23081 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ULBP2 |
0.925476872335015 |
|
23082 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAET1L |
0.925476872335015 |
|
23083 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANKRD28 |
0.925587316794746 |
|
23084 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STK32A |
0.925681635498888 |
|
23085 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DPYSL3 |
0.925681635498888 |
|
23086 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
JAKMIP2 |
0.925681635498888 |
|
23087 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPINK1 |
0.925681635498888 |
|
23088 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCGB3A2 |
0.925681635498888 |
|
23089 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C5orf46 |
0.925681635498888 |
|
23090 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPINK5 |
0.925681635498888 |
|
23091 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPINK6 |
0.925681635498888 |
|
23092 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LASP1 |
0.925725611291096 |
|
23093 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00672 |
0.925725611291096 |
|
23094 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FBXO47 |
0.925725611291096 |
|
23095 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRRC37A11P |
0.925725611291096 |
|
23096 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LIMS1 |
0.925731067924035 |
|
23097 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RANBP2 |
0.925731067924035 |
|
23098 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC138 |
0.925731067924035 |
|
23099 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EDAR |
0.925731067924035 |
|
23100 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SH3RF3 |
0.925731067924035 |
|
23101 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4265 |
0.925731067924035 |
|
23102 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4266 |
0.925731067924035 |
|
23103 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SEPT10 |
0.925731067924035 |
|
23104 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SOWAHC |
0.925731067924035 |
|
23105 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SMAD1 |
0.925840111721948 |
|
23106 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NCK2 |
0.925883750516192 |
|
23107 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C2orf40 |
0.925883750516192 |
|
23108 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UXS1 |
0.925883750516192 |
|
23109 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIMT1 |
0.92601760192058 |
|
23110 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
USP29 |
0.92601760192058 |
|
23111 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DUXA |
0.92601760192058 |
|
23112 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U3|ENSG00000252683.1 |
0.92601760192058 |
|
23113 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZIM3 |
0.92601760192058 |
|
23114 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GCNT1 |
0.926316474506693 |
|
23115 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRUNE2 |
0.926316474506693 |
|
23116 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCA3 |
0.926316474506693 |
|
23117 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF460 |
0.92644584106848 |
|
23118 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF543 |
0.92644584106848 |
|
23119 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPR112 |
0.926529254365541 |
|
23120 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BRS3 |
0.926529254365541 |
|
23121 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HTATSF1 |
0.926529254365541 |
|
23122 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VGLL1 |
0.926529254365541 |
|
23123 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR934 |
0.926529254365541 |
|
23124 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DNASE1L3 |
0.926624535469132 |
|
23125 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ABHD6 |
0.926624535469132 |
|
23126 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TBC1D3P5 |
0.926694032879147 |
|
23127 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IFT88 |
0.92713540801622 |
|
23128 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IL17D |
0.92713540801622 |
|
23129 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
N6AMT2 |
0.92713540801622 |
|
23130 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STXBP4 |
0.927191189862717 |
|
23131 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM45B |
0.927196272967526 |
|
23132 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NFRKB |
0.927196272967526 |
|
23133 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRDM10 |
0.927196272967526 |
|
23134 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00167 |
0.927196272967526 |
|
23135 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR1258 |
0.927207230738513 |
|
23136 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA43|ENSG00000202216.1 |
0.927207230738513 |
|
23137 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00963 |
0.927338799384515 |
|
23138 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NTNG2 |
0.927356923655918 |
|
23139 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DDX60 |
0.927666310600423 |
|
23140 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238744.1 |
0.927666310600423 |
|
23141 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNAPC4 |
0.928007498375423 |
|
23142 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SDCCAG3 |
0.928007498375423 |
|
23143 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PMPCA |
0.928007498375423 |
|
23144 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
INPP5E |
0.928007498375423 |
|
23145 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SEC16A |
0.928007498375423 |
|
23146 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NCEH1 |
0.928424951123598 |
|
23147 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STXBP5L |
0.928569043012612 |
|
23148 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR5682 |
0.928569043012612 |
|
23149 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PID1 |
0.928648500849651 |
|
23150 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4760 |
0.928711496292792 |
|
23151 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA51|ENSG00000207147.1 |
0.928711496292792 |
|
23152 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MRPS6 |
0.928756296704436 |
|
23153 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC5A3 |
0.928756296704436 |
|
23154 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00310 |
0.928756296704436 |
|
23155 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAPPC9 |
0.928949322848542 |
|
23156 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DOCK3 |
0.928989783017141 |
|
23157 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MANF |
0.928989783017141 |
|
23158 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RBM15B |
0.928989783017141 |
|
23159 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VPRBP |
0.928989783017141 |
|
23160 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAD54L2 |
0.928989783017141 |
|
23161 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNU6ATAC29P |
0.928989783017141 |
|
23162 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MYO1C |
0.929168500408467 |
|
23163 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
INPP5K |
0.929168500408467 |
|
23164 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR1D2 |
0.929310208770112 |
|
23165 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR1D5 |
0.929310208770112 |
|
23166 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR1G1 |
0.929310208770112 |
|
23167 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR1A2 |
0.929310208770112 |
|
23168 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR1A1 |
0.929310208770112 |
|
23169 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR1D4 |
0.929310208770112 |
|
23170 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR3A2 |
0.929310208770112 |
|
23171 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR3A1 |
0.929310208770112 |
|
23172 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EVI2B |
0.929327065410559 |
|
23173 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EVI2A |
0.929327065410559 |
|
23174 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAB11FIP4 |
0.929327065410559 |
|
23175 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR548W |
0.929484831151802 |
|
23176 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP405 |
0.929484831151802 |
|
23177 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OSBPL11 |
0.929806285926293 |
|
23178 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C1QL1 |
0.929808450008316 |
|
23179 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UBC |
0.92999008242529 |
|
23180 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR5188 |
0.92999008242529 |
|
23181 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KRT23 |
0.930011320597735 |
|
23182 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KRT39 |
0.930011320597735 |
|
23183 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KRT40 |
0.930011320597735 |
|
23184 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AMOT |
0.930302604168472 |
|
23185 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4329 |
0.930302604168472 |
|
23186 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL266P |
0.930302604168472 |
|
23187 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238811.1 |
0.930302604168472 |
|
23188 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PTENP1 |
0.930418521649563 |
|
23189 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRSS3 |
0.930418521649563 |
|
23190 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FLNB |
0.930598185102552 |
|
23191 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COL6A4P1 |
0.931078453469313 |
|
23192 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CAPN7 |
0.931078453469313 |
|
23193 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM163 |
0.93119390464057 |
|
23194 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAP3K19 |
0.93119390464057 |
|
23195 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAB3GAP1 |
0.93119390464057 |
|
23196 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238337.1 |
0.93119390464057 |
|
23197 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA40|ENSG00000208308.1 |
0.93119390464057 |
|
23198 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZRANB3 |
0.93119390464057 |
|
23199 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
APPL1 |
0.93163576316912 |
|
23200 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ASB14 |
0.93163576316912 |
|
23201 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC34 |
0.931675655329635 |
|
23202 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LGR4 |
0.931675655329635 |
|
23203 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LIN7C |
0.931675655329635 |
|
23204 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP339 |
0.931675655329635 |
|
23205 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NUFIP2 |
0.93172889430872 |
|
23206 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD18|ENSG00000200677.1 |
0.931929004354084 |
|
23207 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATP2B4 |
0.932479713307441 |
|
23208 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA77|ENSG00000221643.1 |
0.932479713307441 |
|
23209 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNRPE |
0.932479713307441 |
|
23210 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ABL1 |
0.93299155671223 |
|
23211 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DNAJC10 |
0.933522723239773 |
|
23212 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FRZB |
0.933522723239773 |
|
23213 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NCKAP1 |
0.933522723239773 |
|
23214 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA77|ENSG00000221498.1 |
0.933522723239773 |
|
23215 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DUSP19 |
0.933522723239773 |
|
23216 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CRLF3 |
0.933573025233156 |
|
23217 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRRC37BP1 |
0.933573025233156 |
|
23218 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL316P |
0.933573025233156 |
|
23219 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SUZ12P |
0.933573025233156 |
|
23220 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLCO3A1 |
0.933860105292837 |
|
23221 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR548F5 |
0.933914371722687 |
|
23222 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FABP5 |
0.933959390061934 |
|
23223 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DNER |
0.934175571344452 |
|
23224 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FBXO36 |
0.934175571344452 |
|
23225 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRIP12 |
0.934175571344452 |
|
23226 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC16A14 |
0.934175571344452 |
|
23227 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNY4P19 |
0.934175571344452 |
|
23228 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZEB2 |
0.934385975541904 |
|
23229 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DNAJC13 |
0.93456042172008 |
|
23230 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAGT1 |
0.93462335338133 |
|
23231 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL460P |
0.93462335338133 |
|
23232 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COX7B |
0.93462335338133 |
|
23233 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PGAM4 |
0.93462335338133 |
|
23234 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4778 |
0.934667943201848 |
|
23235 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DPP7 |
0.934778673899067 |
|
23236 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238824.1 |
0.934778673899067 |
|
23237 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TNNI1 |
0.934785558996037 |
|
23238 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PHLDA3 |
0.934785558996037 |
|
23239 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CSRP1 |
0.934785558996037 |
|
23240 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPS10P7 |
0.934785558996037 |
|
23241 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NAV1 |
0.934785558996037 |
|
23242 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR5191 |
0.934785558996037 |
|
23243 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR1231 |
0.934785558996037 |
|
23244 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IPO9 |
0.934785558996037 |
|
23245 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SHISA4 |
0.934785558996037 |
|
23246 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LMOD1 |
0.934785558996037 |
|
23247 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TIMM17A |
0.934785558996037 |
|
23248 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA70|ENSG00000206637.1 |
0.934785558996037 |
|
23249 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNPEP |
0.934785558996037 |
|
23250 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA70|ENSG00000206661.1 |
0.93481788950461 |
|
23251 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL318P |
0.93481788950461 |
|
23252 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR548I1 |
0.934906895855529 |
|
23253 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HSF5 |
0.93491809308227 |
|
23254 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLXDC1 |
0.934946695372893 |
|
23255 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARL5C |
0.934946695372893 |
|
23256 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATG7 |
0.935087328048092 |
|
23257 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4466 |
0.93511133678546 |
|
23258 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CALCOCO2 |
0.935297924464581 |
|
23259 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA68|ENSG00000212565.1 |
0.935297924464581 |
|
23260 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATP5G1 |
0.935297924464581 |
|
23261 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TOR1B |
0.935467480952672 |
|
23262 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DHX37 |
0.935635968202963 |
|
23263 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR205HG |
0.935640507403103 |
|
23264 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP131 |
0.935799751167929 |
|
23265 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GALNT15 |
0.936010431677459 |
|
23266 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DPH3 |
0.936010431677459 |
|
23267 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OXNAD1 |
0.936010431677459 |
|
23268 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RFTN1 |
0.936010431677459 |
|
23269 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00690 |
0.936010431677459 |
|
23270 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DAZL |
0.936010431677459 |
|
23271 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAK2 |
0.936131317907568 |
|
23272 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STRADB |
0.936131317907568 |
|
23273 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LGALSL |
0.936142930878723 |
|
23274 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AFTPH |
0.936142930878723 |
|
23275 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SERTAD2 |
0.936142930878723 |
|
23276 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL341P |
0.936142930878723 |
|
23277 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL211P |
0.936142930878723 |
|
23278 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238696.1 |
0.936142930878723 |
|
23279 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FANCL |
0.936276521339303 |
|
23280 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF304 |
0.936306803135399 |
|
23281 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DONSON |
0.936350015184081 |
|
23282 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CRYZL1 |
0.936350015184081 |
|
23283 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCG2 |
0.936562186641724 |
|
23284 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SERPINE2 |
0.936562186641724 |
|
23285 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C5orf15 |
0.936708716983864 |
|
23286 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VDAC1 |
0.936708716983864 |
|
23287 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TCF7 |
0.936708716983864 |
|
23288 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA5 |
0.936975693173033 |
|
23289 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NEIL3 |
0.936982846047768 |
|
23290 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AGA |
0.936982846047768 |
|
23291 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP172 |
0.936982846047768 |
|
23292 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ETS1 |
0.937094349895442 |
|
23293 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00903 |
0.937096219707206 |
|
23294 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SAMD12 |
0.937112341745087 |
|
23295 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AP1S3 |
0.937214086414466 |
|
23296 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SH3BP5 |
0.937267119303827 |
|
23297 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA31|ENSG00000252580.1 |
0.93737555121281 |
|
23298 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAMDC2 |
0.937389702845193 |
|
23299 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MMD |
0.937410020139697 |
|
23300 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP237 |
0.93754330399675 |
|
23301 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC6A1 |
0.937666472617427 |
|
23302 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MGARP |
0.937692267995523 |
|
23303 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UAP1L1 |
0.9378359583678 |
|
23304 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAN1B1 |
0.9378359583678 |
|
23305 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD62 |
0.9378359583678 |
|
23306 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00884 |
0.937844595521691 |
|
23307 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM44 |
0.937844595521691 |
|
23308 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LSG1 |
0.937844595521691 |
|
23309 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM43A |
0.937844595521691 |
|
23310 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
XXYLT1 |
0.937844595521691 |
|
23311 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3137 |
0.937844595521691 |
|
23312 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL36P |
0.937844595521691 |
|
23313 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CERS6 |
0.938024733439801 |
|
23314 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF444 |
0.938309948781859 |
|
23315 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GALP |
0.938309948781859 |
|
23316 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZSCAN5B |
0.938309948781859 |
|
23317 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD28|ENSG00000212295.1 |
0.938532480138262 |
|
23318 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARL17A |
0.938551403451267 |
|
23319 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARL17B |
0.938551403451267 |
|
23320 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CRHR1 |
0.938551403451267 |
|
23321 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM215B |
0.938551403451267 |
|
23322 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KANSL1 |
0.938551403451267 |
|
23323 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRRC37A2 |
0.938551403451267 |
|
23324 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRRC37A4P |
0.938551403451267 |
|
23325 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRRC37A |
0.938551403451267 |
|
23326 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAPT |
0.938551403451267 |
|
23327 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NSF |
0.938551403451267 |
|
23328 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLEKHM1 |
0.938551403451267 |
|
23329 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL199P |
0.938551403451267 |
|
23330 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL656P |
0.938551403451267 |
|
23331 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL730P |
0.938551403451267 |
|
23332 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL739P |
0.938551403451267 |
|
23333 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPPL2C |
0.938551403451267 |
|
23334 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STH |
0.938551403451267 |
|
23335 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C21orf54 |
0.938674408892725 |
|
23336 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IFNAR2 |
0.938674408892725 |
|
23337 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IL10RB |
0.938674408892725 |
|
23338 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IFNAR1 |
0.938674408892725 |
|
23339 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U8|ENSG00000253004.1 |
0.938717091583493 |
|
23340 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GAB1 |
0.938729335705214 |
|
23341 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SMARCA5 |
0.938729335705214 |
|
23342 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IDH2 |
0.938738848888612 |
|
23343 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRIG1 |
0.938819641634566 |
|
23344 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL447P |
0.938861680358719 |
|
23345 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP223 |
0.939094978964108 |
|
23346 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RBMX |
0.939443886219174 |
|
23347 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD61|ENSG00000206979.1 |
0.939443886219174 |
|
23348 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPR101 |
0.939443886219174 |
|
23349 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SH3KBP1 |
0.93947960330717 |
|
23350 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NLRP5 |
0.93956058208884 |
|
23351 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF787 |
0.93956058208884 |
|
23352 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GOSR1 |
0.939692708377717 |
|
23353 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TBC1D29 |
0.939692708377717 |
|
23354 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP73 |
0.939721732672214 |
|
23355 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP194 |
0.940059027547436 |
|
23356 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM203A |
0.94007169810336 |
|
23357 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MROH1 |
0.94007169810336 |
|
23358 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADCK5 |
0.94007169810336 |
|
23359 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARHGAP39 |
0.94007169810336 |
|
23360 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BOP1 |
0.94007169810336 |
|
23361 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C8orf33 |
0.94007169810336 |
|
23362 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C8orf82 |
0.94007169810336 |
|
23363 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COMMD5 |
0.94007169810336 |
|
23364 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CPSF1 |
0.94007169810336 |
|
23365 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CYHR1 |
0.94007169810336 |
|
23366 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DGAT1 |
0.94007169810336 |
|
23367 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM203B |
0.94007169810336 |
|
23368 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FBXL6 |
0.94007169810336 |
|
23369 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FOXH1 |
0.94007169810336 |
|
23370 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPT |
0.94007169810336 |
|
23371 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HSF1 |
0.94007169810336 |
|
23372 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIFC2 |
0.94007169810336 |
|
23373 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRRC14 |
0.94007169810336 |
|
23374 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRRC24 |
0.94007169810336 |
|
23375 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MFSD3 |
0.94007169810336 |
|
23376 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR1234 |
0.94007169810336 |
|
23377 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR939 |
0.94007169810336 |
|
23378 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPP1R16A |
0.94007169810336 |
|
23379 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RECQL4 |
0.94007169810336 |
|
23380 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL395P |
0.94007169810336 |
|
23381 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPL8 |
0.94007169810336 |
|
23382 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCRT1 |
0.94007169810336 |
|
23383 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCXA |
0.94007169810336 |
|
23384 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCXB |
0.94007169810336 |
|
23385 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC39A4 |
0.94007169810336 |
|
23386 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC52A2 |
0.94007169810336 |
|
23387 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM249 |
0.94007169810336 |
|
23388 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TONSL |
0.94007169810336 |
|
23389 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VPS28 |
0.94007169810336 |
|
23390 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF16 |
0.94007169810336 |
|
23391 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF250 |
0.94007169810336 |
|
23392 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF251 |
0.94007169810336 |
|
23393 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF252P |
0.94007169810336 |
|
23394 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF34 |
0.94007169810336 |
|
23395 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF517 |
0.94007169810336 |
|
23396 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF7 |
0.94007169810336 |
|
23397 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000239077.1 |
0.940073891512165 |
|
23398 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACTR3 |
0.940073891512165 |
|
23399 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U3|ENSG00000212182.1 |
0.940073891512165 |
|
23400 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARHGAP23 |
0.940213975940363 |
|
23401 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM124B |
0.940278961427536 |
|
23402 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DOCK10 |
0.940278961427536 |
|
23403 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4439 |
0.940278961427536 |
|
23404 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NYAP2 |
0.940278961427536 |
|
23405 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DNAJC28 |
0.940325063251358 |
|
23406 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACAD11 |
0.940679523669528 |
|
23407 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NPHP3 |
0.940679523669528 |
|
23408 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACKR4 |
0.940679523669528 |
|
23409 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IL31RA |
0.940716458891218 |
|
23410 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LMCD1 |
0.940756521364657 |
|
23411 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPL22P19 |
0.940932728964424 |
|
23412 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCNG2 |
0.94134240248811 |
|
23413 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL635P |
0.941471336955611 |
|
23414 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
Vault|ENSG00000251900.1 |
0.941471336955611 |
|
23415 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM205B |
0.941549311443663 |
|
23416 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD112|ENSG00000251801.1 |
0.94189110120983 |
|
23417 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF385B |
0.941907843987883 |
|
23418 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AGAP1 |
0.942212540028208 |
|
23419 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC4A1 |
0.942264587535694 |
|
23420 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL507P |
0.942264587535694 |
|
23421 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RUNDC3A |
0.942264587535694 |
|
23422 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U3|ENSG00000221496.1 |
0.942264587535694 |
|
23423 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GRIP2 |
0.942474029066188 |
|
23424 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR888 |
0.942510485851574 |
|
23425 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR890 |
0.942510485851574 |
|
23426 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR892A |
0.942510485851574 |
|
23427 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR892B |
0.942510485851574 |
|
23428 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR891B |
0.942510485851574 |
|
23429 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR891A |
0.942510485851574 |
|
23430 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLCH1 |
0.942547344277546 |
|
23431 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GCC2 |
0.942594571147685 |
|
23432 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL755P |
0.942698750473933 |
|
23433 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SEMA4B |
0.942698750473933 |
|
23434 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL346P |
0.942698750473933 |
|
23435 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CIB1 |
0.942698750473933 |
|
23436 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GDPGP1 |
0.942698750473933 |
|
23437 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TTLL13 |
0.942698750473933 |
|
23438 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NGRN |
0.942698750473933 |
|
23439 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL736P |
0.942698750473933 |
|
23440 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GABARAPL3 |
0.942698750473933 |
|
23441 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IQGAP1 |
0.942698750473933 |
|
23442 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF774 |
0.942698750473933 |
|
23443 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ALG1L |
0.942769021721053 |
|
23444 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM86JP |
0.942769021721053 |
|
23445 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ROPN1B |
0.942769021721053 |
|
23446 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC41A3 |
0.942769021721053 |
|
23447 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ALDH1L1 |
0.942769021721053 |
|
23448 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U1|ENSG00000272020.1 |
0.942769021721053 |
|
23449 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KLF15 |
0.942769021721053 |
|
23450 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC37 |
0.942769021721053 |
|
23451 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZXDC |
0.942769021721053 |
|
23452 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UROC1 |
0.942769021721053 |
|
23453 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C3orf22 |
0.942769021721053 |
|
23454 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CHST13 |
0.942769021721053 |
|
23455 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP138 |
0.942769021721053 |
|
23456 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TXNRD3NB |
0.942769021721053 |
|
23457 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TXNRD3 |
0.942769021721053 |
|
23458 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NUP210P1 |
0.942769021721053 |
|
23459 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NDST4 |
0.942797408796664 |
|
23460 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ULBP1 |
0.943000127231923 |
|
23461 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAET1K |
0.943000127231923 |
|
23462 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
G6PD |
0.943052980406594 |
|
23463 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RBM6 |
0.943314280102961 |
|
23464 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TNNT2 |
0.943324674412185 |
|
23465 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LAD1 |
0.943324674412185 |
|
23466 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLCO2A1 |
0.943355908145898 |
|
23467 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GBX2 |
0.943506772435075 |
|
23468 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ASB18 |
0.943506772435075 |
|
23469 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL808P |
0.943700292075222 |
|
23470 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EVPLL |
0.943794282541983 |
|
23471 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC144B |
0.943794282541983 |
|
23472 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM106A |
0.943794282541983 |
|
23473 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KRT16P1 |
0.943794282541983 |
|
23474 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KRT17P2 |
0.943794282541983 |
|
23475 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LGALS9C |
0.943794282541983 |
|
23476 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL639P |
0.943794282541983 |
|
23477 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TBC1D28 |
0.943794282541983 |
|
23478 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
USP32P2 |
0.943794282541983 |
|
23479 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF286B |
0.943794282541983 |
|
23480 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KDM3A |
0.943863505322403 |
|
23481 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ULBP3 |
0.943894161155763 |
|
23482 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238594.1 |
0.943894161155763 |
|
23483 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CT49 |
0.943930847945408 |
|
23484 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HRH1 |
0.944191729631149 |
|
23485 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACLY |
0.94419466315984 |
|
23486 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TTC25 |
0.94419466315984 |
|
23487 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UGT8 |
0.944322228123677 |
|
23488 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR577 |
0.944322228123677 |
|
23489 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZSCAN5A |
0.944463552329734 |
|
23490 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF542 |
0.944463552329734 |
|
23491 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF582 |
0.944463552329734 |
|
23492 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF583 |
0.944463552329734 |
|
23493 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SMIM17 |
0.944463552329734 |
|
23494 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF264 |
0.944463552329734 |
|
23495 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AURKC |
0.944463552329734 |
|
23496 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF805 |
0.944463552329734 |
|
23497 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UMPS |
0.944648768299653 |
|
23498 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR544B |
0.944648768299653 |
|
23499 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SAMD5 |
0.944730158025777 |
|
23500 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDK18 |
0.94503983743779 |
|
23501 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPATA3 |
0.945201657424532 |
|
23502 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C2orf72 |
0.945201657424532 |
|
23503 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM133A |
0.945244022019171 |
|
23504 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NAP1L3 |
0.945244022019171 |
|
23505 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TM4SF20 |
0.945366597798938 |
|
23506 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C3orf36 |
0.945649343920783 |
|
23507 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FHL2 |
0.945701109287827 |
|
23508 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDC25A |
0.945888445720258 |
|
23509 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4443 |
0.945888445720258 |
|
23510 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MTHFS |
0.946025919827073 |
|
23511 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COPG1 |
0.946099892770722 |
|
23512 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C9orf135 |
0.946339628393953 |
|
23513 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL570P |
0.946339628393953 |
|
23514 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GUSBP5 |
0.94638446546555 |
|
23515 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FREM3 |
0.94638446546555 |
|
23516 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP156 |
0.946386900442678 |
|
23517 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SMC5 |
0.946402239327771 |
|
23518 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KLF9 |
0.946402239327771 |
|
23519 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EXT1 |
0.946478508485206 |
|
23520 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SMU1 |
0.946502432368727 |
|
23521 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
B4GALT1 |
0.946502432368727 |
|
23522 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CMBL |
0.946761272566668 |
|
23523 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MARCH6 |
0.946761272566668 |
|
23524 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANKRD20A1 |
0.947202471376302 |
|
23525 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANKRD20A2 |
0.947202471376302 |
|
23526 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANKRD20A3 |
0.947202471376302 |
|
23527 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANKRD20A4 |
0.947202471376302 |
|
23528 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CBWD3 |
0.947202471376302 |
|
23529 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CBWD5 |
0.947202471376302 |
|
23530 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CBWD6 |
0.947202471376302 |
|
23531 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CBWD7 |
0.947202471376302 |
|
23532 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CNTNAP3B |
0.947202471376302 |
|
23533 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CNTNAP3 |
0.947202471376302 |
|
23534 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM27A |
0.947202471376302 |
|
23535 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM27B |
0.947202471376302 |
|
23536 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM27C |
0.947202471376302 |
|
23537 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM27D1 |
0.947202471376302 |
|
23538 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM27E1 |
0.947202471376302 |
|
23539 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM27E2 |
0.947202471376302 |
|
23540 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM27E3 |
0.947202471376302 |
|
23541 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM74A1 |
0.947202471376302 |
|
23542 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM74A2 |
0.947202471376302 |
|
23543 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM74A3 |
0.947202471376302 |
|
23544 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM74A4 |
0.947202471376302 |
|
23545 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM74A5 |
0.947202471376302 |
|
23546 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM74A6 |
0.947202471376302 |
|
23547 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM95B1 |
0.947202471376302 |
|
23548 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FOXD4L2 |
0.947202471376302 |
|
23549 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FOXD4L3 |
0.947202471376302 |
|
23550 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FOXD4L4 |
0.947202471376302 |
|
23551 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FOXD4L5 |
0.947202471376302 |
|
23552 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FOXD4L6 |
0.947202471376302 |
|
23553 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR1299 |
0.947202471376302 |
|
23554 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4477A |
0.947202471376302 |
|
23555 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PGM5P2 |
0.947202471376302 |
|
23556 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL343P |
0.947202471376302 |
|
23557 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL422P |
0.947202471376302 |
|
23558 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL462P |
0.947202471376302 |
|
23559 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL544P |
0.947202471376302 |
|
23560 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL565P |
0.947202471376302 |
|
23561 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL640P |
0.947202471376302 |
|
23562 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL722P |
0.947202471376302 |
|
23563 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL763P |
0.947202471376302 |
|
23564 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL787P |
0.947202471376302 |
|
23565 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP283 |
0.947202471376302 |
|
23566 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP284 |
0.947202471376302 |
|
23567 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA70|ENSG00000252133.1 |
0.947202471376302 |
|
23568 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA70|ENSG00000252617.1 |
0.947202471376302 |
|
23569 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA70|ENSG00000252724.1 |
0.947202471376302 |
|
23570 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA70|ENSG00000252878.1 |
0.947202471376302 |
|
23571 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPATA31A1 |
0.947202471376302 |
|
23572 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPATA31A2 |
0.947202471376302 |
|
23573 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPATA31A3 |
0.947202471376302 |
|
23574 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPATA31A4 |
0.947202471376302 |
|
23575 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPATA31A5 |
0.947202471376302 |
|
23576 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPATA31A6 |
0.947202471376302 |
|
23577 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPATA31A7 |
0.947202471376302 |
|
23578 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF658 |
0.947202471376302 |
|
23579 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238566.1 |
0.947359107052457 |
|
23580 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRRCC1 |
0.947359107052457 |
|
23581 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UGP2 |
0.947701980820509 |
|
23582 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACA59|ENSG00000251775.1 |
0.947701980820509 |
|
23583 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VPS54 |
0.947701980820509 |
|
23584 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PELI1 |
0.947701980820509 |
|
23585 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00309 |
0.947701980820509 |
|
23586 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KLHL18 |
0.947709350252197 |
|
23587 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SMIM12 |
0.94776957706849 |
|
23588 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DLGAP3 |
0.94776957706849 |
|
23589 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD112|ENSG00000252728.1 |
0.94776957706849 |
|
23590 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZMYM6NB |
0.94776957706849 |
|
23591 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZMYM6 |
0.94776957706849 |
|
23592 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3915 |
0.947816460304775 |
|
23593 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STXBP5 |
0.947937928153369 |
|
23594 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GNAI2 |
0.948103559213909 |
|
23595 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SEMA3B |
0.948103559213909 |
|
23596 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LSMEM2 |
0.948103559213909 |
|
23597 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IFRD2 |
0.948103559213909 |
|
23598 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HYAL3 |
0.948103559213909 |
|
23599 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HYAL1 |
0.948103559213909 |
|
23600 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NAT6 |
0.948103559213909 |
|
23601 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HYAL2 |
0.948103559213909 |
|
23602 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR28 |
0.948315329014762 |
|
23603 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MYO18A |
0.948397396613427 |
|
23604 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CRYBA1 |
0.948397396613427 |
|
23605 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL814P |
0.948547932817163 |
|
23606 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UBA5 |
0.94894088291289 |
|
23607 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TOR1A |
0.94903036190676 |
|
23608 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C9orf78 |
0.94903036190676 |
|
23609 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
USP20 |
0.94903036190676 |
|
23610 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FNBP1 |
0.94903036190676 |
|
23611 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZIM2 |
0.949087137335015 |
|
23612 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PEG3 |
0.949087137335015 |
|
23613 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM108 |
0.949240355430649 |
|
23614 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDV3 |
0.949240355430649 |
|
23615 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TOPBP1 |
0.949240355430649 |
|
23616 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TFP1 |
0.949240355430649 |
|
23617 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP140 |
0.949240355430649 |
|
23618 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TF |
0.949240355430649 |
|
23619 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GYPA |
0.949330455692917 |
|
23620 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GYPB |
0.949330455692917 |
|
23621 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GYPE |
0.949330455692917 |
|
23622 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EIF3H |
0.949384835738295 |
|
23623 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UTP23 |
0.949384835738295 |
|
23624 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAD21 |
0.949384835738295 |
|
23625 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3610 |
0.949384835738295 |
|
23626 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AARD |
0.949384835738295 |
|
23627 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SEPT11 |
0.949671124848207 |
|
23628 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCNI |
0.949671124848207 |
|
23629 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR944 |
0.949904235696945 |
|
23630 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LEPREL1 |
0.949904235696945 |
|
23631 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL486P |
0.949904235696945 |
|
23632 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLDN1 |
0.949904235696945 |
|
23633 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLDN16 |
0.949904235696945 |
|
23634 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM207 |
0.949904235696945 |
|
23635 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IL1RAP |
0.949904235696945 |
|
23636 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP296 |
0.949904235696945 |
|
23637 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RYK |
0.949905420726926 |
|
23638 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SRPRB |
0.949935771006712 |
|
23639 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAB6B |
0.949935771006712 |
|
23640 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TUSC2 |
0.949942298757677 |
|
23641 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RASSF1 |
0.949942298757677 |
|
23642 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZMYND10 |
0.949942298757677 |
|
23643 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NPRL2 |
0.949942298757677 |
|
23644 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CYB561D2 |
0.949942298757677 |
|
23645 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM115 |
0.949942298757677 |
|
23646 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNU4ATAC15P |
0.950097611579384 |
|
23647 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPINK4 |
0.950097611579384 |
|
23648 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BAG1 |
0.950097611579384 |
|
23649 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNU4ATAC17P |
0.950230602380535 |
|
23650 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HSPB3 |
0.950420421687631 |
|
23651 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00312 |
0.950527474147102 |
|
23652 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CAMK1G |
0.950824679807814 |
|
23653 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LAMB3 |
0.950824679807814 |
|
23654 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4260 |
0.950824679807814 |
|
23655 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP47 |
0.950907430334031 |
|
23656 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNY4P1 |
0.950907430334031 |
|
23657 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C9orf40 |
0.950907430334031 |
|
23658 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C9orf41 |
0.950907430334031 |
|
23659 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NMRK1 |
0.950907430334031 |
|
23660 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OSTF1 |
0.950907430334031 |
|
23661 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238598.1 |
0.950907430334031 |
|
23662 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCSK5 |
0.950907430334031 |
|
23663 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RFK |
0.950907430334031 |
|
23664 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FOXB2 |
0.950907430334031 |
|
23665 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CHMP5 |
0.950962339086225 |
|
23666 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NFX1 |
0.950962339086225 |
|
23667 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AQP7 |
0.950962339086225 |
|
23668 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MSL2 |
0.951050792220112 |
|
23669 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SERPINF1 |
0.951349529806053 |
|
23670 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SMYD4 |
0.951349529806053 |
|
23671 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPA1 |
0.951349529806053 |
|
23672 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COL6A4P2 |
0.951478810374506 |
|
23673 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COL6A5 |
0.951478810374506 |
|
23674 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IYD |
0.951594933988735 |
|
23675 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ERICH1 |
0.951625153339456 |
|
23676 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADAMTS15 |
0.951714235666391 |
|
23677 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ABHD2 |
0.952120962173868 |
|
23678 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RLBP1 |
0.952120962173868 |
|
23679 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FANCI |
0.952120962173868 |
|
23680 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
POLG |
0.952120962173868 |
|
23681 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATOX1 |
0.952129637113921 |
|
23682 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SP110 |
0.952149717250833 |
|
23683 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SP140 |
0.952149717250833 |
|
23684 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SP140L |
0.952149717250833 |
|
23685 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SP100 |
0.952149717250833 |
|
23686 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL834P |
0.952149717250833 |
|
23687 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WNT3 |
0.952193450736571 |
|
23688 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP119 |
0.952221664455845 |
|
23689 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DNAJC19 |
0.952226377548785 |
|
23690 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA33|ENSG00000252045.1 |
0.952259898784016 |
|
23691 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VPS13A |
0.952420595629521 |
|
23692 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DIAPH2 |
0.952554068855642 |
|
23693 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CTNND2 |
0.952724136103662 |
|
23694 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C9orf114 |
0.952761084129311 |
|
23695 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ENDOG |
0.952761084129311 |
|
23696 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCBL1 |
0.952761084129311 |
|
23697 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRRC8A |
0.952761084129311 |
|
23698 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPP1R1C |
0.952993253942635 |
|
23699 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP113 |
0.952993253942635 |
|
23700 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL267P |
0.952993253942635 |
|
23701 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MRPL44 |
0.953329384081876 |
|
23702 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LEPREL4 |
0.953432359752628 |
|
23703 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FKBP10 |
0.953432359752628 |
|
23704 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RECK |
0.953503073673427 |
|
23705 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GLIPR2 |
0.953503073673427 |
|
23706 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCIN |
0.953503073673427 |
|
23707 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR5692C1 |
0.953817413914281 |
|
23708 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DCTD |
0.953922880115567 |
|
23709 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM92A1P2 |
0.953922880115567 |
|
23710 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP67 |
0.953922880115567 |
|
23711 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U3|ENSG00000252048.1 |
0.953922880115567 |
|
23712 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238319.1 |
0.953922880115567 |
|
23713 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FUNDC2P2 |
0.954017149453427 |
|
23714 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SUCLG1 |
0.954017149453427 |
|
23715 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TBC1D8 |
0.954026454034547 |
|
23716 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CNOT11 |
0.954026454034547 |
|
23717 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TPRG1 |
0.954058641411351 |
|
23718 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RGP1 |
0.954095025982462 |
|
23719 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MSMP |
0.954095025982462 |
|
23720 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NPR2 |
0.954095025982462 |
|
23721 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPAG8 |
0.954095025982462 |
|
23722 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM221B |
0.954095025982462 |
|
23723 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HINT2 |
0.954095025982462 |
|
23724 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM8B |
0.954095025982462 |
|
23725 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR13J1 |
0.954095025982462 |
|
23726 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HRCT1 |
0.954095025982462 |
|
23727 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00961 |
0.954095025982462 |
|
23728 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR2S2 |
0.954095025982462 |
|
23729 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP94 |
0.954612347465799 |
|
23730 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MRPS23 |
0.954612347465799 |
|
23731 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TIAF1 |
0.954693304175517 |
|
23732 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NUP214 |
0.954938451257861 |
|
23733 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM78A |
0.954938451257861 |
|
23734 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD62A |
0.954938451257861 |
|
23735 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD62B |
0.954938451257861 |
|
23736 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
POMT1 |
0.954938451257861 |
|
23737 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UCK1 |
0.954938451257861 |
|
23738 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAPGEF1 |
0.954938451257861 |
|
23739 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GMNC |
0.955057068777091 |
|
23740 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MRPL45 |
0.955192502135376 |
|
23741 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPR179 |
0.955192502135376 |
|
23742 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SOCS7 |
0.955192502135376 |
|
23743 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL458P |
0.955192502135376 |
|
23744 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP501 |
0.955613234292307 |
|
23745 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL541P |
0.955675878271792 |
|
23746 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PHF15 |
0.955675878271792 |
|
23747 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SAR1B |
0.955675878271792 |
|
23748 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCBD2 |
0.955675878271792 |
|
23749 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4461 |
0.955675878271792 |
|
23750 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CATSPER3 |
0.955675878271792 |
|
23751 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PITX1 |
0.955675878271792 |
|
23752 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FKSG68 |
0.955784850724958 |
|
23753 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C17orf104 |
0.955856161598187 |
|
23754 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC43 |
0.955856161598187 |
|
23755 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DBF4B |
0.955856161598187 |
|
23756 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL819P |
0.955856161598187 |
|
23757 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADAM11 |
0.955856161598187 |
|
23758 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GJC1 |
0.955856161598187 |
|
23759 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OSTN |
0.955923326539207 |
|
23760 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UTS2B |
0.955923326539207 |
|
23761 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC50 |
0.955923326539207 |
|
23762 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR548M |
0.955925457248294 |
|
23763 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL379P |
0.955925457248294 |
|
23764 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP510 |
0.955925457248294 |
|
23765 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR601 |
0.956176250064353 |
|
23766 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EGFEM1P |
0.95637895055018 |
|
23767 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNU6ATAC3P |
0.956400568345998 |
|
23768 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IL10 |
0.956404274500242 |
|
23769 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4523 |
0.95683871929029 |
|
23770 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC25A48 |
0.957184321198198 |
|
23771 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IL9 |
0.957184321198198 |
|
23772 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LECT2 |
0.957184321198198 |
|
23773 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FBXL21 |
0.957184321198198 |
|
23774 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CYB5R1 |
0.957246359294938 |
|
23775 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM183A |
0.957246359294938 |
|
23776 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPFIA4 |
0.957246359294938 |
|
23777 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MYOG |
0.957246359294938 |
|
23778 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IL13 |
0.957261043077066 |
|
23779 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IL4 |
0.957261043077066 |
|
23780 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIF3A |
0.957261043077066 |
|
23781 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCNI2 |
0.957261043077066 |
|
23782 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SEPT8 |
0.957261043077066 |
|
23783 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SOWAHA |
0.957261043077066 |
|
23784 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SHROOM1 |
0.957261043077066 |
|
23785 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CAB39 |
0.957387207230095 |
|
23786 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ITM2C |
0.957387207230095 |
|
23787 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPR55 |
0.957387207230095 |
|
23788 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PSMD1 |
0.957387207230095 |
|
23789 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HTR2B |
0.957387207230095 |
|
23790 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARMC9 |
0.957387207230095 |
|
23791 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4777 |
0.957387207230095 |
|
23792 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM5C |
0.957583005860429 |
|
23793 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPR107 |
0.957813841261789 |
|
23794 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NCS1 |
0.957813841261789 |
|
23795 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HMCN2 |
0.957813841261789 |
|
23796 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL665P |
0.957813841261789 |
|
23797 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ASS1 |
0.957813841261789 |
|
23798 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238298.1 |
0.957813841261789 |
|
23799 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
APLP2 |
0.957896902122487 |
|
23800 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ST14 |
0.957896902122487 |
|
23801 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZBTB44 |
0.957896902122487 |
|
23802 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNY5P4 |
0.958025021981351 |
|
23803 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DIRC2 |
0.958115253511957 |
|
23804 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SEMA5B |
0.958115253511957 |
|
23805 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SEC22A |
0.958115253511957 |
|
23806 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADCY5 |
0.958115253511957 |
|
23807 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CHMP3 |
0.958268521785954 |
|
23808 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNF103 |
0.958268521785954 |
|
23809 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HS3ST4 |
0.958331359374084 |
|
23810 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00500 |
0.958493630502694 |
|
23811 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCRN4L |
0.958493630502694 |
|
23812 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ELF2 |
0.958493630502694 |
|
23813 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL382P |
0.958493630502694 |
|
23814 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL311P |
0.958493630502694 |
|
23815 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP124 |
0.95910537746073 |
|
23816 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM160A1 |
0.959110469968392 |
|
23817 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP35 |
0.959110469968392 |
|
23818 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PET112 |
0.959110469968392 |
|
23819 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FSTL4 |
0.95922408750388 |
|
23820 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238796.1 |
0.95922408750388 |
|
23821 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SKP1 |
0.95922408750388 |
|
23822 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPP2CA |
0.95922408750388 |
|
23823 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDKL3 |
0.95922408750388 |
|
23824 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3661 |
0.95922408750388 |
|
23825 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UBE2B |
0.95922408750388 |
|
23826 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDKN2AIPNL |
0.95922408750388 |
|
23827 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPANXN2 |
0.959336907923195 |
|
23828 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MEIS1 |
0.959643415526156 |
|
23829 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARHGEF28 |
0.959657757791063 |
|
23830 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MED27 |
0.959661851000049 |
|
23831 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RMND5A |
0.959687477904717 |
|
23832 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CD8A |
0.959687477904717 |
|
23833 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CD8B |
0.959687477904717 |
|
23834 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SMG6 |
0.960047633671952 |
|
23835 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SRR |
0.960047633671952 |
|
23836 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD91A |
0.960047633671952 |
|
23837 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD91B |
0.960047633671952 |
|
23838 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TSR1 |
0.960047633671952 |
|
23839 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SGSM2 |
0.960047633671952 |
|
23840 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
METTL16 |
0.960047633671952 |
|
23841 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATAD5 |
0.960095377304708 |
|
23842 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC25A26 |
0.96018650516236 |
|
23843 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL482P |
0.96018650516236 |
|
23844 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPP2R3A |
0.960432976919629 |
|
23845 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HHAT |
0.960476363017737 |
|
23846 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM2 |
0.960557581356881 |
|
23847 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TEFM |
0.960674190919987 |
|
23848 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADAP2 |
0.960674190919987 |
|
23849 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL138P |
0.960674190919987 |
|
23850 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KRT33A |
0.960690396090826 |
|
23851 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KRT33B |
0.960690396090826 |
|
23852 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KRT31 |
0.960690396090826 |
|
23853 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KRT34 |
0.960690396090826 |
|
23854 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KRT37 |
0.960690396090826 |
|
23855 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ROPN1L |
0.960774789334544 |
|
23856 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANKRD33B |
0.960774789334544 |
|
23857 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DAP |
0.960774789334544 |
|
23858 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00303 |
0.960809752522637 |
|
23859 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SOX13 |
0.960809752522637 |
|
23860 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ETNK2 |
0.960809752522637 |
|
23861 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP74 |
0.960809752522637 |
|
23862 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CFLAR |
0.960994664208075 |
|
23863 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RBM45 |
0.961631901069163 |
|
23864 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OSBPL6 |
0.961631901069163 |
|
23865 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TTN |
0.961631901069163 |
|
23866 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
QRFP |
0.961779128206912 |
|
23867 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FIBCD1 |
0.961779128206912 |
|
23868 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LAMC3 |
0.961779128206912 |
|
23869 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA31|ENSG00000252582.1 |
0.961779128206912 |
|
23870 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AIF1L |
0.961779128206912 |
|
23871 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL328P |
0.961779128206912 |
|
23872 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA67|ENSG00000212395.1 |
0.961779128206912 |
|
23873 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TAB2 |
0.961945429212082 |
|
23874 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL234P |
0.961945429212082 |
|
23875 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SUMO4 |
0.961945429212082 |
|
23876 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP281 |
0.962021726871999 |
|
23877 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCDH10 |
0.962124043522437 |
|
23878 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BRI3BP |
0.962417059496118 |
|
23879 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AACS |
0.962417059496118 |
|
23880 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ODF2 |
0.962525896188233 |
|
23881 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NUP35 |
0.962938341136431 |
|
23882 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP283 |
0.963233521414804 |
|
23883 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MGMT |
0.963261252131767 |
|
23884 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PIP5K1B |
0.96332644362039 |
|
23885 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZC3H12D |
0.963501103112394 |
|
23886 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ABCE1 |
0.963662894272273 |
|
23887 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OTUD4 |
0.963662894272273 |
|
23888 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C4orf51 |
0.963662894272273 |
|
23889 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF827 |
0.963662894272273 |
|
23890 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PTPN14 |
0.963737023563814 |
|
23891 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NT5C3AP1 |
0.963759237349807 |
|
23892 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
POLR1A |
0.963766765673384 |
|
23893 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IMMT |
0.963766765673384 |
|
23894 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4779 |
0.963766765673384 |
|
23895 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MRPL35 |
0.963766765673384 |
|
23896 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PTCD3 |
0.963766765673384 |
|
23897 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
REEP1 |
0.963766765673384 |
|
23898 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD94 |
0.963766765673384 |
|
23899 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U8|ENSG00000202537.1 |
0.963766765673384 |
|
23900 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA19|ENSG00000251974.1 |
0.963766765673384 |
|
23901 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA24|ENSG00000207130.1 |
0.963901565448811 |
|
23902 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAB7A |
0.963901565448811 |
|
23903 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL698P |
0.963901565448811 |
|
23904 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACAD9 |
0.963901565448811 |
|
23905 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIAA1257 |
0.963901565448811 |
|
23906 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EFCC1 |
0.963901565448811 |
|
23907 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GP9 |
0.963901565448811 |
|
23908 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000252435.1 |
0.963901565448811 |
|
23909 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238874.1 |
0.963901565448811 |
|
23910 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAB43 |
0.963901565448811 |
|
23911 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ISY1 |
0.963901565448811 |
|
23912 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPAPDC3 |
0.963916878078189 |
|
23913 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRRC2B |
0.963916878078189 |
|
23914 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UBE2QL1 |
0.964028299875978 |
|
23915 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NSUN2 |
0.964028299875978 |
|
23916 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SRD5A1 |
0.964028299875978 |
|
23917 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PAPD7 |
0.964028299875978 |
|
23918 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP79 |
0.964028299875978 |
|
23919 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP176 |
0.964028299875978 |
|
23920 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADCY2 |
0.964028299875978 |
|
23921 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C5orf49 |
0.964028299875978 |
|
23922 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MTRR |
0.964028299875978 |
|
23923 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FASTKD3 |
0.964028299875978 |
|
23924 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KLHDC8A |
0.964324624187302 |
|
23925 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LEMD1 |
0.964324624187302 |
|
23926 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP192 |
0.964547665925321 |
|
23927 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GDF9 |
0.964547665925321 |
|
23928 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UQCRQ |
0.964547665925321 |
|
23929 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LEAP2 |
0.964547665925321 |
|
23930 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AFF4 |
0.964547665925321 |
|
23931 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP112 |
0.964749444164371 |
|
23932 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HNRNPA3 |
0.964749444164371 |
|
23933 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NFE2L2 |
0.964749444164371 |
|
23934 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3128 |
0.964749444164371 |
|
23935 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238295.1 |
0.964749444164371 |
|
23936 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCCB |
0.964990212922764 |
|
23937 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TENM3 |
0.96502459999218 |
|
23938 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RBBP5 |
0.965034800605711 |
|
23939 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DSTYK |
0.965034800605711 |
|
23940 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EZR |
0.965218046494798 |
|
23941 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3918 |
0.965218046494798 |
|
23942 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OSTCP1 |
0.965218046494798 |
|
23943 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C6orf99 |
0.965218046494798 |
|
23944 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RSPH3 |
0.965218046494798 |
|
23945 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TAGAP |
0.965218046494798 |
|
23946 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FNDC1 |
0.965218046494798 |
|
23947 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SV2B |
0.965289565091406 |
|
23948 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL159P |
0.965516585770616 |
|
23949 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SOX2 |
0.96553024105176 |
|
23950 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP286 |
0.965829244439252 |
|
23951 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC141 |
0.965906805491976 |
|
23952 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACA59|ENSG00000252000.1 |
0.965906805491976 |
|
23953 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SESTD1 |
0.965906805491976 |
|
23954 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238339.1 |
0.965906805491976 |
|
23955 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RMDN1 |
0.966060885872905 |
|
23956 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CPNE3 |
0.966060885872905 |
|
23957 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CNGB3 |
0.966060885872905 |
|
23958 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TBC1D3F |
0.966091772497721 |
|
23959 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TBC1D3 |
0.966091772497721 |
|
23960 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPATA4 |
0.96610712642121 |
|
23961 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ITGB5 |
0.966127627827749 |
|
23962 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MUC13 |
0.966127627827749 |
|
23963 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DCAF4L2 |
0.966184871621253 |
|
23964 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC39 |
0.96649132076176 |
|
23965 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FXR1 |
0.96649132076176 |
|
23966 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C3orf18 |
0.96650504597709 |
|
23967 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HEMK1 |
0.96650504597709 |
|
23968 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GFM2 |
0.966764583567517 |
|
23969 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NSA2 |
0.966764583567517 |
|
23970 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM169A |
0.966764583567517 |
|
23971 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MED10 |
0.966829987216361 |
|
23972 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SEMA5A |
0.966829987216361 |
|
23973 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4636 |
0.966829987216361 |
|
23974 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD123 |
0.966829987216361 |
|
23975 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TAS2R1 |
0.966829987216361 |
|
23976 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP177 |
0.966829987216361 |
|
23977 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM173B |
0.966829987216361 |
|
23978 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCT5 |
0.966829987216361 |
|
23979 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MESP2 |
0.966928475755491 |
|
23980 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DCAKD |
0.966945662485481 |
|
23981 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00613 |
0.966980473411237 |
|
23982 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00649 |
0.967028465665502 |
|
23983 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FOXD1 |
0.967150645377412 |
|
23984 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BTF3 |
0.967150645377412 |
|
23985 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANKRA2 |
0.967150645377412 |
|
23986 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UTP15 |
0.967150645377412 |
|
23987 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NFASC |
0.967280974368254 |
|
23988 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PITPNA |
0.967624350856596 |
|
23989 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
THSD7B |
0.967690849467815 |
|
23990 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAM1L1 |
0.967792003729275 |
|
23991 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4458 |
0.967996996364073 |
|
23992 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PTPLB |
0.968015733031013 |
|
23993 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IL9R|ENSG00000124334.12 |
0.968184330995531 |
|
23994 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPRY3|ENSG00000168939.6 |
0.968184330995531 |
|
23995 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VAMP7|ENSG00000124333.10 |
0.968184330995531 |
|
23996 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WASH6P|ENSG00000182484.10 |
0.968184330995531 |
|
23997 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WASIR1|ENSG00000185203.7
|
0.968184330995531
|
|
23998 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA40|ENSG00000212363.1 |
0.968298168020049 |
|
23999 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GCNT4 |
0.968298168020049 |
|
24000 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANKRD31 |
0.968298168020049 |
|
24001 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COL4A3BP |
0.968298168020049 |
|
24002 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HMGCR |
0.968298168020049 |
|
24003 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
F2R |
0.968298168020049 |
|
24004 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
F2RL1 |
0.968298168020049 |
|
24005 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL208P |
0.968298168020049 |
|
24006 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238688.1 |
0.968298168020049 |
|
24007 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
S100Z |
0.968298168020049 |
|
24008 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNU6ATAC36P |
0.968298168020049 |
|
24009 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CRHBP |
0.968298168020049 |
|
24010 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AGGF1 |
0.968298168020049 |
|
24011 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZBED3 |
0.968298168020049 |
|
24012 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA47 |
0.968298168020049 |
|
24013 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PDE8B |
0.968298168020049 |
|
24014 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WDR41 |
0.968298168020049 |
|
24015 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OTP |
0.968298168020049 |
|
24016 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MFSD4 |
0.968447971860415 |
|
24017 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ELK4 |
0.968447971860415 |
|
24018 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC45A3 |
0.968447971860415 |
|
24019 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EFCAB12 |
0.968758586012981 |
|
24020 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MBD4 |
0.968758586012981 |
|
24021 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IFT122 |
0.968758586012981 |
|
24022 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UBL7 |
0.96923113806411 |
|
24023 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD77|ENSG00000212279.2 |
0.96923113806411 |
|
24024 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STAG1 |
0.969422771897122 |
|
24025 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA31|ENSG00000252852.1 |
0.969854517427733 |
|
24026 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MED30 |
0.969854517427733 |
|
24027 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IL5 |
0.969971125444116 |
|
24028 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NR5A1 |
0.970095959869871 |
|
24029 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NR6A1 |
0.970095959869871 |
|
24030 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL302P |
0.970095959869871 |
|
24031 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR181A2HG |
0.970095959869871 |
|
24032 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR181A2 |
0.970095959869871 |
|
24033 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR181B2 |
0.970095959869871 |
|
24034 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DNAH6 |
0.970159161837393 |
|
24035 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IGF2BP2 |
0.970345247855281 |
|
24036 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C3orf65 |
0.970345247855281 |
|
24037 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR548AQ |
0.970345247855281 |
|
24038 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRA2B |
0.970345247855281 |
|
24039 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL637P |
0.970345247855281 |
|
24040 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAPKAPK3 |
0.97054288312946 |
|
24041 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4787 |
0.97054288312946 |
|
24042 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP142 |
0.970571184668816 |
|
24043 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SOX14 |
0.970571184668816 |
|
24044 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLDN18 |
0.970571184668816 |
|
24045 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
A4GNT |
0.970571184668816 |
|
24046 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DZIP1L |
0.970571184668816 |
|
24047 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DBR1 |
0.970571184668816 |
|
24048 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARMC8 |
0.970571184668816 |
|
24049 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NME9 |
0.970571184668816 |
|
24050 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPOPL |
0.970804811320726 |
|
24051 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NXPH2 |
0.970804811320726 |
|
24052 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP286 |
0.970804811320726 |
|
24053 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WWC2 |
0.970998777174337 |
|
24054 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLDN22 |
0.970998777174337 |
|
24055 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLDN24 |
0.970998777174337 |
|
24056 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238596.1 |
0.970998777174337 |
|
24057 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CDKN2AIP |
0.970998777174337 |
|
24058 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ING2 |
0.970998777174337 |
|
24059 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000239116.1 |
0.970998777174337 |
|
24060 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ENPP6 |
0.970998777174337 |
|
24061 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RWDD4 |
0.970998777174337 |
|
24062 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STOX2 |
0.970998777174337 |
|
24063 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAPPC11 |
0.970998777174337 |
|
24064 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL28P |
0.970998777174337 |
|
24065 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IRF2 |
0.970998777174337 |
|
24066 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD79 |
0.970998777174337 |
|
24067 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CASP3 |
0.970998777174337 |
|
24068 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC111 |
0.970998777174337 |
|
24069 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MLF1IP |
0.970998777174337 |
|
24070 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PDE11A |
0.971194251244565 |
|
24071 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PYDC2 |
0.971251674699534 |
|
24072 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NT5C3B |
0.97130380542656 |
|
24073 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KLHL10 |
0.97130380542656 |
|
24074 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL871P |
0.97130380542656 |
|
24075 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KLHL11 |
0.97130380542656 |
|
24076 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLMAP |
0.971382595850761 |
|
24077 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WNT7A |
0.97155891086618 |
|
24078 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRRN2 |
0.9716801654561 |
|
24079 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP75 |
0.9716801654561 |
|
24080 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCARNA20|ENSG00000251861.1 |
0.9716801654561 |
|
24081 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD112|ENSG00000252946.1 |
0.9716801654561 |
|
24082 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAD2L1 |
0.97171011347327 |
|
24083 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM117A |
0.971742276683474 |
|
24084 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KAT7 |
0.971742276683474 |
|
24085 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRKACG |
0.971807749554958 |
|
24086 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPR37L1 |
0.971846424045367 |
|
24087 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARL8A |
0.971846424045367 |
|
24088 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PTPN7 |
0.971846424045367 |
|
24089 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HOMER2 |
0.972068986854795 |
|
24090 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C9orf173 |
0.972263579002753 |
|
24091 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NELFB |
0.972263579002753 |
|
24092 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EXD3 |
0.972263579002753 |
|
24093 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NRARP |
0.972263579002753 |
|
24094 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TOR4A |
0.972263579002753 |
|
24095 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OLFML2A |
0.97228837617094 |
|
24096 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IL1B |
0.972337055455915 |
|
24097 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNY4P4 |
0.97276625439719 |
|
24098 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DLGAP2 |
0.972988813012403 |
|
24099 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UGT1A10 |
0.973153459058445 |
|
24100 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UGT1A8 |
0.973153459058445 |
|
24101 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UGT1A9 |
0.973153459058445 |
|
24102 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UGT1A7 |
0.973153459058445 |
|
24103 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UGT1A6 |
0.973153459058445 |
|
24104 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UGT1A5 |
0.973153459058445 |
|
24105 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UGT1A4 |
0.973153459058445 |
|
24106 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UGT1A3 |
0.973153459058445 |
|
24107 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DNAJB3 |
0.973153459058445 |
|
24108 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UGT1A1 |
0.973153459058445 |
|
24109 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MROH2A |
0.973153459058445 |
|
24110 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HJURP |
0.973153459058445 |
|
24111 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MSL3P1 |
0.973153459058445 |
|
24112 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EVA1C |
0.97352011481527 |
|
24113 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAD51 |
0.973530125237492 |
|
24114 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RMDN3 |
0.973530125237492 |
|
24115 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GCHFR |
0.973530125237492 |
|
24116 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C15orf62 |
0.973530125237492 |
|
24117 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DNAJC17 |
0.973530125237492 |
|
24118 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZFYVE19 |
0.973530125237492 |
|
24119 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPP1R14D |
0.973530125237492 |
|
24120 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPINT1 |
0.973530125237492 |
|
24121 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RHOV |
0.973530125237492 |
|
24122 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VPS18 |
0.973530125237492 |
|
24123 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DLL4 |
0.973530125237492 |
|
24124 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CHAC1 |
0.973530125237492 |
|
24125 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
INO80 |
0.973530125237492 |
|
24126 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IFNGR2 |
0.973880628016231 |
|
24127 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM50B |
0.973880628016231 |
|
24128 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NUAK2 |
0.973957990922135 |
|
24129 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR135B |
0.973957990922135 |
|
24130 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HEG1 |
0.973979478637062 |
|
24131 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP137 |
0.973979478637062 |
|
24132 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IL36A |
0.974164098583506 |
|
24133 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IL1RN |
0.974164098583506 |
|
24134 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PSD4 |
0.974164098583506 |
|
24135 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ERBB2IP |
0.974304171289898 |
|
24136 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SREK1 |
0.974304171289898 |
|
24137 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238400.1 |
0.974304171289898 |
|
24138 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR1280 |
0.974334790808323 |
|
24139 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DNAJB8 |
0.974334790808323 |
|
24140 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GATA2 |
0.974334790808323 |
|
24141 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C3orf27 |
0.974334790808323 |
|
24142 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPN1 |
0.974334790808323 |
|
24143 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PABPC4L |
0.974345702111885 |
|
24144 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TOPORS |
0.974362641377195 |
|
24145 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NDUFB6 |
0.974362641377195 |
|
24146 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GVQW1 |
0.974362641377195 |
|
24147 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM215 |
0.974362641377195 |
|
24148 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SSUH2 |
0.974565213020884 |
|
24149 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CAV3 |
0.974565213020884 |
|
24150 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OXTR |
0.974565213020884 |
|
24151 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAD18 |
0.974565213020884 |
|
24152 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DNAI1 |
0.974620317202374 |
|
24153 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP24 |
0.974620317202374 |
|
24154 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ENHO |
0.974620317202374 |
|
24155 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CNTFR |
0.974620317202374 |
|
24156 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPP25L |
0.974620317202374 |
|
24157 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DCTN3 |
0.974620317202374 |
|
24158 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARID3C |
0.974620317202374 |
|
24159 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GALT |
0.974620317202374 |
|
24160 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SIGMAR1 |
0.974620317202374 |
|
24161 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IL11RA |
0.974620317202374 |
|
24162 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCL27 |
0.974620317202374 |
|
24163 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCL19 |
0.974620317202374 |
|
24164 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCL21 |
0.974620317202374 |
|
24165 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM205A |
0.974620317202374 |
|
24166 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C9orf106 |
0.975223231322818 |
|
24167 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PAXBP1 |
0.975248926490245 |
|
24168 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DCLK2 |
0.975525612825724 |
|
24169 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SYNJ1 |
0.975608154708306 |
|
24170 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CNTN2 |
0.975651162929466 |
|
24171 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snR65|ENSG00000253036.1 |
0.975798391367904 |
|
24172 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SH2D6 |
0.975938484346119 |
|
24173 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL251P |
0.975938484346119 |
|
24174 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CHCHD6 |
0.976101548779541 |
|
24175 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PLXNA1 |
0.976101548779541 |
|
24176 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNF8 |
0.976355788245146 |
|
24177 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238804.1 |
0.976355788245146 |
|
24178 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GIP |
0.976355788245146 |
|
24179 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IGF2BP1 |
0.976355788245146 |
|
24180 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WDFY1 |
0.97637206669461 |
|
24181 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TBX22 |
0.97637687640816 |
|
24182 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UBE2R2 |
0.976500746272118 |
|
24183 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNU4ATAC11P |
0.976500746272118 |
|
24184 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL205P |
0.976619947234564 |
|
24185 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA70|ENSG00000252014.1 |
0.976619947234564 |
|
24186 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NDST3 |
0.976628450724966 |
|
24187 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNHG8 |
0.976628450724966 |
|
24188 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C9orf163 |
0.976731242255259 |
|
24189 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NOTCH1 |
0.976731242255259 |
|
24190 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4673 |
0.976731242255259 |
|
24191 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4674 |
0.976731242255259 |
|
24192 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
U3|ENSG00000252440.1 |
0.976731242255259 |
|
24193 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AGPAT2 |
0.976731242255259 |
|
24194 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EGFL7 |
0.976731242255259 |
|
24195 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR126 |
0.976731242255259 |
|
24196 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM69B |
0.976731242255259 |
|
24197 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNHG7 |
0.976731242255259 |
|
24198 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LCN10 |
0.976731242255259 |
|
24199 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LCN6 |
0.976731242255259 |
|
24200 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LCN8 |
0.976731242255259 |
|
24201 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LCN15 |
0.976731242255259 |
|
24202 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM141 |
0.976731242255259 |
|
24203 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIAA1984 |
0.976731242255259 |
|
24204 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RABL6 |
0.976731242255259 |
|
24205 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C9orf172 |
0.976731242255259 |
|
24206 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EDF1 |
0.976731242255259 |
|
24207 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAMDC4 |
0.976731242255259 |
|
24208 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4292 |
0.976731242255259 |
|
24209 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PHPT1 |
0.976731242255259 |
|
24210 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4479 |
0.976731242255259 |
|
24211 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRAF2 |
0.976731242255259 |
|
24212 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C8G |
0.976731242255259 |
|
24213 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FBXW5 |
0.976731242255259 |
|
24214 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LCN12 |
0.976731242255259 |
|
24215 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C9orf141 |
0.976731242255259 |
|
24216 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LCNL1 |
0.976731242255259 |
|
24217 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PTGDS |
0.976731242255259 |
|
24218 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C9orf142 |
0.976731242255259 |
|
24219 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLIC3 |
0.976731242255259 |
|
24220 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ABCA2 |
0.976731242255259 |
|
24221 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C9orf139 |
0.976731242255259 |
|
24222 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FUT7 |
0.976731242255259 |
|
24223 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NPDC1 |
0.976731242255259 |
|
24224 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ENTPD2 |
0.976731242255259 |
|
24225 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SAPCD2 |
0.976731242255259 |
|
24226 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SYNE1 |
0.976777471715001 |
|
24227 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NMT1 |
0.977031960530569 |
|
24228 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HEXIM1 |
0.977031960530569 |
|
24229 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HEXIM2 |
0.977031960530569 |
|
24230 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FMNL1 |
0.977031960530569 |
|
24231 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPATA32 |
0.977031960530569 |
|
24232 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAP3K14 |
0.977031960530569 |
|
24233 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP443 |
0.977031960530569 |
|
24234 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANKRD34C |
0.977256232209267 |
|
24235 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMED3 |
0.977256232209267 |
|
24236 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIAA1024 |
0.977256232209267 |
|
24237 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CISH |
0.977416772900101 |
|
24238 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPP2R4 |
0.977641085767189 |
|
24239 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IER5L |
0.977641085767189 |
|
24240 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RORB |
0.977673928280574 |
|
24241 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRPM6 |
0.977673928280574 |
|
24242 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GRIN1 |
0.977700595802137 |
|
24243 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANAPC2 |
0.977700595802137 |
|
24244 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRRC26 |
0.977700595802137 |
|
24245 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR3621 |
0.977700595802137 |
|
24246 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SSNA1 |
0.977700595802137 |
|
24247 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM210 |
0.977700595802137 |
|
24248 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C9orf169 |
0.977700595802137 |
|
24249 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM166A |
0.977700595802137 |
|
24250 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NDOR1 |
0.977700595802137 |
|
24251 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNF208 |
0.977700595802137 |
|
24252 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNF224 |
0.977700595802137 |
|
24253 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC34A3 |
0.977700595802137 |
|
24254 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM203 |
0.977700595802137 |
|
24255 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TPRN |
0.977700595802137 |
|
24256 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TUBB4B |
0.977700595802137 |
|
24257 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AQP3 |
0.977797474294714 |
|
24258 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NOL6 |
0.977797474294714 |
|
24259 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UBAP2 |
0.977845642044597 |
|
24260 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD121B |
0.977845642044597 |
|
24261 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD121A |
0.977845642044597 |
|
24262 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP114 |
0.977845642044597 |
|
24263 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DCAF12 |
0.977845642044597 |
|
24264 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UBAP1 |
0.977845642044597 |
|
24265 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP282 |
0.977845642044597 |
|
24266 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CACNB1 |
0.978184313647238 |
|
24267 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP517 |
0.978234089493827 |
|
24268 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF835 |
0.978412322460825 |
|
24269 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PPIL4 |
0.978642721341405 |
|
24270 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GINM1 |
0.978642721341405 |
|
24271 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA2|ENSG00000202343.1 |
0.978642721341405 |
|
24272 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GNGT2 |
0.978987295940511 |
|
24273 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ABI3 |
0.978987295940511 |
|
24274 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PHOSPHO1 |
0.978987295940511 |
|
24275 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF652 |
0.978987295940511 |
|
24276 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PHB |
0.978987295940511 |
|
24277 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NGFR |
0.978987295940511 |
|
24278 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NXPH3 |
0.978987295940511 |
|
24279 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPOP |
0.978987295940511 |
|
24280 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC35B1 |
0.978987295940511 |
|
24281 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IKBKG |
0.979025571586181 |
|
24282 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BRCC3 |
0.979025571586181 |
|
24283 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLIC2 |
0.979025571586181 |
|
24284 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CMC4 |
0.979025571586181 |
|
24285 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CTAG1A |
0.979025571586181 |
|
24286 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CTAG1B |
0.979025571586181 |
|
24287 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CTAG2 |
0.979025571586181 |
|
24288 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DKC1 |
0.979025571586181 |
|
24289 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
F8A1 |
0.979025571586181 |
|
24290 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
F8A2 |
0.979025571586181 |
|
24291 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
F8A3 |
0.979025571586181 |
|
24292 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
F8 |
0.979025571586181 |
|
24293 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FUNDC2 |
0.979025571586181 |
|
24294 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GAB3 |
0.979025571586181 |
|
24295 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
H2AFB1 |
0.979025571586181 |
|
24296 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
H2AFB2 |
0.979025571586181 |
|
24297 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
H2AFB3 |
0.979025571586181 |
|
24298 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MPP1 |
0.979025571586181 |
|
24299 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MTCP1 |
0.979025571586181 |
|
24300 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAB39B |
0.979025571586181 |
|
24301 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SMIM9 |
0.979025571586181 |
|
24302 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA36A |
0.979025571586181 |
|
24303 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA56 |
0.979025571586181 |
|
24304 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMLHE |
0.979025571586181 |
|
24305 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VBP1 |
0.979025571586181 |
|
24306 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP136 |
0.979066716523005 |
|
24307 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000252388.1 |
0.979066716523005 |
|
24308 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP173 |
0.979066716523005 |
|
24309 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD65|ENSG00000212191.1 |
0.979066716523005 |
|
24310 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLITRK2 |
0.979078256341048 |
|
24311 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM257 |
0.979078256341048 |
|
24312 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCTD3 |
0.979097256023058 |
|
24313 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD116|ENSG00000202498.1 |
0.979097256023058 |
|
24314 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATRX |
0.979459401627572 |
|
24315 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR184 |
0.97975665161734 |
|
24316 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR1471 |
0.980031408700668 |
|
24317 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NPPC |
0.980031408700668 |
|
24318 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DIS3L2 |
0.980031408700668 |
|
24319 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR562 |
0.980031408700668 |
|
24320 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR204 |
0.980059269079451 |
|
24321 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP141 |
0.980120977192334 |
|
24322 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANKRD18B |
0.980152982410192 |
|
24323 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAET1E |
0.980157333965348 |
|
24324 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAET1G |
0.980157333965348 |
|
24325 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC30A8 |
0.980191172597497 |
|
24326 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL228P |
0.980191172597497 |
|
24327 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL826P |
0.980191172597497 |
|
24328 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SMURF2P1 |
0.98024128473262 |
|
24329 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HMGN1 |
0.980293226717617 |
|
24330 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238556.1 |
0.980293226717617 |
|
24331 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP13 |
0.980393307801997 |
|
24332 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRDM5 |
0.980634077174612 |
|
24333 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NEK1 |
0.980639719157557 |
|
24334 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLCN3 |
0.980639719157557 |
|
24335 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C4orf27 |
0.980639719157557 |
|
24336 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MFAP3L |
0.980639719157557 |
|
24337 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AADAT |
0.980639719157557 |
|
24338 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRPSAP2 |
0.980818527642349 |
|
24339 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL627P |
0.980818527642349 |
|
24340 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC5A10 |
0.980818527642349 |
|
24341 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EPN2 |
0.980818527642349 |
|
24342 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM83G |
0.980818527642349 |
|
24343 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GRAPL |
0.980818527642349 |
|
24344 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GRAP |
0.980818527642349 |
|
24345 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD3A |
0.980818527642349 |
|
24346 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD3C |
0.980818527642349 |
|
24347 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD3D |
0.980818527642349 |
|
24348 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP189 |
0.980855118467512 |
|
24349 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CXorf51A |
0.980947273298265 |
|
24350 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CXorf51B |
0.980947273298265 |
|
24351 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
APTX |
0.981313377408578 |
|
24352 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DNAJA1 |
0.981313377408578 |
|
24353 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADORA1 |
0.981468109646785 |
|
24354 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MYBPH |
0.981468109646785 |
|
24355 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CHI3L1 |
0.981468109646785 |
|
24356 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CHIT1 |
0.981468109646785 |
|
24357 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BTG2 |
0.981468109646785 |
|
24358 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FMOD |
0.981468109646785 |
|
24359 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRELP |
0.981468109646785 |
|
24360 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OPTC |
0.981468109646785 |
|
24361 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL113P |
0.981514431046826 |
|
24362 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CTSH |
0.981564519890409 |
|
24363 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RASGRF1 |
0.981564519890409 |
|
24364 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATP8B5P |
0.981786356807722 |
|
24365 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RUSC2 |
0.981786356807722 |
|
24366 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM166B |
0.981786356807722 |
|
24367 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CD72 |
0.981786356807722 |
|
24368 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4667 |
0.981786356807722 |
|
24369 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TESK1 |
0.981786356807722 |
|
24370 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SIT1 |
0.981786356807722 |
|
24371 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARHGEF39 |
0.981786356807722 |
|
24372 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCDC107 |
0.981786356807722 |
|
24373 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RMRP |
0.981786356807722 |
|
24374 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CA9 |
0.981786356807722 |
|
24375 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL22P |
0.981786356807722 |
|
24376 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TPM2 |
0.981786356807722 |
|
24377 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TLN1 |
0.981786356807722 |
|
24378 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CREB3 |
0.981786356807722 |
|
24379 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GBA2 |
0.981786356807722 |
|
24380 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCNK2 |
0.982002462133195 |
|
24381 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TAF1L |
0.98200308070705 |
|
24382 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NOXA1 |
0.982043180116495 |
|
24383 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000272272.1 |
0.982043180116495 |
|
24384 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ENTPD8 |
0.982043180116495 |
|
24385 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NSMF |
0.982043180116495 |
|
24386 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PNPLA7 |
0.982043180116495 |
|
24387 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DPH7 |
0.982043180116495 |
|
24388 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MRPL41 |
0.982043180116495 |
|
24389 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AGPS |
0.9821166502506 |
|
24390 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TTC30B |
0.9821166502506 |
|
24391 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TTC30A |
0.9821166502506 |
|
24392 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACO1 |
0.982171383017796 |
|
24393 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DDX58 |
0.982171383017796 |
|
24394 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PHYHD1 |
0.982191869307585 |
|
24395 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIAA1045 |
0.982240387742019 |
|
24396 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DNAJB5 |
0.982240387742019 |
|
24397 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C9orf131 |
0.982240387742019 |
|
24398 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FLJ00273 |
0.982240387742019 |
|
24399 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL338P |
0.982240387742019 |
|
24400 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VCP |
0.982240387742019 |
|
24401 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FANCG |
0.982240387742019 |
|
24402 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PIGO |
0.982240387742019 |
|
24403 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STOML2 |
0.982240387742019 |
|
24404 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM214B |
0.982240387742019 |
|
24405 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DOLK |
0.982392647445055 |
|
24406 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MMP16 |
0.982864835957456 |
|
24407 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP272 |
0.982864835957456 |
|
24408 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CWC22 |
0.982978982868343 |
|
24409 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RALYL |
0.983002279613957 |
|
24410 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TAC4 |
0.983039511005079 |
|
24411 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CUEDC1 |
0.98313043108878 |
|
24412 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DYNLL2 |
0.98313043108878 |
|
24413 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR4D1 |
0.98313043108878 |
|
24414 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OR4D2 |
0.98313043108878 |
|
24415 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EPX |
0.98313043108878 |
|
24416 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MKS1 |
0.98313043108878 |
|
24417 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KATNA1 |
0.983303579440734 |
|
24418 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LATS1 |
0.98351481053291 |
|
24419 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NUCKS1 |
0.983627555900664 |
|
24420 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA72|ENSG00000201944.1 |
0.983627555900664 |
|
24421 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAB7L1 |
0.983627555900664 |
|
24422 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC41A1 |
0.983627555900664 |
|
24423 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PM20D1 |
0.983627555900664 |
|
24424 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C1orf186 |
0.983627555900664 |
|
24425 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CTSE |
0.983627555900664 |
|
24426 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNX4 |
0.983677087365446 |
|
24427 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238992.1 |
0.983677087365446 |
|
24428 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BRWD1 |
0.983849818226754 |
|
24429 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BUB1 |
0.983857733145149 |
|
24430 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LIMS3L |
0.983857733145149 |
|
24431 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LIMS3|ENSG00000256977.6 |
0.983857733145149 |
|
24432 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LIMS3|ENSG00000257207.4 |
0.983857733145149 |
|
24433 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00116 |
0.983857733145149 |
|
24434 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MALL |
0.983857733145149 |
|
24435 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4267 |
0.983857733145149 |
|
24436 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4436B1 |
0.983857733145149 |
|
24437 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4436B2 |
0.983857733145149 |
|
24438 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NPHP1 |
0.983857733145149 |
|
24439 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RGPD5 |
0.983857733145149 |
|
24440 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RGPD6 |
0.983857733145149 |
|
24441 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACOXL |
0.983857733145149 |
|
24442 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BCL2L11 |
0.983857733145149 |
|
24443 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL32P |
0.983909349741982 |
|
24444 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATG16L1 |
0.983909349741982 |
|
24445 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCARNA5 |
0.983909349741982 |
|
24446 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCARNA6|ENSG00000251791.1 |
0.983909349741982 |
|
24447 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SAG |
0.983909349741982 |
|
24448 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BFSP2 |
0.984242403309121 |
|
24449 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA33|ENSG00000201827.1 |
0.984242403309121 |
|
24450 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLTA |
0.984323343447395 |
|
24451 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GNE |
0.984323343447395 |
|
24452 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HNMT |
0.984682274087563 |
|
24453 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PDE1A |
0.984729328907199 |
|
24454 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL126P |
0.98505856054389 |
|
24455 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VAMP5 |
0.98505856054389 |
|
24456 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNF181 |
0.98505856054389 |
|
24457 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C2orf68 |
0.98505856054389 |
|
24458 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM150A |
0.98505856054389 |
|
24459 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
USP39 |
0.98505856054389 |
|
24460 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PTPRVP |
0.985304996413881 |
|
24461 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IL37 |
0.985398521292471 |
|
24462 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IL36G |
0.985398521292471 |
|
24463 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM81 |
0.985492729723025 |
|
24464 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMCC2 |
0.985495315916044 |
|
24465 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RPL19 |
0.98553767560087 |
|
24466 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
STAC2 |
0.98553767560087 |
|
24467 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SRGAP2 |
0.985716295796769 |
|
24468 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC25A39 |
0.985731057038281 |
|
24469 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GRN |
0.985731057038281 |
|
24470 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM171A2 |
0.985731057038281 |
|
24471 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ITGA2B |
0.985731057038281 |
|
24472 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EPHB3 |
0.985820797447587 |
|
24473 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAGEF1 |
0.985820797447587 |
|
24474 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VPS8 |
0.985820797447587 |
|
24475 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C3orf70 |
0.985820797447587 |
|
24476 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EHHADH |
0.985820797447587 |
|
24477 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAP3K13 |
0.985820797447587 |
|
24478 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000239146.1 |
0.985820797447587 |
|
24479 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM41A |
0.985820797447587 |
|
24480 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LIPH |
0.985820797447587 |
|
24481 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ABCB7 |
0.98605389691435 |
|
24482 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAGEE2 |
0.98605389691435 |
|
24483 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UPRT |
0.98605389691435 |
|
24484 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZDHHC15 |
0.98605389691435 |
|
24485 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CRTC3 |
0.986083350631787 |
|
24486 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BLM |
0.986083350631787 |
|
24487 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL258P |
0.986132746541593 |
|
24488 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CENPF |
0.986216374383056 |
|
24489 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SENP2 |
0.986345234403833 |
|
24490 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPANXN1 |
0.986352365368516 |
|
24491 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PKN3 |
0.98642609741733 |
|
24492 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL560P |
0.98642609741733 |
|
24493 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZDHHC12 |
0.98642609741733 |
|
24494 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZER1 |
0.98642609741733 |
|
24495 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000239055.1 |
0.98642609741733 |
|
24496 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TBC1D13 |
0.98642609741733 |
|
24497 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ELMOD3 |
0.986569334256795 |
|
24498 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CAPG |
0.986569334256795 |
|
24499 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SFTPB |
0.986718543584854 |
|
24500 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GNLY |
0.986718543584854 |
|
24501 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATOH8 |
0.986718543584854 |
|
24502 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP83 |
0.986718543584854 |
|
24503 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADAMTS8 |
0.986722931754064 |
|
24504 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GART |
0.986773736475807 |
|
24505 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SON |
0.986773736475807 |
|
24506 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LSM6 |
0.986819711912687 |
|
24507 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ITSN1 |
0.987077310820179 |
|
24508 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZMYM4 |
0.98725490110335 |
|
24509 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AVPR1B |
0.987382728043302 |
|
24510 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD60|ENSG00000252692.1 |
0.987382728043302 |
|
24511 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP508 |
0.987398795092832 |
|
24512 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR325 |
0.987398795092832 |
|
24513 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP509 |
0.987398795092832 |
|
24514 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP490 |
0.987731260623127 |
|
24515 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00846 |
0.987731260623127 |
|
24516 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TCP10L |
0.987731260623127 |
|
24517 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C21ORF59 |
0.987731260623127 |
|
24518 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C21orf59 |
0.987731260623127 |
|
24519 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAGI1 |
0.988072510479703 |
|
24520 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SYT14 |
0.988179600303687 |
|
24521 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SERTAD4 |
0.988179600303687 |
|
24522 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP105 |
0.988243042192574 |
|
24523 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR5092 |
0.988468634595597 |
|
24524 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KYNU |
0.988572433690711 |
|
24525 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GTDC1 |
0.988572433690711 |
|
24526 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NDUFC1 |
0.988573212034241 |
|
24527 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NAA15 |
0.988573212034241 |
|
24528 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SASH1 |
0.988679560202256 |
|
24529 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NUP43 |
0.988679560202256 |
|
24530 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCMT1 |
0.988679560202256 |
|
24531 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LRP11 |
0.988679560202256 |
|
24532 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SUCLG2 |
0.988770195698716 |
|
24533 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZNF148 |
0.989058227720257 |
|
24534 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NDNF |
0.989327983443331 |
|
24535 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP137 |
0.989327983443331 |
|
24536 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TNIP3 |
0.989327983443331 |
|
24537 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
QRFPR |
0.989327983443331 |
|
24538 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANXA5 |
0.989327983443331 |
|
24539 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM155 |
0.989327983443331 |
|
24540 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EXOSC9 |
0.989327983443331 |
|
24541 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CCNA2 |
0.989327983443331 |
|
24542 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BBS7 |
0.989327983443331 |
|
24543 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRPC3 |
0.989327983443331 |
|
24544 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL335P |
0.989327983443331 |
|
24545 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KIAA1109 |
0.989327983443331 |
|
24546 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADAD1 |
0.989327983443331 |
|
24547 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IL2 |
0.989327983443331 |
|
24548 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IL21 |
0.989327983443331 |
|
24549 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BBS12 |
0.989327983443331 |
|
24550 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FGF2 |
0.989327983443331 |
|
24551 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NUDT6 |
0.989327983443331 |
|
24552 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPATA5 |
0.989327983443331 |
|
24553 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPRY1 |
0.989327983443331 |
|
24554 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TCF7L1 |
0.989427985910106 |
|
24555 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TGOLN2 |
0.989427985910106 |
|
24556 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RETSAT |
0.989427985910106 |
|
24557 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CACNA1B |
0.98975348048908 |
|
24558 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM157B |
0.98975348048908 |
|
24559 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TUBBP5 |
0.98975348048908 |
|
24560 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC43A2 |
0.989895692435489 |
|
24561 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL105P |
0.989895692435489 |
|
24562 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238946.1 |
0.989895692435489 |
|
24563 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCARF1 |
0.989895692435489 |
|
24564 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RILP |
0.989895692435489 |
|
24565 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRPF8 |
0.989895692435489 |
|
24566 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR22HG |
0.989895692435489 |
|
24567 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TLCD2 |
0.989895692435489 |
|
24568 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARHGAP27 |
0.990098661607803 |
|
24569 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NUP188 |
0.990292062913005 |
|
24570 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SH3GLB2 |
0.990292062913005 |
|
24571 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM73B |
0.990292062913005 |
|
24572 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DOLPP1 |
0.990292062913005 |
|
24573 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CRAT |
0.990292062913005 |
|
24574 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZMYM1 |
0.990394053351395 |
|
24575 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SFPQ |
0.990394053351395 |
|
24576 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL136P |
0.990394053351395 |
|
24577 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC20A1 |
0.990469207133554 |
|
24578 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NT5DC4 |
0.990469207133554 |
|
24579 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CKAP2L |
0.990469207133554 |
|
24580 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IL1A |
0.990469207133554 |
|
24581 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GLE1 |
0.990710845206088 |
|
24582 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
B3GNT7 |
0.990777001696211 |
|
24583 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NCL |
0.990777001696211 |
|
24584 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA75|ENSG00000206885.1 |
0.990777001696211 |
|
24585 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD20 |
0.990777001696211 |
|
24586 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD82 |
0.990777001696211 |
|
24587 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C2orf57 |
0.990777001696211 |
|
24588 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00471 |
0.990777001696211 |
|
24589 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NMUR1 |
0.990777001696211 |
|
24590 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL499P |
0.990777001696211 |
|
24591 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HHIP |
0.990827091095607 |
|
24592 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WDR81 |
0.99085995473647 |
|
24593 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SERPINF2 |
0.99085995473647 |
|
24594 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZCCHC5 |
0.990920571590844 |
|
24595 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATP7A |
0.991120183490486 |
|
24596 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000239155.1 |
0.991149147889206 |
|
24597 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TBCA |
0.991194864100917 |
|
24598 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AP3B1 |
0.991194864100917 |
|
24599 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCAMP1 |
0.991194864100917 |
|
24600 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MFF |
0.991248230702737 |
|
24601 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MRAS |
0.991326516072035 |
|
24602 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ESYT3 |
0.991326516072035 |
|
24603 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CEP70 |
0.991326516072035 |
|
24604 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ATP5O |
0.991329346654903 |
|
24605 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL740P |
0.991329346654903 |
|
24606 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPTAN1 |
0.991381726998894 |
|
24607 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WDR34 |
0.991381726998894 |
|
24608 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IL36B |
0.991457613333107 |
|
24609 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IL36RN |
0.991457613333107 |
|
24610 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IL1F10 |
0.991457613333107 |
|
24611 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ALPPL2 |
0.991579227713339 |
|
24612 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ALPP |
0.991579227713339 |
|
24613 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ECEL1P2 |
0.991579227713339 |
|
24614 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ALPI |
0.991579227713339 |
|
24615 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ECEL1 |
0.991579227713339 |
|
24616 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PRSS56 |
0.991579227713339 |
|
24617 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CHRND |
0.991579227713339 |
|
24618 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CHRNG |
0.991579227713339 |
|
24619 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TIGD1 |
0.991579227713339 |
|
24620 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EIF4E2 |
0.991579227713339 |
|
24621 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR5001 |
0.991579227713339 |
|
24622 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EFHD1 |
0.991579227713339 |
|
24623 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL359P |
0.991579227713339 |
|
24624 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000239170.1 |
0.991579227713339 |
|
24625 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GIGYF2 |
0.991579227713339 |
|
24626 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCNJ13 |
0.991579227713339 |
|
24627 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C2orf82 |
0.991579227713339 |
|
24628 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NGEF |
0.991579227713339 |
|
24629 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NEU2 |
0.991579227713339 |
|
24630 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SOD2 |
0.991857989556013 |
|
24631 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNU4ATAC18P |
0.991857989556013 |
|
24632 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WTAP |
0.991857989556013 |
|
24633 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACAT2 |
0.991857989556013 |
|
24634 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA20|ENSG00000207392.1 |
0.991857989556013 |
|
24635 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPR174 |
0.991877324761528 |
|
24636 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ITM2A |
0.991877324761528 |
|
24637 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HMGN5 |
0.991877324761528 |
|
24638 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SH3BGRL |
0.991877324761528 |
|
24639 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARHGAP15 |
0.992062552193945 |
|
24640 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR873 |
0.992150608041433 |
|
24641 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR876 |
0.992150608041433 |
|
24642 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ANAPC1 |
0.992618745918361 |
|
24643 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MERTK |
0.992618745918361 |
|
24644 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL297P |
0.992618745918361 |
|
24645 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMEM87B |
0.992618745918361 |
|
24646 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FBLN7 |
0.992618745918361 |
|
24647 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZC3H8 |
0.992618745918361 |
|
24648 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
snoU13|ENSG00000238951.1 |
0.992618745918361 |
|
24649 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZC3H6 |
0.992618745918361 |
|
24650 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RGPD8 |
0.992618745918361 |
|
24651 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TTL |
0.992618745918361 |
|
24652 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
POLR1B |
0.992618745918361 |
|
24653 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CHCHD5 |
0.992618745918361 |
|
24654 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP235 |
0.992729192888348 |
|
24655 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BTBD1 |
0.992816663695116 |
|
24656 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4515 |
0.992816663695116 |
|
24657 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
B3GALT5 |
0.992975873201585 |
|
24658 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IGSF5 |
0.992975873201585 |
|
24659 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PCP4 |
0.992975873201585 |
|
24660 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPM6A |
0.99298676585461 |
|
24661 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WDR17 |
0.99298676585461 |
|
24662 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA51|ENSG00000201516.1 |
0.99298676585461 |
|
24663 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ASB5 |
0.99298676585461 |
|
24664 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SPCS3 |
0.99298676585461 |
|
24665 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VEGFC |
0.99298676585461 |
|
24666 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR5702 |
0.993382074755044 |
|
24667 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
IRS1 |
0.993382074755044 |
|
24668 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RHBDD1 |
0.993382074755044 |
|
24669 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA48|ENSG00000212391.1 |
0.993382074755044 |
|
24670 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COL4A4 |
0.993382074755044 |
|
24671 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
COL4A3 |
0.993382074755044 |
|
24672 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
INPP5D |
0.993628229070095 |
|
24673 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GPATCH8 |
0.99372390075193 |
|
24674 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FZD2 |
0.993872458249152 |
|
24675 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC12A8 |
0.994133816005589 |
|
24676 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
WRB |
0.994267190480339 |
|
24677 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LCA5L |
0.994267190480339 |
|
24678 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SH3BGR |
0.994267190480339 |
|
24679 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C21orf88 |
0.994267190480339 |
|
24680 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACA64|ENSG00000239005.1 |
0.994875586019633 |
|
24681 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RAB33B |
0.994875586019633 |
|
24682 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SETD7 |
0.994875586019633 |
|
24683 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
OMG |
0.994957176351621 |
|
24684 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C15orf40 |
0.995377462018852 |
|
24685 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM103A1 |
0.995377462018852 |
|
24686 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
B4GALNT2 |
0.995410602661799 |
|
24687 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRPM3 |
0.995658682289842 |
|
24688 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HMGA1P4 |
0.995718976515391 |
|
24689 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SET |
0.995718976515391 |
|
24690 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TEX41 |
0.996194567388912 |
|
24691 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EHMT1 |
0.996293625943963 |
|
24692 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR602 |
0.996293625943963 |
|
24693 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GATA4 |
0.996305669061827 |
|
24694 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C8orf49 |
0.996305669061827 |
|
24695 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
NEIL2 |
0.996305669061827 |
|
24696 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ZMYND19 |
0.996323207043435 |
|
24697 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ARRDC1 |
0.996323207043435 |
|
24698 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
C9orf37 |
0.996323207043435 |
|
24699 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP167 |
0.99675252508267 |
|
24700 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM46D |
0.996920972869013 |
|
24701 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
BRWD3 |
0.997007943676759 |
|
24702 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ACA64|ENSG00000239008.1 |
0.997007943676759 |
|
24703 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HSP90AA6P |
0.997588751152997 |
|
24704 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNU6ATAC13P |
0.997588751152997 |
|
24705 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00290 |
0.997787422073545 |
|
24706 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TRABD2A |
0.99779933777805 |
|
24707 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
TMSB10 |
0.99779933777805 |
|
24708 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MCCC1 |
0.997968542281535 |
|
24709 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LAMP3 |
0.997968542281535 |
|
24710 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MCF2L2 |
0.997968542281535 |
|
24711 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
B3GNT5 |
0.997968542281535 |
|
24712 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP151 |
0.997968542281535 |
|
24713 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ABCC5 |
0.997968542281535 |
|
24714 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
AP2M1 |
0.997968542281535 |
|
24715 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CYP2AB1P |
0.997968542281535 |
|
24716 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DVL3 |
0.997968542281535 |
|
24717 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HTR3C |
0.997968542281535 |
|
24718 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HTR3D |
0.997968542281535 |
|
24719 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HTR3E |
0.997968542281535 |
|
24720 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KLHL24 |
0.997968542281535 |
|
24721 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KLHL6 |
0.997968542281535 |
|
24722 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LINC00888 |
0.997968542281535 |
|
24723 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAP6D1 |
0.997968542281535 |
|
24724 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4448 |
0.997968542281535 |
|
24725 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PARL |
0.997968542281535 |
|
24726 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA4|ENSG00000251730.1 |
0.997968542281535 |
|
24727 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA63|ENSG00000199363.1 |
0.997968542281535 |
|
24728 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA63|ENSG00000201229.1 |
0.997968542281535 |
|
24729 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORA81|ENSG00000253092.1 |
0.997968542281535 |
|
24730 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
YEATS2 |
0.997968542281535 |
|
24731 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ABCF3 |
0.997968542281535 |
|
24732 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FGF16 |
0.998375974075459 |
|
24733 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SLC5A7 |
0.998516747031804 |
|
24734 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
PBDC1 |
0.999039396522331 |
|
24735 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAGEE1 |
0.999039396522331 |
|
24736 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ST3GAL5 |
0.999040103887991 |
|
24737 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
UNC13B |
0.99905901124404 |
|
24738 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL830P |
0.999429571925737 |
|
24739 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MAT2A |
0.999429571925737 |
|
24740 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GGCX |
0.999429571925737 |
|
24741 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VAMP8 |
0.999429571925737 |
|
24742 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL703P |
0.999446932067444 |
|
24743 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RNA5SP150 |
0.999446932067444 |
|
24744 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SKP265 |
0.999446932067444 |
|
24745 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
DCUN1D1 |
0.999446932067444 |
|
24746 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
VWA5B2 |
0.999446932067444 |
|
24747 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ALG3 |
0.999446932067444 |
|
24748 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ECE2 |
0.999446932067444 |
|
24749 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR1224 |
0.999446932067444 |
|
24750 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CAMK2N2 |
0.999446932067444 |
|
24751 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
EIF4G1 |
0.999446932067444 |
|
24752 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SNORD66|ENSG00000212158.1 |
0.999446932067444 |
|
24753 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FAM131A |
0.999446932067444 |
|
24754 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CLCN2 |
0.999446932067444 |
|
24755 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
POLR2H |
0.999446932067444 |
|
24756 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
THPO |
0.999446932067444 |
|
24757 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CHRD |
0.999446932067444 |
|
24758 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
LPAR4 |
0.99951144929046 |
|
24759 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
P2RY10 |
0.99951144929046 |
|
24760 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GALNTL6 |
0.999569644265013 |
|
24761 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
RN7SL253P |
0.999569644265013 |
|
24762 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GALNT7 |
0.999569644265013 |
|
24763 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR548T |
0.999569644265013 |
|
24764 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HMGB2 |
0.999569644265013 |
|
24765 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SAP30 |
0.999569644265013 |
|
24766 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
SCRG1 |
0.999569644265013 |
|
24767 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HAND2 |
0.999569644265013 |
|
24768 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
FBXO8 |
0.999569644265013 |
|
24769 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
CEP44 |
0.999569644265013 |
|
24770 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MIR4276 |
0.999569644265013 |
|
24771 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
HPGD |
0.999569644265013 |
|
24772 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
GLRA3 |
0.999569644265013 |
|
24773 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
ADAM29 |
0.999569644265013 |
|
24774 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
MMAA |
0.999696862010522 |
|
24775 |
Ovarian serous cystadenocarcinoma (OV) |
Topotecan |
KCMF1 |
0.999803388357677 |
|